Citrus Sinensis ID: 036673
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 469 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.805 | 0.660 | 0.572 | 1e-127 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.750 | 0.492 | 0.579 | 1e-119 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.771 | 0.697 | 0.420 | 6e-84 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.735 | 0.672 | 0.434 | 5e-83 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.737 | 0.685 | 0.430 | 3e-81 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.718 | 0.656 | 0.432 | 5e-79 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.603 | 0.228 | 0.404 | 2e-64 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.603 | 0.189 | 0.404 | 4e-64 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.603 | 0.190 | 0.404 | 6e-64 | |
| Q14AX6 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.603 | 0.190 | 0.404 | 6e-64 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 220/384 (57%), Positives = 279/384 (72%), Gaps = 6/384 (1%)
Query: 82 DELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALK 141
+++ GWP WL D E L G VP+ AD+++K+ K+GQGTYSNVYKA+D TGKIVALK
Sbjct: 89 EQVAAGWPSWLSDAC-GEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKDMLTGKIVALK 147
Query: 142 KVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKII 201
KVRFD EPESVKFMAREI +L++LDHPNV+KLEGL TSRM SLYLVF +M DL +
Sbjct: 148 KVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLA 207
Query: 202 CRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261
P K +E +VKC M+QL+SGL+HCH RG+LHRDIK SNLLID G+LKIADFGL+ F
Sbjct: 208 SSPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIF 267
Query: 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ 321
P K P+TSRVVTLWYRAPELLLG+TDYGVGIDLWSAGC+LAE+ GRP+MPGRTEVEQ
Sbjct: 268 DPNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQ 327
Query: 322 LHRIFKLCGTPSEDYWKKMKLT--TTFRPQH-YKPSFREVFGEFPPSSYGILTTLLALDP 378
LH+I+KLCG+PSEDYWKK K T ++P+ YK S RE F +FPPSS ++ LL+++P
Sbjct: 328 LHKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEP 387
Query: 379 AYRGTAASALQNEFFNASPLACDLSSLPVI--CREEDEPARTSRRKKRRSSKGRKSTQSI 436
R TA++AL++EFF + P AC+ + LP +E D R +++R++ + +
Sbjct: 388 EDRQTASAALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGAR 447
Query: 437 HEGHHKRVSSVSSADETKGETESS 460
H R + A E E +S+
Sbjct: 448 KNRHRDRSNRALPAPEANAELQSN 471
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1100), Expect = e-119, Method: Compositional matrix adjust.
Identities = 212/366 (57%), Positives = 270/366 (73%), Gaps = 14/366 (3%)
Query: 83 ELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKK 142
+++ GWP WL ++ E + G +P+ ADS++KL K+GQGTYS+VYKARD +T ++VALKK
Sbjct: 135 QVMAGWPSWLA-SVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKK 193
Query: 143 VRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIIC 202
VRF +P+SV+FMAREI IL++LDHPNV+KLEGL TSR+ S+YL+F++M+ DL +
Sbjct: 194 VRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLAS 253
Query: 203 RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262
PG +E Q+KCYM+QLL GL+HCH RG+LHRDIK SNLL+D + LKI DFGL+NF+
Sbjct: 254 TPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQ 313
Query: 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQL 322
QK PLTSRVVTLWYR PELLLGSTDYGV +DLWS GC+LAE+F G+P+MPGRTEVEQL
Sbjct: 314 GHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQL 373
Query: 323 HRIFKLCGTPSEDYWKKMKL--TTTFRPQH-YKPSFREVFGEFPPSSYGILTTLLALDPA 379
H+IFKLCG+PSE+YWK KL T F+PQ YK E F P S+ ++ LLA++P
Sbjct: 374 HKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPD 433
Query: 380 YRGTAASALQNEFFNASPLACDLSSLP-------VICREEDEPARTSRRKKRRSSKGRKS 432
RGT ASAL++EFF SPLA D SSLP + + ++E A +RKK SSK S
Sbjct: 434 ARGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEA---KRKKDTSSKQNDS 490
Query: 433 TQSIHE 438
Q E
Sbjct: 491 KQVSRE 496
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (797), Expect = 6e-84, Method: Compositional matrix adjust.
Identities = 161/383 (42%), Positives = 228/383 (59%), Gaps = 21/383 (5%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQK 165
+S D ++KL ++G+GTY VY AR+ +T +IVALKK+R D +E E A REI+IL+K
Sbjct: 20 RSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMD-NEREGFPITAIREIKILKK 78
Query: 166 LDHPNVIKLEGLATS---------------RMQYSLYLVFDFMQSDLTKIICRPGQKLTE 210
L H NVI+L+ + TS + + S+Y+VF++M DLT + RPG + T
Sbjct: 79 LHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTV 138
Query: 211 PQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270
PQ+KCYM+QLL+GL +CH +LHRDIK SNLLID G LK+ADFGL+ F G LT
Sbjct: 139 PQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNGNLT 198
Query: 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG 330
+RV+TLWYR PELLLGST YG +D+WS GC+ AE+ G+P++PG+ E EQL +IF +CG
Sbjct: 199 NRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFDVCG 258
Query: 331 TPSEDYW---KKMKLTTTFR-PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAAS 386
TP E W KM F+ P+ K +E F F + +L +L LDPA R +A
Sbjct: 259 TPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRISAQD 318
Query: 387 ALQNEFFNASPLACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSS 446
AL E+F + PL CD SLP + + R++ R++ + K ++ H H R+
Sbjct: 319 ALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQADEAAKRQKTQHPQPHGRLPP 378
Query: 447 VSSADETKGETESSKELEKNADP 469
+ + + + + P
Sbjct: 379 IQQTGQPHPQIRPGQPMNNPHAP 401
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (790), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 159/366 (43%), Positives = 224/366 (61%), Gaps = 21/366 (5%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQK 165
+S D ++KL ++G+GTY VY A++ +T +IVALKK+R D +E E A REI+IL+K
Sbjct: 20 RSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMD-NEREGFPITAIREIKILKK 78
Query: 166 LDHPNVIKLEGLATS---------------RMQYSLYLVFDFMQSDLTKIICRPGQKLTE 210
L H NVI+L+ + TS + + S+Y+VF++M DLT + RPG + T
Sbjct: 79 LHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTV 138
Query: 211 PQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270
PQ+KCYM+QLL+GL +CH +LHRDIK SNLLID G LK+ADFGL+ F G LT
Sbjct: 139 PQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNGNLT 198
Query: 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG 330
+RV+TLWYR PELLLGST YG +D+WS GC+ AE+ G+P++ G+ E EQL +IF+LCG
Sbjct: 199 NRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFELCG 258
Query: 331 TPSEDYWK---KMKLTTTFRPQH-YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAAS 386
TP E W KM F+PQ K +E F F + +L +L LDP+ R +A
Sbjct: 259 TPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRISAKD 318
Query: 387 ALQNEFFNASPLACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSS 446
AL E+F PL CD SLP + + R+++R++ + K + H H R+
Sbjct: 319 ALDAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQAEEAAKRQKLQHPPPHSRLPP 378
Query: 447 VSSADE 452
+ + +
Sbjct: 379 IQNPGQ 384
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (775), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 158/367 (43%), Positives = 224/367 (61%), Gaps = 21/367 (5%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQK 165
+S D ++KL ++G+GTY VY A++ TG+IVALKK+R D +E E A REI+IL+K
Sbjct: 21 RSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMD-NEREGFPITAIREIKILKK 79
Query: 166 LDHPNVIKLEGLATS--------------RMQYSLYLVFDFMQSDLTKIICRPGQKLTEP 211
L H NVI+L+ + TS + + +Y+VF++M DLT + RPG + T P
Sbjct: 80 LHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVP 139
Query: 212 QVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS 271
Q+KCYM+QLL+GL +CH +LHRDIK SNLLID G LK+ADFGL+ + G LT+
Sbjct: 140 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTN 199
Query: 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT 331
RV+TLWYR PELLLG+T YG ID+WS GC+ AE+ +P++PG+ E EQL++IF+LCG+
Sbjct: 200 RVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGS 259
Query: 332 PSEDYW---KKMKLTTTFRP-QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA 387
P E W KM F+P + K RE F F + +L +L LDPA R +A A
Sbjct: 260 PDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAKDA 319
Query: 388 LQNEFFNASPLACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEG-HHKRVSS 446
L E+F PL CD SLP + + R+++R++ + K + H H R+
Sbjct: 320 LDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQNEEAAKRQKLQHPPLQHSRLPP 379
Query: 447 VSSADET 453
+ ++
Sbjct: 380 LQHGGQS 386
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 155/358 (43%), Positives = 218/358 (60%), Gaps = 21/358 (5%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQK 165
+S D ++KL ++G+GTY VY A++ TG+IVALKK+R D +E E A REI+IL+K
Sbjct: 21 RSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMD-NEREGFPITAIREIKILKK 79
Query: 166 LDHPNVIKLEGLATS--------------RMQYSLYLVFDFMQSDLTKIICRPGQKLTEP 211
L H NVI L+ + TS + + +Y+VF++M DLT + RPG + T P
Sbjct: 80 LHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVP 139
Query: 212 QVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS 271
Q+KCYM+QLL+GL +CH +LHRDIK SNLLID G LK+ADFGL+ + G LT+
Sbjct: 140 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTN 199
Query: 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT 331
RV+TLWYR PELLLG+T YG ID+WS GC+ AE+ G+P++PG+TE EQL++I++LCG+
Sbjct: 200 RVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGS 259
Query: 332 PSEDYW---KKMKLTTTFRPQH-YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA 387
P E W KM + K RE++ F + +L +L LDP+ R A A
Sbjct: 260 PDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDA 319
Query: 388 LQNEFFNASPLACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIH-EGHHKRV 444
L E+F PL CD SLP + + R++ R + + K + H + H R+
Sbjct: 320 LDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRL 377
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (630), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 120/297 (40%), Positives = 183/297 (61%), Gaps = 14/297 (4%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
D +D + +G+GTY VYKA+D+DTG++VALKKVR D +E E A REI+IL++L H
Sbjct: 708 DKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLD-NEKEGFPITAIREIKILRQLIH 766
Query: 169 PNVIKLEGLATSRMQY--------SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQL 220
+V+ ++ + T + + YLVF++M DL ++ + +E +K +M+QL
Sbjct: 767 KSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIKSFMKQL 826
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
+ GL++CH++ LHRDIK SN+L++ SG +K+ADFGL+ + ++ P T++V+TLWYR
Sbjct: 827 MEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVITLWYRP 886
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK-- 338
PELLLG Y ID+WS GC+L E+F +P+ E+ QL I +LCG+P W
Sbjct: 887 PELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 946
Query: 339 -KMKLTTTFRP-QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
K+ T +P + Y+ RE F P + +L +L LDP+ R TA LQ++F
Sbjct: 947 IKLPYFNTMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQSDFL 1003
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 246 bits (627), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 120/297 (40%), Positives = 183/297 (61%), Gaps = 14/297 (4%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
D +D + +G+GTY VYKA+D+DTG++VALKKVR D +E E A REI+IL++L H
Sbjct: 725 DKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLD-NEKEGFPITAIREIKILRQLIH 783
Query: 169 PNVIKLEGLATSRMQY--------SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQL 220
+V+ ++ + T + + YLVF++M DL ++ +E +K +M+QL
Sbjct: 784 RSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 843
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
+ GL++CH++ LHRDIK SN+L++ SG +K+ADFGL+ + ++ P T++V+TLWYR
Sbjct: 844 MEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 903
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK-- 338
PELLLG Y ID+WS GC+L E+F +P+ E+ QL I +LCG+P W
Sbjct: 904 PELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDV 963
Query: 339 -KMKLTTTFRP-QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
K+ T +P + Y+ RE F P ++ +L +L LDP+ R TA LQ++F
Sbjct: 964 IKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFL 1020
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 120/297 (40%), Positives = 182/297 (61%), Gaps = 14/297 (4%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
D +D + +G+GTY VYKA+D+DTG++VALKKVR D +E E A REI+IL++L H
Sbjct: 721 DKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLD-NEKEGFPITAIREIKILRQLVH 779
Query: 169 PNVIKLEGLATSRMQY--------SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQL 220
+V+ ++ + T + + YLVF++M DL ++ +E +K +M+QL
Sbjct: 780 QSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 839
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
+ GL +CH++ LHRDIK SN+L++ SG +K+ADFGL+ + ++ P T++V+TLWYR
Sbjct: 840 MEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 899
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK-- 338
PELLLG Y ID+WS GC+L E+F +P+ E+ QL I +LCG+P W
Sbjct: 900 PELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDV 959
Query: 339 -KMKLTTTFRP-QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
K+ T +P + Y+ RE F P ++ +L +L LDP+ R TA LQ++F
Sbjct: 960 IKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFL 1016
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 OS=Mus musculus GN=Cdk12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 120/297 (40%), Positives = 182/297 (61%), Gaps = 14/297 (4%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
D +D + +G+GTY VYKA+D+DTG++VALKKVR D +E E A REI+IL++L H
Sbjct: 721 DKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLD-NEKEGFPITAIREIKILRQLVH 779
Query: 169 PNVIKLEGLATSRMQY--------SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQL 220
+V+ ++ + T + + YLVF++M DL ++ +E +K +M+QL
Sbjct: 780 QSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 839
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
+ GL +CH++ LHRDIK SN+L++ SG +K+ADFGL+ + ++ P T++V+TLWYR
Sbjct: 840 MEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 899
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK-- 338
PELLLG Y ID+WS GC+L E+F +P+ E+ QL I +LCG+P W
Sbjct: 900 PELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDV 959
Query: 339 -KMKLTTTFRP-QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
K+ T +P + Y+ RE F P ++ +L +L LDP+ R TA LQ++F
Sbjct: 960 IKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFL 1016
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 469 | ||||||
| 255586487 | 572 | Cell division protein kinase 7, putative | 0.965 | 0.791 | 0.716 | 0.0 | |
| 359480867 | 587 | PREDICTED: probable serine/threonine-pro | 0.991 | 0.792 | 0.658 | 1e-178 | |
| 296082537 | 644 | unnamed protein product [Vitis vinifera] | 0.980 | 0.714 | 0.655 | 1e-174 | |
| 359493201 | 582 | PREDICTED: probable serine/threonine-pro | 0.959 | 0.773 | 0.637 | 1e-165 | |
| 224093918 | 331 | predicted protein [Populus trichocarpa] | 0.703 | 0.996 | 0.870 | 1e-165 | |
| 356507487 | 588 | PREDICTED: probable serine/threonine-pro | 0.972 | 0.775 | 0.621 | 1e-163 | |
| 255566684 | 483 | Cell division protein kinase, putative [ | 0.812 | 0.788 | 0.729 | 1e-162 | |
| 449448580 | 574 | PREDICTED: probable serine/threonine-pro | 0.982 | 0.803 | 0.629 | 1e-162 | |
| 449487945 | 535 | PREDICTED: probable serine/threonine-pro | 0.982 | 0.861 | 0.629 | 1e-161 | |
| 296081212 | 432 | unnamed protein product [Vitis vinifera] | 0.891 | 0.967 | 0.663 | 1e-159 |
| >gi|255586487|ref|XP_002533885.1| Cell division protein kinase 7, putative [Ricinus communis] gi|223526162|gb|EEF28496.1| Cell division protein kinase 7, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 676 bits (1745), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/477 (71%), Positives = 384/477 (80%), Gaps = 24/477 (5%)
Query: 1 MGCIQAK---LSPPQNVVERLKMEGGYVKGVSAGRVVVQKAVGKENGKVSRHGGDGNG-- 55
MGCI K SP +E LK E GYV+ + G+ V +GGDG+G
Sbjct: 1 MGCILDKNSGRSPHNQGLETLKQERGYVR----------RPEGENKRVVELNGGDGDGEK 50
Query: 56 ---VGERVRNGGGDGGSRSRKSVKKKISEDELVDGWPKWLVDNIPKEVLAGLVPKSADSY 112
V E ++NG D G+ SR+ KKI DELVDGWPKWLVDNIPKEVLAGLVPKSADSY
Sbjct: 51 LVVVKEGLKNG--DVGNVSRRITLKKIGGDELVDGWPKWLVDNIPKEVLAGLVPKSADSY 108
Query: 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
DKLAK+GQGTYSNVYKARDRDTGKIVALKKVRFDTSE ES+ FMAREI ILQKLDHPN+I
Sbjct: 109 DKLAKIGQGTYSNVYKARDRDTGKIVALKKVRFDTSESESINFMAREIMILQKLDHPNII 168
Query: 173 KLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
KLEGLATSRMQYSLYLVF FMQSDLT++I RP +LTEPQVKCYMQQLLSGLQHCHERGI
Sbjct: 169 KLEGLATSRMQYSLYLVFGFMQSDLTRVISRPAHRLTEPQVKCYMQQLLSGLQHCHERGI 228
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
LHRDIKASNLLIDK+GMLKIADFGL+N FIPK K PLTSRVVTLWYRAPELLLGSTDYGV
Sbjct: 229 LHRDIKASNLLIDKNGMLKIADFGLANVFIPKPKRPLTSRVVTLWYRAPELLLGSTDYGV 288
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR-PQHY 351
GIDLWSAGCLLAEMF GRP+MPGRTEVEQLHRIFKLCG+PSEDYWK M+L T+FR PQHY
Sbjct: 289 GIDLWSAGCLLAEMFTGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKIMRLQTSFRPPQHY 348
Query: 352 KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICRE 411
KPSF+E F +FP SS+G+LTTLLAL+PAYRGTA SALQ+ FF+ SPLAC LS LPVI +E
Sbjct: 349 KPSFQEAFRDFPDSSFGLLTTLLALNPAYRGTATSALQSLFFSTSPLACQLSGLPVIYKE 408
Query: 412 EDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGETESSKELEKNAD 468
EDEP++ + R K+R S+ HE H ++ S A E +TESSKELE++++
Sbjct: 409 EDEPSQANDRNKKRKKSKILSSGVNHECHRRKTVSTQQAKE---DTESSKELERHSE 462
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480867|ref|XP_003632535.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 632 bits (1629), Expect = e-178, Method: Compositional matrix adjust.
Identities = 318/483 (65%), Positives = 384/483 (79%), Gaps = 18/483 (3%)
Query: 1 MGCIQAK---LSPPQNVVERLKMEGGYVKGVSAGRVVVQKAVGKENGKVSRHGGDGNG-- 55
MGC+Q + SP + +V +LK++ GY K GR + K K +GK + DG G
Sbjct: 1 MGCVQTRPSVYSPSEGLV-KLKLQNGYAKRGYGGRPIRHKPPEKLDGKSAGTLVDGGGGG 59
Query: 56 ------VGERVRNG-GGDGGSRSRKSVKKKISEDELVDGWPKWLVDNIPKEVLAGLVPKS 108
VG N G GG+ S+K K+I DELVDGWPKWLVDNI ++ L GLVPKS
Sbjct: 60 GGGEEMVGREDENKLNGGGGNVSQKITVKRIGGDELVDGWPKWLVDNIHRDALVGLVPKS 119
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
DSY+KLAKVGQGTYSNVYKARDR+T KIVALKKVRFDTSE ESVKFMAREI ILQKLDH
Sbjct: 120 VDSYEKLAKVGQGTYSNVYKARDRETRKIVALKKVRFDTSEAESVKFMAREIMILQKLDH 179
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
PN+IKLEGLATSRMQYSLYLVFDFM +DLT++I RP +LTEPQVK YMQQLL+G+QHCH
Sbjct: 180 PNIIKLEGLATSRMQYSLYLVFDFMPTDLTRVISRPNGRLTEPQVKFYMQQLLAGVQHCH 239
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
ERGILHRD+K SNLLIDK+G+LKIADFGL+NF PK K PLTSRVVTLWYRAPELLLGST
Sbjct: 240 ERGILHRDLKGSNLLIDKNGVLKIADFGLANFLDPKPKKPLTSRVVTLWYRAPELLLGST 299
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR- 347
DYGVGIDLWS GCLLAEMF GRP+MPGRTEVEQLHRIFKLCG+PSEDYWKK++L T+FR
Sbjct: 300 DYGVGIDLWSVGCLLAEMFTGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLPTSFRP 359
Query: 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPV 407
PQ YKPSF++ F +FP SS+ +LT+LLALDPA+RG+AA+AL++ FF +SPL CDLS LPV
Sbjct: 360 PQQYKPSFQDAFRDFPSSSFALLTSLLALDPAFRGSAATALESGFFTSSPLPCDLSGLPV 419
Query: 408 IC-REEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGETESSKELEKN 466
+ +E DEP++ ++RKK R+S+ R+ +++ +EG K+ +A+E KG++ +S + EK+
Sbjct: 420 VVYKEADEPSQANKRKKHRTSRSRQQSRTHNEGRRKK---DPTAEEAKGDSGTSSQEEKS 476
Query: 467 ADP 469
DP
Sbjct: 477 TDP 479
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296082537|emb|CBI21542.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1592), Expect = e-174, Method: Compositional matrix adjust.
Identities = 314/479 (65%), Positives = 381/479 (79%), Gaps = 19/479 (3%)
Query: 1 MGCIQAK---LSPPQNVVERLKMEGGYVKGVSAGRVVVQKAVGKENGKVSRHGGDGNG-- 55
MGC+Q + SP + +V +LK++ GY K GR + K K +GK + DG G
Sbjct: 115 MGCVQTRPSVYSPSEGLV-KLKLQNGYAKRGYGGRPIRHKPPEKLDGKSAGTLVDGGGGG 173
Query: 56 ------VGERVRNG-GGDGGSRSRKSVKKKISEDELVDGWPKWLVDNIPKEVLAGLVPKS 108
VG N G GG+ S+K K+I DELVDGWPKWLVDNI ++ L GLVPKS
Sbjct: 174 GGGEEMVGREDENKLNGGGGNVSQKITVKRIGGDELVDGWPKWLVDNIHRDALVGLVPKS 233
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
DSY+KLAKVGQGTYSNVYKARDR+T KIVALKKVRFDTSE ESVKFMAREI ILQKLDH
Sbjct: 234 VDSYEKLAKVGQGTYSNVYKARDRETRKIVALKKVRFDTSEAESVKFMAREIMILQKLDH 293
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
PN+IKLEGLATSRMQYSLYLVFDFM +DLT++I RP +LTEPQVK YMQQLL+G+QHCH
Sbjct: 294 PNIIKLEGLATSRMQYSLYLVFDFMPTDLTRVISRPNGRLTEPQVKFYMQQLLAGVQHCH 353
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
ERGILHRD+K SNLLIDK+G+LKIADFGL+NF PK K PLTSRVVTLWYRAPELLLGST
Sbjct: 354 ERGILHRDLKGSNLLIDKNGVLKIADFGLANFLDPKPKKPLTSRVVTLWYRAPELLLGST 413
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348
DYGVGIDLWS GCLLAEMF GRP+MPGRTEVEQLHRIFKLCG+PSEDYWKK++L T+FRP
Sbjct: 414 DYGVGIDLWSVGCLLAEMFTGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLPTSFRP 473
Query: 349 -QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPV 407
Q YKPSF++ F +FP SS+ +LT+LLALDPA+RG+AA+AL++ FF +SPL CDLS LPV
Sbjct: 474 PQQYKPSFQDAFRDFPSSSFALLTSLLALDPAFRGSAATALESGFFTSSPLPCDLSGLPV 533
Query: 408 IC-REEDEPARTSRRKKR-RSSKGRKSTQSIHEGHHKRVSSVSSADETKGETESSKELE 464
+ +E DEP++ ++RK R R+S+ R+ +++ +EG K+ +A+E KG++ +S +++
Sbjct: 534 VVYKEADEPSQANKRKNRHRTSRSRQQSRTHNEGRRKK---DPTAEEAKGDSGTSSQVQ 589
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493201|ref|XP_003634541.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1515), Expect = e-165, Method: Compositional matrix adjust.
Identities = 304/477 (63%), Positives = 370/477 (77%), Gaps = 27/477 (5%)
Query: 1 MGCIQAK--LSPPQNVVERLKMEGGYVKGVSAGRVVVQKAVGKENGKVSRHGGDGNGVGE 58
MG +QAK ++ P +E+LK++ GYV + R Q+ K++G+V R N V
Sbjct: 1 MGSVQAKSSMNSPPRGLEKLKIDNGYVSKAAGRRSTGQRYPDKDSGRVLRPESGSNKVLF 60
Query: 59 RVRNGGGDGGSRSRKSVKKKISED------------ELVDGWPKWLVDNIPKEVLAGLVP 106
+GGG+ KS+ K+ D E+VDGWP WL DNIPK+ LAGLVP
Sbjct: 61 VSGDGGGE-----EKSINKEEKRDDGGSEVSHVKGKEIVDGWPNWLTDNIPKKALAGLVP 115
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL 166
+SA+S++KL K+GQGTYSNVYKARD+DTGKIVALKKVRF+T+EPESVKFMAREI IL++L
Sbjct: 116 RSAESFEKLDKIGQGTYSNVYKARDKDTGKIVALKKVRFETTEPESVKFMAREITILREL 175
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
DHPNVIKLEGL TSRMQYSLYLVFDFMQSDL ++I P ++LTEPQ+KCYM QLLSGLQH
Sbjct: 176 DHPNVIKLEGLVTSRMQYSLYLVFDFMQSDLARVIACP-ERLTEPQIKCYMHQLLSGLQH 234
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
CHERGILHRDIK SNLLIDK G LKIADFGL+ F P +K PLTS+VVTLWYRAPELLLG
Sbjct: 235 CHERGILHRDIKGSNLLIDKDGRLKIADFGLAKHFYPNRKHPLTSKVVTLWYRAPELLLG 294
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
+TDYGVGIDLWSAGCLLAEMF+GRP+MPGRTEVEQ+HRIFKLCGTPSE+YWKK+++ TTF
Sbjct: 295 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQIHRIFKLCGTPSEEYWKKLRMPTTF 354
Query: 347 R-PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSL 405
R PQ YKPS E F +FP SS G+L+TLLALDP+YRG+A SALQNEFF+ PLACDL+ L
Sbjct: 355 RPPQMYKPSLVEAFRDFPTSSLGLLSTLLALDPSYRGSARSALQNEFFHTWPLACDLTGL 414
Query: 406 PVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGETESSKE 462
PVI +E+DE + +K R SK ++ +Q+ GH ++ +A++ KG++ SSKE
Sbjct: 415 PVIYKEDDEATQAREHRKHRRSKMKQHSQT---GHRRK---DPTAEKPKGDSGSSKE 465
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224093918|ref|XP_002310047.1| predicted protein [Populus trichocarpa] gi|222852950|gb|EEE90497.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1513), Expect = e-165, Method: Compositional matrix adjust.
Identities = 288/331 (87%), Positives = 310/331 (93%), Gaps = 1/331 (0%)
Query: 77 KKISEDELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGK 136
KK +ELVDGWPKWLVDNI +VLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGK
Sbjct: 1 KKAGGEELVDGWPKWLVDNIAGDVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGK 60
Query: 137 IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSD 196
IVALKKVRFDTSEPESVKFMAREI +LQKLDHPNVIKLEGLATSRMQYSLYLVFD MQSD
Sbjct: 61 IVALKKVRFDTSEPESVKFMAREIMMLQKLDHPNVIKLEGLATSRMQYSLYLVFDLMQSD 120
Query: 197 LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFG 256
LT+II RPG++LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK+GMLKIADFG
Sbjct: 121 LTRIISRPGERLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKNGMLKIADFG 180
Query: 257 LSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR 316
L+NFFIPK K PLT+RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRP+MPGR
Sbjct: 181 LANFFIPKPKRPLTNRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPIMPGR 240
Query: 317 TEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR-PQHYKPSFREVFGEFPPSSYGILTTLLA 375
TEVEQLHRIFKLCG+P EDYWK M+L T+FR PQHYKPSF+E F +FP SS +LTTLLA
Sbjct: 241 TEVEQLHRIFKLCGSPPEDYWKIMRLPTSFRPPQHYKPSFQEAFKDFPESSLVLLTTLLA 300
Query: 376 LDPAYRGTAASALQNEFFNASPLACDLSSLP 406
L+PAYRGTAASALQ+ FF++SP+AC+LS LP
Sbjct: 301 LNPAYRGTAASALQSHFFSSSPMACELSGLP 331
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507487|ref|XP_003522496.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1496), Expect = e-163, Method: Compositional matrix adjust.
Identities = 296/476 (62%), Positives = 366/476 (76%), Gaps = 20/476 (4%)
Query: 1 MGCIQAKLSPPQNVVERLKMEGGYVKGVSAGRVV-VQKAVGK---------ENGKVSRHG 50
MGC+ SPP+ ER + + V + R K VG+ + +VS +
Sbjct: 1 MGCVCGTFSPPRE--ERPRPQVKRVASNKSSRTTRSSKHVGEGVNSKKEKTQRQRVSVNV 58
Query: 51 GDGNGV--GERVRNGGGDGGS-RSRKSVKKKISEDELVDGWPKWLVDNIPKEVLAGLVPK 107
DG GV GE+ + + S + R + ++K++ E V+GWPKWL+DNIP VLA +VPK
Sbjct: 59 NDG-GVAEGEKAKPIAKENKSYKDRDAREEKMARYEFVEGWPKWLLDNIPANVLANIVPK 117
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD 167
SADSY+KLAK+G+GTYSNVYKAR++ T KIVALKKVRFDTS+ ES+KFMAREI +LQ LD
Sbjct: 118 SADSYEKLAKIGRGTYSNVYKAREKGTRKIVALKKVRFDTSDSESIKFMAREIMMLQMLD 177
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
HPNVIKL+GLATSRMQYSLYLVFDFMQSDLT+II RPG+KLTE Q+KCYMQQLLSGLQHC
Sbjct: 178 HPNVIKLKGLATSRMQYSLYLVFDFMQSDLTRIISRPGEKLTEAQIKCYMQQLLSGLQHC 237
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
HE+GI+HRDIKASNLLID++G+LKIADFGL+ + +GPLT+RVVTLWYRAPELLLGS
Sbjct: 238 HEKGIMHRDIKASNLLIDRNGVLKIADFGLATSI--EAEGPLTNRVVTLWYRAPELLLGS 295
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347
TDYG IDLWSAGCLLAEMF+GRP+MPGRTEVEQ+H IFKLCG+PS DY+KK+KLTT++R
Sbjct: 296 TDYGYSIDLWSAGCLLAEMFVGRPIMPGRTEVEQIHMIFKLCGSPSPDYFKKLKLTTSYR 355
Query: 348 P-QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406
P QHYKPSF E F +FP SS G+L T L L+PA+RG AASALQ++FF SPLACD S+LP
Sbjct: 356 PTQHYKPSFHENFQKFPSSSLGLLATFLDLNPAHRGNAASALQSDFFKCSPLACDPSALP 415
Query: 407 VICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGETESSKE 462
VI ++EDE +T R K++R SK +S+Q+ + A++ + +TESSKE
Sbjct: 416 VIPKDEDERLQTKRGKRQRVSKREQSSQT-SRSDASQSEKNQIAEQPREDTESSKE 470
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255566684|ref|XP_002524326.1| Cell division protein kinase, putative [Ricinus communis] gi|223536417|gb|EEF38066.1| Cell division protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1491), Expect = e-162, Method: Compositional matrix adjust.
Identities = 294/403 (72%), Positives = 336/403 (83%), Gaps = 22/403 (5%)
Query: 42 ENGKVSRHG--GDGNGVGERVRN----------GGGDGGSRSRKSVKKKISEDE-----L 84
ENG +S+ G G +G+R+ N G GG R + +I E +
Sbjct: 2 ENGYLSKGGLVGHRRSIGQRLNNSDPLLKNCDAGFDSGGGRK---LSDRIGEKDRIFGKT 58
Query: 85 VDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR 144
V+GWPKWL DN+PK+VLAGL+PKSA++YDK+ KVGQGTYSNVYKARDRDTGKIVALKKV+
Sbjct: 59 VNGWPKWLTDNVPKQVLAGLIPKSAENYDKIDKVGQGTYSNVYKARDRDTGKIVALKKVK 118
Query: 145 FDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRP 204
FDTSEP+SV+FMAREI +LQKLDHPNV+KLEG+ATSRMQYSLYLVFDFMQSDL II RP
Sbjct: 119 FDTSEPQSVRFMAREIMMLQKLDHPNVVKLEGIATSRMQYSLYLVFDFMQSDLATIITRP 178
Query: 205 GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP- 263
+LTEPQVKCYM QLLSGLQHCHERGILHRDIK SNLLIDK+G+LKIADFGL+N++ P
Sbjct: 179 EGRLTEPQVKCYMHQLLSGLQHCHERGILHRDIKGSNLLIDKNGVLKIADFGLANYYSPE 238
Query: 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLH 323
+ K PLTSRVVTLWYRAPELLLG+TDYGVGIDLWSAGCLLAEMF GRP+MPGRTEVEQLH
Sbjct: 239 RNKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFAGRPIMPGRTEVEQLH 298
Query: 324 RIFKLCGTPSEDYWKKMKLTTTFR-PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG 382
RIFKLCGTPSEDYWKK++L+TTFR P+ YKPS E FGEFP SS G+LTTLLALDPAYRG
Sbjct: 299 RIFKLCGTPSEDYWKKLRLSTTFRPPKSYKPSLFEAFGEFPESSLGLLTTLLALDPAYRG 358
Query: 383 TAASALQNEFFNASPLACDLSSLPVICREEDEPARTSRRKKRR 425
+A+SALQN+FF SPLACDLS LPVI REEDE A+ + +KR+
Sbjct: 359 SASSALQNDFFYTSPLACDLSGLPVIWREEDELAQANELRKRK 401
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448580|ref|XP_004142044.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 576 bits (1485), Expect = e-162, Method: Compositional matrix adjust.
Identities = 299/475 (62%), Positives = 358/475 (75%), Gaps = 14/475 (2%)
Query: 1 MGCIQAK--LSPPQNVVERLKMEGGYVKGVSAGRVVVQKAVGKENGKVSRHGGDGNGVGE 58
MGC+Q+ P + +L E +V G + R VG+ + V+ G E
Sbjct: 1 MGCVQSSSFQYSPNGGIRKLNPERDHVAGGNRNR---SAKVGRTSVVVNDGGIRKVVYIE 57
Query: 59 RVRNGGGDGGSRSRK-SVKKKISEDELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAK 117
+ GD G+ SR+ SV E+ELVDGWPKWLV NIPK+ LAGLVPK ADSYDKLAK
Sbjct: 58 TKKERSGDVGNVSRRISVSDNAGEEELVDGWPKWLVQNIPKDALAGLVPKGADSYDKLAK 117
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGL 177
VG+GTYSNVYKARDRDTGKIVA+KKVRFDTS+ ES+KFMAREI +LQKLDHPN+IKLEG+
Sbjct: 118 VGRGTYSNVYKARDRDTGKIVAMKKVRFDTSDSESIKFMAREIMVLQKLDHPNIIKLEGI 177
Query: 178 ATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDI 237
TSRM YSLYLVFDFM+SDLT II R +KL E QVK YM+QLLSGLQHCH+RGILHRDI
Sbjct: 178 VTSRMPYSLYLVFDFMESDLTGIISRYSRKLREDQVKAYMEQLLSGLQHCHDRGILHRDI 237
Query: 238 KASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLW 297
K SNLLIDKSGMLKIADFGL+NFFIPK++ PLT+RVVTLWYRAPELLLGSTDYGVGIDLW
Sbjct: 238 KPSNLLIDKSGMLKIADFGLANFFIPKRRRPLTNRVVTLWYRAPELLLGSTDYGVGIDLW 297
Query: 298 SAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF-RPQHYKPSFR 356
SAGCLLAE+F+G+P++PGRTEVEQLH+I+KLCG+P +DY+ KMKL +F PQ+Y+P +
Sbjct: 298 SAGCLLAELFLGKPILPGRTEVEQLHKIWKLCGSPPKDYFDKMKLPASFCPPQNYQPGYS 357
Query: 357 EVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICR--EEDE 414
E F F S+ +LTTLL+LDPA RGTA+SALQ+EFF+ PL C+LS LPVI +EDE
Sbjct: 358 EAFSGFSTPSFRLLTTLLSLDPARRGTASSALQSEFFSVYPLPCELSELPVIFHKDKEDE 417
Query: 415 PARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGETESSKELEKNADP 469
A+ RKK+RSS RK S+ + H V+S A+ TK S + E + P
Sbjct: 418 AAKIRNRKKQRSS--RKLHSSLSQTH---VASQQVANPTKARDSESLKEENSVHP 467
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449487945|ref|XP_004157879.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 576 bits (1484), Expect = e-161, Method: Compositional matrix adjust.
Identities = 299/475 (62%), Positives = 358/475 (75%), Gaps = 14/475 (2%)
Query: 1 MGCIQAK--LSPPQNVVERLKMEGGYVKGVSAGRVVVQKAVGKENGKVSRHGGDGNGVGE 58
MGC+Q+ P + +L E +V G + R VG+ + V+ G E
Sbjct: 1 MGCVQSSSFQYSPNGGIRKLNPERDHVAGGNRNR---SAKVGRTSVVVNDGGIRKVVYIE 57
Query: 59 RVRNGGGDGGSRSRK-SVKKKISEDELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAK 117
+ GD G+ SR+ SV E+ELVDGWPKWLV NIPK+ LAGLVPK ADSYDKLAK
Sbjct: 58 TKKERSGDVGNVSRRISVSDNAGEEELVDGWPKWLVQNIPKDALAGLVPKGADSYDKLAK 117
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGL 177
VG+GTYSNVYKARDRDTGKIVA+KKVRFDTS+ ES+KFMAREI +LQKLDHPN+IKLEG+
Sbjct: 118 VGRGTYSNVYKARDRDTGKIVAMKKVRFDTSDSESIKFMAREIMVLQKLDHPNIIKLEGI 177
Query: 178 ATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDI 237
TSRM YSLYLVFDFM+SDLT II R +KL E QVK YM+QLLSGLQHCH+RGILHRDI
Sbjct: 178 VTSRMPYSLYLVFDFMESDLTGIISRYSRKLREDQVKAYMEQLLSGLQHCHDRGILHRDI 237
Query: 238 KASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLW 297
K SNLLIDKSGMLKIADFGL+NFFIPK++ PLT+RVVTLWYRAPELLLGSTDYGVGIDLW
Sbjct: 238 KPSNLLIDKSGMLKIADFGLANFFIPKRRRPLTNRVVTLWYRAPELLLGSTDYGVGIDLW 297
Query: 298 SAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF-RPQHYKPSFR 356
SAGCLLAE+F+G+P++PGRTEVEQLH+I+KLCG+P +DY+ KMKL +F PQ+Y+P +
Sbjct: 298 SAGCLLAELFLGKPILPGRTEVEQLHKIWKLCGSPPKDYFDKMKLPASFCPPQNYQPGYS 357
Query: 357 EVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICR--EEDE 414
E F F S+ +LTTLL+LDPA RGTA+SALQ+EFF+ PL C+LS LPVI +EDE
Sbjct: 358 EAFSGFSTPSFRLLTTLLSLDPARRGTASSALQSEFFSVYPLPCELSELPVIFHKDKEDE 417
Query: 415 PARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGETESSKELEKNADP 469
A+ RKK+RSS RK S+ + H V+S A+ TK S + E + P
Sbjct: 418 AAKIRNRKKQRSS--RKLHSSLSQTH---VASQQVANPTKARDSESLKEENSVHP 467
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081212|emb|CBI18238.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 569 bits (1466), Expect = e-159, Method: Compositional matrix adjust.
Identities = 290/437 (66%), Positives = 346/437 (79%), Gaps = 19/437 (4%)
Query: 1 MGCIQAK--LSPPQNVVERLKMEGGYVKGVSAGRVVVQKAVGKENGKVSRHGGDGNGVGE 58
MG +QAK ++ P +E+LK++ GYV + R Q+ K++G+V R N
Sbjct: 1 MGSVQAKSSMNSPPRGLEKLKIDNGYVSKAAGRRSTGQRYPDKDSGRVLRPESGSN---- 56
Query: 59 RVRNGGGDGGSRSRKSVKKKISED-----------ELVDGWPKWLVDNIPKEVLAGLVPK 107
+V GDGG + K++ +D E+VDGWP WL DNIPK+ LAGLVP+
Sbjct: 57 KVLFVSGDGGGEEKSINKEEKRDDGGSEVSHVKGKEIVDGWPNWLTDNIPKKALAGLVPR 116
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD 167
SA+S++KL K+GQGTYSNVYKARD+DTGKIVALKKVRF+T+EPESVKFMAREI IL++LD
Sbjct: 117 SAESFEKLDKIGQGTYSNVYKARDKDTGKIVALKKVRFETTEPESVKFMAREITILRELD 176
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
HPNVIKLEGL TSRMQYSLYLVFDFMQSDL ++I P ++LTEPQ+KCYM QLLSGLQHC
Sbjct: 177 HPNVIKLEGLVTSRMQYSLYLVFDFMQSDLARVIACP-ERLTEPQIKCYMHQLLSGLQHC 235
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
HERGILHRDIK SNLLIDK G LKIADFGL+ F P +K PLTS+VVTLWYRAPELLLG+
Sbjct: 236 HERGILHRDIKGSNLLIDKDGRLKIADFGLAKHFYPNRKHPLTSKVVTLWYRAPELLLGA 295
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347
TDYGVGIDLWSAGCLLAEMF+GRP+MPGRTEVEQ+HRIFKLCGTPSE+YWKK+++ TTFR
Sbjct: 296 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQIHRIFKLCGTPSEEYWKKLRMPTTFR 355
Query: 348 -PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406
PQ YKPS E F +FP SS G+L+TLLALDP+YRG+A SALQNEFF+ PLACDL+ LP
Sbjct: 356 PPQMYKPSLVEAFRDFPTSSLGLLSTLLALDPSYRGSARSALQNEFFHTWPLACDLTGLP 415
Query: 407 VICREEDEPARTSRRKK 423
VI +E+DE + +K
Sbjct: 416 VIYKEDDEATQAREHRK 432
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 469 | ||||||
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.695 | 0.469 | 0.646 | 5.8e-114 | |
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.690 | 0.565 | 0.640 | 7.3e-114 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.682 | 0.551 | 0.635 | 3.3e-111 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.688 | 0.452 | 0.614 | 2.1e-109 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.695 | 0.530 | 0.604 | 8.1e-108 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.692 | 0.504 | 0.604 | 3.5e-107 | |
| TAIR|locus:2096199 | 593 | AT3G05050 [Arabidopsis thalian | 0.690 | 0.546 | 0.601 | 1.2e-106 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.699 | 0.469 | 0.571 | 2.2e-105 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.688 | 0.436 | 0.584 | 2.5e-104 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.699 | 0.462 | 0.567 | 6.7e-104 |
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1124 (400.7 bits), Expect = 5.8e-114, P = 5.8e-114
Identities = 214/331 (64%), Positives = 260/331 (78%)
Query: 80 SEDELVD-GWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIV 138
+E E V GWP WL ++ E + G VP+ ADS++KL K+GQGTYSNVY+ARD D KIV
Sbjct: 102 TEGEYVAAGWPPWLA-SVAGEAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIV 160
Query: 139 ALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLT 198
ALKKVRFD EPESV+FMAREI+IL++LDHPN+IKLEGL TSRM SLYLVF++M+ DL
Sbjct: 161 ALKKVRFDNLEPESVRFMAREIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLA 220
Query: 199 KIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258
+ P K +E QVKCY+QQLL GL HCH RG+LHRDIK SNLLID SG+LKIADFGL+
Sbjct: 221 GLASHPAIKFSESQVKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLA 280
Query: 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE 318
+FF P+Q PLTSRVVTLWYR PELLLG+T YG +DLWSAGC+LAE++ G+P+MPGRTE
Sbjct: 281 SFFDPRQTQPLTSRVVTLWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTE 340
Query: 319 VEQLHRIFKLCGTPSEDYWKKMKL--TTTFRP-QHYKPSFREVFGEFPPSSYGILTTLLA 375
VEQLH+IFKLCG+P+EDYW K +L T F+P Q YK E F EFP + +L TLL+
Sbjct: 341 VEQLHKIFKLCGSPTEDYWVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLS 400
Query: 376 LDPAYRGTAASALQNEFFNASPLACDLSSLP 406
++P RGTA +AL++EFF+ PL CD SSLP
Sbjct: 401 VNPDDRGTATAALKSEFFSTRPLPCDPSSLP 431
|
|
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1123 (400.4 bits), Expect = 7.3e-114, P = 7.3e-114
Identities = 210/328 (64%), Positives = 258/328 (78%)
Query: 82 DELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALK 141
+++ GWP WL D E L G VP+ AD+++K+ K+GQGTYSNVYKA+D TGKIVALK
Sbjct: 89 EQVAAGWPSWLSDACG-EALNGWVPRKADTFEKIDKIGQGTYSNVYKAKDMLTGKIVALK 147
Query: 142 KVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKII 201
KVRFD EPESVKFMAREI +L++LDHPNV+KLEGL TSRM SLYLVF +M DL +
Sbjct: 148 KVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLA 207
Query: 202 CRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261
P K +E +VKC M+QL+SGL+HCH RG+LHRDIK SNLLID G+LKIADFGL+ F
Sbjct: 208 SSPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIF 267
Query: 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ 321
P K P+TSRVVTLWYRAPELLLG+TDYGVGIDLWSAGC+LAE+ GRP+MPGRTEVEQ
Sbjct: 268 DPNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQ 327
Query: 322 LHRIFKLCGTPSEDYWKKMKLT--TTFRPQH-YKPSFREVFGEFPPSSYGILTTLLALDP 378
LH+I+KLCG+PSEDYWKK K T ++P+ YK S RE F +FPPSS ++ LL+++P
Sbjct: 328 LHKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEP 387
Query: 379 AYRGTAASALQNEFFNASPLACDLSSLP 406
R TA++AL++EFF + P AC+ + LP
Sbjct: 388 EDRQTASAALKSEFFTSEPYACEPADLP 415
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 3.3e-111, P = 3.3e-111
Identities = 206/324 (63%), Positives = 251/324 (77%)
Query: 86 DGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRF 145
+GWP WL+ + L P+ A +Y+KL K+GQGTYSNVYKA+D +GKIVALKKVRF
Sbjct: 89 EGWPPWLIAACGDSI-KDLTPRRATTYEKLEKIGQGTYSNVYKAKDLLSGKIVALKKVRF 147
Query: 146 DTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPG 205
D E ESVKFMAREI +L++L+HPNVIKL+GL TSR+ SLYLVF++M+ DL+ + G
Sbjct: 148 DNLEAESVKFMAREILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQG 207
Query: 206 QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265
K PQVKC+M+QLLSGL+HCH RG+LHRDIK SNLLID G+LKIADFGL+ F+ PKQ
Sbjct: 208 LKFDLPQVKCFMKQLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQ 267
Query: 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
K +TSRVVTLWYR PELLLG+T YG G+DLWSAGC++AE+ G+P+MPGRTEVEQLH+I
Sbjct: 268 KQTMTSRVVTLWYRPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKI 327
Query: 326 FKLCGTPSEDYWKKMKL--TTTFRPQH-YKPSFREVFGEFPPSSYGILTTLLALDPAYRG 382
FKLCG+PS+ YWKK +L T F+PQH YK E F F PSS ++ TLL +DPA RG
Sbjct: 328 FKLCGSPSDSYWKKYRLPNATLFKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRG 387
Query: 383 TAASALQNEFFNASPLACDLSSLP 406
T+ SAL +EFF PL CD SSLP
Sbjct: 388 TSTSALNSEFFTTEPLPCDPSSLP 411
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 2.1e-109, P = 2.1e-109
Identities = 201/327 (61%), Positives = 254/327 (77%)
Query: 83 ELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKK 142
+++ GWP WL ++ E + G +P+ ADS++KL K+GQGTYS+VYKARD +T ++VALKK
Sbjct: 135 QVMAGWPSWLA-SVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKK 193
Query: 143 VRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIIC 202
VRF +P+SV+FMAREI IL++LDHPNV+KLEGL TSR+ S+YL+F++M+ DL +
Sbjct: 194 VRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLAS 253
Query: 203 RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262
PG +E Q+KCYM+QLL GL+HCH RG+LHRDIK SNLL+D + LKI DFGL+NF+
Sbjct: 254 TPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQ 313
Query: 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQL 322
QK PLTSRVVTLWYR PELLLGSTDYGV +DLWS GC+LAE+F G+P+MPGRTEVEQL
Sbjct: 314 GHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQL 373
Query: 323 HRIFKLCGTPSEDYWKKMKL--TTTFRPQH-YKPSFREVFGEFPPSSYGILTTLLALDPA 379
H+IFKLCG+PSE+YWK KL T F+PQ YK E F P S+ ++ LLA++P
Sbjct: 374 HKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPD 433
Query: 380 YRGTAASALQNEFFNASPLACDLSSLP 406
RGT ASAL++EFF SPLA D SSLP
Sbjct: 434 ARGTTASALESEFFTTSPLASDPSSLP 460
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 200/331 (60%), Positives = 256/331 (77%)
Query: 80 SEDELVD-GWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIV 138
+E EL+ GWP WL ++ E + G VP+ ADS++KL K+GQGTYS VYKARD +TGKIV
Sbjct: 109 AEAELIAAGWPYWLT-SVAGEAIKGWVPRRADSFEKLDKIGQGTYSIVYKARDLETGKIV 167
Query: 139 ALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLT 198
A+KKVRF +PESV+FMAREI IL+KLDHPNV+KL+ L TS++ SL+LVF++M+ DL+
Sbjct: 168 AMKKVRFANMDPESVRFMAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYMEHDLS 227
Query: 199 KIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258
+ RPG K TEPQ+KC+M+QLL GL+HCH RGILHRDIK SNLL++ G+LKI DFGL+
Sbjct: 228 GLALRPGVKFTEPQIKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLA 287
Query: 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE 318
+F+ P Q PLTSRVVTLWYRAPELLLGST+YG IDLWS GC+LAE+F+ +P+MPGRTE
Sbjct: 288 SFYKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTE 347
Query: 319 VEQLHRIFKLCGTPSEDYWKKMKL--TTTFRPQH-YKPSFREVFGEFPPSSYGILTTLLA 375
VEQ+H+IFKLCG+PSE++W K T+++PQH YK E F SS +L LL+
Sbjct: 348 VEQMHKIFKLCGSPSEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLS 407
Query: 376 LDPAYRGTAASALQNEFFNASPLACDLSSLP 406
++P R +A+S L +EFF PL C +SSLP
Sbjct: 408 VEPEKRCSASSTLLSEFFTTEPLPCHISSLP 438
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1060 (378.2 bits), Expect = 3.5e-107, P = 3.5e-107
Identities = 199/329 (60%), Positives = 250/329 (75%)
Query: 81 EDELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVAL 140
E EL GWP WLV ++ E L P+ A +++KL K+GQGTYS+VYKARD KIVAL
Sbjct: 107 EAELAAGWPAWLV-SVAGEALVNWTPRRASTFEKLEKIGQGTYSSVYKARDLTNNKIVAL 165
Query: 141 KKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKI 200
K+VRFD S+ ESVKFMAREI ++++LDHPNV+KLEGL T+ + SLYLVF++M DL +
Sbjct: 166 KRVRFDLSDLESVKFMAREIIVMRRLDHPNVLKLEGLITASVSSSLYLVFEYMDHDLVGL 225
Query: 201 ICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260
PG K +EPQVKCYMQQLLSGL HCH RG+LHRDIK SNLLID +G+LKIADFGL+ F
Sbjct: 226 ASIPGIKFSEPQVKCYMQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADFGLATF 285
Query: 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVE 320
F P+ PLTSRVVTLWYR PELLLG+ YGVG+DLWS GC+L E++ G+P++ G+TEVE
Sbjct: 286 FDPQNCVPLTSRVVTLWYRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAGKTEVE 345
Query: 321 QLHRIFKLCGTPSEDYWKKMKL--TTTFRPQ-HYKPSFREVFGEFPPSSYGILTTLLALD 377
QLH+IFKLCG+P+EDYW+K+KL + FRP Y E+F + P + +L LL++D
Sbjct: 346 QLHKIFKLCGSPTEDYWRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEALLSID 405
Query: 378 PAYRGTAASALQNEFFNASPLACDLSSLP 406
P RG+AA AL++E+F P ACD SSLP
Sbjct: 406 PDRRGSAARALESEYFRTEPFACDPSSLP 434
|
|
| TAIR|locus:2096199 AT3G05050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
Identities = 199/331 (60%), Positives = 248/331 (74%)
Query: 82 DELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALK 141
+++ GWP WL + + E L+G +P+ ADS++K+ K+G GTYSNVYKA+D TG IVALK
Sbjct: 109 EQVAAGWPSWLSE-VCGEALSGWLPRKADSFEKIDKIGSGTYSNVYKAKDSLTGNIVALK 167
Query: 142 KVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKII 201
KVR D +E ES+KFMAREI IL++LDHPNVIKLEGL TSRM SLYLVF +M DL +
Sbjct: 168 KVRCDVNERESLKFMAREILILRRLDHPNVIKLEGLVTSRMSSSLYLVFRYMDHDLAGLA 227
Query: 202 CRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261
P K TE QVKCYM+QLLSGL+HCH RG+LHRDIK SNLLID G+L+I DFGL+ FF
Sbjct: 228 ASPEIKFTEQQVKCYMKQLLSGLEHCHNRGVLHRDIKGSNLLIDDGGVLRIGDFGLATFF 287
Query: 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ 321
++ +T+RVVTLWYR+PELL G +Y VG+DLWSAGC+LAE+ GR +MPGR EVEQ
Sbjct: 288 DASKRQEMTNRVVTLWYRSPELLHGVVEYSVGVDLWSAGCILAELLAGRAIMPGRNEVEQ 347
Query: 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP------SFREVFGEFPPSSYGILTTLLA 375
LHRI+KLCG+PSE+YWKK++L +T + H+KP REV+ +F P + +L TLLA
Sbjct: 348 LHRIYKLCGSPSEEYWKKIRLPSTHKHAHHKPLPQYKRRIREVYKDFSPEALSLLDTLLA 407
Query: 376 LDPAYRGTAASALQNEFFNASPLACDLSSLP 406
LDPA R TA L ++FF PLAC S LP
Sbjct: 408 LDPAERQTATDVLMSDFFTTEPLACQPSDLP 438
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1043 (372.2 bits), Expect = 2.2e-105, P = 2.2e-105
Identities = 191/334 (57%), Positives = 251/334 (75%)
Query: 79 ISEDELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIV 138
+ +++ GWP WL N+ E + G VP +D+++KL K+GQGTYSNV++A + +TG+IV
Sbjct: 89 LEAEQVAAGWPAWL-SNVAGEAIHGWVPLRSDAFEKLEKIGQGTYSNVFRAVETETGRIV 147
Query: 139 ALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLT 198
ALKKVRFD EPESVKFMAREI IL++L+HPN+IKLEGL TS++ ++ LVF++M+ DLT
Sbjct: 148 ALKKVRFDNFEPESVKFMAREILILRRLNHPNIIKLEGLITSKLSCNIQLVFEYMEHDLT 207
Query: 199 KIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258
++ P K T PQ+KCYM+QLLSGL HCH RG++HRDIK SNLL+ G+LK+ADFGL+
Sbjct: 208 GLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSRGVMHRDIKGSNLLLSNEGILKVADFGLA 267
Query: 259 NFFIPK--QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR 316
NF +K PLTSRVVTLWYR PELLLG+TDYG +DLWS GC+ AE+ +G+P++ GR
Sbjct: 268 NFSNSSGHKKKPLTSRVVTLWYRPPELLLGATDYGASVDLWSVGCVFAELLLGKPILRGR 327
Query: 317 TEVEQLHRIFKLCGTPSEDYWKKMKL--TTTFRPQH-YKPSFREVFGEFPPSSYGILTTL 373
TEVEQLH+IFKLCG+P EDYWKK KL F+PQ Y RE + + ++ TL
Sbjct: 328 TEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQTYDSCLRETLKDLSETEINLIETL 387
Query: 374 LALDPAYRGTAASALQNEFFNASPLACDLSSLPV 407
L++DP RGTA+SAL +++F P ACD SSLP+
Sbjct: 388 LSIDPHKRGTASSALVSQYFTTKPFACDPSSLPI 421
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1033 (368.7 bits), Expect = 2.5e-104, P = 2.5e-104
Identities = 191/327 (58%), Positives = 251/327 (76%)
Query: 83 ELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKK 142
++ GWP WLV ++ E L P+ A++++KL K+GQGTYS+VY+ARD KIVALKK
Sbjct: 185 QVAAGWPSWLV-SVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRARDLLHNKIVALKK 243
Query: 143 VRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIIC 202
VRFD ++ ESVKFMAREI ++++LDHPNV+KLEGL T+ + SLYLVF++M DL +
Sbjct: 244 VRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEYMDHDLLGLSS 303
Query: 203 RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262
PG K TEPQVKCYM+QLLSGL+HCH RG+LHRDIK SNLLID G+LKIADFGL+ FF
Sbjct: 304 LPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIADFGLATFFD 363
Query: 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQL 322
P + LTS VVTLWYR PELLLG++ YGVG+DLWS GC+L E++ G+P++PG+TEVEQL
Sbjct: 364 PAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILPGKTEVEQL 423
Query: 323 HRIFKLCGTPSEDYWKKMKLTTT--FRPQ-HYKPSFREVFGEFPPSSYGILTTLLALDPA 379
H+IFKLCG+P+E+YW+K KL ++ F+ Y+ E+F +FP S +L TLL++DP
Sbjct: 424 HKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLETLLSIDPD 483
Query: 380 YRGTAASALQNEFFNASPLACDLSSLP 406
+R +A AL++E+F P ACD S+LP
Sbjct: 484 HRSSADRALESEYFKTKPFACDPSNLP 510
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 6.7e-104, P = 6.7e-104
Identities = 190/335 (56%), Positives = 252/335 (75%)
Query: 79 ISEDELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIV 138
+ +++ GWP WL N+ E + G VP +D+++KL K+GQGTYS+V++AR+ +TG+IV
Sbjct: 99 LEAEQVAAGWPAWL-SNVAGEAIHGWVPFRSDAFEKLEKIGQGTYSSVFRARETETGRIV 157
Query: 139 ALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLT 198
ALKKVRFD EPESV+FMAREI IL+KL+HPN+IKLEG+ TS++ S++LVF++M+ DLT
Sbjct: 158 ALKKVRFDNFEPESVRFMAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEYMEHDLT 217
Query: 199 KIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258
++ P T PQ+KCYM+QLLSGL HCH RG++HRDIK SNLL++ G+LK+ADFGL+
Sbjct: 218 GLLSSPDIDFTTPQIKCYMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLA 277
Query: 259 NFFIPK-QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT 317
NF K PLTSRVVTLWYR PELLLG+T+YG +DLWS GC+ AE+ IG+P++ GRT
Sbjct: 278 NFCNASGNKQPLTSRVVTLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRT 337
Query: 318 EVEQLHRIFKLCGTPSEDYWKKMKL--TTTFRPQ-HYKPSFREVFG--EFPPSSYGILTT 372
EVEQLH+IFKLCG+P EDYWKK KL F+PQ HY RE + ++ T
Sbjct: 338 EVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIET 397
Query: 373 LLALDPAYRGTAASALQNEFFNASPLACDLSSLPV 407
LL++ P RGTA++AL +++F + P ACD SSLPV
Sbjct: 398 LLSIQPHKRGTASTALVSQYFTSKPFACDPSSLPV 432
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 469 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-148 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-121 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-113 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-101 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-98 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-98 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-97 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-96 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-94 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-94 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-91 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-89 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-87 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-87 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-87 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-86 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-86 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-85 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-83 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-80 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-79 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-78 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-77 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-77 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-72 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-70 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-70 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-70 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-69 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-66 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-66 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-64 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-64 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-64 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-63 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-62 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-62 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-62 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-61 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-60 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-57 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-56 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-55 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-54 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-54 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-54 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-53 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-53 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-51 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-48 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-47 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-46 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-46 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-45 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-43 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-43 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-43 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-42 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-41 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-40 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-40 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-39 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-39 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-38 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-37 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-37 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-34 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-32 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-31 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-30 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-27 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-27 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-25 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-24 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-24 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-23 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-21 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-20 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-20 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-20 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-19 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-19 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-18 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-18 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-18 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-14 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-04 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 423 bits (1089), Expect = e-148
Identities = 140/287 (48%), Positives = 202/287 (70%), Gaps = 5/287 (1%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y+K+A++G+GTY VYKAR++ TG++VALKK+R + + REI++LQKL HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 172 IKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
++L+ + TS+ + S+Y+VF++M DLT ++ P K TE Q+KCYM+QLL GLQ+ H G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG 291
ILHRDIK SN+LI+ G+LK+ADFGL+ + + T+RV+TLWYR PELLLG+T YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 292 VGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW---KKMKLTTTFRP 348
+D+WS GC+LAE+F+G+P+ G TE+EQL +IF+LCG+P+++ W K+ +P
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 349 -QHYKPSFREVFGEF-PPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ YK RE F PS+ +L LL LDP R +A ALQ+E+F
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 354 bits (911), Expect = e-121
Identities = 126/287 (43%), Positives = 181/287 (63%), Gaps = 10/287 (3%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHPN 170
Y+KL K+G+GTY VYKARD+ TG+IVALKK+R D E E + A REI +L++L HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPN 59
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
++KL + + LYLVF++ DL K + + L+ +K M QLL GL +CH
Sbjct: 60 IVKLLDVIHTE--RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPELLLGSTD 289
ILHRD+K N+LI++ G+LK+ADFGL+ F IP + T VVTLWYRAPE+LLGS
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKH 175
Query: 290 YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR-- 347
Y +D+WS GC+ AEM G+PL PG +E++QL +IF++ GTP+E+ W + ++
Sbjct: 176 YSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235
Query: 348 -PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P+ +V P +L+ +L +PA R +A AL++ +F
Sbjct: 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 335 bits (861), Expect = e-113
Identities = 124/301 (41%), Positives = 185/301 (61%), Gaps = 10/301 (3%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD--TSEPESVKFMA-REIRILQKLDH 168
Y+K K+G+GTY+ VYKARD++TG+IVA+KK++ + + F A REI++LQ+L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
PN+I L + + ++ LVF+FM++DL K+I LT +K YM L GL++ H
Sbjct: 62 PNIIGLLDVFGHKS--NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
ILHRD+K +NLLI G+LK+ADFGL+ F +T +VVT WYRAPELL G+
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVTRWYRAPELLFGAR 178
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW---KKMKLTTT 345
YGVG+D+WS GC+ AE+ + P +PG ++++QL +IF+ GTP+E+ W +
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238
Query: 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSL 405
F+P +++F + +L LL L+P R TA AL++ +F+ P S L
Sbjct: 239 FKPFP-PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQL 297
Query: 406 P 406
P
Sbjct: 298 P 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 302 bits (776), Expect = e-101
Identities = 135/290 (46%), Positives = 179/290 (61%), Gaps = 15/290 (5%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y KL K+G+GTY VYKARD+ TG+IVA+KK++ K REI++L++L+HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 172 IKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
IKL L R + LYLVF+FM +DL K+I + L E +K Y+ QLL GL CH G
Sbjct: 61 IKL--LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG 291
ILHRD+K NLLI+ G+LK+ADFGL+ F P T VVT WYRAPELLLG Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 292 VGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY 351
+D+WS GC+ AE+ RPL PG++E++QL +IF+ GTP + W K T+ R Y
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF--TSLARN--Y 233
Query: 352 KPSFREVFGE-----FPPSSY---GILTTLLALDPAYRGTAASALQNEFF 393
K SF + G FP +S +L+ +L DP R TA AL + +F
Sbjct: 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 297 bits (762), Expect = 2e-98
Identities = 124/294 (42%), Positives = 181/294 (61%), Gaps = 9/294 (3%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQK 165
+S D Y+KL ++ +GTY VY+ARD+ TG+IVALKK++ + E E + REI IL K
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKME-KEKEGFPITSLREINILLK 60
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
L HPN++ ++ + +Y+V ++++ DL ++ Q + +VKC M QLLSG+
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
H H+ ILHRD+K SNLL++ G+LKI DFGL+ + P T VVTLWYRAPELLL
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRAPELLL 179
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW---KKMKL 342
G+ +Y ID+WS GC+ AE+ +PL PG++E++QL++IFKL GTP+E W ++
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239
Query: 343 TTTFRPQHYKPS-FREVFGEFPPSSYG--ILTTLLALDPAYRGTAASALQNEFF 393
Y + R+ F S G +L LL DPA R +A AL++ +F
Sbjct: 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 298 bits (764), Expect = 2e-98
Identities = 136/309 (44%), Positives = 190/309 (61%), Gaps = 30/309 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
Y+ L K+G+GT+ VYKAR TG++VALKK+ +E + A REI+IL+KL H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKH 66
Query: 169 PNVIKLEGLA------TSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLS 222
PNV+ L +A + R + S+Y+V +M DL+ ++ P KLTE Q+KCYM QLL
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF---IPKQKGP-------LTSR 272
G+ + HE ILHRDIKA+N+LID G+LKIADFGL+ + P KG T+
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTP 332
VVT WYR PELLLG Y +D+W GC+ AEMF RP++ G+++++QLH IFKLCGTP
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246
Query: 333 SEDYW--------KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA 384
+E+ W + + T +Y + E FG+ P +L+ LL+LDP R TA
Sbjct: 247 TEETWPGWRSLPGCEGVHSFT----NYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA 302
Query: 385 ASALQNEFF 393
+ AL++ +F
Sbjct: 303 SDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 294 bits (754), Expect = 5e-97
Identities = 131/306 (42%), Positives = 187/306 (61%), Gaps = 9/306 (2%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQK 165
+S ++KL ++G+GTY VY+ARD +G+IVALKKVR D +E + + + REI +L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD-NERDGIPISSLREITLLLN 62
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
L HPN+++L+ + + S++LV ++ + DL ++ +E QVKC M QLL GLQ
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
+ HE I+HRD+K SNLL+ G LKIADFGL+ + K P+T +VVTLWYRAPELLL
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLL 181
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM-KL-- 342
G T Y ID+W+ GC+LAE+ +PL+PG++E+EQL I +L GTP+E W L
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241
Query: 343 --TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400
T Q Y + + F + +L LL DP R TA AL++ +F PL C
Sbjct: 242 VGKFTLPKQPYN-NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300
Query: 401 DLSSLP 406
+ +P
Sbjct: 301 EPEMMP 306
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 292 bits (749), Expect = 1e-96
Identities = 117/288 (40%), Positives = 167/288 (57%), Gaps = 8/288 (2%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L ++G+G + V+KA+DR+TG+ VALKKV E REI+ LQ HP V
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 172 IKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
+KL L LV ++M SDL++++ + L E QVK YM+ LL G+ + H G
Sbjct: 62 VKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG 291
I+HRD+K +NLLI G+LKIADFGL+ F ++ + +V T WYRAPELL G+ Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 292 VGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL-----TTTF 346
G+DLW+ GC+ AE+ G PL PG ++EQL +F+ GTP+E+ W + TF
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
P E+F + P + +L LL DP+ R +AA AL++ +F
Sbjct: 240 PESKPIP-LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 285 bits (732), Expect = 4e-94
Identities = 133/289 (46%), Positives = 182/289 (62%), Gaps = 13/289 (4%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHPN 170
Y K+ K+G+GTY VYKARD+ TG+IVALKK+R +T E E V A REI +L++L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHE 229
+++L + S + LYLVF+F+ DL K + P L P +K Y+ QLL G+ +CH
Sbjct: 60 IVRLLDVVHS--ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPELLLGST 288
+LHRD+K NLLID+ G LK+ADFGL+ F +P + T VVTLWYRAPE+LLGS
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSR 175
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL----TT 344
Y +D+WS GC+ AEM RPL PG +E++QL RIF+ GTP ED W +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
TF P+ + +V +L+ +L DPA R +A +ALQ+ +F
Sbjct: 236 TF-PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 286 bits (733), Expect = 6e-94
Identities = 132/300 (44%), Positives = 181/300 (60%), Gaps = 17/300 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
Y+KLAK+GQGT+ V+KAR + T +IVALKKV + +E E A REI+ILQ L H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME-NEKEGFPITALREIKILQLLKH 70
Query: 169 PNVIKL------EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLS 222
NV+ L + +R + S YLVF+F + DL ++ K T ++K M+ LL+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN-FFIPKQKGP--LTSRVVTLWYR 279
GL + H ILHRD+KA+N+LI K G+LK+ADFGL+ F + K P T+RVVTLWYR
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW-- 337
PELLLG DYG ID+W AGC++AEM+ P+M G TE QL I +LCG+ + + W
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 338 -KKMKLTTTFR-PQHYKPSFREVFGEFPPSSYG--ILTTLLALDPAYRGTAASALQNEFF 393
K++L PQ K +E + + ++ LL LDPA R A +AL ++FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 278 bits (712), Expect = 7e-91
Identities = 122/299 (40%), Positives = 184/299 (61%), Gaps = 14/299 (4%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQK 165
+ D +D + ++G+GTY VYKARD+DTG++VALKKVR D +E E A REI+IL++
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD-NEKEGFPITAIREIKILRQ 62
Query: 166 LDHPNVIKLEGLATSRM--------QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYM 217
L+H N++ L+ + T + + + YLVF++M DL ++ +E +K +M
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 218 QQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW 277
+QLL GL +CH++ LHRDIK SN+L++ G +K+ADFGL+ + ++ P T++V+TLW
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337
YR PELLLG YG ID+WS GC+L E+F +P+ E+ QL I +LCG+P W
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 338 K---KMKLTTTFRPQH-YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
K+ T +P+ Y+ RE F P + +L +L LDP+ R TA AL + +
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 272 bits (697), Expect = 3e-89
Identities = 105/283 (37%), Positives = 162/283 (57%), Gaps = 30/283 (10%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y+ L K+G+G++ VY ARD+ TGK+VA+K ++ + + + REI+IL+KL HPN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-KIKKDRERILREIKILKKLKHPNI 59
Query: 172 IKLEGLATSRMQYSLYLVFDFM-QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
++L + LYLV ++ DL ++ + G +L+E + + Y++Q+LS L++ H +
Sbjct: 60 VRLYDVFEDE--DKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSK 116
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
GI+HRD+K N+L+D+ G +K+ADFGL+ P +K LT+ V T Y APE+LLG Y
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KGY 173
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350
G +D+WS G +L E+ G+P PG +QL +FK G P
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKP------------------ 212
Query: 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
KP F + P + ++ LL DP R TA ALQ+ FF
Sbjct: 213 -KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 1e-87
Identities = 130/301 (43%), Positives = 182/301 (60%), Gaps = 22/301 (7%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
D+Y+KL K+G+GTY VYKARD++TGK+VALKK R + + E + A REI +LQ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 169 -PNVIKL---EGLATSRMQYSLYLVFDFMQSDLTKIICR----PGQKLTEPQVKCYMQQL 220
+++L E + + SLYLVF+++ SDL K + PG+ L +K +M QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGM-LKIADFGLS-NFFIPKQKGPLTSRVVTLWY 278
L G+ HCH+ G++HRD+K NLL+DK LKIAD GL F IP + T +VTLWY
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWY 177
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338
RAPE+LLGST Y +D+WS GC+ AEM +PL PG +E++QL IFKL GTP+E W
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 339 KMKLTTTFRPQHYKPSFRE-----VFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ + R H P ++ + P +L +L DPA R +A +AL + +F
Sbjct: 238 GV---SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
Query: 394 N 394
+
Sbjct: 295 D 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 7e-87
Identities = 132/294 (44%), Positives = 180/294 (61%), Gaps = 21/294 (7%)
Query: 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHP 169
++ K+ K+G+GTY VYKAR++ TG++VALKK+R DT E E V A REI +L++L+HP
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 59
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKII-CRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++KL L + LYLVF+F+ DL K + P + P +K Y+ QLL GL CH
Sbjct: 60 NIVKL--LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPELLLGS 287
+LHRD+K NLLI+ G +K+ADFGL+ F +P + T VVTLWYRAPE+LLG
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGC 175
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347
Y +D+WS GC+ AEM R L PG +E++QL RIF+ GTP E W + T
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV----TSL 231
Query: 348 PQHYKPSF----REVFGEFPP----SSYGILTTLLALDPAYRGTAASALQNEFF 393
P YKPSF R+ F + P +L+ +L DP R +A +AL + FF
Sbjct: 232 PD-YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 268 bits (688), Expect = 9e-87
Identities = 108/294 (36%), Positives = 167/294 (56%), Gaps = 13/294 (4%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y+ L +G G Y V A D+ TG+ VA+KK+ + K + REI++L+ L H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 172 IKLEGLAT--SRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
I L + S ++ +Y+V + M++DL K+I + Q LT+ ++ ++ Q+L GL++ H
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVI-KSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFF--IPKQKGPLTSRVVTLWYRAPELLLG 286
++HRD+K SN+L++ + LKI DFGL+ +KG LT VVT WYRAPELLL
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
S+ Y ID+WS GC+ AE+ +PL PGR ++QL+ I ++ GTPSE+ K +
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF-ITSEKA 239
Query: 347 R------PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
R P+ K ++F P + +L +L DP R TA AL + +
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 266 bits (683), Expect = 1e-86
Identities = 119/295 (40%), Positives = 169/295 (57%), Gaps = 21/295 (7%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE---PESVKFMAREIRILQKLD- 167
Y++LA++G+G Y VYKARD +TG+ VALKKVR SE P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 168 --HPNVIKL----EGLATSRMQYSLYLVFDFMQSDLTKIICR-PGQKLTEPQVKCYMQQL 220
HPN+++L G T R + L LVF+ + DL + + P L +K M+QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
L G+ H I+HRD+K N+L+ G +KIADFGL+ + + LTS VVTLWYRA
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYRA 174
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
PE+LL S+ Y +D+WS GC+ AE+F RPL G +E +QL +IF + G PSE+ W +
Sbjct: 175 PEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 341 KLTT--TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+F SF+ E +L +L +P R +A ALQ+ +F
Sbjct: 234 VSLPRSSFPSYT-PRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 264 bits (676), Expect = 9e-86
Identities = 122/291 (41%), Positives = 177/291 (60%), Gaps = 15/291 (5%)
Query: 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE--PESVKFMAREIRILQKLDH 168
++ +L K+G+GTY+ VYK R+R TG+IVALK++ D E P + REI ++++L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKH 57
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQK--LTEPQVKCYMQQLLSGLQH 226
N+++L + + + L LVF++M DL K + G + L VK + QLL G+
Sbjct: 58 ENIVRLHDVIHT--ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPELLL 285
CHE +LHRD+K NLLI+K G LK+ADFGL+ F IP ++ VVTLWYRAP++LL
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLL 173
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
GS Y ID+WS GC++AEM GRPL PG +QL +IF++ GTP+E W +
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233
Query: 346 FRP--QHYKP-SFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
++P Y P +++F P +L LL L+P R +A ALQ+ +F
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 263 bits (674), Expect = 9e-85
Identities = 128/320 (40%), Positives = 187/320 (58%), Gaps = 32/320 (10%)
Query: 116 AKVGQGTYSNVYKARDRDTGKIVALKKVR------FDTSEPESV-----KFMA-REIRIL 163
A +G+GTY V KA D TGKIVA+KKV+ T + + V F RE++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 164 QKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
++ H N++ L + + LV D M SDL K++ R +LTE QVKC + Q+L+G
Sbjct: 75 NEIKHENIMGLVDVYVE--GDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNG 131
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI-------------PKQKGPLT 270
L H+ +HRD+ +N+ I+ G+ KIADFGL+ + +++ +T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG 330
S+VVTLWYRAPELL+G+ Y +D+WS GC+ AE+ G+PL PG E++QL RIF+L G
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 331 TPSEDYW---KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA 387
TP+ED W KK+ L T F P+ K + +F + +L +LL L+P R +A A
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPK-DLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310
Query: 388 LQNEFFNASPLACDLSSLPV 407
L++E+F + PL CD S LP
Sbjct: 311 LKHEYFKSDPLPCDPSQLPF 330
|
Length = 335 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 4e-83
Identities = 122/289 (42%), Positives = 172/289 (59%), Gaps = 11/289 (3%)
Query: 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHP 169
Y+KL K+G+GTY V+KA++R+T +IVALK+VR D + E V A REI +L++L H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHK 59
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N+++L + S L LVF++ DL K + VK +M QLL GL CH
Sbjct: 60 NIVRLYDVLHS--DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLS-NFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
+LHRD+K NLLI+K+G LK+ADFGL+ F IP + ++ VVTLWYR P++L G+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAK 175
Query: 289 DYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347
Y ID+WSAGC+ AE+ GRPL PG +QL RIF+L GTP+E+ W + ++
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 348 P-QHYKP--SFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P Y S V + + +L LL +P R +A ALQ+ +F
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 255 bits (652), Expect = 4e-82
Identities = 129/291 (44%), Positives = 178/291 (61%), Gaps = 16/291 (5%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHPN 170
Y K+ K+G+GTY VYK R++ TG+IVA+KK+R + SE E V A REI +L++L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE-SEEEGVPSTAIREISLLKELQHPN 60
Query: 171 VIKLEGLATSRMQYS-LYLVFDFMQSDLTKII--CRPGQKLTEPQVKCYMQQLLSGLQHC 227
++ L+ + MQ S LYL+F+F+ DL K + GQ + VK Y+ Q+L G+ C
Sbjct: 61 IVCLQDVL---MQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPELLLG 286
H R +LHRD+K NLLID G++K+ADFGL+ F IP + T VVTLWYRAPE+LLG
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV--YTHEVVTLWYRAPEVLLG 175
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK----L 342
S Y +D+WS G + AEM +PL G +E++QL RIF++ GTP+ED W +
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
TF P+ K S R +L +L DPA R +A AL + +F
Sbjct: 236 KNTF-PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 1e-80
Identities = 99/284 (34%), Positives = 152/284 (53%), Gaps = 26/284 (9%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y+ L K+G G++ VYKA+ + TGKIVA+K ++ + + + + REIRIL++L HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 172 IKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
++L + LYLV ++ + DL + G L+E + K Q+L GL++ H
Sbjct: 61 VRLIDAFEDK--DHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
GI+HRD+K N+L+D++G++KIADFGL+ + LT+ V T WY APE+LLG Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK-LCGTPSEDYWKKMKLTTTFRPQ 349
G +D+WS G +L E+ G+P G ++QL I + L D K
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK----------- 225
Query: 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
S E + + L DP+ R TA LQ+ +F
Sbjct: 226 --WSSGSEEAKDL-------IKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (631), Expect = 8e-79
Identities = 113/294 (38%), Positives = 177/294 (60%), Gaps = 15/294 (5%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLD 167
++Y KL K+G+G+Y+ VYK R + TG++VALK++R + E F A RE +L+ L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDLK 61
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
H N++ L + ++ +L LVF+++ +DL + + G L+ V+ ++ QLL GL +C
Sbjct: 62 HANIVTLHDIIHTKK--TLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNF-FIPKQKGPLTSRVVTLWYRAPELLLG 286
H+R +LHRD+K NLLI + G LK+ADFGL+ +P + ++ VVTLWYR P++LLG
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLG 177
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV-EQLHRIFKLCGTPSEDYWKKMKLTTT 345
ST+Y +D+W GC+ EM GRPL PG T+V +QLH+IF++ GTP+E+ W +
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237
Query: 346 FRPQ---HYKP-SFREVFGEFPPSSYG--ILTTLLALDPAYRGTAASALQNEFF 393
F+P Y P +G + L +P R +AA A+++ +F
Sbjct: 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 246 bits (629), Expect = 1e-78
Identities = 123/301 (40%), Positives = 185/301 (61%), Gaps = 30/301 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
D Y+K+ K+G+GTY VYKARDR T + +ALKK+R + E E V A REI +L+++ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQH 60
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQ-VKCYMQQLLSGLQHC 227
N+++L+ + S + LYLVF+++ DL K + P+ +K Y+ Q+L G+ +C
Sbjct: 61 GNIVRLQDVVHS--EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 228 HERGILHRDIKASNLLIDKS-GMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPELLL 285
H +LHRD+K NLLID+ LK+ADFGL+ F IP + T VVTLWYRAPE+LL
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILL 176
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
GS Y +D+WS GC+ AEM +PL PG +E+++L +IF++ GTP+E+ W + T+
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV---TS 233
Query: 346 FRPQHYKPSFREVFGEFPPSSYG------------ILTTLLALDPAYRGTAASALQNEFF 393
P ++ F ++PP +L+ +L LDP+ R TA +AL++E+F
Sbjct: 234 L------PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
Query: 394 N 394
Sbjct: 288 K 288
|
Length = 294 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 2e-77
Identities = 109/290 (37%), Positives = 179/290 (61%), Gaps = 15/290 (5%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKV--RFDTSEPESVKFMAREIRILQKL-DH 168
Y + ++G GT+ +VY AR+++TG++VA+KK+ +F + E E + RE++ L+KL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKII-CRPGQKLTEPQVKCYMQQLLSGLQHC 227
PN++KL R LY VF++M+ +L +++ R G+ +E ++ + Q+L GL H
Sbjct: 58 PNIVKL--KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H+ G HRD+K NLL+ ++KIADFGL+ + + P T V T WYRAPE+LL S
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAPEILLRS 173
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK-MKLTTT- 345
T Y +D+W+ GC++AE++ RPL PG +E++QL++I + GTP++ W + KL +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 346 -FRPQHYKP-SFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
FR + P S ++ P + ++ +L DP R TA+ ALQ+ +F
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 6e-77
Identities = 102/290 (35%), Positives = 160/290 (55%), Gaps = 8/290 (2%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y+ L VG+G Y V K R++ TG+IVA+KK + + + K RE+++L++L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N++ L R + LYLVF++++ L +++ L V+ Y+ QLL + +CH
Sbjct: 61 NIVNL--KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
I+HRDIK N+L+ +SG+LK+ DFG + + PLT V T WYRAPELL+G T+
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 290 YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG--TPS--EDYWKKMKLTT- 344
YG +D+W+ GC++AE+ G PL PG ++++QL+ I K G PS E + +
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 345 -TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P + R G+ + L L +DP R T LQ+ +F
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 7e-72
Identities = 105/296 (35%), Positives = 154/296 (52%), Gaps = 15/296 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
Y + +G G Y V A D +GK VA+KK+ P K RE++IL+ H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 170 NVIKLEGLATSRMQY--SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
N+I + + +Y+V D M+SDL II Q LTE ++ ++ QLL GL++
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFG----LSNFFIPKQKGPLTSRVVTLWYRAPEL 283
H ++HRD+K SNLL+++ L+I DFG LS+ + K +T V T WYRAPEL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-EHKYFMTEYVATRWYRAPEL 182
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM--- 340
LL +Y ID+WS GC+ AEM R L PG+ V QL I + G+PSE+ ++
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242
Query: 341 ---KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
K P+ + ++F + P + +L+ +L DP R T ALQ+ F
Sbjct: 243 RVRKYIQNL-PRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 1e-70
Identities = 108/315 (34%), Positives = 162/315 (51%), Gaps = 33/315 (10%)
Query: 112 YDKLAKVGQGTYSNVYKAR--DRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
Y+ +G+GTY VYKA+ + GK A+KK + D + + A REI +L++L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQK----LTEPQVKCYMQQLLSGL 224
NV+ L + S+YL+FD+ + DL +II Q + VK + Q+L+G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 225 QHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFFIPKQKGPLTSR--VVTLWY 278
+ H +LHRD+K +N+L+ + G++KI D GL+ F K VVT+WY
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---------VEQLHRIFKLC 329
RAPELLLG+ Y ID+W+ GC+ AE+ P+ GR +QL RIF++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 330 GTPSEDYW---KKM----KLTTTFRPQHYK----PSFREVFGEFPPSSYGILTTLLALDP 378
GTP+E W KKM L F+ + Y + E + + +L LL DP
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301
Query: 379 AYRGTAASALQNEFF 393
R TA AL++ +F
Sbjct: 302 TKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 1e-70
Identities = 116/309 (37%), Positives = 167/309 (54%), Gaps = 34/309 (11%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHP 169
Y+ L K+G+G Y V+KA DR T ++VALKK+ FD + REI LQ+L DHP
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 170 NVIKLEGLATSRMQ--YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCY-MQQLLSGLQH 226
N++KL L + + +YLVF++M++DL +I R + E K Y M QLL L++
Sbjct: 68 NIVKL--LNVIKAENDKDIYLVFEYMETDLHAVI-RAN--ILEDVHKRYIMYQLLKALKY 122
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGL----SNFFIPKQKGPLTSRVVTLWYRAPE 282
H ++HRD+K SN+L++ +K+ADFGL S + LT V T WYRAPE
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSE-------- 334
+LLGST Y G+D+WS GC+L EM +G+PL PG + + QL +I ++ G PS
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242
Query: 335 DYWKKM--KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ--- 389
+ M L P + E+ + + +L LL +P R TA AL+
Sbjct: 243 PFAATMLDSL-----PSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297
Query: 390 -NEFFNASP 397
+F N S
Sbjct: 298 VAQFHNPSD 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 2e-70
Identities = 114/289 (39%), Positives = 174/289 (60%), Gaps = 10/289 (3%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
++Y KL K+G+GTY+ V+K R + T +VALK++R + E + RE+ +L+ L H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHA 63
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N++ L + + + L LVF+++ SDL + + G ++ VK +M QLL GL +CH+
Sbjct: 64 NIVTLHDIIHT--ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNF-FIPKQKGPLTSRVVTLWYRAPELLLGST 288
R ILHRD+K NLLI++ G LK+ADFGL+ +P + ++ VVTLWYR P++LLGST
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGST 179
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR- 347
+Y ID+W GC+L EM GRP+ PG T E+LH IF+L GTP+E+ W + FR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239
Query: 348 ---PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
PQ+ +L++LL + R +A +AL++ +F
Sbjct: 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 7e-69
Identities = 111/294 (37%), Positives = 161/294 (54%), Gaps = 17/294 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D Y L+ VG G Y V A D TG+ VA+KK+ K RE+R+L+ +DH
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 170 NVIKLEGL---ATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
NVI L + A+S + +YLV M +DL I+ QKL++ ++ + Q+L GL+
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLK 132
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
+ H GI+HRD+K SN+ +++ LKI DFGL+ +T V T WYRAPE++L
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 188
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
Y +D+WS GC++AE+ G+ L PG ++QL RI L GTP E+ +K+ +
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 346 FR------PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
R PQ K F+EVF P + +L +L LDP R TAA AL + +
Sbjct: 249 -RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 216 bits (550), Expect = 1e-66
Identities = 113/289 (39%), Positives = 170/289 (58%), Gaps = 10/289 (3%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
++Y KL K+G+GTY+ VYK R + T +VALK++R + E + RE+ +L+ L H
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 64
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N++ L + + + SL LVF+++ DL + + G + VK ++ QLL GL +CH
Sbjct: 65 NIVTLHDIIHT--EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNF-FIPKQKGPLTSRVVTLWYRAPELLLGST 288
R +LHRD+K NLLI++ G LK+ADFGL+ IP + ++ VVTLWYR P++LLGST
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGST 180
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348
DY ID+W GC+ EM GRPL PG T EQLH IF++ GTP+E+ W + F+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240
Query: 349 QHYKPSFREVFGEFPP----SSYGILTTLLALDPAYRGTAASALQNEFF 393
+Y + P +L+ LL + R +A A+++ +F
Sbjct: 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 2e-66
Identities = 100/295 (33%), Positives = 162/295 (54%), Gaps = 20/295 (6%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESV--KFMAREIRILQKLD 167
+ Y+KL+K+G+G+Y V+K R+R+TG+IVA+KK F SE + V K REIR+L++L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK--FVESEDDPVIKKIALREIRMLKQLK 58
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
HPN++ L + R + L+LVF++ + + + + + E +K + Q L + C
Sbjct: 59 HPNLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H+ +HRD+K N+LI K G +K+ DFG + T V T WYRAPELL+G
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVGD 175
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT---------PSEDYWK 338
T YG +D+W+ GC+ AE+ G+PL PG+++V+QL+ I K G + ++K
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ + P+ +P F + L L +DP R + L++ +F
Sbjct: 236 GLSIPE---PETREP-LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 1e-64
Identities = 100/289 (34%), Positives = 163/289 (56%), Gaps = 12/289 (4%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHPN 170
Y+ L VG+G+Y V K + ++TG+IVA+KK ++ + + VK +A REIR+L++L H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
++ L + R + LYLVF+F+ + + + L E +V+ Y+ Q+L G++ CH
Sbjct: 62 LVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
I+HRDIK N+L+ +SG++K+ DFG + + T V T WYRAPELL+G T Y
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRWYRAPELLVGDTKY 178
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF---- 346
G +D+W+ GCL+ EM G PL PG ++++QL+ I K G + + + F
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238
Query: 347 --RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ +P + F + + L +DP R +++ L +EFF
Sbjct: 239 LPEVKEIEP-LEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 2e-64
Identities = 114/295 (38%), Positives = 171/295 (57%), Gaps = 15/295 (5%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKL 166
+A SY L K+G+G+Y+ VYK R G++VALK + T E V F A RE +L+ L
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGL 60
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
H N++ L + ++ +L VF++M +DL + + + L V+ +M QLL GL +
Sbjct: 61 KHANIVLLHDIIHTKE--TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNF-FIPKQKGPLTSRVVTLWYRAPELLL 285
H + ILHRD+K NLLI G LK+ADFGL+ IP Q +S VVTLWYR P++LL
Sbjct: 119 IHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLL 176
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV-EQLHRIFKLCGTPSEDYWKKMKLTT 344
G+TDY +D+W AGC+ EM G+P PG ++V EQL +I+ + G P+ED W +
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236
Query: 345 TFRPQHYKPS----FREVFGEF--PPSSYGILTTLLALDPAYRGTAASALQNEFF 393
++P+ + P R V+ PP + + + +L + P R +A AL + +F
Sbjct: 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 7e-64
Identities = 118/291 (40%), Positives = 167/291 (57%), Gaps = 13/291 (4%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL---DH 168
Y+ +A++G G Y VYKARD +G VALK VR T+E RE+ +L++L DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 169 PNVIKLEGL-ATSRM--QYSLYLVFDFMQSDLTKIICR-PGQKLTEPQVKCYMQQLLSGL 224
PN+++L + ATSR + + LVF+ + DL + + P L +K M+Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
H I+HRD+K N+L+ G +K+ADFGL+ + + LT VVTLWYRAPE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVL 179
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW-KKMKLT 343
L ST Y +D+WS GC+ AEMF +PL G +E +QL +IF L G P ED W + + L
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 344 -TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
F P+ +P + V E S +L +L +P R +A ALQ+ FF
Sbjct: 239 RGAFSPRGPRP-VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 5e-63
Identities = 112/302 (37%), Positives = 177/302 (58%), Gaps = 12/302 (3%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
++Y KL K+G+GTY+ V+K R + T +VALK++R + E + RE+ +L+ L H
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 64
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N++ L + + SL LVF+++ DL + + G ++ VK ++ Q+L GL +CH
Sbjct: 65 NIVTLHDIVHT--DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNF-FIPKQKGPLTSRVVTLWYRAPELLLGST 288
R +LHRD+K NLLI++ G LK+ADFGL+ +P + ++ VVTLWYR P++LLGS+
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSS 180
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348
+Y ID+W GC+ EM GRPL PG T ++LH IF+L GTP+E+ W + F+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240
Query: 349 QHYKPSFREVFGEFPP--SSYGI--LTTLLALDPAYRGTAASALQNEFFNASPLACDLSS 404
++ + P + GI LT L + R +A A+++ +F + L + S
Sbjct: 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS--LGTRIHS 298
Query: 405 LP 406
LP
Sbjct: 299 LP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 2e-62
Identities = 111/311 (35%), Positives = 168/311 (54%), Gaps = 39/311 (12%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKV------RFDTSEPESVKFMAREIRILQKLDHPNV 171
+G+G Y V A++ +T + VA+KK+ R D K REI++L+ LDH NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA------KRTLREIKLLRHLDHENV 66
Query: 172 IKLEGL--ATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
I ++ + R ++ +Y+V++ M +DL +II R Q L++ + ++ QLL GL++ H
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQII-RSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
+LHRD+K SNLL++ + LKI DFGL+ K +T VVT WYRAPELLL +
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCS 184
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED------------Y 336
+Y ID+WS GC+ AE+ +PL PG+ V QL I +L G+PSE+ Y
Sbjct: 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244
Query: 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396
+ + P + SF +F P + +L +L DP+ R T AL + + +
Sbjct: 245 IRSL-------PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL--A 295
Query: 397 PLACDLSSLPV 407
L D S PV
Sbjct: 296 SLH-DPSDEPV 305
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 2e-62
Identities = 112/288 (38%), Positives = 157/288 (54%), Gaps = 12/288 (4%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALK--KVRFDTSEPESVKFMAREIRILQKL-DH 168
Y L K+G+GT+S V KA+ R TGK A+K K F + E + REI+ L++L H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPH 57
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
PN+++L + R L LVF+ M +L ++I + L E +VK YM QLL L H H
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
GI HRDIK N+LI K +LK+ADFG S I K P T + T WYRAPE LL
Sbjct: 118 RNGIFHRDIKPENILI-KDDILKLADFG-SCRGI-YSKPPYTEYISTRWYRAPECLLTDG 174
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT--TF 346
YG +D+W+ GC+ E+ PL PG E++Q+ +I + GTP + KK + + +
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234
Query: 347 RPQHYKPS-FREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
K + R++ +L LLA DP R TA AL++ +F
Sbjct: 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 3e-62
Identities = 75/191 (39%), Positives = 116/191 (60%), Gaps = 6/191 (3%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGL 177
+G+G + VY ARD+ TGK VA+K ++ + S + + REI IL+KL+HPN++KL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 178 ATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRD 236
+ LYLV ++ + L ++ KL+E ++ + Q+L GL++ H GI+HRD
Sbjct: 60 FED--ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 237 IKASNLLIDK-SGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGID 295
+K N+L+D +G +K+ADFGLS + K L + V T Y APE+LLG Y D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLS-KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 296 LWSAGCLLAEM 306
+WS G +L E+
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 9e-62
Identities = 109/297 (36%), Positives = 164/297 (55%), Gaps = 16/297 (5%)
Query: 103 GLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRI 162
G V + + Y L VG G + V ARD+ TG+ VA+KK+ S P K RE+++
Sbjct: 3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKL 62
Query: 163 LQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKII-CRPGQKLTEPQ-VKCYMQQL 220
L+ L H N+I L + S ++ +Y V + + +DL +++ RP E Q ++ ++ Q+
Sbjct: 63 LKHLRHENIISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRP----LEKQFIQYFLYQI 117
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
L GL++ H G++HRD+K SN+LI+++ LKI DFGL+ Q +T V T +YRA
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRA 173
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
PE++L Y V +D+WSAGC+ AEM G+PL PG+ V Q I L GTP +D +
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233
Query: 341 KLTTTFR-----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
T R P+ F E F PS+ +L +L DP R +AA AL + +
Sbjct: 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 3e-61
Identities = 113/298 (37%), Positives = 176/298 (59%), Gaps = 15/298 (5%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLD 167
ADSY+KL K+G+G+Y+ VYK + + GK+VALK +R E E F A RE +L+ L
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL--QEEEGTPFTAIREASLLKGLK 61
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
H N++ L + ++ +L LVF+++ +DL + + + L VK ++ QLL GL +
Sbjct: 62 HANIVLLHDIIHTKE--TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNF-FIPKQKGPLTSRVVTLWYRAPELLLG 286
H+R ILHRD+K NLLI +G LK+ADFGL+ +P ++ VVTLWYR P++LLG
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT--YSNEVVTLWYRPPDVLLG 177
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVE-QLHRIFKLCGTPSEDYWKKMKLTTT 345
ST+Y +D+W GC+ EM G PG +++ QL RIF + GTP+ED W +
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237
Query: 346 FRPQHY----KPSFREVFGEFPPSSYG--ILTTLLALDPAYRGTAASALQNEFFNASP 397
F+P+ + + R+ + + ++ + + LL P R +A +AL +E+F+ P
Sbjct: 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 1e-60
Identities = 103/298 (34%), Positives = 155/298 (52%), Gaps = 21/298 (7%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA----REIRILQ 164
Y L+ +G+G Y V A + TG VA+KK+ P + REI+IL+
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-----SPFEHQTFCQRTLREIKILR 58
Query: 165 KLDHPNVIKLEGLATSRMQYSL---YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLL 221
+ H N+I + + S Y+V + M++DL K+I Q L+ ++ ++ Q+L
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLI--KTQHLSNDHIQYFLYQIL 116
Query: 222 SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP--KQKGPLTSRVVTLWYR 279
GL++ H +LHRD+K SNLL++ + LKI DFGL+ P G LT V T WYR
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS-EDYW- 337
APE++L S Y ID+WS GC+LAEM RPL PG+ + QL+ I + GTPS ED
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 338 -KKMKLTTTFR--PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
++ + P K + ++F P + +L +L +P R T AL + +
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 7e-57
Identities = 108/293 (36%), Positives = 161/293 (54%), Gaps = 15/293 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D Y L +VG G Y V A DR TG VA+KK+ K RE+R+L+ + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 170 NVIKLEGLATSRMQ----YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
NVI L + T + + YLV FM +DL K++ +KL+E +++ + Q+L GL+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM--KHEKLSEDRIQFLVYQMLKGLK 132
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
+ H GI+HRD+K NL +++ LKI DFGL+ + +T VVT WYRAPE++L
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVIL 188
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT-- 343
Y +D+WS GC++AEM G+PL G ++QL I K+ GTPS+++ +K++
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248
Query: 344 ---TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P+ K FR + P + +L +L LD R TAA AL + +F
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 9e-57
Identities = 104/313 (33%), Positives = 160/313 (51%), Gaps = 47/313 (15%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L +G G+ V+ A D D K VA+KK+ ++P+SVK REI+I+++LDH N+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL--TDPQSVKHALREIKIIRRLDHDNI 64
Query: 172 IKL-EGLATSRMQY-----------SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQ 219
+K+ E L S S+Y+V ++M++DL ++ + L+E + +M Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQ 122
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIP--KQKGPLTSRVVTL 276
LL GL++ H +LHRD+K +N+ I+ +LKI DFGL+ P KG L+ +VT
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 277 WYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK--------- 327
WYR+P LLL +Y ID+W+AGC+ AEM G+PL G E+EQ+ I +
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 328 ----LCGTPS---EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAY 380
L PS D + P+ R++ P + L +L +P
Sbjct: 243 RNELLNVIPSFVRNDGGE---------PRR---PLRDLLPGVNPEALDFLEQILTFNPMD 290
Query: 381 RGTAASALQNEFF 393
R TA AL + +
Sbjct: 291 RLTAEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 4e-56
Identities = 70/203 (34%), Positives = 120/203 (59%), Gaps = 4/203 (1%)
Query: 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN 170
+ + +G+G++ +VY A D+DTG+++A+K V E ++ + REIRIL L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 171 VIKLEGLATSRMQYSLYLVFDFM-QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
+++ G + +L + +++ L+ ++ + G KL EP ++ Y +Q+L GL + H
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS 119
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLS-NFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
GI+HRDIK +N+L+D G++K+ADFG + + S T ++ APE++ G
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-E 178
Query: 289 DYGVGIDLWSAGCLLAEMFIGRP 311
+YG D+WS GC + EM G+P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 5e-55
Identities = 115/296 (38%), Positives = 169/296 (57%), Gaps = 22/296 (7%)
Query: 112 YDKLAKVGQGTYSNVYKARD-RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD--- 167
Y+ +A++G+G Y V+KARD ++ G+ VALK+VR T E RE+ +L+ L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 168 HPNVIKLEGLAT-SRM--QYSLYLVFDFMQSDLTKIICRPGQKLTEPQV-----KCYMQQ 219
HPNV++L + T SR + L LVF+ + DLT + K+ EP V K M Q
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL----DKVPEPGVPTETIKDMMFQ 118
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
LL GL H ++HRD+K N+L+ SG +K+ADFGL+ + + LTS VVTLWYR
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYR 176
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW-K 338
APE+LL S+ Y +DLWS GC+ AEMF +PL G ++V+QL +I + G P E+ W +
Sbjct: 177 APEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235
Query: 339 KMKL-TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ L F + +P + + +L L +PA R +A SAL + +F
Sbjct: 236 DVALPRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 1e-54
Identities = 101/299 (33%), Positives = 161/299 (53%), Gaps = 20/299 (6%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDT--GKIVALKKVRFDTSEPESVKFMAREIRILQKL-DH 168
Y+ + ++GQG Y V AR+ +T + VA+KK+ S+ K RE+++L+ H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 169 PNVIKLEGL--ATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
N+ L + LYL + M++DL +II R GQ LT+ + ++ Q+L GL++
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLKY 120
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP---KQKGPLTSRVVTLWYRAPEL 283
H +LHRD+K NLL++ LKI DFGL+ F + G +T V T WYRAPE+
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343
+L Y ID+WS GC+LAE+ +P+ G+ V+QL++I ++ GTP E+ ++
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG-- 238
Query: 344 TTFRPQHY--------KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
+ + Q+Y K F +F P + +L LLA DP R + AL++ +
Sbjct: 239 -SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 4e-54
Identities = 109/294 (37%), Positives = 157/294 (53%), Gaps = 17/294 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y L+ VG G Y +V A D TG VA+KK+ K RE+R+L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 170 NVIKLEGL---ATSRMQYS-LYLVFDFMQSDLTKII-CRPGQKLTEPQVKCYMQQLLSGL 224
NVI L + A S +++ +YLV M +DL I+ C QKLT+ V+ + Q+L GL
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGL 133
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
++ H I+HRD+K SNL +++ LKI DFGL+ +T V T WYRAPE++
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM---- 340
L Y +D+WS GC++AE+ GR L PG ++QL I +L GTP + KK+
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 341 -KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ Q K +F VF P + +L +L LD R TAA AL + +F
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 4e-54
Identities = 104/292 (35%), Positives = 160/292 (54%), Gaps = 16/292 (5%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L +VG G Y +V A D+ TG+ VA+KK+ K RE+ +L+ + H NV
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 172 IKLEGLATS----RMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I L + TS YLV +MQ+DL KI+ G L+E +V+ + Q+L GL++
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H GI+HRD+K NL +++ LKI DFGL+ +T VVT WYRAPE++L
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILNW 189
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM-----KL 342
Y +D+WS GC++AEM G+ L G+ ++QL +I K+ G P ++ +K+ K
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
P++ + F +F + P + +L +L LD R TA AL++ +F+
Sbjct: 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 4e-53
Identities = 111/337 (32%), Positives = 168/337 (49%), Gaps = 34/337 (10%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y +G+G+Y V A D TG+ VA+KK+ + REI++L+ L HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 172 IKLEG--LATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
++++ L SR ++ +Y+VF+ M+SDL ++I + LT + ++ QLL L++ H
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL--TSRVVTLWYRAPELLLG 286
+ HRD+K N+L + LKI DFGL+ + T V T WYRAPEL G
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-G 179
Query: 287 S--TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW------K 338
S + Y ID+WS GC+ AE+ G+PL PG+ V QL I L GTPS + K
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239
Query: 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398
+ ++ R + P F + F P + +L LLA DP R TA AL + +F
Sbjct: 240 ARRYLSSMRKKQPVP-FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG--- 295
Query: 399 ACDLSSLPVICREEDEPARTSRRK------KRRSSKG 429
+ + E EP+ K +RR +K
Sbjct: 296 ---------LAKVEREPSAQPITKLEFEFERRRLTKE 323
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 9e-53
Identities = 104/281 (37%), Positives = 151/281 (53%), Gaps = 10/281 (3%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK-LEG 176
+G G + V+ D GK VALKK+ S K + RE+++L H NV+ L+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 177 LATSRMQY--SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
L + +Y+V + MQSDL KII P Q L+ VK ++ Q+L GL++ H GILH
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILH 126
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RDIK NLL++ + +LKI DFGL+ P + +T VVT +YRAPE+L+GS Y +
Sbjct: 127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAV 186
Query: 295 DLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS-EDYWKKMKLTTT--FRPQHY 351
D+WS GC+ AE+ R L ++ ++QL I L GTPS E + R H
Sbjct: 187 DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHK 246
Query: 352 KPSFREVFGEFPPSSY---GILTTLLALDPAYRGTAASALQ 389
PS ++ +++ +L +L DP R +AA AL
Sbjct: 247 PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 178 bits (451), Expect = 2e-51
Identities = 100/369 (27%), Positives = 157/369 (42%), Gaps = 31/369 (8%)
Query: 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHP 169
SY L K+G+G++ VY ARDR K+VALK + S+ + V+ REI+IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 170 -NVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQ--KLTEPQVKCYMQQLLSGLQ 225
N++KL + SLYLV +++ L ++ + G+ L+E + + Q+LS L+
Sbjct: 58 PNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 226 HCHERGILHRDIKASNLLIDKSGM-LKIADFGLSNFFIPKQ-----KGPLTSRVVTLWYR 279
+ H +GI+HRDIK N+L+D+ G +K+ DFGL+ ++ V T Y
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 280 APELLLGSTD--YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337
APE+LLG + D+WS G L E+ G P G + K
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK---------- 225
Query: 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397
++L T PS E ++ +L LLA DP R +++S L ++
Sbjct: 226 IILELPTPSLASPLSPSNPE---LISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282
Query: 398 LACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGET 457
L S + + + S S+ S G +
Sbjct: 283 LKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVS 342
Query: 458 ESSKELEKN 466
S
Sbjct: 343 SSPHNSSSL 351
|
Length = 384 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 6e-49
Identities = 100/291 (34%), Positives = 158/291 (54%), Gaps = 15/291 (5%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L VG G Y +V A D + VA+KK+ + RE+R+L+ + H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 172 IKLEGL---ATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I L + ATS ++ +YLV + M +DL I+ QKL++ V+ + QLL GL++
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV--KCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H GI+HRD+K SN+ +++ L+I DFGL+ + +T V T WYRAPE++L
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNW 190
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347
Y +D+WS GC++AE+ G+ L PG ++QL RI ++ GTPS + KK+ +
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250
Query: 348 -----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P + +++F P + +L +L LD R +A+ AL + +F
Sbjct: 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 1e-48
Identities = 72/212 (33%), Positives = 121/212 (57%), Gaps = 10/212 (4%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+G + VYK + +TG VA+K++ + + E++K + +EI +L+ L HPN++K G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ SLY++ ++ ++ L +II + G E V Y+ Q+L GL + HE+G++HR
Sbjct: 67 SIET--SDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVIHR 123
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI- 294
DIKA+N+L K G++K+ADFG++ + S V T ++ APE++ S G
Sbjct: 124 DIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIEMS---GASTA 179
Query: 295 -DLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
D+WS GC + E+ G P + L RI
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-47
Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 57/295 (19%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
++ L K+G+G + VYKAR + TGK VA+K + E + + EI+IL+K HPN+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPNI 59
Query: 172 IKLEGLATSRMQY----SLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
+K G Y L++V +F DL K + LTE Q+ ++LL G
Sbjct: 60 VKYYG------SYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKG 110
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
L++ H GI+HRDIKA+N+L+ G +K+ DFGLS + + V T ++ APE+
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--ARNTMVGTPYWMAPEV 168
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343
+ G Y D+WS G E+ G+P +L + K +
Sbjct: 169 ING-KPYDYKADIWSLGITAIELAEGKPPYS------ELPPM------------KALFKI 209
Query: 344 TTFRPQHYKPSFR------EVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
T P P R + F +F L L +P R TA L++ F
Sbjct: 210 ATNGP----PGLRNPEKWSDEFKDF-------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 97/294 (32%), Positives = 157/294 (53%), Gaps = 17/294 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
+ ++ L VG+G Y V K R ++T +IVA+KK + D+ E E VK RE+++L+ L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQ 59
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N+++L+ R + LYLVF++++ ++ +++ + +V+ Y+ QL+ + CH
Sbjct: 60 ENIVELK--EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
+ I+HRDIK NLLI + +LK+ DFG + T V T WYR+PELLLG+
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT-PSEDY--------WKK 339
YG +D+WS GC+L E+ G+PL PG +E++QL I K+ G P+E +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
++ PQ + R G ++ LL L+P R L + F
Sbjct: 237 LRFPAVNHPQSLE---RRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 37/288 (12%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y+ + ++G+G++ VY R + GK+ LK++ + + E++IL+KL+HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 172 IKL-EGLATSRMQYSLYLVFDFMQS-DLTKII---CRPGQKLTEPQVKCYMQQLLSGLQH 226
IK E + L +V ++ DL++ I + G+ E Q+ + QL L++
Sbjct: 62 IKYYESFEE---KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLL 285
H R ILHRDIK N+ + +G++K+ DFG+S L VV T +Y +PEL
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVVGTPYYLSPELCQ 176
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
Y D+WS GC+L E+ + G +E +I K G
Sbjct: 177 NKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYPPI---------- 223
Query: 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P Y R ++++LL DP R + A LQ+ F
Sbjct: 224 --PSQYSSELRN-----------LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 9e-46
Identities = 110/315 (34%), Positives = 161/315 (51%), Gaps = 43/315 (13%)
Query: 117 KVGQGTYSNVYKARDRDTG--KIVALKKVRFDTSEPESVKFMA-REIRILQKLDHPNVIK 173
KVG+GTY +VYKA+ +D K ALK++ E + A REI +L++L HPNVI
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-----EGTGISMSACREIALLRELKHPNVIA 62
Query: 174 LEGLATSRMQYSLYLVFDFMQSDLTKII--------CRPGQKLTEPQVKCYMQQLLSGLQ 225
L+ + S ++L+FD+ + DL II + +L VK + Q+L G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 226 HCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFFIPKQK--GPLTSRVVTLWYR 279
+ H +LHRD+K +N+L+ + G +KIAD G + F K L VVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---------VEQLHRIFKLCG 330
APELLLG+ Y ID+W+ GC+ AE+ P+ R E +QL RIF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 331 TPSEDYWKKMK-------LTTTFRPQHYKPS----FREVFGEFPPSS-YGILTTLLALDP 378
P++ W+ ++ L FR Y S + E P S + +L LL +DP
Sbjct: 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302
Query: 379 AYRGTAASALQNEFF 393
R T+ ALQ+ +F
Sbjct: 303 TKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 110/316 (34%), Positives = 162/316 (51%), Gaps = 45/316 (14%)
Query: 117 KVGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHPNVIK 173
KVG+GTY +VYKA+ +D + ALK++ E + A REI +L++L HPNVI
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPNVIS 62
Query: 174 LEGLATSRMQYSLYLVFDFMQSDLTKIIC---------RPGQKLTEPQVKCYMQQLLSGL 224
L+ + S ++L+FD+ + DL II +P Q L VK + Q+L G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ-LPRGMVKSLLYQILDGI 121
Query: 225 QHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFFIPKQK--GPLTSRVVTLWY 278
+ H +LHRD+K +N+L+ + G +KIAD G + F K L VVT WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---------VEQLHRIFKLC 329
RAPELLLG+ Y ID+W+ GC+ AE+ P+ R E +QL RIF +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241
Query: 330 GTPSEDYWKKMK-------LTTTFRPQHYKP----SFREVFGEFPPS-SYGILTTLLALD 377
G P++ W+ +K L FR Y + E P S ++ +L LL +D
Sbjct: 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301
Query: 378 PAYRGTAASALQNEFF 393
P R T+ A+Q+ +F
Sbjct: 302 PIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 98/308 (31%), Positives = 159/308 (51%), Gaps = 35/308 (11%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L +G G V A D TG+ VA+KK+ K RE+ +++ ++H N+
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 172 IKLEGLATSRMQYS----LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I L + T + +YLV + M ++L ++I L ++ + Q+L G++H
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHL 134
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGL----SNFFIPKQKGPLTSRVVTLWYRAPEL 283
H GI+HRD+K SN+++ LKI DFGL F+ +T VVT +YRAPE+
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM------MTPYVVTRYYRAPEV 188
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343
+LG Y +D+WS GC++ EM G L PG ++Q ++I + GTPS+++ +++ T
Sbjct: 189 ILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247
Query: 344 TTF----RPQHYKPSFREVFGE--FPPSS-----------YGILTTLLALDPAYRGTAAS 386
RP++ SF E+F + FPP S +L+ +L +DP R +
Sbjct: 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307
Query: 387 ALQNEFFN 394
ALQ+ + N
Sbjct: 308 ALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 109/337 (32%), Positives = 163/337 (48%), Gaps = 30/337 (8%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD 167
SY +G G++ VY+A DT + VA+KKV D ++ RE+ I++ L+
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLN 117
Query: 168 HPNVIKL------EGLATSRMQYSLYLVFDFMQSDLTKII---CRPGQKLTEPQVKCYMQ 218
H N+I L E + L +V +F+ + K + R L VK Y
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 219 QLLSGLQHCHERGILHRDIKASNLLID-KSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW 277
QL L + H + I HRD+K NLLID + LK+ DFG + + Q+ S + + +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRF 235
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337
YRAPEL+LG+T+Y IDLWS GC++AEM +G P+ G++ V+QL RI ++ GTP+ED
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 338 KKM--KLTTTFRPQHYKPSFREVFGE-FPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
K+M P ++VF + P + ++ L +P R AL + FF+
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355
Query: 395 ASPLAC--------DLSSLPVICREE-DEPARTSRRK 422
C L L C E E + RRK
Sbjct: 356 DLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRK 392
|
Length = 440 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 6e-43
Identities = 78/276 (28%), Positives = 127/276 (46%), Gaps = 41/276 (14%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G++ V R +DTGK+ A+K ++ E E E IL +++HP ++K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL---TERNILSRINHPFIVK 57
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
L + + LYLV ++ +L + + G + +E + + Y +++ L++ H GI
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGI 114
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTDYG 291
++RD+K N+L+D G +K+ DFGL+ +G T+ T Y APE+LLG YG
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELS--SEGSRTNTFCGTPEYLAPEVLLG-KGYG 171
Query: 292 VGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY 351
+D WS G LL EM G+P E +I K L
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI------------LKDPLRF------- 212
Query: 352 KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA 387
P F P + +++ LL DP R + A
Sbjct: 213 -PEF------LSPEARDLISGLLQKDPTKRLGSGGA 241
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 83/286 (29%), Positives = 141/286 (49%), Gaps = 33/286 (11%)
Query: 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+ K+G GT+ VY A + DTG+++A+K++R ++P+++K +A E+++L+ L HPN++K
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 174 LEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
G+ R + +Y+ ++ + + G+ L E ++ Y QLL GL + H GI+
Sbjct: 64 YYGVEVHREK--VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL----WYRAPELLLGSTD 289
HRDIK +N+ +D +G++K+ DFG + + V +L Y APE++ G
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFG-CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 290 YGVG--IDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI-FKLCGTPSEDYWKKMKLTTTF 346
G G D+WS GC++ EM G+ E++ +I F +
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWS---ELDNEFQIMFHVG----------AGHKPPI 227
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
P + S P L L DP R TA+ LQ+ F
Sbjct: 228 -PDSLQLS---------PEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 92/300 (30%), Positives = 140/300 (46%), Gaps = 42/300 (14%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L K+G+G VYKA DR TGK VA+KK+R E + EI I++ HPN+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNI 77
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+ + + L++V ++M LT II + ++ EPQ+ +++L GL++ H +
Sbjct: 78 VDY--YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
++HRDIK+ N+L+ K G +K+ADFG + + K+K S V T ++ APE++ DY
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAA-QLTKEKSKRNSVVGTPYWMAPEVIKRK-DY 193
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTP--SEDYWKKMKLTTTFRP 348
G +D+WS G + EM G P P E + + L TT
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEP--------------------PYLREPPLRALFLITTKGI 233
Query: 349 QHYKP--SFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406
K + F +F L L DP R +A LQ+ F AC
Sbjct: 234 PPLKNPEKWSPEFKDF-------LNKCLVKDPEKRPSAEELLQHPFLK---KACPKEEFA 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 82/284 (28%), Positives = 145/284 (51%), Gaps = 43/284 (15%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRF---DTSEPESVKFMAREIRILQKLDHPNVIKL 174
+G G++ +VY+ + D G A+K+V + E+VK + +EI +L KL HPN+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 175 EGLATSRMQYSLYLVFDFM-QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
G T R + +LY+ + + L K++ + G EP ++ Y +Q+L GL++ H+R +
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYGS-FPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 234 HRDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
HRDIK +N+L+D +G++K+ADFG++ F KG + ++ APE++
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKG-------SPYWMAPEVIAQQG 177
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348
YG+ D+WS GC + EM G+P +++E + +FK+ + P
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSK----------ELPPIP 224
Query: 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
H ++ + L DP+ R TAA L++ F
Sbjct: 225 DHLSDEAKD-----------FILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 73/235 (31%), Positives = 118/235 (50%), Gaps = 28/235 (11%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKV--RFDTSEPESVKFMAREIRILQKLD-HPNVIKL 174
+G+G++S V A++++T K A+K + R E + VK++ E +L +L+ HP +IKL
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 175 EGLATSRMQYSLYLVFDFM-QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
T + + +LY V ++ +L + I + G L E + Y ++L L++ H +GI+
Sbjct: 68 --YYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGII 124
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFF-------------------IPKQKGPLTSRVV 274
HRD+K N+L+DK +KI DFG + I K + S V
Sbjct: 125 HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVG 184
Query: 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLC 329
T Y +PELL G DLW+ GC++ +M G+P G E +I KL
Sbjct: 185 TAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 9e-40
Identities = 93/303 (30%), Positives = 157/303 (51%), Gaps = 26/303 (8%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L +G G V A D + VA+KK+ K RE+ +++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 172 IKLEGLATSRMQYS----LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I L + T + +YLV + M ++L ++I +L ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHL 135
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H GI+HRD+K SN+++ LKI DFGL+ +T VVT +YRAPE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG- 192
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT---- 343
Y +D+WS GC++ EM + L PGR ++Q +++ + GTP ++ KK++ T
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 344 TTFRPQHYKPSFREVFGE--FPPSS----------YGILTTLLALDPAYRGTAASALQNE 391
RP++ +F ++F + FP S +L+ +L +DPA R + ALQ+
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312
Query: 392 FFN 394
+ N
Sbjct: 313 YIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 74/202 (36%), Positives = 115/202 (56%), Gaps = 9/202 (4%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKLDH 168
++ K+G+G +S VYKA G++VALKKV+ F+ + ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKII---CRPGQKLTEPQVKCYMQQLLSGL 224
PNVIK LA+ L +V + + DL+++I + + + E + Y QL S L
Sbjct: 62 PNVIKY--LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
+H H + I+HRDIK +N+ I +G++K+ D GL FF K S V T +Y +PE +
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYYMSPERI 178
Query: 285 LGSTDYGVGIDLWSAGCLLAEM 306
Y D+WS GCLL EM
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 92/303 (30%), Positives = 157/303 (51%), Gaps = 26/303 (8%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L +G G V A D + VA+KK+ K RE+ +++ ++H N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 172 IKLEGLATSRMQYS----LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I L + T + +Y+V + M ++L ++I +L ++ + Q+L G++H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHL 142
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H GI+HRD+K SN+++ LKI DFGL+ +T VVT +YRAPE++LG
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG- 199
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT-TF 346
Y +D+WS GC++ EM G L PG ++Q +++ + GTP ++ KK++ T T+
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 347 ---RPQHYKPSFREVFGE--FPPSS----------YGILTTLLALDPAYRGTAASALQNE 391
RP++ SF ++F + FP S +L+ +L +D + R + ALQ+
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 392 FFN 394
+ N
Sbjct: 320 YIN 322
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 1e-38
Identities = 93/306 (30%), Positives = 156/306 (50%), Gaps = 36/306 (11%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y +L +G G V A D G VA+KK+ K RE+ +L+ ++H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 172 IKLEGLATSRMQYS----LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I L + T + +YLV + M ++L ++I +L ++ + Q+L G++H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGIKHL 139
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGL-----SNFFIPKQKGPLTSRVVTLWYRAPE 282
H GI+HRD+K SN+++ LKI DFGL +NF +T VVT +YRAPE
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM-------MTPYVVTRYYRAPE 192
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342
++LG Y +D+WS GC++ E+ G + G ++Q +++ + GTPS ++ +++
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 343 T----TTFRPQHYKPSFREVFGE--FPPSS----------YGILTTLLALDPAYRGTAAS 386
T RPQ+ SF E+F + FP S +L+ +L +DP R +
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311
Query: 387 ALQNEF 392
AL++ +
Sbjct: 312 ALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 90/288 (31%), Positives = 139/288 (48%), Gaps = 41/288 (14%)
Query: 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
+++ +GQG+ VYK R + TGKI ALKK+ D + E K + RE++ L+ + P V+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD-GDEEFRKQLLRELKTLRSCESPYVV 62
Query: 173 KLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
K G + + +V ++M +DL K + K+ EP + +Q+L GL + H
Sbjct: 63 KCYGAFYKEGE--ISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLH 116
Query: 229 -ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
+R I+HRDIK SNLLI+ G +KIADFG+S + + V T+ Y +PE + G
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISK-VLENTLDQCNTFVGTVTYMSPERIQGE 175
Query: 288 TDYGVGIDLWSAGCLLAEMFIGR-PLMPGRTE--VEQLHRIFKLCGTPSEDYWKKMKLTT 344
+ Y D+WS G L E +G+ P +P E + I C P
Sbjct: 176 S-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPPPS--------- 222
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
+ + P FR+ ++ L DP R +AA LQ+ F
Sbjct: 223 -LPAEEFSPEFRD-----------FISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 68/209 (32%), Positives = 116/209 (55%), Gaps = 21/209 (10%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ +D L K+G+G+Y +VYKA ++TG++VA+K V + E ++ + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
++K G + L++V ++ SD+ KI + LTE ++ + Q L GL+
Sbjct: 59 YIVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMKITNKT---LTEEEIAAILYQTLKGLE 113
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR---VVTLWYRAPE 282
+ H +HRDIKA N+L+++ G K+ADFG+S + + R + T ++ APE
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSG----QLTDTMAKRNTVIGTPFWMAPE 169
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRP 311
++ Y D+WS G EM G+P
Sbjct: 170 VIQEI-GYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 90/292 (30%), Positives = 142/292 (48%), Gaps = 46/292 (15%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKV--------RFDTSEPESVKFMAREIRILQKLDHP 169
+G+GTY VY A + TG+++A+K+V R D+ + + VK + EI L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N+++ G T+ S++L + + + G + E V+ + +Q+L GL + H
Sbjct: 69 NIVQYLGFETTEEYLSIFLEY-VPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHS 126
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLS--------NFFIPKQKGPLTSRVVTLWYRAP 281
+GILHRD+KA NLL+D G+ KI+DFG+S N +G ++++ AP
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG-------SVFWMAP 179
Query: 282 ELL-LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
E++ S Y +D+WS GC++ EMF GR P E E + +FKL G
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGR--RPWSDE-EAIAAMFKL-GNKRS------ 229
Query: 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
P P +V P + L ++P R TA LQ+ F
Sbjct: 230 ------AP----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 72/231 (31%), Positives = 112/231 (48%), Gaps = 25/231 (10%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKK-VRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+G + V + RDT K+ A+K + E SV+ + E RILQ+L+HP ++
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN--- 64
Query: 177 LATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
+ YS +YLV D + DL + + K +E QVK ++ +++ L++ H
Sbjct: 65 -----LWYSFQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVKFWICEIVLALEYLHS 118
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
+GI+HRDIK N+L+D+ G + I DF ++ P TS T Y APE+L
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLC-RQG 175
Query: 290 YGVGIDLWSAGCLLAEMFIGRPLMPG--RTEVEQLHRIFKLCGTPSEDYWK 338
Y V +D WS G E G+ G RT +Q+ + T Y
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TADVLYPA 223
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 117 KVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
K+G+G + VYK T VA+K ++ SE E +F+ E I++KL HPN++
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLSHPNIV 64
Query: 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
+L G+ T LY+V ++M DL + + G+KLT + Q+ G+++ +
Sbjct: 65 RLLGVCTQ--GEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLTSRVVTLWYRAPELLL 285
+HRD+ A N L+ ++ ++KI+DFGLS +++ + G L + W APE L
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WM-APESLK 177
Query: 286 GSTDYGVGIDLWSAGCLLAEMF 307
+ D+WS G LL E+F
Sbjct: 178 DGK-FTSKSDVWSFGVLLWEIF 198
|
Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 66/213 (30%), Positives = 112/213 (52%), Gaps = 28/213 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ + L +G+G++ VYKA D+ T ++VA+K + + +E E ++ + +EI+ L + P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
+ K G L+++ ++ DL K KL E + ++++L GL+
Sbjct: 60 YITKYYGSFLKG--SKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLE 112
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR-------VVTLWY 278
+ HE G +HRDIKA+N+L+ + G +K+ADFG+S G LTS V T ++
Sbjct: 113 YLHEEGKIHRDIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNTFVGTPFW 164
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRP 311
APE++ S Y D+WS G E+ G P
Sbjct: 165 MAPEVIKQS-GYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 11/218 (5%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y+ L +G+G++ V K R + GKI+ K++ + + + + E+ IL++L HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKII--CRP-GQKLTEPQVKCYMQQLLSGLQHC 227
++ R +LY+V ++ + DL ++I C+ + + E + + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 228 HERG-----ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
H R +LHRD+K +N+ +D + +K+ DFGL+ + + V T +Y +PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-ILGHDSSFAKTYVGTPYYMSPE 180
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVE 320
L + Y D+WS GCL+ E+ P R +++
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 66/213 (30%), Positives = 117/213 (54%), Gaps = 20/213 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y+ + ++G GTY +VYKARD TG++VA+K ++ + + + + +EI +L++ HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHP 60
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
N++ G + R L++V ++ D+ ++ P L+E Q+ ++ L GL
Sbjct: 61 NIVAYFG-SYLRRDK-LWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLA 115
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLS---NFFIPKQKGPLTSRVVTLWYRAPE 282
+ HE G +HRDIK +N+L+ + G +K+ADFG+S I K+K S + T ++ APE
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK----SFIGTPYWMAPE 171
Query: 283 LLL--GSTDYGVGIDLWSAGCLLAEMFIGRPLM 313
+ Y D+W+ G E+ +P M
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-33
Identities = 88/291 (30%), Positives = 142/291 (48%), Gaps = 38/291 (13%)
Query: 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRF---DTSEPESV-KFMAREIRILQKLDHP 169
K ++G G +S+ Y+ARD TG ++A+K+V + +SE E V + + +EIR++ +L+HP
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
++I++ G ++L++ ++M + E + Y +QLL GL + HE
Sbjct: 64 HIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 230 RGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPK--QKGPLTSRVV-TLWYRAPELLL 285
I+HRD+K +NLLID +G L+IADFG + K G +++ T+ + APE+L
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLC---GTPSEDYWKKMKL 342
G YG D+WS GC++ EM +P L IFK+ PS
Sbjct: 182 GEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS--------- 231
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P+H P R+V L L P R + L++ F
Sbjct: 232 ----IPEHLSPGLRDV-----------TLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 4e-32
Identities = 76/257 (29%), Positives = 130/257 (50%), Gaps = 24/257 (9%)
Query: 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPES-------VKFMAREIRILQKL 166
K A +G G++ +VY + +G+++A+K+V + S + +AREI +L++L
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
H N+++ G + +++L + + ++ G E V+ +++Q+L GL +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEY-VPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNY 121
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAP 281
H RGI+HRDIK +N+L+D G +KI+DFG+S N K G S ++++ AP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG----TPSEDYW 337
E ++ T Y D+WS GCL+ EM G+ P + QL IFK+ +
Sbjct: 182 E-VVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPEIPSNIS 237
Query: 338 KKMK--LTTTFRPQHYK 352
+ L TF H K
Sbjct: 238 SEAIDFLEKTFEIDHNK 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 7e-32
Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
P ++ + +G+GTY VYKAR + TG++VA+K + E E +K E IL+K
Sbjct: 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRK 58
Query: 166 L-DHPNVIKLEGLATSR----MQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCY 216
+HPN+ G + L+LV + +DL K + + G++L E +
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 217 MQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR---V 273
+++ L GL + HE ++HRDIK N+L+ K+ +K+ DFG+S + L R +
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFI 174
Query: 274 VTLWYRAPELLLGS----TDYGVGIDLWSAGCLLAEMFIGRP 311
T ++ APE++ Y D+WS G E+ G+P
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRF-DTSEPESVKFMAREIRILQKLDHPNVIKL-E 175
+ +G Y V+ A+ + TG I A+K ++ D V + E IL + P V+KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 176 GLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ +LYLV +++ DL ++ G L E + Y+ +++ L++ H GI+H
Sbjct: 61 SFQGKK---NLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNF-FIPKQKGP-----LTSRVV-TLWYRAPELLLGS 287
RD+K N+LID +G LK+ DFGLS + +Q R+V T Y APE++LG
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRP 311
+ +D WS GC+L E +G P
Sbjct: 177 -GHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 81/281 (28%), Positives = 127/281 (45%), Gaps = 32/281 (11%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPES---VKFMAREIRILQKLDHPNVIKL 174
+GQG + VY D DTG+ +A+K+V FD PE+ V + EI++L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 175 EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
G +L + ++M K + LTE + Y +Q+L G+++ H I+H
Sbjct: 70 YGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFF--IPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
RDIK +N+L D +G +K+ DFG S I + S T ++ +PE++ G YG
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGR 186
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352
D+WS GC + EM +P E E + IFK+ P T P H
Sbjct: 187 KADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQP----------TNPQLPSHVS 233
Query: 353 PSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P R L + R +A L++ F
Sbjct: 234 PDARN-----------FLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 85/294 (28%), Positives = 138/294 (46%), Gaps = 39/294 (13%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
D ++ + ++G G + VYKA+ ++TG A K ++ + SE E FM EI IL + H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMV-EIDILSECKH 61
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
PN++ L + L+++ +F L I+ + LTEPQ++ +Q+L L
Sbjct: 62 PNIVGL--YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR---VVTLWYRAPELL 284
H ++HRD+KA N+L+ G +K+ADFG+S K K L R + T ++ APE++
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVS----AKNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 285 LGSTD----YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
T Y D+WS G L E+ P P E+ + + K+ +
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP------- 225
Query: 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
T +P + SF + L + L DP R TAA L++ F +
Sbjct: 226 --PTLDQPSKWSSSFND-----------FLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 31/291 (10%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D Y+ + +G G + VY A + VA+K++ + SV + +E++ + + +HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDELRKEVQAMSQCNHP 59
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS----DLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
NV+K + L+LV ++ D+ K G L E + ++++L GL+
Sbjct: 60 NVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLE 116
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP---KQKGPLTSRVVTLWYRAPE 282
+ H G +HRDIKA N+L+ + G +KIADFG+S + + + V T + APE
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342
++ Y D+WS G E+ G P + L P L
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAA--PYSKYPPMKVLMLTLQNDPP-------SL 227
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
T + Y SFR+ +++ L DP+ R TA L+++FF
Sbjct: 228 ETGADYKKYSKSFRK-----------MISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 19/201 (9%)
Query: 117 KVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
K+G+G + VYK + VA+K ++ D SE + +F+ RE RI++KLDHPNV+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDHPNVV 64
Query: 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
KL G+ T + LY+V ++M+ DL + + KL+ + + Q+ G+++ +
Sbjct: 65 KLLGVCTE--EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN 122
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNF-----FIPKQKGPLTSRVVTLWYRAPELLLG 286
+HRD+ A N L+ ++ ++KI+DFGLS + K+ G L R W APE L
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WM-APESLKE 177
Query: 287 STDYGVGIDLWSAGCLLAEMF 307
+ D+WS G LL E+F
Sbjct: 178 GK-FTSKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 117 KVGQGTYSNVYKA--RDRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
K+G+G + VYK + +D VA+K ++ D SE E F+ +E R+++KL HPNV++
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL-KEARVMKKLGHPNVVR 60
Query: 174 LEGLATSRMQYSLYLVFDFM-QSDL--------TKIICRPGQKLTEPQVKCYMQQLLSGL 224
L G+ T LYLV ++M DL L+ + + Q+ G+
Sbjct: 61 LLGVCTEEE--PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLTSRVVTLWY 278
++ + +HRD+ A N L+ + ++KI+DFGLS +++ K G L R W
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----WM 174
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
APE L + D+WS G LL E+F
Sbjct: 175 -APESLKDGI-FTSKSDVWSFGVLLWEIF 201
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 78/237 (32%), Positives = 116/237 (48%), Gaps = 31/237 (13%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIR-ILQKLDHPN 170
+ L +VGQG Y V+ A+ +DTG+IVALK+++ +S+ F E+R +L + D
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMK------KSLLFKLNEVRHVLTERDILT 56
Query: 171 VIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSG 223
K E L ++ Y+ LYL +++ D ++ G L+E + YM ++
Sbjct: 57 TTKSEWLV--KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEA 113
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
+ HE G +HRD+K N LID SG +K+ DFGLS + S V + Y APE+
Sbjct: 114 VDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN----SVVGSPDYMAPEV 169
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
L G Y +D WS GC+L E G P G T E + YWK+
Sbjct: 170 LRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWKET 216
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 6e-30
Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 21/248 (8%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPES---VKFMAREIRILQKLDHPNVIKL 174
+GQG + VY D DTG+ +A+K+V+FD PE+ V + EI++L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 175 EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
G M+ +L + + M K + LTE + Y +Q+L G+ + H I+H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFF--IPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
RDIK +N+L D G +K+ DFG S I + S T ++ +PE++ G YG
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGR 188
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS------------EDYWKKM 340
D+WS GC + EM +P E E + IFK+ P+ D+ K++
Sbjct: 189 KADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRI 245
Query: 341 KLTTTFRP 348
+ RP
Sbjct: 246 FVEAKLRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 7e-30
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRF-DTSEPESVKFMAREIRILQKLDH 168
D ++ + +G G++ V R + +GK ALK + + + V+ + E RILQ + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 169 PNVIKLEGLATSRMQYSLYLVFDF-----MQSDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
P ++ L G + + +LYLV ++ + S L R + EP + Y Q++
Sbjct: 61 PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHL-----RKSGRFPEPVARFYAAQVVLA 113
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW----YR 279
L++ H I++RD+K NLL+D G +KI DFG + + R TL Y
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYTLCGTPEYL 165
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRP 311
APE++L S YG +D W+ G L+ EM G P
Sbjct: 166 APEIIL-SKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-29
Identities = 72/221 (32%), Positives = 116/221 (52%), Gaps = 9/221 (4%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAR---EIRILQKLDHPNVIKL 174
+GQG + VY D DTG+ +A K+V+FD PE+ K ++ EI++L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 175 EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
G R + +L + ++M K + LTE + Y +Q+L G+ + H I+H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFF--IPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
RDIK +N+L D +G +K+ DFG S I + S T ++ +PE++ G YG
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGR 188
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS 333
D+WS GC + EM +P E E + IFK+ P+
Sbjct: 189 KADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 77/253 (30%), Positives = 111/253 (43%), Gaps = 48/253 (18%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT--SEPESVKFMAREIRILQKLD 167
D ++ + +G+G + V+ RD+DTG++ A+K +R + A E IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRA-ERDILADAD 59
Query: 168 HPNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQL 220
P ++KL YS LYLV ++M DL ++ R E + Y+ +L
Sbjct: 60 SPWIVKL--------YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAEL 110
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI---------------PKQ 265
+ L H+ G +HRDIK N+LID G +K+ADFGL +
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 266 KGPLTSR-------------VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPL 312
L R V T Y APE+L G T YG+ D WS G +L EM G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPP 229
Query: 313 MPGRTEVEQLHRI 325
T E ++I
Sbjct: 230 FYSDTLQETYNKI 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 59/204 (28%), Positives = 113/204 (55%), Gaps = 10/204 (4%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH--- 168
Y +L +G+G Y VY+ + TG++VALK + DT + + V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 169 PNVIKLEGLATSRMQ-YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
PN+ K G S ++ L+++ ++ + + + + G + E + ++++L L++
Sbjct: 62 PNITKYYG---SYLKGPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYI 117
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H+ G++HRDIKA+N+L+ +G +K+ DFG++ + ++ V T ++ APE++
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPYWMAPEVITEG 176
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRP 311
Y D+WS G + EM G P
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 36/279 (12%)
Query: 114 KLAKVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ ++G+G + V R +TG+ VA+K + E F REI IL+ LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF-EREIEILRTLDHE 66
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQ-KLTEPQVKCYMQQLLSGLQHCH 228
N++K +G+ SL L+ +++ S + + + ++ ++ + Q+ G+ +
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR----VVTLWYRAPELL 284
+ +HRD+ A N+L++ ++KI+DFGL+ +P+ K + WY APE L
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 285 LGSTDYGVGIDLWSAGCLLAEMF-IGRP---------LMPGRTE----VEQLHRIFKLCG 330
S D+WS G L E+F G P M G + V +L + K
Sbjct: 185 RTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 331 T-------PSEDYWKKMKLTTTFRPQHYKPSFREVFGEF 362
P E Y MKL PQ +PSF ++
Sbjct: 244 RLPRPPSCPDEVY-DLMKLCWEAEPQD-RPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 84/302 (27%), Positives = 136/302 (45%), Gaps = 57/302 (18%)
Query: 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
D K+G+G+ V A D+ TG+ VA+KK+ D + + + + E+ I++ HPN++
Sbjct: 22 DNFVKIGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 173 KLEGLATSRMQYSLYLVFD-------FMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
++ YS YLV D F++ LT I+ ++ E Q+ +L L
Sbjct: 80 EM---------YSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKAL 128
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF---IPKQKGPLTSRVVTLWYRAP 281
H +G++HRDIK+ ++L+ G +K++DFG +P++K S V T ++ AP
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK----SLVGTPYWMAP 184
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTP--SEDYWKK 339
E ++ YG +D+WS G ++ EM G P P +E +
Sbjct: 185 E-VISRLPYGTEVDIWSLGIMVIEMVDGEP--------------------PYFNEPPLQA 223
Query: 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF-NASPL 398
MK P K + P L +L DPA R TAA L + F A P
Sbjct: 224 MKRIRDNLPPKLKNLHK-----VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278
Query: 399 AC 400
+
Sbjct: 279 SS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 79/234 (33%), Positives = 125/234 (53%), Gaps = 13/234 (5%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKLDHPNVIKLE 175
K+G+G +S VY+A G VALKKV+ FD + ++ +EI +L++L+HPNVIK
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 176 GLATSRMQYSLYLVFDFMQS-DLTKII---CRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
A+ L +V + + DL+++I + + + E V Y QL S L+H H R
Sbjct: 69 --ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG 291
++HRDIK +N+ I +G++K+ D GL FF K S V T +Y +PE + Y
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLVGTPYYMSPE-RIHENGYN 184
Query: 292 VGIDLWSAGCLLAEM-FIGRPLMPGRTEVEQLHRIFKLCG---TPSEDYWKKMK 341
D+WS GCLL EM + P + + L + + C PS+ Y ++++
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 72/217 (33%), Positives = 115/217 (52%), Gaps = 14/217 (6%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIK 173
L K+G+G+Y +VYK + + ALK+V + S+ E + EIRIL ++HPN+I
Sbjct: 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIIS 63
Query: 174 L-EGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQK---LTEPQVKCYMQQLLSGLQHCH 228
E L +V ++ DL+K I + +K + E ++ QLL GLQ H
Sbjct: 64 YKEAFLDGN---KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
E+ ILHRD+K++N+L+ + ++KI D G+S +K +++ T Y APE+ G
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKG-R 176
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
Y D+WS GCLL EM P R+ + +++
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 26/205 (12%)
Query: 117 KVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
K+G+G + VYK VA+K ++ D SE + +F+ RE RI++KLDHPN++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDHPNIV 64
Query: 173 KLEGLATSRMQYSLYLVFDFM-----QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
KL G+ T + L +V ++M L K ++L+ + + Q+ G+++
Sbjct: 65 KLLGVCTE--EEPLMIVMEYMPGGDLLDYLRK---NRPKELSLSDLLSFALQIARGMEYL 119
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPE 282
+ +HRD+ A N L+ ++ ++KI+DFGLS + + + G L R W APE
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WM-APE 174
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMF 307
L + D+WS G LL E+F
Sbjct: 175 SLKEGK-FTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 24/228 (10%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D + L ++G G V K R TGKI+A+K +R + K + RE+ IL K + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
++ G + + ++M L KI+ ++ E + +L GL + H
Sbjct: 60 YIVGFYG--AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 229 E-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT-----SRVVTLWYRAPE 282
E I+HRD+K SN+L++ G +K+ DFG+S G L + V T Y APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS--------GQLVNSLAKTFVGTSSYMAPE 169
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGR-----PLMPGRTEVEQLHRI 325
+ G DY V D+WS G L E+ GR P E L I
Sbjct: 170 RIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 79/292 (27%), Positives = 118/292 (40%), Gaps = 49/292 (16%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRF-DTSEPESVKFMAREIRILQKLDHPN 170
Y + +G+G + R + +V K+V SE E + EI IL L HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILSLLQHPN 60
Query: 171 VIKL------EGLATSRMQY----SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQL 220
+I + M+Y +LY KI+ + GQ E V Y+ Q+
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLY----------DKIVRQKGQLFEEEMVLWYLFQI 110
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
+S + + H+ GILHRDIK N+ + K+G++K+ DFG+S + T V T +Y +
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMS 169
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
PEL G Y D+W+ GC+L E+ L R F P K +
Sbjct: 170 PELCQG-VKYNFKSDIWALGCVLYELLT-------------LKRTFD-ATNPLNLVVKIV 214
Query: 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
+ T Y + + +LL DP R TA L
Sbjct: 215 QGNYTPVVSVYSSELISL-----------VHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G G + V + + + ALK V+ +T + E + E IL++ +HP ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
L T + + +Y++ ++ +L I+ G E + Y+ ++ ++ H RGI
Sbjct: 58 L--YRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTDYG 291
++RD+K NLL+D +G +K+ DFG + QK T T Y APE++L Y
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEIILNK-GYD 170
Query: 292 VGIDLWSAGCLLAEMFIGRP 311
+D WS G LL E+ GRP
Sbjct: 171 FSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 8e-28
Identities = 80/246 (32%), Positives = 123/246 (50%), Gaps = 31/246 (12%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKLDHPNVIKLE 175
K+G+G +S VY+A K VALKKV+ F+ + ++ + +EI +L++L+HPNVIK
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY- 67
Query: 176 GLATSRMQYSLYLVFDFMQS-DLTKIICRPGQK---LTEPQVKCYMQQLLSGLQHCHERG 231
L + L +V + + DL+++I ++ + E V Y QL S ++H H R
Sbjct: 68 -LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG 291
++HRDIK +N+ I +G++K+ D GL FF K S V T +Y +PE + Y
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLVGTPYYMSPE-RIHENGYN 184
Query: 292 VGIDLWSAGCLLAEM------FIGR----------------PLMPGRTEVEQLHRIFKLC 329
D+WS GCLL EM F G P +P E+L + +C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMC 244
Query: 330 GTPSED 335
P D
Sbjct: 245 IYPDPD 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 70/201 (34%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQ-KLDHPNVI 172
L + +G + +VY A+ R TG A+K ++ D V + E I+ + + P V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
KL + + + LYLV +++ D +I G L E K Y+ +++ G++ H+RG
Sbjct: 61 KL--YYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTDY 290
I+HRDIK NLLID++G LK+ DFGLS + G + V T Y APE +LG D
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILGVGDD 171
Query: 291 GVGIDLWSAGCLLAEMFIGRP 311
+ D WS GC++ E G P
Sbjct: 172 KMS-DWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRF-DTSEPESVKFMAREIRILQKLDH 168
D +++ VG GT+ V+ RDR + ALK + + + + + E R+L+++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
P +I+L T Q LY++ +++ R + + Y +++ L++ H
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW----YRAPELL 284
+ I++RD+K N+L+DK G +K+ DFG + L R TL Y APE +
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAK--------KLRDRTWTLCGTPEYLAPE-V 169
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRP 311
+ S + +D W+ G L+ EM +G P
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 72/257 (28%), Positives = 119/257 (46%), Gaps = 27/257 (10%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPES---VKFMAREIRILQKLDHPNVIKL 174
+G+G + VY D DTG+ +A+K+V FD E+ V + EI++L+ L H +++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 175 EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
G + L + ++M K + LTE + Y +Q+L G+ + H I+H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFF--IPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
RDIK +N+L D +G +K+ DFG S I + S T ++ +PE++ G YG
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGR 188
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED----------------- 335
D+WS C + EM +P E E + IFK+ P++
Sbjct: 189 KADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQI 245
Query: 336 -YWKKMKLTTTFRPQHY 351
+K + T F +H
Sbjct: 246 FVEEKRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 74/221 (33%), Positives = 115/221 (52%), Gaps = 23/221 (10%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
KS +++ ++G G VYK R TG++ ALK V + E + + REI IL+
Sbjct: 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVRRQICREIEILRD 128
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQS---DLTKIICRPGQKLTEPQVKCYMQQLLS 222
++HPNV+K + + + ++ +FM + T I E + +Q+LS
Sbjct: 129 VNHPNVVKCHDMFDHNGE--IQVLLEFMDGGSLEGTHI-------ADEQFLADVARQILS 179
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
G+ + H R I+HRDIK SNLLI+ + +KIADFG+S + + P S V T+ Y +PE
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR-ILAQTMDPCNSSVGTIAYMSPE 238
Query: 283 LLLGSTDYGVGI------DLWSAGCLLAEMFIGR-PLMPGR 316
+ +TD G D+WS G + E ++GR P GR
Sbjct: 239 RI--NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 82/291 (28%), Positives = 139/291 (47%), Gaps = 39/291 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ ++ + ++G G + VYKA++++TG + A K + +T E ++ EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYMVEIEILATCNHP 69
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
++KL L L+++ +F + I+ + LTEPQ++ +Q+L LQ+ H
Sbjct: 70 YIVKL--LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR---VVTLWYRAPELLL 285
I+HRD+KA N+L+ G +K+ADFG+S K L R + T ++ APE+++
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 286 GST----DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341
T Y D+WS G L EM + P E+ + + K+ K +
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIA---------KSE 231
Query: 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
T +P + FR+ L T L P R +AA L++ F
Sbjct: 232 PPTLSQPSKWSMEFRD-----------FLKTALDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
L+++G+G +V K R ++TG I ALK + D + P+ K + RE+ I + P ++K
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKY 64
Query: 175 EGLATSRMQYSLYLVFDFMQS----DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
G S+ + ++ + + K + + G ++ E + + +L GL + H R
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
I+HRDIK SN+L+ + G +K+ DFG+S + G T T +Y APE + G Y
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQGKP-Y 180
Query: 291 GVGIDLWSAGCLLAEMFIGR 310
+ D+WS G L E+ R
Sbjct: 181 SITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 68/199 (34%), Positives = 104/199 (52%), Gaps = 10/199 (5%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGL 177
+G+GTY VY ARD T +A+K++ S V+ + EI + L H N+++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 178 ATSRMQYSLYL--VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ + +++ V S L + P K E + Y +Q+L GL++ H+ I+HR
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 236 DIKASNLLIDK-SGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELL-LGSTDYGV 292
DIK N+L++ SG++KI+DFG S P T TL Y APE++ G YG
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 293 GIDLWSAGCLLAEMFIGRP 311
D+WS GC + EM G+P
Sbjct: 191 PADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 73/256 (28%), Positives = 128/256 (50%), Gaps = 28/256 (10%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ ++ + ++G G + VYKA++++TG + A K + DT E ++ EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCDHP 62
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++KL L + +L+++ +F + ++ + LTEPQ++ +Q L L + H
Sbjct: 63 NIVKL--LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR---VVTLWYRAPELLL 285
E I+HRD+KA N+L G +K+ADFG+S K + R + T ++ APE+++
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 286 GSTD----YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341
T Y D+WS G L EM + P E+ + + K+ K +
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIA---------KSE 224
Query: 342 LTTTFRPQHYKPSFRE 357
T +P + F++
Sbjct: 225 PPTLAQPSRWSSEFKD 240
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 59/198 (29%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y+ + K+G+G++ +Y A+ + + +K++ + + +E+ +L K+ HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHE 229
+ A+ + L++V ++ DL K I R G +E Q+ + Q+ GL+H H+
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 230 RGILHRDIKASNLLIDKSGML-KIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
R ILHRDIK+ N+ + K+GM+ K+ DFG++ + T V T +Y +PE + +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPE-ICQNR 177
Query: 289 DYGVGIDLWSAGCLLAEM 306
Y D+WS GC+L E+
Sbjct: 178 PYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDH 168
+D + VG+G + V R++ TG I A+K ++ E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 169 PNVIKLEGLATSRMQY------SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLL 221
P + +L QY +LYLV ++ DL ++ R + E + Y+ +L+
Sbjct: 61 PWIPQL--------QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV 112
Query: 222 SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
+ H+ G +HRDIK N+LID++G +K+ADFG + + V T Y AP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
Query: 282 ELLL-----GSTDYGVGIDLWSAGCLLAEMFIGR 310
E+L G YGV D WS G + EM GR
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 84/310 (27%), Positives = 144/310 (46%), Gaps = 35/310 (11%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y + K+GQG V+ A D TG+ VA+K++ +P+ + + EI ++++L +PN+
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKK-ELIINEILVMKELKNPNI 78
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+ L + + L++V +++ LT ++ + E Q+ ++ L L+ H
Sbjct: 79 VNF--LDSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHAN 134
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
++HRDIK+ N+L+ G +K+ DFG P+Q ++ V T ++ APE++ Y
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA-Y 192
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350
G +D+WS G + EM G P + L+ I GTP P+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQ-----------NPEK 240
Query: 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICR 410
P FR+ L L +D RG+A LQ+ F LA LSSL +
Sbjct: 241 LSPIFRD-----------FLNRCLEMDVEKRGSAKELLQHPFLK---LAKPLSSLTPLIL 286
Query: 411 EEDEPARTSR 420
E +++R
Sbjct: 287 AAKEAMKSNR 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 72/269 (26%), Positives = 115/269 (42%), Gaps = 34/269 (12%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKV---RFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
+G+G + V + + TGK+ A KK+ R + E + ++I L+K+ ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 175 EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQK-LTEPQVKCYMQQLLSGLQHCHERGI 232
++ L LV M DL I G+ E + Y Q++ GL+H H+R I
Sbjct: 59 AYAFETKDD--LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
++RD+K N+L+D G ++I+D GL+ K + R T Y APE+L G Y
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEVLQGEV-YDF 173
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352
+D ++ GC L EM GR R E + + K+ L
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL------------KRRTLEMAVEYPD-- 219
Query: 353 PSFREVFGEFPPSSYGILTTLLALDPAYR 381
+F P + + LL DP R
Sbjct: 220 --------KFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 16/233 (6%)
Query: 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQ 164
+ D+++ + +G+GTY VYK ++ G + A+K + + E ++ E ILQ
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIE---AEYNILQ 73
Query: 165 KL-DHPNVIKLEGLATSRMQYS---LYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCY 216
L +HPNV+K G+ + L+LV + ++L K + GQ+L E +
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 217 MQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL 276
+ L GLQH H I+HRD+K +N+L+ G +K+ DFG+S + TS V T
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTP 192
Query: 277 WYRAPELLLGSTDYGVG----IDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
++ APE++ Y D+WS G E+ G P + V+ L +I
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 57/197 (28%), Positives = 105/197 (53%), Gaps = 6/197 (3%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y K+ K+G+G++ + ++ GK +K++ P+ + +E+ +L + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKII-CRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
++ + + +LY+V D+ + DL K I + G E Q+ + Q+ L+H H+
Sbjct: 62 VQYQ--ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
R ILHRDIK+ N+ + K G +K+ DFG++ + T + T +Y +PE + +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPE-ICENRP 177
Query: 290 YGVGIDLWSAGCLLAEM 306
Y D+W+ GC+L EM
Sbjct: 178 YNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 87/303 (28%), Positives = 145/303 (47%), Gaps = 44/303 (14%)
Query: 106 PKSADSY-DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQ 164
P +Y D K+G+G+ V A + +GK+VA+KK+ D + + + + E+ I++
Sbjct: 15 PGDPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 72
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSG 223
H NV+++ + + L++V +F++ LT I+ ++ E Q+ +L
Sbjct: 73 DYQHENVVEMYN--SYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKA 128
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS---NFFIPKQKGPLTSRVVTLWYRA 280
L H +G++HRDIK+ ++L+ G +K++DFG + +P++K S V T ++ A
Sbjct: 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK----SLVGTPYWMA 184
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTP--SEDYWK 338
PE L+ YG +D+WS G ++ EM G P P +E K
Sbjct: 185 PE-LISRLPYGPEVDIWSLGIMVIEMVDGEP--------------------PYFNEPPLK 223
Query: 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF-NASP 397
MK+ P K + PS G L LL DPA R TAA L++ F A P
Sbjct: 224 AMKMIRDNLPPKLKNLHK-----VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278
Query: 398 LAC 400
+C
Sbjct: 279 PSC 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 65/220 (29%), Positives = 118/220 (53%), Gaps = 16/220 (7%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP-ESVKFMAREIRILQKLDHPN 170
+ L ++G G++ VY ARD T ++VA+KK+ + + E + + +E++ LQ++ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 171 VIKLEGLATSRMQYSLYLVFDFM---QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I+ +G +++ +LV ++ SDL ++ +P L E ++ L GL +
Sbjct: 87 SIEYKGCYLR--EHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYL 141
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H ++HRDIKA N+L+ + G +K+ADFG ++ P S V T ++ APE++L
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMAPEVILAM 196
Query: 288 TD--YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
+ Y +D+WS G E+ +P + + L+ I
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 69/287 (24%), Positives = 120/287 (41%), Gaps = 43/287 (14%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
++ L K+G+G++ V+K + ++ A+K++ + E R+L KLD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 172 IK-----LEGLATSRMQYSLYLVFDFMQS-DLTKII-CRPGQKLTEPQV-KCYMQQLLSG 223
I+ L+ L +V ++ ++ DL K++ + G+ L E QV + ++Q LL G
Sbjct: 62 IRYYESFLDK-------GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
L H H + ILHRDIK+ NL +D +KI D G++ T V T +Y +PE
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPE- 171
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343
L Y D+W+ G +L E G+ + + +I +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR---------------- 215
Query: 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390
+ P V + ++ L D R L+N
Sbjct: 216 -----GVFPP----VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 49/281 (17%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y+K+ VG+G + V+ R + K+V +K++ + + E ++L+ L HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 172 IK-----LEGLATS-RMQYSLY-LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
I+ LE A M+Y+ + +++Q R L E + + Q+L L
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQK-------RCNSLLDEDTILHFFVQILLAL 114
Query: 225 QHCHERGILHRDIKASNLLIDKSGM-LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
H H + ILHRD+K N+L+DK M +KI DFG+S K K + V T Y +PEL
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA--YTVVGTPCYISPEL 172
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343
G Y D+W+ GC+L E+ L R F+ P+ +K+
Sbjct: 173 CEGKP-YNQKSDIWALGCVLYELA-------------SLKRAFEAANLPA----LVLKIM 214
Query: 344 T-TFRP--QHYKPSFREVFGEFPPSSYGILTTLLALDPAYR 381
+ TF P Y P R+ ++ ++L LDP+ R
Sbjct: 215 SGTFAPISDRYSPDLRQ-----------LILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 16/220 (7%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP-ESVKFMAREIRILQKLDHPN 170
+ L ++G G++ VY ARD ++VA+KK+ + + E + + +E+R LQKL HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 171 VIKLEGLATSRMQYSLYLVFDFM---QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I+ G +++ +LV ++ SDL ++ +P L E ++ L GL +
Sbjct: 77 TIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYL 131
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H ++HRD+KA N+L+ + G++K+ DFG ++ P V T ++ APE++L
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAM 186
Query: 288 TD--YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
+ Y +D+WS G E+ +P + + L+ I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 33/290 (11%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y + K+GQG VY A D TG+ VA+K++ +P+ + + EI ++++ HPN+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKK-ELIINEILVMRENKHPNI 78
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+ L + + L++V +++ LT ++ + E Q+ ++ L L+ H
Sbjct: 79 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN 134
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
++HRDIK+ N+L+ G +K+ DFG P+Q ++ V T ++ APE++ Y
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVT-RKAY 192
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350
G +D+WS G + EM G P + L+ I GTP + KL+ FR
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP--ELQNPEKLSAIFR--- 246
Query: 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN-ASPLA 399
L L +D RG+A LQ+ F A PL+
Sbjct: 247 -----------------DFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 68/217 (31%), Positives = 109/217 (50%), Gaps = 20/217 (9%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRIL-QKLDHPNVIKLE 175
+G+G++ V A + T ++ A+K ++ D + + V+ E R+L HP + +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL- 61
Query: 176 GLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ + + L+ V +++ DL I R G + EP+ + Y +++ GLQ HERGI++
Sbjct: 62 -HSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW------YRAPELLLGST 288
RD+K N+L+D G +KIADFG+ K + V T Y APE+L
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTFCGTPDYIAPEILSY-Q 171
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
YG +D W+ G LL EM G+ G E E I
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 9e-24
Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 36/219 (16%)
Query: 111 SYDKLAKVGQGTYSNVYKARDRDTG-KIVALKKVRF--------DTSEPESVKFMAREIR 161
Y L +G G + VYK R ++ G ++ALK++ +S+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 162 IL-QKLDHPNVIK-----LEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEP 211
I+ ++L HPN+++ LE LY+V D ++ + + Q+ TE
Sbjct: 61 IIKEQLRHPNIVRYYKTFLEN-------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113
Query: 212 QVKCYMQQLLSGLQHCH-ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP-- 268
++ Q++ L++ H E+ I+HRD+ +N+++ + + I DFGL+ KQK P
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA-----KQKQPES 168
Query: 269 -LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEM 306
LTS V T+ Y PE ++ + YG D+W+ GC+L +M
Sbjct: 169 KLTSVVGTILYSCPE-IVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 66/203 (32%), Positives = 112/203 (55%), Gaps = 19/203 (9%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPN 170
+ L ++G G++ VY ARD T ++VA+KK+ + E + + +E+R LQ+L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 171 VIKLEGLATSRMQYSLYLVFDFM---QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I+ +G +++ +LV ++ SD+ ++ +P L E ++ L GL +
Sbjct: 77 TIEYKGCYLR--EHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYL 131
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H +HRDIKA N+L+ + G +K+ADFG ++ P S V T ++ APE++L
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFVGTPYWMAPEVILAM 186
Query: 288 TD--YGVGIDLWSAG--CL-LAE 305
+ Y +D+WS G C+ LAE
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAE 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-23
Identities = 72/257 (28%), Positives = 127/257 (49%), Gaps = 22/257 (8%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+G+G + +VYK + + VA+K R KF+ +E IL++ DHPN++KL G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLIG 59
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ + +Y+V + + L + + +LT ++ +G+++ + +HR
Sbjct: 60 VCVQK--QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS----RVVTLWYRAPELLLGSTDYG 291
D+ A N L+ ++ +LKI+DFG+S ++ G T + + + + APE L Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPE-ALNYGRYT 173
Query: 292 VGIDLWSAGCLLAEMF-IGRPLMPG------RTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344
D+WS G LL E F +G PG R +E +R+ P E Y + M
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIY-RLMLQCW 232
Query: 345 TFRPQHYKPSFREVFGE 361
+ P++ +PSF E++ E
Sbjct: 233 AYDPEN-RPSFSEIYNE 248
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 7/196 (3%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+GT+ VY+ R +DT +I A+K + + + + V E IL + + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 177 LATS-RMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
L S + LYLV D+M +L + + G + +E + K Y+ +L+ L+H H+ I++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVY 119
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTDYGVG 293
RD+K N+L+D +G + + DFGLS + K T+ T Y APE+LL Y
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 294 IDLWSAGCLLAEMFIG 309
+D WS G L+ EM G
Sbjct: 178 VDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 4e-23
Identities = 79/293 (26%), Positives = 138/293 (47%), Gaps = 39/293 (13%)
Query: 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
D K+G+G+ V A ++ TGK VA+KK+ D + + + + E+ I++ H NV+
Sbjct: 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVV 82
Query: 173 KLEGLATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
+ + + L++V +F++ LT I+ ++ E Q+ +L L + H +G
Sbjct: 83 DM--YNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG 138
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFF---IPKQKGPLTSRVVTLWYRAPELLLGST 288
++HRDIK+ ++L+ G +K++DFG +PK+K S V T ++ APE ++
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK----SLVGTPYWMAPE-VISRL 193
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348
YG +D+WS G ++ EM G P ++ + RI + L +
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------------RDNLPPRVKD 240
Query: 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN-ASPLAC 400
H S F L +L +P+ R TA LQ+ F A P +C
Sbjct: 241 SHKVSSVLRGF----------LDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 64/217 (29%), Positives = 117/217 (53%), Gaps = 16/217 (7%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP-ESVKFMAREIRILQKLDHPNVIK 173
L ++G G++ VY A + T ++VA+KK+ + + E + + +E++ LQ+L HPN I+
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 174 LEGLATSRMQYSLYLVFDFM---QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+G +++ +LV ++ SDL ++ +P L E ++ L GL + H
Sbjct: 86 YKGCYLK--EHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHSH 140
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD- 289
++HRDIKA N+L+ + G +K+ADFG ++ + P S V T ++ APE++L +
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 290 -YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
Y +D+WS G E+ +P + + L+ I
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 98.3 bits (244), Expect = 6e-23
Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 36/311 (11%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y + K+GQG VY A D TG+ VA+K++ +P+ + + EI ++++ +PN+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ-QQPKK-ELIINEILVMRENKNPNI 78
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+ L + + L++V +++ LT ++ + E Q+ ++ L L H
Sbjct: 79 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLHSN 134
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
++HRDIK+ N+L+ G +K+ DFG P+Q ++ V T ++ APE++ Y
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA-Y 192
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350
G +D+WS G + EM G P + L+ I GTP P+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQ-----------NPER 240
Query: 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSL-PVIC 409
FR+ L L +D RG+A LQ+ F LA LSSL P+I
Sbjct: 241 LSAVFRD-----------FLNRCLEMDVDRRGSAKELLQHPFLK---LAKPLSSLTPLII 286
Query: 410 REEDEPARTSR 420
++ +SR
Sbjct: 287 AAKEAIKNSSR 297
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 7e-23
Identities = 72/248 (29%), Positives = 124/248 (50%), Gaps = 21/248 (8%)
Query: 98 KEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA 157
K ++ P +D+++ + +G+GTY V+K ++ G A+K + E ++
Sbjct: 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE--- 62
Query: 158 REIRILQKL-DHPNVIKLEGLATSRMQYS---LYLVFDFMQ----SDLTKIICRPGQKLT 209
E IL+ L DHPNV+K G+ + + L+LV + +DL K + G+++
Sbjct: 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122
Query: 210 EPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269
EP + + + L GLQH H +HRD+K +N+L+ G +K+ DFG+S +
Sbjct: 123 EPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 270 TSRVVTLWYRAPELL-----LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHR 324
TS V T ++ APE++ L ST Y D+WS G E+ G P + ++ +
Sbjct: 183 TS-VGTPFWMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGDPPL---ADLHPMRA 237
Query: 325 IFKLCGTP 332
+FK+ P
Sbjct: 238 LFKIPRNP 245
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 1e-22
Identities = 74/281 (26%), Positives = 137/281 (48%), Gaps = 31/281 (11%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+ KL K+G+G++ V+K D T K+VA+K + + +E E ++ + +EI +L + D P V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 172 IKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
K G + L+++ +++ + PG L E Q+ ++++L GL + H
Sbjct: 65 TKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEK 121
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG 291
+HRDIKA+N+L+ + G +K+ADFG++ Q + V T ++ APE++ S Y
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSA-YD 179
Query: 292 VGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY 351
D+WS G E+ G P +E+ + +F + P++
Sbjct: 180 SKADIWSLGITAIELAKGE---PPHSELHPMKVLFLI-------------------PKNN 217
Query: 352 KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
P+ G + + L +P++R TA L+++F
Sbjct: 218 PPTLE---GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-22
Identities = 78/290 (26%), Positives = 136/290 (46%), Gaps = 33/290 (11%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y + K+GQG VY A D TG+ VA++++ +P+ + + EI ++++ +PN+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKK-ELIINEILVMRENKNPNI 79
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+ L + + L++V +++ LT ++ + E Q+ ++ L L+ H
Sbjct: 80 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
++HRDIK+ N+L+ G +K+ DFG P+Q ++ V T ++ APE++ Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA-Y 193
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350
G +D+WS G + EM G P + L+ I GTP + KL+ FR
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTP--ELQNPEKLSAIFR--- 247
Query: 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN-ASPLA 399
L L +D RG+A LQ++F A PL+
Sbjct: 248 -----------------DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-22
Identities = 75/282 (26%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+ KL ++G+G++ V+K D T ++VA+K + + +E E ++ + +EI +L + D P V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 172 IKLEGLATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
K G S ++ + L+++ +++ + R G E Q+ ++++L GL + H
Sbjct: 65 TKYYG---SYLKGTKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSE 120
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
+HRDIKA+N+L+ + G +K+ADFG++ Q T V T ++ APE++ S Y
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIQQSA-Y 178
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350
D+WS G E+ G P +++ + +F + P++
Sbjct: 179 DSKADIWSLGITAIELAKGE---PPNSDMHPMRVLFLI-------------------PKN 216
Query: 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
P+ + GEF + L DP++R TA L+++F
Sbjct: 217 NPPT---LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 14/214 (6%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQ-KLDHPNVIKLE 175
+G+G++ V+ A + T + A+K ++ D + V+ E R+L +HP + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
T + + +L+ V +++ + K P+ Y +++ GLQ H +GI++R
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW----YRAPELLLGSTDYG 291
D+K N+L+D G +KIADFG+ K+ ++ T Y APE+LLG Y
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMC-----KENMLGDAKTCTFCGTPDYIAPEILLGQK-YN 174
Query: 292 VGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
+D WS G LL EM IG+ G E E I
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-22
Identities = 72/285 (25%), Positives = 136/285 (47%), Gaps = 38/285 (13%)
Query: 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
+ K+G+G+ V AR++ +G+ VA+K + D + + + + E+ I++ H NV+
Sbjct: 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNVV 81
Query: 173 KLEGLATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
++ + + L+++ +F+Q LT I+ + +L E Q+ + +L L + H +G
Sbjct: 82 EM--YKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG 137
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFF---IPKQKGPLTSRVVTLWYRAPELLLGST 288
++HRDIK+ ++L+ G +K++DFG +PK+K S V T ++ APE++ T
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK----SLVGTPYWMAPEVI-SRT 192
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348
YG +D+WS G ++ EM G P + V+ + R+
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL----------------------- 229
Query: 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ P + + P L +L +P R TA L + F
Sbjct: 230 RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 4e-22
Identities = 78/291 (26%), Positives = 128/291 (43%), Gaps = 53/291 (18%)
Query: 117 KVGQGTYSNVYKARDRDTG---KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
++G+G++ VY +D+ ++ LK++ P +E ++L KLDHP ++K
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 174 LEGLATSRMQYSLYLVF------DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
R + + + D +L G+ L+E QV + QLL G+ +
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKH----TGKTLSENQVCEWFIQLLLGVHYM 122
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H+R ILHRD+KA N+ + K+ +LKI DFG+S + T+ T +Y +PE L
Sbjct: 123 HQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPE-ALKH 179
Query: 288 TDYGVGIDLWSAGCLLAEM------FIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341
Y D+WS GC+L EM F G+ L + ++ P+
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---------LSVVLRIVEGPT-------- 222
Query: 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
PS E + I+ ++L DP+ R +AA L+N F
Sbjct: 223 -----------PSLPET---YSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-22
Identities = 78/283 (27%), Positives = 137/283 (48%), Gaps = 35/283 (12%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+ KL ++G+G++ VYK D T ++VA+K + + +E E ++ + +EI +L + D P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 172 IKLEG--LATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
+ G L ++ L+++ +++ + +PG L E + ++++L GL + H
Sbjct: 65 TRYYGSYLKGTK----LWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHS 119
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
+HRDIKA+N+L+ + G +K+ADFG++ Q + V T ++ APE++ S
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSA- 177
Query: 290 YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349
Y D+WS G E+ G P LH + L P T Q
Sbjct: 178 YDFKADIWSLGITAIELAKGEP------PNSDLHPMRVLFLIPKNS-------PPTLEGQ 224
Query: 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
+ KP F EF + L DP +R TA L+++F
Sbjct: 225 YSKP-----FKEF-------VEACLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 69/221 (31%), Positives = 110/221 (49%), Gaps = 17/221 (7%)
Query: 115 LAKVGQGTYSNVY---KARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
L +GQG++ V+ K D G++ A+K ++ T + E IL +++HP +
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 172 IKLEGLATSRMQYSLYLVFDFMQ-----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
+KL + + LYL+ DF++ + L+K + TE VK Y+ +L L H
Sbjct: 61 VKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKFYLAELALALDH 113
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
H GI++RD+K N+L+D+ G +K+ DFGLS I +K S T+ Y APE ++
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPE-VVN 171
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
+ D WS G L+ EM G G+ E + I K
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRILQKLDHPN 170
LA +G+G + V A + TG++ A+K ++ E ES+ R HP
Sbjct: 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
++ L A + + + V ++ DL I +EP+ Y ++ GLQ+ HE
Sbjct: 64 LVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHE 119
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW----YRAPELLL 285
I++RD+K NLL+D G +KIADFGL K+ R T + APE+L
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLC-----KEGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVE 320
T Y +D W G L+ EM +G PG E E
Sbjct: 175 E-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 74/288 (25%), Positives = 138/288 (47%), Gaps = 34/288 (11%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ ++ + ++G GTY +VYKAR+ +TG++ A+K ++ + E +V + +EI +++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV--VQQEIIMMKDCKHS 66
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N++ G R + L++ +F + I L+E Q+ ++ L GL + H
Sbjct: 67 NIVAYFGSYLRRDK--LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLS---NFFIPKQKGPLTSRVVTLWYRAPEL--L 284
+G +HRDIK +N+L+ +G +K+ADFG+S I K+K S + T ++ APE+ +
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK----SFIGTPYWMAPEVAAV 180
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344
Y D+W+ G E+ L P ++ + +F + +
Sbjct: 181 ERKGGYNQLCDIWAVGITAIEL---AELQPPMFDLHPMRALF-------------LMTKS 224
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
F+P K + + S + + L +P R TA LQ+ F
Sbjct: 225 NFQPPKLKDKMK-----WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVR--FDTSEPESVKFMAREIRILQKLDHPNVIKLE 175
+G+G++ V + R RDT +I ALK +R S E +A E +L +++ P ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-ERTVLAQVNCPFIVPLK 59
Query: 176 GLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
S + LYLV F+ +L + R G + + + Y +LL L++ H+ +++
Sbjct: 60 FSFQSPEK--LYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIY 116
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD+K N+L+D G + + DFGL + T T Y APELLLG Y +
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF-CGTPEYLAPELLLGH-GYTKAV 174
Query: 295 DLWSAGCLLAEMFIGRP 311
D W+ G LL EM G P
Sbjct: 175 DWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 73/252 (28%), Positives = 131/252 (51%), Gaps = 21/252 (8%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGL 177
+G+G + V+K +D VA+K + D + +KF++ E RIL++ DHPN++KL G+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIGV 60
Query: 178 ATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRD 236
T R +Y+V + + D + + +L Q+ + +G+ + + +HRD
Sbjct: 61 CTQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 237 IKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS---RVVTLWYRAPELLLGSTDYGVG 293
+ A N L+ ++ +LKI+DFG+S + G +S + + + + APE L Y
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPE-ALNYGRYSSE 174
Query: 294 IDLWSAGCLLAEMF-IGRPLMPG------RTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
D+WS G LL E F +G PG R +VE+ +R+ P +D +K M+ +
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCP-DDVYKVMQRCWDY 233
Query: 347 RPQHYKPSFREV 358
+P++ +P F E+
Sbjct: 234 KPEN-RPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN 170
+Y + VG+G+Y V R R GK +KK+ + K +E ++L +L HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 171 VIKLEGLATSRMQYS-----LYLVFDFMQS-DL-TKIICRPGQKLTEPQVKCYMQQLLSG 223
++ R + LY+V F + DL K+ + G+ L E QV + Q+
Sbjct: 61 IV------AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA 114
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
LQ+ HE+ ILHRD+K N+ + ++ ++K+ D G++ + Q ++ + T +Y +PE
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPE- 172
Query: 284 LLGSTDYGVGIDLWSAGCLLAEM 306
L + Y D+W+ GC + EM
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 36/233 (15%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQKLDH 168
+ K+ +G+G V+ R + TGK+ ALK + + + + VK + E IL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 169 PNVIKLEG-LATSRMQYSLYLVFDF-MQSDLTKII-CRPGQKLTEPQVKCYMQQLLSGLQ 225
P + L T L LV D+ +L +++ +PG+ L+E + Y ++L L+
Sbjct: 61 PFLPTLYASFQTETY---LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE 117
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLTSR------- 272
+ H GI++RD+K N+L+ +SG + ++DF LS + K + R
Sbjct: 118 YLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 273 ---------------VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGR 310
V T Y APE++ G +G +D W+ G LL EM G
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 68/251 (27%), Positives = 105/251 (41%), Gaps = 63/251 (25%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKLDH 168
D ++ + +G+G + V + +DTG I A+KK+R + E E V + E IL + D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 169 PNVIKLEGLATSRMQYS------LYLVFDF-----MQSDLTKIICRPGQKLTEPQVKCYM 217
P V+K + YS LYL+ ++ M + L K TE + + Y+
Sbjct: 61 PWVVK--------LYYSFQDENYLYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYI 107
Query: 218 QQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN----------FFIPKQKG 267
+ + + H+ G +HRDIK NLL+D G +K++DFGL + I
Sbjct: 108 AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 268 PLTSRVVTL-----------W----------------YRAPELLLGSTDYGVGIDLWSAG 300
P W Y APE+ L T Y D WS G
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLG 226
Query: 301 CLLAEMFIGRP 311
++ EM +G P
Sbjct: 227 VIMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 59/196 (30%), Positives = 105/196 (53%), Gaps = 8/196 (4%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRIL-QKLDHPNVIKLE 175
+G+G+Y+ V R + T +I A+K V+ + ++ E + ++ E + Q +HP ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ + + L+ V +++ + +KL E + Y ++ L + HERGI++R
Sbjct: 63 --SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTDYGVGI 294
D+K N+L+D G +K+ D+G+ + + G TS T Y APE+L G DYG +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNYIAPEILRGE-DYGFSV 177
Query: 295 DLWSAGCLLAEMFIGR 310
D W+ G L+ EM GR
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 66/255 (25%), Positives = 125/255 (49%), Gaps = 17/255 (6%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+G G Y VY+ + VA+K ++ DT E V+ +E +++++ HPN+++L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 177 LATSRMQYSLYLVFDFM-QSDLTKIICRPGQKLTEPQVKCYM-QQLLSGLQHCHERGILH 234
+ T + Y++ +FM +L + ++ V YM Q+ S +++ ++ +H
Sbjct: 70 VCTREPPF--YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD+ A N L+ ++ ++K+ADFGLS + + APE L + + +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKS 186
Query: 295 DLWSAGCLLAEM-------FIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347
D+W+ G LL E+ + G L +E+ +R+ + G P + Y + M+ +
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVY-ELMRACWQWN 245
Query: 348 PQHYKPSFREVFGEF 362
P +PSF E+ F
Sbjct: 246 PSD-RPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 35/285 (12%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHPNVIKLEG 176
+G+G + V + R TGK+ A KK+ + + MA E +IL+K++ V+ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 66
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQK-LTEPQVKCYMQQLLSGLQHCHERGILH 234
+ +L LV M DL I G E + Y ++ GL+ H I++
Sbjct: 67 -YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD+K N+L+D G ++I+D GL+ IP+ + + RV T+ Y APE ++ + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLA-VEIPEGE-TIRGRVGTVGYMAPE-VVKNERYTFSP 182
Query: 295 DLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPS 354
D W GCL+ EM G+ R E + + + E+Y +K
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK--------------- 227
Query: 355 FREVFGEFPPSSYGILTTLLALDPAYR-----GTAASALQNEFFN 394
F ++ I LL DP +R A + FF
Sbjct: 228 -------FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 78/277 (28%), Positives = 120/277 (43%), Gaps = 54/277 (19%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKLDH 168
D ++ L +G+G + V + +DTG I A+K +R D E E V + E IL + D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
V+K+ + + + +LYL+ +F+ + L+E + Y+ + + + H
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGL---------SNFFIPKQKGPLT--------- 270
+ G +HRDIK NLL+D G +K++DFGL + F+ P +
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 271 ----------------SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMP 314
S V T Y APE+ + T Y D WS G ++ EM IG P P
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYP--P 235
Query: 315 GRTEVEQLHRIFKLCGTPSEDYWKKM--KLTTTFRPQ 349
+E TP E Y K M K T F P+
Sbjct: 236 FCSE------------TPQETYRKVMNWKETLVFPPE 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 7/195 (3%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+GT+ V R++ TGK A+K ++ + + V E R+LQ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK- 61
Query: 177 LATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRD 236
+ + L V ++ + +E + + Y +++S L + H +++RD
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 237 IKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTDYGVGID 295
+K NL++DK G +KI DFGL I G T Y APE +L DYG +D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 177
Query: 296 LWSAGCLLAEMFIGR 310
W G ++ EM GR
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 44/260 (16%)
Query: 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQ 164
+P+ + ++ K+G G + V+ T K VA+K ++ T PE+ +E +I++
Sbjct: 3 IPRESLKLER--KLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQIMK 56
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLS 222
KL H +++L + + +Y+V ++M S L + G+KL PQ+ Q+
Sbjct: 57 KLRHDKLVQLYAVCSEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQ--KGPLTSRVVT 275
G+ + R +HRD+ A N+L+ ++ + KIADFGL+ + + ++ K P+
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK----- 169
Query: 276 LWYRAPELLLGSTDYG---VGIDLWSAGCLLAEMFI-GRPLMPGRT------EVEQLHRI 325
W APE YG + D+WS G LL E+ GR PG T +VE+ +R+
Sbjct: 170 -W-TAPEAAN----YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM 223
Query: 326 FKLCGTPSEDY------WKK 339
+ P E Y W K
Sbjct: 224 PRPPNCPEELYDLMLQCWDK 243
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 61/207 (29%), Positives = 113/207 (54%), Gaps = 13/207 (6%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y+ + +VG GTY +VYKAR+ TG++ A+K ++ + + S+ + +EI ++++ H N+
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNI 68
Query: 172 IKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
+ G SR + L++ ++ + I L+E Q+ ++ L GL + H +G
Sbjct: 69 VAYFGSYLSREK--LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLS---NFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
+HRDIK +N+L+ +G +K+ADFG++ I K+K S + T ++ APE+
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK----SFIGTPYWMAPEVAAVEK 182
Query: 289 DYGVG--IDLWSAGCLLAEMFIGRPLM 313
+ G D+W+ G E+ +P M
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 7e-20
Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-----EPESVKFMAREIRILQKLDHPNVI 172
+G+G Y VY + G+++A+K+V DTS E E K + E+ +L+ L H N++
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEK-LQEEVDLLKSLKHVNIV 65
Query: 173 KLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
+ G S+++ F ++ I+ R G L EP Y +Q+L G+ + H +
Sbjct: 66 QYLGTCLDDNTISIFMEF-VPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFI-----PKQKGPLTSRVVTLWYRAPELLLGS 287
+HRDIK +N+++ +G++K+ DFG + L S T ++ APE ++
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINE 182
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRP 311
+ YG D+WS GC + EM G+P
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 7e-20
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 38/218 (17%)
Query: 114 KLAKV-GQGTYSNVYKARDR---DTGKIVALKKVRFDTSEPESVKFMAREIRILQK---L 166
+L +V G G Y V+ R D GK+ A+K + ++ I+QK
Sbjct: 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMK--------------VLKKATIVQKAKTA 48
Query: 167 DHPNVIK--LEGLATS----RMQYS------LYLVFDFMQSD--LTKIICRPGQKLTEPQ 212
+H + LE + + Y+ L+L+ D++ T + R + TE +
Sbjct: 49 EHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESE 106
Query: 213 VKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272
V+ Y+ +++ L H H+ GI++RDIK N+L+D G + + DFGLS F+ +++ S
Sbjct: 107 VRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF 166
Query: 273 VVTLWYRAPELLLGSTD-YGVGIDLWSAGCLLAEMFIG 309
T+ Y APE++ G + + +D WS G L E+ G
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 115 LAKVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN 170
+ ++G+G + +V R +TG++VA+KK++ T E ++ REI IL+ L H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDN 66
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
++K +G+ S + +L LV +++ L + + ++L ++ Y Q+ G+++
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR----VVTLWYRAPELLL 285
+ +HRD+ N+L++ +KI DFGL+ +P+ K R WY APE L
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTK-VLPQDKEYYKVREPGESPIFWY-APESLT 184
Query: 286 GSTDYGVGIDLWSAGCLLAEMF 307
S + V D+WS G +L E+F
Sbjct: 185 ESK-FSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 8e-20
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH-PNVIKLEG 176
VG GTY VYK R TG++ A+K + E E +K +EI +L+K H N+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHHRNIATYYG 70
Query: 177 LATSR----MQYSLYLVFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHER 230
+ M L+LV +F + +T +I G L E + +++L GL H H+
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD- 289
++HRDIK N+L+ ++ +K+ DFG+S + + G + + T ++ APE++ +
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACDENP 189
Query: 290 ---YGVGIDLWSAGCLLAEMFIGRP 311
Y DLWS G EM G P
Sbjct: 190 DATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRIL-QKLDHPNVIKLE 175
+G+G+Y+ V + T +I A+K ++ + ++ E + ++ E + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 176 GL--ATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
SR L+ V +F+ DL + R +KL E + Y ++ L HERGI
Sbjct: 63 SCFQTESR----LFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGI 117
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTDYG 291
++RD+K N+L+D G +K+ D+G+ I + G TS T Y APE+L G DYG
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCGTPNYIAPEILRGE-DYG 174
Query: 292 VGIDLWSAGCLLAEMFIGR 310
+D W+ G L+ EM GR
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 10/217 (4%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIK 173
L +G+G++ V A + T ++ A+K ++ D + + V+ E R+L D P +
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
+ + + LY V +++ DL I + G K EPQ Y ++ GL H RGI
Sbjct: 65 -QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV--TLWYRAPELLLGSTDY 290
++RD+K N+++D G +KIADFG+ +T+R T Y APE ++ Y
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE-IIAYQPY 178
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
G +D W+ G LL EM G+P G E E I +
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 79/277 (28%), Positives = 122/277 (44%), Gaps = 54/277 (19%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKLDH 168
+ ++ L +G+G + V + +DTG + A+K +R D E E V + E IL + D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
V+K+ + + + +LYL+ +F+ + LTE + + Y+ + + + H
Sbjct: 61 LWVVKM--FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH 118
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLS---------------NFFIP---------- 263
+ G +HRDIK NLL+D G +K++DFGL N +P
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 264 KQKGPLTSR---------VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMP 314
K+K R V T Y APE+ + T Y D WS G ++ EM IG P P
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYP--P 235
Query: 315 GRTEVEQLHRIFKLCGTPSEDYWKKM--KLTTTFRPQ 349
+E TP E Y K M K T F P+
Sbjct: 236 FCSE------------TPQETYKKVMNWKETLIFPPE 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 8/211 (3%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQ-KLDHPNVIKLE 175
+G+G++ V A + T + A+K ++ D E + V+ E R+L +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 176 GLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
T + + L+ V +++ DL I G + E + + Y +++ GLQ H++GI++
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD+K N+L+DK G +KIADFG+ + + G ++ T Y APE+L G Y +
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQK-YNESV 177
Query: 295 DLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
D WS G LL EM IG+ G E E I
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 60/207 (28%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 111 SYDKLAKVGQGTYSNVY---KARDRDTGKIVALKKVRFDT--SEPESVKFMAREIRILQK 165
+++ L +G G Y V+ K DTGK+ A+K ++ + ++V+ E +L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 166 L-DHPNVIKLEGLATSRMQYSLYLVFDFMQSD--LTKIICRPGQKLTEPQVKCYMQQLLS 222
+ P ++ L + + L+L+ D++ T + R +E +V+ Y +++
Sbjct: 61 VRQSPFLVTLH--YAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIIL 116
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
L+H H+ GI++RDIK N+L+D G + + DFGLS F+ ++K S T+ Y APE
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIG 309
++ G +G +D WS G L+ E+ G
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y+ L VG+G++ + ++ + A+K++R S +V+ +E +L K+ HPN+
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNI 60
Query: 172 IKLEGLATSRMQYSLYLVFDFMQSD--LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
+ + + LY+V ++ + KI + G+ E + + Q+ G+QH HE
Sbjct: 61 VAFK--ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
+ +LHRDIK+ N+ + ++G +K+ DFG S + + V T +Y PE + +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFG-SARLLTSPGAYACTYVGTPYYVPPE-IWENMP 176
Query: 290 YGVGIDLWSAGCLLAEM 306
Y D+WS GC+L E+
Sbjct: 177 YNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 114 KLAKVGQGTYSNV----YKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
++ +G+G + V Y +TG+ VA+K ++ ++ + + +EI IL+ L H
Sbjct: 8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHE 66
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++K +G+ T + L+ +F+ S L + + R K+ Q Y Q+ G+ +
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR----VVTLWYRAPELL 284
R +HRD+ A N+L++ +KI DFGL+ I K T + WY APE L
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 285 LGSTDYGVGIDLWSAGCLLAEMF 307
+ S Y + D+WS G L E+
Sbjct: 185 IQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 8/213 (3%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQ-KLDHPNVIKLE 175
+G+G++ V AR +++G++ A+K ++ D + + V+ E RIL +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL- 61
Query: 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ L+ V +F+ + ++ E + + Y ++ S L H++GI++R
Sbjct: 62 -YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTDYGVGI 294
D+K N+L+D G K+ADFG+ I G TS T Y APE +L YG +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGI--FNGKTTSTFCGTPDYIAPE-ILQEMLYGPSV 177
Query: 295 DLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
D W+ G LL EM G E + I
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 72/261 (27%), Positives = 128/261 (49%), Gaps = 27/261 (10%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPE-SVKFMAREIRILQKLDHPNVIKLE 175
++G+G + V+ R R VA+K R +T P+ KF+ +E RIL++ HPN+++L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFL-QEARILKQYSHPNIVRLI 59
Query: 176 GLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
G+ T + +Y+V + +Q D + G +L ++ ++ +G+++ + +H
Sbjct: 60 GVCTQK--QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS----RVVTLWYRAPELLLGSTDY 290
RD+ A N L+ + +LKI+DFG+S ++ G S + + + + APE L Y
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPE-ALNYGRY 173
Query: 291 GVGIDLWSAGCLLAEMF-IGRPLMPG------RTEVEQLHRIF--KLCGTPSEDYWKKMK 341
D+WS G LL E F +G R +EQ R+ +LC + ++ M+
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELC---PDAVYRLME 230
Query: 342 LTTTFRPQHYKPSFREVFGEF 362
+ P +PSF V E
Sbjct: 231 RCWEYDPGQ-RPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 14/217 (6%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIK 173
L +G+G++ V A + T ++ A+K ++ D + + V+ E R+L P +
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
M LY V +++ DL I + G K EP Y ++ GL H +GI
Sbjct: 65 QLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 233 LHRDIKASNLLIDKSGMLKIADFGL--SNFFIPKQKGPLTSRVV--TLWYRAPELLLGST 288
++RD+K N+++D G +KIADFG+ N F G T+R T Y APE++
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIF-----GGKTTRTFCGTPDYIAPEIIA-YQ 176
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
YG +D W+ G LL EM G+P G E E I
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 68/240 (28%), Positives = 121/240 (50%), Gaps = 22/240 (9%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
L K+G G + V++ +T VA+K ++ T +P+ F+ E +I++KL HP +I+L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQIMKKLRHPKLIQL 66
Query: 175 EGLATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
+ T ++ +Y+V + M+ S L + G+ L PQ+ Q+ SG+ + +
Sbjct: 67 YAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
+HRD+ A N+L+ ++ + K+ADFGL+ + + APE L + +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL-YNRFSI 183
Query: 293 GIDLWSAGCLLAEMFI-GR---PLMPGRTEVEQLHRIFKL-C--GTPSEDY------WKK 339
D+WS G LL E+ GR P M ++Q+ + +++ C G P E Y WK+
Sbjct: 184 KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKE 243
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 67/218 (30%), Positives = 113/218 (51%), Gaps = 15/218 (6%)
Query: 118 VGQGTYSNVYKAR---DRDTGKIVA---LKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+G+G Y V++ R DTGKI A LKK ++ ++ A E IL+ + HP +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHPFI 62
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+ L + + LYL+ +++ +L + R G + E Y+ ++ L+H H++
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGIFM-EDTACFYLSEISLALEHLHQQ 119
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTD 289
GI++RD+K N+L+D G +K+ DFGL I +G +T T+ Y APE+L+ S
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTHTFCGTIEYMAPEILMRS-G 176
Query: 290 YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
+G +D WS G L+ +M G P + + +I K
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 9e-19
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 114 KLAKVGQGTYSNV----YKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
K+ +G+G + V Y + TG++VA+K ++ + ++ +EI IL+ L H
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHE 66
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++K +G + + L L+ +++ L + P KL Q+ + QQ+ G+ + H
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV------TLWYRAPE 282
+ +HRD+ A N+L+D ++KI DFGL+ +P +G RV WY A E
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVP--EGHEYYRVREDGDSPVFWY-AVE 180
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMF 307
L + D+WS G L E+
Sbjct: 181 -CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKV---RFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
+G+G + V + R TGK+ A K++ R + ES+ E +IL+K++ V+ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL--NEKQILEKVNSQFVVNL 65
Query: 175 EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQK-LTEPQVKCYMQQLLSGLQHCHERGI 232
+ +L LV M DL I G E + Y ++L GL+ H
Sbjct: 66 A--YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
++RD+K N+L+D G ++I+D GL+ IP+ + + RV T+ Y APE +L + Y +
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA-VKIPEGES-IRGRVGTVGYMAPE-VLNNQRYTL 180
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTE 318
D W GCL+ EM G+ GR E
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 5/194 (2%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+GT+ V R++ TG+ A+K +R + + V E R+LQ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 177 LATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRD 236
+ + L V ++ + TE + + Y +++S L++ H R +++RD
Sbjct: 63 AFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 237 IKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDL 296
IK NL++DK G +KI DFGL I + + T Y APE +L DYG +D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 297 WSAGCLLAEMFIGR 310
W G ++ EM GR
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRIL-QKLDHPNVIKLE 175
+G+G+Y+ V R + +I A+K V+ + + E + ++ E + Q +P ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 176 GL--ATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
TSR L+LV +++ + +KL E + Y ++ L HERGI+
Sbjct: 63 SCFQTTSR----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTDYGV 292
+RD+K N+L+D G +K+ D+G+ + G TS T Y APE+L G +YG
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPEILRGE-EYGF 175
Query: 293 GIDLWSAGCLLAEMFIGR 310
+D W+ G L+ EM GR
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKF--MAREIRILQKLD 167
D + L ++G+G Y +VYK R TG +A+K++R E + KF + E+ IL K
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL---ELDESKFNQIIMELDILHKAV 57
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKII--CRPGQKLTEPQVKCYMQQLLSGL 224
P ++ G ++ ++Y+ ++M + L K+ + + E ++ ++ GL
Sbjct: 58 SPYIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 225 QHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
+ E I+HRD+K +N+L++ +G +K+ DFG+S + + + Y APE
Sbjct: 116 KFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAPER 172
Query: 284 L--LGSTD---YGVGIDLWSAGCLLAEMFIGRPLMPGRT 317
+ G Y V D+WS G + EM +GR P T
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 29/206 (14%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAREIRILQKL----DHPN 170
+G+G + VY R DTGK+ A+K K R + E+ +A RI+ L D P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET---LALNERIMLSLVSTGDCPF 58
Query: 171 VIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSG 223
++ M Y+ L + D M DL + + G +E +++ Y +++ G
Sbjct: 59 IVC--------MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILG 109
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
L+H H R +++RD+K +N+L+D+ G ++I+D GL+ F +K P S V T Y APE+
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHAS-VGTHGYMAPEV 166
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIG 309
L Y D +S GC+L ++ G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 9/209 (4%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQKL 166
A+ +D + +G+G + V R + + ++ A+K + +F+ + F E I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
+ +++L A +Y LY+V ++M DL ++ + E + Y +++ L
Sbjct: 101 NSEWIVQLH-YAFQDDKY-LYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLALD 156
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
H G +HRD+K N+L+DKSG LK+ADFG + V T Y +PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 286 ---GSTDYGVGIDLWSAGCLLAEMFIGRP 311
G YG D WS G L EM +G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-18
Identities = 74/270 (27%), Positives = 136/270 (50%), Gaps = 24/270 (8%)
Query: 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQ 164
VP+ ++ + K+G G + V+ K VA+K ++ + PE+ F+A E +++
Sbjct: 3 VPR--ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMK 56
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLS 222
+L HP +++L + T Q +Y++ ++M+ S + + G KLT ++ Q+
Sbjct: 57 QLQHPRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
G+ + +HRD++A+N+L+ ++ KIADFGL+ + + + APE
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRT--EV----EQLHRIFKLCGTPSED 335
+ T + + D+WS G LL E+ GR PG T EV E+ +R+ + P E
Sbjct: 174 AINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEEL 232
Query: 336 YWKKMKLTTTFRPQHYKPSF---REVFGEF 362
Y + M+L +P+ +P+F R V +F
Sbjct: 233 Y-ELMRLCWKEKPEE-RPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 76/263 (28%), Positives = 129/263 (49%), Gaps = 29/263 (11%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D ++K++++G G V+K + +G I+A K + + +P + RE+++L + + P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 63
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
++ G S + S+ + + M + + ++ E + ++ GL + E
Sbjct: 64 YIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 230 R-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
+ I+HRD+K SN+L++ G +K+ DFG+S I S V T Y +PE L G T
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG-T 177
Query: 289 DYGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQLHRIF--KLCGTPSEDYWKKMKLTTT 345
Y V D+WS G L EM IGR P+ P + ++L +F + G P+E T+
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAES-------ETS 228
Query: 346 FRPQHYKPSFREVFGEFPPSSYG 368
RP +P R P SSYG
Sbjct: 229 PRP---RPPGR------PLSSYG 242
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 53/199 (26%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G G++ V A+ + TG+ A+K ++ + + + V+ +A+E IL +L HP ++ +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM-- 83
Query: 177 LATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRD 236
+ + + + +Y + +F+ R + K Y +L+ ++ H + I++RD
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRD 143
Query: 237 IKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW----YRAPELLLGSTDYGV 292
+K NLL+D G +K+ DFG + + R TL Y APE ++ S +G
Sbjct: 144 LKPENLLLDNKGHVKVTDFGFAK--------KVPDRTFTLCGTPEYLAPE-VIQSKGHGK 194
Query: 293 GIDLWSAGCLLAEMFIGRP 311
+D W+ G LL E G P
Sbjct: 195 AVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 69/254 (27%), Positives = 119/254 (46%), Gaps = 37/254 (14%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAR-EIRILQKLDHPNVIK 173
+G+G + VY R DTGK+ A+K K R + E++ R + ++ D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 174 LEGLATSRMQYSLY------LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
M Y+ + + D M DL + + G +E +++ Y +++ GL+H
Sbjct: 62 --------MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEH 112
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
H R +++RD+K +N+L+D+ G ++I+D GL+ F +K P S V T Y APE+L
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHAS-VGTHGYMAPEVLQK 169
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
T Y D +S GC+L ++ G H F+ T + +M LT
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRG-------------HSPFRQHKTKDKHEIDRMTLTVNV 216
Query: 347 R-PQHYKPSFREVF 359
P + P + +
Sbjct: 217 ELPDSFSPELKSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQKLD 167
A+ YD + +G+G + V R + + K+ A+K + +F+ + F E I+ +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
P V++L + LY+V ++M DL ++ + E K Y +++ L
Sbjct: 102 SPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDA 157
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL- 285
H G++HRD+K N+L+DK G LK+ADFG + V T Y +PE+L
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 286 --GSTDYGVGIDLWSAGCLLAEMFIG 309
G YG D WS G L EM +G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH-PNVIKLEG 176
VG GTY VYK R TG++ A+K + E E +K EI +L+K H N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSHHRNIATYYG 80
Query: 177 LATSR----MQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
+ L+LV +F +DL K G L E + +++L GL H H
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLH 138
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
++HRDIK N+L+ ++ +K+ DFG+S + + G + + T ++ APE++
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 289 D----YGVGIDLWSAGCLLAEMFIGRP 311
+ Y D+WS G EM G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 30/267 (11%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHPNVIKLEG 176
+G+G + V + R TGK+ A KK+ + + MA E +IL+K++ V+ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA- 66
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQK-LTEPQVKCYMQQLLSGLQHCHERGILH 234
+ +L LV M DL I G+ E + Y ++ GL+ H+ I++
Sbjct: 67 -YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD+K N+L+D G ++I+D GL+ +P+ + + RV T+ Y APE ++ + Y
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLA-VHVPEGQ-TIKGRVGTVGYMAPE-VVKNERYTFSP 182
Query: 295 DLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPS 354
D W+ GCLL EM G+ R + + + +L E+Y +K
Sbjct: 183 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK--------------- 227
Query: 355 FREVFGEFPPSSYGILTTLLALDPAYR 381
F P + + LL DP R
Sbjct: 228 -------FSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 70/247 (28%), Positives = 110/247 (44%), Gaps = 53/247 (21%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
P + + L ++G GT VYK R + TG ++A+K++R T E K + ++ ++ K
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR-RTGNKEENKRILMDLDVVLK 69
Query: 166 -LDHPNVIKLEGLATSRMQYSLYLVFDF--------MQSDLTKIICRPGQ--------KL 208
D P ++K G Y + D M + L K++ R K+
Sbjct: 70 SHDCPYIVKCYG----------YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKM 119
Query: 209 TEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI-----P 263
T VK L L+ H G++HRD+K SN+L+D SG +K+ DFG+S +
Sbjct: 120 TVAIVKA-----LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172
Query: 264 KQKG-PLTSRVVTLWYRAPELLLGST---DYGVGIDLWSAGCLLAEMFIGR-PLMPGRTE 318
+ G Y APE + Y + D+WS G L E+ G+ P +TE
Sbjct: 173 RSAGCAA--------YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224
Query: 319 VEQLHRI 325
E L +I
Sbjct: 225 FEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 56/208 (26%), Positives = 107/208 (51%), Gaps = 13/208 (6%)
Query: 111 SYDKLAKVGQGTYSNVYKARD---RDTGKIVALKKVRFDT--SEPESVKFMAREIRILQK 165
+++ L +G G Y V+ R D+GK+ A+K ++ T + ++ + E ++L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 166 LDH-PNVIKLEGLATSRMQYSLYLVFDFMQSD--LTKIICRPGQKLTEPQVKCYMQQLLS 222
+ P ++ L + L+L+ D++ T + R ++ E +V+ Y +++
Sbjct: 61 IRQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVL 116
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
L+H H+ GI++RDIK N+L+D +G + + DFGLS F + S T+ Y AP+
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 283 LLL-GSTDYGVGIDLWSAGCLLAEMFIG 309
++ G + +D WS G L+ E+ G
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 72/253 (28%), Positives = 126/253 (49%), Gaps = 17/253 (6%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D +++++++G G V K + + +G I+A K + + +P + RE+++L + + P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 63
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
++ G S + S+ + + M + + +++ E + +L GL + E
Sbjct: 64 YIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 230 R-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
+ I+HRD+K SN+L++ G +K+ DFG+S I S V T Y +PE L G T
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG-T 177
Query: 289 DYGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347
Y V D+WS G L E+ IGR P+ P + ++L IF G P D + + + R
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF---GRPVVDGEEGEPHSISPR 232
Query: 348 PQHYKPSFREVFG 360
P +P R V G
Sbjct: 233 P---RPPGRPVSG 242
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 8/213 (3%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D ++KL ++G G V K R +G I+A K + + +P + RE+++L + + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSP 59
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
++ G S + S+ + + M + + ++ E + +L GL + E
Sbjct: 60 YIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 230 -RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
I+HRD+K SN+L++ G +K+ DFG+S I S V T Y +PE L G T
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG-T 173
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ 321
Y V D+WS G L EM IGR +P E
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 8/196 (4%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAR-EIRILQKLDHPNVIKLEG 176
+G+G + V + ++TGK+ A KK+ + +S + MA E IL+K++ P ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQK-LTEPQVKCYMQQLLSGLQHCHERGILH 234
S+ L LV M DL I G++ L +V Y Q+ G+ H H I++
Sbjct: 61 AFESKTH--LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD+K N+L+D G +++D GL+ + K +T R T Y APE+L Y +
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLA-VELKDGK-TITQRAGTNGYMAPEILKEEP-YSYPV 175
Query: 295 DLWSAGCLLAEMFIGR 310
D ++ GC + EM GR
Sbjct: 176 DWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 69/258 (26%), Positives = 109/258 (42%), Gaps = 48/258 (18%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKLDHPN 170
+ K+ +G G + V R DT + A+K +R D + E IL + D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
V+KL + + + +LY V D++ D+ ++ R G E + Y+ +L ++ H+
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHK 119
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGL---------SNFFIPKQ--------------- 265
G +HRDIK N+LID+ G +K+ DFGL S ++
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 266 --KGPLT----------------SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
+ L S V T Y APE+LL T Y D WS G +L EM
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 308 IGRPLMPGRTEVEQLHRI 325
+G+P T E ++
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 72/264 (27%), Positives = 113/264 (42%), Gaps = 52/264 (19%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRF-DTSEPESVKFMAREIRILQKLDHPN 170
+ K+ +G G + V AR DT + A+K +R D V + E IL + D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
V++L + + + +LY V D++ D+ ++ R G E + Y+ +L ++ H+
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHK 119
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFI-------------PKQKG--------- 267
G +HRDIK N+LID+ G +K+ DFGL F +Q
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 268 -----------PLTSR-------------VVTLWYRAPELLLGSTDYGVGIDLWSAGCLL 303
PL R V T Y APE+LL T Y D WS G +L
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238
Query: 304 AEMFIGRPLMPGRTEVEQLHRIFK 327
EM +G+P +T +E ++
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 26/233 (11%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRI-LQKLDH 168
D + + ++G+G Y V K R TG I+A+K++R T + K + ++ I ++ +D
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDC 59
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKI---ICRPGQKLTEPQVKCYMQQLLSGLQ 225
P + G A R + +++ + M + L K + G + E + ++ L+
Sbjct: 60 PYTVTFYG-ALFR-EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 226 HCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW------Y 278
+ H + ++HRD+K SN+LI+++G +K+ DFG+S G L V Y
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS--------GYLVDSVAKTIDAGCKPY 169
Query: 279 RAPELLLGSTD---YGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQLHRIFK 327
APE + + Y V D+WS G + E+ GR P +T +QL ++ +
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 59/193 (30%), Positives = 92/193 (47%), Gaps = 11/193 (5%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGL 177
+G G VYKA T +I+A+K + D + E K + E+ IL K D P +I G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 178 ATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDI 237
+ S+ +FM + +K+ E + ++ GL + ILHRD+
Sbjct: 68 FFVENRISI--CTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 238 KASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLW 297
K SN+L++ G +K+ DFG+S + + V T Y APE + G YG+ D+W
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGE-QYGIHSDVW 177
Query: 298 SAGCLLAEMFIGR 310
S G E+ +GR
Sbjct: 178 SLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQKLD 167
A+ Y+ + +G+G + V R + T K+ A+K + +F+ + F E I+ +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
P V++L A +Y LY+V ++M DL ++ + E + Y +++ L
Sbjct: 102 SPWVVQL-FYAFQDDRY-LYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDA 157
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL- 285
H G +HRD+K N+L+DKSG LK+ADFG + + V T Y +PE+L
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 286 --GSTDYGVGIDLWSAGCLLAEMFIG 309
G YG D WS G L EM +G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQ-KLDHPNVIKLE 175
+G+G++ V A + T ++ A+K ++ D + + V E RIL HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 176 GLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ + L+ V +++ DL I R +K EP+ + Y ++ L H G+++
Sbjct: 63 --CCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGSTDYGVG 293
RD+K N+L+D G K+ADFG+ I G T+ T Y APE +L +YG
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGI--LNGVTTTTFCGTPDYIAPE-ILQELEYGPS 176
Query: 294 IDLWSAGCLLAEMFIGRP 311
+D W+ G L+ EM G+P
Sbjct: 177 VDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 8e-17
Identities = 64/249 (25%), Positives = 120/249 (48%), Gaps = 21/249 (8%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
++G G + V+ + K VA+K +R E E +++ KL HP +++L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHPKLVQLYG 66
Query: 177 LATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ T R + LVF+FM+ L+ + K ++ + + G+ + ++HR
Sbjct: 67 VCTERS--PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGID 295
D+ A N L+ ++ ++K++DFG++ F + Q T + + +PE+ S Y D
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSD 183
Query: 296 LWSAGCLLAEMFI-GRPLMPGRTE---VEQL---HRIFK--LCGTPSEDYWKKMKLTTTF 346
+WS G L+ E+F G+ R+ VE + R++K L S+ ++ M+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLA---SQSVYELMQHCWKE 240
Query: 347 RPQHYKPSF 355
RP+ +PSF
Sbjct: 241 RPED-RPSF 248
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 53/195 (27%), Positives = 104/195 (53%), Gaps = 13/195 (6%)
Query: 118 VGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
+G G + V + R + GK VA+K ++ +S+ + + F+ E I+ + DHPN+I+L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNIIRL 70
Query: 175 EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
EG+ T + ++ ++M++ L K + K T Q+ ++ + SG+++ E +
Sbjct: 71 EGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR---VVTLWYRAPELLLGSTDY 290
HRD+ A N+L++ + + K++DFGLS + + T++ + W APE + +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRW-TAPE-AIAYRKF 185
Query: 291 GVGIDLWSAGCLLAE 305
D+WS G ++ E
Sbjct: 186 TSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 21/196 (10%)
Query: 125 NVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184
V+ A+ + T +VA+KK+ D+ E +K + +EI ++L HPN++ +
Sbjct: 15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE- 73
Query: 185 SLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKAS 240
LY+V M DL K G L E + ++ +L+ L + H +G +HR +KAS
Sbjct: 74 -LYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSKGFIHRSVKAS 130
Query: 241 NLLIDKSGMLKIADFGLSNFFIPKQK------GPLTSRVVTLWYRAPELL----LGSTDY 290
++L+ G + ++ S I K S V L + +PE+L G Y
Sbjct: 131 HILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG---Y 187
Query: 291 GVGIDLWSAGCLLAEM 306
D++S G E+
Sbjct: 188 NEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 14/225 (6%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+S + K+G G + V+ K VA+K ++ T PES E +I++KL H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMKKLRHD 61
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICR--PGQKLTEPQVKCYMQQLLSGLQHC 227
+++L + + +Y+V ++M + G+ L P + Q+ +G+ +
Sbjct: 62 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
+HRD++++N+L+ + KIADFGL+ + + + APE L
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 288 TDYGVGIDLWSAGCLLAEMFI-GR---PLMPGRTEVEQLHRIFKL 328
+ + D+WS G LL E+ GR P M R +EQ+ R +++
Sbjct: 179 R-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQ-KLDHPNVIKLE 175
+G+G++ V A + G+ A+K ++ D + V+ E R+L ++P + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 176 GLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
T + + L+ V +F+ DL I G + + Y +++ GLQ H +GI++
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 235 RDIKASNLLIDKSGMLKIADFGL--SNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
RD+K N+++D+ G +KIADFG+ N F + ++ T Y APE+L G Y
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPDYIAPEILQG-LKYTF 175
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
+D WS G LL EM IG+ G E E I
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 5/194 (2%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+GT+ V R++ +GK A+K ++ + + V E R+L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 177 LATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRD 236
+ + + L V +++ + +E + + Y +++S L + H I++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 237 IKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDL 296
+K NL++DK G +KI DFGL I + + T Y APE +L DYG +D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI-TDAATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 297 WSAGCLLAEMFIGR 310
W G ++ EM GR
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 61/224 (27%), Positives = 114/224 (50%), Gaps = 15/224 (6%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+GQG + V+ T + VA+K ++ T PE+ +E ++++KL H +++L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYA 68
Query: 177 LATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ + + +Y+V ++M S L + G+ L PQ+ Q+ SG+ + +H
Sbjct: 69 VVS---EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD++A+N+L+ ++ + K+ADFGL+ + + + APE L + +
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKS 184
Query: 295 DLWSAGCLLAEMFI-GRPLMPG---RTEVEQLHRIFKLCGTPSE 334
D+WS G LL E+ GR PG R ++Q+ R +++ P E
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+GT+ V +++ TG+ A+K ++ + + V E R+LQ HP L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF---LTA 59
Query: 177 LATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH-ERGILH 234
L S + L V ++ + +E + + Y +++S L + H E+ +++
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD+K NL++DK G +KI DFGL I K + + T Y APE +L DYG +
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGI-KDGATMKTFCGTPEYLAPE-VLEDNDYGRAV 177
Query: 295 DLWSAGCLLAEMFIGR 310
D W G ++ EM GR
Sbjct: 178 DWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 10/213 (4%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALK----KVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G++ V A+ + GK A+K K+ + E + + MA +L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 174 LEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
L + + LY V DF+ + + EP+ + Y ++ S L + H I+
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVG 293
+RD+K N+L+D G + + DFGL I Q T+ T Y APE++ Y
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIR-KQPYDNT 176
Query: 294 IDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIF 326
+D W G +L EM G P R E I
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 8e-16
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+G G + V++ ++ + VA+K ++ D + F +E++ L++L H ++I L
Sbjct: 13 KLGSGYFGEVWEGLWKNRVR-VAIKILKSD-DLLKQQDF-QKEVQALKRLRHKHLISLFA 69
Query: 177 LATSRMQYSLYLVFDFM-QSDLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ + Y++ + M + L + P GQ L + Q+ G+ + E+ +H
Sbjct: 70 VCSVGEPV--YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH 127
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD+ A N+L+ + + K+ADFGL+ ++ W APE T +
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPEAASHGT-FSTKS 185
Query: 295 DLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRI 325
D+WS G LL EMF G+ PG E +I
Sbjct: 186 DVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 19/214 (8%)
Query: 111 SYDKLAKV-GQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKL 166
S K+ +V G G + V + R + GK VA+K ++ +E + F++ E I+ +
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQF 62
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICR--PGQKLTEPQVKCYMQQLLSGL 224
DHPN+I LEG+ T + ++ +FM++ R GQ T Q+ ++ + +G+
Sbjct: 63 DHPNIIHLEGVVTKSR--PVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLRGIAAGM 119
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI-----PKQKGPLTSRVVTLWYR 279
++ E +HRD+ A N+L++ + + K++DFGLS F P L ++ W
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-T 178
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEM--FIGRP 311
APE + + D+WS G ++ E+ + RP
Sbjct: 179 APE-AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 60/254 (23%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRILQK 165
+ + + +G+G + V + +DTGKI A+K + F + VK E +L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVK---AERDVLAE 57
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
D P V+ L + QY LYL+ +F+ DL ++ + +E + YM + + +
Sbjct: 58 SDSPWVVSLY-YSFQDAQY-LYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAI 114
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ---------------KGPL 269
+ H+ G +HRDIK N+LID+ G +K++DFGLS F KQ K +
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF-HKQHDSAYYQKLLQGKSNKNRI 173
Query: 270 TSR----VVTLW----------------------------YRAPELLLGSTDYGVGIDLW 297
+R V ++ Y APE+ L YG D W
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWW 232
Query: 298 SAGCLLAEMFIGRP 311
S G ++ E IG P
Sbjct: 233 SLGAIMFECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 67/252 (26%), Positives = 123/252 (48%), Gaps = 25/252 (9%)
Query: 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLE 175
+G+G + V + TG+ VA+K ++ D + + F+ E ++ KL H N+++L
Sbjct: 12 EIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT---AQAFLE-ETAVMTKLHHKNLVRLL 65
Query: 176 GLATSRMQYSLYLVFDFM-QSDLTKIICRPGQKLTE-PQVKCYMQQLLSGLQHCHERGIL 233
G+ + LY+V + M + +L + G+ L Q+ + + G+++ + ++
Sbjct: 66 GVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVG 293
HRD+ A N+L+ + G+ K++DFGL+ G S++ W APE L +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKW-TAPE-ALKHKKFSSK 177
Query: 294 IDLWSAGCLLAEMF-IGRPLMPGRT------EVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
D+WS G LL E+F GR P + VE+ +R+ G P+ D + M
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA-DVYVLMTSCWET 236
Query: 347 RPQHYKPSFREV 358
P+ +PSF ++
Sbjct: 237 EPKK-RPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQ 164
+P+ + +K K+G G + V+ A K VA+K ++ + SV+ E +++
Sbjct: 3 IPRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMK 56
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLS 222
L H ++KL + T +Y++ +FM S L + G K P++ + Q+
Sbjct: 57 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
G+ +R +HRD++A+N+L+ S + KIADFGL+ + + + APE
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 283 LLLGSTDYG---VGIDLWSAGCLLAEMF-IGRPLMPGRTEVE 320
+ ++G + D+WS G LL E+ GR PG + E
Sbjct: 174 ----AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDT--SEPESVKFMAREIRILQKLDHPNVIKLE 175
+G+G++ V A+ + GK A+K ++ + E MA +L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 176 GLATSRMQYS------LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
YS LY V D++ + + EP+ + Y ++ S L + H
Sbjct: 62 -------HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
I++RD+K N+L+D G + + DFGL I + ++ T Y APE+L
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI-EHSKTTSTFCGTPEYLAPEVLR-KQP 172
Query: 290 YGVGIDLWSAGCLLAEMFIGRP 311
Y +D W G +L EM G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 70/255 (27%), Positives = 128/255 (50%), Gaps = 23/255 (9%)
Query: 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
A +G+G + +V R G+ VA+K ++ D++ ++ F+A E ++ L HPN++
Sbjct: 9 KLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLV 63
Query: 173 KLEGLATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+L G+ LY+V ++M S + + R +T Q + + G+++ E+
Sbjct: 64 QLLGVVLQGN--PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
+HRD+ A N+L+ + + K++DFGL+ +G + ++ W APE L +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKW-TAPEALREKK-F 176
Query: 291 GVGIDLWSAGCLLAEMF-IGR---PLMPGR---TEVEQLHRIFKLCGTPSEDYWKKMKLT 343
D+WS G LL E++ GR P +P + VE+ +R+ G P E Y K MK
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVY-KVMKDC 235
Query: 344 TTFRPQHYKPSFREV 358
P +P+F+++
Sbjct: 236 WELDPAK-RPTFKQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+GQG + V+ T K VA+K ++ T PE+ +E +I++KL H ++ L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYA 68
Query: 177 LATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ + + +Y+V +FM S L + G+ L PQ+ Q+ G+ + +H
Sbjct: 69 VVS---EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD++A+N+L+ + + KIADFGL+ + + + APE L + +
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKS 184
Query: 295 DLWSAGCLLAEMFI-GRPLMPG---RTEVEQLHRIFKL 328
D+WS G LL E+ GR PG R +EQ+ R +++
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 10/210 (4%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHPNVIKLEG 176
+G+G + V + R TGK+ A KK+ + + MA E RIL+K++ V+ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA- 66
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQK-LTEPQVKCYMQQLLSGLQHCHERGILH 234
+ +L LV M DL I G E + Y +L GL+ I++
Sbjct: 67 -YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
RD+K N+L+D G ++I+D GL+ IP+ + + RV T+ Y APE ++ + Y
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLA-VQIPEGE-TVRGRVGTVGYMAPE-VINNEKYTFSP 182
Query: 295 DLWSAGCLLAEMFIGRPLMPGRTEVEQLHR 324
D W GCL+ EM G+ P R E++ R
Sbjct: 183 DWWGLGCLIYEMIQGQS--PFRKRKERVKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 64/257 (24%), Positives = 103/257 (40%), Gaps = 31/257 (12%)
Query: 159 EIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQ 218
E +LQ ++HP+VI+++ S + V SDL + + + L Q +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI--PKQKGPLTSRVVTL 276
Q+L GL++ H + I+HRD+K N+ I+ + I D G + F + P G L V T
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVET- 222
Query: 277 WYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI----------GRPLMPGRTEVEQLHRIF 326
APE +L Y D+WSAG +L EM P ++ L +I
Sbjct: 223 --NAPE-VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 327 KLCGTPSEDYWKK--MKLTTTFRPQHYKPSFREVFGEFPP-SSYGILTT-------LLAL 376
E++ + +L F Y R+ + +P + +L
Sbjct: 280 STLKVHPEEFPRDPGSRLVRGF--IEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTF 337
Query: 377 DPAYRGTAASALQNEFF 393
D A R +A L F
Sbjct: 338 DAAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 49/175 (28%), Positives = 92/175 (52%), Gaps = 15/175 (8%)
Query: 138 VALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSD 196
VA+K ++ + SE E ++ E +++ KL H +++L G+ T Q +Y+V ++M +
Sbjct: 31 VAIKMIKEGSMSEDEFIE----EAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEYMSNG 84
Query: 197 LTKIICRPGQKLTEPQVKCYM-QQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255
R K +P M + + G+ + + +HRD+ A N L+D G +K++DF
Sbjct: 85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDF 144
Query: 256 GLSNFFIPKQKGPLTSRVVTLW---YRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
GLS + + + TS V + + + PE+LL S + D+W+ G L+ E++
Sbjct: 145 GLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVY 195
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 64/258 (24%), Positives = 126/258 (48%), Gaps = 20/258 (7%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD 167
+S + K+G G + V+ ++ K VA+K ++ T SV+ E +++ L
Sbjct: 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMKTLQ 59
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
H +++L + T + +Y++ ++M S L + G K+ P++ + Q+ G+
Sbjct: 60 HDKLVRLYAVVTK--EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL- 284
+ + +HRD++A+N+L+ +S M KIADFGL+ + + + APE +
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTE------VEQLHRIFKLCGTPSEDYW 337
GS + + D+WS G LL E+ G+ PG + +++ +R+ ++ P E Y
Sbjct: 178 FGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELY- 234
Query: 338 KKMKLTTTFRPQHYKPSF 355
MK + + +P+F
Sbjct: 235 DIMKTCWKEKAEE-RPTF 251
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 34/264 (12%)
Query: 157 AREIRILQKLDHPNVIKLEGLATSRMQYSLY--LVFDFMQSDLTKIICRPGQKLTEP--Q 212
A E IL+ ++HP++I+L+G T Y+ + L+ ++DL C K
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFT----YNKFTCLILPRYKTDL---YCYLAAKRNIAICD 183
Query: 213 VKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272
+ + +L +Q+ HE I+HRDIKA N+ I+ G + + DFG + F +
Sbjct: 184 ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG------RPLMPGRTEVE-QLHRI 325
T+ APE LL YG +D+WSAG +L EM + + G + + Q+ I
Sbjct: 244 AGTIATNAPE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302
Query: 326 FKLCGT-PSEDYWKKMKLTTTFRPQHY--------KPSFREVFG---EFPPSSYGILTTL 373
+ GT P+E + + KP R ++ E P ++ +
Sbjct: 303 IRRSGTHPNE---FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKM 359
Query: 374 LALDPAYRGTAASALQNEFFNASP 397
LA D +R +A + L F P
Sbjct: 360 LAFDAHHRPSAEALLDFAAFQDIP 383
|
Length = 391 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 65/265 (24%), Positives = 112/265 (42%), Gaps = 28/265 (10%)
Query: 117 KVGQGTYSNVYKAR-DRDTGKI--VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
K+G G++ V + GK+ VA+K ++ D F+ +E I+ LDH N+I+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLIR 60
Query: 174 LEGLATSRMQYSLYLVFDF--MQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
L G+ + + L +V + + S L ++ + Y Q+ +G+++ +
Sbjct: 61 LYGVV---LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS---RVVTLWYRAPELLLGST 288
+HRD+ A N+L+ +KI DFGL +P+ + V + APE L T
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR-ALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 289 DYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFK---------LCGTPSEDYWK 338
+ D+W G L EMF G G + + L +I K C +D +
Sbjct: 177 -FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEAC---PQDIYN 232
Query: 339 KMKLTTTFRPQHYKPSFREVFGEFP 363
M P +P+F + P
Sbjct: 233 VMLQCWAHNPAD-RPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 118 VGQGTYSNVYKAR------DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+GQG + V++AR +VA+K ++ + S F RE ++ + DHPN+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPF-TMVAVKMLKEEASADMQADFQ-REAALMAEFDHPNI 70
Query: 172 IKLEGLATSRMQYSLYLVFDFMQ-SDLTKII--CRPGQK-------------------LT 209
+KL G+ + + L+F++M DL + + P + L+
Sbjct: 71 VKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 210 EPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS-NFFIPKQKGP 268
+ C +Q+ +G+ + ER +HRD+ N L+ ++ ++KIADFGLS N +
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
+ + + + PE + Y D+W+ G +L E+F
Sbjct: 189 SENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIF 226
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 8/219 (3%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPN 170
++ L +G+G++ V A + T ++ A+K ++ D + + V+ E R+L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
+ M LY V +++ DL I + G + EP Y ++ GL H
Sbjct: 62 FLTQLHSCFQTMD-RLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHS 119
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGST 288
+GI++RD+K N+++D G +KIADFG+ + G T T Y APE ++
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM--WDGVTTKTFCGTPDYIAPE-IIAYQ 176
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
YG +D W+ G LL EM G+ G E E I +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 41/264 (15%)
Query: 118 VGQGTYSNVYKA--RDRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
+G G + +V K + ++ VA+K ++ + +F+ RE ++ +LDHP +++L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL-REASVMAQLDHPCIVRL 61
Query: 175 EGLATSRMQYSLYLVFDFM-QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
G+ L LV + L K + + +++ +K Q+ G+ + + +
Sbjct: 62 IGVCKGEP---LMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 234 HRDIKASNLLIDKSGMLKIADFGLS-------NFFIPKQKG--PLTSRVVTLWYRAPELL 284
HRD+ A N+L+ KI+DFG+S +++ G PL WY APE
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------WY-APE-- 168
Query: 285 LGSTDYGV---GIDLWSAGCLLAEMFI--GRPL--MPGRTEVEQL---HRIFKLCGTPSE 334
+YG D+WS G L E F +P M G + L R+ + P E
Sbjct: 169 --CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQE 226
Query: 335 DYWKKMKLTTTFRPQHYKPSFREV 358
Y M +RP+ +P+F E+
Sbjct: 227 IY-SIMLSCWKYRPED-RPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 8/203 (3%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
+ + ++ +G G +V K + TG ++A KKV ++ K + RE++I+ +
Sbjct: 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
P ++ G + + + +FM I + G + + ++ GL + +
Sbjct: 63 PYIVSFYGAFLNENNICMCM--EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 229 -ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
I+HRDIK SN+L++ G +K+ DFG+S I + V T Y +PE + G
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---NSIADTFVGTSTYMSPERIQGG 177
Query: 288 TDYGVGIDLWSAGCLLAEMFIGR 310
Y V D+WS G + E+ +G+
Sbjct: 178 -KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 6/211 (2%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDT--SEPESVKFMAREIRILQKLDHPNVIKLE 175
+G+G++ V AR + K A+K ++ + E M+ +L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ + LY V D++ + + EP+ + Y ++ S L + H I++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGID 295
D+K N+L+D G + + DFGL I + G ++ T Y APE +L Y +D
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENI-EHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVD 178
Query: 296 LWSAGCLLAEMFIGRPLMPGRTEVEQLHRIF 326
W G +L EM G P R E I
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 72/257 (28%), Positives = 107/257 (41%), Gaps = 54/257 (21%)
Query: 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRF-DTSEPESVKFMAREIRILQKLDHPNVI 172
K+ +G G + V A DT + A+K +R D V + E IL + D+ V+
Sbjct: 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVV 64
Query: 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
KL + + + +LY V D++ D+ ++ R E + Y+ +L ++ H+ G
Sbjct: 65 KL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKMG 121
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK------QKGP----------------- 268
+HRDIK N+LID G +K+ DFGL F QKG
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 269 ---LTSRVVTLWYR--------------------APELLLGSTDYGVGIDLWSAGCLLAE 305
R+ TL R APE+LL Y D WS G +L E
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILFE 240
Query: 306 MFIGRP--LMPGRTEVE 320
M +G+P L P TE +
Sbjct: 241 MLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 133 DTGKIVALKKVRFDTSEPE-SVKFMAREIRILQKLDHPNVIKL--EGLATSRMQYSLYLV 189
TG VA+K +R D E E RE + +L HPN++ L G A + L+ V
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAV 57
Query: 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM 249
F+++ + + L + M Q+L L H +GI+HRD+K N+++ ++G+
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 250 ---LKIADFGLSNFF-----IPKQKGPLTSRVV-TLWYRAPELLLGSTDYGVGIDLWSAG 300
K+ DFG+ T+ V+ T Y APE L G DL++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS-DLYAWG 176
Query: 301 CLLAEMFIGRPLMPGRTEVEQLHR 324
+ E G+ ++ G + E L++
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 4/148 (2%)
Query: 159 EIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQ 218
E R+L++L HP V+ L L + LV +SDL + + L QV +
Sbjct: 210 EARLLRRLSHPAVLAL--LDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVAR 267
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLW 277
QLLS + + H GI+HRDIK N+L++ + + DFG + F P + T+
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAE 305
APE+L G Y +D+WSAG ++ E
Sbjct: 328 TNAPEVLAGDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQKLDH 168
D ++ L +G+G + V + ++TG++ A+K + +++ + E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 169 PNVIKLEGLATSRMQYSLYLVFDF-MQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
+ L A LYLV D+ + DL ++ + +L E + Y+ +++ +
Sbjct: 61 RWITNLH-YAFQDENN-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV--TLWYRAPELLL 285
H+ G +HRDIK N+L+DK+G +++ADFG + G + S V T Y +PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA--DGTVQSNVAVGTPDYISPEILQ 176
Query: 286 ----GSTDYGVGIDLWSAGCLLAEMFIG 309
G YG D WS G + EM G
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 7/208 (3%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDT--SEPESVKFMAREIRILQKLDHPNVIKLE 175
+G+G++ V A+ + G A+K ++ T + E MA +L+ L HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ + LY V D++ + + EP+ + Y ++ S + + H I++R
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGID 295
D+K N+L+D G + + DFGL + + + ++ T Y APE +L Y +D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGV-EPEETTSTFCGTPEYLAPE-VLRKEPYDRTVD 178
Query: 296 LWSAGCLLAEMFIGRPLMPGRTEVEQLH 323
W G +L EM G P R +V Q++
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSR-DVSQMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 118 VGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
+G G + V R + GK VA+K ++ +E + F++ E I+ + DHPN+I L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHPNIIHL 70
Query: 175 EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
EG+ T + +V ++M++ L + + + T Q+ ++ + SG+++ + G +
Sbjct: 71 EGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR--VVTLWYRAPELLLGSTDYG 291
HRD+ A N+L++ + + K++DFGLS + T+R + + + APE + +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAYRKFT 187
Query: 292 VGIDLWSAGCLLAEM 306
D+WS G ++ E+
Sbjct: 188 SASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 73/310 (23%), Positives = 126/310 (40%), Gaps = 57/310 (18%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVK--FMAREIRILQKLDHP 169
YD + +G+G VY A D + VALKK+R D SE +K F+ RE +I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICR--------PGQKLTEPQVKCYMQ--- 218
++ + + + +Y +++ K + + + + V ++
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ----------KGP 268
++ + +++ H +G+LHRD+K N+L+ G + I D+G + F ++ +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 269 LTSR-------VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ 321
S V T Y APE LLG D+++ G +L +M P R
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLS--FPYR----- 232
Query: 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR 381
+ K P P +RE+ PP I LA+DPA R
Sbjct: 233 -----------RKKGRKISYRDVILSPIEVAP-YREI----PPFLSQIAMKALAVDPAER 276
Query: 382 GTAASALQNE 391
++ L+ +
Sbjct: 277 YSSVQELKQD 286
|
Length = 932 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 51/194 (26%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
+ ++G G + V+ + R K VA+K + E F+ E +++ KL HP +++L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQL 64
Query: 175 EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYM-QQLLSGLQHCHERGIL 233
G+ T Q LY+V +FM++ R Q + M Q + G+++ +
Sbjct: 65 YGVCTQ--QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVG 293
HRD+ A N L+ +G++K++DFG++ + + + + + + PE+ S Y
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK-YSSK 181
Query: 294 IDLWSAGCLLAEMF 307
D+WS G L+ E+F
Sbjct: 182 SDVWSFGVLMWEVF 195
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 67/258 (25%), Positives = 119/258 (46%), Gaps = 27/258 (10%)
Query: 117 KVGQGTYSNVYKA--RDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
++G G + V K + + + K VA+K ++ D ++P + RE ++Q+LD+P ++++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 175 EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
G+ + S LV + + + + +TE + + Q+ G+++ E +H
Sbjct: 62 IGICEAE---SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 235 RDIKASNLLIDKSGMLKIADFGLS-------NFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
RD+ A N+L+ KI+DFGLS N++ K G + WY APE +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WY-APE-CMNY 172
Query: 288 TDYGVGIDLWSAGCLLAEMFI--GRPL--MPGRTEVEQLHRIFKLCGTP---SEDYWKKM 340
+ D+WS G L+ E F +P M G EV Q+ + P + + M
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIESGERMECPQRCPPEMYDLM 231
Query: 341 KLTTTFRPQHYKPSFREV 358
KL T+ +P F V
Sbjct: 232 KLCWTYGVDE-RPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTG-KIVALKKVRFDTSE---PESVKFMAREIRILQK 165
+ ++ + +G G++ V A ++ VA+K RF+ S+ + V + E +IL
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIK--RFEKSKIIKQKQVDHVFSERKILNY 87
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKC-YMQQLLSGL 224
++HP + L G + + + LYLV +F+ R ++ V C Y Q++
Sbjct: 88 INHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-DVGCFYAAQIVLIF 144
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW----YRA 280
++ I++RD+K NLL+DK G +K+ DFG + + +R TL Y A
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIA 196
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRP 311
PE+LL + +G D W+ G + E+ +G P
Sbjct: 197 PEILL-NVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 71/303 (23%), Positives = 117/303 (38%), Gaps = 52/303 (17%)
Query: 155 FMAREIRILQKLDHPNVIKLEG---------LATSRMQYSLYLVFDFMQSDLTKIICRPG 205
+ EI L +L+H N++K+E + T + + LY FM + RP
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLY---SFMYDEAFDWKDRPL 265
Query: 206 QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265
K Q + M+QLL +++ H++ ++HRDIK N+ ++ G + + DFG + F ++
Sbjct: 266 LK----QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMP----GRTEVEQ 321
+ V T+ +PE+L G Y D+WS G +L +M + P G +Q
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDM-LSHDFCPIGDGGGKPGKQ 379
Query: 322 LHRIFKLCGTPSEDY-------WKKMKLTTTFRPQHYKPSFREVFG-----EFPPSSYGI 369
L +I E++ + + H P G E+P
Sbjct: 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP------ 433
Query: 370 LTTLLALDPAYRGTAASALQNEFFNAS------------PLACDLSSLPVICREEDEPAR 417
L +L D R AA L F+A A + CR E + A
Sbjct: 434 LVKMLTFDWHLRPGAAELLALPLFSAEEEEEILFIHGLKSGAAHFKPIKPACRIESDTAA 493
Query: 418 TSR 420
Sbjct: 494 LPL 496
|
Length = 501 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 74/306 (24%), Positives = 127/306 (41%), Gaps = 52/306 (16%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT----SEPESVKFMAREIRILQK 165
+ ++ + + G Y VY R ++T + A+KK+ ++ + V F+ R+I L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDI--LTF 57
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
++P V+ + ++ L +V ++++ + + L + Y + + L+
Sbjct: 58 AENPFVVSMFCSFETKRH--LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF------------FIPKQKGPLTSRV 273
+ H GI+HRD+K NLLI G +K+ DFGLS I K +
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 274 V--TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT 331
V T Y APE++L YG +D W+ G +L E +G G T E ++
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI----- 229
Query: 332 PSEDY-WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR---GTAASA 387
S+D W P E P + +++ LL +P R G A
Sbjct: 230 -SDDIEW---------------PEGDEA---LPADAQDLISRLLRQNPLERLGTGGAFEV 270
Query: 388 LQNEFF 393
Q+ FF
Sbjct: 271 KQHRFF 276
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 60/225 (26%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKI-VALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVI 172
L ++G G + V+ + R GKI VA+K +R SE + ++ E +++ KL HPN++
Sbjct: 9 LKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPNLV 62
Query: 173 KLEGLATSRMQYSLYLVFDFMQSD--LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+L G+ T Q +++V ++M + L + R G+ TE + + +++
Sbjct: 63 QLYGVCTK--QRPIFIVTEYMANGCLLNYLRERKGKLGTE-WLLDMCSDVCEAMEYLESN 119
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW---YRAPELLLGS 287
G +HRD+ A N L+ + ++K++DFGL+ + + Q TS T + + PE+
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFD-Y 175
Query: 288 TDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTE---VEQLHRIFKL 328
+ + D+WS G L+ E+F G+ + VE + ++L
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 12/224 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQKLDH 168
D ++ + +G+G + V + + T +I A+K + +++ + E +L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 169 PNVIKLEGLATSRMQYSLYLVFDF-MQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
+ L A Y LYLV D+ + DL ++ + +L E + Y+ +++ +
Sbjct: 61 QWITTLH-YAFQDENY-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV--TLWYRAPELLL 285
H+ +HRDIK N+L+D +G +++ADFG + Q G + S V T Y +PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 286 GSTD----YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
D YG D WS G + EM G + VE +I
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 35/271 (12%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+G + V + R TGK+ A KK+ + + + + E RIL K+ ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICR-----PGQKLTEPQVKCYMQQLLSGLQHCHER 230
++ L LV M DL I PG EP+ Y Q++SGL+H H+R
Sbjct: 61 AFQTKTD--LCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQR 116
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
I++RD+K N+L+D G ++I+D GL+ Q T + APELL G +Y
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGE-EY 174
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350
+D ++ G L EM R P R E++ K++K
Sbjct: 175 DFSVDYFALGVTLYEMIAARG--PFRARGEKVEN-------------KELKQRILNDSVT 219
Query: 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYR 381
Y +F P+S LLA DP R
Sbjct: 220 YPD-------KFSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 69/245 (28%), Positives = 112/245 (45%), Gaps = 47/245 (19%)
Query: 108 SADSYDKLAKVGQGTYSNVYKA----RDRDTGKI-VALKKVRFDTSEPESVKFMAREIRI 162
DS L +G G + VY+ RD D ++ VA+K + SE + F+ E I
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALI 62
Query: 163 LQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKII--CRPGQKLTEPQVKCYMQQ 219
+ K +H N+++L G++ R+ +++ + M DL + RP + M+
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPR--FILLELMAGGDLKSFLRENRPRPERPSSLT---MKD 117
Query: 220 LL-------SGLQHCHERGILHRDIKASNLLIDKSG---MLKIADFGL------SNFFIP 263
LL G ++ E +HRDI A N L+ G + KIADFG+ ++++
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY-- 175
Query: 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGI-----DLWSAGCLLAEMF-IGRPLMPGRT 317
+KG ++ + + PE L GI D+WS G LL E+F +G PGRT
Sbjct: 176 -RKGGRA--MLPIKWMPPEAFLD------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
Query: 318 EVEQL 322
E +
Sbjct: 227 NQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 116 AKVGQGTYSNVYKA--RDRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
+G+G + +VY+ + KI VA+K + TS KF+ E I+++ DHP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIV 70
Query: 173 KLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
KL G+ T +++V + +L + L + Y QL + L + +
Sbjct: 71 KLIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLS 258
+HRDI A N+L+ +K+ DFGLS
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 50/184 (27%), Positives = 89/184 (48%), Gaps = 18/184 (9%)
Query: 137 IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS- 195
+VA+K +R D ++ F+ +EI+I+ +L PN+I+L LA L ++ ++M++
Sbjct: 48 LVAVKMLREDANKNARNDFL-KEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEYMENG 104
Query: 196 DLTKIICR-----PGQKLTEPQVK----CYMQ-QLLSGLQHCHERGILHRDIKASNLLID 245
DL + + R +K + +M Q+ SG+++ +HRD+ N L+
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164
Query: 246 KSGMLKIADFGLSNFFIPKQKGPLTSRVV--TLWYRAPELLLGSTDYGVGIDLWSAGCLL 303
K+ +KIADFG+S + R V W +LLG + D+W+ G L
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTL 222
Query: 304 AEMF 307
E+
Sbjct: 223 WEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 53/186 (28%), Positives = 90/186 (48%), Gaps = 19/186 (10%)
Query: 137 IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS- 195
+VA+K +R D ++ F+ +EI+I+ +L +PN+I+L G+ S L ++ ++M++
Sbjct: 46 LVAVKMLRADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENG 102
Query: 196 DLTKIICRPG--QKLTE----PQVK----CYMQ-QLLSGLQHCHERGILHRDIKASNLLI 244
DL + + + T P V YM Q+ SG+++ +HRD+ N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 245 DKSGMLKIADFGLSNFFIPKQKGPLTSRVV--TLWYRAPELLLGSTDYGVGIDLWSAGCL 302
+KIADFG+S + R V W +LLG + D+W+ G
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVT 220
Query: 303 LAEMFI 308
L EMF
Sbjct: 221 LWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 12/225 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQKLDH 168
+ ++ L +G+G + V + ++ K+ A+K + +++ + E +L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 169 PNVIKLEGLATSRMQYSLYLVFDF-MQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
+ L + + +LYLV D+ + DL ++ + +L E + Y+ +++ +
Sbjct: 61 QWITTLH--YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV--TLWYRAPELLL 285
H+ +HRDIK N+L+D +G +++ADFG + + G + S V T Y +PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISPEILQ 176
Query: 286 GSTD----YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIF 326
D YG D WS G + EM G + VE +I
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 50/215 (23%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 118 VGQGTYSNVYKAR-----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
+G+G + V+ + ++VA+K ++ +T+ ++ K RE +L H N++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 173 KLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPG-------------QKLTEPQVKCYMQ 218
K G+ T +VF++M+ DL K + G +LT Q+
Sbjct: 72 KFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLTSR 272
Q+ SG+ + + +HRD+ N L+ ++KI DFG+S +++ + G
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY--RVGG---HT 184
Query: 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
++ + + PE ++ + D+WS G +L E+F
Sbjct: 185 MLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 68/256 (26%), Positives = 116/256 (45%), Gaps = 48/256 (18%)
Query: 118 VGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNV 171
+G+G + V KA VA+K ++ D +E + ++ E+ +++ + H N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNI 78
Query: 172 IKLEGLATSRMQYSLYLVF---------DFMQS------DLTKIICR-PGQKLTEPQVKC 215
I L G+ T + LY+V DF+++ + R P + LT+ +
Sbjct: 79 INLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 216 YMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPL 269
+ Q+ G++ + +HRD+ A N+L+ + ++KIADFGL+ +++ G L
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI--GRPLMPGRTEVEQL----- 322
+ W APE L Y D+WS G LL E+F G P PG VE+L
Sbjct: 197 PVK----WM-APEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKLLK 248
Query: 323 --HRIFKLCGTPSEDY 336
+R+ K E Y
Sbjct: 249 EGYRMEKPQNCTQELY 264
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 114 KLAKVGQGTYSNVYKAR---DRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
K+ +G G + VYK + + KI VA+K +R + + P++ K + E ++ +DHP
Sbjct: 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHP 69
Query: 170 NVIKLEGLA-TSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
+V++L G+ +S++Q L+ M L + + + + Q+ G+ +
Sbjct: 70 HVVRLLGICLSSQVQ----LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS--RVVTLWYRAPELLL 285
E+ ++HRD+ A N+L+ +KI DFGL+ +K +V W A E +L
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-ALESIL 184
Query: 286 GSTDYGVGIDLWSAGCLLAEM--FIGRP 311
Y D+WS G + E+ F +P
Sbjct: 185 -HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 46/240 (19%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD 167
+A+ L ++G+G + V K + +G I+A+K++R E E + R+L LD
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE-------QKRLLMDLD 54
Query: 168 H-------PNVIKLEGLATSR---------MQYSLYLVFDFMQSDLTKIICRPGQ---KL 208
P ++K G M SL + ++ L +I P + K+
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVI--PEEILGKI 112
Query: 209 TEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF---IPKQ 265
VK L+ L+ + I+HRD+K SN+L+D++G +K+ DFG+S I K
Sbjct: 113 AVATVKA-----LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK- 164
Query: 266 KGPLTSRVVTLWYRAPELLLGSTD--YGVGIDLWSAGCLLAEMFIGRPLMPGRTEV-EQL 322
T Y APE + S Y V D+WS G L E+ G+ P V +QL
Sbjct: 165 ----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 36/220 (16%)
Query: 115 LAKVGQGTYSNVYKAR-----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
L ++G+G + VYK +R + VA+K ++ + +EP+ + +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHP 68
Query: 170 NVIKLEGLATSRMQYSLYLVFDFM-QSDLTKIICR------PGQKLTEPQVKCYMQ---- 218
N++ L G+ T + +F+++ DL + + R G + + VK +
Sbjct: 69 NIVCLLGVCTKEQPTCM--LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 219 -----QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKG 267
Q+ +G+++ +HRD+ A N L+ + +KI+DFGLS +++ + K
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
L R + PE +L + D+WS G +L E+F
Sbjct: 187 LLPVR-----WMPPEAIL-YGKFTTESDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 158 REIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYM 217
REI IL+ + H +I L + R + ++ +V + DL + R G L Q
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCDLFTYVDRSG-PLPLEQAITIQ 191
Query: 218 QQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSR 272
++LL L + H RGI+HRD+K N+ +D+ + DFG + + P+ G
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG----W 247
Query: 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGR 310
TL +PELL Y D+WSAG +L EM +
Sbjct: 248 SGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 118 VGQGTYSNVYKARDRDTG--KIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKL 174
+G+G + V KAR + G A+K+++ S+ + F A E+ +L KL HPN+I L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLGHHPNIINL 73
Query: 175 EGLATSRMQYSLYLVF-------DFMQSDLT-------KIICRPGQKLTEPQVKCYMQQL 220
G R L + + DF++ I L+ Q+ + +
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS---NFFIPKQKGPLTSRVVTLW 277
G+ + ++ +HRD+ A N+L+ ++ + KIADFGLS ++ K G L R
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR----- 188
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEM 306
+ A E L S Y D+WS G LL E+
Sbjct: 189 WMAIESLNYSV-YTTNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 115 LAKVGQGTYSNVYKA-----RDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ ++GQG++ VY+ + VA+K V + S E ++F+ E ++++ +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-EASVMKEFNCH 69
Query: 170 NVIKLEGLATSRMQYSLYLVFDFM-QSDLTKII--CRPGQKLTEPQVKCYMQQLL----- 221
+V++L G+ S Q +L +V + M + DL + RP + +Q+ +
Sbjct: 70 HVVRLLGVV-STGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 222 --SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL------SNFFIPKQKGPLTSRV 273
G+ + + +HRD+ A N ++ + +KI DFG+ ++++ KG L R
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186
Query: 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEM 306
W APE L + D+WS G +L EM
Sbjct: 187 ---WM-APESLK-DGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 59/290 (20%)
Query: 118 VGQGTYSNVYKA-----RDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
+G+G + V KA + R VA+K ++ + S E ++ E +L++++HP+VI
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS-EFNLLKQVNHPHVI 66
Query: 173 KLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQK------------------------L 208
KL G + L L+ ++ + + R +K L
Sbjct: 67 KLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 209 TEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFI 262
T + + Q+ G+Q+ E ++HRD+ A N+L+ + +KI+DFGLS + ++
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQ 321
+ KG R+ W A E L Y D+WS G LL E+ +G PG
Sbjct: 185 KRSKG----RIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--- 235
Query: 322 LHRIFKLCGTP---------SEDYWKKMKLTTTFRPQHYKPSFREVFGEF 362
R+F L T SE+ + M P +P+F ++ E
Sbjct: 236 -ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDK-RPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 138 VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SD 196
VA+K +R D S+ F+ +E++IL +L PN+ +L L + L ++ ++M+ D
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARL--LGVCTVDPPLCMIMEYMENGD 105
Query: 197 L-----TKIICRPGQKLTEPQVK----CYM-QQLLSGLQHCHERGILHRDIKASNLLIDK 246
L + G + YM Q+ SG+++ +HRD+ N L+ K
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 247 SGMLKIADFGLSN 259
+ +KIADFG+S
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 67/255 (26%), Positives = 118/255 (46%), Gaps = 42/255 (16%)
Query: 106 PKSADSYDKLA---KVGQGTYSNVYKAR----DRDTGK---IVALKKVRFDTSEPESVKF 155
P+ S DKL +G+G + V A D+D K VA+K ++ D +E +
Sbjct: 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 67
Query: 156 MAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFMQS------------------- 195
++ E+ +++ + H N+I L G T LY++ ++
Sbjct: 68 VS-EMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 196 DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255
D+ ++ P +++T + Q+ G+++ + +HRD+ A N+L+ ++ ++KIADF
Sbjct: 125 DIARV---PDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 181
Query: 256 GLSNFF--IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPL 312
GL+ I K R+ W APE L Y D+WS G L+ E+F +G
Sbjct: 182 GLARDVNNIDYYKKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP 239
Query: 313 MPGRTEVEQLHRIFK 327
PG VE+L ++ K
Sbjct: 240 YPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 59/232 (25%), Positives = 108/232 (46%), Gaps = 35/232 (15%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y+ + K+G G + V+ + + T + K + + + + E+ ++++L H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQ---KLTEPQVKCYMQQLLSGLQ 225
N+++ ++ LY++ +F + DL++ I + + K+ E + +QLL L
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 226 HCH--------ERGILHRDIKASNLL-----------------IDKSGMLKIADFGLS-N 259
+CH ER +LHRD+K N+ ++ + KI DFGLS N
Sbjct: 133 YCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 260 FFIPKQKGPLTSRVVTLWYRAPELLLGST-DYGVGIDLWSAGCLLAEMFIGR 310
I S V T +Y +PELLL T Y D+W+ GC++ E+ G+
Sbjct: 192 IGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 118 VGQGTYSNVYKARDRDTGKIV--ALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKL 174
+G+G + V +A + G + A+K ++ SE + F A E+ +L KL HPN+I L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDF-AGELEVLCKLGHHPNIINL 68
Query: 175 EGLATSR------MQYSLY-LVFDFMQS----DLTKIICR---PGQKLTEPQVKCYMQQL 220
G +R ++Y+ Y + DF++ + + LT Q+ + +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS---NFFIPKQKGPLTSRVVTLW 277
+G+Q+ E+ +HRD+ A N+L+ ++ KIADFGLS ++ K G L R
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR----- 183
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEM 306
+ A E L S Y D+WS G LL E+
Sbjct: 184 WMAIESLNYSV-YTTKSDVWSFGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 76/316 (24%), Positives = 125/316 (39%), Gaps = 62/316 (19%)
Query: 124 SNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183
++VY AR TG +V ++ + E +K + E+ + HPN++ + T+
Sbjct: 14 TSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW 73
Query: 184 YSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKA 239
L+++ FM + L K G ++E + + L GL + H+ G +HR+IKA
Sbjct: 74 --LWVISPFMAYGSANSLLKTYFPEG--MSEALIGNILFGALRGLNYLHQNGYIHRNIKA 129
Query: 240 SNLLIDKSGMLKIADFGLSNFFIPKQKG---------PLTSRVVTLWYRAPELLLGS-TD 289
S++LI G++ ++ GLS+ + + G P S V W +PELL
Sbjct: 130 SHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL-SPELLRQDLYG 186
Query: 290 YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHR----IFKLCGTP------------- 332
Y V D++S G E L GR + + R + KL G P
Sbjct: 187 YNVKSDIYSVGITACE------LATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240
Query: 333 --------------SEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDP 378
E T + PS + F P+ ++ L DP
Sbjct: 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSK----TFSPAFQNLVELCLQQDP 296
Query: 379 AYRGTAASALQNEFFN 394
R +A+S L + FF
Sbjct: 297 EKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 24/192 (12%)
Query: 126 VYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185
VYK R + VA+K ++ + E M RE I+ +LD+P ++++ G+ + +
Sbjct: 15 VYKMRKKQID--VAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE---A 68
Query: 186 LYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI 244
L LV + L K + ++T V M Q+ G+++ + +HRD+ A N+L+
Sbjct: 69 LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL 128
Query: 245 DKSGMLKIADFGLS-------NFFIPKQKG--PLTSRVVTLWYRAPELLLGSTDYGVGID 295
KI+DFGLS +++ + G PL WY APE + + D
Sbjct: 129 VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK------WY-APECIN-FRKFSSRSD 180
Query: 296 LWSAGCLLAEMF 307
+WS G + E F
Sbjct: 181 VWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 60/234 (25%), Positives = 107/234 (45%), Gaps = 36/234 (15%)
Query: 118 VGQGTYSNVYKARDRD-----TGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+G G + VY+ D +G I VA+K +R ++ E +F+ E ++ +HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLS-------G 223
+KL G+ + Y++ + M+ DL + R + +++LL G
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 224 LQHCHERGILHRDIKASNLLIDKSG-----MLKIADFGL------SNFFIPKQKGPLTSR 272
+ + +HRD+ A N L+ + G ++KI DFGL S+++ + +G L R
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAE-MFIGRPLMPGRTEVEQLHRI 325
+ APE LL + D+WS G L+ E + +G+ P E L +
Sbjct: 179 -----WMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 48/202 (23%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 118 VGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
+G G + V++ + G+ VA+K ++ +E + F++ E I+ + H N+I+L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 175 EGLATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
EG+ T ++ ++M++ L K + + + Q+ ++ + +G+++ + +
Sbjct: 72 EGVVTKFKP--AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR--VVTLWYRAPELLLGSTDYG 291
HRD+ A N+L++ + K++DFGLS +G T+ + + + APE + +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKFT 188
Query: 292 VGIDLWSAGCLLAEM--FIGRP 311
D+WS G ++ E+ F RP
Sbjct: 189 SASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 44/154 (28%), Positives = 86/154 (55%), Gaps = 13/154 (8%)
Query: 118 VGQGTYSNVYKAR---DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
+G+G + +V +A+ + + + VA+K ++ D ++ RE +++ DHPNVIKL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 175 EGLAT-SRMQYSL---YLVFDFMQ-SDLTK--IICRPGQK-LTEPQVKC--YMQQLLSGL 224
G++ SR + L ++ FM+ DL ++ R G++ T P +M + SG+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258
++ + +HRD+ A N +++++ + +ADFGLS
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 52/282 (18%)
Query: 118 VGQGTYSNVYKA------RDR-DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HP 169
+G+G + V +A + R D VA+K ++ + ++ + ++ E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS-EMELMKLIGKHK 78
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-------------------DLTKIICRPGQKLTE 210
N+I L G+ T + LY++ ++ D+TK+ P ++L+
Sbjct: 79 NIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV---PEEQLSF 133
Query: 211 PQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN--FFIPKQKGP 268
+ Q+ G+++ R +HRD+ A N+L+ + ++KIADFGL+ I K
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQL----- 322
R+ W APE L Y D+WS G L+ E+F +G PG VE+L
Sbjct: 194 SNGRLPVKWM-APEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFKLLR 250
Query: 323 --HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEF 362
HR+ K E Y M + + H P+ R F +
Sbjct: 251 EGHRMDKPSNCTHELY---MLMRECW---HAVPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 118 VGQGTYSNVYKARDRDTGKIV--ALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKL 174
+G+G + V KAR + G + A+K+++ S+ + F A E+ +L KL HPN+I L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLGHHPNIINL 61
Query: 175 EGLATSR------MQYSLY-LVFDFMQS----DLTKIICR---PGQKLTEPQVKCYMQQL 220
G R ++Y+ + + DF++ + L+ Q+ + +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS---NFFIPKQKGPLTSRVVTLW 277
G+ + ++ +HRD+ A N+L+ ++ + KIADFGLS ++ K G L R
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR----- 176
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEM 306
+ A E L S Y D+WS G LL E+
Sbjct: 177 WMAIESLNYSV-YTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 114 KLAKV-GQGTYSNVYKAR---DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
KL K+ G+G + +V + + D + VA+K ++ D ++ E ++ DHP
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 170 NVIKLEGLA---TSRMQYSLYLV-FDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLL--- 221
NV+KL G+ +S + +V FM+ DL + +L K +Q LL
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY--SRLGGLPEKLPLQTLLKFM 119
Query: 222 ----SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258
G+++ R +HRD+ A N ++ + + +ADFGLS
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 79/320 (24%), Positives = 134/320 (41%), Gaps = 49/320 (15%)
Query: 113 DKLAKVGQG--TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN 170
+ L +G+G V AR + TG+ V ++++ + E V F+ E+ + + +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQSDLTK-IICRP-GQKLTEPQVKCYMQQLLSGLQHCH 228
++ AT L++V FM K +IC ++E + +Q +L L + H
Sbjct: 61 IVPYR--ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG---------PLTSRVVTLWYR 279
G +HR +KAS++LI G + ++ GL + G P S V W
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL- 175
Query: 280 APELLLGSTD-YGVGIDLWSAG---CLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT---- 331
+PE+L + Y D++S G C LA + MP T++ + KL GT
Sbjct: 176 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA-TQM----LLEKLNGTVPCL 230
Query: 332 ------PSEDYWKKMK------------LTTTFRPQHYKPSFREVFGEFPPSSYGILTTL 373
P+E+ K +T RP + + S F P + +
Sbjct: 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQC 290
Query: 374 LALDPAYRGTAASALQNEFF 393
L +P R +A++ L + FF
Sbjct: 291 LQRNPDARPSASTLLNHSFF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 120 QGTYSNVYKA--RDRDTGKI--VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLE 175
+GT+ ++ D GK V +K V+ D + V + +E +L L H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 176 GLATSRMQYSLYLVFDFMQSDLTKI---ICR-----PGQKLTEPQVKCYMQQLLSGLQHC 227
+ + L + +M K+ CR Q L+ Q+ Q+ G+ +
Sbjct: 75 HVCIEDGEPPFVL-YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK---GPLTSRVVTLWYRAPELL 284
H+RG++H+DI A N +ID+ +KI D LS P G +R V W A E L
Sbjct: 134 HKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK-WM-ALESL 191
Query: 285 LGSTDYGVGIDLWSAGCLLAEM 306
+ Y D+WS G LL E+
Sbjct: 192 VNKE-YSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 138 VALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM-QS 195
VA+K ++ D +E + ++ E+ +++ + H N+I L G T LY++ ++ +
Sbjct: 53 VAVKMLKSDATEKDLSDLIS-EMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKG 109
Query: 196 DLTKII---------------CRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKAS 240
+L + + P ++L+ + Q+ G+++ + +HRD+ A
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169
Query: 241 NLLIDKSGMLKIADFGLSN--FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWS 298
N+L+ + ++KIADFGL+ I K R+ W APE L Y D+WS
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWS 227
Query: 299 AGCLLAEMF-IGRPLMPGRTEVEQLHRIFK 327
G LL E+F +G PG VE+L ++ K
Sbjct: 228 FGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 33/278 (11%)
Query: 112 YDKLAKVGQGTYSNVYKA---RDRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLD 167
+ K+ +G G + VYK + + KI VA+K++R TS P++ K + E ++ +D
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVD 67
Query: 168 HPNVIKLEGLA-TSRMQYSLYL-----VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLL 221
+P+V +L G+ TS +Q L + D+++ I Q L + Q+
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI---GSQYLLN-----WCVQIA 119
Query: 222 SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRA 280
G+ + ER ++HRD+ A N+L+ +KI DFGL+ +K V + + A
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEM--FIGRPL--MPGRTEVEQLHRIFKLCGTP--SE 334
E +L Y D+WS G + E+ F +P +P L + +L P +
Sbjct: 180 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 238
Query: 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFP-----PSSY 367
D + M +P FRE+ EF P Y
Sbjct: 239 DVYMIMVKCWMIDADS-RPKFRELIIEFSKMARDPQRY 275
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 55/189 (29%), Positives = 81/189 (42%), Gaps = 35/189 (18%)
Query: 210 EPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269
E +V Q++ L H R ++HRD+K++N+ + +G++K+ DFG S + +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 270 TSRVV-TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKL 328
S T +Y APE L Y D+WS G +L E+ LHR FK
Sbjct: 228 ASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELL-------------TLHRPFK- 272
Query: 329 CGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFP-PSSYG---ILTTLLALDPAYRGTA 384
PS+ + L + P FP P S G +L LL+ +PA R T
Sbjct: 273 --GPSQREIMQQVLYGKYDP-------------FPCPVSSGMKALLDPLLSKNPALRPTT 317
Query: 385 ASALQNEFF 393
L EF
Sbjct: 318 QQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 118 VGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G + V+ A+ + + G+ + L K T + RE+ + +KL H NV++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 174 LEGLATSRMQYSLYLVFD---------FMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
L GL R Y++ + F+++ +K L+ Q Q+ G+
Sbjct: 73 LLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
H +HRD+ A N L+ +K++ LS + L + ++ L + APE +
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190
Query: 285 LGSTDYGVGIDLWSAGCLLAEMF 307
D+ D+WS G L+ E+F
Sbjct: 191 Q-EDDFSTKSDVWSFGVLMWEVF 212
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 63/250 (25%), Positives = 117/250 (46%), Gaps = 23/250 (9%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGL 177
+G+G + +V R G VA+K ++ D + + F+A E ++ +L H N+++L G+
Sbjct: 14 IGKGEFGDVMLGDYR--GNKVAVKCIKNDAT---AQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 178 ATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ LY+V ++M S + + R L + + + +++ +HR
Sbjct: 68 IVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGID 295
D+ A N+L+ + + K++DFGL+ Q T ++ W APE L + D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKW-TAPEALR-EKKFSTKSD 181
Query: 296 LWSAGCLLAEMF-IGR---PLMPGRTEVEQLHRIFKL---CGTPSEDYWKKMKLTTTFRP 348
+WS G LL E++ GR P +P + V ++ + +K+ G P Y MK
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY-DVMKQCWHLDA 240
Query: 349 QHYKPSFREV 358
+PSF ++
Sbjct: 241 AT-RPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 11/199 (5%)
Query: 114 KLAKVGQGTYSNVYKA---RDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN 170
KL +G G + V+K + D+ KI K D S ++ + + + + LDH
Sbjct: 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 171 VIKLEGLATSRMQYSLYLVFDFM-QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
+++L G+ SL LV L + + L ++ + Q+ G+ + E
Sbjct: 71 IVRLLGICPGA---SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVT--LWYRAPELLLGS 287
++HR++ A N+L+ +++IADFG+++ P K S T W +L G
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 288 TDYGVGIDLWSAGCLLAEM 306
Y D+WS G + EM
Sbjct: 188 --YTHQSDVWSYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 12/218 (5%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL-EG 176
+G G V A+ G+ A+K V + E+ L D +++K E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 177 LATS-----RMQYSLYLVFDFMQS-DLTKII---CRPGQKLTEPQVKCYMQQLLSGLQHC 227
A + LV D+ + DL + I + + E + Q+L + H
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLG 286
H + ++HRDIK++N+L+ +G++K+ DFG S + + T +Y APE+
Sbjct: 160 HSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR- 218
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHR 324
Y D++S G LL E+ + G E +H+
Sbjct: 219 RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 51/211 (24%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 117 KVGQGTYSNVYKAR------DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN 170
++G+G + V+ A ++D KI+ K D S+ F RE +L L H +
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQD--KILVAVKTLKDASDNARKDFH-REAELLTNLQHEH 68
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQ-SDLTKII------------CRPGQKLTEPQVKCYM 217
++K G+ L +VF++M+ DL K + +LT+ Q+
Sbjct: 69 IVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 218 QQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS-NFFIPKQKGPLTSRVVTL 276
QQ+ +G+ + + +HRD+ N L+ ++ ++KI DFG+S + + ++ +
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 277 WYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
+ PE ++ + D+WS G +L E+F
Sbjct: 187 RWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 43/221 (19%)
Query: 121 GTYSNVYKARDRDTG-----KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLE 175
G + V + + T KI+ K EP + M D+PN IK
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMK---------DNPNFIK-- 73
Query: 176 GLATSRMQYSLY------LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
+ YS+ L+ D+++ DL ++ + KL+E +VK ++QL+ L H
Sbjct: 74 ------LYYSVTTLKGHVLIMDYIKDGDLFDLL-KKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 229 ERGILHRDIKASNLLIDKS-GMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
+ I+H DIK N+L D++ + + D+GL K G + TL Y +PE + G
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC-----KIIGTPSCYDGTLDYFSPEKIKGH 181
Query: 288 TDYGVGIDLWSAGCLLAEMFIGR-PLMPGRTE---VEQLHR 324
+Y V D W+ G L E+ G+ P E +E L +
Sbjct: 182 -NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 27/154 (17%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESV-KFMAREIRILQKLDHPNVIKLEG 176
+ +G + VY R ++ K+ A+K V+ + + + K M +++ + +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVK----KADMINKNMVHQVQA----------ERDA 57
Query: 177 LATSRMQ------YSL------YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
LA S+ YSL YLV +++ K + E Y+ ++ L
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 117
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258
+ H GI+HRD+K N+LI G +K+ DFGLS
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 31/236 (13%)
Query: 118 VGQGTYSNVYKA------RDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPN 170
+G+G + V A +D+ + K+ D + + + + E+ +++ + H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQS---------------DLTKIICR-PGQKLTEPQVK 214
+I L G T LY++ ++ D + C+ P ++LT +
Sbjct: 80 IINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 215 CYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN--FFIPKQKGPLTSR 272
Q+ G+++ + +HRD+ A N+L+ + ++KIADFGL+ I K R
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197
Query: 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFK 327
+ W APE L Y D+WS G LL E+F +G PG VE+L ++ K
Sbjct: 198 LPVKWM-APEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 118 VGQGTYSNVYKA---RDRDTGKIVALKKVRFDTSEPES-VKFMAREIRILQKLDHPNVIK 173
+G G + VYK + +T KI K+ +T+ P++ V+FM E I+ +DHP++++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIMASMDHPHLVR 73
Query: 174 LEGLATSRMQYSLYLVFDFM-QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
L G+ S ++ LV M L + + + + Q+ G+ + ER +
Sbjct: 74 LLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266
+HRD+ A N+L+ +KI DFGL+ +K
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 54/230 (23%), Positives = 110/230 (47%), Gaps = 38/230 (16%)
Query: 105 VPKSADSYDKLAKVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREI 160
+P SA + + ++G+ + +YK D ++VA+K ++ D + P+ +E
Sbjct: 2 LPLSAVRF--MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEA 58
Query: 161 RILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM-QSDLTK--IICRPGQKL-----TEPQ 212
++ +L HPN++ L G+ T + + ++F+++ Q DL + I+ P + +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 213 VKCYMQ---------QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS----- 258
VK + Q+ +G+++ +H+D+ A N+LI + +KI+D GLS
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 259 -NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
+++ + K L R W ++ G + D+WS G +L E+F
Sbjct: 177 ADYYRVQPKSLLPIR----WMPPEAIMYGK--FSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 51/160 (31%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 208 LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN--FFIPKQ 265
LT + CY Q+ G++ R +HRD+ A N+L+ ++ ++KI DFGL+ + P
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHR 324
+R+ W APE + Y + D+WS G LL E+F +G PG E+ R
Sbjct: 236 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 293
Query: 325 IFKLCGT--PSEDYWKKMKLTTTFRPQHYKPSFREVFGEF 362
K GT + DY T H +PS R F E
Sbjct: 294 RLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 52/182 (28%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 138 VALK--KVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDF-M 193
VA+K K +SE E+ + E++I+ L +H N++ L G T + + ++ ++
Sbjct: 68 VAVKMLKPTAHSSEREA---LMSELKIMSHLGNHENIVNLLGACT--IGGPILVITEYCC 122
Query: 194 QSDLTKIICRPGQK-LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKI 252
DL + R + LT + + Q+ G+ + +HRD+ A N+L+ ++KI
Sbjct: 123 YGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI 182
Query: 253 ADFGL-------SNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAE 305
DFGL SN+ + KG +R+ W APE + Y D+WS G LL E
Sbjct: 183 CDFGLARDIMNDSNYVV---KG--NARLPVKWM-APESIFNCV-YTFESDVWSYGILLWE 235
Query: 306 MF 307
+F
Sbjct: 236 IF 237
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 118 VGQGTYSNVYKAR--DRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
+G+G + VY D D KI A+K + T E +F+ +E I++ HPNV+ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFL-KEGIIMKDFSHPNVLSL 61
Query: 175 EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
G+ L ++ DL I T + + Q+ G+++ + +H
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121
Query: 235 RDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
RD+ A N ++D+S +K+ADFGL+ ++ +++ W A E L
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT--GAKLPVKWM-ALESLQTQK 178
Query: 289 DYGVGIDLWSAGCLLAEM 306
+ D+WS G LL E+
Sbjct: 179 -FTTKSDVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 42/171 (24%), Positives = 83/171 (48%), Gaps = 7/171 (4%)
Query: 138 VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSD- 196
VA+ +R S+ + F+A E L + DH N+++LEG+ T ++ +V ++M +
Sbjct: 36 VAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYMSNGA 92
Query: 197 LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFG 256
L + + +L Q+ + L SG+++ E G +H+ + A +L++ + KI+ F
Sbjct: 93 LDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 257 -LSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEM 306
L ++ + LW APE + + D+WS G ++ E+
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLW-AAPE-AIQYHHFSSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 125 NVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184
NV K R +VA+K +R D ++ F+ +E++IL +L PN+I+L G+ +
Sbjct: 40 NVRKGRPL----LVAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--ED 92
Query: 185 SLYLVFDFMQS-DLTKIICR------------------PGQKLTEPQVKCYMQQLLSGLQ 225
L ++ ++M++ DL + + ++ + Q+ SG++
Sbjct: 93 PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV--TLWYRAPEL 283
+ +HRD+ N L+ ++ +KIADFG+S + R V W +
Sbjct: 153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFI 308
L+G + D+W+ G L E+ +
Sbjct: 213 LMGK--FTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 38/249 (15%)
Query: 138 VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SD 196
V +K++R S E +KF+ E + + L H N+++ G T Y LV +F D
Sbjct: 25 VVVKELRVSASVQEQMKFLE-EAQPYRSLQHSNLLQCLGQCTEVTPY--LLVMEFCPLGD 81
Query: 197 LTKII--CRPGQKLT-EPQVKCYMQ-QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKI 252
L + CR + +T +P M ++ GL H H+ +H D+ N L+ +KI
Sbjct: 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKI 141
Query: 253 ADFGLSN-------FFIPKQKGPLTSRVVTLWYRAPELL------LGSTDYGVGIDLWSA 299
D+GLS+ + P Q V L + APEL+ L D ++WS
Sbjct: 142 GDYGLSHNKYKEDYYVTPDQL------WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSL 195
Query: 300 GCLLAEMF-IGRPLMPGRTEVEQLHRIFK---------LCGTPSEDYWKKMKLTTTFRPQ 349
G + E+F +G ++ + L + P D W ++ +P+
Sbjct: 196 GVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQPE 255
Query: 350 HYKPSFREV 358
+PS EV
Sbjct: 256 Q-RPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 30/214 (14%)
Query: 117 KVGQGTYSNVYKAR------DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN 170
++G+G + V+ A ++D +VA+K ++ + SE F RE +L L H +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDK-MLVAVKALK-EASESARQDFQ-REAELLTVLQHQH 68
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQ-SDLTKII---------------CRPGQKLTEPQVK 214
+++ G+ T L +VF++M+ DL + + PGQ LT Q+
Sbjct: 69 IVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ-LTLGQML 125
Query: 215 CYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR-V 273
Q+ SG+ + +HRD+ N L+ + ++KI DFG+S + R +
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
+ + + PE +L + D+WS G +L E+F
Sbjct: 186 LPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 29/179 (16%)
Query: 208 LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN--FFIPKQ 265
LT + CY Q+ G++ R +HRD+ A N+L+ ++ ++KI DFGL+ + P
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHR 324
++R+ W APE + Y D+WS G LL E+F +G PG Q+
Sbjct: 231 VRKGSARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGV----QI-- 282
Query: 325 IFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT 383
+E++ +++K T R P Y I+ DP R T
Sbjct: 283 --------NEEFCQRLKDGTRMRAPENA----------TPEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 39/173 (22%)
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL-------SNFFIPKQKGPLTS 271
Q+ G+ + +HRD+ A N+L+ + KI DFGL SN+ + KG +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV---KG--NA 274
Query: 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCG 330
R+ W APE + Y V D+WS G LL E+F +G+ PG + +++ K G
Sbjct: 275 RLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK-RG 331
Query: 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT 383
Q +P F PP Y I+ L+P R T
Sbjct: 332 Y-----------------QMSRPDFA------PPEIYSIMKMCWNLEPTERPT 361
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 117 KVGQG-TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLE 175
KV G + + KAR V +K++R ++ P+ +E++ ++L+HPNV++
Sbjct: 10 KVLLGEAHRGMSKAR-------VVVKELR-ASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 176 GLATSRMQYSLYLVFDFMQ-SDLTKII--CR-----PGQKLTEPQVKCYMQQLLSGLQHC 227
G + Y LV +F DL + R QK ++ C ++ SGL
Sbjct: 62 GQCIESIPY--LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC---EVASGLLWL 116
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLTSRVVTLWYRAP 281
H+ +H D+ N + +KI D+GL+ +++I K V L + AP
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC-----HAVPLRWLAP 171
Query: 282 ELL------LGSTDYGVGIDLWSAGCLLAEMF 307
EL+ L D ++WS G + E+F
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 17/150 (11%)
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQ-----SDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
PN++ L S + S++LV + S ++K + P E VK + +++
Sbjct: 45 PNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISKFLNIP-----EECVKRWAAEMVVA 97
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
L H GI+ RD+ +N+L+D G +++ F + G + Y APE
Sbjct: 98 LDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE- 152
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLM 313
+ G ++ D WS G +L E+ G+ L+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 25/53 (47%), Positives = 33/53 (62%)
Query: 204 PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFG 256
P K +K M+Q+L+GL+ H GI+HRDIK NLL+ G +KI DFG
Sbjct: 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 72/285 (25%), Positives = 126/285 (44%), Gaps = 41/285 (14%)
Query: 114 KLAKVGQGTYSNVYK---ARDRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
K+ +G G + VYK D + KI VA+K +R +TS P++ K + E ++ + P
Sbjct: 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSP 69
Query: 170 NVIKLEG--------LATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLL 221
V +L G L T M Y L D+++ + +I + + + Q+
Sbjct: 70 YVCRLLGICLTSTVQLVTQLMPYGCLL--DYVRENKDRIGSQ--------DLLNWCVQIA 119
Query: 222 SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRA 280
G+ + E ++HRD+ A N+L+ +KI DFGL+ I + + V + + A
Sbjct: 120 KGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEM--FIGRPL--MPGRTEVEQLHRIFKLCGTP--SE 334
E +L + D+WS G + E+ F +P +P R + L + +L P +
Sbjct: 180 LESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTI 238
Query: 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPA 379
D + M + +P FRE+ EF + +A DP+
Sbjct: 239 DVYMIMVKCWMIDSEC-RPRFRELVDEF---------SRMARDPS 273
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 37/146 (25%), Positives = 67/146 (45%), Gaps = 18/146 (12%)
Query: 163 LQKLDHPNVIKLEGLAT---SRMQYSLYLVFDFMQSD---LTKIICRPGQKLTEPQVKCY 216
+ +DH + K G + RM Y L+ +++ +I C+ + +K
Sbjct: 77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN-----KKLIKNI 131
Query: 217 MQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL 276
M+ +L+ L++ HE GI H DIK N+++D + I D+G+++ FI K S+
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191
Query: 277 WYRAPELLLGSTDYGVGIDLWSAGCL 302
+R T Y G+D + C+
Sbjct: 192 LHRG-------TLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 38/154 (24%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 118 VGQGTYSNVYKARDRDTGKI--VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLE 175
+G+G + +V + + I VA+K ++ ++ E +++ DHPNV++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 176 GLATSRMQYSLY----LVFDFMQ-SDLTKIIC------RPGQKLTEPQVKCYMQQLLSGL 224
G+ ++ Y ++ FM+ DL + P T+ VK +M + SG+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258
++ + +HRD+ A N +++++ + +ADFGLS
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 63/266 (23%), Positives = 118/266 (44%), Gaps = 48/266 (18%)
Query: 100 VLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMARE 159
VL + S + L+ +G+GT+ V +A DR + A+K VR + P+ + E
Sbjct: 119 VLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR---NVPKYTRDAKIE 175
Query: 160 IRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSD---LTKIICRPGQKLTE------ 210
I+ ++K+ A ++ L + + Q++ + ++ + G L +
Sbjct: 176 IQFMEKVR---------QADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG 226
Query: 211 PQVKCYMQQLL----SGLQHCH-ERGILHRDIKASNLLIDKSGM---------------- 249
P ++ Q++ L + H E ++H D+K N+L++ S
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286
Query: 250 LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG 309
++I D G ++ T+ V T YR+PE++LG + D+WS GC++ E++ G
Sbjct: 287 VRICDLG----GCCDERHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTG 341
Query: 310 RPLMPGRTEVEQLHRIFK-LCGTPSE 334
+ L +E LH + K L PSE
Sbjct: 342 KLLYDTHDNLEHLHLMEKTLGRLPSE 367
|
Length = 467 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 53/263 (20%), Positives = 106/263 (40%), Gaps = 29/263 (11%)
Query: 119 GQGTYSNVYKARDRDTGKIVALKKVRFDTS-----EPESVKFMA--REIRILQKLDHPNV 171
GQGT++N+YK R + + + + + +A ++ +L H ++
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 172 IKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+KL G+ R + + V ++++ L + R ++ +QL S L + ++
Sbjct: 64 VKLYGV-CVRDENIM--VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120
Query: 231 GILHRDIKASNLLIDKSGM-------LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
++H ++ N+L+ + G+ +K++D G IP RV + + APE
Sbjct: 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-----IPITVLSREERVERIPWIAPEC 175
Query: 284 L-LGSTDYGVGIDLWSAGCLLAEMFIGRPL-MPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341
+ G + D WS G L E+ + + E+ P D +
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELAN 235
Query: 342 LTT---TFRPQHYKPSFREVFGE 361
L T+ P +PSFR + +
Sbjct: 236 LINQCWTYDPTK-RPSFRAILRD 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 51/210 (24%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
++GQG++ VY+ + K VA+K V S E ++F+ E ++++ + +V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHV 71
Query: 172 IKLEGLATSRMQYSLYLVFDFMQSDLTKII--CRPGQK----LTEPQVKCYMQ---QLLS 222
++L G+ S+ Q +L ++ + DL + RP + P +K +Q ++
Sbjct: 72 VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL------SNFFIPKQKGPLTSRVVTL 276
G+ + + +HRD+ A N ++ + +KI DFG+ ++++ KG L R
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 277 WYRAPELLLGSTDYGVGIDLWSAGCLLAEM 306
+ +PE L + D+WS G +L E+
Sbjct: 187 -WMSPESLKDGV-FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 42/156 (26%), Positives = 68/156 (43%), Gaps = 30/156 (19%)
Query: 208 LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN--FFIPKQ 265
LT + Y Q+ G++ R +HRD+ A N+L+ ++ ++KI DFGL+ + P
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229
Query: 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
+R+ W APE + Y D+WS G LL E I
Sbjct: 230 VRKGDARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWE-------------------I 268
Query: 326 FKLCGTP------SEDYWKKMKLTTTFR-PQHYKPS 354
F L +P E++ +++K T R P++ P
Sbjct: 269 FSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPE 304
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 115 LAKVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
L ++GQG++ VY+ RD K VA+K V S E ++F+ E +++
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCH 69
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKII--CRP----GQKLTEPQVKCYMQ---QL 220
+V++L G+ S+ Q +L ++ DL + RP P ++ +Q ++
Sbjct: 70 HVVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL------SNFFIPKQKGPLTSRVV 274
G+ + + + +HRD+ A N ++ +KI DFG+ ++++ KG L R
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEM 306
+ APE L + D+WS G +L E+
Sbjct: 187 ---WMAPESLKDGV-FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 14/96 (14%)
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL-------SNFFIPKQKGPLTS 271
Q+ +G++ + +HRD+ A N+LI + ++KI DFGL SN+ KG S
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYI---SKG---S 300
Query: 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
+ L + APE + + Y D+WS G LL E+F
Sbjct: 301 TFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIF 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 117 KVGQGTYSNVYKAR-----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
++G+G + V+ A +VA+K ++ T K RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 172 IKLEGLATSRMQYSLYLVFDFMQ-SDLTK---------IICRPGQ------KLTEPQVKC 215
+K G+ L +VF++M+ DL K +I GQ +L Q+
Sbjct: 70 VKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 216 YMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS-NFFIPKQKGPLTSRVV 274
Q+ SG+ + + +HRD+ N L+ + ++KI DFG+S + + ++
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
+ + PE ++ + D+WS G +L E+F
Sbjct: 188 PIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 32/190 (16%)
Query: 138 VALKKVRFDTSEPESVKFMAR--EIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ- 194
V +K+++ + S E +F+ + RILQ HPN+++ G + Y LVF++ +
Sbjct: 25 VVVKELKANASSKEQNEFLQQGDPYRILQ---HPNILQCLGQCVEAIPY--LLVFEYCEL 79
Query: 195 SDLTKIIC------RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248
DL + R Q L ++ C ++ +G+ H H+ LH D+ N +
Sbjct: 80 GDLKSYLSQEQWHRRNSQLLLLQRMAC---EIAAGVTHMHKHNFLHSDLALRNCFLTSDL 136
Query: 249 MLKIADFGLSNFFIPKQKGPLTS--RVVTLWYRAPELL---------LGSTDYGVGIDLW 297
+K+ D+G+ K+ T + V L + APEL+ T ++W
Sbjct: 137 TVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPS---NVW 192
Query: 298 SAGCLLAEMF 307
+ G L E+F
Sbjct: 193 ALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 49/180 (27%), Positives = 72/180 (40%), Gaps = 41/180 (22%)
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL-------SNFFIPKQKGPLTS 271
Q+ G+ + +HRD+ A N+L+ + KI DFGL SN+ + KG +
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV---KG--NA 276
Query: 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCG 330
R+ W APE + Y D+WS G LL E+F +G P G
Sbjct: 277 RLPVKWM-APESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYP---------------G 319
Query: 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFGEF-PPSSYGILTTLLALDPAYRGTAASALQ 389
P + + KM K +R + E P Y I+ + DP R T +Q
Sbjct: 320 MPVDSKFYKM----------IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 206 QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL-------S 258
+ LT + + Q+ G++ + +HRD+ A N+L+ + ++KI DFGL S
Sbjct: 232 EGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDS 291
Query: 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGR- 316
N+ KG S + + + APE + + Y D+WS G LL E+F +G PG
Sbjct: 292 NYV---SKG---STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMI 344
Query: 317 ------TEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFR 356
+++ +R+ K E Y +K + P+ +PSF
Sbjct: 345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNS-EPEK-RPSFL 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 67/279 (24%), Positives = 116/279 (41%), Gaps = 38/279 (13%)
Query: 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV--IK 173
A +GQGT +N+Y R R G + D RE+R++ K+ P+ I
Sbjct: 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIA 60
Query: 174 LEGLATSRM--QYS-LYLVF----------DFMQSDLTK----IICRPGQKLTEPQV--K 214
L T+ + Q S ++L F + M + + +C +K P
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI 120
Query: 215 CYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM-------LKIADFGLSNFFIPKQKG 267
QQL S L + ++ ++H ++ A N+L+ + G+ +K++D G+S + +++
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE- 179
Query: 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEM-FIGRPLMPGRTEVEQLHRIF 326
RV + + APE + G D WS G L E+ F G + RT E+
Sbjct: 180 ----RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE 235
Query: 327 KLCGTPSEDYWKKMKLTT---TFRPQHYKPSFREVFGEF 362
K P + L + T+ P +PSFR + +
Sbjct: 236 KKHRLPEPSCKELATLISQCLTYEPTQ-RPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 25/100 (25%)
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQS-----DLTKIICRPGQKLTEPQ--------VKCYM 217
V + EG +T + D MQS ++ + Q L P+ ++ M
Sbjct: 213 VWRYEGEST---------LADLMQSKEFPYNVEPYLLGKVQDL--PKGLERENKIIQTIM 261
Query: 218 QQLLSGLQHCHERGILHRDIKASNLLID-KSGMLKIADFG 256
+Q+L L H GI+HRD+K N++ SG KI D G
Sbjct: 262 RQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 47/215 (21%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 115 LAKVGQGTYSNVYKARDRDTG-----KIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ ++G+ + VYK T + VA+K ++ D +E + E + +L HP
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHP 68
Query: 170 NVIKLEGLATSRMQYSLYLVFDFM-QSDLTK-IICRP-----GQKLTEPQVKCYMQ---- 218
N++ L G+ T S+ +F + SDL + ++ R G + VK ++
Sbjct: 69 NIVCLLGVVTKEQPLSM--IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 219 -----QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL-SNFFIPKQKGPLTSR 272
Q+ +G++ ++H+D+ N+L+ +KI+D GL + + +
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
++ + + +PE ++ + + D+WS G +L E+F
Sbjct: 187 LLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 58/265 (21%), Positives = 119/265 (44%), Gaps = 34/265 (12%)
Query: 118 VGQGTYSNVY------KARDRDTG-----KIVALKKVRFDTSEPESVKFMAREIRILQKL 166
+G+GT + +Y K D D G +I + KV + S+ F +++++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFF-ETASMMRQV 61
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
H +++ L G+ ++ +V +F++ L + R LT P +QL S L
Sbjct: 62 SHKHIVLLYGVCVRDVEN--IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 226 HCHERGILHRDIKASNLLIDKSGM-------LKIADFGLSNFFIPKQKGPLTSRVVTLWY 278
+ ++ ++H ++ N+L+ + G+ +K++D G+ + +Q+ V + +
Sbjct: 120 YLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE-----CVERIPW 174
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEM-FIGRPLMPGRTEVEQLHRIFKLC---GTPS- 333
APE + S + + D WS G L E+ + G + +T E+ R ++ TPS
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQCMLVTPSC 233
Query: 334 EDYWKKMKLTTTFRPQHYKPSFREV 358
++ M + P + +P FR +
Sbjct: 234 KELADLMTHCMNYDP-NQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 26/139 (18%), Positives = 54/139 (38%), Gaps = 10/139 (7%)
Query: 125 NVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184
VY +D ++ + + S + RE+ ILQ L + + LA+
Sbjct: 13 RVYLLGTKDEDYVL-----KINPSREKGADR-EREVAILQLLARKGLPVPKVLASGESDG 66
Query: 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI 244
YL+ ++ + + + + + +LL+ L + H D+ N+L+
Sbjct: 67 WSYLLMEW----IEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV 122
Query: 245 DKSGMLKIADFGLSNFFIP 263
D +L I D+ + + P
Sbjct: 123 DDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 469 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.9 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.73 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.65 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.6 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.37 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.25 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.21 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.21 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.97 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.92 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.84 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.82 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.78 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.66 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.64 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.53 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.32 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.31 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.3 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.25 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.98 | |
| PLN02236 | 344 | choline kinase | 96.93 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.86 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.85 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.73 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.55 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.49 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.29 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.22 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.15 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.94 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.79 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.72 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.63 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.0 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.87 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-70 Score=531.51 Aligned_cols=345 Identities=57% Similarity=1.042 Sum_probs=312.7
Q ss_pred cChhhhhcCCccccccCCchhhhhccCCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHH
Q 036673 79 ISEDELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAR 158 (469)
Q Consensus 79 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~ 158 (469)
........+|+.|+... ..+.+.+..+...+.|+.+++||+|+||.||+|++..||+.||+|+++++...++......+
T Consensus 87 ~e~~~~~a~~p~~l~~~-~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~R 165 (560)
T KOG0600|consen 87 TEAEQVAAGWPAWLSSV-AGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIR 165 (560)
T ss_pred chhhhhhccCccccccc-cccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHH
Confidence 33355677999997743 44566788999999999999999999999999999999999999999998877888888999
Q ss_pred HHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 036673 159 EIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIK 238 (469)
Q Consensus 159 E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 238 (469)
||.||++|+||||++|.++..+.....+|||||||+++|..++...+-.|++.+++.|++||+.||+|||++||+|||||
T Consensus 166 EI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK 245 (560)
T KOG0600|consen 166 EIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIK 245 (560)
T ss_pred HHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeecccc
Confidence 99999999999999999999988777899999999999999999888899999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh
Q 036673 239 ASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE 318 (469)
Q Consensus 239 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~ 318 (469)
.+|||||.+|.+||+|||||+++........+..+.|.||+|||+++|...|+.++|+||+||||.||++|+|.|++.++
T Consensus 246 ~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 246 GSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred ccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 99999999999999999999999888877899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcccC--ccCCC-CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 319 VEQLHRIFKLCGTPSEDYWKKMKLT--TTFRP-QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 319 ~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.+|+..|++.||.|.+++|...++. ..|++ ..+...+++.+..++..+.+|+..||+.||.+|.||.++|+|+||..
T Consensus 326 veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 326 VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 9999999999999999999965554 55665 55678889999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccCCCChhhhhhhhhc
Q 036673 396 SPLACDLSSLPVICREEDEPARTSRRKKR 424 (469)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (469)
.+.+++.+.+|..........+..+..++
T Consensus 406 ~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r 434 (560)
T KOG0600|consen 406 EPLPCDPSSLPKYPPSHELDAKRRREQKR 434 (560)
T ss_pred CCCCCCcccCCCCCcchhHHHHHHHHHhh
Confidence 99999999999865554444444443333
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-62 Score=454.07 Aligned_cols=306 Identities=39% Similarity=0.720 Sum_probs=272.2
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
.+.+.|+.++.|++|+||.||+|+++.|++.||+|+++.+......--.-.+||.+|.+++|||||.+..+....+-..+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 45678999999999999999999999999999999998875444433456789999999999999999999988888889
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|||||||+.+|...+..-..+|...+++.++.|+++||+|||.++|+||||||+|+|+++.|.+||+|||+|+.+... .
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~ 231 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-L 231 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-c
Confidence 999999999999988877788999999999999999999999999999999999999999999999999999987543 3
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
...+..+.|.||+|||++++...|++++|+||+|||+.||++++|.|++.++.+++.+|++.+|.|.+..|.........
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 45778899999999999999999999999999999999999999999999999999999999999999999987764421
Q ss_pred ----CCCCCCCcchhcccCC--ChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCCCCCCCccccCCC
Q 036673 347 ----RPQHYKPSFREVFGEF--PPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICREED 413 (469)
Q Consensus 347 ----~~~~~~~~~~~~~~~~--~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 413 (469)
.+.+....++..+..+ ++...+|++.+|..||.+|.||.|+|+|.||...|.+++...+|.++....
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 2233334455555554 499999999999999999999999999999999999999999998765543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-62 Score=436.21 Aligned_cols=297 Identities=42% Similarity=0.778 Sum_probs=266.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|...++||+|.||+||+|++..||+.||||+++.............+||+.|+.++|+||+.++++|-..+ .+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS--NLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC--ceEEE
Confidence 5789999999999999999999999999999999877555455567789999999999999999999987754 46899
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
+|||+.+|...+......++..+++.|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.+... ..
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-~~ 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-IQ 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-cc
Confidence 99999999999999988999999999999999999999999999999999999999999999999999998765433 34
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC-
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP- 348 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~- 348 (469)
+..+.|.||+|||.+.|.+.|+..+||||.|||+.||+-|.|.|++.++.+|+..|+..+|+|.++.|..+.....+..
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 4458899999999999999999999999999999999999999999999999999999999999999999876655433
Q ss_pred C-CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCCCCCCCccc
Q 036673 349 Q-HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVIC 409 (469)
Q Consensus 349 ~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~ 409 (469)
+ ...+....+++..++++.||+.+||..||.+|+||.|+|+|+||+..|.++....+|.-.
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~ 300 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPS 300 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCc
Confidence 2 233455568889999999999999999999999999999999999988888777776643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-61 Score=441.96 Aligned_cols=283 Identities=34% Similarity=0.614 Sum_probs=254.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+.|+.+.++|+|+||+||+|++++||+.||||++.....++...+...+|+++|++|+|+|+|.++++|.. ...++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 56899999999999999999999999999999997777777777888999999999999999999998876 4458999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
+|||+...+..+.+....++...++.++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+.. .....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99999999998888777799999999999999999999999999999999999999999999999999998753 45567
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC-
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP- 348 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~- 348 (469)
+.++.|.||+|||.+.+...|+..+||||+||++.||++|.|.|++.++.+++..|.+.+|...............|..
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 8889999999999999988999999999999999999999999999999999999999999988777766665554422
Q ss_pred ----CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 349 ----QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 349 ----~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.....++..-++.++.-+.||+++||..||.+|++.+|+|.|+||+.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 22234566667888999999999999999999999999999999964
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-61 Score=460.95 Aligned_cols=285 Identities=38% Similarity=0.694 Sum_probs=254.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|.++++||.|+||.||+|+.+.++..||||.++.....-+..- -.+|+..|++|+ |||||++.+++.+.+. .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~-~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDR-IL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCc-eE
Confidence 35789999999999999999999999999999999976544333322 358999999998 9999999999888655 79
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|+|||||+.+|.+++...++.|++..++.|+.||++||+|+|.+|++||||||+|||+.....+||+|||+|+.. ...
T Consensus 86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev--~Sk 163 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV--RSK 163 (538)
T ss_pred eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc--ccC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999987 345
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc-C--
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL-T-- 343 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~-- 343 (469)
.+.+.++.|.||+|||+++....|+.++|||++|||++|+.+=+|+|+|.++.+++.+|..++|+|..+.|..... .
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 5678899999999999999999999999999999999999999999999999999999999999999888877322 1
Q ss_pred ccC-CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 TTF-RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
-.| .++.....+..+.+..+.++.+||.+||.+||.+||||.|+|+||||+..
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 122 23444556778888899999999999999999999999999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-59 Score=444.01 Aligned_cols=265 Identities=28% Similarity=0.441 Sum_probs=220.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-----HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-----PESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
..+.|.+.+.||.|+||.|-+|..+.||+.||||++...... ......+.+|++||++|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346689999999999999999999999999999999765221 112244679999999999999999999998865
Q ss_pred ccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC---CcEEEeeecCc
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS---GMLKIADFGLS 258 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~---~~~kl~DFGla 258 (469)
. .||||||++| +|++.+.. ++.+.+...+.+++|++.||.|||++||+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s--~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 S--SYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred c--eEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 4 5999999997 56666655 4579999999999999999999999999999999999999776 67999999999
Q ss_pred ccccCCCCCCcccccccCccccchhccCCC--CCCccccchhhHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHH
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGST--DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVE-QLHRIFKLCGTPSED 335 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~ 335 (469)
+... ....+.+.||||.|.|||++.+.. .+..++|||||||+||-+|+|.+||....... ...+|.+.-.....
T Consensus 327 K~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p- 403 (475)
T KOG0615|consen 327 KVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP- 403 (475)
T ss_pred hccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC-
Confidence 9874 455678999999999999986532 34558999999999999999999998766555 45555443222221
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
..|..+++++.+||+.||..||++|||++|+|+||||+..+..
T Consensus 404 ---------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 404 ---------------------LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL 446 (475)
T ss_pred ---------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence 2355689999999999999999999999999999999987643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-56 Score=441.98 Aligned_cols=260 Identities=27% Similarity=0.478 Sum_probs=228.2
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.+|...+.||+|||++||.+++.++|+.||+|++... .......+.+.+||+|.++|+|||||+++++|++.. ++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~--nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN--NVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC--ceEE
Confidence 6799999999999999999999999999999999764 233445577889999999999999999999998854 5899
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|.|+|..+.+..+.+.+++++|.+++.+++||+.||.|||+++|+|||||..||||+++.+|||+|||||..+... ...
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-GER 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc-ccc
Confidence 9999998766667677789999999999999999999999999999999999999999999999999999987533 244
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
..+.||||.|.|||++.. ...+..+||||+|||||.||+|+|||...+-.+.+.+|...-.
T Consensus 175 k~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------------------ 235 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------------------ 235 (592)
T ss_pred cceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc------------------
Confidence 568899999999999875 5589999999999999999999999999988888888754211
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
.+...++.++.+||.+||..||.+|||++++|.|+||+..-.+
T Consensus 236 --------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 236 --------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred --------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 1223678999999999999999999999999999999654433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-56 Score=419.70 Aligned_cols=293 Identities=38% Similarity=0.633 Sum_probs=256.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEee---ccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATS---RMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~ 185 (469)
...|..++.||.|+||.|+.|.++.+|+.||||++.......-..+...+|+++|+.++|+||+.+++++.. .....
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456777899999999999999999999999999997555556667888899999999999999999998865 33456
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC-
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK- 264 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 264 (469)
+|+|+|+|+.+|.+.+... ..|++..+..++.||++||.|+|+.+|+||||||+|+|++.+..+||+|||+|+.....
T Consensus 101 vYiV~elMetDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHHhhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 8999999998988877653 35999999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc--
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL-- 342 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 342 (469)
....++.++.|.||+|||+++....|+.++||||+||||.||++|++.|+|.+..+++..|...+|.|+++.+..+..
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 234467889999999999999988999999999999999999999999999999999999999999999988877662
Q ss_pred -CccC--CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCCC
Q 036673 343 -TTTF--RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDL 402 (469)
Q Consensus 343 -~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~ 402 (469)
...+ .++....+|...++..++.+.+|+.+||+.||.+|+|++|+|+||||.....+.+.
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE 322 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence 1111 23444567888999999999999999999999999999999999999875544443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-56 Score=416.99 Aligned_cols=258 Identities=33% Similarity=0.504 Sum_probs=222.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++.+.++.||+|..|+||+++++.|++.+|+|++... .++...+++.+|+++++..+|||||.++|.|..... .++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 35678889999999999999999999999999999543 556777899999999999999999999999998765 5899
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+++.++.+....++++|.....++.++++||.|||+ ++||||||||+||||+..|+|||||||.+..+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999987777776666789999999999999999999995 89999999999999999999999999999987443
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR-----TEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
...+++||..|||||.+.+. .|+.++||||||++++||.+|+.||... ...+++..|.. .|+
T Consensus 233 ~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~pp--------- 299 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPP--------- 299 (364)
T ss_pred hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCC---------
Confidence 56789999999999999874 6999999999999999999999999874 33444444432 111
Q ss_pred CccCCCCCCCCcchhccc-CCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 343 TTTFRPQHYKPSFREVFG-EFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
|. ... .+|+++.+||..||++||.+|+|+.|+|+|||+++..
T Consensus 300 ----------P~---lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 300 ----------PR---LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ----------CC---CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 11 122 4899999999999999999999999999999998743
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=413.74 Aligned_cols=278 Identities=39% Similarity=0.702 Sum_probs=241.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc---EE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY---SL 186 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~---~~ 186 (469)
-.|.-.+++|.|+||.||+|....+++.||||++-.+... -.+|+.+|+.++|||||+++-+|...... ++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3588889999999999999999999999999998654332 23799999999999999998877654443 67
Q ss_pred EEEEecchhhHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC-CcEEEeeecCccccc
Q 036673 187 YLVFDFMQSDLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS-GMLKIADFGLSNFFI 262 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~ 262 (469)
.+|||||+.+|.+.+.. .+..++.-.++-+..||++||+|||+.||+||||||.|||+|.+ |.+||||||.|+.+.
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 78999999998887764 46679999999999999999999999999999999999999987 899999999999885
Q ss_pred CCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.+. +..++..|..|+|||.+.+...|+.++||||.|||+.||+-|++.|++++..+++..|++.+|.|..+....+..
T Consensus 178 ~~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 178 KGE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred cCC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 544 447889999999999999999999999999999999999999999999999999999999999999998888776
Q ss_pred Ccc-CCCCCCC-Ccchh-cccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 343 TTT-FRPQHYK-PSFRE-VFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 343 ~~~-~~~~~~~-~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.-. +.-+... ..+.+ +....++++.+|+.++|..+|.+|.++.|+|.||||+.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 522 2212222 22223 56778999999999999999999999999999999985
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-55 Score=410.14 Aligned_cols=289 Identities=44% Similarity=0.756 Sum_probs=250.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC-eeeEeeeEeecc----c
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN-VIKLEGLATSRM----Q 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~----~ 183 (469)
...|..+++||+|+||+||+|+.+.+|+.||+|+++.....+..-....+|+.+|+.|+|+| ||.+++++.... .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 35688889999999999999999999999999999876543233345679999999999999 999999987754 2
Q ss_pred cEEEEEEecchhhHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 184 YSLYLVFDFMQSDLTKIICRPG---QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
..+++||||+.-++...+.... ..++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 3689999999999888876644 3588899999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
+.- .....+..++|.+|+|||++++...|+..+||||+|||++||+++++.|++.++.+++.+|+..+|+|.++.|...
T Consensus 170 ~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 531 2333678899999999999999989999999999999999999999999999999999999999999999999998
Q ss_pred ccCccCCC----CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 341 KLTTTFRP----QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 341 ~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
.....+.. ..-...+....+..++...+|+.+||+.||.+|.||..+|.||||...+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 76555443 22133455556667789999999999999999999999999999997543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-55 Score=409.82 Aligned_cols=260 Identities=30% Similarity=0.487 Sum_probs=224.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|+++++||+|+||+||+++.++|++.||+|++++.. ......+....|..||.+++||.||+++-.|+ +...+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ--t~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ--TEEKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc--cCCeE
Confidence 4578999999999999999999999999999999997653 23345677889999999999999999954444 46679
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|||+||+.|+.+...++..+.|++..++.|+..|+.||.|||++|||||||||+|||||.+|+++|+|||||+.... ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-DG 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc-CC
Confidence 99999999866666666667899999999999999999999999999999999999999999999999999986432 23
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
....+.|||+.|||||++.+. .|+.++|+|||||++|||++|.+||.+.+......+|.+.-.
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~---------------- 242 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL---------------- 242 (357)
T ss_pred CccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC----------------
Confidence 345568999999999999874 699999999999999999999999999999888888865320
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC----CHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG----TAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp----ta~elL~hp~f~~~ 396 (469)
.....-++.++++||+++|..||++|. .+.++-+||||..-
T Consensus 243 ---------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 243 ---------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred ---------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 111223688999999999999999995 78999999999853
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=404.17 Aligned_cols=264 Identities=30% Similarity=0.487 Sum_probs=225.9
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
....+|.+.+.||.|+||+||+|+++.++..||||.+..........+.+..|++||+.|+|||||.+++++...+ ++
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~--~i 84 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD--FI 84 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC--eE
Confidence 3457899999999999999999999999999999999887667788888999999999999999999999888744 68
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC------CcEEEeeecCccc
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS------GMLKIADFGLSNF 260 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~------~~~kl~DFGla~~ 260 (469)
|||||||.|+.+..+.+..+.+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999964444444445579999999999999999999999999999999999999765 4689999999998
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
+. ......+.||+|.|||||++.. ..|+.++|+||+|+|||+|++|++||...+..+.+..+-+....
T Consensus 165 L~--~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~--------- 232 (429)
T KOG0595|consen 165 LQ--PGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI--------- 232 (429)
T ss_pred CC--chhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc---------
Confidence 84 4455678999999999998864 56999999999999999999999999999988887754332111
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
.......+++.+.+|+..+|+.+|..|.+..+-+.|+|+...+.
T Consensus 233 --------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~ 276 (429)
T KOG0595|consen 233 --------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ 276 (429)
T ss_pred --------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence 11122345667778999999999999999999999999987663
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=416.53 Aligned_cols=260 Identities=33% Similarity=0.542 Sum_probs=226.3
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecccc
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 184 (469)
+..++|..++.||+|+|++|++|+.+.+++.||||++.+.. ..+..++-+..|-.+|.+| .||.|++| |+...++.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL--y~TFQD~~ 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL--YFTFQDEE 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE--EEEeeccc
Confidence 45688999999999999999999999999999999996542 2233346677899999999 89999999 55555567
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+|+|+||+++ +|+..+.+. +.|++..++.++.+|+.||+|||++|||||||||+|||||.++++||+|||.|+.+.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 79999999995 788888776 4799999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC------------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 036673 264 KQKG------------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT 331 (469)
Q Consensus 264 ~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (469)
.... ...+++||..|++||+|.. ...++.+|||+||||||+|+.|.|||.+.++.-.+++|+....
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y- 304 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY- 304 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-
Confidence 3322 1256899999999998765 5689999999999999999999999999999999999987543
Q ss_pred CCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
++.+.+++.+.+||+++|..||.+|+|+.||.+||||...
T Consensus 305 -------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 305 -------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred -------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 3345678999999999999999999999999999999854
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-52 Score=415.17 Aligned_cols=277 Identities=34% Similarity=0.572 Sum_probs=233.7
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-C-----CCeeeEeeeEeecccc
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-H-----PNVIKLEGLATSRMQY 184 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~~~~~~~~~ 184 (469)
+|.+++.||+|+||+|.+|.+..|++.||||+++. ......+...|+.||..|+ | -|||+++++|... .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--N 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--c
Confidence 68999999999999999999999999999999974 3455677778999999996 4 3899999999984 4
Q ss_pred EEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC--cEEEeeecCcccc
Q 036673 185 SLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG--MLKIADFGLSNFF 261 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~--~~kl~DFGla~~~ 261 (469)
++|||+|.+.-+|.+++..++ ..|+...++.++.||+.||.+||+.+|||+|||||||||.+.+ .|||+|||.|+..
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 679999999999999997754 3599999999999999999999999999999999999997654 7999999999975
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.. ...+++.+..|+|||+++| .+|+.+.||||||||++||++|.|+|+++++.+++..|+..+|.|+..+++...
T Consensus 342 ~q----~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQ----RVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CC----cceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 22 2338899999999999998 569999999999999999999999999999999999999999999988877655
Q ss_pred cCccCCCC-CCC-------------------------------C----cchhccc-CCChhHHHHHHHccccCCCCCCCH
Q 036673 342 LTTTFRPQ-HYK-------------------------------P----SFREVFG-EFPPSSYGILTTLLALDPAYRGTA 384 (469)
Q Consensus 342 ~~~~~~~~-~~~-------------------------------~----~~~~~~~-~~~~~l~~li~~~L~~dP~~Rpta 384 (469)
....|... ... | .+..... .....+.+||++||.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 44332211 110 1 1111111 223457999999999999999999
Q ss_pred HHHhcCccCCCCC
Q 036673 385 ASALQNEFFNASP 397 (469)
Q Consensus 385 ~elL~hp~f~~~~ 397 (469)
.|+|+||||....
T Consensus 497 ~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 497 AQALNHPFLTGTS 509 (586)
T ss_pred HHHhcCccccccc
Confidence 9999999999643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=381.77 Aligned_cols=257 Identities=25% Similarity=0.444 Sum_probs=225.5
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
...++|++++.||.|+||.|.+++.+.+|..+|+|++.+.. ......+...+|..+|+.+.||.++++.+.+.+ ...
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCe
Confidence 45689999999999999999999999999999999997652 334455778899999999999999999766655 567
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+||||||++|+-+..+++..++|++..++.++.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+...
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 89999999987666666666789999999999999999999999999999999999999999999999999999762
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
....+.||||.|+|||++.. ..|+.++|.|||||++|||+.|.+||...+....+.+|+..--
T Consensus 196 -~rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--------------- 258 (355)
T KOG0616|consen 196 -GRTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--------------- 258 (355)
T ss_pred -CcEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc---------------
Confidence 33668999999999998876 6799999999999999999999999999999999998876422
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.+...+++++++||+++|+.|-.+|. -..++..||||+..
T Consensus 259 -----------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 259 -----------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred -----------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 23345789999999999999999993 56799999999863
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=408.38 Aligned_cols=259 Identities=31% Similarity=0.510 Sum_probs=224.5
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeecc
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE---PESVKFMAREIRILQKLD-HPNVIKLEGLATSRM 182 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 182 (469)
...+.|.+.+.||+|+||+|++|.+..++..||||++...... ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999999999999999987654111 133466778999999998 999999999998865
Q ss_pred ccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC-CcEEEeeecCccc
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS-GMLKIADFGLSNF 260 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~ 260 (469)
. +|+|||||.| +|++.+.. .+++.+.+++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~--~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 K--IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred e--EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 5 7999999997 88888887 6789999999999999999999999999999999999999999 9999999999987
Q ss_pred ccCCCCCCcccccccCccccchhccCCC-CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGST-DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
.. .......+.|||+.|+|||++.+.. +-+.++||||+||+||.|++|+.||...+....+..|.+...
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~--------- 240 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF--------- 240 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc---------
Confidence 63 3445678899999999999998866 446899999999999999999999999777777776543211
Q ss_pred cccCccCCCCCCCCcchhcccCC-ChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEF-PPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.+...+ +.++.+||.+||..||.+|+|+.+++.||||+.
T Consensus 241 -----------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 -----------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -----------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 122234 899999999999999999999999999999997
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-52 Score=404.50 Aligned_cols=266 Identities=32% Similarity=0.486 Sum_probs=220.9
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
....++|++++.||+|+||.||+|+.++||..+|+|++++.. .....++.+..|-.+|...++|+||+|+ |...+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy--YsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY--YSFQDKE 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE--EEecCCC
Confidence 346789999999999999999999999999999999997652 3345567788999999999999999995 4444566
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC-
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP- 263 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~- 263 (469)
++||||||++|+...-++...+.|++..++.++.+++.|++-||+.|+|||||||+|+|||..|++||+||||+.-+..
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 7999999999855555555556899999999999999999999999999999999999999999999999999854321
Q ss_pred ---------------------CCCC------------------------CcccccccCccccchhccCCCCCCccccchh
Q 036673 264 ---------------------KQKG------------------------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWS 298 (469)
Q Consensus 264 ---------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws 298 (469)
.... ...+.+|||.|+|||++++. .|+..+|+||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHHH
Confidence 0000 01245899999999999984 5999999999
Q ss_pred hHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCC
Q 036673 299 AGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDP 378 (469)
Q Consensus 299 lGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 378 (469)
||||+||||.|.|||.+++..+...+|+.-- . ...+. .-..+++++.|||.+||+ ||
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------~---~l~fP----------~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------E---TLKFP----------EEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------h---hccCC----------CcCcccHHHHHHHHHHhc-CH
Confidence 9999999999999999999999999887521 1 00000 012456899999999999 99
Q ss_pred CCCCC---HHHHhcCccCCCCC
Q 036673 379 AYRGT---AASALQNEFFNASP 397 (469)
Q Consensus 379 ~~Rpt---a~elL~hp~f~~~~ 397 (469)
++|.- ++||.+||||+...
T Consensus 431 ~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHhcCcccHHHHhcCCccccCC
Confidence 99975 89999999999643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-51 Score=394.75 Aligned_cols=281 Identities=40% Similarity=0.720 Sum_probs=236.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.++||.|+||+||+|++..++..||+|+++..... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEE
Confidence 46799999999999999999999999999999998754322 2234567899999999999999999988764 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+.+++...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~~~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TKT 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC-Ccc
Confidence 9999999888887666667899999999999999999999999999999999999999999999999999764322 222
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|........+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 34567899999999887766789999999999999999999999999999999999999999999988887654433222
Q ss_pred CCC----CCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 QHY----KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 ~~~----~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
..+ ........+.++.++.+||.+||++||.+|||+.|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 111 111223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=378.45 Aligned_cols=261 Identities=27% Similarity=0.441 Sum_probs=225.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..+.|++.+.||+|.|+.||++.+..||+.+|+|++..........+.+.+|+.|-+.|+|||||++.+.+.+ ....|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeE
Confidence 4578999999999999999999999999999999997665555566889999999999999999999887655 44579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC---CCcEEEeeecCcccccC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---SGMLKIADFGLSNFFIP 263 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 263 (469)
||+|+|.| ++...+... ..+++..+-.+++||+.||+|+|.+||||||+||+|+||-. ...+||+|||+|..+.
T Consensus 87 lvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999998 555555443 46899999999999999999999999999999999999943 3469999999998875
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.......++|||.|||||++.. .+|+..+|||+.|||||-||.|++||.+.+....+.+|.+.....+.
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~--------- 233 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS--------- 233 (355)
T ss_pred -CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC---------
Confidence 4455678899999999998876 56999999999999999999999999999999999888765333222
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..|+.+++++++||++||..||.+|+|+.|+|+|||+.+.
T Consensus 234 -------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 234 -------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred -------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 2367789999999999999999999999999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=391.23 Aligned_cols=281 Identities=32% Similarity=0.617 Sum_probs=232.8
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||+|+||+||+|++..+++.||||++............+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEEEE
Confidence 479999999999999999999999999999999976544444556788999999999999999999888764 457999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||++++++..+......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999988877766566799999999999999999999999999999999999999999999999999987643333334
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
....+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+..+...++.......+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 456789999999988764 4899999999999999999999999998888888888887777776665543322211111
Q ss_pred CC------CCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 350 HY------KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 350 ~~------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.. ..........++.++.+||++||++||++|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 10 011122334578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=409.66 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=224.6
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
+-|++++.||.|+.|.|.+|++..||+.+|||++... .........+.+||-||+.|.||||++++++++. +.++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEE
Confidence 4588999999999999999999999999999999765 3333334667899999999999999999998876 556899
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|.||++| .|++.+.+ .++|++.+++++++||+.|+.|+|..+|+||||||+|+|||..++|||+|||+|..- ..+.
T Consensus 90 vlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe--~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE--VPGK 166 (786)
T ss_pred EEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc--cCCc
Confidence 9999997 55555554 458999999999999999999999999999999999999999999999999999865 3344
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
...+.||+|.|.|||++.|..+.+.++||||+|||||.||||+.||.+++-...+.++.....
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f----------------- 229 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF----------------- 229 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-----------------
Confidence 577899999999999999988889999999999999999999999997777666666644211
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
+....++.++.+||.+||.+||++|+|.+|+++|||+......
T Consensus 230 ---------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 230 ---------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred ---------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 3346789999999999999999999999999999999865433
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=349.79 Aligned_cols=283 Identities=42% Similarity=0.751 Sum_probs=251.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
..|+..++||+|.||+||+|+++++++.||+|.++.+..++..-....+|+.+|+.|+|.|||+++++... +..+-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEe
Confidence 35778889999999999999999999999999999887666666778899999999999999999887765 4457899
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
+|||..++......-++.+..+.++.++.|+++||.|+|++++.||||||.|+||+.+|++||+|||+++.++-.. ...
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-rcy 158 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCY 158 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eee
Confidence 9999999988888778889999999999999999999999999999999999999999999999999998764322 223
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
...+.|.||++|.++.+..-|++..|+||.|||+.|+.. |+|.|++.+..+++.+|+..+|.|.++.|..+.....+.+
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 456779999999999999999999999999999999985 8999999999999999999999999999999887766655
Q ss_pred CCCC---CcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 349 QHYK---PSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 349 ~~~~---~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
...- .++..+.+.++..-++|++++|.-+|.+|++|+++|+||||..
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 3222 2456667778888899999999999999999999999999976
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=401.07 Aligned_cols=257 Identities=33% Similarity=0.505 Sum_probs=227.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|-+.+.||+|+||.||+|+.+.|.+.||+|.+.+........+.+.+|++|++.|+|||||.++++|+.. .++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~--~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS--AHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc--ceEEEE
Confidence 578899999999999999999999999999999988777777788999999999999999999999998874 457999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
.||+.|+|...+.. .+.++|+.++.++.+++.||.|||+++|+|||+||.||||+..|.+|+||||+|+.... .....
T Consensus 80 te~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vl 157 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVL 157 (808)
T ss_pred ehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cceee
Confidence 99999988777655 45799999999999999999999999999999999999999999999999999997643 34456
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
+...|||.|||||++.+ .+|+..+|+||||||+|||++|+|||...+-.+....|...--
T Consensus 158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v------------------- 217 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV------------------- 217 (808)
T ss_pred eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-------------------
Confidence 78899999999998875 6799999999999999999999999988777777766654211
Q ss_pred CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
......+..+.+||+.+|.+||.+|+|-.++|.|||++..-
T Consensus 218 -------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 218 -------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred -------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 12236788999999999999999999999999999998643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=393.70 Aligned_cols=266 Identities=31% Similarity=0.440 Sum_probs=225.4
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC------------CHHHHHHHHHHHHHHHhCCCCCeeeE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS------------EPESVKFMAREIRILQKLDHPNVIKL 174 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~hpnIv~~ 174 (469)
+..++|++++.||.|.||.|-+|++..+++.||||++.+... .....+...+||.||++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 456899999999999999999999999999999999964321 11123578899999999999999999
Q ss_pred eeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEee
Q 036673 175 EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIAD 254 (469)
Q Consensus 175 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~D 254 (469)
+++..++....+|||+|||..+-..+.-.....+++.+++.|+++++.||.|||.+|||||||||+|+||+.+|++||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 99999999999999999999776666544333399999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCC----CCCcccccccCccccchhccC---CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036673 255 FGLSNFFIPKQ----KGPLTSRVVTLWYRAPELLLG---STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327 (469)
Q Consensus 255 FGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 327 (469)
||.+..+.... .......+|||.|+|||.+.+ ....+.+.||||+||+||.|+.|+.||.++...+.+.+|++
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 99998653221 122445789999999998876 23456789999999999999999999999999999999876
Q ss_pred HhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 328 LCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.--.. ...+++.+.++|||.+||++||++|++..++..|||....
T Consensus 334 ~pL~f------------------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DPLEF------------------------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CcccC------------------------CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 31111 1123578899999999999999999999999999998864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=404.01 Aligned_cols=257 Identities=28% Similarity=0.499 Sum_probs=223.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
...|....+||+|+.|.||.|+...+++.||||++........ +.+.+|+.+|+..+|+|||.+++.|... ..+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhccc--ceeEE
Confidence 3568889999999999999999999999999999987655444 6788999999999999999999977665 44799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||||+|+.+..+.... .++|.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+..... .
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999986665555433 499999999999999999999999999999999999999999999999999998755443 4
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
..+.+|||+|||||++.. ..|++++||||||+|++||+-|+|||-.++....+..|.. .|.|..
T Consensus 426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l-------------- 489 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL-------------- 489 (550)
T ss_pred cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc--------------
Confidence 567899999999998865 6699999999999999999999999998888888877754 233322
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.....+|+++++||.+||+.||.+|++|.|||+||||+.
T Consensus 490 --------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 490 --------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred --------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 234568999999999999999999999999999999965
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-50 Score=391.36 Aligned_cols=284 Identities=38% Similarity=0.697 Sum_probs=231.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||.|+||+||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEEE
Confidence 47899999999999999999999999999999998754322 2224567899999999999999999988764 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+.+++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC-CCcc
Confidence 999999999888877666799999999999999999999999999999999999999999999999999875422 1223
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE-VEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+..+ .+.+..++...+.+....|........+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 34567899999999987766688999999999999999999999987544 46677777777888777766554333222
Q ss_pred CCCC----CCcchhccc--CCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 348 PQHY----KPSFREVFG--EFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~----~~~~~~~~~--~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+..+ ...+...+. .+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 2211 111222222 246789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=387.83 Aligned_cols=261 Identities=33% Similarity=0.534 Sum_probs=213.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.+|...+.||+|+||+||++.+.++|...|||.+....... .+.+.+|+.+|.+|+|||||+++|.........++|.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45788889999999999999999999999999997653222 6778999999999999999999997544433356899
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-CCcEEEeeecCcccccC--CC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-SGMLKIADFGLSNFFIP--KQ 265 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~--~~ 265 (469)
|||+.+ ++.+.+.+.+..|++..++.+.+||++||.|||++|||||||||+||||+. ++.+||+|||++..... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 999997 566666655558999999999999999999999999999999999999999 79999999999987653 22
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR-TEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........||+.|||||++........++|||||||++.||+||.+||... ...+.+..+....
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--------------- 239 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--------------- 239 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------------
Confidence 233456889999999999975322345999999999999999999999863 3333333322111
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..| .+...+++++.+||.+||..||++||||.++|+|||.+..
T Consensus 240 ------~~P---~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 240 ------SLP---EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ------CCC---CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 011 4455689999999999999999999999999999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=376.90 Aligned_cols=289 Identities=38% Similarity=0.664 Sum_probs=240.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCC----cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTG----KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
..|+++..||+|.||.||+|...+++ +.+|||+++-............+|+.+++.|+||||+.+..++... +.+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 56999999999999999999766554 3789999976644444556678999999999999999998888775 567
Q ss_pred EEEEEecchhhHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC----CcEEEeeecC
Q 036673 186 LYLVFDFMQSDLTKIICRP----GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS----GMLKIADFGL 257 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~----~~~kl~DFGl 257 (469)
++|++||.+.+|+..+... ...++...++.|+.||+.|+.|||++.|+||||||.||||..+ |.|||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 8999999999999988542 2458999999999999999999999999999999999999887 8999999999
Q ss_pred cccccCCCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC---------hHHHHHHHH
Q 036673 258 SNFFIPKQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT---------EVEQLHRIF 326 (469)
Q Consensus 258 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~---------~~~~~~~i~ 326 (469)
++.+...-. ......+.|.||+|||.++|...|+.++|||++|||+.||||-.|.|.+.. ..+++.+|+
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 998743322 124467789999999999999999999999999999999999999998754 357899999
Q ss_pred HHhCCCCHHHHhhcccCccC-------CCCCCCC-cch---hcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 327 KLCGTPSEDYWKKMKLTTTF-------RPQHYKP-SFR---EVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~---~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
+.+|.|.++.|..+.....+ +...+.+ ++. .....-++.+.+|+.+||+.||.+|+|++|+|+|+||..
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 99999999999887654332 2112211 122 223334667999999999999999999999999999998
Q ss_pred CCCC
Q 036673 396 SPLA 399 (469)
Q Consensus 396 ~~~~ 399 (469)
.+.+
T Consensus 343 d~lp 346 (438)
T KOG0666|consen 343 DPLP 346 (438)
T ss_pred CCCC
Confidence 8665
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-52 Score=375.44 Aligned_cols=249 Identities=30% Similarity=0.513 Sum_probs=214.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
..+|+++++||.|.||.||++.+..+|..||.|.+.+..-+....+.+..|+.+|++|+|||||++++.....+...++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 46799999999999999999999999999999999988777777888999999999999999999988655555666899
Q ss_pred EEecchh-hHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 189 VFDFMQS-DLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHE--RG--ILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 189 v~e~~~~-~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~--ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
|||||.+ +|.+.+. +..+.+++..++.++.|++.||..+|+ .. |+||||||.||+|+.+|.+||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999995 6665553 345679999999999999999999999 44 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
+... .....+.+|||.||+||++.. ..|+.++||||+||++|||+.-++||.+.+-.+...+|.+...+|
T Consensus 178 l~s~-~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~-------- 247 (375)
T KOG0591|consen 178 LSSK-TTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP-------- 247 (375)
T ss_pred hcch-hHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC--------
Confidence 7433 334568899999999998876 569999999999999999999999999997777777765432211
Q ss_pred ccCccCCCCCCCCcchhcc-cCCChhHHHHHHHccccCCCCCCCH
Q 036673 341 KLTTTFRPQHYKPSFREVF-GEFPPSSYGILTTLLALDPAYRGTA 384 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~L~~dP~~Rpta 384 (469)
++ ..+|..+..||..|++.||..||+.
T Consensus 248 -----------------~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 248 -----------------LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred -----------------CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 12 2467889999999999999999985
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=406.19 Aligned_cols=280 Identities=35% Similarity=0.559 Sum_probs=228.5
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec------
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR------ 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 181 (469)
...+|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3568999999999999999999999999999999885432 2345799999999999999998876442
Q ss_pred cccEEEEEEecchhhHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-cEEEeeecC
Q 036673 182 MQYSLYLVFDFMQSDLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGL 257 (469)
Q Consensus 182 ~~~~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~kl~DFGl 257 (469)
....+++||||+++++...+. .....+++..++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 223578999999998766553 3456799999999999999999999999999999999999999665 799999999
Q ss_pred cccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 036673 258 SNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 258 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 337 (469)
|+.+... ......++|+.|+|||++.+...++.++|||||||+||||++|.+||.+.+..+.+.+++..++.|..+.+
T Consensus 218 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 218 AKNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred chhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 9866332 22345678999999999877667899999999999999999999999999999999999999999887776
Q ss_pred hhcccCc-cC-CCCCCCCcchhc-ccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 338 KKMKLTT-TF-RPQHYKPSFREV-FGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 338 ~~~~~~~-~~-~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+...- .+ .+......+... ....++++.+||.+||++||.+|||+.|+|+||||..
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 6543210 00 011111222222 2357889999999999999999999999999999975
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=392.37 Aligned_cols=287 Identities=33% Similarity=0.557 Sum_probs=232.1
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc---ccEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM---QYSLY 187 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~ 187 (469)
+|++.++||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999999999999999998754333334456889999999999999999999876433 23579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC-
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK- 266 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 266 (469)
+|||||++++...+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 99999998887776543 4699999999999999999999999999999999999999999999999999976432221
Q ss_pred -CCcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 267 -GPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 267 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
......++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....+.+....+..+....
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 122456789999999987542 458899999999999999999999999998888888888888888776655432211
Q ss_pred cC-----CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 345 TF-----RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 345 ~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
.. ........+...++.+++.+.+||.+||+.||++|||+.++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00 0011112233445567889999999999999999999999999999986433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=381.37 Aligned_cols=281 Identities=38% Similarity=0.656 Sum_probs=226.6
Q ss_pred cCcceeceeeeeCCeEEEEEEECC-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeEeeeEee---cc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRD-TGKIVALKKVRFDTSEPESVKFMAREIRILQKL---DHPNVIKLEGLATS---RM 182 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~---~~ 182 (469)
++|++++.||+|+||+||+|++.. +++.||||++............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999854 478899999876543333334556788777766 69999999998753 22
Q ss_pred ccEEEEEEecchhhHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 183 QYSLYLVFDFMQSDLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 183 ~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
...+++||||+.+++...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 3457999999999888777543 345899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
... .......+|+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.++.+.+..++...+.+....|....
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 322 23445678999999998865 458899999999999999999999999999999999999888877655544321
Q ss_pred -cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 342 -LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 342 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.............+....+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1111111111223445556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=397.84 Aligned_cols=259 Identities=28% Similarity=0.431 Sum_probs=224.5
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 183 (469)
+...++|.++++||+|+||+|+++..+.+++.||||+++++ ....+.++....|..|+... +||.++.++..|.. .
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--K 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--C
Confidence 45678999999999999999999999999999999999876 34556678888999999888 59999999776665 5
Q ss_pred cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 184 YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.++|+||||+.|+.+. .....+.|++..++.|+..|+.||+|||++|||+||||.+|||||.+|++||+|||+++...
T Consensus 442 ~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred CeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC-
Confidence 5789999999987633 33444679999999999999999999999999999999999999999999999999998642
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.....+.+.||||.|||||++.+ ..|+.++|+|||||+|||||.|++||+++++.+....|+..--
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~------------- 585 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV------------- 585 (694)
T ss_pred CCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-------------
Confidence 23445778999999999999886 5699999999999999999999999999999999998865211
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNA 395 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~ 395 (469)
.+...++.++.++|+++|.+||++|.- +.++.+||||+.
T Consensus 586 -------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 586 -------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred -------------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 122356889999999999999999986 479999999985
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=382.23 Aligned_cols=285 Identities=36% Similarity=0.691 Sum_probs=238.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|.+.+.||+|+||+||+|++..+++.||+|+++..... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEE
Confidence 46799999999999999999999999999999998754322 2224567899999999999999999988764 35799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+++++...+...+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KT 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cc
Confidence 99999998888887766678999999999999999999999999999999999999999999999999997643222 22
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|..+.....+..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 33456799999999887666789999999999999999999999999999999999999999999888877654332211
Q ss_pred CCC----CCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 349 QHY----KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 349 ~~~----~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
..+ ...+......+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 111 1112233456889999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=393.35 Aligned_cols=285 Identities=35% Similarity=0.552 Sum_probs=234.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc---ccEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM---QYSLY 187 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~ 187 (469)
+|++++.||+|+||+||+|.+..+++.||||++..........+.+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999999999999998654344445567889999999999999999999887643 12579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+.+++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 99999998888776543 46999999999999999999999999999999999999999999999999999865443333
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc-----
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL----- 342 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~----- 342 (469)
......+++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+...++.+....+.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 344567899999999988766689999999999999999999999999999999999999988887655433210
Q ss_pred --CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 343 --TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 343 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.....+. ............++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus 240 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPP-SLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCC-chHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0000000 01111223456688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=376.04 Aligned_cols=273 Identities=26% Similarity=0.422 Sum_probs=222.5
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
+...+.|++...||.|..++||+|+...++..||||++..+..+.+ .+.+.+|+..|..++||||++++..|.. ...
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~ 98 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV--DSE 98 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe--cce
Confidence 4556889999999999999999999999999999999988766555 7889999999999999999999777766 456
Q ss_pred EEEEEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 186 LYLVFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
+|+||.||.+ ++++.+... ...++|..+..|++++++||.|||.+|-||||||+.||||+.+|.|||+|||.+..+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 8999999996 566655432 23499999999999999999999999999999999999999999999999999876644
Q ss_pred CCCC---CcccccccCccccchh-ccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 264 KQKG---PLTSRVVTLWYRAPEL-LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 264 ~~~~---~~~~~~gt~~y~aPE~-~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
.... ...+.+||++|||||+ +..-..|+.++||||||++..||.+|..||..-.....+..-+ .+.|+......
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp~~~t~~ 256 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPPTLLTSG 256 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCCCccccc
Confidence 3221 1256799999999999 4555579999999999999999999999998877776654433 23332110000
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.-.+-...++.+++.+|..||+.||.+||||+++|+|+||+...
T Consensus 257 --------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 257 --------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred --------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 00011234566899999999999999999999999999999643
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=387.66 Aligned_cols=282 Identities=31% Similarity=0.530 Sum_probs=229.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc----c
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ----Y 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----~ 184 (469)
.++|++.+.||.|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999999999999999997554444555678899999999999999999998865332 3
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+|+||||+++++...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~- 175 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT- 175 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc-
Confidence 4799999999988777643 489999999999999999999999999999999999999999999999999976422
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....+.+...+++......
T Consensus 176 -~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 176 -NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred -CccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 223345678999999998876 458999999999999999999999999999888888888888888877665432110
Q ss_pred c----CCCCCCCCcch------------hcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 T----FRPQHYKPSFR------------EVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~----~~~~~~~~~~~------------~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. -.+......+. ......+..+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 0 00000000111 1112346789999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=362.92 Aligned_cols=259 Identities=29% Similarity=0.456 Sum_probs=217.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC------CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT------SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRM 182 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 182 (469)
+.|.-.+.||.|..++|.++.++.+|..+|+|++.... ...+..+.-.+|+.||+++ .||||+++.++|+...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45777788999999999999999999999999985431 1223345567899999999 7999999999998744
Q ss_pred ccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
.+++|+|.|+. .|.+.+ .....+++.+.+.|++|++.|+.|||.++||||||||+|||++++.++||+|||+|+.+
T Consensus 97 --F~FlVFdl~prGELFDyL-ts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 --FVFLVFDLMPRGELFDYL-TSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred --hhhhhhhhcccchHHHHh-hhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 57999999995 555554 44457999999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCcccccccCccccchhcc-----CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLL-----GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
.+. ......||||+|+|||.+. +...|+..+|+|++|||+|.||.|.+||......-.+..|.........
T Consensus 174 ~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s-- 249 (411)
T KOG0599|consen 174 EPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS-- 249 (411)
T ss_pred CCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC--
Confidence 543 4477899999999999873 3456899999999999999999999999876666666666554332222
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.-|.+++...+|||.+||+.||.+|+|+.|+|+||||.+
T Consensus 250 --------------------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 250 --------------------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred --------------------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 225568899999999999999999999999999999964
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=375.18 Aligned_cols=280 Identities=38% Similarity=0.664 Sum_probs=226.6
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeEeeeEeec---ccc
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL---DHPNVIKLEGLATSR---MQY 184 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~---~~~ 184 (469)
+|++.+.||+|+||+||+|++..+++.||+|.++...........+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999999876433322223455677777665 799999999987643 234
Q ss_pred EEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.++++|||+.+++...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 579999999998877775532 3589999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc-
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL- 342 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 342 (469)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+.++....+.+....|.....
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 Q--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred c--ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 2 22345678999999998876 4589999999999999999999999999998888989888887776655543211
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.................+.++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 111111122233455667788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=378.54 Aligned_cols=299 Identities=42% Similarity=0.742 Sum_probs=246.4
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||.|+||.||+|.+..+++.||+|++............+.+|+.++++++|+||+++++++.......++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 35789999999999999999999999999999999976543333234456899999999999999999998776556689
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+.+++...+......+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||++....... .
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~ 163 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-K 163 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-C
Confidence 999999998877776655679999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|..........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 22344568899999988776668999999999999999999999999999999999999998888877776543322111
Q ss_pred C----CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCCCCCCCc
Q 036673 348 P----QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPV 407 (469)
Q Consensus 348 ~----~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~ 407 (469)
. ......+......+++.+.+||.+||+.||++|||+.++|.||||+..++++..-.+|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~ 307 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPT 307 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCC
Confidence 1 11112223334456889999999999999999999999999999999888876555554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=386.22 Aligned_cols=283 Identities=30% Similarity=0.512 Sum_probs=231.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----c
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----Q 183 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~ 183 (469)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999999999999999999765444455567889999999999999999998775432 2
Q ss_pred cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 184 YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
..+|+||||+++++...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 35799999999988877643 488999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....++...+.|...+++.+...
T Consensus 179 --~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 179 --SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred --CCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 222345678999999998876 45899999999999999999999999999999999999988888887776654321
Q ss_pred c--------cCCC--------CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 T--------TFRP--------QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~--------~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. .+.. ....+.........+..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 1 0000 000011111122345688999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=377.75 Aligned_cols=274 Identities=36% Similarity=0.639 Sum_probs=216.6
Q ss_pred ceeeeeCCeEEEEEEECC--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
.+||+|+||+||+|+++. +++.||+|.+..... ...+.+|+.+|++++||||+++++++.......+|++|||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 579999999999999763 578999999864322 23467899999999999999999988776677789999999
Q ss_pred hhhHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----cCCCcEEEeeecCcccc
Q 036673 194 QSDLTKIICRP--------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFF 261 (469)
Q Consensus 194 ~~~l~~~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~~ 261 (469)
.+++...+... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 99887766421 2358999999999999999999999999999999999999 45678999999999875
Q ss_pred cCCCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHhC
Q 036673 262 IPKQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---------VEQLHRIFKLCG 330 (469)
Q Consensus 262 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---------~~~~~~i~~~~~ 330 (469)
..... ......++|+.|+|||++.+...++.++|||||||++|+|++|++||..... .+++..++...+
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 43221 1234567899999999988766789999999999999999999999975442 466778888888
Q ss_pred CCCHHHHhhcccCccC-------CCC-----CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 331 TPSEDYWKKMKLTTTF-------RPQ-----HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~-------~~~-----~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.|....|......... ... .....+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8888777765322110 000 00001111112345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=384.19 Aligned_cols=283 Identities=31% Similarity=0.535 Sum_probs=230.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----c
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----Q 183 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~ 183 (469)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 357899999999999999999999999999999999765445555677889999999999999999999876432 2
Q ss_pred cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 184 YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
..+|+||||+++++...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 35799999999988776643 589999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....++..++.+...++..+...
T Consensus 172 --~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 172 --SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred --ccccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 222345678999999998876 45899999999999999999999999999988888888888888776665543211
Q ss_pred c--------cCC----CC----CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 T--------TFR----PQ----HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~--------~~~----~~----~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. .+. +. ...+.........+..+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 000 00 00001111222346778999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=361.90 Aligned_cols=291 Identities=42% Similarity=0.713 Sum_probs=245.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec------c
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR------M 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 182 (469)
.+.|+...+||+|.||.||+|+.+++|+.||+|++..+......-....+|+.+|..|+|+|++.+++.|... .
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4578889999999999999999999999999998866433333334567899999999999999998877432 2
Q ss_pred ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 183 QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 183 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
...+|+||++|+.+|...+.....+++..++..++.+++.||.|+|++.|+|||+|++|+||+.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 34589999999999999998887889999999999999999999999999999999999999999999999999997764
Q ss_pred CCCC---CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 263 PKQK---GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 263 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
...+ ...+..+.|.+|++||.+++.+.|+++.|||+.|||+.||+|+.+.|.++++..++..|-..||....+.|..
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 4332 2345678899999999999999999999999999999999999999999999999999999999999999888
Q ss_pred cccCccCCCC----CCCCcchhccc-----CCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 340 MKLTTTFRPQ----HYKPSFREVFG-----EFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 340 ~~~~~~~~~~----~~~~~~~~~~~-----~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
+....-+..- .....++.+.. .-++++.+||.+||..||.+|++++++|+|.||...|.+
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 6643322111 11111222211 125688999999999999999999999999999998876
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=381.48 Aligned_cols=263 Identities=33% Similarity=0.507 Sum_probs=226.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 185 (469)
....|++.+.||.|.||+||+++.+.||+.+|+|++.+... .......+.+|+.||++|. |||||.+++.|++.. .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--S 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--e
Confidence 45679999999999999999999999999999999976533 2224567889999999998 999999999998855 5
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC----CcEEEeeecCccc
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS----GMLKIADFGLSNF 260 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 260 (469)
+++|||+|.| .|++.+... .+++..+..+++||+.++.|||+.||+||||||+|+|+... +.+|++|||++..
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 7999999996 666666655 39999999999999999999999999999999999999643 4799999999998
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
... .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......|........
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~------- 258 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT------- 258 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC-------
Confidence 754 455778999999999998864 5699999999999999999999999999998888887755322111
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
...|+.++..+.+||.+||..||.+|+||.++|+|||++.....
T Consensus 259 ---------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 259 ---------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred ---------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 24567789999999999999999999999999999999875333
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=383.45 Aligned_cols=283 Identities=35% Similarity=0.589 Sum_probs=232.4
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----c
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----Q 183 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~ 183 (469)
..++|++++.||.|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 347899999999999999999999999999999998754333344466778999999999999999998775422 2
Q ss_pred cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 184 YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
...|++++++.+++...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 34689999998887766543 4699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+...++......
T Consensus 171 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 171 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred ----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 2345678999999999877667899999999999999999999999999888888888888888777665543221
Q ss_pred cc-----CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 TT-----FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.. ..+......+...+...++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 10 001111223344455678889999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=389.12 Aligned_cols=277 Identities=25% Similarity=0.359 Sum_probs=217.9
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
...+|++++.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+||||+++++++... ...+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 159 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYN--KFTC 159 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeE
Confidence 34689999999999999999999999999999997531 3467899999999999999999988764 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+|+|++.+++...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.........
T Consensus 160 lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 160 LILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 99999998887777554 46899999999999999999999999999999999999999999999999999754333333
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHHHHhhc
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT-------EVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ...++..++...+.++..+....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 3445689999999998876 458999999999999999999997765432 34566677776666544331100
Q ss_pred ---------ccCc-cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 341 ---------KLTT-TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 341 ---------~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.... ........+.+ .....++.++.+||.+||++||.+||||.|+|+||||+..+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLW-TNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCH-HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0000 00001111111 11234677899999999999999999999999999998743
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=372.90 Aligned_cols=283 Identities=39% Similarity=0.715 Sum_probs=235.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|.+.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++... ..+++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEEE
Confidence 47899999999999999999999999999999998754322 2224567899999999999999999988764 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+.+++...+......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... ..
T Consensus 82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 160 (301)
T cd07873 82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 160 (301)
T ss_pred EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cc
Confidence 99999998888887766679999999999999999999999999999999999999999999999999997542221 22
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+....+....+.+....|+.+.....+..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 23456789999999887766688999999999999999999999999988888888888888888888776533322221
Q ss_pred CCC----CCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 349 QHY----KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 349 ~~~----~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+ ...+......+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 111 11223344568899999999999999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=377.51 Aligned_cols=252 Identities=29% Similarity=0.419 Sum_probs=209.2
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcE-EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
....+.+.||.|+||+||+|.+. |+. ||||++..........+.|.+|+.+|.+++|||||+++|++..... .++|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEE
Confidence 34455566999999999999998 556 9999997665555557899999999999999999999999988653 4699
Q ss_pred EEecchhhHH-HHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcEEEcCCC-cEEEeeecCcccccCC
Q 036673 189 VFDFMQSDLT-KIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERG-ILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~~l~-~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 264 (469)
||||++++.+ ..+.. ....++...+..++.||++||.|||+++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999997554 44444 2678999999999999999999999999 99999999999999998 9999999999876432
Q ss_pred CCCCcccccccCccccchhccC-CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 265 QKGPLTSRVVTLWYRAPELLLG-STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. ...+...||+.|||||++.+ ...|+.++||||||++||||+||+.||.+.........+......|
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp----------- 265 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP----------- 265 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 2 33455789999999999975 3569999999999999999999999999988865555554322222
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+....++.+..||..||..||.+||+..+++.
T Consensus 266 -------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 -------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 122237889999999999999999999998775
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=349.44 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=223.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++.+.||+|.||.||+|+.+.++..||+|++.+... ......++.+|++|-..|+||||++++++|.+. ..+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--KRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--cee
Confidence 35789999999999999999999999999999999976422 222336788999999999999999999999884 457
Q ss_pred EEEEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 187 YLVFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
||++||... .++..+.. ...++++.....++.|++.||.|+|..+|+||||||+|+|++..+.+||+|||.+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--- 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--- 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec---
Confidence 999999985 66666642 4567999999999999999999999999999999999999999999999999999753
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
..+...+.|||..|.+||+..+ ..++..+|+|++|++.||++.|.+||...+..+.+.+|.+.-..
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~------------- 240 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK------------- 240 (281)
T ss_pred CCCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-------------
Confidence 2455678899999999998766 56899999999999999999999999999988888888764221
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
+...++..+.|||.+||.++|.+|.+..|++.|||...
T Consensus 241 -------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 -------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred -------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 22467899999999999999999999999999999865
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=368.10 Aligned_cols=280 Identities=42% Similarity=0.763 Sum_probs=231.3
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++++.||.|+||.||+|++..++..||||++............+.+|+.++..++||||+++++++... ..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEEE
Confidence 48899999999999999999999999999999876543333446678899999999999999999998764 4579999
Q ss_pred ecchhhHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 191 DFMQSDLTKIICRP--GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 191 e~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||+.+++...+... +..+++..++.++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++....... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 99998887776542 2569999999999999999999999999999999999999999999999999997653221 22
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+....+....++...+.+....|........+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 23456789999999887666678999999999999999999999999988888888888888877777765433222211
Q ss_pred ---CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 ---QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 ---~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
......+......+++++.+||.+||+.||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 111122333455689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=378.31 Aligned_cols=254 Identities=23% Similarity=0.395 Sum_probs=212.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++.+.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|..++||||+++++++... ..+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEE
Confidence 478999999999999999999999999999999997542 1223346788999999999999999999988764 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+.+ +|...+.. ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 99999987 55555543 457999999999999999999999999999999999999999999999999999865322
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.... +
T Consensus 172 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~-------------- 232 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--L-------------- 232 (329)
T ss_pred --cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--c--------------
Confidence 234678999999998876 457899999999999999999999998877766655543210 0
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 396 (469)
.+...++..+.+||.+||+.||.+|++ +.++++||||...
T Consensus 233 ----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 233 ----------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 112236788999999999999999997 7999999999863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=372.84 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=211.2
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 479999999999999999999999999999999965321 22334668899999999999999999887765 446799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+.+ +|.+.+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---- 153 (291)
T cd05612 79 LMEYVPGGELFSYLR-NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---- 153 (291)
T ss_pred EEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC----
Confidence 9999987 4555554 445799999999999999999999999999999999999999999999999999986532
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 154 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~----------------- 215 (291)
T cd05612 154 RTWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL----------------- 215 (291)
T ss_pred CcccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-----------------
Confidence 1234678999999998876 4579999999999999999999999998877666665543110
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNA 395 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~ 395 (469)
.+...+++.+.+||++||+.||.+|++ +.++++||||+.
T Consensus 216 ---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 216 ---------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred ---------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 112345788999999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=376.36 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=206.6
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
+.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|..++||||+++++++... ..+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCCC
Confidence 35999999999999999999999999997542 2233446678899999999999999998887764 45799999999
Q ss_pred hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccc
Q 036673 195 SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274 (469)
Q Consensus 195 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 274 (469)
++.+.........+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... ........+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccceec
Confidence 754444444455799999999999999999999999999999999999999999999999999875322 1222345679
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCc
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPS 354 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (469)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+....
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~------------------------- 211 (323)
T cd05571 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------------------------- 211 (323)
T ss_pred CccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence 999999998865 458999999999999999999999998876655554442210
Q ss_pred chhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 355 FREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 355 ~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
..+...+++++.+||.+||+.||++|| ++.++++||||...
T Consensus 212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 012235788999999999999999999 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=367.71 Aligned_cols=253 Identities=28% Similarity=0.520 Sum_probs=220.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.+|++.+.||+|.||.|-+|+....|+.||||.++++. .+....-.+.+||+||..|+||||+.++++|+..+ .++|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd--KIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD--KIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc--eEEE
Confidence 57999999999999999999998889999999998764 33445567899999999999999999999887744 5799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||..+ .|.+++.. .+.|++.+++.+++||++|+.|+|.++++|||||.+|||||.++++||+||||+.++ ....
T Consensus 131 vMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly--~~~k 207 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY--ADKK 207 (668)
T ss_pred EEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh--cccc
Confidence 9999986 55555554 457999999999999999999999999999999999999999999999999999987 3445
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
...++||+|-|.+||++.+..+-++.+|.|||||+||.|+.|..||.+.+....+.+|-.... +
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY---------------r- 271 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY---------------R- 271 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc---------------c-
Confidence 678999999999999998877778999999999999999999999999888777777644211 1
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
-+.-|..+..||+.||-+||++|.|+.++..|=|.+
T Consensus 272 -----------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 -----------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -----------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 123356778899999999999999999999998876
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=378.58 Aligned_cols=259 Identities=28% Similarity=0.507 Sum_probs=222.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
...|+....||+|.||.||+|.+..+++.||+|++..+... ..+..+.+|+.+|.+++++||.++++.|.. ...+|+
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHH
Confidence 35688889999999999999999999999999999877544 445788999999999999999999998877 445799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
+||||.|+....+++.+..+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+......
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r- 167 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR- 167 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc-
Confidence 9999998776667777777799999999999999999999999999999999999999999999999999887544433
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
..+++|||.|||||++.+ ..|+.++||||||++.+||++|.||+........+..| +
T Consensus 168 r~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------------p 224 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------------P 224 (467)
T ss_pred cccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------------c
Confidence 378899999999999984 56999999999999999999999999876653333222 2
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
...+|.+. ..+++.+++||..||.+||+.||+|.++|+|+|++...
T Consensus 225 k~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 225 KSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred CCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 22233332 37889999999999999999999999999999999743
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=367.55 Aligned_cols=280 Identities=40% Similarity=0.701 Sum_probs=231.3
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||.|+||.||+|++..+|+.||+|.+............+.+|+.+++.++||||+++++++.+.. .+++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK--KLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--ceEEEE
Confidence 588999999999999999999999999999999765433333456778999999999999999999887643 579999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
||+.+++...+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+.... ....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 999999888877666679999999999999999999999999999999999999999999999999998653222 2233
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC-
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPL-MPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP- 348 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~- 348 (469)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+...++.+....|..+.....+..
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999887766678999999999999999998766 667777788888888888888777765443322211
Q ss_pred --CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 --QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 --~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
......+....+.+++++.+||.+||+.||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111112234456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=388.48 Aligned_cols=281 Identities=22% Similarity=0.310 Sum_probs=219.7
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC------CCeeeEeeeEe
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH------PNVIKLEGLAT 179 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~~~~~ 179 (469)
....++|+++++||+|+||+||+|.+..+++.||||+++... .....+..|+.++..+.| .+|+++++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 345688999999999999999999999999999999996421 223445668888777754 45888888876
Q ss_pred eccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCC----------
Q 036673 180 SRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSG---------- 248 (469)
Q Consensus 180 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~---------- 248 (469)
.. ..++||||+++.++++.++... ..+++..+..++.||+.||+|||+ .|||||||||+||||+.++
T Consensus 202 ~~-~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 202 NE-TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred cC-CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 54 3467999999988888877654 469999999999999999999998 5999999999999998765
Q ss_pred ------cEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHH
Q 036673 249 ------MLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQL 322 (469)
Q Consensus 249 ------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~ 322 (469)
.+||+|||++... .......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~----~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE----RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred cCCCCceEEECCCCccccC----ccccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 4999999988643 222346789999999999876 45899999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHhhcccC---------ccCCCCCCCCcchhcc------c-CCChhHHHHHHHccccCCCCCCCHHH
Q 036673 323 HRIFKLCGTPSEDYWKKMKLT---------TTFRPQHYKPSFREVF------G-EFPPSSYGILTTLLALDPAYRGTAAS 386 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~------~-~~~~~l~~li~~~L~~dP~~Rpta~e 386 (469)
..+...++.++..++...... ....+......+..+. . ..++.+.+||.+||++||.+|||+.|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 999888888876654321110 0000000000000000 0 12456889999999999999999999
Q ss_pred HhcCccCCCC
Q 036673 387 ALQNEFFNAS 396 (469)
Q Consensus 387 lL~hp~f~~~ 396 (469)
+|+||||...
T Consensus 435 ~L~Hp~~~~~ 444 (467)
T PTZ00284 435 MTTHPYVLKY 444 (467)
T ss_pred HhcCcccccc
Confidence 9999999874
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=362.95 Aligned_cols=265 Identities=27% Similarity=0.384 Sum_probs=220.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..+.|++++.||.|.-|+||+++...++..+|+|++.+... ......+...|-+||..++||.+++||..++. ....
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~ 152 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYS 152 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--ccee
Confidence 35789999999999999999999999999999999976532 24455778889999999999999999988877 4457
Q ss_pred EEEEecchhhHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC-
Q 036673 187 YLVFDFMQSDLTKIIC--RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP- 263 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~- 263 (469)
||+||||.|+.+..+. +++..|++..++.|+..++.||+|||..|||.|||||+||||-++|+|.|+||.|+.....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999985444443 3456799999999999999999999999999999999999999999999999999743210
Q ss_pred --------------------------------C-C---------------------CCCcccccccCccccchhccCCCC
Q 036673 264 --------------------------------K-Q---------------------KGPLTSRVVTLWYRAPELLLGSTD 289 (469)
Q Consensus 264 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 289 (469)
. . .....+++||-.|+|||++.|..
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G- 311 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG- 311 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-
Confidence 0 0 01123568899999999998754
Q ss_pred CCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHH
Q 036673 290 YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGI 369 (469)
Q Consensus 290 ~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (469)
.+.++|+|+|||+|||||.|..||.+.+..+.+..|+..-- .|.+ .+.++.+++||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-----------------------~Fp~-~~~vs~~akDL 367 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-----------------------KFPE-EPEVSSAAKDL 367 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-----------------------cCCC-CCcchhHHHHH
Confidence 79999999999999999999999999999999988764211 1111 12567899999
Q ss_pred HHHccccCCCCCCC----HHHHhcCccCCCCCCC
Q 036673 370 LTTLLALDPAYRGT----AASALQNEFFNASPLA 399 (469)
Q Consensus 370 i~~~L~~dP~~Rpt----a~elL~hp~f~~~~~~ 399 (469)
|+++|.+||++|.. |+||-+||||+....+
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 99999999999999 9999999999975443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=366.36 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=209.0
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.++..++|+||+++++++... ..+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence 378899999999999999999999999999998654221 22234577899999999999999998887664 357999
Q ss_pred Eecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+.+ ++...+.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... .
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 999996 45444433 2346899999999999999999999999999999999999999999999999999865322 2
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-------------- 221 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------------
Confidence 2345678999999998875 4689999999999999999999999987655433333322111110
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 396 (469)
......++..+.+||.+||+.||.+||+ ++++++||||...
T Consensus 222 --------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 222 --------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred --------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 1223457889999999999999999997 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=374.59 Aligned_cols=262 Identities=29% Similarity=0.473 Sum_probs=214.8
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++++.||.|+||.||+|++..+++.||||++..... .......+.+|+.++..++||||+++++++... ..+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEEEE
Confidence 469999999999999999999999999999999975422 223446688999999999999999999888764 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999998754444444455799999999999999999999999999999999999999999999999999986532 2
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
....+||+.|+|||++.+. .++.++|||||||++|||++|.+||...+..+....+........
T Consensus 155 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 218 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------------- 218 (333)
T ss_pred cCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------------
Confidence 3456799999999988764 689999999999999999999999998877666655432111000
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+........+++++.+||.+||..+|.+||++.++++||||...
T Consensus 219 ---~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 219 ---RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred ---CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 011111113568899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=370.65 Aligned_cols=273 Identities=28% Similarity=0.496 Sum_probs=237.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.+.-|++.+.||+|.|++|-+|++.-||..||||++.+...+.-....+.+|+..|+.+.|||||++|++... +..+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKly 93 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLY 93 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEE
Confidence 3567999999999999999999999999999999998776666666778899999999999999999887655 55689
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE-cCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI-DKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~ 265 (469)
||+|.-++ ++.+++.+....+.++.++.|+.||+.|+.|+|+..+|||||||+||.+ .+-|.|||+|||++..+.+..
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999886 8999998888889999999999999999999999999999999999865 678999999999999886554
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
..++.||+..|-|||++++..+..+++||||||||||-|++|++||...++.+.+..|+..-.
T Consensus 174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--------------- 236 (864)
T KOG4717|consen 174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--------------- 236 (864)
T ss_pred --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc---------------
Confidence 478899999999999999988777899999999999999999999999999999988875322
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCCCCCCCccccC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICRE 411 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~ 411 (469)
.+...++.++++||..||..||.+|.+.+++..++|++.......- .+|.+...
T Consensus 237 -----------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT-~iPLvsr~ 290 (864)
T KOG4717|consen 237 -----------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST-AIPLVSRH 290 (864)
T ss_pred -----------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc-cCceeehh
Confidence 2345678999999999999999999999999999999975433221 25554433
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=378.70 Aligned_cols=260 Identities=28% Similarity=0.480 Sum_probs=211.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++++.||.|+||+||+|++..+++.||||++.... ........+.+|+.+|..++||||+++++++.. ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 47999999999999999999999999999999997542 223344667889999999999999999988876 445799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+.+ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 79 IMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred EECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999986 55555544 457999999999999999999999999999999999999999999999999998754221100
Q ss_pred -------------------------------------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCC
Q 036673 268 -------------------------------------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGR 310 (469)
Q Consensus 268 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~ 310 (469)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCC
Confidence 0113479999999998865 45899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC---HHHH
Q 036673 311 PLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT---AASA 387 (469)
Q Consensus 311 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~el 387 (469)
+||...+..+....+....... .+. ....+++++.+||.+||. ||.+|++ +.++
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~-----------------~~~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETL-----------------QFP-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCcc-----------------CCC-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 9999888776665554311000 000 011468899999999997 9999998 9999
Q ss_pred hcCccCCCC
Q 036673 388 LQNEFFNAS 396 (469)
Q Consensus 388 L~hp~f~~~ 396 (469)
|+||||+..
T Consensus 294 l~h~~~~~~ 302 (364)
T cd05599 294 KSHPFFKGV 302 (364)
T ss_pred hcCCCcCCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=377.28 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=209.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.++..++||||+++++.+.+. ..+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEE
Confidence 47999999999999999999999999999999997532 2233446788899999999999999998887764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC-
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK- 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 266 (469)
||||+++ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 79 IMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999987 55555544 45799999999999999999999999999999999999999999999999999975432110
Q ss_pred ---------------------------------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCC
Q 036673 267 ---------------------------------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLM 313 (469)
Q Consensus 267 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf 313 (469)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 01124589999999998876 45899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCC---CCCCHHHHhcC
Q 036673 314 PGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPA---YRGTAASALQN 390 (469)
Q Consensus 314 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~---~Rpta~elL~h 390 (469)
.+.+..+....+....... .+.+ ...+++++.+||.+|+. +|. .||+++|+++|
T Consensus 237 ~~~~~~~~~~~i~~~~~~~-----------------~~p~-----~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETYKKVMNWKETL-----------------IFPP-----EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHHHHHHcCcCcc-----------------cCCC-----cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 9888777766664321110 0000 12367899999999876 455 45899999999
Q ss_pred ccCCCC
Q 036673 391 EFFNAS 396 (469)
Q Consensus 391 p~f~~~ 396 (469)
|||+..
T Consensus 294 p~f~~~ 299 (363)
T cd05628 294 PFFEGV 299 (363)
T ss_pred CCCCCC
Confidence 999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=368.23 Aligned_cols=274 Identities=37% Similarity=0.656 Sum_probs=215.7
Q ss_pred ceeeeeCCeEEEEEEECC--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
.+||+|+||+||+|+... ++..||+|.+..... ...+.+|+.+|+.++||||+++++++.......+++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 579999999999999764 568999998864322 23567899999999999999999998776677789999999
Q ss_pred hhhHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----cCCCcEEEeeecCcccc
Q 036673 194 QSDLTKIICR--------PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFF 261 (469)
Q Consensus 194 ~~~l~~~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~~ 261 (469)
++++...+.. ....+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9988776632 12358999999999999999999999999999999999999 56679999999999876
Q ss_pred cCCCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHhC
Q 036673 262 IPKQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---------VEQLHRIFKLCG 330 (469)
Q Consensus 262 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---------~~~~~~i~~~~~ 330 (469)
..... .......+|+.|+|||++.+...++.++|||||||++|||+||.+||....+ ..++..++..++
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43221 1234567899999999987766689999999999999999999999975432 355677778888
Q ss_pred CCCHHHHhhcccCccCCC-------CCC-CCc----chhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 331 TPSEDYWKKMKLTTTFRP-------QHY-KPS----FREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~-------~~~-~~~----~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.+....|+.......+.. ..+ ... +.......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888777766543221110 000 011 111122346678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=374.94 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=211.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCC-cEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTG-KIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
..++|++.+.||.|+||.||+|.+..++ ..||+|++.... ........+.+|+.++..++||||+++++++... ..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CE
Confidence 4578999999999999999999876654 689999986532 2233446788999999999999999999988774 45
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+|+||||+.+ +|...+ .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 7999999986 455544 4445799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+.....
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-------------- 245 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-------------- 245 (340)
T ss_pred ---CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 2345679999999999876 4578999999999999999999999998877666665543110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.....+++.+.+||++||+.||++|+ |+.++++||||...
T Consensus 246 ------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 246 ------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 11234678899999999999999995 89999999999863
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=373.08 Aligned_cols=262 Identities=27% Similarity=0.426 Sum_probs=215.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|.+.+.||+|+||+||+|++..+++.||||+++.... .......+.+|+.++..++||||+++++++... ..+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEE
Confidence 469999999999999999999999999999999975422 233456788999999999999999998887663 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+++ +|...+......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999986 666666555467999999999999999999999999999999999999999999999999999876433332
Q ss_pred CcccccccCccccchhccC-----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 268 PLTSRVVTLWYRAPELLLG-----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
......||+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+..+.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 228 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL---------- 228 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc----------
Confidence 3344578999999998763 3457889999999999999999999998887776666554321000
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+ .....++..+.+||.+||+ ||.+|||+.++++||||...
T Consensus 229 -------~~-----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 229 -------KF-----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred -------CC-----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 00 0112468899999999998 99999999999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=377.31 Aligned_cols=260 Identities=28% Similarity=0.413 Sum_probs=207.8
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.++..++||||+++++++... ..+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEE
Confidence 5899999999999999999999999999999997542 2334456788999999999999999999888764 457999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC--
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK-- 266 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 266 (469)
|||+++ +|...+. ....+++..++.++.||+.||+|||+.||+||||||+||||+.++.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 80 MDYIPGGDMMSLLI-RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred EecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999987 5555544 345799999999999999999999999999999999999999999999999999754311000
Q ss_pred --------------------------------------------CCcccccccCccccchhccCCCCCCccccchhhHHH
Q 036673 267 --------------------------------------------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCL 302 (469)
Q Consensus 267 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~ 302 (469)
......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhH
Confidence 01124579999999998875 458999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHcccc--CCCC
Q 036673 303 LAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLAL--DPAY 380 (469)
Q Consensus 303 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~--dP~~ 380 (469)
+|||++|.+||...+..+....+........ . .....+++++.+||.+||+. +|..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------~-----~~~~~~s~~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLH-----------------I-----PPQVKLSPEAVDLITKLCCSAEERLG 295 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccC-----------------C-----CCCCCCCHHHHHHHHHHccCcccccC
Confidence 9999999999988776665554432111000 0 01224688999999996654 4555
Q ss_pred CCCHHHHhcCccCCCC
Q 036673 381 RGTAASALQNEFFNAS 396 (469)
Q Consensus 381 Rpta~elL~hp~f~~~ 396 (469)
|+++.++++||||...
T Consensus 296 R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 296 RNGADDIKAHPFFSEV 311 (381)
T ss_pred CCCHHHHhcCcccCCC
Confidence 9999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=372.35 Aligned_cols=261 Identities=27% Similarity=0.460 Sum_probs=207.0
Q ss_pred CcceeceeeeeCCeEEEEEEEC---CCCcEEEEEEeecCC--CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecccc
Q 036673 111 SYDKLAKVGQGTYSNVYKARDR---DTGKIVALKKVRFDT--SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 184 (469)
+|++++.||+|+||+||+++.. .+++.||+|++.... ......+.+..|+.++..+ .||||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence 4899999999999999999874 468999999986432 1223346678899999999 599999998877653 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+++||||+.+ ++...+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 57999999997 55555543 45699999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.........+||+.|+|||++.+...++.++|||||||++|||++|..||...........+......
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------ 225 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------------ 225 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------------
Confidence 44333445689999999999876556789999999999999999999999754322111111111000
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
..+ .+...+++.+.+||.+||+.||++|| +++++++||||+..
T Consensus 226 -------~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 226 -------CDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred -------CCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 000 12235788999999999999999999 88899999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=358.89 Aligned_cols=282 Identities=40% Similarity=0.736 Sum_probs=235.9
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++.. ...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 5899999999999999999999889999999997665444455778899999999999999999998876 44579999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
||+.+++...+......+++.+++.++.||+.||+|||+.+|+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99966787777665667999999999999999999999999999999999999999999999999999876433322234
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC---
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR--- 347 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--- 347 (469)
...++..|+|||++.+...++.++|||||||++|+|++|.+||.+..+...+..+....+.+....|..........
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 56789999999988766667899999999999999999999999999989999988888888776665533221111
Q ss_pred -CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 348 -PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 348 -~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
+......+....+..+.++.+||.+||..||.+|||++++|+||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 11111223455567789999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=378.27 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=209.3
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+|+++++||+|+||+||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++.+... ..+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEEE
Confidence 5899999999999999999999999999999986532 2233456788999999999999999999888764 457999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC---
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ--- 265 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 265 (469)
||||++ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 80 MDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999987 55555544 4568999999999999999999999999999999999999999999999999975321000
Q ss_pred -------------------------------------------CCCcccccccCccccchhccCCCCCCccccchhhHHH
Q 036673 266 -------------------------------------------KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCL 302 (469)
Q Consensus 266 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~ 302 (469)
.......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHH
Confidence 001123578999999998876 458999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC
Q 036673 303 LAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG 382 (469)
Q Consensus 303 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 382 (469)
||||++|++||.+.+..+....+........ . .....+++++.+||.+|+ .||.+|+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------~----p~~~~~s~~~~~li~~l~-~~p~~R~ 294 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLH------------------I----PPQAKLSPEASDLIIKLC-RGPEDRL 294 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcC------------------C----CCcccCCHHHHHHHHHHc-cCHhHcC
Confidence 9999999999998877666555543111000 0 112356889999999976 5999999
Q ss_pred C---HHHHhcCccCCCC
Q 036673 383 T---AASALQNEFFNAS 396 (469)
Q Consensus 383 t---a~elL~hp~f~~~ 396 (469)
+ +.++++||||+..
T Consensus 295 ~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 295 GKNGADEIKAHPFFKTI 311 (382)
T ss_pred CCCCHHHHhcCCCcCCc
Confidence 7 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=375.16 Aligned_cols=260 Identities=31% Similarity=0.514 Sum_probs=213.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||+|+||+||+|++..+++.||||++..... .......+..|+.++..++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 479999999999999999999999999999999975422 22344678899999999999999999888766 445799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC--
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ-- 265 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 265 (469)
||||+.+ +|...+... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999986 555555544 579999999999999999999999999999999999999999999999999998654332
Q ss_pred --------------------------CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChH
Q 036673 266 --------------------------KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV 319 (469)
Q Consensus 266 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~ 319 (469)
........||+.|+|||++.+. .++.++|||||||+||+|++|+.||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 1123456789999999988764 6899999999999999999999999988876
Q ss_pred HHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-HHHHhcCccCCCC
Q 036673 320 EQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-AASALQNEFFNAS 396 (469)
Q Consensus 320 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-a~elL~hp~f~~~ 396 (469)
+....+....... . . .....+++.+.+||.+||. ||.+|++ +.++|+||||+..
T Consensus 237 ~~~~~i~~~~~~~--------------~----~----p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 237 ETYNKIINWKESL--------------R----F----PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHHhccCCcc--------------c----C----CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 6665554311100 0 0 0012268899999999998 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=367.55 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=205.2
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchhh
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSD 196 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~~ 196 (469)
||+|+||+||+|++..+++.||+|++.... ........+.+|+.+|.+++||||+++++++... ..+|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCCC
Confidence 699999999999999999999999986432 2233446678899999999999999998887764 4579999999974
Q ss_pred -HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccccc
Q 036673 197 -LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVT 275 (469)
Q Consensus 197 -l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 275 (469)
|...+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 79 ~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt 156 (312)
T cd05585 79 ELFHHLQ-REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGT 156 (312)
T ss_pred cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccccCC
Confidence 445544 3457999999999999999999999999999999999999999999999999999754222 2223456799
Q ss_pred CccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcc
Q 036673 276 LWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSF 355 (469)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (469)
+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-------------------------- 209 (312)
T cd05585 157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-------------------------- 209 (312)
T ss_pred cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--------------------------
Confidence 99999998876 458999999999999999999999998877666555443210
Q ss_pred hhcccCCChhHHHHHHHccccCCCCCC---CHHHHhcCccCCCC
Q 036673 356 REVFGEFPPSSYGILTTLLALDPAYRG---TAASALQNEFFNAS 396 (469)
Q Consensus 356 ~~~~~~~~~~l~~li~~~L~~dP~~Rp---ta~elL~hp~f~~~ 396 (469)
..+...+++.+.+||.+||..||.+|| ++.++|+||||...
T Consensus 210 ~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 210 LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 012345788999999999999999997 58999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=369.37 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=205.7
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
+.||+|+||.||++++..+++.||||++.... ........+.+|+.+|+.++||||+++++++... ..+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCCC
Confidence 35999999999999999999999999997542 2233456778999999999999999998877664 45799999999
Q ss_pred hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccc
Q 036673 195 SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274 (469)
Q Consensus 195 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 274 (469)
++.+.........+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 7544444444457999999999999999999999999999999999999999999999999998753222 222345679
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCc
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPS 354 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (469)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~------------------------- 211 (328)
T cd05593 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED------------------------- 211 (328)
T ss_pred CcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-------------------------
Confidence 999999998865 458999999999999999999999998776655544432100
Q ss_pred chhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 355 FREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 355 ~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
..+...+++++.+||.+||+.||.+|+ ++.++++||||...
T Consensus 212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 212 -IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 012335788999999999999999997 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=375.34 Aligned_cols=265 Identities=24% Similarity=0.383 Sum_probs=215.3
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
....++|++.+.||+|+||+||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~ 116 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DK 116 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 345678999999999999999999999999999999996432 122333557789999999999999999887766 44
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+|+||||+++ +|...+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 57999999986 55554433 3589999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCcccccccCccccchhccCC---CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGS---TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.........+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+....+..+.......
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 266 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL-------- 266 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC--------
Confidence 322233456799999999988653 247889999999999999999999999888776666654311100
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCC--CCCHHHHhcCccCCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAY--RGTAASALQNEFFNAS 396 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rpta~elL~hp~f~~~ 396 (469)
.+ .....++.++.+||.+||+.+|.+ |+|++++++||||+..
T Consensus 267 -------------~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 267 -------------TF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred -------------CC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 00 011246889999999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.41 Aligned_cols=288 Identities=41% Similarity=0.738 Sum_probs=235.7
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE---PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
+|++.+.||.|+||.||+|.+..+++.||||.+...... ......+..|+.++..++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488899999999999999999988999999999765332 3334567789999999999999999998877 44679
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+.++|...+......+++..+..++.||+.||+|||++||+|+||+|+|||++.++.++|+|||++....... .
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence 999999777777775544479999999999999999999999999999999999999999999999999998653322 2
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+.++.+.+.++....+.+....|........+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 23344568899999988665668899999999999999999999999988888888888887777776665433222211
Q ss_pred C--CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCC
Q 036673 348 P--QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACD 401 (469)
Q Consensus 348 ~--~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~ 401 (469)
. ..........+..++..+.+||.+||.+||.+|||+.++|+|+||...+.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 1 11122234455667889999999999999999999999999999999776653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=377.09 Aligned_cols=260 Identities=28% Similarity=0.471 Sum_probs=208.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++++.||.|+||+||+|.+..+++.||||++.... ........+.+|+.++..++||||+++++++... ..+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeEE
Confidence 47999999999999999999999999999999986532 1233456788999999999999999999888764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+++ +|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 79 v~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 79 IMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999986 5555554 4457999999999999999999999999999999999999999999999999999643110000
Q ss_pred ----------------------------------------------CcccccccCccccchhccCCCCCCccccchhhHH
Q 036673 268 ----------------------------------------------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGC 301 (469)
Q Consensus 268 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv 301 (469)
.....+||+.|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecch
Confidence 0013579999999998875 45899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCC
Q 036673 302 LLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR 381 (469)
Q Consensus 302 ~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 381 (469)
+||||++|.+||.+.+..+.+..+....... .+ + -...++.++.+||.+||+ +|.+|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------~~-p----~~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETL-----------------YF-P----DDIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCcc-----------------CC-C----CCCCCCHHHHHHHHHHhc-CHhhc
Confidence 9999999999998887766666554311000 00 0 012467899999999998 77765
Q ss_pred ---CCHHHHhcCccCCCC
Q 036673 382 ---GTAASALQNEFFNAS 396 (469)
Q Consensus 382 ---pta~elL~hp~f~~~ 396 (469)
+|+.++|+||||+..
T Consensus 294 ~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 294 LGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 599999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=376.16 Aligned_cols=260 Identities=28% Similarity=0.413 Sum_probs=208.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+|..++||||+++++.+... ..+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEE
Confidence 36999999999999999999999999999999986432 1223346678999999999999999999888764 46799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC--
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ-- 265 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 265 (469)
||||+++ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 79 v~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 79 VMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999987 55555544 4578999999999999999999999999999999999999999999999999985321000
Q ss_pred ----------------------------------------CCCcccccccCccccchhccCCCCCCccccchhhHHHHHH
Q 036673 266 ----------------------------------------KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAE 305 (469)
Q Consensus 266 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~e 305 (469)
.......+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeee
Confidence 001123579999999998865 458999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC---
Q 036673 306 MFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG--- 382 (469)
Q Consensus 306 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp--- 382 (469)
|++|++||.+.+..+....+....... . ......+++++.+||.+|+ .+|.+|+
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------~-~~~~~~~s~~~~~li~~l~-~~p~~R~~~~ 293 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTL---------------------H-IPSQAKLSREASDLILRLC-CGAEDRLGKN 293 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccc---------------------c-CCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence 999999999887766655443211000 0 0112357889999999976 5999999
Q ss_pred CHHHHhcCccCCCC
Q 036673 383 TAASALQNEFFNAS 396 (469)
Q Consensus 383 ta~elL~hp~f~~~ 396 (469)
|+.++++||||+..
T Consensus 294 t~~ell~h~~~~~~ 307 (376)
T cd05598 294 GADEIKAHPFFKGI 307 (376)
T ss_pred CHHHHhCCCCcCCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=373.97 Aligned_cols=266 Identities=25% Similarity=0.391 Sum_probs=214.8
Q ss_pred CCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
+....++|++.+.||+|+||.||++++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~ 115 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--D 115 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 3455688999999999999999999999999999999986431 222334567899999999999999999988776 4
Q ss_pred cEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
..+|+||||+++ +|...+.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|..+.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 467999999986 55555533 358999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccCccccchhccCCC---CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGST---DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
..........+||+.|+|||++.+.. .++.++|||||||+||+|++|++||.+.+....+..+........
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 267 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN------ 267 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC------
Confidence 33222334668999999999886532 378899999999999999999999998887776666543211110
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCC--CCCHHHHhcCccCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAY--RGTAASALQNEFFNAS 396 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rpta~elL~hp~f~~~ 396 (469)
+ .....++..+.+||.+||..+|.+ |+|+.++++||||+..
T Consensus 268 -----------~-----p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 268 -----------F-----PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred -----------C-----CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0 001246888999999999865544 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=355.38 Aligned_cols=281 Identities=33% Similarity=0.627 Sum_probs=225.8
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++... ..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEEE
Confidence 479999999999999999999998999999999875443333345678999999999999999999988764 357999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||++++++..+......+++..++.++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999988777766556799999999999999999999999999999999999999999999999999987533221 22
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc-----
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT----- 344 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~----- 344 (469)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+....+..............
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 345678899999998765668899999999999999999999999888877777766655443332211111100
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
..........+....+.++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0111111223334456778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.90 Aligned_cols=284 Identities=42% Similarity=0.767 Sum_probs=234.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||.|+||.||+|.+..+++.+|+|.++...........+.+|+.++.+++||||+++++++.......+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 36799999999999999999999989999999999765443333456678999999999999999999887765567899
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+.+++...+......+++..++.++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++..+.... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99999998877776655579999999999999999999999999999999999999999999999999998654322 22
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.++...++.+....|...........
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 33456789999999887656678999999999999999999999999999999999998888888777765433222111
Q ss_pred C----CCCCcchhcccC--CChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 Q----HYKPSFREVFGE--FPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 ~----~~~~~~~~~~~~--~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
. .....+...++. +++.+.+||++||+.||++|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 001111222232 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=365.65 Aligned_cols=264 Identities=23% Similarity=0.387 Sum_probs=212.8
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++++.||+|+||+||++++..+++.||||++.... ......+.+.+|+.++..++|+||+++++++... ..+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEE
Confidence 47999999999999999999999999999999996421 2223346688999999999999999999887764 46799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+.+ +|..++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999976 666666555567999999999999999999999999999999999999999999999999999765433322
Q ss_pred CcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 268 PLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------ 226 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH------------ 226 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc------------
Confidence 2334578999999998863 245788999999999999999999999887776666555321100
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCC--CCCHHHHhcCccCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAY--RGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rpta~elL~hp~f~~~ 396 (469)
..+......+++.+.+||++||+.++.+ |+++.++|+||||...
T Consensus 227 ---------~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 227 ---------FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ---------ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 0011112347889999999999765544 7899999999999763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=367.58 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=206.7
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
+.||+|+||.||++++..+|..||+|++.... ........+.+|+.+++.++||||+++++++... ..+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCCC
Confidence 35999999999999999999999999997542 1233446677899999999999999998888764 45799999999
Q ss_pred hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccc
Q 036673 195 SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274 (469)
Q Consensus 195 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 274 (469)
++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccC
Confidence 7544444444457999999999999999999999999999999999999999999999999998753222 222345678
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCc
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPS 354 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (469)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~------------------------ 212 (323)
T cd05595 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------------ 212 (323)
T ss_pred CcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------------------
Confidence 999999998865 4589999999999999999999999988776665554432100
Q ss_pred chhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 355 FREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 355 ~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.+...+++++.+||.+||+.||.+|+ ++.++++|+||...
T Consensus 213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 12235788999999999999999998 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=361.47 Aligned_cols=285 Identities=46% Similarity=0.806 Sum_probs=234.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc------
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM------ 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 182 (469)
.++|++.++||.|+||.||+|.+..+++.||||++............+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999999999999998755333222345678999999999999999998775533
Q ss_pred ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 183 QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 183 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
...+++||||+.+++...+......+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 23579999999998888877666679999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCC----------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 036673 263 PKQKG----------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTP 332 (469)
Q Consensus 263 ~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~ 332 (469)
..... ..+...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......++..++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 22211 12334668899999988765668899999999999999999999999999998888888888877
Q ss_pred CHHHHhhcccCccCC----CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 333 SEDYWKKMKLTTTFR----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 333 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
....|.......... .....+.+...+..++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 766555433222211 1223334444556677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=358.19 Aligned_cols=280 Identities=42% Similarity=0.765 Sum_probs=230.0
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++++.||.|+||.||+|.+..+++.||||++............+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEEEe
Confidence 48899999999999999999999999999999876544444446788999999999999999999988764 4579999
Q ss_pred ecchhhHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 191 DFMQSDLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 191 e~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
||+.+++...+... ...+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.+||+|||++..+.... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 99988777766543 3568999999999999999999999999999999999999999999999999987653222 222
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC---
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF--- 346 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--- 346 (469)
....+++.|+|||++.+...++.++|||||||++|+|+||+.||...++.+.+.+++...+.+....|........+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 34456889999998876666788999999999999999999999999988888888888888877666543221111
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.+......+....+.+++++.+||.+||+.||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01111223334455688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=364.75 Aligned_cols=279 Identities=26% Similarity=0.400 Sum_probs=212.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||.||++++..++..||+|++.... .......+.+|+++|+.++||||+++++++.... .+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEEE
Confidence 478999999999999999999999999999999997542 3445577899999999999999999999887643 5799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||++++.+..+......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999744444444445699999999999999999999986 6999999999999999999999999999765322
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC-cc-
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT-TT- 345 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~- 345 (469)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...........+...... ..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2345678999999998876 45899999999999999999999999876654432221110000000000000000 00
Q ss_pred ---C-------CC------------CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 ---F-------RP------------QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ---~-------~~------------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. .+ ....+. .....+++++.+||.+||++||++|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0 00 000000 0012467899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=369.75 Aligned_cols=259 Identities=25% Similarity=0.458 Sum_probs=229.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|..+++||+|+||.+++++++..+..|++|.+..........+...+|+.+++++.|||||.+.+.+...+. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~-~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ-LLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc-eEEE
Confidence 368999999999999999999999999999999998876666666678899999999999999999999887543 3799
Q ss_pred EEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||+||+| ++.+.+.+.+ ..|+++.+..|+.||+.||.|||+++|+|||||+.||+++.++.|||+|||+|+.+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999997 5566665544 579999999999999999999999999999999999999999999999999999886543
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
....+.+|||.||+||++.+ .+|+.++|||||||++|||++=+++|.+.+-...+.+|......|
T Consensus 161 ~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P-------------- 225 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP-------------- 225 (426)
T ss_pred hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC--------------
Confidence 34668899999999998876 679999999999999999999999999999999999998765443
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
+...++.++..||..||..+|..||+|.++|.+|.+..
T Consensus 226 -----------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 226 -----------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -----------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 23456889999999999999999999999999999874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=366.17 Aligned_cols=283 Identities=31% Similarity=0.538 Sum_probs=230.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----cc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----QY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~ 184 (469)
.++|++.+.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 47899999999999999999999999999999998654444445566788999999999999999999876432 23
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
..|+||||+.+++...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 5799999999988877654 2899999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+...++.|..+++.......
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred --CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 22344567899999998876 458999999999999999999999999999888899998888988877766543211
Q ss_pred c--------CCCC---------CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 345 T--------FRPQ---------HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 345 ~--------~~~~---------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. .... .+...........+..+.+||.+||+.||.+|||+.|+|+||||+.+-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 0 0000 000000111223466789999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=353.09 Aligned_cols=278 Identities=38% Similarity=0.645 Sum_probs=227.4
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEEEEE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
|++++.||+|+||.||+|.+..+++.||+|+++........ ....+|+.++.++. |+||+++++++.+.....+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999999999999999998754333222 23457999999885 99999999998876446789999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
||+.++++..+......+++..+..++.||+.||.|||+.+|+||||+|+||+++. +.+||+|||++...... ....
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--PPYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--CCcC
Confidence 99999988888765567999999999999999999999999999999999999999 99999999999865322 2223
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC---
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR--- 347 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--- 347 (469)
...+++.|+|||++.....++.++|||||||++|||++|.+||.+.+..+.+..+....+.+...............
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 45678999999987655567899999999999999999999999999888888888888887776543332221110
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
+......+......++.++.+||.+||..||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111122333445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=355.35 Aligned_cols=281 Identities=38% Similarity=0.737 Sum_probs=227.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||.|+||.||+|.++.+++.||||.+...... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeEEE
Confidence 47899999999999999999999988999999998754322 1223466899999999999999999988764 46799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+.+++...+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 99999998888877666679999999999999999999999999999999999999999999999999987542211 11
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT-EVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.... ..+.+..+.+..+.+....|........+.
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2234568899999988765668899999999999999999999998766 566777788888888777776654332221
Q ss_pred CCCC----CCcchhcccCCC--hhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 348 PQHY----KPSFREVFGEFP--PSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 348 ~~~~----~~~~~~~~~~~~--~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.... ...+......++ ..+.+||.+||+.||.+|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1111 112223333455 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=358.82 Aligned_cols=287 Identities=43% Similarity=0.712 Sum_probs=227.7
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc---
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ--- 183 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--- 183 (469)
...++|++.++||+|+||.||+|.+..+++.||||.+............+.+|+.++++++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34578999999999999999999999999999999987543333333456689999999999999999998765432
Q ss_pred ---cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 184 ---YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 184 ---~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
...++||||+.+++...+......+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 89 RYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 35699999999988888776666799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCC---CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 036673 261 FIPKQKG---PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 261 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 337 (469)
+...... ......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+...++..+...+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 5332221 2234567889999998876556788999999999999999999999998888888877777777666655
Q ss_pred hhcccCccCCCCCCCC----cc-hhc-ccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 338 KKMKLTTTFRPQHYKP----SF-REV-FGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~----~~-~~~-~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
........+....... .. ... ....+..+.+||.+||..||.+|||++++|+||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 4432211111000000 00 011 11235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=365.91 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=205.3
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
+.||+|+||+||++.+..+++.||+|++.... ........+.+|+.++..++||||+++++++... ..+||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCCC
Confidence 35999999999999999999999999997542 2223446677899999999999999998877664 45799999999
Q ss_pred hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 195 SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 195 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
++.+.........+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 75444444445579999999999999999999997 79999999999999999999999999998753222 22234567
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (325)
T cd05594 158 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----------------------- 213 (325)
T ss_pred CCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 9999999998865 4589999999999999999999999988776555544322100
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.+...+++++.+||.+||+.||.+|+ ++.++|+||||...
T Consensus 214 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 214 ---RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 11234688999999999999999997 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=362.83 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=208.3
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCC-CeeeEeeeEeeccccEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHP-NVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~~~l 188 (469)
+|++++.||+|+||.||+|.+..+++.||||++.... ......+.+..|+.++..+.|+ +|+.+++++... ..+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 5899999999999999999999999999999997542 1233446678899999999765 577887777653 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+++ +|...+ .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 v~E~~~~g~L~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05587 79 VMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GK 156 (324)
T ss_pred EEcCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CC
Confidence 9999987 454444 44457999999999999999999999999999999999999999999999999998753221 12
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----------------- 218 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----------------- 218 (324)
T ss_pred ceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 2345678999999998876 4589999999999999999999999998887766665543110
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH-----HHHhcCccCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA-----ASALQNEFFNA 395 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta-----~elL~hp~f~~ 395 (469)
.+...++.++.+||.+||..||.+|+++ .++++||||..
T Consensus 219 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 219 ---------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 1123468899999999999999999986 89999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=356.86 Aligned_cols=285 Identities=41% Similarity=0.811 Sum_probs=234.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc------
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM------ 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 182 (469)
.++|++.+.||.|+||+||+|.+..+++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 47899999999999999999999999999999999765433333456778999999999999999999886643
Q ss_pred --ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 183 --QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 183 --~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
...+++|+||+++++...+......+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 236899999999988877766555799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
+............++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence 64333222333456889999998876556789999999999999999999999998888888888888888777665544
Q ss_pred ccCccCCC----CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 341 KLTTTFRP----QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 341 ~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.....+.. ..........+..++..+.+||.+||..||.+|||+.++|.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 32221111 111222334455678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=362.31 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=207.0
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHH---HhCCCCCeeeEeeeEeeccccEEE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRIL---QKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
|++++.||+|+||.||+|.+..+++.||||+++... ......+.+.+|+.++ ..++||||+++++++... ..+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEEE
Confidence 788999999999999999999999999999997542 1223345566676665 566899999999988764 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+.++.+...... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GD 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CC
Confidence 99999997544443332 46999999999999999999999999999999999999999999999999998753222 22
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~----------------- 218 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV----------------- 218 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence 2345679999999998875 4589999999999999999999999998877766665543110
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.....++..+.+||.+||+.||.+|| ++.++++||||+..
T Consensus 219 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 219 ---------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 11234688899999999999999999 79999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=355.84 Aligned_cols=284 Identities=44% Similarity=0.793 Sum_probs=229.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccc---cE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQ---YS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~---~~ 185 (469)
++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.++..+. ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998765433333456788999999995 6999999988765432 23
Q ss_pred EEEEEecchhhHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-CCcEEEeeecCccc
Q 036673 186 LYLVFDFMQSDLTKIICRP----GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-SGMLKIADFGLSNF 260 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 260 (469)
+|+||||+++++...+... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 6999999999887776542 245899999999999999999999999999999999999998 88999999999976
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
+.... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....|...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 53221 22234467889999998876566889999999999999999999999999998888888888777776665443
Q ss_pred ccCccCC--CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 341 KLTTTFR--PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 341 ~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
.....+. +......+....+.++.++.+||.+||..||.+|||+.++|.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 2221110 11111223344556899999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=363.10 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=204.9
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|+++.+++.||||++.... ........+..|+.++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence 35999999999999999999999999987532 1223345677899998877 799999999887664 4579999999
Q ss_pred hh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccc
Q 036673 194 QS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272 (469)
Q Consensus 194 ~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 272 (469)
++ +|...+ .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 79 ~~g~L~~~i-~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 156 (320)
T cd05590 79 NGGDLMFHI-QKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTF 156 (320)
T ss_pred CCchHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccccc
Confidence 97 554444 44457999999999999999999999999999999999999999999999999998753222 2223456
Q ss_pred cccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCC
Q 036673 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352 (469)
Q Consensus 273 ~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (469)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---------------------- 213 (320)
T cd05590 157 CGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------------------- 213 (320)
T ss_pred ccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----------------------
Confidence 79999999998865 4589999999999999999999999998887776665542110
Q ss_pred CcchhcccCCChhHHHHHHHccccCCCCCCCH------HHHhcCccCCC
Q 036673 353 PSFREVFGEFPPSSYGILTTLLALDPAYRGTA------ASALQNEFFNA 395 (469)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta------~elL~hp~f~~ 395 (469)
.....++.++.+||.+||+.||.+|+++ .++++||||+.
T Consensus 214 ----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 214 ----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 1122467899999999999999999998 99999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=369.37 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=209.6
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++++.||+|+||+||+|.+..+++.||||++.... ........+..|+.++..++||||+++++.+.. ...+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 46999999999999999999999999999999997432 223345678889999999999999999888766 445799
Q ss_pred EEecchhh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC-
Q 036673 189 VFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK- 266 (469)
Q Consensus 189 v~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 266 (469)
||||++++ |...+. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 79 IMEFLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999974 555444 445799999999999999999999999999999999999999999999999999875422110
Q ss_pred ---------------------------------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCC
Q 036673 267 ---------------------------------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLM 313 (469)
Q Consensus 267 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf 313 (469)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCC
Confidence 01124579999999998876 45899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC---HHHHhcC
Q 036673 314 PGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT---AASALQN 390 (469)
Q Consensus 314 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~h 390 (469)
.+.+..+....+....... .+.+ ...++.++.+||.+|+ .||.+|++ +.++++|
T Consensus 237 ~~~~~~~~~~~i~~~~~~~-----------------~~p~-----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQETYRKVMNWKETL-----------------VFPP-----EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHHHHHHHcCCCce-----------------ecCC-----CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9887776666554211000 0000 1236789999999977 49999984 7999999
Q ss_pred ccCCCC
Q 036673 391 EFFNAS 396 (469)
Q Consensus 391 p~f~~~ 396 (469)
|||+..
T Consensus 294 p~f~~~ 299 (360)
T cd05627 294 PFFEGV 299 (360)
T ss_pred CCCCCC
Confidence 999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=367.76 Aligned_cols=267 Identities=25% Similarity=0.390 Sum_probs=214.2
Q ss_pred CCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.....++|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.++..++||||+++++.+.. .
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~ 115 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--D 115 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--C
Confidence 3445689999999999999999999999999999999986432 222334567889999999999999999988766 4
Q ss_pred cEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
..+|+||||+++ +|...+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 467999999986 55555433 358999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccCccccchhccCCC---CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGST---DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
..........+||+.|+|||++.+.. .++.++|||||||++|||++|.+||.+.+.......+........
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 267 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT------ 267 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc------
Confidence 33322334668999999999886432 378899999999999999999999998887766666543211100
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCC--CCCHHHHhcCccCCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAY--RGTAASALQNEFFNASP 397 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rpta~elL~hp~f~~~~ 397 (469)
+ .....++..+.+||..||..++.+ |+++.++++|+||+...
T Consensus 268 ---------------~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 268 ---------------F-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred ---------------C-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 0 012357889999999999844433 78999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=352.54 Aligned_cols=282 Identities=35% Similarity=0.654 Sum_probs=233.0
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||.|+||.||+|.+..+++.||||+++...........+.+|+++++.++|+||+++++++... ...++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEEEEE
Confidence 469999999999999999999999999999999876544445557788999999999999999999998773 457999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||++++++..+......+++..+..++.||+.||+|||+++|+|+||+|+||++++++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99999988877766666799999999999999999999999999999999999999999999999999987654433234
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
....++..|+|||++.+...++.++||||||+++|+|++|++||.+....+.+..+...++......+........+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 45678899999999877547899999999999999999999999988888888887777776666555544332222111
Q ss_pred CCC-----Ccchh-cccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 350 HYK-----PSFRE-VFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 350 ~~~-----~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.+. ..+.. ....++.++.+||.+||..||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 111 11111 122358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=361.38 Aligned_cols=264 Identities=22% Similarity=0.363 Sum_probs=213.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.++||+|+||+||++++..+++.||+|++.... ........+.+|+.++..++|+||+++++++... ..+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEE
Confidence 47999999999999999999999999999999986421 1223335578899999999999999998887764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+.+ +|..++.+....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999985 666676655567999999999999999999999999999999999999999999999999999765333322
Q ss_pred CcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 268 PLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.....+||+.|+|||++.. ...++.++|||||||++|||++|+.||...+..+.+..+......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------ 226 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER------------ 226 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc------------
Confidence 2334679999999998852 345789999999999999999999999988777766665431100
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCC--CCCHHHHhcCccCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAY--RGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rpta~elL~hp~f~~~ 396 (469)
..+......++.++.+||.+||+.++.+ |+++.++++||||...
T Consensus 227 ---------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 227 ---------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ---------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 0011122457899999999999776554 6899999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=375.04 Aligned_cols=265 Identities=28% Similarity=0.412 Sum_probs=222.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+.|.|+..||.|+||.||+|..+.++-..|.|+|.. ...+..+.+.-||+||..++||+||+|++.|+..+ .+||+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~en--kLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ceEEE
Confidence 458899999999999999999999999999999864 34566788999999999999999999999777744 47999
Q ss_pred EecchhhH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQSDL-TKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~~l-~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
.|||+|+- ...+..-+..|++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+..... .-..
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 99999855 444555667899999999999999999999999999999999999999999999999999865321 2223
Q ss_pred cccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 269 LTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
..+++|||+|||||++.. ..+|++++||||||++|.||..+.||....+....+-+|.+.-
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--------------- 251 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--------------- 251 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC---------------
Confidence 568899999999998743 4579999999999999999999999998888877777765421
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDL 402 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~ 402 (469)
|+-.-.....+..+.||+.+||.+||..||+++++|+||||+..+....+
T Consensus 252 --------PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~i 301 (1187)
T KOG0579|consen 252 --------PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMI 301 (1187)
T ss_pred --------CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHH
Confidence 11111123457788999999999999999999999999999976655433
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=353.63 Aligned_cols=281 Identities=34% Similarity=0.637 Sum_probs=226.0
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||.|+||.||+|.+..+++.||+|++..........+.+.+|+++++.++||||+++++++.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 46899999999999999999999889999999986544433445678899999999999999999998865 4457999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||++++++..+......+++..+..++.||+.||+|||+.+|+|+||+|+||++++++.++|+|||++..+.... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9999987776665555569999999999999999999999999999999999999999999999999998653322 223
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc-----
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT----- 344 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~----- 344 (469)
....++..|+|||++.+...++.++|||||||++|+|++|.+||......+....+....+..............
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 445688999999988765667889999999999999999999999888877777777665554332222111110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
...............+.++..+.+||.+||..||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000111122334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=361.47 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=205.3
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||.||+|++..+++.||||++.... ........+..|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence 35999999999999999999999999997542 1233445677899999876 899999999988764 3579999999
Q ss_pred hh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccc
Q 036673 194 QS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272 (469)
Q Consensus 194 ~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 272 (469)
++ +|...+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 79 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~ 156 (321)
T cd05591 79 NGGDLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTF 156 (321)
T ss_pred CCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC-Ccccccc
Confidence 97 4444443 4457999999999999999999999999999999999999999999999999998754222 2223456
Q ss_pred cccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCC
Q 036673 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352 (469)
Q Consensus 273 ~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (469)
+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+.....
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---------------------- 213 (321)
T cd05591 157 CGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---------------------- 213 (321)
T ss_pred ccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence 78999999998865 4589999999999999999999999998887777766543110
Q ss_pred CcchhcccCCChhHHHHHHHccccCCCCCC-------CHHHHhcCccCCC
Q 036673 353 PSFREVFGEFPPSSYGILTTLLALDPAYRG-------TAASALQNEFFNA 395 (469)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-------ta~elL~hp~f~~ 395 (469)
.....++.++.+||.+||+.||.+|+ ++.++++||||..
T Consensus 214 ----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 214 ----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred ----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 01123578899999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=361.21 Aligned_cols=251 Identities=27% Similarity=0.461 Sum_probs=204.4
Q ss_pred ceeeeeCCeEEEEEEEC---CCCcEEEEEEeecCC--CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 116 AKVGQGTYSNVYKARDR---DTGKIVALKKVRFDT--SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+.||+|+||.||++++. .+++.||||++.... ........+..|+.+|+.++||||+++++++... ..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 56999999999999874 468999999997532 1222335677899999999999999999888764 4579999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
||+.++.+.........+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTH 158 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Cccc
Confidence 999974444444444578999999999999999999999999999999999999999999999999987542222 2234
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
..+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+....+..+....
T Consensus 159 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--------------------- 216 (323)
T cd05584 159 TFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--------------------- 216 (323)
T ss_pred ccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence 5678999999998876 457899999999999999999999999887766665553211
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
..+...+++.+.+||.+||+.||++|| ++.++++||||...
T Consensus 217 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 217 -----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 012335678999999999999999999 89999999999863
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.77 Aligned_cols=282 Identities=38% Similarity=0.677 Sum_probs=223.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.+++|.+++.||+|+||.||+|.+..++..||||++...... .....+.+|+.+++.++|+||+++++++... ...|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~ 79 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLT 79 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--CeEE
Confidence 357899999999999999999999989999999998654322 2224567899999999999999999988764 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+.++++..+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...... ..
T Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~ 158 (291)
T cd07870 80 FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQ 158 (291)
T ss_pred EEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC-CC
Confidence 99999999888887665567889999999999999999999999999999999999999999999999999754222 11
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT-EVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||.... ..+.+..+....+.|....+........+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 22344678999999988765567889999999999999999999997654 34566666666777766665544332222
Q ss_pred CCCCC----CCcchhcccC--CChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 347 RPQHY----KPSFREVFGE--FPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 347 ~~~~~----~~~~~~~~~~--~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
..... ...+...+.. .+..+.+||.+||+.||.+|||+.|+|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 11111 1122222222 36788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=353.90 Aligned_cols=256 Identities=29% Similarity=0.513 Sum_probs=215.1
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
-|+++.+||+|+||.||+|.++.+|..+|||.+..+. ..+.+..|+.||++++.|+||++||.|.... .+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceEeeh
Confidence 4788999999999999999999999999999997653 3467889999999999999999999776643 479999
Q ss_pred ecch-hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 191 DFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 191 e~~~-~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||. |+..+.+...+.+|++.++..+++..+.||+|||...-+|||||..||||+.+|.+||+|||.|..+... ....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKR 186 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKR 186 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhh
Confidence 9999 4666666667788999999999999999999999999999999999999999999999999999876432 2234
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
.+.+|||.|||||++.. ..|+..+||||||+...||..|+|||.+-.....+ +-. +.
T Consensus 187 NTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---FMI-------------------PT 243 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---FMI-------------------PT 243 (502)
T ss_pred CccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccccccccee---Eec-------------------cC
Confidence 67899999999999975 45899999999999999999999999764443322 221 12
Q ss_pred CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
..+|.|++ ....+.++.|||++||.+.|++|.||.++++|||.+.++
T Consensus 244 ~PPPTF~K-PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 244 KPPPTFKK-PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred CCCCCCCC-hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 22233322 345678899999999999999999999999999998754
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=366.72 Aligned_cols=274 Identities=23% Similarity=0.319 Sum_probs=208.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
..+|++++.||.|+||.||+|.+..++..||+|+.... ....|+.++++++||||+++++++.... ..++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGA--ITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCC--eeEE
Confidence 35799999999999999999999999999999975422 2346999999999999999999887744 4689
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 135 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~~~ 212 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--APA 212 (357)
T ss_pred EEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc--Ccc
Confidence 999999999888877777899999999999999999999999999999999999999999999999999975322 122
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC-CCCCCCCCh---------HHHHHHHHHHhCCCCHHHHh
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTE---------VEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg-~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~ 338 (469)
.....||+.|+|||++.+ ..++.++|||||||++|||+++ .++|..... ...+..++...+..+..+..
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 345678999999998876 4589999999999999999985 444443221 22333444443333222210
Q ss_pred --------hcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 339 --------KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 339 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
............+.....-....++..+.+||.+||+.||.+||||.|+|+||||+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000000000000000000012256778899999999999999999999999999975
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=364.90 Aligned_cols=260 Identities=29% Similarity=0.417 Sum_probs=205.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|+++++||.|+||+||+|++..+++.||||++.... .......+.+|+++++.++|+||+++++++... ..++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 148 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQ 148 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEE
Confidence 3467889999999999999999999999999999986543 334456788999999999999999999988664 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+.++.+.. ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus 149 lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-D 223 (353)
T ss_pred EEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-c
Confidence 9999999855432 1246788889999999999999999999999999999999999999999999998653221 2
Q ss_pred CcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 268 PLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.....+||+.|+|||++.. ....+.++|||||||++|||++|+.||......+....+.......
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 292 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----------- 292 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----------
Confidence 2345678999999998743 1234568999999999999999999997433222211111110000
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.......++.++.+||.+||+.||++|||+.|+|+||||....
T Consensus 293 -----------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 -----------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0012335688999999999999999999999999999999753
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=351.74 Aligned_cols=282 Identities=49% Similarity=0.923 Sum_probs=234.4
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEe
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 191 (469)
|++.+.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++........++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999999998999999999865433444466889999999999999999999987753356899999
Q ss_pred cchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccc
Q 036673 192 FMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS 271 (469)
Q Consensus 192 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 271 (469)
|+++++...+......+++..+..++.||+.||+|||+.|++|+||+|+|||+++++.++|+|||++.............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99998888887665679999999999999999999999999999999999999999999999999998764443223344
Q ss_pred ccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc---CC-
Q 036673 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT---FR- 347 (469)
Q Consensus 272 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~- 347 (469)
..++..|+|||.+.+...++.++|||||||++|+|++|++||...+....+..+...++.+....|........ +.
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 56788999999877655688999999999999999999999999998888888888888887776655432211 11
Q ss_pred CCCCCCcchhcccCC-ChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 348 PQHYKPSFREVFGEF-PPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~-~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.......+....... +..+.++|.+||..||.+||++.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 111222233344444 8899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=359.37 Aligned_cols=251 Identities=29% Similarity=0.469 Sum_probs=202.1
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|++..+++.||||+++.... .....+.+..|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 359999999999999999999999999975421 223334556677777654 899999999887664 4579999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
+++.+.........+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 874444443444579999999999999999999999999999999999999999999999999997643222 2334567
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-----------------------~ 213 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-----------------------P 213 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------------C
Confidence 9999999998876 458999999999999999999999999887766665543210 0
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCH-HHHhcCccCCCC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTA-ASALQNEFFNAS 396 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta-~elL~hp~f~~~ 396 (469)
.....++.++.+||.+||+.||.+||++ .++++||||...
T Consensus 214 ---~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 214 ---HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 1123467889999999999999999986 589999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=350.99 Aligned_cols=279 Identities=42% Similarity=0.793 Sum_probs=232.3
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||.|++|+||+|++..++..||||++...... .....+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEEE
Confidence 589999999999999999999999999999999765332 22355678999999999999999999988754 469999
Q ss_pred ecchhhHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 191 DFMQSDLTKIICRPG--QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 191 e~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||+.+++...+.... ..+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NT 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cc
Confidence 999998887775533 468999999999999999999999999999999999999999999999999997653221 12
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|++||++.+...++.++|||||||++|+|++|.+||.+.+..+....++.....|....|+.+.....+..
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23456788999999887666678999999999999999999999999999999999999888888888877664333221
Q ss_pred CCC---CCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 QHY---KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 ~~~---~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
... ......+.+.++..+.++|.+||+.||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 111 112233345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=359.19 Aligned_cols=286 Identities=35% Similarity=0.603 Sum_probs=230.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc---ccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM---QYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~ 185 (469)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 478999999999999999999999999999999986432 2234466778999999999999999998775432 235
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+|+|+||+.+++...+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 799999999988776643 469999999999999999999999999999999999999999999999999997653322
Q ss_pred C--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 266 K--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 266 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+.+..+...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 12234578999999998766566899999999999999999999999998888888888888887766555443211
Q ss_pred cc---C--CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 344 TT---F--RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 344 ~~---~--~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.. . .+......+....+.++.++.+||.+||+.||.+|||+.++++||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 10 0 011111122233456788999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=373.46 Aligned_cols=275 Identities=24% Similarity=0.324 Sum_probs=210.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
...|.+.+.||.|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|+|||++++++... ...+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEE
Confidence 4579999999999999999999999999999996432 2356899999999999999999988764 34689
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC-
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG- 267 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 267 (469)
|||++.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9999999988888766567999999999999999999999999999999999999999999999999999865332221
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHHH----
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT-------EVEQLHRIFKLCGTPSEDY---- 336 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~---- 336 (469)
.....+||+.|+|||++.+ ..++.++|||||||+||||++|..++.... ...++.+++...+.....+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1234578999999998876 458999999999999999999875443221 1234444444333221111
Q ss_pred ----Hhhccc--CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 337 ----WKKMKL--TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 337 ----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
...+.. .....+..-.+.+ .....++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAW-TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcch-hhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 111000 0000111111111 112356778999999999999999999999999999975
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=360.01 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=212.6
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||+|+||+||++++..+++.||+|++.... ........+.+|+.++..++|+||+.+++++... ..+|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEE
Confidence 47999999999999999999999999999999986421 2223345678899999999999999998887764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+.| +|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999986 666666554567999999999999999999999999999999999999999999999999999866433322
Q ss_pred CcccccccCccccchhccCC----CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 268 PLTSRVVTLWYRAPELLLGS----TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||...+..+.+..+......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------ 226 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER------------ 226 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc------------
Confidence 23346799999999987642 34788999999999999999999999887776666555431100
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCC--CCCHHHHhcCccCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAY--RGTAASALQNEFFNA 395 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rpta~elL~hp~f~~ 395 (469)
..+......++.++.+||.+||+.++.+ |++++++++||||+.
T Consensus 227 ---------~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 227 ---------FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred ---------ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 0111223457889999999999976654 579999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=361.56 Aligned_cols=289 Identities=35% Similarity=0.607 Sum_probs=236.0
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec--cccEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR--MQYSLY 187 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~~~ 187 (469)
++|++.+.||.|+||.||+|.+..+++.||+|++............+.+|+.+|+.++||||+++++++... ....++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 689999999999999999999999999999999876543334456778899999999999999998877543 334689
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+.+++...+... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 85 lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 99999998887776543 46999999999999999999999999999999999999999999999999999765332211
Q ss_pred ---CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 268 ---PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 268 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....+.++...+.......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 12345789999999988665568999999999999999999999999998888888888888888777655432111
Q ss_pred cC-----CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 345 TF-----RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 345 ~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
.. .+......+....+.++.++.+||.+||+.||.+|||+.++|.||||...+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 00 01111122334456679999999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=352.26 Aligned_cols=284 Identities=40% Similarity=0.749 Sum_probs=231.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||.|++|+||+|.+..+++.||||.+............+.+|+.++++++||||+++++++... ...|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEEE
Confidence 579999999999999999999998999999999865443333446678899999999999999999988764 457999
Q ss_pred EecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-CCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-SGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+++++...+.... ..+++..+..++.||+.||+|||+++|+|+||+|+|||++. ++.+||+|||++....... .
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 9999988877765433 33688899999999999999999999999999999999985 4579999999997653221 1
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.+++...+.+....|........+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 22345678999999988765668899999999999999999999999988888888888888888887776433222111
Q ss_pred C---CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 348 P---QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 348 ~---~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. ......+....+.+++++.++|.+||+.||++||++.++|+||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 1 111122333456688999999999999999999999999999999864
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.12 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=202.1
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhCCCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIR-ILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|++..+++.||||++..... .......+..|.. +++.++||||+++++.+... ..+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcCC
Confidence 359999999999999999999999999965321 1222244455554 56789999999998887764 4579999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
.++.+.........+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCcccccc
Confidence 9754444444455799999999999999999999999999999999999999999999999999875322 222334567
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (323)
T cd05575 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------------------------ 212 (323)
T ss_pred CChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 8999999998876 458999999999999999999999999877766655553210
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCH----HHHhcCccCCCC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTA----ASALQNEFFNAS 396 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta----~elL~hp~f~~~ 396 (469)
....+.++..+.+||.+||+.||.+||++ .++++||||...
T Consensus 213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 213 --LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 01234568899999999999999999998 699999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=358.81 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=208.5
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~l 188 (469)
+|++++.||+|+||.||+|++..+++.||||++..... .......+..|..++..+ .|++|+++++++... ..+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence 58899999999999999999999999999999975422 223345567788888877 588999998877664 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+++ +|...+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 v~E~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~ 156 (323)
T cd05616 79 VMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GV 156 (323)
T ss_pred EEcCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-CC
Confidence 9999986 5554443 3456999999999999999999999999999999999999999999999999999753221 22
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....+.....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------------- 218 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----------------- 218 (323)
T ss_pred ccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence 2345678999999998875 5589999999999999999999999998887776666543210
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH-----HHHhcCccCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA-----ASALQNEFFNA 395 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta-----~elL~hp~f~~ 395 (469)
.+...++.++.+||.+||+.||.+|+++ .++++||||..
T Consensus 219 ---------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 219 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred ---------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 1123468899999999999999999984 89999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=359.69 Aligned_cols=286 Identities=36% Similarity=0.613 Sum_probs=231.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc---cE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ---YS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~ 185 (469)
.++|.+.+.||.|+||+||+|.+..+++.||||.+............+.+|+.+++.++|+||+++++++..... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999999999999999987543333344567789999999999999999998765322 34
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+|+||||+.+++...+... .++++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 7999999998887776543 579999999999999999999999999999999999999999999999999998653321
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......++..|+|||++.....++.++|||||||++|+|++|++||.+.+.......+....+.+..+.+........
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 2234557789999999887545588999999999999999999999999888888888888777776554432211100
Q ss_pred C-----CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 F-----RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~-----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. .+....+.+....+.+++.+.+||.+||+.||++|||+.++|+||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 01111223344556789999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=368.28 Aligned_cols=277 Identities=25% Similarity=0.331 Sum_probs=214.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..+|++++.||.|+||.||+|.... ++..||+|.+... ..+.+|+.+|+.|+||||+++++++... ..+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK--STV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC--CEE
Confidence 3579999999999999999997653 4678999987532 2345799999999999999999888764 457
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|+|||++.+++...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 162 ~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 999999999888877 3345799999999999999999999999999999999999999999999999999976543322
Q ss_pred C-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhh---
Q 036673 267 G-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT---EVEQLHRIFKLCGTPSEDYWKK--- 339 (469)
Q Consensus 267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~--- 339 (469)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ....+..+++.++..+..+...
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 2 2235678999999998865 458999999999999999999999997653 3455666666655443332211
Q ss_pred -----cccCcc-CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 340 -----MKLTTT-FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 340 -----~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
...... .++....+.. -....++.++.+||.+||..||.+|||+.++|.||||+..+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPV-IRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred hHHHHHHhhcccccCCccccch-hhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 111110 0110000110 00124577899999999999999999999999999998754
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=358.57 Aligned_cols=250 Identities=29% Similarity=0.435 Sum_probs=201.9
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||.||+|++..+++.||||+++.... .......+..|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCC
Confidence 359999999999999999999999999975421 112335566788888754 899999999888764 4679999999
Q ss_pred hh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccc
Q 036673 194 QS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272 (469)
Q Consensus 194 ~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 272 (469)
.+ +|...+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 79 ~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (316)
T cd05620 79 NGGDLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTF 156 (316)
T ss_pred CCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceecc
Confidence 97 4545443 3457999999999999999999999999999999999999999999999999998743211 2233456
Q ss_pred cccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCC
Q 036673 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352 (469)
Q Consensus 273 ~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (469)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+... .+
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~-------------------- 213 (316)
T cd05620 157 CGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP-------------------- 213 (316)
T ss_pred CCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC--------------------
Confidence 78999999998876 45899999999999999999999999887766555444211 00
Q ss_pred CcchhcccCCChhHHHHHHHccccCCCCCCCH-HHHhcCccCCCC
Q 036673 353 PSFREVFGEFPPSSYGILTTLLALDPAYRGTA-ASALQNEFFNAS 396 (469)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta-~elL~hp~f~~~ 396 (469)
.....++.++.+||.+||+.||.+|+++ +++++||||+..
T Consensus 214 ----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 214 ----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 1122367889999999999999999998 589999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=359.45 Aligned_cols=250 Identities=26% Similarity=0.450 Sum_probs=199.8
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||.||+|++..+++.||||+++... ........+..|+.++..+ +||||+++++++... ..+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 35999999999999999999999999997642 2233456688999999998 799999999988764 4579999999
Q ss_pred hh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccc
Q 036673 194 QS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272 (469)
Q Consensus 194 ~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 272 (469)
++ +|...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 79 ~~g~L~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~~ 156 (329)
T cd05588 79 SGGDLMFHM-QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTSTF 156 (329)
T ss_pred CCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCccccc
Confidence 97 444444 3445799999999999999999999999999999999999999999999999999874321 12233456
Q ss_pred cccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE--------VEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 273 ~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+.+...+.. .
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------~ 220 (329)
T cd05588 157 CGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------------K 220 (329)
T ss_pred cCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------------C
Confidence 89999999998876 4589999999999999999999999963211 1111111100 0
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC------HHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT------AASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt------a~elL~hp~f~~ 395 (469)
...+...++..+.+||.+||+.||.+|+| +.++++||||..
T Consensus 221 ----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 221 ----------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 00122356888999999999999999997 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=351.36 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=209.1
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.|++.+.||+|+||+||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++.+... ..+++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEE
Confidence 488999999999999999999989999999998654222 22234567899999999999999998887664 357999
Q ss_pred Eecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+.+ +|...+... ...+++..+..++.|++.||.|||+.+|+||||||+|||+++++.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--E 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--C
Confidence 999986 555454332 346999999999999999999999999999999999999999999999999999765322 2
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 220 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--------------- 220 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc---------------
Confidence 2234578999999998875 458899999999999999999999998766544433332211100
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.......++..+.+||.+||..||.+|| ++.++++||||...
T Consensus 221 -------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 221 -------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred -------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 0112345788999999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=349.54 Aligned_cols=279 Identities=45% Similarity=0.813 Sum_probs=230.0
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEe
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 191 (469)
|++.+.||.|++|.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++... ...|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEe
Confidence 6788899999999999999998999999999976543333345678899999999999999999988764 46799999
Q ss_pred cchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 192 FMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 192 ~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
|+++++...+.... ..+++..+..++.||+.||+|||+++++|+||+|+|||++.++.++|+|||++..+.... ....
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccC
Confidence 99888777765433 368999999999999999999999999999999999999999999999999997653221 1223
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC--
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP-- 348 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-- 348 (469)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..++...+.+....|........+..
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 345688999999887655678899999999999999999999999998888888888888888777655433222211
Q ss_pred -CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 -QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 -~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.............++..+.+||.+||+.||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 111223344456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=355.58 Aligned_cols=283 Identities=36% Similarity=0.646 Sum_probs=223.7
Q ss_pred CcceeceeeeeCCeEEEEEEECC--CCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRD--TGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
+|++.++||.|+||.||+|.+.. ++..||||.+.... ........+.+|+.++..++||||+++++++.......++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 79999999997632 1222335677899999999999999999999887557789
Q ss_pred EEEecchhhHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC----CCcEEEeeecCcc
Q 036673 188 LVFDFMQSDLTKIICRP----GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK----SGMLKIADFGLSN 259 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~ 259 (469)
+||||+++++...+... ...+++..++.++.||+.||+|||+.+|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 99999998777665321 236899999999999999999999999999999999999999 8999999999998
Q ss_pred cccCCCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChH---------HHHHHHHHH
Q 036673 260 FFIPKQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV---------EQLHRIFKL 328 (469)
Q Consensus 260 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---------~~~~~i~~~ 328 (469)
.+..... .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.... ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6533222 12234567899999998877666889999999999999999999999865532 356677777
Q ss_pred hCCCCHHHHhhcccCccCCC-------CCCC-Ccchh---cccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 329 CGTPSEDYWKKMKLTTTFRP-------QHYK-PSFRE---VFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~-------~~~~-~~~~~---~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
++.+....|........+.. ..+. ..+.. .....+..+.++|.+||+.||++|||+.|+++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 77777666654332211110 1111 11111 112567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=350.84 Aligned_cols=252 Identities=28% Similarity=0.390 Sum_probs=200.6
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchhh
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSD 196 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~~ 196 (469)
||+|+||+||++.+..+++.||+|++..... .....+.+..|+.+++.++||||+++.+++... ..+|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCCC
Confidence 6999999999999999999999999865422 222335677899999999999999998877664 4579999999874
Q ss_pred -HHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccc
Q 036673 197 -LTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272 (469)
Q Consensus 197 -l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 272 (469)
|...+. ..+..+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++..+.... ......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-cccccc
Confidence 444432 234569999999999999999999999999999999999999999999999999997653322 223345
Q ss_pred cccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCC
Q 036673 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352 (469)
Q Consensus 273 ~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (469)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 158 ~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------- 216 (280)
T cd05608 158 AGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-------------------- 216 (280)
T ss_pred CCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--------------------
Confidence 78999999998876 458899999999999999999999998654332222221111000
Q ss_pred CcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCC
Q 036673 353 PSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNA 395 (469)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~ 395 (469)
.......++..+.+||.+||+.||++|| |++++++||||+.
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 217 --SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred --CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 0012345788999999999999999999 8899999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=366.63 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=219.8
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
..|.-++.||.|+||.||.|++..+.+.||||++.+. ....+.+..+..|+.+|++|+|||++.+.|+|... ...||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHHH
Confidence 3467778899999999999999999999999999876 34556778999999999999999999999988763 34699
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||||-|+-.+++--...++.+.++..|..+.+.||+|||+.+.||||||..||||++.|.|||+|||.|.... +
T Consensus 104 VMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----P 178 (948)
T KOG0577|consen 104 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----P 178 (948)
T ss_pred HHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-----c
Confidence 99999986655554445689999999999999999999999999999999999999999999999999998763 4
Q ss_pred cccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 269 LTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
..+++|||+|||||+++. ...|+-++||||||++..||...+||+..-+....+..|...
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN------------------ 240 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------------ 240 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc------------------
Confidence 568999999999999853 456999999999999999999999998887777777776531
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
-.|.+. .++.+..+.+||..||++-|.+|||++++|.|+|....
T Consensus 241 ----esPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 241 ----ESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred ----CCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 112221 34567889999999999999999999999999998753
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.32 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=204.6
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|++..+++.||||+++... ........+..|+.++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 35999999999999999999999999997542 1223345677899999888 799999999988764 4579999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
.++.+.........+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCccccee
Confidence 87544444444457999999999999999999999999999999999999999999999999998753211 22234557
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.... .
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-----------------------~ 213 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-----------------------V 213 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-----------------------C
Confidence 8999999998876 458999999999999999999999998877665555443210 0
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCH-----HHHhcCccCCC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTA-----ASALQNEFFNA 395 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta-----~elL~hp~f~~ 395 (469)
.....++..+.+||.+||+.||.+|||+ .++++||||+.
T Consensus 214 ---~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 214 ---RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred ---CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 1123467899999999999999999999 99999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=356.91 Aligned_cols=252 Identities=25% Similarity=0.442 Sum_probs=199.9
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|++..+++.||+|++.... ........+.+|+.++.++ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence 35999999999999999999999999997642 2334456678899998877 899999999988774 3579999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
+++.+.........+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..... ........+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~-~~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC-CCCcccccc
Confidence 9754444444445799999999999999999999999999999999999999999999999999975322 122234568
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE--------VEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+...+.. .
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------------~- 220 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------------K- 220 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------------C-
Confidence 9999999998876 4589999999999999999999999953111 1111111100 0
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH------HHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA------ASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta------~elL~hp~f~~~ 396 (469)
...+...++..+.+||.+||+.||.+|||+ .++++||||...
T Consensus 221 ---------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 221 ---------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 001234567889999999999999999984 799999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=359.68 Aligned_cols=250 Identities=30% Similarity=0.457 Sum_probs=205.4
Q ss_pred ceeeeeCCeEEEEEEE---CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEec
Q 036673 116 AKVGQGTYSNVYKARD---RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDF 192 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 192 (469)
+.||+|+||.||++++ ..+++.||+|++............+.+|+.+|.+++||||+++++++... ..+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEEcC
Confidence 5699999999999986 35789999999975433333345677899999999999999999888764 457999999
Q ss_pred chh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccc
Q 036673 193 MQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS 271 (469)
Q Consensus 193 ~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 271 (469)
+.+ +|...+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 986 55555543 4569999999999999999999999999999999999999999999999999997653221 22345
Q ss_pred ccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCC
Q 036673 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY 351 (469)
Q Consensus 272 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (469)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~--------------------- 215 (318)
T cd05582 158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--------------------- 215 (318)
T ss_pred ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 678999999998865 4578999999999999999999999998877666655532110
Q ss_pred CCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCCC
Q 036673 352 KPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNAS 396 (469)
Q Consensus 352 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 396 (469)
.+...+++.+.+||.+||+.||.+||| +.+++.||||...
T Consensus 216 -----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 216 -----GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 122346889999999999999999999 6779999999863
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=374.29 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=217.6
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc---
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ--- 183 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--- 183 (469)
...++|.+.+.||+|+||+||+|++..+++.||||++............+.+|+.++..++|+||+++++.+.....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34579999999999999999999999999999999997765555666778899999999999999999876654321
Q ss_pred ---cEEEEEEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeec
Q 036673 184 ---YSLYLVFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFG 256 (469)
Q Consensus 184 ---~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFG 256 (469)
..+++||||+.+ +|.+.+.. ....+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 246899999996 66655533 23569999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCC-CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 036673 257 LSNFFIPKQ-KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335 (469)
Q Consensus 257 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 335 (469)
+++.+.... .......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..+.....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~----- 262 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----- 262 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-----
Confidence 998754322 222345689999999998876 4589999999999999999999999988776665555432110
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
......+++++.+||.+||+.||.+||++.++|+|||++.
T Consensus 263 --------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 --------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 0123457889999999999999999999999999999874
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=355.31 Aligned_cols=283 Identities=38% Similarity=0.638 Sum_probs=231.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc----
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ---- 183 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---- 183 (469)
..++|++++.||.|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4578999999999999999999999999999999986543334444668899999999999999999998865432
Q ss_pred cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 184 YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
...++||||+.+++...+.. ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 24589999997777666543 4699999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
......+++.|+|||++.+...++.++|+|||||++|+|++|.+||...+....+..+.+....+...++..+...
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 171 ----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred ----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 2234567899999998876455789999999999999999999999998888888888887777776666554322
Q ss_pred cc-----CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 TT-----FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.. ..+......+......++..+.+||.+||+.||.+|||+.+++.||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 10 001111223445556788999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=354.94 Aligned_cols=295 Identities=41% Similarity=0.722 Sum_probs=235.5
Q ss_pred ccCcce-eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHH------------HHHHHHHHHHHHHhCCCCCeeeEe
Q 036673 109 ADSYDK-LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPE------------SVKFMAREIRILQKLDHPNVIKLE 175 (469)
Q Consensus 109 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~hpnIv~~~ 175 (469)
.++|.. .+.||.|+||+||+|.+..+++.||||++........ ....+.+|+.++..++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 467765 4779999999999999998999999999865432210 012467899999999999999999
Q ss_pred eeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 176 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
+++... ...++||||+.+++...+.. ...+++..+..++.||+.||+|||+.||+|+||+|+|||++.++.++|+||
T Consensus 87 ~~~~~~--~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVEG--DFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEecC--CcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 988764 35799999999988777654 346999999999999999999999999999999999999999999999999
Q ss_pred cCcccccCC-------------CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHH
Q 036673 256 GLSNFFIPK-------------QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQL 322 (469)
Q Consensus 256 Gla~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~ 322 (469)
|++...... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999765411 0111233456889999998876566789999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHhhcccCccCCC--CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCC
Q 036673 323 HRIFKLCGTPSEDYWKKMKLTTTFRP--QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 400 (469)
..++...+.+....|........+.+ ....+.+.......+..+.+||.+||+.||.+|||++++|.||||+..+...
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence 99988888887665544322111111 1122334455566788999999999999999999999999999999887765
Q ss_pred CCCCCC
Q 036673 401 DLSSLP 406 (469)
Q Consensus 401 ~~~~~~ 406 (469)
.....|
T Consensus 324 ~~~~~~ 329 (335)
T PTZ00024 324 DPSQLP 329 (335)
T ss_pred CcccCC
Confidence 544443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=345.97 Aligned_cols=259 Identities=30% Similarity=0.484 Sum_probs=210.3
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEe
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 191 (469)
|++++.||+|+||+||++.+..+++.||+|++..............+|+.++++++||||+++++++.. ...+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 789999999999999999999999999999998765444444445679999999999999999998887 445789999
Q ss_pred cchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 192 FMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 192 ~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
|+.+ ++...+. ....+++..+..++.||+.||++||+++|+|+||||+|||++.++.++|+|||.+... ........
T Consensus 79 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~ 156 (260)
T PF00069_consen 79 YCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFN 156 (260)
T ss_dssp EETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBS
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 9998 6666665 3456999999999999999999999999999999999999999999999999999754 22233455
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
...+++.|+|||++.....++.++||||||+++|+|++|..||......+....+.+.........+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------- 223 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS------------- 223 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-------------
Confidence 6778999999998873466899999999999999999999999887444444443332221111000
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
......+..+.+||.+||+.||++|||+.++++||||
T Consensus 224 ------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 ------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0011123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=386.22 Aligned_cols=263 Identities=24% Similarity=0.424 Sum_probs=215.6
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
...++|++++.||.|+||+||+|.+..++..||+|++............+..|+.+|..|+|||||+++++|.......+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44578999999999999999999999999999999998765555566788999999999999999999999887767778
Q ss_pred EEEEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCcEEEcC---------
Q 036673 187 YLVFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHER-------GILHRDIKASNLLIDK--------- 246 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-------~ivHrDlkp~NILl~~--------- 246 (469)
||||||+.+ +|...+.. ....+++..++.|+.||+.||+|||+. +||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999986 66665543 235699999999999999999999984 4999999999999964
Q ss_pred --------CCcEEEeeecCcccccCCCCCCcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 036673 247 --------SGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRT 317 (469)
Q Consensus 247 --------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~ 317 (469)
.+.+||+|||++..+... ......+||+.|+|||++.+. ..++.++||||||||||+|++|.+||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 235899999999865322 223456799999999988643 457899999999999999999999998766
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 318 EVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 318 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
....+...+... +. .....++.++.+||..||..||.+|||+.|+|.|+||+..
T Consensus 248 ~~~qli~~lk~~--p~-----------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 248 NFSQLISELKRG--PD-----------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cHHHHHHHHhcC--CC-----------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 655443332210 00 0112457889999999999999999999999999999743
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=341.90 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=208.8
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE---PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
++|++.+.||.|+||.||+|.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++.... .+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE--TL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--eE
Confidence 5689999999999999999999999999999998754322 223456889999999999999999999887654 68
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
++|+||+++ .+.+.+. ....+++..+..++.|++.||.|||+.||+|+||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 80 SIFMEYMPGGSVKDQLK-AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEEECCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999987 4545444 34568999999999999999999999999999999999999999999999999997653322
Q ss_pred CCCc--ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 266 KGPL--TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 266 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.... ....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------- 223 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-------------- 223 (263)
T ss_pred cccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--------------
Confidence 1111 34567889999998876 448899999999999999999999998765554443332110
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
....+...++..+.+||.+||..||.+|||+.++|+|+||
T Consensus 224 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 ----------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ----------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0012234578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=356.61 Aligned_cols=277 Identities=27% Similarity=0.448 Sum_probs=210.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.++||.|+||.||++.+..++..+|+|++.... .......+.+|+++++.++||||+++++++... ..+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEE
Confidence 478999999999999999999999999999999987543 334456788999999999999999999998874 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||||+.+ +|.+.+. ....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999987 5555554 345689999999999999999999975 7999999999999999999999999999765322
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHH--hCCCCHHHHhh-cc--
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKL--CGTPSEDYWKK-MK-- 341 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~-~~-- 341 (469)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.. .++.. .+.+....... ..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred -ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCc
Confidence 2234578999999998875 45889999999999999999999999876543332 22110 01110000000 00
Q ss_pred --cCccCCCC----------------CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 342 --LTTTFRPQ----------------HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 342 --~~~~~~~~----------------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
....+.+. ...+.+ ....++.++.+||.+||++||++|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00000000 000000 012357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=356.19 Aligned_cols=286 Identities=36% Similarity=0.637 Sum_probs=233.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.++.++ +||||+++++++.......+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 35789999999999999999999998899999998864433334445677899999999 99999999998876656668
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|+||||+.+++...+... .+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..+.....
T Consensus 85 ~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 999999999887776543 689999999999999999999999999999999999999999999999999986643322
Q ss_pred ----CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 267 ----GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 267 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.......+++.|+|||++.+...++.++|||||||++|+|++|++||.+....+...++....+.+....+..+..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1233456899999999887666688999999999999999999999999988888888888777776554443321
Q ss_pred C------ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 343 T------TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 343 ~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. .... ......+....+.++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 243 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 243 PFAATMLDSLP-SRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhHHHhhhhcc-cccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0111 111122334455688999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=354.19 Aligned_cols=250 Identities=30% Similarity=0.470 Sum_probs=201.5
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|++..+++.||||+++.... .......+..|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 359999999999999999999999999975421 122334566788888764 999999999888764 4579999999
Q ss_pred hh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccc
Q 036673 194 QS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272 (469)
Q Consensus 194 ~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 272 (469)
++ +|...+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 79 ~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (316)
T cd05619 79 NGGDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTF 156 (316)
T ss_pred CCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCceeee
Confidence 86 5555443 3457999999999999999999999999999999999999999999999999998753221 1223456
Q ss_pred cccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCC
Q 036673 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352 (469)
Q Consensus 273 ~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (469)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+... .+
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~-------------------- 213 (316)
T cd05619 157 CGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP-------------------- 213 (316)
T ss_pred cCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC--------------------
Confidence 78999999998875 45899999999999999999999999887766555443211 00
Q ss_pred CcchhcccCCChhHHHHHHHccccCCCCCCCHH-HHhcCccCCCC
Q 036673 353 PSFREVFGEFPPSSYGILTTLLALDPAYRGTAA-SALQNEFFNAS 396 (469)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~-elL~hp~f~~~ 396 (469)
.....++..+.+||.+||+.||.+||++. ++++||||...
T Consensus 214 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 214 ----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred ----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 01123678899999999999999999996 99999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=353.72 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=207.0
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~l 188 (469)
+|+..+.||+|+||+||+|++..+++.||||++..... .....+.+..|+.++..+. |++|+++++++... ..+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 47888999999999999999999999999999975421 2233456778999998886 56777888777664 35799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+++ +|...+ .....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 v~Ey~~~g~L~~~i-~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~ 156 (323)
T cd05615 79 VMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GV 156 (323)
T ss_pred EEcCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-Cc
Confidence 9999987 454444 44457999999999999999999999999999999999999999999999999998754222 12
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----------------- 218 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----------------- 218 (323)
T ss_pred cccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence 2345678999999998875 4589999999999999999999999998877666665543110
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 396 (469)
.....++..+.+|+.+||+.||.+|++ ..++++||||...
T Consensus 219 ---------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 219 ---------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ---------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 112346788999999999999999997 4799999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=355.60 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=201.3
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHH-HHHHhCCCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREI-RILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|++..+++.||+|++..... .......+..|. .+++.++||||+++++++... ..+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeCC
Confidence 359999999999999999999999999975321 111223344444 456788999999998887764 4579999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence 98544444444557899999999999999999999999999999999999999999999999999754222 22344567
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (325)
T cd05602 158 GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------ 212 (325)
T ss_pred CCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC------------------------
Confidence 9999999998876 458999999999999999999999999887776665553210
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCHH----HHhcCccCCC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTAA----SALQNEFFNA 395 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~----elL~hp~f~~ 395 (469)
....+.++..+.+||.+||+.||.+|+++. ++++|+||..
T Consensus 213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 213 --LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred --cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 012345788999999999999999999976 8999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=356.66 Aligned_cols=251 Identities=26% Similarity=0.382 Sum_probs=201.8
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhCCCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIR-ILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|.+..+|+.||||++..... .......+..|.. +++.++||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcCC
Confidence 359999999999999999999999999965421 2223344555655 46778999999998887764 4579999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
.++.+.........+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccccc
Confidence 97544444444567999999999999999999999999999999999999999999999999998753221 22334567
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------------------------ 212 (325)
T cd05604 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------------------------ 212 (325)
T ss_pred CChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 9999999998876 458899999999999999999999998877666555543210
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCH----HHHhcCccCCCC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTA----ASALQNEFFNAS 396 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta----~elL~hp~f~~~ 396 (469)
....+.++..+.++|.+||+.||.+||++ .++++||||...
T Consensus 213 --~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 213 --LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred --ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 01223567889999999999999999987 599999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=356.10 Aligned_cols=287 Identities=38% Similarity=0.645 Sum_probs=236.4
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc---
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ--- 183 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--- 183 (469)
...++|++.+.||.|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34578999999999999999999999999999999986543334445667889999999999999999887654332
Q ss_pred -cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 184 -YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 184 -~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
..+++|+||+.+++...+.. ..+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 34799999998888777654 469999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.. .....+++.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+....+.+.+.++..+..
T Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 22 34457789999999886655678999999999999999999999999988888888888888888777765542
Q ss_pred Ccc--C---CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 343 TTT--F---RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 343 ~~~--~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
... + .+....+.+......++..+.+||.+||+.||.+|||+.++|+||||+....+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 211 0 01111233444455678999999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=359.21 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=200.6
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC---CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKL---DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
||+|+||+||+|++..+++.||||++..... .......+..|..++..+ .||||+++++++... ..+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCC
Confidence 7999999999999999999999999864321 122334455677777665 699999998887764 4579999999
Q ss_pred hh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccc
Q 036673 194 QS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272 (469)
Q Consensus 194 ~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 272 (469)
.+ +|...+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 79 ~~g~L~~~l-~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~ 156 (330)
T cd05586 79 SGGELFWHL-QKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTF 156 (330)
T ss_pred CCChHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCc
Confidence 87 454444 44557999999999999999999999999999999999999999999999999999754222 2223456
Q ss_pred cccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCC
Q 036673 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352 (469)
Q Consensus 273 ~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (469)
+||+.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+......
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------------- 215 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--------------------- 215 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC---------------------
Confidence 79999999999876666899999999999999999999999887766555544221000
Q ss_pred CcchhcccCCChhHHHHHHHccccCCCCCC----CHHHHhcCccCCCC
Q 036673 353 PSFREVFGEFPPSSYGILTTLLALDPAYRG----TAASALQNEFFNAS 396 (469)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp----ta~elL~hp~f~~~ 396 (469)
-....+++++.+||.+||+.||.+|| ++.++++||||...
T Consensus 216 ----~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 216 ----FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred ----CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 00123678899999999999999998 79999999999863
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=352.69 Aligned_cols=250 Identities=25% Similarity=0.389 Sum_probs=199.6
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHH-HHHHhCCCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREI-RILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|++..+++.||+|++..... .......+..|. .+++.++||||+++++++... ..+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 359999999999999999999999999865321 122233445555 467889999999998887664 4579999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
+++.+.........+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence 97544444344457999999999999999999999999999999999999999999999999998753222 22234567
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
||+.|+|||++.+ ..++.++|||||||++|||++|.+||...+.......+... +
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~--------------------- 212 (321)
T cd05603 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P--------------------- 212 (321)
T ss_pred CCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C---------------------
Confidence 8999999998865 45899999999999999999999999887765555444321 0
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCH----HHHhcCccCCC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTA----ASALQNEFFNA 395 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta----~elL~hp~f~~ 395 (469)
..+....+..+.++|.+||+.||.+|+++ .++++|+||..
T Consensus 213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 213 --LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 01223567889999999999999999976 49999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=344.09 Aligned_cols=278 Identities=26% Similarity=0.429 Sum_probs=224.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC--CCC----eeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD--HPN----VIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpn----Iv~~~~~~~~~ 181 (469)
..++|.++.++|+|+||.|-.+.+..++..||||+++... ...+...-|+++|++|. -|+ +|.+.++|...
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 3689999999999999999999999999999999997432 23345567999999993 232 67777777764
Q ss_pred cccEEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC--------------
Q 036673 182 MQYSLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-------------- 246 (469)
Q Consensus 182 ~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-------------- 246 (469)
.++|||+|.++-++.+.+..++ .+++...++.+..||+++++|||+.+++|.||||+|||+.+
T Consensus 164 --ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 164 --GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred --CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 4579999999999999887644 46999999999999999999999999999999999999832
Q ss_pred ------CCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHH
Q 036673 247 ------SGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVE 320 (469)
Q Consensus 247 ------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~ 320 (469)
+..|+|+|||.|+... ......+.|..|+|||++++ ..++..+||||+||||+||.+|..+|+..++.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceec----cCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3469999999998642 22367788999999999997 569999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHhhcccCccCCCCC------C-----------CCcchhccc---CCChhHHHHHHHccccCCCC
Q 036673 321 QLHRIFKLCGTPSEDYWKKMKLTTTFRPQH------Y-----------KPSFREVFG---EFPPSSYGILTTLLALDPAY 380 (469)
Q Consensus 321 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~------~-----------~~~~~~~~~---~~~~~l~~li~~~L~~dP~~ 380 (469)
++..+...+|+++.....+......|.... . ...+..... .....+.|||++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 999998999988877666552111111100 0 011111111 22345899999999999999
Q ss_pred CCCHHHHhcCccCCC
Q 036673 381 RGTAASALQNEFFNA 395 (469)
Q Consensus 381 Rpta~elL~hp~f~~ 395 (469)
|+|+.|+|.||||+.
T Consensus 397 RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 397 RITLREALSHPFFAR 411 (415)
T ss_pred cccHHHHhcCHHhhc
Confidence 999999999999986
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=339.94 Aligned_cols=258 Identities=29% Similarity=0.431 Sum_probs=220.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|+.+++||+|.||.|-+++.+.+++.||||++++. ....+.+..-..|-.+|+..+||.+..+.-.|.. ++.+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceE
Confidence 457899999999999999999999999999999999765 3344555666789999999999999887434443 6678
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|+||||..|+-+.+.+.....|+++.++.+-..|+.||.|||+++||.||||.+|+|||.+|++||+|||+++.-. ...
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc-ccc
Confidence 9999999986665555556679999999999999999999999999999999999999999999999999998532 234
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
..+.+.||||.|+|||++.. ..|+.++|.|.+||++|||++|+.||...+....+..|...-.
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~---------------- 385 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL---------------- 385 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc----------------
Confidence 45678999999999998876 5699999999999999999999999998887777666643211
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNA 395 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~ 395 (469)
.+...++++++.|+..+|.+||.+|.. |.|+.+|+||..
T Consensus 386 ----------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 386 ----------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred ----------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 234568999999999999999999964 889999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=353.58 Aligned_cols=286 Identities=37% Similarity=0.648 Sum_probs=236.3
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc---ccEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM---QYSLY 187 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~ 187 (469)
+|++.+.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999999988999999998765433455577889999999999999999999877653 23579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC-
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK- 266 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 266 (469)
++|||+++++.+.+... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999998887777554 3799999999999999999999999999999999999999999999999999987644321
Q ss_pred -CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 -GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 1234557799999999887754789999999999999999999999999999999999988888887766553221110
Q ss_pred --C---CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 346 --F---RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 346 --~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
+ ........+....+.++..+.+||.+||++||.+|||+.++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0 111112234445566889999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.70 Aligned_cols=281 Identities=37% Similarity=0.637 Sum_probs=229.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc----c
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ----Y 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----~ 184 (469)
.++|.+.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999999899999999986543333334567899999999999999999998765422 3
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
..++|+||+..++.... +..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 46899999987665544 23589999999999999999999999999999999999999999999999999875421
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
......+++.|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+....+.+...+++......
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 22345678999999988765568899999999999999999999999988888888888888888777766553321
Q ss_pred cC-----CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 TF-----RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.. .+......+...++.++..+.+||.+||+.||.+|||+.++|.||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 10 11111233334455678899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=354.28 Aligned_cols=246 Identities=26% Similarity=0.441 Sum_probs=207.9
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
.+++++.||+|.||.||+|.+.. ...||+|.++...... +.|.+|+.+|++|+|+|||+++++|.... -+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEE
Confidence 46778999999999999999985 4689999998653332 56779999999999999999999998755 479999
Q ss_pred ecch-hhHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 191 DFMQ-SDLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 191 e~~~-~~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||. |+|++++.. .+..+...+.+.++.||++||+||+++++|||||-..||||+++..+||+|||||+....+....
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999 577777765 56679999999999999999999999999999999999999999999999999999554333323
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....-...|.|||.+.- ..++.++|||||||+||||+| |+.||++-+..+.+..+-+...-|
T Consensus 361 ~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp--------------- 424 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP--------------- 424 (468)
T ss_pred cCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC---------------
Confidence 333334678999998875 459999999999999999998 999999999999998876543322
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHh
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASAL 388 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL 388 (469)
....+|+++.+||..|+..+|++|||.+.+.
T Consensus 425 ----------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ----------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 1345799999999999999999999998654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=344.03 Aligned_cols=279 Identities=45% Similarity=0.806 Sum_probs=233.4
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEe
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 191 (469)
|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|+||+++++++... ..+++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEe
Confidence 6778899999999999999998899999999876544434456788999999999999999999988764 45799999
Q ss_pred cchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccc
Q 036673 192 FMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS 271 (469)
Q Consensus 192 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 271 (469)
|+++++...+......+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99998888887766689999999999999999999999999999999999999999999999999998764433 12334
Q ss_pred ccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC----
Q 036673 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR---- 347 (469)
Q Consensus 272 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---- 347 (469)
..++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+....+.+....|..........
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5678899999988765468999999999999999999999999999999888888888887776666644311111
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
+...........+.++.++.+||.+||..||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1111122234456688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=351.24 Aligned_cols=287 Identities=37% Similarity=0.589 Sum_probs=229.7
Q ss_pred CCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc--
Q 036673 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM-- 182 (469)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 182 (469)
+-...++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++.+++||||+++++++....
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 344568899999999999999999999989999999998754333334466788999999999999999998875432
Q ss_pred --ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 183 --QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 183 --~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
....|++++++.+++...+.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus 92 ~~~~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 92 EEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred cccccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 234689999998777666543 3599999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
... ......+++.|+|||++.+...++.++|||||||++|+|++|++||...+....+..+....+.+....+..+
T Consensus 170 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 170 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 422 2334577899999998876556889999999999999999999999988888888888777777766655443
Q ss_pred ccCcc--C---CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 341 KLTTT--F---RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 341 ~~~~~--~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
..... + .+......+.......++.+.+||.+||+.||.+|||+.++|.||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 22100 0 001111222233335688899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.84 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=200.3
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++.++ .||||+.+++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence 359999999999999999999999999976422 234456688999999888 699999999887764 4579999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
+++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG-PGDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC-CCCceeccc
Confidence 8744443333445799999999999999999999999999999999999999999999999999875321 122234568
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT------EVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.... ..+.+...... .+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~--------------- 219 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP--------------- 219 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC---------------
Confidence 9999999998876 458999999999999999999999996422 11222221110 00
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH------HHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA------ASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta------~elL~hp~f~~~ 396 (469)
..+...++..+.+||.+||+.||.+|+++ .++++||||+..
T Consensus 220 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 220 --------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred --------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 01233467889999999999999999984 699999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=332.22 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=209.5
Q ss_pred CccCccee-ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEee--ccc
Q 036673 108 SADSYDKL-AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATS--RMQ 183 (469)
Q Consensus 108 ~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~ 183 (469)
.+++|.+. ++||-|-.|.|..+.++.|++.+|+|++.-. ....+|+++--.. .|||||.++++|.. .+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 35677664 6799999999999999999999999998521 3456788876655 79999999999864 345
Q ss_pred cEEEEEEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC---CcEEEeeecCc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS---GMLKIADFGLS 258 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~---~~~kl~DFGla 258 (469)
.++.+|||+|+| .|+..+...+ ..|+|.++..|++||..|+.|||+.+|.||||||+|+|.... ..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 678999999997 5666664433 459999999999999999999999999999999999999654 47999999999
Q ss_pred ccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCH
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ----LHRIFKLCGTPSE 334 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~ 334 (469)
+... ....+.+.|.||+|.|||++. ...|+...|+||+||++|.||+|.|||........ -.+|......++.
T Consensus 212 K~t~--~~~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 212 KETQ--EPGDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred cccC--CCccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 8642 245577889999999999775 46699999999999999999999999987654322 2223222222221
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
.-|..+|++++++|+.+|..+|++|.|+.+++.|||+.....
T Consensus 289 ----------------------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 289 ----------------------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred ----------------------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 235668999999999999999999999999999999987543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=351.44 Aligned_cols=280 Identities=23% Similarity=0.360 Sum_probs=206.4
Q ss_pred eeceeeee--CCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEe
Q 036673 114 KLAKVGQG--TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 114 ~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 191 (469)
++++||+| +|++||++.+..+|+.||||++............+.+|+.+++.++||||+++++++.... .+++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEEEEEe
Confidence 45679999 7889999999999999999999766555556677889999999999999999999987754 5799999
Q ss_pred cchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC---
Q 036673 192 FMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK--- 266 (469)
Q Consensus 192 ~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--- 266 (469)
|+++ ++.+.+... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9996 555555432 34589999999999999999999999999999999999999999999999987543321110
Q ss_pred ---CCcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC--------CCH
Q 036673 267 ---GPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT--------PSE 334 (469)
Q Consensus 267 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~--------~~~ 334 (469)
.......++..|+|||++.+. ..++.++|||||||++|||++|+.||.................. +.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 011223567889999998653 35889999999999999999999999876554433332221100 000
Q ss_pred HHHhhcccC------------ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 335 DYWKKMKLT------------TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 335 ~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
......... ....+.............+++.+.+||.+||+.||++|||++++|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000000000 0000001111112223356789999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.24 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=205.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.|++.+.||+|+||+||++.+..+++.||||.+...... ......+.+|+.+++.++|+||+.+++.+... ..+++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEE
Confidence 377889999999999999999999999999998654322 23335577899999999999999998887664 457999
Q ss_pred Eecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+.+ +|...+.. ....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++...... .
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--Q 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC--c
Confidence 999986 55555533 2345999999999999999999999999999999999999999999999999999764322 2
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......|++.|+|||++.+ ..++.++|||||||++|+|++|++||....................
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------- 221 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence 2234578999999998876 4589999999999999999999999986543211111111000000
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNA 395 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~ 395 (469)
......+++++.+||.+||+.||.+||| +.|+++||||+.
T Consensus 222 --------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 222 --------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred --------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 0123456788999999999999999999 999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=334.36 Aligned_cols=255 Identities=26% Similarity=0.440 Sum_probs=211.0
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||.|+||.||++.+..+++.||+|++..........+.+.+|+.++++++|+||+++++.+... ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48999999999999999999999899999999976655555567788999999999999999998876543 34579999
Q ss_pred ecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 191 DFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 191 e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||+++ ++.+.+.. ....+++.++..++.|++.||+|||++||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-~~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-CDM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc-CCc
Confidence 99986 56666654 2346899999999999999999999999999999999999999999999999999865322 223
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------------ 219 (257)
T cd08223 159 ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------------ 219 (257)
T ss_pred cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------------
Confidence 345578999999998865 4578999999999999999999999987665554444322110
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
......+++++.+||.+||+.||.+|||+.++++||||
T Consensus 220 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 -------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=341.19 Aligned_cols=279 Identities=44% Similarity=0.809 Sum_probs=234.3
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEe
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 191 (469)
|++.+.||.|+||.||+|....+++.||+|++............+..|+.+++.++|+||+++++++... ...++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEec
Confidence 6677889999999999999999999999999976543344446678899999999999999999988764 45799999
Q ss_pred cchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccc
Q 036673 192 FMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS 271 (469)
Q Consensus 192 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 271 (469)
|+++++...+......+++..+..++.|++.||+|||++||+|+||+|+||++++++.++|+|||++....... .....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-cccCc
Confidence 99998888887654579999999999999999999999999999999999999999999999999997653322 12334
Q ss_pred ccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC---C
Q 036673 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR---P 348 (469)
Q Consensus 272 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~ 348 (469)
..++..|+|||.+.+...++.++|||||||++|||++|.+||...+..+.+..+...++.+....|..+.....+. +
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 5567889999988765568999999999999999999999999999999999999999999888887665443211 1
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
...........+.++..+.++|.+||..||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111122334455678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=332.53 Aligned_cols=269 Identities=25% Similarity=0.367 Sum_probs=216.3
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
+.||+|+|+.|-.+....++..||||++.+.. ......+.+|++++.+. .|+||+.+++||++... +|||||-|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~--FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR--FYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce--EEEEEeccc
Confidence 56999999999999999999999999997653 34457788999999999 79999999999988554 699999999
Q ss_pred h-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC---cEEEeeecCccccc------CC
Q 036673 195 S-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG---MLKIADFGLSNFFI------PK 264 (469)
Q Consensus 195 ~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~------~~ 264 (469)
| .++..+.+ ...|++.++..++++|+.||+|||.+||.||||||+|||..+.. -+|||||.|..-+. +.
T Consensus 160 GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 160 GGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred CchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 7 66766655 35799999999999999999999999999999999999997765 48999999976432 22
Q ss_pred CCCCcccccccCccccchhcc----CCCCCCccccchhhHHHHHHHHhCCCCCCCCCh---------------HHHHHHH
Q 036673 265 QKGPLTSRVVTLWYRAPELLL----GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---------------VEQLHRI 325 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---------------~~~~~~i 325 (469)
......+.+|+..|||||+.. ....|+.+.|.||||||||.||+|.+||.+.-. ...+..|
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 223356778999999999862 234689999999999999999999999987532 1223333
Q ss_pred HHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCCCCCC
Q 036673 326 FKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSL 405 (469)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~ 405 (469)
.......++ +-|..+|.++++||+.+|..|+.+|.+|.++|+|||++.-...+.+...
T Consensus 319 QEGkYeFPd----------------------kdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp 376 (463)
T KOG0607|consen 319 QEGKYEFPD----------------------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTP 376 (463)
T ss_pred hccCCcCCh----------------------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCC
Confidence 333333332 2355689999999999999999999999999999999976555555555
Q ss_pred CccccC
Q 036673 406 PVICRE 411 (469)
Q Consensus 406 ~~~~~~ 411 (469)
+++.+.
T Consensus 377 ~v~~r~ 382 (463)
T KOG0607|consen 377 QVLQRN 382 (463)
T ss_pred cccccC
Confidence 555443
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=367.98 Aligned_cols=256 Identities=24% Similarity=0.358 Sum_probs=211.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDT-GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
..|.+.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.+|..++|||||++++++... ..+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEE
Confidence 3499999999999999999998877 788999977543 334446678899999999999999999998774 45799
Q ss_pred EEecchh-hHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
||||+.+ +|...+. ....++++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999986 5555443 23456899999999999999999999999999999999999999999999999999876432
Q ss_pred CC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 265 QK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 265 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~------------ 289 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD------------ 289 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 21 12345679999999998865 56899999999999999999999999887776666555431110
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.....++..+.+||.+||..||++|||+.++|.|+|++.
T Consensus 290 -------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 -------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 112346788999999999999999999999999999863
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=341.81 Aligned_cols=253 Identities=27% Similarity=0.386 Sum_probs=197.6
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS- 195 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~- 195 (469)
||+|+||+||++++..+|+.||+|++...... ......+..|+++++.++||||+++++++... ..+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCCC
Confidence 69999999999999999999999998643221 12224456799999999999999998887663 457999999986
Q ss_pred hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccc
Q 036673 196 DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274 (469)
Q Consensus 196 ~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 274 (469)
+|...+.. ....+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++...... .......+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCC
Confidence 55455433 2335899999999999999999999999999999999999999999999999999765322 22334578
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCc
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPS 354 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (469)
++.|+|||++.+. .++.++|||||||++|+|++|..||...........+...... ..
T Consensus 157 ~~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~ 214 (277)
T cd05607 157 TNGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE---------------------DE 214 (277)
T ss_pred CCCccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc---------------------cc
Confidence 9999999988764 4899999999999999999999999764332211111111000 00
Q ss_pred chhcccCCChhHHHHHHHccccCCCCCCCH----HHHhcCccCCCC
Q 036673 355 FREVFGEFPPSSYGILTTLLALDPAYRGTA----ASALQNEFFNAS 396 (469)
Q Consensus 355 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta----~elL~hp~f~~~ 396 (469)
.......++.++.+||.+||+.||.+||++ .+++.||||+..
T Consensus 215 ~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 215 VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 001123568899999999999999999999 678899999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=337.37 Aligned_cols=258 Identities=27% Similarity=0.463 Sum_probs=206.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC---CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS---EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
.+|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468999999999999999999999999999999865422 22344678899999999999999999998876655678
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+++|||+++ +|...+.. ...+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++..+....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999987 55555543 4468999999999999999999999999999999999999999999999999997653211
Q ss_pred --CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 266 --KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 266 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
........++..|+|||.+.+ ..++.++|||||||++|+|++|++||...........+.....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~------------- 226 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT------------- 226 (266)
T ss_pred ccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-------------
Confidence 111234567899999998865 4578999999999999999999999986654444333211100
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
.+ .+...+++.+.+|| .||..||++|||+.|+++||||+
T Consensus 227 --------~~---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 --------NP---QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------CC---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 01 11224567788898 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=352.60 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=197.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 182 (469)
.++|++.++||.|+||.||+|.+. .+++.||||++.... .......+.+|+.+|..+ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 468999999999999999999752 345789999987432 234446788999999999 8999999999876543
Q ss_pred ccEEEEEEecchh-hHHHHHhcC---------------------------------------------------------
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRP--------------------------------------------------------- 204 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~--------------------------------------------------------- 204 (469)
..+++||||+++ +|.+.+...
T Consensus 85 -~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 85 -GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred -CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 347999999996 555554321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC-CcccccccCccc
Q 036673 205 ----GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYR 279 (469)
Q Consensus 205 ----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~ 279 (469)
..++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 124788899999999999999999999999999999999999999999999999865322211 112334568899
Q ss_pred cchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhc
Q 036673 280 APELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREV 358 (469)
Q Consensus 280 aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (469)
|||++.+ ..++.++|||||||+||||++ |.+||.+....+.+...+.. +.. ...
T Consensus 244 aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~-----------------------~~~ 298 (338)
T cd05102 244 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR-----------------------MRA 298 (338)
T ss_pred CcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC-----------------------CCC
Confidence 9998875 458999999999999999997 99999876543333222211 000 011
Q ss_pred ccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 359 FGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 359 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
...+++++.+||.+||+.||.+|||+.++++
T Consensus 299 ~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 299 PENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=346.01 Aligned_cols=285 Identities=36% Similarity=0.626 Sum_probs=231.4
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
....++|++.+.||.|+||.||+|.+..+++.||||++..........+.+.+|+.++..++||||+++++++..... .
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE-D 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC-c
Confidence 346788999999999999999999999999999999886543333444677899999999999999999998865433 4
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
.++++||+.+++...+.. .++++..+..++.||+.||+|||+++|+|+||+|+|||++.++.++|+|||++.....
T Consensus 85 ~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 85 IYFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred EEEEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 689999998877666543 3588999999999999999999999999999999999999999999999999975422
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
......+++.|+|||++.+...++.++|||||||++|+|++|++||...........+.+.++.++.+++........
T Consensus 161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 223456788999999876655689999999999999999999999999888777878888888888777654322111
Q ss_pred C-----CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 346 F-----RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 346 ~-----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. .+...........+.++..+.++|.+||+.||++|||+.++|.||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 0 000111122334456788999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=340.37 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=209.5
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.|+..+.||.|+||+||+|.+..+++.||+|++...... ......+.+|+.+|+.++|+||+.+.+.+... ..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEE
Confidence 377889999999999999999999999999998654322 22335577899999999999999998877664 457999
Q ss_pred Eecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+.+ ++...+... ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 999997 455455432 346999999999999999999999999999999999999999999999999999764221 2
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...........+........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-------------- 221 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--------------
Confidence 2345678999999998865 4589999999999999999999999987766544444332211110
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 396 (469)
......++.++.+|+.+||+.||++||| +.++++|+||+..
T Consensus 222 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 222 --------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred --------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0123456788999999999999999999 8899999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=350.02 Aligned_cols=284 Identities=33% Similarity=0.596 Sum_probs=222.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc-----
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ----- 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----- 183 (469)
..+|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 3689999999999999999999999999999999865433 334678899999999999999999877654322
Q ss_pred -------cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-CCcEEEeee
Q 036673 184 -------YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-SGMLKIADF 255 (469)
Q Consensus 184 -------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~kl~DF 255 (469)
..+|+||||+++++...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 34689999999877766643 36999999999999999999999999999999999999974 567899999
Q ss_pred cCcccccCCCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036673 256 GLSNFFIPKQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS 333 (469)
Q Consensus 256 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 333 (469)
|++..+..... .......++..|+|||++.....++.++|||||||++|+|++|+.||...+..+....+......+.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99976532211 1123346788999999876656688999999999999999999999998888877777665544333
Q ss_pred HHHHhhcc----cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 334 EDYWKKMK----LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 334 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...+.... .............+......++.++.+||.+||+.||.+|||+.++|.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 32211110 0000001111223344556788999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=346.91 Aligned_cols=285 Identities=35% Similarity=0.590 Sum_probs=230.7
Q ss_pred CcceeceeeeeCCeEEEEEEECCC--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec--cccE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDT--GKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR--MQYS 185 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~ 185 (469)
+|++.+.||.|+||.||++.+..+ +..||||++..........+.+.+|+.++.++ .||||+++++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999999988 89999999875433334456778899999999 599999998865432 2345
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+|++++|+.++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 789999999888777754 4569999999999999999999999999999999999999999999999999998654322
Q ss_pred C---CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 266 K---GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 266 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
. .......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..++...+.++...+..+..
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 1123457899999999887656689999999999999999999999999998899999999888887766554322
Q ss_pred Ccc-----CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 343 TTT-----FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 343 ~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
... .........+....+.++..+.+||.+||+.||.+|||+.+++.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 110 000111223344455678899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=337.05 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=206.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecc----
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRM---- 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~---- 182 (469)
..+.|++.+.||.|+||.||+|.+..+++.||+|++...... ...+.+|+.++..+ +||||+++++++....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 356799999999999999999999999999999998754322 25677899999998 7999999999887542
Q ss_pred ccEEEEEEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
...+|++|||+.+ ++...+... ...+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 2457999999986 555555442 34689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
..... .......|++.|+|||++.+ ...++.++|||||||++|+|++|.+||...........+.. .+
T Consensus 161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~---- 232 (272)
T cd06637 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP---- 232 (272)
T ss_pred ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CC----
Confidence 53221 22345678999999998853 23578899999999999999999999976544333322211 00
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.+ ......++..+.+||.+||..||.+|||+.++++||||
T Consensus 233 ---------------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 ---------------AP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ---------------CC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00 01122467889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.23 Aligned_cols=283 Identities=29% Similarity=0.407 Sum_probs=225.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-----C---CCeeeEeeeEee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-----H---PNVIKLEGLATS 180 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~~~~~~~~ 180 (469)
..+|-+.++||.|.|+|||+|.+..+.+.||+|+++. .....+....||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 3789999999999999999999999999999999973 3445567789999999982 3 369999999865
Q ss_pred --ccccEEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEc-----------
Q 036673 181 --RMQYSLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLID----------- 245 (469)
Q Consensus 181 --~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~----------- 245 (469)
.+..++|||+|++..+|+.+|...+ +.++...++.|++||+.||.|||+ .||||-||||+||||.
T Consensus 154 sGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred cCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 4577899999999999999997754 349999999999999999999996 5999999999999981
Q ss_pred --------------------------------------------------------------------------------
Q 036673 246 -------------------------------------------------------------------------------- 245 (469)
Q Consensus 246 -------------------------------------------------------------------------------- 245 (469)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------CC----------------------------------------------------CcE
Q 036673 246 -----------------------KS----------------------------------------------------GML 250 (469)
Q Consensus 246 -----------------------~~----------------------------------------------------~~~ 250 (469)
.. -.+
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 00 027
Q ss_pred EEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC------ChHHHHHH
Q 036673 251 KIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR------TEVEQLHR 324 (469)
Q Consensus 251 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~------~~~~~~~~ 324 (469)
||+|||.|+++ ....+.-+.|..|+|||++++.. |++.+||||++||+|||+||..+|... .+.+++..
T Consensus 394 KIaDlGNACW~----~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 394 KIADLGNACWV----HKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEeeccchhhh----hhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 89999999985 23356778899999999999854 899999999999999999999998633 47789999
Q ss_pred HHHHhCCCCHHHHhhcccCcc----------CCCCCCCCc---chh---cccCCChhHHHHHHHccccCCCCCCCHHHHh
Q 036673 325 IFKLCGTPSEDYWKKMKLTTT----------FRPQHYKPS---FRE---VFGEFPPSSYGILTTLLALDPAYRGTAASAL 388 (469)
Q Consensus 325 i~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~---~~~---~~~~~~~~l~~li~~~L~~dP~~Rpta~elL 388 (469)
|+.++|..+..+...-+..+. +..-.+-+- +.+ +..+-..++.+||.-||+.+|++||||.++|
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 999988776555443333222 222111111 111 1112234578999999999999999999999
Q ss_pred cCccCCCCCCC
Q 036673 389 QNEFFNASPLA 399 (469)
Q Consensus 389 ~hp~f~~~~~~ 399 (469)
+|||++..+.+
T Consensus 549 ~hPwLn~~~~~ 559 (590)
T KOG1290|consen 549 KHPWLNPVAGP 559 (590)
T ss_pred cCccccCCCCC
Confidence 99999976544
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=348.69 Aligned_cols=265 Identities=29% Similarity=0.473 Sum_probs=211.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
....|+++++||.||.+.||++...+ .+.||+|++.....+.....-+.+|+..|.+| .|.+||++++|-.. +.++
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~l 435 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYL 435 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceE
Confidence 44679999999999999999998765 67788888877777778889999999999999 69999999998776 5678
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||||||-+.+|..++.+....++.-.++.|..|++.|+.++|.+||||.||||.|+|+- .|.+||+|||+|..+..+..
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 99999999999999988766666568999999999999999999999999999999986 47999999999998766554
Q ss_pred CC-cccccccCccccchhccCCC----------CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 036673 267 GP-LTSRVVTLWYRAPELLLGST----------DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335 (469)
Q Consensus 267 ~~-~~~~~gt~~y~aPE~~~~~~----------~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 335 (469)
.. ..+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||..-. ..+.++ ..+..|..+
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl-~aI~~P~~~ 591 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKL-HAITDPNHE 591 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHH-HhhcCCCcc
Confidence 33 45789999999999884321 25678999999999999999999995321 112222 112222211
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
. .|..+.. ..++.++++.||++||.+|||+.++|+|||++.-+.
T Consensus 592 I-----------------efp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 592 I-----------------EFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred c-----------------cccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 0 1111111 223899999999999999999999999999986443
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=334.54 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=211.6
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+... ...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEE
Confidence 47999999999999999999998889999999987554333 557789999999999999999999887664 457999
Q ss_pred Eecchh-hHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 190 FDFMQS-DLTKIICRP--GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||++.+ .+...+... ...+++..+..++.||+.||.|||++||+|+||+|+||++++++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999987 444444332 24689999999999999999999999999999999999999999999999999987644332
Q ss_pred C---CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 267 G---PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 267 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. ......++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+..+... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~---------- 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DP---------- 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CC----------
Confidence 2 2234568999999998876546899999999999999999999999876665544443321 00
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
..+... .....++..+.+||.+||+.||.+|||+.++++||||
T Consensus 225 -----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 -----PSLETG--ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----CCcCCc--cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 000000 1124678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=339.53 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=210.2
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+.|+++++||.|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++.+.... .+|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--KLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--eEEEE
Confidence 6799999999999999999999999999999998643 3445677889999999999999999999887643 57999
Q ss_pred EecchhhHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQSDLTK-IICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||++++.+. .+......+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++...... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-ccc
Confidence 9999985544 44444567999999999999999999999999999999999999999999999999998754222 122
Q ss_pred cccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 269 LTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+.......+.... .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~------------- 232 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-P------------- 232 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC-C-------------
Confidence 335567899999998752 2346889999999999999999999998766544443332110 0
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
+ .......++.++.+||.+||..||.+||++.++|+||||..
T Consensus 233 --------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 233 --------P-TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred --------c-cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0 00112356778999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=380.55 Aligned_cols=267 Identities=25% Similarity=0.377 Sum_probs=226.1
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
....++|++++.||+|+||.|.+++++.|++.||+|++++.. ........|+.|-.||..-+.+-|+.++ |...+..
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh--yAFQD~~ 148 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH--YAFQDER 148 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH--HHhcCcc
Confidence 445789999999999999999999999999999999996521 1223346789999999988999999994 4444467
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
++|+|||||+| +|+.++.+.. ++++..++.|+..|+.||+-||+.|+|||||||+|||||..|++||+|||.|-.+..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 79999999996 7888887776 899999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCcccccccCccccchhccC---C-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLG---S-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~---~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
+........+|||.|++||++.. . ..|+..+|+||+||++||||.|..||..++-.+.+.+|+..-...
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l------- 300 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL------- 300 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc-------
Confidence 55555678899999999999842 2 468999999999999999999999999999999999987641100
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC---HHHHhcCccCCCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT---AASALQNEFFNASPL 398 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~hp~f~~~~~ 398 (469)
.|+. ...+|.++++||.++|+ +|..|.. ++++-.||||.+.+.
T Consensus 301 ----------~FP~-----~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 301 ----------SFPD-----ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ----------CCCc-----ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 0010 12489999999999987 5888888 999999999997554
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=336.76 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=204.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++.+++||||+++++++... ..+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEE
Confidence 3679999999999999999999998999999999875432 2335678999999999999999999988764 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||++++.+..+......+++..+..++.|++.||.|||+.+|+|+||||+|||++.++.++|+|||++..+.... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 99999974444333344579999999999999999999999999999999999999999999999999998653221 12
Q ss_pred cccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 269 LTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
.....+++.|+|||.+.. ...++.++|||||||++|+|++|.+||......+....+... .
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~----------------~- 225 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS----------------N- 225 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC----------------C-
Confidence 234568899999998742 334678999999999999999999998654433222211110 0
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
+.+........++..+.+||.+||+.||++|||++++|+|+|
T Consensus 226 ----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 226 ----FQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ----CCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000000112346789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=336.18 Aligned_cols=279 Identities=40% Similarity=0.699 Sum_probs=222.6
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeEeeeEeeccc---cE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL---DHPNVIKLEGLATSRMQ---YS 185 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~---~~ 185 (469)
|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.++.++ +||||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999998899999999976544333345566788877766 69999999999876543 23
Q ss_pred EEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
++++|||+.+++...+.... ..+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 79999999988777665532 35999999999999999999999999999999999999999999999999999775322
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc-C
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL-T 343 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~ 343 (469)
.......++..|+|||++.+ ..++.++|||||||++|+|++|.+||......+.+.+++.....+....|..... .
T Consensus 161 --~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 --MALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred --cccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 22234457889999998876 4578999999999999999999999999999998888887766655443332211 0
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
....+......+....+.+++.+.+||.+||+.||.+||++.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 01111112223344455678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.70 Aligned_cols=258 Identities=28% Similarity=0.409 Sum_probs=210.3
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
-|++.+.||.|+||.||++.+..++..+++|.+... .......+.+|+++++.++||||+++++++... ...++||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEE
Confidence 378889999999999999999999999999998543 334456788999999999999999999988764 3579999
Q ss_pred ecchhhHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 191 DFMQSDLTK-IICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 191 e~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
||++++.+. .+.....++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... ....
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 160 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-cccc
Confidence 999975544 44444567999999999999999999999999999999999999999999999999999764322 1223
Q ss_pred ccccccCccccchhcc----CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 270 TSRVVTLWYRAPELLL----GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
....+++.|+|||++. ....++.++|||||||++|+|++|.+||...+..+....+......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 226 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-------------- 226 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC--------------
Confidence 3457899999999874 2344778999999999999999999999887766555544321100
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. ......++..+.+||.+||+.||.+|||+.++++||||...
T Consensus 227 --------~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 227 --------T-LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred --------C-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0 01123467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=330.41 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=211.5
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|.+.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++... ...|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 48888999999999999999999999999999876555556667888999999999999999999988764 4579999
Q ss_pred ecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 191 DFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 191 e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||+.+ ++...+... ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+.... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NF 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-ch
Confidence 99986 565555443 4579999999999999999999999999999999999999999999999999998664322 22
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+....+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------ 218 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------------ 218 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 234578899999998876 4578999999999999999999999988776555544432110
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
......++..+.++|.+||+.+|++||++.++++|||+
T Consensus 219 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 -------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 01122467889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.63 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=203.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHH-HHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRI-LQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||+|+||.||++.+..+|+.||||+++........ ..+..|+.+ ++.++||||+++++++.... .+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREG--DVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCC--cEEE
Confidence 4799999999999999999999999999999999765433333 344556665 66679999999999887643 4799
Q ss_pred EEecchhhHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 189 VFDFMQSDLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+|||+++++...+.. ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999877655532 345699999999999999999999997 9999999999999999999999999999865321
Q ss_pred CCCCcccccccCccccchhccCC---CCCCccccchhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGS---TDYGVGIDLWSAGCLLAEMFIGRPLMPGR-TEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGv~l~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.......++..|+|||++.+. ..++.++|+|||||++|+|++|+.||... ...+.+..+.... +
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-------- 225 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--S-------- 225 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--C--------
Confidence 122335678999999987542 34688999999999999999999999642 2233333322110 0
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+. .....++.++.+||.+||..||.+|||+.++++||||...
T Consensus 226 ------------~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 226 ------------PQ--LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ------------CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 00 0012367899999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=321.65 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=219.0
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 184 (469)
+...++.+.+..||.|+.|+||+++.+.+|...|||.+... .+.+..+.++..+.++..- ++|+||+.+|+|.....
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d- 165 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD- 165 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-
Confidence 34556778889999999999999999999999999999765 4455667777888877665 58999999999988544
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
++|.||.|..-...++.+-..+++|..+-.+...++.||.||.++ +|+|||+||+|||+|..|++||||||++..+..
T Consensus 166 -V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 166 -VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred -HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 588999998766666666567899999999999999999999965 899999999999999999999999999988744
Q ss_pred CCCCCcccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPG-RTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
. ...+...|.+.|||||.+.- ...|+..+||||||+.|+||.||+.||.+ +.+.+.+.++++..
T Consensus 245 S--kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e----------- 311 (391)
T KOG0983|consen 245 S--KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE----------- 311 (391)
T ss_pred c--cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-----------
Confidence 3 33556789999999998843 34689999999999999999999999987 45677777776521
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+|.+.. ...+++.+.+|+..||++|+.+||.-.++|+|||+...
T Consensus 312 -----------PP~L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 312 -----------PPLLPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred -----------CCCCCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 111211 22389999999999999999999999999999999864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=366.78 Aligned_cols=283 Identities=22% Similarity=0.318 Sum_probs=205.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCC-cEEEEEE--------------e-ecCCCCHHHHHHHHHHHHHHHhCCCCCee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTG-KIVALKK--------------V-RFDTSEPESVKFMAREIRILQKLDHPNVI 172 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~--------------~-~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 172 (469)
.++|++++.||+|+||+||+|..+... ..+++|. + +...........+.+|+.+|.+++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 478999999999999999998765322 2222221 1 01112223446688999999999999999
Q ss_pred eEeeeEeeccccEEEEEEecchhhHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC
Q 036673 173 KLEGLATSRMQYSLYLVFDFMQSDLTKIICRPG----QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 173 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 248 (469)
++++++.... ..|+|++++.++++..+.... .......++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 227 ~l~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRSEA--NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEECC--eeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 9999987754 469999999988877664422 2345677889999999999999999999999999999999999
Q ss_pred cEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCC-CCC--CChHHHHHHH
Q 036673 249 MLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPL-MPG--RTEVEQLHRI 325 (469)
Q Consensus 249 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p-f~~--~~~~~~~~~i 325 (469)
.+||+|||++..+...........+||+.|+|||++.+ ..++.++|||||||+||||++|..+ |.. .....++.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999998764433333345689999999998876 4589999999999999999998754 432 2344556666
Q ss_pred HHHhCCCCHH-------HHhhcccCccC-CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 326 FKLCGTPSED-------YWKKMKLTTTF-RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 326 ~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+..+.....+ +++.+...... .+......+. ...++..+.++|.+||++||.+|||+.|+|+||||...
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 5554433222 22221111100 0011111111 12367788999999999999999999999999999864
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=337.92 Aligned_cols=260 Identities=28% Similarity=0.460 Sum_probs=211.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||.|+||+||++.+..++..||+|++... .....+.+.+|++++++++||||+++++++... ..+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--CeEEE
Confidence 46799999999999999999999888999999998653 334457788999999999999999999988764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+++ ++...+......+++..++.++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 9999997 5555555545679999999999999999999999999999999999999999999999999987643221 1
Q ss_pred CcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 268 PLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
......+++.|+|||++.. ...++.++|||||||++|+|++|++||...+....+..+.... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~------------ 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-P------------ 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC-C------------
Confidence 2234568999999998742 2346789999999999999999999998776555444432210 0
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+. ......++..+.+||.+||+.||.+||++.++|+||||...
T Consensus 226 ---------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 226 ---------PT-LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ---------CC-cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00 01123467889999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=332.86 Aligned_cols=258 Identities=27% Similarity=0.461 Sum_probs=208.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC---CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS---EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
.+|++.+.||+|+||.||++.+..++..||||.+..... .......+.+|+.+++++.||||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999999865422 23345678899999999999999999998876655678
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+++|||+++ +|.+.+. ....+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 999999987 5555544 33468999999999999999999999999999999999999999999999999997653211
Q ss_pred --CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 266 --KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 266 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+.. .+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~---------- 226 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT---------- 226 (265)
T ss_pred ccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC----------
Confidence 112234568899999998876 4578999999999999999999999987655444433221 110
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
.......++..+.++|.+||. +|++||+++++++|||+.
T Consensus 227 -----------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 -----------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred -----------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 001223467788999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.19 Aligned_cols=277 Identities=26% Similarity=0.401 Sum_probs=209.2
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|++++.+++||||+++++++... ..+++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEE
Confidence 46999999999999999999999999999999986542 344556788999999999999999999988774 457999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+++ +|..++. ....+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++......
T Consensus 78 ~ey~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 78 MEHMDGGSLDQVLK-KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred eeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 999997 5555544 34679999999999999999999997 59999999999999999999999999998765222
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH--HHHhhcccCcc
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSE--DYWKKMKLTTT 345 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~~ 345 (469)
.....++++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.... ..++........ ...........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCC
Confidence 2345678999999998765 4588999999999999999999999976653332 222211100000 00000000000
Q ss_pred C-------------CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 346 F-------------RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 346 ~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. ......+.+ ....++.++.+||.+||..||.+|||+.++++||||....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccC--cCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 0 000000100 0113678899999999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=335.23 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=204.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|.+.+.||.|+||.||+|.+..+++.||+|+++.... .....+.+|+.+++.++||||+++++++... ...|+|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEE
Confidence 579999999999999999999999999999999875432 3335678899999999999999999988764 457999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||++++.+..+......+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccc
Confidence 999997444444444457999999999999999999999999999999999999999999999999998765322 2223
Q ss_pred ccccccCccccchhcc--CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 270 TSRVVTLWYRAPELLL--GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
....|++.|+|||++. ....++.++|||||||++|+|++|.+||...........+......
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---------------- 227 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ---------------- 227 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC----------------
Confidence 4557899999999874 2334788999999999999999999998765543333222111000
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
+ +.+ .....++..+.+||.+||+.||++|||+.++++|||
T Consensus 228 ~----~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 228 P----PKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred C----Ccc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 000 111246778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.75 Aligned_cols=256 Identities=26% Similarity=0.379 Sum_probs=205.2
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++++.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.++.+++||||+++++++.... ..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--RISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--EEEEE
Confidence 36888999999999999999999999999999987543 2344567889999999999999999999988754 46899
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||++++.+... ..+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++..+... ..
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 999998666543 24789999999999999999999999999999999999999999999999999765322 23
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhcccCccC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ---LHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
...+++..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ............
T Consensus 151 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------- 216 (279)
T cd06619 151 KTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------------- 216 (279)
T ss_pred cCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------------
Confidence 45678999999998876 4589999999999999999999999965322110 001111100000
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+. .....+++++.+||.+||+.||.+||++.++++||||...
T Consensus 217 -----~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 217 -----PPV--LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred -----CCC--CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 000 0123467889999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=338.11 Aligned_cols=257 Identities=27% Similarity=0.480 Sum_probs=211.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.+|++.+.||.|+||+||+|.+..+++.||||.+...... ..+.+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVG--DELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecC--ceEEEE
Confidence 5799999999999999999999999999999998754332 236688999999999999999999988764 457999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
+||+.++.+..+... ..+++.++..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 999997555444433 3589999999999999999999999999999999999999999999999999876543322 22
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+... ..+.
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------------- 234 (296)
T cd06655 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------------- 234 (296)
T ss_pred CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc----------------
Confidence 34568899999998765 45789999999999999999999999887766554443221 1100
Q ss_pred CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
......+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 235 ------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 235 ------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 01123567889999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=330.76 Aligned_cols=256 Identities=27% Similarity=0.522 Sum_probs=213.0
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||.|+||.||+|.+..++..||+|++..........+.+..|+.+++.++||||+++++++.......++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48899999999999999999999999999999976655556667788999999999999999999988776667789999
Q ss_pred ecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 191 DFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCH-----ERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 191 e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
||+++ +|...+.. ...++++..++.++.||+.||+||| +.+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99986 55555533 2457999999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
..... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------- 225 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG------------- 225 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-------------
Confidence 43221 1334578999999998866 44789999999999999999999999877644433332110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.+..+...++..+.+||.+||..||.+|||+.++|+|||+
T Consensus 226 ------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 ------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0112233567899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=350.74 Aligned_cols=253 Identities=20% Similarity=0.324 Sum_probs=213.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+...+...||.|.||+||+|++.. .||||+++.....++..+.|++|+.+|++-+|.||+-++|++..+.. .||
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~---AIi 465 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL---AII 465 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce---eee
Confidence 456778899999999999999975 49999999998888999999999999999999999999999987653 899
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC-CCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP-KQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~-~~~~ 267 (469)
+-+|+| +|...++.....|.....+.|++||++||.|||.++|||||||..||+|.+++.|||+||||+..-.. ....
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 999999 66777777777899999999999999999999999999999999999999999999999999975321 1222
Q ss_pred CcccccccCccccchhcc--CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 268 PLTSRVVTLWYRAPELLL--GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
......|...|||||++. ...+|+..+||||||||+|||++|..||........+..+-...
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~---------------- 609 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGY---------------- 609 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccc----------------
Confidence 344566788999999874 34579999999999999999999999998554444443332221
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..+++.......+.++++|+..||..++++||+..+||.
T Consensus 610 -----l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 610 -----LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 134444556677889999999999999999999999987
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=353.59 Aligned_cols=259 Identities=28% Similarity=0.449 Sum_probs=222.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
....|.+.++||+|.|++|.+|++..++..||||.+.+...+......+.+|+++|..|+|||||+++.+... ...+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeE
Confidence 4567999999999999999999999999999999998877777766778999999999999999999888776 44589
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+.++.+.......++..+..++.++.|+++|++|||+++|||||||.+||||+.+.++||+|||++..+. ...
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~ 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGL 209 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--ccc
Confidence 999999975544444555578889999999999999999999999999999999999999999999999999884 455
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
...+.||++.|.|||++.+..+.++.+|+||+|++||.|+.|..||.+.+-.+.-.+.+...
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk------------------ 271 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK------------------ 271 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee------------------
Confidence 67899999999999999988888899999999999999999999998866544433322110
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..+.--++.++.+||+++|.++|.+|++.+++..|.|....
T Consensus 272 --------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 272 --------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred --------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 01222457788999999999999999999999999998753
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=336.65 Aligned_cols=244 Identities=17% Similarity=0.201 Sum_probs=198.8
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEee--ccccEEEEEEec
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATS--RMQYSLYLVFDF 192 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~~~lv~e~ 192 (469)
..||+|+++.||+|.. +|+.||||+++.... .....+.+.+|+.+|.+++||||+++++++.+ .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5699999999999988 489999999976533 23335778899999999999999999999876 444567999999
Q ss_pred chhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccc
Q 036673 193 MQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS 271 (469)
Q Consensus 193 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 271 (469)
+.++.+..+......+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..+... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----ccc
Confidence 99854444444455799999999999999999999984 9999999999999999999999999999865321 234
Q ss_pred ccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 272 RVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 272 ~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
..+++.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------------------ 241 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL------------------ 241 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC------------------
Confidence 5788999999988642 468999999999999999999999999877666555543321111
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......++.+.+||.+||+.||.+|||+.++++
T Consensus 242 ------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 ------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111246789999999999999999999999985
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=331.66 Aligned_cols=255 Identities=29% Similarity=0.535 Sum_probs=205.4
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-------HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-------PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
+|.+...||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 477888999999999999999888999999988654221 12335688999999999999999999988764
Q ss_pred cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 184 YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
...+++|||+++..+..+......+++..+..++.|++.||+|||++|++|+||+|+|||+++++.++|+|||++..+..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 35689999998744444444445789999999999999999999999999999999999999999999999999987642
Q ss_pred CCC-----CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 036673 264 KQK-----GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 264 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 228 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--------- 228 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---------
Confidence 211 11223457889999998865 457889999999999999999999998765544443332210
Q ss_pred hcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.+ .....++..+.+||.+||+.||.+||++.++++||||
T Consensus 229 -------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 -------------SP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -------------CC---cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 00 1223567889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=334.89 Aligned_cols=277 Identities=36% Similarity=0.702 Sum_probs=225.6
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEEEEE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
|.+.+.||.|+||+||+|....+++.||||++........ .....+|+..+.+++ ||||+++++++.. ....++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 6788899999999999999998899999999865433222 233457999999998 9999999998877 44579999
Q ss_pred ecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 191 DFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 191 e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
||+.+++...+.... ..+++..+..++.|++.+|.|||+++|+|+||+|+||+++.++.++|+|||++...... ...
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCc
Confidence 999888887776543 46899999999999999999999999999999999999999999999999999865322 223
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc-C--
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT-F-- 346 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~-- 346 (469)
....++..|+|||++.....++.++|+||||+++|+|++|++||+.....+.+..+....+.+....|........ .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 4456789999999886656688999999999999999999999999999999988888888887665544321111 1
Q ss_pred -CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 347 -RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 347 -~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.+......+.......+..+.+||.+||+.||.+|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 11111122333344457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=335.84 Aligned_cols=253 Identities=27% Similarity=0.480 Sum_probs=210.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||.|+||.||++.+..+++.||+|++.... ........+.+|++++++++||||+++++++... ..+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEE
Confidence 46999999999999999999999999999999986532 2233456788999999999999999999988764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+.+ +|...+.. ...+++..+..++.||+.||.|||++||+|+||+|+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999965 55555544 357999999999999999999999999999999999999999999999999999875332
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+... .+
T Consensus 155 -~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------------- 215 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KV--------------- 215 (290)
T ss_pred -CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc---------------
Confidence 334578999999998865 45789999999999999999999999877755544444311 00
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.+...++..+.++|.+||+.||.+|+ +++++++||||...
T Consensus 216 ---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 216 ---------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred ---------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 11234578899999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=337.52 Aligned_cols=257 Identities=27% Similarity=0.488 Sum_probs=209.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
..+|++.+.||.|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++.+... ...|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG--DELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--CEEEE
Confidence 46899999999999999999999989999999998764433 236688999999999999999999988764 45799
Q ss_pred EEecchhh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+.++ +...+.. ..+++.++..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++....... .
T Consensus 95 v~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~ 171 (296)
T cd06654 95 VMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (296)
T ss_pred eecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-c
Confidence 99999874 5544432 358999999999999999999999999999999999999999999999999987653322 1
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...........+... ..+.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~-------------- 235 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE-------------- 235 (296)
T ss_pred ccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC--------------
Confidence 2234578899999998765 45789999999999999999999999877654443322211 0000
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
......++..+.+||.+||..||++|||+.++++||||...
T Consensus 236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred --------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 01123567889999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=327.06 Aligned_cols=254 Identities=27% Similarity=0.458 Sum_probs=214.0
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++++.||.|+||.||.++...+++.+++|.+............+.+|+.++++++|+||+++++++... ..++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEEE
Confidence 58999999999999999999999999999999876655556667788999999999999999999998774 4579999
Q ss_pred ecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 191 DFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 191 e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||+++ ++...+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 99986 666666543 45689999999999999999999999999999999999999999999999999986533321 2
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..||......+....+... .+
T Consensus 158 ~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~---------------- 218 (256)
T cd08221 158 AETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NY---------------- 218 (256)
T ss_pred ccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CC----------------
Confidence 3456789999999988764 4788999999999999999999999887766666555321 00
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
......++..+.++|.+||..||.+||++.++|+|+|+
T Consensus 219 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 219 -------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 01124567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=339.48 Aligned_cols=262 Identities=31% Similarity=0.429 Sum_probs=212.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||.|+||+||+|.+..+++.||||.+...... ....+.+..|++++..++||||+++++++... ...|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEEE
Confidence 4699999999999999999999999999999999765333 23456788999999999999999999887663 45799
Q ss_pred EEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||||+.+ +|..++.. .+..+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999987 66565543 235699999999999999999999999999999999999999999999999999875432111
Q ss_pred C----------------------------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh
Q 036673 267 G----------------------------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE 318 (469)
Q Consensus 267 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~ 318 (469)
. ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 1123467889999998876 4578999999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC----HHHHhcCccCC
Q 036673 319 VEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT----AASALQNEFFN 394 (469)
Q Consensus 319 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----a~elL~hp~f~ 394 (469)
...+..+..... .+ .....++..+.+||.+||+.||++||| ++++|+||||+
T Consensus 238 ~~~~~~~~~~~~-------------------~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 238 DETFSNILKKEV-------------------TF-----PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred HHHHHHHhcCCc-------------------cC-----CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence 665554432100 00 011226889999999999999999999 99999999998
Q ss_pred CCCC
Q 036673 395 ASPL 398 (469)
Q Consensus 395 ~~~~ 398 (469)
....
T Consensus 294 ~~~~ 297 (316)
T cd05574 294 GVNW 297 (316)
T ss_pred cCCh
Confidence 7543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.99 Aligned_cols=259 Identities=24% Similarity=0.410 Sum_probs=207.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++++.||+|+||.||++.+..++..||+|.+.... .......+.+|+.++.+++||||+++++.+... ..+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEE
Confidence 46899999999999999999999899999999987542 334456788999999999999999999987764 457999
Q ss_pred EecchhhHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 190 FDFMQSDLTKIICRP---GQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|||+++..+..+... ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++..+...
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 999998544444332 2369999999999999999999997 59999999999999999999999999999765221
Q ss_pred CCCcccccccCccccchhccCCC-----CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGST-----DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
......+++.|+|||++.+.. .++.++|||||||++|+|++|..||...........+.......
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 226 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-------- 226 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC--------
Confidence 223456788999999875432 35789999999999999999999997655443333322211110
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...+...++.++.+||.+||+.||.+||++.++++||||...
T Consensus 227 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 227 --------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred --------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 012234578899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=342.27 Aligned_cols=265 Identities=28% Similarity=0.449 Sum_probs=214.7
Q ss_pred CCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.|...+.|+.-++||+|+||.||-++.+.||+.||.|.+.+.... ........+|-.||.+++.+.||.+ .|..+..
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl--aYAfeTk 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL--AYAFETK 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE--eeeecCC
Confidence 566778899999999999999999999999999999988543221 1222456789999999999999999 4444446
Q ss_pred cEEEEEEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
..+|||+..|+| +|...+...+ ..|++..++.++.+|+.||++||+.+||.|||||+|||||+.|+++|+|+|||..+
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 678999999997 5544444433 35999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
. ...+....+||.+|||||++.+.. |+...|.|||||+||||+.|+.||........-..+-......+
T Consensus 338 ~--~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-------- 406 (591)
T KOG0986|consen 338 P--EGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-------- 406 (591)
T ss_pred C--CCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--------
Confidence 3 344566779999999999998755 99999999999999999999999976543322222221111111
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.++...+|+++++|.+.+|++||.+|. .++++-+||||+.-
T Consensus 407 --------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 407 --------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred --------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 134467899999999999999999996 47799999999953
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.30 Aligned_cols=256 Identities=28% Similarity=0.484 Sum_probs=210.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++|+||+++++++... ..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEE
Confidence 468899999999999999999999999999999875532 33446688999999999999999999988764 467999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
+||+.+ ++...+.. . ++++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++..+.... ..
T Consensus 78 ~e~~~~~~L~~~~~~-~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 78 MEYCGGGSCLDLLKP-G-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred EEeeCCCcHHHHHhh-c-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 999987 55555543 2 79999999999999999999999999999999999999999999999999998764332 22
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+.......+....
T Consensus 155 ~~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------------- 214 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN------------------- 214 (274)
T ss_pred cccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-------------------
Confidence 3455788899999988764 48999999999999999999999997766444433332110
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+.+.. ..++..+.++|.+||..||.+|||+.++++||||...
T Consensus 215 ---~~~~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 215 ---PPSLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ---CCCCcc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 011100 1267889999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=329.80 Aligned_cols=256 Identities=26% Similarity=0.462 Sum_probs=205.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC----HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE----PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
+|++.+.||.|+||.||+|... +++.+|||.+...... ......+.+|+.+++.++|+||+++++++... ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeE
Confidence 4788899999999999999875 6899999998754322 23346688999999999999999999998774 467
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC--
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK-- 264 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 264 (469)
+++|||+.+..+..+.....++++..+..++.||+.||+|||+.+|+|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999987444444344457899999999999999999999999999999999999999999999999998764211
Q ss_pred ---CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 265 ---QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 265 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.........++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL---------- 226 (265)
T ss_pred cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----------
Confidence 1112234568999999998865 45789999999999999999999999876554443332221110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
...+...++.++.+||.+||..||.+|||+.++|+||||
T Consensus 227 -------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 -------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 012234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.09 Aligned_cols=261 Identities=26% Similarity=0.473 Sum_probs=209.9
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecc--
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRM-- 182 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-- 182 (469)
+...++|++.+.||.|+||.||+|.+..+++.+++|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 4567899999999999999999999998899999999875432 336688999999999 7999999999987644
Q ss_pred --ccEEEEEEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeec
Q 036673 183 --QYSLYLVFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFG 256 (469)
Q Consensus 183 --~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFG 256 (469)
...+++||||+.+ ++.+.+.. .+..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 4567999999997 44444322 24579999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 036673 257 LSNFFIPKQKGPLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTP 332 (469)
Q Consensus 257 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~ 332 (469)
++...... ........+++.|+|||++.. ...++.++|||||||+||+|++|.+||........+..+... +
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~ 234 (275)
T cd06608 159 VSAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---P 234 (275)
T ss_pred cceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---C
Confidence 98765322 222345668999999998753 234678899999999999999999999866555444443221 0
Q ss_pred CHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 333 SEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
. +.+ .....++..+.+||.+||..||++|||+.++++|||+
T Consensus 235 ~-------------------~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 P-------------------PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C-------------------CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 000 1112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=337.15 Aligned_cols=256 Identities=27% Similarity=0.465 Sum_probs=212.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
..|++.+.||.|+||+||+|.+..+++.||+|++.... ...+..+.+.+|+.+++.++||||+++++++.... ..|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~--~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--TAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--eEEE
Confidence 56999999999999999999999889999999986542 33444567889999999999999999999988744 4699
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+.+++...+......+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 999999988887766556799999999999999999999999999999999999999999999999999976422
Q ss_pred cccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 269 LTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+.......+... ..
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~--------------- 231 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DS--------------- 231 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CC---------------
Confidence 234567889999998742 345788999999999999999999999877665544433210 00
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+.+ ....++..+.+||.+||..||.+||++.+++.||||...
T Consensus 232 ------~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 ------PTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ------CCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 000 012357789999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=313.06 Aligned_cols=278 Identities=31% Similarity=0.596 Sum_probs=228.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++++++|+|.|+.||.|....+++.++||+++. -..+.+.+|+.||+.|. ||||++++++..++.....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 45889999999999999999999999999999999864 33477899999999996 9999999999988887778
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC-CcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS-GMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~ 265 (469)
.||+||+++.....+.. .|+.-+++.++.+++.||.|+|++||+|||+||.|++||.. -.++|+|+|+|.++.+..
T Consensus 111 aLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 99999999855554443 58999999999999999999999999999999999999975 469999999999986654
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCC-HHHHhhccc-
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQLHRIFKLCGTPS-EDYWKKMKL- 342 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~-~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~- 342 (469)
. ....+.+..|--||.+.....|+..-|+|||||+|..|+..+ |.|.+.++.+++-+|.+.+|+.. ..+..+...
T Consensus 188 e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 188 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred e--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 4 345677889999999988888999999999999999999876 55678899999999999988754 223332211
Q ss_pred -CccCCC---CCCCCcchhcc-----cCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 343 -TTTFRP---QHYKPSFREVF-----GEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 343 -~~~~~~---~~~~~~~~~~~-----~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
...|.. ......+..+. .-.++++.|||.++|..|..+|+||.|++.||||..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 111111 11122222221 124689999999999999999999999999999975
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=346.51 Aligned_cols=268 Identities=26% Similarity=0.386 Sum_probs=201.7
Q ss_pred hccCCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec
Q 036673 102 AGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR 181 (469)
Q Consensus 102 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 181 (469)
...+...+++|...+.||+|+||.||+|...+ +..||||++....... ..+|.+|+.+|.+++|||+|+|+|||.+.
T Consensus 67 ~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 67 YDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred HHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 33445667899999999999999999999886 5999999887654432 35599999999999999999999999986
Q ss_pred cccEEEEEEecchh-hHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcEEEcCCCcEEEeeec
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPGQ-KLTEPQVKCYMQQLLSGLQHCHER---GILHRDIKASNLLIDKSGMLKIADFG 256 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~kl~DFG 256 (469)
.. ..+||||||.+ +|.+.+..... +++|..+..|+.++++||+|||+. .||||||||+|||||.++++||+|||
T Consensus 144 ~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG 222 (361)
T KOG1187|consen 144 GE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG 222 (361)
T ss_pred Cc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence 64 46999999995 77777766655 899999999999999999999985 39999999999999999999999999
Q ss_pred CcccccCCCCCCcccc-cccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCC
Q 036673 257 LSNFFIPKQKGPLTSR-VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT--EVEQLHRIFKLCGTPS 333 (469)
Q Consensus 257 la~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~--~~~~~~~i~~~~~~~~ 333 (469)
+|+...... ...... .||.+|+|||.+.. ...+.++|||||||+|+||+||+.+..... ....+..+..
T Consensus 223 La~~~~~~~-~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~------ 294 (361)
T KOG1187|consen 223 LAKLGPEGD-TSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK------ 294 (361)
T ss_pred CcccCCccc-cceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH------
Confidence 996542211 112222 89999999998765 558999999999999999999998876432 1111111110
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCC-----hhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFP-----PSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..+........+ .+.+.. ..++ ..+..+..+|++.+|.+||+..|+++
T Consensus 295 -~~~~~~~~~eii-----D~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 295 -PLLEEGKLREIV-----DPRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -HHHHCcchhhee-----CCCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 011111111111 111110 1111 23667889999999999999999754
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=333.15 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=206.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec----c
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR----M 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~----~ 182 (469)
..+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.++.++ +||||+++++++... .
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 3478999999999999999999999999999999986432 2335678899999998 799999999988542 2
Q ss_pred ccEEEEEEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 183 QYSLYLVFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
...+|++|||+++ ++...+.. ....+++..+..++.||+.||+|||+.+|+|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 4567999999987 55555543 234588999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
..... .......+++.|+|||++.. ...++.++|||||||++|+|++|.+||...........+... .
T Consensus 171 ~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~---- 242 (282)
T cd06636 171 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P---- 242 (282)
T ss_pred hhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---C----
Confidence 53221 22345678999999998753 235788999999999999999999999765544333322110 0
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.+. .....++..+.+||.+||..||.+|||+.++|+||||
T Consensus 243 ---------------~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 ---------------PPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ---------------CCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000 1123467899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=337.05 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=209.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
..+|++++.||.|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++... ...|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG--DELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CEEEE
Confidence 47899999999999999999999989999999998754332 236678999999999999999999988764 35799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+++..+..+... ..+++.++..++.|++.||.|||+.+|+|+||||+|||++.++.++|+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 171 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cC
Confidence 9999987544444332 358999999999999999999999999999999999999999999999999997653322 12
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+.. .+.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~--------------- 234 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------- 234 (297)
T ss_pred cCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------------
Confidence 234578899999998865 5578999999999999999999999977654333222111 01100
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
......++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 235 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 235 -------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred -------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 011234678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=327.92 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=208.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++... ..+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEEEEE
Confidence 679999999999999999999998899999999976533 2457788999999999999999999988764 457999
Q ss_pred EecchhhHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQSDLTK-IICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||++++.+. .+......+++..+..++.|++.||+|||+++|+|+||+|+||+++.++.++|+|||++..+.... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999975444 444443679999999999999999999999999999999999999999999999999997653221 12
Q ss_pred cccccccCccccchhccCC--CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 269 LTSRVVTLWYRAPELLLGS--TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|.+||...+.......+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP--------------- 222 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------------
Confidence 2345788899999987653 25788999999999999999999999877665554433221000
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
+........++.++.+||.+||..||..|||+.+++.|+|
T Consensus 223 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 223 ------PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0000112245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=331.99 Aligned_cols=262 Identities=28% Similarity=0.457 Sum_probs=208.3
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecc--
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRM-- 182 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-- 182 (469)
....++|.+.+.||.|+||.||++.+..+++.+|+|++.... .....+.+|+.++.++ +||||+++++++...+
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 345788999999999999999999999999999999986432 2235677899999999 8999999999887543
Q ss_pred -ccEEEEEEecchh-hHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecC
Q 036673 183 -QYSLYLVFDFMQS-DLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL 257 (469)
Q Consensus 183 -~~~~~lv~e~~~~-~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGl 257 (469)
....++||||+++ ++...+. .....+++..++.++.|++.||+|||+.+|+|+||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 2457999999987 4444432 2345789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCccccchhccCCC----CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036673 258 SNFFIPKQKGPLTSRVVTLWYRAPELLLGST----DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS 333 (469)
Q Consensus 258 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 333 (469)
+........ ......++..|+|||++.... .++.++|||||||++|+|++|++||........+..+... +.
T Consensus 175 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~ 250 (291)
T cd06639 175 SAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PP 250 (291)
T ss_pred chhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CC
Confidence 986532221 123456889999999875432 3678999999999999999999999876655544433211 00
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
+.+ .....++..+.+||.+||+.||++||++.++|+||||+
T Consensus 251 -------------------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 -------------------PTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -------------------CCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000 01124567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=346.03 Aligned_cols=258 Identities=25% Similarity=0.407 Sum_probs=215.4
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
.++||.|.||+||-|.++.+|+.||||++.+-.........+.+|+.||+.+.||.||.+.-.|+.. ..+++|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~--ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP--ERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC--ceEEEEehhhc
Confidence 3679999999999999999999999999976544444447899999999999999999997666664 45799999999
Q ss_pred hhHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC---CcEEEeeecCcccccCCCCCCcc
Q 036673 195 SDLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS---GMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 195 ~~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
|+.+..++. ..++|++...+.++.||+.||.|||-++|+|+||||+||||... -.+||||||+|+.+.. .....
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ksFRr 724 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KSFRR 724 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--hhhhh
Confidence 998888755 45679999999999999999999999999999999999999654 3799999999998843 34466
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
+.+|||.|+|||++.+ +.|+..-|+||.|||+|--|+|..||..+.+. -.+|.+...-
T Consensus 725 sVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFM------------------- 782 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFM------------------- 782 (888)
T ss_pred hhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccc-------------------
Confidence 8899999999999876 56999999999999999999999999754433 2333221111
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCC
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACD 401 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~ 401 (469)
|++ ..|.++++.+.|||..+|+..-.+|.|.++.|.|||++...+-.+
T Consensus 783 yPp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~D 830 (888)
T KOG4236|consen 783 YPP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLD 830 (888)
T ss_pred cCC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHH
Confidence 111 346688999999999999999999999999999999997654333
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=325.70 Aligned_cols=255 Identities=29% Similarity=0.526 Sum_probs=207.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC---CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT---SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
+|+..+.||.|+||+||+|.+..++..|++|.+.... ...+..+.+.+|+.+++.++|+||+++++++... ..++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEE
Confidence 4778889999999999999999889999999986543 2234557788999999999999999999987664 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
++|||+++..+..+......+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999874444343444568999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......+++.|+|||.+.....++.++|+|||||++|+|++|++||......+....+....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------------------ 218 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK------------------ 218 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc------------------
Confidence 23456789999999987654347899999999999999999999997765444433322100
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
....+...++..+.+||.+||..||.+|||+.++|.|||+
T Consensus 219 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 219 ------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0012234567889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=327.19 Aligned_cols=254 Identities=30% Similarity=0.501 Sum_probs=208.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||.|+||.||+|.+..+++.||+|.+..... .+.+.+|+.+++.++||||+++++++... ..+|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEE
Confidence 3679999999999999999999998899999999864321 57789999999999999999999988774 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
++||+.+ .+.+.+......+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++........
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999997 55555544556799999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+... .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~--------------- 215 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---P--------------- 215 (256)
T ss_pred ccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---C---------------
Confidence 2234557889999998866 45889999999999999999999999876554333221110 0
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.........++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 216 -----~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 216 -----PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -----CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00001123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=330.06 Aligned_cols=261 Identities=30% Similarity=0.504 Sum_probs=205.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC--------CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS--------EPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
+|.+.+.||.|+||.||+|.+..+++.||||.+..... .....+.+..|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 47888999999999999999998899999998864311 112235678899999999999999999988764
Q ss_pred ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 183 QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 183 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
...++||||+.++.+.........+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 81 -EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred -CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 4579999999874444443444579999999999999999999999999999999999999999999999999997643
Q ss_pred CCCC-CCcccccccCccccchhccCCC-CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 263 PKQK-GPLTSRVVTLWYRAPELLLGST-DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 263 ~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.... .......++..|+|||++.... .++.++|+||||+++|+|++|..||......+.+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 230 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA--------- 230 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC---------
Confidence 2211 1123456789999999876543 4788999999999999999999999765544433322111000
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
... .......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 231 --------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 231 --------PPI---PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --------CcC---CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 000 012234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=329.97 Aligned_cols=260 Identities=30% Similarity=0.530 Sum_probs=205.9
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC----CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS----EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
+|+..+.||+|+||.||++.+..+++.||+|++..... .....+.+.+|+.++++++|+||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS--HF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--eE
Confidence 47888999999999999999999999999999875431 1234577889999999999999999999887643 56
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-cEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 265 (469)
++||||+.+..+..+.....++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++..+....
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999754444444445799999999999999999999999999999999999998776 59999999997764321
Q ss_pred C---CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 266 K---GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 266 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------- 226 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA----------- 226 (268)
T ss_pred ccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-----------
Confidence 1 11223467899999998865 45789999999999999999999999755433333222211000
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
... ......+++.+.++|.+||..||.+|||+.++|+||||+
T Consensus 227 -------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 -------TTA---PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -------CCC---CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000 122235678899999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=325.37 Aligned_cols=254 Identities=25% Similarity=0.479 Sum_probs=210.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||.|+||.||++.+..+++.||+|.+............+.+|+.+++.++||||+++++++... ...++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEEEEE
Confidence 58999999999999999999999999999999876544444556788999999999999999999988664 4579999
Q ss_pred ecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 191 DFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 191 e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||+.+ ++...+... ...+++..+..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-EL 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hh
Confidence 99986 666655442 3358999999999999999999999999999999999999999999999999997653221 11
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+.....
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~------------------ 218 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY------------------ 218 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC------------------
Confidence 234467889999998865 4578899999999999999999999987766665554432110
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
......++.++.++|.+||+.||.+||++.++|+||||
T Consensus 219 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 -------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 01223567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=334.08 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=209.0
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||.|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+... ..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEE
Confidence 469999999999999999999999999999999875432 223346778999999999999999999887663 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC--
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK-- 266 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 266 (469)
||||++|..+..+......+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999744444444445799999999999999999999999999999999999999999999999999864211100
Q ss_pred ------------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 036673 267 ------------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSE 334 (469)
Q Consensus 267 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 334 (469)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 235 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW-- 235 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC--
Confidence 01112457889999998765 458999999999999999999999998876665555443211000
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC---HHHHhcCccCCCCC
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT---AASALQNEFFNASP 397 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~hp~f~~~~ 397 (469)
+ .....++..+.+||.+||+.||.+||+ +.++|+||||....
T Consensus 236 ------------------~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 236 ------------------P---EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ------------------C---CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 0 011246788999999999999999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=331.10 Aligned_cols=263 Identities=27% Similarity=0.473 Sum_probs=206.8
Q ss_pred cCCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEee--
Q 036673 104 LVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATS-- 180 (469)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-- 180 (469)
.++...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.++..+ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34556789999999999999999999999999999999875422 1225577899999999 79999999998753
Q ss_pred -ccccEEEEEEecchh-hHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 181 -RMQYSLYLVFDFMQS-DLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 181 -~~~~~~~lv~e~~~~-~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
......++||||+++ +|...+. .....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 234568999999987 4444432 23456899999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 036673 256 GLSNFFIPKQKGPLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT 331 (469)
Q Consensus 256 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (469)
|++....... .......+++.|+|||++.. ...++.++|||||||++|+|++|++||........+..+...
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--- 244 (286)
T cd06638 169 GVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--- 244 (286)
T ss_pred CceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---
Confidence 9997653321 22334578999999998743 234788999999999999999999999776544333222110
Q ss_pred CCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
. .+.. .....++..+.+||.+||+.||.+|||+.++|+|+||
T Consensus 245 ~-------------------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 P-------------------PPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred C-------------------CCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0 0000 0112346789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=348.13 Aligned_cols=237 Identities=26% Similarity=0.387 Sum_probs=198.5
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
++-||.|+.|.||+|+.+ ++.||||+++. .-..+|+-|++|+||||+.|.|+|.... +.|||||||.
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsP--cyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSP--CYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCc--eeEEeeeccc
Confidence 466999999999999988 78999998852 2236889999999999999999998854 4599999999
Q ss_pred hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccc
Q 036673 195 SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274 (469)
Q Consensus 195 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 274 (469)
.+-+..+++.+.+++......|..+|+.||+|||.++|||||||+-||||..+..|||+|||.++.+... ....+++|
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 7777777777889999999999999999999999999999999999999999999999999999876433 44568899
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCc
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPS 354 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (469)
|..|||||++.+ .+.++++|||||||||||||||..||.+-+....+ +. .|.....
T Consensus 274 TVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---wG-VGsNsL~------------------- 329 (904)
T KOG4721|consen 274 TVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---WG-VGSNSLH------------------- 329 (904)
T ss_pred hHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeE---Ee-ccCCccc-------------------
Confidence 999999999976 56899999999999999999999999764433222 11 1111000
Q ss_pred chhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCc
Q 036673 355 FREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391 (469)
Q Consensus 355 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 391 (469)
..+....|+.++-||+.||.-.|..||+..++|.|-
T Consensus 330 -LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 330 -LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred -ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 023446788899999999999999999999999983
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.87 Aligned_cols=253 Identities=26% Similarity=0.460 Sum_probs=208.6
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||+|+||.||+|.+..+++.+|||.+............+.+|+.+++.++||||+++++.+... ...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEEEE
Confidence 58899999999999999999999999999999976544455567889999999999999999999887653 4579999
Q ss_pred ecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-cEEEeeecCcccccCCCCC
Q 036673 191 DFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 191 e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 267 (469)
||+++ ++.+.+... ...+++..+..++.|++.+|+|||++||+|+||+|+||+++.++ .++|+|||++...... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK--S 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--c
Confidence 99987 555555443 34589999999999999999999999999999999999998654 6899999999876332 2
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~------------------ 217 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT------------------ 217 (256)
T ss_pred cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC------------------
Confidence 2334568899999998865 457899999999999999999999998776555444432210
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 218 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 218 -------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 011223467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=324.03 Aligned_cols=259 Identities=31% Similarity=0.542 Sum_probs=208.0
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|.+.+.||+|+||.||++.+..+++.||+|++..........+.+.+|+.+++.++|+||+++++++... ..+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEEEE
Confidence 58899999999999999999998899999999987655555678899999999999999999999987654 4579999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC--
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP-- 268 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 268 (469)
||+.+..+..+......+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.+||+|||++..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 999975544444445568999999999999999999999999999999999999999999999999998764332221
Q ss_pred -cccccccCccccchhccCCC--CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 269 -LTSRVVTLWYRAPELLLGST--DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 269 -~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||............... +..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~------------- 224 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK------------- 224 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC-------------
Confidence 12356788999999886533 3788999999999999999999999765332222211111 100
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
+.+ .....++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 225 -------~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 225 -------PPI-PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -------CCC-CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 1122357889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=327.91 Aligned_cols=252 Identities=17% Similarity=0.230 Sum_probs=201.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC---CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR---DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.++|++.+.||+|+||.||+|.+. ..+..||+|+++.... ......+.+|+.++..++||||+++++++... ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CC
Confidence 357999999999999999999865 3467899999875432 34446788999999999999999999988764 35
Q ss_pred EEEEEecchhh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+++||||++++ +...+......+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 79999999974 55555554557999999999999999999999999999999999999999999999999987654222
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.........++..|+|||++.+ ..++.++|||||||++|||++ |.+||......+.+..+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------ 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------------ 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------------
Confidence 1111122344678999998865 558999999999999999775 99999887776655544221100
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.+++.+||+.||.+|||+.++++
T Consensus 228 -------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 -------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=335.43 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=209.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+.|.....||.|+||.||++.+..++..||||++.... ....+.+.+|+.+++.++||||+++++.+... ...|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEE
Confidence 44555677999999999999999889999999986432 23446788999999999999999999988764 457999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||++++.+..+... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++....... ...
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 175 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR 175 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence 999998555444433 368999999999999999999999999999999999999999999999999987643222 223
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
....+++.|+|||.+.+ ..++.++|||||||++|||++|..||...+....+..+......
T Consensus 176 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 236 (292)
T cd06658 176 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP------------------ 236 (292)
T ss_pred ceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------
Confidence 34578999999998765 45789999999999999999999999877766554443221100
Q ss_pred CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
.+ .....++..+.+||.+||..||.+|||+.++|+||||...+.+
T Consensus 237 ----~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 237 ----RV-KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred ----cc-ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 00 1122457789999999999999999999999999999975443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=332.89 Aligned_cols=261 Identities=23% Similarity=0.378 Sum_probs=204.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|...+.||.|+||.||++.+..+++.||||.+...... .....+.+|+.++.++. ||||+++++++.... ..++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--DCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--cEEE
Confidence 4677788899999999999999999999999998754333 44567889999999995 999999999887643 4589
Q ss_pred EEecchhhHHHH---Hh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 189 VFDFMQSDLTKI---IC-RPGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 189 v~e~~~~~l~~~---~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
+|||+..++... +. .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999998654332 22 2335799999999999999999999975 999999999999999999999999999976532
Q ss_pred CCCCCcccccccCccccchhccCC--CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGS--TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.. ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ....+........
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~-------- 228 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP-------- 228 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC--------
Confidence 21 22344678999999988765 3688999999999999999999999975441 1122211111000
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.... ......++.++.+||.+||+.||.+|||+.++++||||+.
T Consensus 229 -------~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 229 -------PILS---NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred -------CcCC---CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 0000 0112357889999999999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=324.84 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=200.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.+.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++... ...++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 82 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKI 82 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEE
Confidence 344555567999999999999999889999999886432 33456788999999999999999999988764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-CCcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKL--TEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-SGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~ 264 (469)
|+||+.+ +|...+......+ ++..+..++.||+.||+|||++||+||||||+|||++. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999986 5555555443445 88899999999999999999999999999999999976 679999999999765322
Q ss_pred CCCCcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. .......+++.|+|||++.+. ..++.++|||||||++|+|++|++||................
T Consensus 163 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 227 (268)
T cd06624 163 N-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-------------- 227 (268)
T ss_pred C-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh--------------
Confidence 2 222344678999999987543 347889999999999999999999996543221111000000
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.....+...+++++.+||.+||..+|.+|||+.+++.||||
T Consensus 228 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 ---------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ---------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00011233567889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=323.43 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=208.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC---CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT---SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.++++++|+||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46999999999999999999999999999999886432 223445678899999999999999999998877666678
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+++|||+++ ++...+. ....+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK-AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 999999987 4555544 33468999999999999999999999999999999999999999999999999998653211
Q ss_pred --CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 266 --KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 266 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
........++..|+|||++.+ ..++.++|+|||||++|+|++|++||......+...++.. .+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~---------- 226 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT---------- 226 (264)
T ss_pred ccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC----------
Confidence 112234568999999998876 4478999999999999999999999987655554443321 110
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.......+++.+.++|.+||. +|..|||+.++|.|||.
T Consensus 227 -----------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 -----------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -----------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 012334578899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=330.84 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=212.3
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.|...+.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++... ...|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 99 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLV 99 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEE
Confidence 36777889999999999999999999999999875432 334446788899999999999999999988774 456999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||+.+++...+.....++++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.... ..
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~~ 174 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PA 174 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----CC
Confidence 9999998888877666679999999999999999999999999999999999999999999999999986432 22
Q ss_pred ccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 270 TSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
....++..|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+.... .+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~--------------- 238 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SP--------------- 238 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CC---------------
Confidence 34578899999998742 2457889999999999999999999998876665555443210 00
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. .....++..+.+||.+||+.+|.+||++.++|.||||...+
T Consensus 239 ------~--~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 239 ------T--LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred ------C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 0 11234567899999999999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.89 Aligned_cols=265 Identities=23% Similarity=0.364 Sum_probs=208.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||++.+..+++.||+|++..... ....+.+.+|++++..++||||+++++++... ..+++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEE
Confidence 4679999999999999999999999999999999875432 34457788999999999999999999998775 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||++++.+..+......+++..+..++.+++.||.|||+ .+|+|+||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999985555554445579999999999999999999997 69999999999999999999999999998754221
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCHHHHhhcccC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ----LHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
......++..|+|||++.+. .++.++|||||||++|+|++|..||......+. ...+.. .+..+...
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 228 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD--------LLQQIVQE 228 (284)
T ss_pred ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH--------HHHHHhhc
Confidence 12345789999999988654 588999999999999999999999986554211 000100 00000000
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. .+.+ ....++..+.+||.+||..||.+|||+.++++|+||....
T Consensus 229 ~-------~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 229 P-------PPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred c-------CCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 0000 0113677899999999999999999999999999997754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=333.17 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=209.1
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
.|+....||.|+||.||+|.+..+++.||||++...... ..+.+.+|+.++..++||||+++++++... ...|+||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv~ 97 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVLM 97 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEEE
Confidence 344556799999999999999988999999998654332 235678999999999999999999988764 4569999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
||++++.+..+... ..+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+.... ....
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 99997555444433 468999999999999999999999999999999999999999999999999987543222 2234
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
...+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+... +
T Consensus 176 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~------------------ 233 (297)
T cd06659 176 SLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---P------------------ 233 (297)
T ss_pred ceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---C------------------
Confidence 5678999999998865 45789999999999999999999999877766555433210 0
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
.........++..+.++|.+||+.||.+||++.++++||||.....+
T Consensus 234 --~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 234 --PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred --CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 00011233567889999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.22 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=193.6
Q ss_pred eeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH-HHHHHHHHHHHHHH---hCCCCCeeeEeeeEeeccccEEEEEEec
Q 036673 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP-ESVKFMAREIRILQ---KLDHPNVIKLEGLATSRMQYSLYLVFDF 192 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~---~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 192 (469)
.||+|+||.||++.+..+++.||+|.+....... .....+.+|..++. ..+||||+.+++++...+ ..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEEEEEec
Confidence 3899999999999999999999999986543221 11233344544443 347999999988877643 57999999
Q ss_pred chhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccc
Q 036673 193 MQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272 (469)
Q Consensus 193 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 272 (469)
+.++.+.........+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++...... .....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccCc
Confidence 997544444444457999999999999999999999999999999999999999999999999999754322 12345
Q ss_pred cccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV--EQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 273 ~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
.+++.|+|||.+.+...++.++|||||||++|+|++|..||...... ..+..... .
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~------------------- 213 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T------------------- 213 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---c-------------------
Confidence 78999999998865456889999999999999999999999754321 11111100 0
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.. ..+...+++++.+||.+||..||.+|+ |+.++++||||+..
T Consensus 214 ~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 214 VN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 00 022345788999999999999999999 69999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=326.46 Aligned_cols=253 Identities=28% Similarity=0.436 Sum_probs=206.6
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.. ...+++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 48999999999999999999999999999999975432 22455788999999999999999999887765 4457999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
+||+.+..+........++++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999975444444434579999999999999999999999999999999999999999999999999998654322 23
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE--VEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+. .+.+...... .
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~--------------- 217 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A--------------- 217 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c---------------
Confidence 45567889999998865 4489999999999999999999999987664 2222111110 0
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH--HHHhcCccC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA--ASALQNEFF 393 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta--~elL~hp~f 393 (469)
.......++..+.++|.+||..||.+||++ .++++||||
T Consensus 218 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 -------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 011223467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=327.45 Aligned_cols=255 Identities=31% Similarity=0.494 Sum_probs=207.0
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||.|+||.||++.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++... ..++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEE
Confidence 468888999999999999999999999999999876533 34456788999999999999999999988775 457999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||+.+ +|...+......+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999995 5655555444679999999999999999999999 9999999999999999999999999999876532211
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT-----EVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+.+..+.. ..
T Consensus 157 --~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~---------- 220 (265)
T cd06605 157 --KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EP---------- 220 (265)
T ss_pred --hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CC----------
Confidence 12678899999998866 468999999999999999999999997542 1122222211 00
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.+.+ ....++..+.+||.+||..||.+|||+.+++.||||+.
T Consensus 221 ---------~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 221 ---------PPRL--PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred ---------CCCC--ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0000 01126788999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=331.08 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=212.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
..|...+.||+|+||.||++.+..++..||+|++.... ...+....+.+|+.+++.++|||++++++++.... ..++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH--TAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--eEEE
Confidence 34888899999999999999999899999999987542 23344567889999999999999999999887743 4699
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+.|++.+.+.....++++.++..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 999999988877766666799999999999999999999999999999999999999999999999999875422
Q ss_pred cccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 269 LTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
.....+++.|+|||++.. ...++.++|||||||++|+|++|.+||...........+......+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 243 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-------------- 243 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--------------
Confidence 234568899999998742 2457889999999999999999999998776655555543321100
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.....++..+.+||.+||+.||.+||++.++++|+|+...
T Consensus 244 ----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 ----------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ----------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0122457789999999999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=347.93 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=214.1
Q ss_pred ceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC--CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD--TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 113 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+...+||+|+|-+||+|.+..+|-.||.-.++.. ...++..+.|..|+.+|+.|+||||+++++++.+....++.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4456799999999999999999999997655443 34566678999999999999999999999999988888899999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcEEEcCC-CcEEEeeecCcccccCCCCC
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER--GILHRDIKASNLLIDKS-GMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~ 267 (469)
|.+..+.+..+.+.-+.++...++.|++||++||.|||++ .|+|||||.+||+|+.+ |.|||+|+|||+... ..
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r---~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR---KS 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh---cc
Confidence 9999877666666666799999999999999999999998 59999999999999764 899999999999863 23
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+|||.|||||++. ..|++.+||||||+.++||+|+..||..-....++.+-+.....| ..
T Consensus 200 ~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP-~s------------ 264 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP-AA------------ 264 (632)
T ss_pred ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH-HH------------
Confidence 345689999999999886 569999999999999999999999997666655555443322222 11
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
|.++ -.+++++||.+||.. ...|+||.|+|+||||....
T Consensus 265 -------l~kV---~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 265 -------LSKV---KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred -------hhcc---CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 1111 267899999999999 89999999999999999753
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=326.34 Aligned_cols=262 Identities=28% Similarity=0.431 Sum_probs=206.8
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|+..+.||.|++|.||++.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++.......+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 468899999999999999999999999999999875433 2445678899999999999999999999877666678999
Q ss_pred Eecchh-hHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 190 FDFMQS-DLTKII---CRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 190 ~e~~~~-~l~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|||+++ +|.+.+ ......+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999986 444333 2334568999999999999999999999999999999999999999999999999987653221
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHhhc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE-----VEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+.. ......
T Consensus 160 ---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~---- 228 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPNPEL---- 228 (287)
T ss_pred ---cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCchhh----
Confidence 224467889999998765 4588999999999999999999999976522 222111110 000000
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
+........+++.+.+||.+||..||.+|||+.|+++||||+.
T Consensus 229 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 229 ------------KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred ------------ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 0000001124678899999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=348.27 Aligned_cols=252 Identities=30% Similarity=0.479 Sum_probs=204.1
Q ss_pred eeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchhh
Q 036673 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSD 196 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~~ 196 (469)
+||+|.||+||.|++.+|...+|||.+.... ....+-+..||.+-++|+|.|||+++|.+.. +.++-|.||-++|+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 5999999999999999999999999986443 2344678899999999999999999998655 34678899999985
Q ss_pred HHHHHhc-CCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-CCcEEEeeecCcccccCCCCCCcccc
Q 036673 197 LTKIICR-PGQKL--TEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-SGMLKIADFGLSNFFIPKQKGPLTSR 272 (469)
Q Consensus 197 l~~~~~~-~~~~l--~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 272 (469)
.+..+++ .=+++ .+..+..+.+||++||.|||++.|||||||-+||||+. .|.+||+|||.++.+.. -+....++
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 5555444 33566 88899999999999999999999999999999999964 78999999999987632 23445688
Q ss_pred cccCccccchhcc-CCCCCCccccchhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 273 VVTLWYRAPELLL-GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV-EQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 273 ~gt~~y~aPE~~~-~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
.||..|||||++. |.+.|+.++|||||||++.||.||+|||...... ..+.++- +. +
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-my--------------------K 795 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-MY--------------------K 795 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-ce--------------------e
Confidence 9999999999984 4457999999999999999999999999654322 2222110 00 0
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
..| .+..+++.++++||.+|+.+||..||+|.++|+.||++..+
T Consensus 796 vHP---~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 796 VHP---PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred cCC---CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 011 22335677889999999999999999999999999999763
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=326.18 Aligned_cols=257 Identities=26% Similarity=0.480 Sum_probs=207.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeEeeeEeeccccEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD---HPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~~~ 187 (469)
.|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+. ||||+++++++... ...|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEEE
Confidence 47888999999999999999998999999999875432 334467889999999996 99999999988764 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+.+..+..+... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... .
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-S 156 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-c
Confidence 99999987444444333 379999999999999999999999999999999999999999999999999998764433 2
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......++..|+|||.+.+...++.++|+|||||++|+|++|.+||...........+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------------- 217 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------------- 217 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-------------------
Confidence 2344578999999998876566789999999999999999999999765543322211000
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..+.+. ...++.++.+||.+||..||.+|||+.+++.|+||+..
T Consensus 218 ---~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 218 ---KPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred ---CCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 001110 11267889999999999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=319.53 Aligned_cols=284 Identities=35% Similarity=0.563 Sum_probs=237.4
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc---cEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ---YSLY 187 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~~~ 187 (469)
+.+-.+.||.|+||+||-+.+..+|+.||+|++......-...+.+.+|+++|.-++|.||+..+++.....- ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3444567999999999999999999999999986554555566888899999999999999998876543321 1258
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+++|.|..+|...+..+. .++.+.++-++.||++||.|||+.+|.||||||.|+|++.+-.+||||||+|+....+...
T Consensus 134 V~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 899999999988887654 7999999999999999999999999999999999999999999999999999987776666
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC---c
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT---T 344 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~ 344 (469)
.++..+.|.+|+|||++.+.+.|+.++||||.|||+.||+..+.+|...+..+++..|...+|+|..+-++..-.. -
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 7788889999999999999999999999999999999999999999999999999999999999997765543211 1
Q ss_pred cCCCCCCCCcchhccc-----CCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFG-----EFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+...-.|++..+.. .-..+..+++..+|..||.+|++.++++.|+|...
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1222222333322211 23456788999999999999999999999999874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=329.67 Aligned_cols=258 Identities=20% Similarity=0.286 Sum_probs=197.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECC----------------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeee
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRD----------------TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 173 (469)
++|++.++||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+|.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 679999999999999999998643 34579999987543 3444567889999999999999999
Q ss_pred EeeeEeeccccEEEEEEecchh-hHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 036673 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRP------------------GQKLTEPQVKCYMQQLLSGLQHCHERGILH 234 (469)
Q Consensus 174 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 234 (469)
+++++.... ..++||||+.+ +|...+... ...+++..+..++.||+.||.|||++||+|
T Consensus 84 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 84 LLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred EEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999887744 46999999986 555554321 124688899999999999999999999999
Q ss_pred ccCCCCcEEEcCCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh--CCC
Q 036673 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI--GRP 311 (469)
Q Consensus 235 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt--g~~ 311 (469)
|||||+|||++.++.+||+|||++..+...... ......++..|+|||++.+ ..++.++|||||||++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999765332211 1223345788999998865 458999999999999999987 567
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 312 LMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 312 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
||...+..+.+..+......... .......+.++..+.+||.+||..||.+|||+.++.+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGR------------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccc------------------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 88776665554443221110000 0000112356788999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.57 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=203.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEee-eEee---cc-
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEG-LATS---RM- 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~-~~~~---~~- 182 (469)
..+++|.+.|.+|||+.||+|.+...+..||+|++... +....+.+.+||.+|+.|+ |+|||.++| .... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 35688999999999999999999987799999998654 6677789999999999995 999999999 3322 22
Q ss_pred ccEEEEEEecch-hhHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEcCCCcEEEeeecCc
Q 036673 183 QYSLYLVFDFMQ-SDLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERG--ILHRDIKASNLLIDKSGMLKIADFGLS 258 (469)
Q Consensus 183 ~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~kl~DFGla 258 (469)
...++|+||||. |+|.+++... ...|++.++++|+.|+++|+++||... |||||||-|||||..+|+.||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 345789999999 5888887532 234999999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCCC--------cccccccCccccchhcc--CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 036673 259 NFFIPKQKGP--------LTSRVVTLWYRAPELLL--GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKL 328 (469)
Q Consensus 259 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~ 328 (469)
+-........ -.....|+.|+|||++. .+...++++|||+|||+||-|+....||........+.--
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~--- 270 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN--- 270 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc---
Confidence 7532222110 11234599999999862 3456899999999999999999999999765443322111
Q ss_pred hCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 329 CGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
|.. | .++.++..+.+||+.||+.||.+||++.|++.+-+
T Consensus 271 -----------------Y~~----P----~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 271 -----------------YSF----P----PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred -----------------ccC----C----CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 000 1 12467889999999999999999999999997644
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=325.74 Aligned_cols=256 Identities=28% Similarity=0.503 Sum_probs=207.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
.|...+.||.|++|.||++.+..+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++... ...++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEEE
Confidence 4666678999999999999998889999999986432 23345678999999999999999999987764 3569999
Q ss_pred ecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 191 DFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 191 e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
||+.+ ++.+.+.. .++++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++....... ...
T Consensus 96 e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~ 172 (285)
T cd06648 96 EFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRR 172 (285)
T ss_pred eccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccc
Confidence 99987 44444443 468999999999999999999999999999999999999999999999999887543222 122
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+... ..
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~------------------ 232 (285)
T cd06648 173 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LP------------------ 232 (285)
T ss_pred ccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CC------------------
Confidence 34568999999998765 45889999999999999999999999877665555443221 00
Q ss_pred CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
+.. .....++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 233 ---~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 233 ---PKL-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ---CCC-cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 000 11223678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=322.66 Aligned_cols=248 Identities=26% Similarity=0.429 Sum_probs=201.8
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS- 195 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~- 195 (469)
||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++... ..++++|||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCCC
Confidence 6899999999999999999999999975432 234457789999999999999999999987764 457999999986
Q ss_pred hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccccc
Q 036673 196 DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVT 275 (469)
Q Consensus 196 ~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 275 (469)
+|.+.+.. ...+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 79 ~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 79 ELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred cHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 55555544 4468999999999999999999999999999999999999999999999999998763322 22345788
Q ss_pred CccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 276 LWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT--EVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.... ..+....+......
T Consensus 156 ~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------- 212 (262)
T cd05572 156 PEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK---------------------- 212 (262)
T ss_pred cCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC----------------------
Confidence 99999998765 457899999999999999999999998766 33333333210000
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNA 395 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~ 395 (469)
.......+.++.+||.+||+.||.+||| +.|+++||||+.
T Consensus 213 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 213 --LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred --CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 0112234788999999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.99 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=196.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDT-----GKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 182 (469)
.++|++.+.||+|+||.||+|++..+ +..||||++..... ......+.+|+.+++.+ +|+||+++++++....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 35799999999999999999986443 35799999975433 34456788999999999 8999999999887644
Q ss_pred ccEEEEEEecchh-hHHHHHhcC---------------------------------------------------------
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRP--------------------------------------------------------- 204 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~--------------------------------------------------------- 204 (469)
.+++|||||.+ +|.+.+...
T Consensus 116 --~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 116 --PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred --CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 57999999986 555554321
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC-ccc
Q 036673 205 ------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP-LTS 271 (469)
Q Consensus 205 ------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~ 271 (469)
..++++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||++..+....... ...
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1247889999999999999999999999999999999999999999999999997653222111 112
Q ss_pred ccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 272 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
..+++.|+|||++.+ ..++.++|||||||++|+|++ |++||........+..+......
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~------------------- 333 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ------------------- 333 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC-------------------
Confidence 234668999998865 458999999999999999997 99999875543333333221100
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+ .....+++++.+||.+||+.||.+|||+.++++
T Consensus 334 --~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 334 --M---SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --c---cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 011235789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=321.12 Aligned_cols=254 Identities=26% Similarity=0.500 Sum_probs=207.0
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|.+.+.||.|+||.||++.+..++..||+|.+..........+.+.+|+.+++.++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEEEEE
Confidence 58899999999999999999999999999999876533334446778999999999999999999887663 4579999
Q ss_pred ecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-cEEEeeecCcccccCCCCC
Q 036673 191 DFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 191 e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 267 (469)
||+.+ ++...+... ...+++..+..++.|++.||.|||+++|+|+||||+|||+++++ .+||+|||.+....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 99986 666655443 23589999999999999999999999999999999999999886 46999999998764322 2
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 218 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------------ 218 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc------------------
Confidence 2234568899999998765 457899999999999999999999998766554443332110
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
+....+.++..+.++|.+||..+|++|||+.++++||||
T Consensus 219 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 -------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 011223567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=324.86 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=194.5
Q ss_pred eeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH-HHHHHHHHHH---HHHHhCCCCCeeeEeeeEeeccccEEEEEEec
Q 036673 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP-ESVKFMAREI---RILQKLDHPNVIKLEGLATSRMQYSLYLVFDF 192 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~---~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 192 (469)
.||+|+||.||+|.+..+++.||+|++....... .....+..|. .+++...||||+.+++++... ...++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 3899999999999999999999999987542221 1112233343 445556899999998887764 357999999
Q ss_pred chhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccc
Q 036673 193 MQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272 (469)
Q Consensus 193 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 272 (469)
+.|+.+..+......+++..++.++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++..+... .....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCc
Confidence 997554444444567999999999999999999999999999999999999999999999999999765322 22345
Q ss_pred cccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCC
Q 036673 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352 (469)
Q Consensus 273 ~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (469)
+|+..|+|||++.+...++.++|||||||++|+|++|+.||.......... +....... .
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-------------------~ 215 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM-------------------A 215 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhcc-------------------C
Confidence 789999999998765568899999999999999999999997653221111 00000000 0
Q ss_pred CcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 353 PSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
..+...++..+.+||.+||..||.+|| ++.++++||||+..
T Consensus 216 ---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 216 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 012234688999999999999999999 99999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=340.30 Aligned_cols=254 Identities=23% Similarity=0.330 Sum_probs=197.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEE-----CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARD-----RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 182 (469)
.++|++.++||+|+||+||+|.+ ..++..||||+++.... ....+.+.+|+.+|..+ +||||+++++++....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 35799999999999999999974 34577899999865432 23346788999999999 8999999999887754
Q ss_pred ccEEEEEEecchh-hHHHHHhcCC--------------------------------------------------------
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPG-------------------------------------------------------- 205 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~-------------------------------------------------------- 205 (469)
..++|||||++ +|...+....
T Consensus 113 --~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 113 --PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred --cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 46999999986 5655553321
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 206 ------------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 206 ------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 24788899999999999999999999999999999999999999999999999865332211
Q ss_pred C-cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 268 P-LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 268 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
. .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||........+.+++.....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------- 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR-------------- 335 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc--------------
Confidence 1 112334667999998866 458999999999999999998 89999876544433333221000
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
+ ......+.++.+||.+||+.||++|||+.++++.
T Consensus 336 -------~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 -------M---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -------C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 0112346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=329.72 Aligned_cols=259 Identities=27% Similarity=0.494 Sum_probs=209.2
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
...++|++.+.||.|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~ 91 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGD--EL 91 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--cE
Confidence 335789999999999999999999988899999999864322 23466889999999999999999999887743 46
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|+|+||+++ ++...+.. ..+++.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999987 55555443 358899999999999999999999999999999999999999999999999987654332
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
. ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+..+.+..+.. .+.
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~-------------- 232 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT-------------- 232 (293)
T ss_pred c-ccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCC--------------
Confidence 2 2234568899999998765 4578999999999999999999999987655443322211 000
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+.+ .....++..+.+||.+||..||.+||++.+++.|+||+..
T Consensus 233 -------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 233 -------PEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred -------CCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 001 1123467889999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=320.43 Aligned_cols=248 Identities=22% Similarity=0.372 Sum_probs=199.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||+|+||.||++.... +..+|+|.+...... ...+.+|+.+|+.++||||+++++++.... ..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK--PLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCC--CEEEE
Confidence 568999999999999999998865 568999987643322 256788999999999999999999887643 46999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||+++ +|...+......+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999985 5666665544568999999999999999999999999999999999999999999999999998653222222
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+.+..+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------------- 220 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---------------- 220 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------------
Confidence 223345668999998765 458899999999999999999 99999887776666655331100
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......+..+.+||.+||+.||.+|||+.++++
T Consensus 221 ---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 ---------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001124678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=324.35 Aligned_cols=257 Identities=27% Similarity=0.479 Sum_probs=209.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
..|+.++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++++... ...|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEE
Confidence 458888999999999999999998899999999875432 34457788999999999999999999988774 457999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||+++ ++.+.+. . .++++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~i~-~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 81 MEYLGGGSALDLLR-A-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred EecCCCCcHHHHHh-c-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 999987 4555443 3 468999999999999999999999999999999999999999999999999997653322 12
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...........+.. .
T Consensus 158 ~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~------------------ 216 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--N------------------ 216 (277)
T ss_pred cccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--C------------------
Confidence 234567889999998865 4578999999999999999999999987655443322210 0
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
..+ .+...++..+.+||.+||..||++||++.++++|+||.....
T Consensus 217 --~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 217 --NPP---TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred --CCC---CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 001 122346778999999999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=328.67 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=211.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.+.|...+.||.|+||.||+|++..++..||||.+... .........+.+|+.+++.++|+||+++++++... ...+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeE
Confidence 35588889999999999999999989999999998653 22334456778899999999999999999988774 4569
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+.+++...+......+++..+..++.|++.||.|||+.+++|+||+|+|||++.++.++|+|||++.....
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 9999999988777766566799999999999999999999999999999999999999999999999999876532
Q ss_pred CcccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 268 PLTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|..||......+....+.....
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------------- 231 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--------------- 231 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC---------------
Confidence 234567889999998752 23478899999999999999999999977655444443322100
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+. .....++..+.+||.+||..+|.+||++.++++|||+...
T Consensus 232 -------~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 232 -------PA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -------CC--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00 0122467789999999999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=325.62 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=203.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCC-----cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTG-----KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++..++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--Q 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--C
Confidence 57999999999999999999986554 689999986442 344456788999999999999999999988764 3
Q ss_pred EEEEEEecchh-hHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPG---------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 248 (469)
..+++|||+++ +|.+.+.... ..+++..+..++.||+.||.|||+++|+|+||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 46899999986 6666554321 4588999999999999999999999999999999999999999
Q ss_pred cEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036673 249 MLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIF 326 (469)
Q Consensus 249 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~ 326 (469)
.++|+|||++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999976533221 12334466889999998765 458999999999999999998 999998877665554443
Q ss_pred HHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 327 KLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.... ......+++++.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~~~~-------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQL-------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCc-------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2110 01234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.04 Aligned_cols=254 Identities=29% Similarity=0.527 Sum_probs=211.6
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||.|+||.||++.+..++..||+|++............+.+|+++++.++|||++++++.+... ...++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 58899999999999999999998999999999976655556667888999999999999999999987764 5679999
Q ss_pred ecchh-hHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 191 DFMQS-DLTKIICRP---GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 191 e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||+++ ++...+... ...+++..+..++.+|+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99997 565555443 3679999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
.......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----------------- 219 (258)
T ss_pred ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----------------
Confidence 22334578999999998765 457899999999999999999999997766544443332110
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
+......++..+.++|.+||..||.+|||+.++|+||||
T Consensus 220 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 --------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 011222567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.36 Aligned_cols=250 Identities=24% Similarity=0.446 Sum_probs=204.9
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||.|+||.||++.+..+++.||+|.++.... ....+.+.+|+.+++.++||||+++++.+... ..+|++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence 58899999999999999999999999999999875433 34456788999999999999999999988764 4679999
Q ss_pred ecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 191 DFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 191 e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||+++ ++...+.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-ccc
Confidence 99986 66665543 3446899999999999999999999999999999999999999999999999999765322 222
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....+++.|+|||++.+ ..++.++|+||||+++|+|++|.+||...+.......+.....
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------ 217 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY------------------ 217 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC------------------
Confidence 334678999999998765 4588999999999999999999999987665544443322110
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
......++..+.+||.+||+.||.+|||+.++|.-
T Consensus 218 -------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01123467789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.38 Aligned_cols=254 Identities=31% Similarity=0.522 Sum_probs=210.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||.|++|.||++.+..+++.||+|.+............+.+|++++.+++||||+++++++... ...+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 48889999999999999999998899999999977655445667899999999999999999999888764 4579999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
||+++..+..+......+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........ ...
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-ccc
Confidence 9999744444444446799999999999999999999999999999999999999999999999999987643322 123
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
...++..|+|||.+.+. .++.++||||||+++|+|++|.+||...........+...
T Consensus 158 ~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------------- 214 (254)
T cd06627 158 SVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---------------------- 214 (254)
T ss_pred ccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc----------------------
Confidence 45678999999987654 4789999999999999999999999876654443332210
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
....+...++..+.++|.+||..+|++|||+.+++.||||
T Consensus 215 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 ---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0012233567899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=318.89 Aligned_cols=255 Identities=34% Similarity=0.516 Sum_probs=208.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||.|++|.||+|.+..+++.||||++...... .....+.+|+.++..++|+||+++++++... ..+++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEE
Confidence 4688999999999999999999999999999998765432 4457788999999999999999999988764 457999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+++ +|...+.. ...+++..+..++.||+.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 78 LEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred EEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 999996 55555443 3679999999999999999999999 9999999999999999999999999999987643222
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT---EVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.... ..+....+.. ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~------------ 219 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP------------ 219 (264)
T ss_pred cccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC------------
Confidence 2234567899999998765 468899999999999999999999997764 2222222211 00
Q ss_pred cCCCCCCCCcchhcccC-CChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGE-FPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
....... ++..+.++|.+||..+|.+|||+.++|+||||+.
T Consensus 220 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 220 ----------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred ----------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 0011223 6789999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=330.08 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=200.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcE----EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKI----VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..+|++.+.||+|+||+||+|.+..++.. ||||++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~-- 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC--
Confidence 36799999999999999999998766654 899998643 23344567889999999999999999999887643
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+++++|+.+ ++.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 83 -~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 83 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred -ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 4789999985 66676666556789999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCC-cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQKGP-LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
..... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.. .+......+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~--------- 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERL--------- 230 (316)
T ss_pred CCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCC---------
Confidence 32211 122334678999998865 458999999999999999997 99999876554432 222211000
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....++..+.++|.+||..||.+|||+.+++.+
T Consensus 231 ---------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 ---------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=335.11 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=198.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 183 (469)
++|++.+.||.|+||.||+|.... +++.||+|+++.... ....+.+.+|+.++.++ +|+||+++++++....
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~- 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG- 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-
Confidence 579999999999999999997543 357899999864432 34446778899999999 8999999999876543
Q ss_pred cEEEEEEecchh-hHHHHHhcC----------------------------------------------------------
Q 036673 184 YSLYLVFDFMQS-DLTKIICRP---------------------------------------------------------- 204 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~---------------------------------------------------------- 204 (469)
..++++|||+.+ ++...+...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 457899999997 555444321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC-cccccccCccccc
Q 036673 205 --GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP-LTSRVVTLWYRAP 281 (469)
Q Consensus 205 --~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aP 281 (469)
..++++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....... .....++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 1268999999999999999999999999999999999999999999999999998753322211 2233456789999
Q ss_pred hhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhccc
Q 036673 282 ELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFG 360 (469)
Q Consensus 282 E~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (469)
|++.+ ..++.++|||||||+||||++ |.+||.+....+.+...+.....+ ....
T Consensus 245 E~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------------------~~~~ 299 (337)
T cd05054 245 ESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM------------------------RAPE 299 (337)
T ss_pred HHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC------------------------CCCc
Confidence 98876 458999999999999999998 999998754433333322110000 0112
Q ss_pred CCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 361 EFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 361 ~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.+++++.+++.+||+.+|++||++.++++|
T Consensus 300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=324.46 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=199.7
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS- 195 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~- 195 (469)
||+|+||+||+|.+..+++.||+|++..... .......+..|+++|+.++||||+++++++... ...|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCCC
Confidence 6899999999999999999999999865422 122335567899999999999999998888664 357999999996
Q ss_pred hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccc
Q 036673 196 DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274 (469)
Q Consensus 196 ~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 274 (469)
+|...+.... ..+++..+..++.|++.||.|||+.||+|+||+|+|||++.++.++|+|||++..... ........+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccccC
Confidence 5555554433 3699999999999999999999999999999999999999999999999999876532 222334567
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCc
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPS 354 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (469)
+..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+..... ..
T Consensus 157 ~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~ 213 (277)
T cd05577 157 TPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL----------------------EM 213 (277)
T ss_pred CCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc----------------------cc
Confidence 88999999887644 88999999999999999999999976544211111111000 00
Q ss_pred chhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 355 FREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 355 ~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.......+++.+.+||.+||+.||.+|| ++.++++||||...
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 0122345688999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=334.38 Aligned_cols=277 Identities=22% Similarity=0.343 Sum_probs=201.4
Q ss_pred eeeee--CCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 117 KVGQG--TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 117 ~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
.||.| +||+||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++.... ..++||||+.
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~v~e~~~ 82 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWVISPFMA 82 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEEEEeccc
Confidence 46666 9999999999999999999999766555566688899999999999999999999988743 4699999999
Q ss_pred h-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC----
Q 036673 195 S-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP---- 268 (469)
Q Consensus 195 ~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~---- 268 (469)
+ ++..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 6 555554432 2358999999999999999999999999999999999999999999999998654321111100
Q ss_pred --cccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH---------H
Q 036673 269 --LTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED---------Y 336 (469)
Q Consensus 269 --~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~---------~ 336 (469)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||........+..+.......+.. .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 1112345679999988653 347899999999999999999999998776655544433211110000 0
Q ss_pred Hhhcc------cCccCCC-----CCCCCcc-hhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 337 WKKMK------LTTTFRP-----QHYKPSF-REVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 337 ~~~~~------~~~~~~~-----~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
+.... ....... ......+ ......+++.+.+||.+||+.||++|||+.++|+||||..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 00000 0000000 0000000 0112346778999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=304.41 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=200.9
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec---cc
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR---MQ 183 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~ 183 (469)
...++|++.+.||+|||+-||++....++..||+|++.... .+..+...+|++..++++||||++++++.... ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 45689999999999999999999999999999999998754 45567888999999999999999998876432 33
Q ss_pred cEEEEEEecch-hhHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEcCCCcEEEeeecC
Q 036673 184 YSLYLVFDFMQ-SDLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHERG--ILHRDIKASNLLIDKSGMLKIADFGL 257 (469)
Q Consensus 184 ~~~~lv~e~~~-~~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~kl~DFGl 257 (469)
...||+++|.. |++++.+. ..+..+++.++..|+.+|++||.+||+.. ++||||||.|||+.+++.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 45799999998 45766653 34557999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCC--------CcccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036673 258 SNFFIPKQKG--------PLTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327 (469)
Q Consensus 258 a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 327 (469)
++...-.-.+ .......|..|+|||.+.- ....++++|||||||+||+|+.|..||... +.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~ 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQ 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hh
Confidence 8764211111 1123345889999997732 234689999999999999999999999521 11
Q ss_pred HhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 328 LCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..+.. .-.....++ .+.. ...+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 247 ~GgSl----------aLAv~n~q~--s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 247 QGGSL----------ALAVQNAQI--SIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCeE----------EEeeecccc--ccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11100 000000000 0000 12378999999999999999999999999864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=319.63 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=200.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.+|.+.+.||.|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++.... .++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCC--CcEEE
Confidence 4688999999999999999999999999999998643 223466889999999999999999999887644 46999
Q ss_pred Eecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+++ +|...+... ...+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999986 566655443 345899999999999999999999999999999999999999999999999999875432221
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+....+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------- 222 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY----------------- 222 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-----------------
Confidence 1222334668999998765 457899999999999999998 999998876655444332110
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+ .....++.++.+||.+||..||++|||+.++++
T Consensus 223 -----~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 -----RM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred -----CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00 112356889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=314.60 Aligned_cols=258 Identities=32% Similarity=0.571 Sum_probs=209.9
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|.+.+.||+|++|.||+|.+..+++.|++|++..........+.+.+|+.++++++||||+++++.+........++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47888999999999999999998899999999976655455668889999999999999999999988775335679999
Q ss_pred ecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC-C
Q 036673 191 DFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG-P 268 (469)
Q Consensus 191 e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 268 (469)
||+.+ ++.+.+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99976 55555544 347999999999999999999999999999999999999999999999999999876433211 1
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....++..|+|||.+.+. .++.++||||||+++|+|++|..||........ .+.....
T Consensus 160 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~------------------ 218 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS------------------ 218 (260)
T ss_pred ccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc------------------
Confidence 3456788999999987653 478999999999999999999999987652211 1111100
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
..........++..+.+||.+||+.||.+||++.++++||||
T Consensus 219 ---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 ---SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 011112334558899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.49 Aligned_cols=255 Identities=26% Similarity=0.478 Sum_probs=205.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+.|++.+.||.|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++++... ...|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEE
Confidence 457888999999999999999998899999999875433 23456788999999999999999999988764 357999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||+++..+..+... ..+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++..+.... ...
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 999997444433333 468999999999999999999999999999999999999999999999999997653322 122
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
....++..|+|||++.+ ..++.++|||||||++|||++|.+||...........+...
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------------- 216 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------------- 216 (277)
T ss_pred hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------------
Confidence 33467889999998865 45789999999999999999999999755443332221100
Q ss_pred CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+ .....++.++.+||.+||..+|.+|||+.++|+||||..
T Consensus 217 -~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 217 -SPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred -CCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 001 112346788999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.27 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=200.2
Q ss_pred cceeceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc----c
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ----Y 184 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----~ 184 (469)
|.+.+.||+|+||.||+|....+ +..||||+++...........+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987653 4789999998665555556788999999999999999999998765332 3
Q ss_pred EEEEEEecchh-hHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCc
Q 036673 185 SLYLVFDFMQS-DLTKIICR-----PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla 258 (469)
..+++|||+.+ ++...+.. ....+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 46899999996 45444422 2236899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 259 NFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 259 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
......... .......+..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+....+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------- 232 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN------- 232 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 865332211 1122334678999998754 558999999999999999999 899998877665554432210
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.......++..+.++|.+||+.||.+|||+.+++++
T Consensus 233 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 ------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001223567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.30 Aligned_cols=247 Identities=27% Similarity=0.426 Sum_probs=202.6
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 185 (469)
...+.|.+...+|.|+|+.|-.+.+..+++..++|++..... ...+|+.++... +||||+++.+.+.+ ...
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~ 390 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYED--GKE 390 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecC--Cce
Confidence 357889999999999999999999999999999999975522 233577666655 89999999998877 445
Q ss_pred EEEEEecchhhH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE-cCCCcEEEeeecCcccccC
Q 036673 186 LYLVFDFMQSDL-TKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI-DKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 186 ~~lv~e~~~~~l-~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~ 263 (469)
+|+|||.+.|.. ++.+.. ...+. .++..|+.+|+.|+.|||++|||||||||+|||+ +..++++|+|||.++....
T Consensus 391 ~~~v~e~l~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeehhccccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 799999999844 444433 22333 7888999999999999999999999999999999 6899999999999987643
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. ..+.+-|..|.|||++. ...|+.++||||||++||+||+|+.||........+. ..++.+.
T Consensus 469 ~----~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~---~~i~~~~---------- 530 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH---TRIQMPK---------- 530 (612)
T ss_pred h----hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH---HhhcCCc----------
Confidence 3 34557789999999887 4679999999999999999999999998776662222 2222221
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
+...+|+++++||+.||+.||.+|+++.+++.||||-.
T Consensus 531 --------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 531 --------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred --------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 11468999999999999999999999999999999943
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.82 Aligned_cols=255 Identities=27% Similarity=0.474 Sum_probs=207.0
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
-|++.+.||.|+||.||+|.+..++..||||++..... ......+.+|+.++.+++||||+++++++... ...|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEE
Confidence 47888999999999999999988899999999865432 33456788999999999999999999988764 3569999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
||++++.+..+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.... ....
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 99997444443333 368999999999999999999999999999999999999999999999999987653221 1223
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+... .
T Consensus 160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-------------------- 217 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N-------------------- 217 (277)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C--------------------
Confidence 4567889999998765 45788999999999999999999999766554444332110 0
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+ .+...++.++.++|.+||..||.+||++.++++||||...
T Consensus 218 -~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 218 -PP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred -CC---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 00 1223567889999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=322.64 Aligned_cols=254 Identities=31% Similarity=0.535 Sum_probs=208.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~ 187 (469)
++|.+.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.++.++. ||||+++++++... ...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEE
Confidence 47999999999999999999999899999999986532 22333467889999999998 99999998887653 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+.+ ++.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999965 66666554 34799999999999999999999999999999999999999999999999999987643321
Q ss_pred -------------------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036673 267 -------------------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327 (469)
Q Consensus 267 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 327 (469)
.......++..|+|||++.. ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 11223456889999998765 4478899999999999999999999988776555444432
Q ss_pred HhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH----HHHhcCccC
Q 036673 328 LCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA----ASALQNEFF 393 (469)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta----~elL~hp~f 393 (469)
... .....+++.+.+||.+||..||.+|||+ .++|+||||
T Consensus 237 ~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 237 LEY--------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cCC--------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 100 1223457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.35 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=198.6
Q ss_pred cceeceeeeeCCeEEEEEEECCCCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----ccE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGK--IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----QYS 185 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~ 185 (469)
|.+.+.||+|+||.||+|.+..++. .||+|.++...........+.+|+.+++.++||||+++++++.... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999999887665 6999998765455566678889999999999999999998775322 224
Q ss_pred EEEEEecchh-hHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 186 LYLVFDFMQS-DLTKIICR-----PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
.+++|||+.+ ++...+.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 6899999985 55555422 22358999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 036673 260 FFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 260 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 337 (469)
.+...... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |++||.+....+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------- 232 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR------- 232 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 75332211 1123345778999998765 458999999999999999999 8999987666554443321100
Q ss_pred hhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
......++..+.++|.+||+.||.+|||+.+++++
T Consensus 233 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 ------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01123467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=317.17 Aligned_cols=249 Identities=23% Similarity=0.391 Sum_probs=200.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|+++++||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++|+||+++++++... ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEE
Confidence 4689999999999999999998764 6789999876432 2346788999999999999999998887654 34699
Q ss_pred EEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+|||+.+ ++...+.. ....+++..+..++.||+.||+|||+.+++|+||||+|||++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999975 66666644 345689999999999999999999999999999999999999999999999999987533222
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------------- 223 (261)
T ss_pred eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 22223345678999998765 457889999999999999998 99999887766655554321100
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++.++.+||.+||..||++|||++++++
T Consensus 224 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 -----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112346788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=317.66 Aligned_cols=250 Identities=31% Similarity=0.460 Sum_probs=196.7
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHH-HhCCCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRIL-QKLDHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||.|+||.||+|.+..+++.||||++..... .......+..|..++ ..++|+||+++++++... ..+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEecc
Confidence 459999999999999998899999999864321 122223344555544 455899999999888763 4579999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
+++.+..+......+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 9755444444445799999999999999999999999999999999999999999999999999875422 23446
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
+++.|+|||.+.+.. ++.++||||||+++|+|++|.+||...+.......+...... +..
T Consensus 155 ~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~~ 214 (260)
T cd05611 155 GTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-------------------WPE 214 (260)
T ss_pred CCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-------------------CCC
Confidence 788999999887644 789999999999999999999999877665554443221100 000
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCH---HHHhcCccCCC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTA---ASALQNEFFNA 395 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta---~elL~hp~f~~ 395 (469)
.....++..+.++|.+||+.||.+|||+ .|+|.||||..
T Consensus 215 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 215 ---EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred ---cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 1223568899999999999999999955 79999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.21 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=207.4
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEe
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 191 (469)
|+...+||+|+||.||++....++..||||++.... ......+.+|+.+++.++|+||+++++++... ...++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEe
Confidence 444567999999999999999999999999885432 23346688999999999999999999988764 45799999
Q ss_pred cchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccc
Q 036673 192 FMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS 271 (469)
Q Consensus 192 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 271 (469)
|+++..+..+... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++....... .....
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 9998555555433 368999999999999999999999999999999999999999999999999987653222 22334
Q ss_pred ccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCC
Q 036673 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY 351 (469)
Q Consensus 272 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (469)
..+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+....+....+....
T Consensus 176 ~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~---------------------- 232 (292)
T cd06657 176 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL---------------------- 232 (292)
T ss_pred cccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC----------------------
Confidence 568899999998764 457899999999999999999999998776655544332111
Q ss_pred CCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 352 KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 352 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
.+.+ .....++..+.++|.+||..||.+||++.++|+||||.....
T Consensus 233 ~~~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 233 PPKL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred Cccc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 0001 112346788999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=371.86 Aligned_cols=265 Identities=29% Similarity=0.517 Sum_probs=222.4
Q ss_pred cCCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 104 LVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.+....-+|....+||.|.||.||.|.+.+||...|+|-++.........+.+.+|+.+|..|+|||+|+++|+-.+.+.
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 34445567888899999999999999999999999999998776666667888999999999999999999998887554
Q ss_pred cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 184 YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
++|.||||.++.+..+.+.++..++.....+..|++.||+|||++|||||||||.||||+.+|.+|++|||.|..+..
T Consensus 1309 --v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1309 --VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred --HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 689999999988888878777788999999999999999999999999999999999999999999999999987754
Q ss_pred CCC---CCcccccccCccccchhccCCC--CCCccccchhhHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHH
Q 036673 264 KQK---GPLTSRVVTLWYRAPELLLGST--DYGVGIDLWSAGCLLAEMFIGRPLMPGRT-EVEQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 264 ~~~---~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGv~l~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 337 (469)
... ......+||+.|||||++.+.. ...-++||||||||+.||+||+.||...+ +...+..+..+. .
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh-~------ 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH-K------ 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC-C------
Confidence 431 2245678999999999997754 35678999999999999999999997543 333333332211 1
Q ss_pred hhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
| .+...++.+.++||.+||+.||++|.++.|+|+|.|-+.
T Consensus 1460 ---------------P---q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1460 ---------------P---QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred ---------------C---CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 1 122347899999999999999999999999999999765
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=316.71 Aligned_cols=253 Identities=21% Similarity=0.338 Sum_probs=202.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.++|++.+.||+|+||+||+|.+..+ ...||||++.... .......+.+|+.++..++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--Cc
Confidence 36799999999999999999998654 4589999886543 334456788999999999999999999988764 34
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.++||||+.+ +|...+......+++..+..++.|++.||+|||+++|+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 6999999986 666666555567999999999999999999999999999999999999999999999999999876421
Q ss_pred CCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 265 QKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+......+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---------- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 111 1112334678999998765 458899999999999999998 999997766555544443211100
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....+..+.+|+.+||+.||.+||++.+++++
T Consensus 229 ---------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 ---------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=315.78 Aligned_cols=249 Identities=21% Similarity=0.352 Sum_probs=199.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||+|+||+||+|.+.. +..+|||.+...... ...+.+|+.++..++||||+++++++.... .+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR--PIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCC--CcEEE
Confidence 568999999999999999998765 556999988643322 256889999999999999999999887643 46999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||+.+ ++...+......+++..+..++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999986 5666665544579999999999999999999999999999999999999999999999999987653322211
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+......
T Consensus 158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------------- 220 (256)
T ss_pred cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------------
Confidence 222345678999998865 448899999999999999998 99999876665554444321110
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
......+..+.+++.+||..||.+|||+.+++++
T Consensus 221 ---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ---------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0112347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=314.52 Aligned_cols=244 Identities=25% Similarity=0.404 Sum_probs=193.4
Q ss_pred eeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-
Q 036673 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS- 195 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~- 195 (469)
.||+|+||+||+|.+..+++.||+|.+... ...+....+.+|+++++.++||||+++++++.... ..++||||+.+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~ 78 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVMELVQGG 78 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEEEeeccCC
Confidence 599999999999999988999999987643 23445567889999999999999999999887643 57999999986
Q ss_pred hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC-cccccc
Q 036673 196 DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP-LTSRVV 274 (469)
Q Consensus 196 ~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~g 274 (469)
++..++......+++..+..++.|++.||.|||+++|+|+||||+|||++.++.+||+|||++.......... ......
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 5666665555568999999999999999999999999999999999999999999999999987643211110 011122
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...........+..... .
T Consensus 159 ~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~----------------------~ 215 (252)
T cd05084 159 PVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR----------------------L 215 (252)
T ss_pred ceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----------------------C
Confidence 457999998765 457899999999999999998 8999976655443333221100 0
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.+||.+||+.||++|||+.++++
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 ---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=322.46 Aligned_cols=261 Identities=26% Similarity=0.423 Sum_probs=206.4
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++.+.||.|+||.||+|.+..+++.||||.++..... .....+..|+.++..+ .||||+++++++.... .+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS--DV 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCC--eE
Confidence 457899999999999999999999988999999999754332 3345566788777666 5999999999987744 47
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|++|||+.+.+...+......+++..+..++.||+.||+|||+ .+|+||||+|+|||++.++.+||+|||++..+....
T Consensus 90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9999999987766665545679999999999999999999997 599999999999999999999999999997653222
Q ss_pred CCCcccccccCccccchhccCC---CCCCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGS---TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE-VEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||..... .+.+..+.....
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 236 (296)
T cd06618 170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----------- 236 (296)
T ss_pred --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-----------
Confidence 12334578899999988643 2478899999999999999999999965322 233333221100
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+.+ .....++.++.+||.+||..||.+|||+.++++||||...
T Consensus 237 -----------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 237 -----------PSL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred -----------CCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 000 0111467889999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=316.41 Aligned_cols=253 Identities=30% Similarity=0.474 Sum_probs=201.0
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||.|+||.||+|++..+++.||||.+... .........+.+|+.+++.++||||+++++++...+ ..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN--ELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC--eEEE
Confidence 5799999999999999999999999999999988643 233444567889999999999999999999887643 5699
Q ss_pred EEecchh-hHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
++||+++ ++...+. .....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999996 5544442 23345899999999999999999999999999999999999999999999999999865332
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE-VEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ...+...+.....++
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 227 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP---------- 227 (267)
T ss_pred h-HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC----------
Confidence 2 12234568899999998865 4578899999999999999999999865432 122222221111110
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.+||.+||..||.+||++.++|+
T Consensus 228 -------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 -------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred -------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 011245778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=315.85 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=198.6
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.+|++.+.||+|+||.||++.+.. +..+|+|++...... ...+.+|+.+++.++||||+++++++... ...++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEE
Confidence 468899999999999999998864 678999998643322 24577899999999999999999887654 357999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||+++ ++.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999986 5666665545578999999999999999999999999999999999999999999999999997653222111
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---------------- 220 (256)
T ss_pred cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------
Confidence 112223457999998875 458899999999999999999 89999877666555443221100
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
......+.++.+|+.+||..+|++|||+.++++.
T Consensus 221 ---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ---------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1112467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=317.72 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=192.7
Q ss_pred cCcceecee--eeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 110 DSYDKLAKV--GQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 110 ~~y~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
+.|++.+.+ |.|+||.||++.++.++..+|+|++....... .|+.+...+ +||||+++++.+...+ ..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~--~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLK--GH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCC--ee
Confidence 466776666 99999999999999999999999986532211 122222222 7999999999887754 57
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-cEEEeeecCcccccCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPK 264 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 264 (469)
|+||||+++ +|...+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999986 666655443 4799999999999999999999999999999999999999998 999999999876532
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcccC
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ-LHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+.... ..
T Consensus 163 ----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~----------- 225 (267)
T PHA03390 163 ----PSCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK----------- 225 (267)
T ss_pred ----CccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc-----------
Confidence 123467899999998866 4578999999999999999999999985543321 11111100 00
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-HHHHhcCccCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-AASALQNEFFN 394 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-a~elL~hp~f~ 394 (469)
.......+++.+.+||.+||+.||.+|++ .+++|+||||+
T Consensus 226 -----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 226 -----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred -----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 00122357899999999999999999997 59999999996
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=321.39 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=204.1
Q ss_pred CcceeceeeeeCCeEEEEEEEC---CCCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecccc
Q 036673 111 SYDKLAKVGQGTYSNVYKARDR---DTGKIVALKKVRFDTS--EPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 184 (469)
+|++.+.||.|+||.||+|.+. .+|..||+|++..... .....+.+.+|+.++..+ +|+||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 4888999999999999999875 4689999999865321 122335678899999999 699999998877663 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+++||||+++ ++...+.. ...+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred eEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 57899999997 55555543 45799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
..........++..|+|||.+... ..++.++|||||||++|+|++|..||...........+.......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------- 227 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---------- 227 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc----------
Confidence 333333456789999999987643 246789999999999999999999997543322222222211000
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.+ .....+++.+.+||.+||..||.+|| ++.+++.||||+..
T Consensus 228 ---------~~---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 228 ---------EP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred ---------CC---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 00 11234678899999999999999997 89999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.78 Aligned_cols=250 Identities=31% Similarity=0.506 Sum_probs=202.1
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS- 195 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~- 195 (469)
||.|+||.||++.+..+++.||+|++..... .......+.+|+.++.+++||||+++++.+.. ....|++|||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999999999999999865422 23445778899999999999999999887765 4457999999987
Q ss_pred hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC-------CC
Q 036673 196 DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK-------GP 268 (469)
Q Consensus 196 ~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-------~~ 268 (469)
++...+... ..+++..+..++.||+.||+|||+++|+|+||+|+|||++.++.++|+|||++........ ..
T Consensus 79 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 79 DLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 555555443 3799999999999999999999999999999999999999999999999999876432211 12
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....++..|+|||.+... .++.++||||||+++|+|++|..||......+....+......+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 220 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW---------------- 220 (265)
T ss_pred ccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCC----------------
Confidence 2345678899999988664 47889999999999999999999998777665554443210000
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH---HHHhcCccCCC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA---ASALQNEFFNA 395 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta---~elL~hp~f~~ 395 (469)
+ . ...++..+.+||.+||+.||.+|||+ .++|+||||+.
T Consensus 221 ----~---~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 221 ----P---E-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred ----C---c-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 0 0 11257899999999999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.00 Aligned_cols=252 Identities=33% Similarity=0.560 Sum_probs=207.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++|+||+++++++... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEE
Confidence 48888999999999999999998899999999975433 3457788999999999999999999988765 4569999
Q ss_pred ecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 191 DFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 191 e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
||+++ ++.+.+......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 99995 66555555445799999999999999999999999999999999999999999999999999987643322 3
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......+.. ...+
T Consensus 155 ~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~----------------- 215 (253)
T cd05122 155 NTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPP----------------- 215 (253)
T ss_pred cceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCC-----------------
Confidence 456788999999988654 478999999999999999999999987655444433322 0000
Q ss_pred CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
.+ .....++..+.++|.+||..||++|||+.++|+|||
T Consensus 216 ----~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 216 ----GL-RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ----Cc-CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00 001124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.30 Aligned_cols=273 Identities=21% Similarity=0.293 Sum_probs=197.2
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchhh-HHHH
Q 036673 122 TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSD-LTKI 200 (469)
Q Consensus 122 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~~-l~~~ 200 (469)
+++.||.++...+++.||||++............+.+|+.+++.++||||+++++++... ...+++|||++++ +...
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCHHHH
Confidence 456667777777899999999987644556667899999999999999999999988764 3469999999964 4444
Q ss_pred Hhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC------CCccccc
Q 036673 201 ICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK------GPLTSRV 273 (469)
Q Consensus 201 ~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~------~~~~~~~ 273 (469)
+.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||.+..+..... .......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 443 234689999999999999999999999999999999999999999999999999875532211 1123345
Q ss_pred ccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC--HHHHhhc--ccCcc---
Q 036673 274 VTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS--EDYWKKM--KLTTT--- 345 (469)
Q Consensus 274 gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~--~~~~~--- 345 (469)
++..|+|||++... ..++.++|||||||++|+|++|..||........+........... ...+... .....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 67889999988653 3478899999999999999999999987665544332222111000 0000000 00000
Q ss_pred CCC-CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 FRP-QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
... ......-......++.++.+||.+||+.||++|||+.++|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000 000000011122346788999999999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=319.71 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=201.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.++|.+.+.||+|+||.||+|.+.. ++..||||++..... .+....+.+|+++|..++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence 3578999999999999999998753 357899999865433 33457889999999999999999999988775
Q ss_pred cEEEEEEecchh-hHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRP-------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM 249 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~ 249 (469)
...++||||+++ +|...+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 457999999986 555554332 234889999999999999999999999999999999999999999
Q ss_pred EEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 036673 250 LKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFK 327 (469)
Q Consensus 250 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~ 327 (469)
+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999975432211 11223455788999998875 458999999999999999998 9999987776655544431
Q ss_pred HhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 328 LCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.. .......++..+.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GR-------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CC-------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 10 00112346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=314.90 Aligned_cols=243 Identities=25% Similarity=0.360 Sum_probs=194.7
Q ss_pred eeeeeCCeEEEEEEE--CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 117 KVGQGTYSNVYKARD--RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
+||+|+||.||+|.+ ..++..+|+|++..........+.+.+|+.++..+.||||+++++++... ..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE---SWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CcEEEEecCC
Confidence 589999999999965 45678999999876655555667889999999999999999999887532 3589999999
Q ss_pred hh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC--ccc
Q 036673 195 SD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP--LTS 271 (469)
Q Consensus 195 ~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~~~ 271 (469)
++ +...+. ....+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++..+....... ...
T Consensus 79 ~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 79 LGPLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 64 555543 34579999999999999999999999999999999999999999999999999998654332211 122
Q ss_pred ccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 272 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
..+++.|+|||.+.. ..++.++|||||||++|||++ |.+||......+....+.+...
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-------------------- 216 (257)
T cd05116 158 GKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-------------------- 216 (257)
T ss_pred CCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--------------------
Confidence 234678999998754 457889999999999999998 9999988766655554422110
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+ .....+++++.+||.+||+.||.+||+++++.+
T Consensus 217 --~---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 217 --M---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --C---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0 122357889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=353.24 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=198.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.++||+|+||.||+|++..+++.||||++..... .....+.+.+|+.++..++||||+++++++... ...|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEEEE
Confidence 689999999999999999999999999999999975432 234456788999999999999999999988764 45799
Q ss_pred EEecchh-hHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecC
Q 036673 189 VFDFMQS-DLTKIICRP----------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL 257 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGl 257 (469)
||||++| +|...+... ...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999997 454444321 12356778899999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-----------------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHH
Q 036673 258 SNFFIPKQK-----------------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVE 320 (469)
Q Consensus 258 a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~ 320 (469)
+........ ......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 986521110 01123578999999998876 457999999999999999999999997754432
Q ss_pred HHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 321 QLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 321 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.... .....| ... .....+++.+.+++.+||+.||.+|++..+.|.+
T Consensus 239 i~~~--~~i~~P----------------~~~-----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYR--DVILSP----------------IEV-----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhh--hhccCh----------------hhc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2211 000000 000 1123578899999999999999999987766644
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=319.13 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=201.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
..++|++.+.||+|+||.||+|..++ .+..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35789999999999999999997653 245899998864432 233345778999999999999999999877644
Q ss_pred ccEEEEEEecchh-hHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEE
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRP---------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKI 252 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl 252 (469)
..++||||+.+ +|...+... ...++...+..++.||+.||.|||+++|+||||||+|||++.++.++|
T Consensus 83 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 83 --PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred --CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 46999999985 565555431 123567788999999999999999999999999999999999999999
Q ss_pred eeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 036673 253 ADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 253 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~ 330 (469)
+|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+....+....+....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~- 238 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG- 238 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 999999765322211 1122345678999998765 457899999999999999998 789998766655444332110
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc------CccCCC
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ------NEFFNA 395 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~------hp~f~~ 395 (469)
. ......+++.+.+||.+||+.||.+|||+.++++ ||||..
T Consensus 239 ~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 239 Y------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred C------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 0 0112245788999999999999999999999987 899876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=318.51 Aligned_cols=254 Identities=16% Similarity=0.267 Sum_probs=198.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
..++|++.+.||+|+||+||+|.+.. ++..||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35789999999999999999998652 35689999885432 2233456889999999999999999999876543
Q ss_pred ccEEEEEEecchh-hHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEE
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPG---------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKI 252 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl 252 (469)
..++||||+.+ +|...+.... ..+++..+..++.|++.||+|||+.+++|+||||+|||++.++.++|
T Consensus 83 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 83 --PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred --CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 46999999986 5555543311 23577889999999999999999999999999999999999999999
Q ss_pred eeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 036673 253 ADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 253 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~ 330 (469)
+|||++......... ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~- 238 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG- 238 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 999998765322211 1122345778999998865 458999999999999999999 789998776655444332210
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
+......++..+.+||.+||+.||.+|||+.+++++
T Consensus 239 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 ------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.00 Aligned_cols=280 Identities=32% Similarity=0.576 Sum_probs=231.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----cc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----QY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~ 184 (469)
..+|.-+..+|.|.- .|.-|.+.-+++.||+|++..........+...+|+.++..++|+||++++.+|.... ..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 467888899999999 8888989888999999998655444445577889999999999999999999885432 23
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+|+|||+|..++-..+.. .+.-..+..++.|++.|++|||+.||+||||||+||++..+..+||.|||+|+.-...
T Consensus 95 e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 4699999999999888773 4778889999999999999999999999999999999999999999999999864332
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
-..+.++.|..|+|||++.+.. |.+.+||||+||++.||++|...|++.+..++..++...+|+|.+.|.+.+....
T Consensus 172 --~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred --cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 3567889999999999999865 8999999999999999999999999999999999999999999999988754321
Q ss_pred c-C---CCCCCCCcchhccc------------CCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 T-F---RPQHYKPSFREVFG------------EFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~-~---~~~~~~~~~~~~~~------------~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
. + .++...-.+.+.++ --..-+++|+.+||..||++|.+++++|+||||+-
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 1 0 00000011111111 12345789999999999999999999999999983
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=317.94 Aligned_cols=259 Identities=32% Similarity=0.558 Sum_probs=212.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++.+... ...|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEE
Confidence 45679999999999999999999998899999999975433 346788999999999999999999988775 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+++||+++ +|.+.+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 99999995 6666665543479999999999999999999999999999999999999999999999999987653222
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
.......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...........+... ..+
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-------------- 234 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIP-------------- 234 (286)
T ss_pred hhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCC--------------
Confidence 12234457889999998765 45799999999999999999999999876665444433221 000
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+ .....++..+.+||.+||+.||.+|||+.++|+|+||...
T Consensus 235 -------~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 235 -------PL-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred -------CC-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 00 1112367889999999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=313.30 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=199.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||.|+||.||+|.+.. ++.||||.++.... ..+.+.+|+.++++++||||+++++++... ..+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeee
Confidence 4679999999999999999998764 57899999865432 235678999999999999999999987664 34699
Q ss_pred EEecch-hhHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQ-SDLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~-~~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+|||+. +++.+.+... +..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999996 4676666543 24689999999999999999999999999999999999999999999999999987642221
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
........+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.........+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-------------- 223 (261)
T ss_pred cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 11122223467999998765 458999999999999999999 99999887766555544321100
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.+||.+||+.||.+||++.++++
T Consensus 224 -----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 -----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 012246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=313.27 Aligned_cols=252 Identities=28% Similarity=0.475 Sum_probs=208.4
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
+|++.++||.|+||.||++.+..+++.+|+|.+............+.+|+.+++.++|+||+++++++... ...++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 58899999999999999999999999999999876544445556778999999999999999999888764 4579999
Q ss_pred ecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 191 DFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 191 e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||+++ ++...+.. ....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99986 55555433 2346899999999999999999999999999999999999999999999999999876433
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+....
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 217 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK----------------- 217 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence 2334568899999998865 457889999999999999999999998776554433332110
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
+......++.++.++|.+||..+|.+|||+.++|+||++
T Consensus 218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 --------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 011222467889999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=317.02 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=199.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGK----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++++.||.|+||+||+|.+..++. .||+|++.... .......+.+|+.++..+.||||+++++++....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTST-- 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC--
Confidence 4679999999999999999999877666 48999986543 3344567889999999999999999999886532
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+++++|+++ ++.+.+......+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||++..+..
T Consensus 83 -~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 83 -VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred -cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 5799999985 67666665556799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||...........+ .....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~--------- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERL--------- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcC---------
Confidence 2221 1122334678999998865 458899999999999999998 89999766554433322 211110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.++|.+||..||++||++.+++.
T Consensus 231 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 ---------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ---------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112346788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=317.99 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=200.5
Q ss_pred cCcceeceeeeeCCeEEEEEEEC----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDR----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
++|++.+.||+|+||+||+|.+. .++..||+|.+... ........+.+|+.+++.++||||+++++++.... .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ--P 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--c
Confidence 57899999999999999999853 34678999998643 33444567889999999999999999999877643 4
Q ss_pred EEEEEecchh-hHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC
Q 036673 186 LYLVFDFMQS-DLTKIICRP----------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 248 (469)
.|+||||+.+ +|...+... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 6999999986 665555321 12478899999999999999999999999999999999999999
Q ss_pred cEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036673 249 MLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIF 326 (469)
Q Consensus 249 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~ 326 (469)
.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999986533221 12233445778999998865 458999999999999999998 999998776655444332
Q ss_pred HHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 327 KLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
... . ......+++.+.++|.+||+.||.+||++.+++++
T Consensus 241 ~~~-~------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQ-L------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCC-c------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 210 0 01223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=317.56 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=200.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 34679999999999999999999987 678999998864432 333456888999999999999999999887654
Q ss_pred ccEEEEEEecchh-hHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC---cEEE
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPG------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG---MLKI 252 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~---~~kl 252 (469)
. .++||||+.+ +|...+.... ..+++..+..++.||+.||+|||+++++|+||||+|||++.++ .+||
T Consensus 83 ~--~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 P--RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred C--cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 3 5899999986 6666554432 2589999999999999999999999999999999999998765 5999
Q ss_pred eeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 036673 253 ADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 253 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~ 330 (469)
+|||++..+...... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~ 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-G 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999865222111 1112233568999998875 458999999999999999997 99999887766544433211 0
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.+ .....++..+.+||.+||+.||.+|||+.++|+|
T Consensus 239 ~~------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 RL------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cC------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 1123467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=352.71 Aligned_cols=262 Identities=29% Similarity=0.482 Sum_probs=204.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeE----------
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLA---------- 178 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~---------- 178 (469)
.++|+.+..||+||||.||+++++-+|+.||||+|.... .......+.+|+.+|.+|+|||||+++..+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 467899999999999999999999999999999998776 556667788999999999999999954100
Q ss_pred --------------------------------------------------e------e------------c---------
Q 036673 179 --------------------------------------------------T------S------------R--------- 181 (469)
Q Consensus 179 --------------------------------------------------~------~------------~--------- 181 (469)
. . .
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0 0 0
Q ss_pred ----------------------cc--------cEEEEEEecchhhHHHHHhcCCCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 036673 182 ----------------------MQ--------YSLYLVFDFMQSDLTKIICRPGQKL-TEPQVKCYMQQLLSGLQHCHER 230 (469)
Q Consensus 182 ----------------------~~--------~~~~lv~e~~~~~l~~~~~~~~~~l-~~~~~~~i~~qi~~aL~~LH~~ 230 (469)
.+ ..+||-||||+..+++.+.+.+... ....++.++++|+.||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 00 3579999999999999888876544 4788999999999999999999
Q ss_pred CceeccCCCCcEEEcCCCcEEEeeecCccccc-----------------CCCCCCcccccccCccccchhccCCC--CCC
Q 036673 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFI-----------------PKQKGPLTSRVVTLWYRAPELLLGST--DYG 291 (469)
Q Consensus 231 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ 291 (469)
|||||||||.||+|+.++.|||+|||+|+... .......+..+||.-|+|||++.+.. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999998721 01122467889999999999887766 699
Q ss_pred ccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHH
Q 036673 292 VGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILT 371 (469)
Q Consensus 292 ~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (469)
.++|||||||||+||+. ||.. ..+....+.+ +..+.. +.+ ..++..--+.-..+|.
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~-LR~g~i-----------------P~~-~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGT--SMERASILTN-LRKGSI-----------------PEP-ADFFDPEHPEEASLIR 852 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHh-cccCCC-----------------CCC-cccccccchHHHHHHH
Confidence 99999999999999983 3643 3333322221 111110 000 1222223345567999
Q ss_pred HccccCCCCCCCHHHHhcCccCCC
Q 036673 372 TLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 372 ~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.||+.||.+||||.|+|++.||-.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHhcCCCccCCCHHHHhhccCCCc
Confidence 999999999999999999999964
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=319.35 Aligned_cols=252 Identities=19% Similarity=0.315 Sum_probs=200.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDT-----GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.+|++.+.||.|+||.||+|.+..+ +..||||++..... ......+.+|+.++..++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--
Confidence 4688999999999999999987543 57899999875432 334567889999999999999999999887654
Q ss_pred EEEEEEecchh-hHHHHHhc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC
Q 036673 185 SLYLVFDFMQS-DLTKIICR---------------PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 248 (469)
.+++++||+.+ ++...+.. ....+++..+..++.|++.||+|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 46899999986 45444421 123588899999999999999999999999999999999999999
Q ss_pred cEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036673 249 MLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIF 326 (469)
Q Consensus 249 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~ 326 (469)
.+||+|||+++....... .......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999876533221 11223445789999998865 447899999999999999998 889998877666555543
Q ss_pred HHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 327 KLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.... ......++..+.+|+.+||+.||.+||++.++++.
T Consensus 241 ~~~~-------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQV-------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCc-------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 2110 01234578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=351.24 Aligned_cols=148 Identities=26% Similarity=0.456 Sum_probs=129.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|.++++||+|+||+||+|.+..+++.||||+++... ........+..|+.++..++||||+++++++.. ...+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 468999999999999999999999999999999997542 334445778899999999999999999877765 34579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
|||||+.+ +|..++.. ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999976 55555543 3468999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=313.77 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=197.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.++||+|+||+||+|.+..+ ..||+|++...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEE
Confidence 5799999999999999999988764 56999998753332 2567889999999999999999887643 235899
Q ss_pred Eecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+.+ ++.+.+... ...+++..+..++.|++.||+|||+.+|+|+||||+|||++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999986 666666542 345899999999999999999999999999999999999999999999999999765433222
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------- 222 (262)
T ss_pred cccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---------------
Confidence 2223445678999998765 458999999999999999999 89999877666555443221000
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 223 ----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 112346788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=314.54 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=203.9
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
...+|++.++||.|+||.||+|.+.. +..+|+|++.... ......+..|+.+++.++||||+++++++.... ..+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--PVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC--CeE
Confidence 34679999999999999999999988 8999999986542 223466889999999999999999998887644 469
Q ss_pred EEEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+||||+++ +|.+.+.. .+..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999987 66666654 33468999999999999999999999999999999999999999999999999997653222
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
. ......++..|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+.+..+......
T Consensus 159 ~-~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (261)
T cd05148 159 Y-LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM------------- 223 (261)
T ss_pred c-cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-------------
Confidence 1 1223345678999998865 458899999999999999998 89999887766666554321110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+++++.++|.+||+.||.+|||+.++++
T Consensus 224 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=312.45 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=198.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.++||+|+||.||+|.+.. +..||+|.+....... ..+.+|+.++++++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC---CCcEE
Confidence 3679999999999999999998764 6779999987543332 458899999999999999999987643 23689
Q ss_pred EEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+|||+.+ ++...+... ...+++..+..++.|++.||+|||+++|+|+||||+|||+++++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999986 666665442 34589999999999999999999999999999999999999999999999999986533222
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR--------------- 221 (260)
T ss_pred ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 22223345668999998765 457899999999999999999 8999988776665554432110
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
. ......+..+.+||.+||..||.+|||+.++++
T Consensus 222 -------~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 222 -------M---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -------C---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 112356788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=317.62 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=198.7
Q ss_pred cCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
++|.+.+.||.|+||+||++... .++..+|+|.+... .......+.+|+.++.+++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 57899999999999999999863 34567999988643 334456788999999999999999999988764 4
Q ss_pred EEEEEEecchh-hHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEE
Q 036673 185 SLYLVFDFMQS-DLTKIICRPG------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLK 251 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~k 251 (469)
..++||||+.+ +|...+.... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 56999999986 5555553221 2489999999999999999999999999999999999999999999
Q ss_pred EeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 036673 252 IADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLC 329 (469)
Q Consensus 252 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~ 329 (469)
|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986532221 11223345778999998865 458899999999999999998 999998777666555443211
Q ss_pred CCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 330 GTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
. ......++.++.+|+.+||+.||.+|||+.++++
T Consensus 240 ~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 V-------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred c-------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0112246788999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=331.90 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=197.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDT-----GKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 181 (469)
..++|.++++||.|+||.||+|.+... +..||||++.... .....+.+.+|+.+|.++. ||||+++++++...
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 457899999999999999999987532 3479999986543 3344467889999999996 99999999988764
Q ss_pred cccEEEEEEecchh-hHHHHHhcC--------------------------------------------------------
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRP-------------------------------------------------------- 204 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~-------------------------------------------------------- 204 (469)
..+|||||||.+ +|.+++...
T Consensus 114 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 114 --GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred --CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 357999999986 555554321
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc
Q 036673 205 ---------------------------------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID 245 (469)
Q Consensus 205 ---------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~ 245 (469)
...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 12478888999999999999999999999999999999999
Q ss_pred CCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHH
Q 036673 246 KSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLH 323 (469)
Q Consensus 246 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~ 323 (469)
.++.+||+|||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|||++ |..||........+.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999999865332221 1223456788999998876 458999999999999999997 999997654333332
Q ss_pred HHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 324 RIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 324 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..+..... . .....++..+.+||.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~~~---------------------~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYR---------------------M---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCC---------------------C---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22211000 0 112356788999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.83 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=201.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCC----------------cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTG----------------KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 172 (469)
..+|++++.||+|+||.||+|.+..++ ..||+|++..... ......+.+|+.++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence 368999999999999999999887543 5689999875433 34557788999999999999999
Q ss_pred eEeeeEeeccccEEEEEEecchh-hHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 036673 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPG----------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASN 241 (469)
Q Consensus 173 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 241 (469)
++++++... ...+++|||+.+ +|...+.... ..+++..+..++.|++.||+|||+++|+|+||||+|
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999988764 456999999986 5555554322 268999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh--CCCCCCCCCh
Q 036673 242 LLIDKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI--GRPLMPGRTE 318 (469)
Q Consensus 242 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt--g~~pf~~~~~ 318 (469)
||++.++.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ +..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999976533221 12234456788999998765 458999999999999999998 6788877666
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 319 VEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 319 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+.+..+........ ..........++.++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDG------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhcccccc------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 555544432211100 00001112346789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=318.62 Aligned_cols=250 Identities=25% Similarity=0.312 Sum_probs=196.8
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGK--IVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
++|++.+.||.|+||.||+|....++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++.... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG--YL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC--cc
Confidence 579999999999999999999887664 4688887632 2233446788999999999 7999999999876643 46
Q ss_pred EEEEecchh-hHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcE
Q 036673 187 YLVFDFMQS-DLTKIICRPG---------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGML 250 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~ 250 (469)
+++|||+++ +|...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 999999985 6666664321 248899999999999999999999999999999999999999999
Q ss_pred EEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 036673 251 KIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLC 329 (469)
Q Consensus 251 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~ 329 (469)
||+|||++...... ........+..|+|||++.+ ..++.++|||||||++|||++ |.+||......+....+....
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999998643111 11112233567999998765 458899999999999999997 999998877665554432110
Q ss_pred CCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 330 GTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.. .....++.++.+||.+||..||.+|||++++++.
T Consensus 236 ----------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 ----------------------RM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred ----------------------CC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 1123467899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=311.10 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=199.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|+++++||.|+||.||+|.... ++.||+|.+...... ...+.+|+.++++++||||+++++++.. ...++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEE
Confidence 3679999999999999999998764 788999998654332 3567889999999999999999987643 23699
Q ss_pred EEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+|||+.+ ++...+.. .+..+++.++..++.|++.||+|||+.|++|+||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999986 66665543 334689999999999999999999999999999999999999999999999999976542222
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......++..|+|||++.. ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------------
Confidence 22233445778999998765 457899999999999999999 99999887765555443221100
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++.++.+||.+||+.||++|||+++++.
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -----------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=315.74 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=196.5
Q ss_pred cCc-ceeceeeeeCCeEEEEEEE----CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSY-DKLAKVGQGTYSNVYKARD----RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y-~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
++| ++++.||+|+||+||++.. ..++..||+|++..... ......+.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 8999999999999988653 35678999999875422 23446678999999999999999999988776666
Q ss_pred EEEEEEecchhh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.++++|||+.++ +...+.. ..+++.++..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++..+..
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 789999999974 5444443 3599999999999999999999999999999999999999999999999999986533
Q ss_pred CCCC--CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCC-HHHHhh
Q 036673 264 KQKG--PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLC-GTPS-EDYWKK 339 (469)
Q Consensus 264 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~-~~~~-~~~~~~ 339 (469)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +..+.... +... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh
Confidence 2211 1122345677999998765 45789999999999999999999998654321 11111100 0000 000000
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.... ........++.++.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 LERG----------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhcC----------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 000123456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=320.50 Aligned_cols=251 Identities=26% Similarity=0.355 Sum_probs=196.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcE--EEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKI--VALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 185 (469)
.++|++.+.||+|+||+||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++.... .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~--~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--Y 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC--C
Confidence 46899999999999999999999877754 577766432 2334456788999999999 8999999999887644 4
Q ss_pred EEEEEecchh-hHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc
Q 036673 186 LYLVFDFMQS-DLTKIICRPG---------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM 249 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~ 249 (469)
.|+||||+++ +|...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 6999999985 6666654321 25889999999999999999999999999999999999999999
Q ss_pred EEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 036673 250 LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKL 328 (469)
Q Consensus 250 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~ 328 (469)
+||+|||++....... .......+..|+|||++.+ ..++.++|||||||++|+|+| |.+||...+..+....+...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999999986431111 1112234678999998765 458899999999999999998 99999876655444332110
Q ss_pred hCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 329 CGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
+.. .....++.++.+||.+||+.||.+||++.++|++
T Consensus 240 ----------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 ----------------------YRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ----------------------CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 1122467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=309.41 Aligned_cols=246 Identities=30% Similarity=0.463 Sum_probs=201.5
Q ss_pred ceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEec
Q 036673 116 AKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDF 192 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 192 (469)
+.||+|+||.||+|.+... +..||+|++....... ..+.+.+|+.++..++|+||+++++++.. ...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 3599999999999999866 8899999997654433 45788899999999999999999998877 4457999999
Q ss_pred chh-hHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 193 MQS-DLTKIICRP--------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 193 ~~~-~l~~~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
+.+ ++...+... ...+++..+..++.||+.||+|||+++|+|+||||+||+++.++.++|+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 965 666666554 36799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
... .......+++.|+|||.+... .++.++|||||||++|+|++ |..||......+....+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY------------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence 321 123345668899999988664 58999999999999999999 699998876665555443210
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.......++.++.++|.+||..||.+|||+.+++++
T Consensus 225 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 -------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001123457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.90 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=200.5
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDT-----GKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
..++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+.++..+ +|+||+++++++...
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 346899999999999999999988643 37899999875433 33446688999999999 899999999988764
Q ss_pred cccEEEEEEecchh-hHHHHHhc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICR---------------PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID 245 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~ 245 (469)
. .++++|||+.+ ++...+.. ....+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 89 ~--~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 89 G--PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred C--CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 4 47999999986 55555432 234689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHH
Q 036673 246 KSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLH 323 (469)
Q Consensus 246 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~ 323 (469)
.++.+||+|||++..+...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999865332211 1122234678999998765 458899999999999999997 999998776655444
Q ss_pred HHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 324 RIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 324 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.+..... ......++..+.+||.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYR-------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCc-------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3321100 01123457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=312.28 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=201.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCC---cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTG---KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
..+|++.+.||.|+||.||+|.+..++ ..+|+|.++.... ......+.+|+.++.+++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Cc
Confidence 357999999999999999999986544 3799998865432 34456788999999999999999999988654 35
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.|+||||+++ +|..++......+++.++..++.|++.||+|||+++|+||||||+|||++.++.++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 7999999986 666666665567899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCc--ccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 265 QKGPL--TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 265 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
..... ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....+......
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---------- 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL---------- 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC----------
Confidence 22111 12223568999998865 458999999999999999886 99999877665555444321110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.+|+.+||+.+|.+||++.++++
T Consensus 229 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 ---------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 012245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=312.46 Aligned_cols=252 Identities=19% Similarity=0.297 Sum_probs=200.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDT-----GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.++|++.+.||.|+||.||+|.+... +..||+|.+.... .......+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 46899999999999999999998643 3789999986443 233346688999999999999999999988775
Q ss_pred cEEEEEEecchh-hHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEe
Q 036673 184 YSLYLVFDFMQS-DLTKIICRP---------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIA 253 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~ 253 (469)
...++||||+.+ +|...+... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 446999999985 665555331 1247888999999999999999999999999999999999999999999
Q ss_pred eecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 036673 254 DFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGT 331 (469)
Q Consensus 254 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 331 (469)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+.. ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGH 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCC
Confidence 9999976533221 12234456789999998865 458899999999999999998 9999987766555443321 000
Q ss_pred CCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+ .....++.++.+||.+||+.+|.+|||+.++++
T Consensus 240 ~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 L------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 112345789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=315.44 Aligned_cols=264 Identities=22% Similarity=0.370 Sum_probs=199.5
Q ss_pred cCcceeceeeeeCCeEEEEEEE----CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARD----RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
..|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3478999999999999999974 4568899999986543 3344567899999999999999999999887765566
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.++||||+++ +|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 7999999986 555555444446899999999999999999999999999999999999999999999999999876432
Q ss_pred CCC--CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-----HHHH
Q 036673 265 QKG--PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS-----EDYW 337 (469)
Q Consensus 265 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~-----~~~~ 337 (469)
... ......++..|+|||++.+ ..++.++|||||||++|+|+++..|+..... .. .+..+... ....
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccccHHHHH
Confidence 221 1223456778999998876 4588999999999999999998766533211 11 11111110 0000
Q ss_pred hhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
+...... .......++..+.+||.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0000000 001234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=314.02 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=197.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGK----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
++|++.+.||.|+||+||+|.+..++. .|++|.+... ........+..|+.++.+++||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~---~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA---S 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC---c
Confidence 679999999999999999999987776 4777776433 2233446677899999999999999999987532 3
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.++++||+.+ ++.+.+......+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 5789999984 777777666667999999999999999999999999999999999999999999999999999876433
Q ss_pred CCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 265 QKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+ .....+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~---------- 230 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERL---------- 230 (279)
T ss_pred CcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcC----------
Confidence 221 1233456778999998865 458999999999999999998 99999876654433222 111000
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......+.++.+++.+||..||++|||+.++++
T Consensus 231 --------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 --------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001124567889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.78 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=201.7
Q ss_pred CcceeceeeeeCCeEEEEEEEC---CCCcEEEEEEeecCC--CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecccc
Q 036673 111 SYDKLAKVGQGTYSNVYKARDR---DTGKIVALKKVRFDT--SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 184 (469)
+|++.+.||.|+||.||++.+. .+++.||||+++... ......+.+.+|+.++.++ +||||+++++.+... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--T 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--C
Confidence 4888999999999999999864 457899999986432 1223345678899999999 699999998877653 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+++||||+.+ ++...+.. ...+++..+..++.|++.||.|||+.+++|+||+|+|||++.++.++|+|||++..+..
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 57999999987 55555543 45699999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCCcccccccCccccchhccCCC-CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGST-DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
..........+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||...........+.+.....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 227 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS---------- 227 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc----------
Confidence 3322233456899999999876533 36789999999999999999999996543222222221110000
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC---HHHHhcCccCCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT---AASALQNEFFNAS 396 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~hp~f~~~ 396 (469)
. ......++..+.+||.+||+.||++||| +.++|+||||+..
T Consensus 228 ---------~---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 228 ---------K---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred ---------C---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 0 0122346788999999999999999998 5688999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=309.39 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=197.8
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++...||.|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEE
Confidence 5799999999999999999988764 5699998764332 23567889999999999999999887643 236899
Q ss_pred Eecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+.+ ++.+.+... ...+++..+..++.||+.||.|||+.||+|+||||+|||+++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999986 677776543 345899999999999999999999999999999999999999999999999999765332222
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+....+.....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------- 221 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---------------- 221 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 2223345678999998765 457899999999999999999 9999988776655544322100
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+ .....++..+.+||.+||..||.+||+++++++
T Consensus 222 ------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 ------M---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ------C---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=313.17 Aligned_cols=266 Identities=23% Similarity=0.369 Sum_probs=198.6
Q ss_pred cCcceeceeeeeCCeEEEEEEE----CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARD----RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.+|++++.||+|+||+||++.. ..++..||||++... .....+.+.+|+.++..++||||+++++++...+...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5799999999999999999974 456889999998643 3344577889999999999999999999877665566
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+++||||+++ +|...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 8999999985 666666555556999999999999999999999999999999999999999999999999999875332
Q ss_pred CCCC--cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCC-HHHHhhc
Q 036673 265 QKGP--LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG-TPS-EDYWKKM 340 (469)
Q Consensus 265 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~-~~~-~~~~~~~ 340 (469)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|..++..... .....+..... ... ....+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHHH
Confidence 2211 112233456999998865 4588999999999999999998876643321 11111100000 000 0000100
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..... ......++..+.+||.+||..||++|||+.++++
T Consensus 240 ~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGR----------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000 0112456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=324.80 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=195.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 182 (469)
.++|++.+.||.|+||+||+|.+. .+++.||||+++.... ......+.+|+.+|.++ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 368999999999999999999853 4578999999975433 33456788999999999 6899999999876543
Q ss_pred ccEEEEEEecchh-hHHHHHhcCC--------------------------------------------------------
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPG-------------------------------------------------------- 205 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~-------------------------------------------------------- 205 (469)
..+++||||+++ +|.+.+....
T Consensus 85 -~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 85 -GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred -CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 356899999996 5555543211
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC-Ccccccc
Q 036673 206 ----------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG-PLTSRVV 274 (469)
Q Consensus 206 ----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~g 274 (469)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......... ......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 23678889999999999999999999999999999999999999999999999765322211 1122334
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
++.|+|||++.+ ..++.++|||||||++|+|++ |..||............+..... .
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~ 301 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR---------------------M 301 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC---------------------C
Confidence 678999998865 458999999999999999997 99999765433322222111000 0
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....+++++.+++..||+.||.+|||+.++++|
T Consensus 302 ---~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=342.83 Aligned_cols=275 Identities=21% Similarity=0.282 Sum_probs=187.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCC----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeE----e
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDT----GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLA----T 179 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~----~ 179 (469)
..++|.+.+.||+|+||.||+|.+..+ +..||||++...... +....| .+....+.+++.+...+ .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 568999999999999999999999988 899999987532211 111111 12222233333322211 1
Q ss_pred eccccEEEEEEecchhh-HHHHHhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 036673 180 SRMQYSLYLVFDFMQSD-LTKIICRPGQK-------------------LTEPQVKCYMQQLLSGLQHCHERGILHRDIKA 239 (469)
Q Consensus 180 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~-------------------l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 239 (469)
......++|||||+.++ |.+.+...... .....+..++.||+.||+|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 12344579999999874 54444332211 12345678999999999999999999999999
Q ss_pred CcEEEcC-CCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCC---------------------CCCccccch
Q 036673 240 SNLLIDK-SGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST---------------------DYGVGIDLW 297 (469)
Q Consensus 240 ~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Dvw 297 (469)
+||||+. ++.+||+|||+|+.+...........++++.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 579999999999866444444455678899999999764321 234567999
Q ss_pred hhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcc---hhcccCCChhHHHHHHHcc
Q 036673 298 SAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSF---REVFGEFPPSSYGILTTLL 374 (469)
Q Consensus 298 slGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L 374 (469)
||||+||||+++. |...+....+..++...+.....+.+... .. ..+.+ .+..+..+..+.+||.+||
T Consensus 364 SlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 364 SAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDLVAWRKLVE-PR------ASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcHHHHHHhhc-cc------cchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999865 44555555666666555443333222211 10 11111 1223334556779999999
Q ss_pred ccCCCCCCCHHHHhcCccCCCCC
Q 036673 375 ALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 375 ~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
++||.+|||+.|+|+||||+...
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCC
Confidence 99999999999999999998744
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.07 Aligned_cols=252 Identities=31% Similarity=0.477 Sum_probs=199.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||.|+||.||+|++..++..||||.+.... ........+.+|+.+++.++||||+++++++.... ..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--eEEE
Confidence 57899999999999999999998889999999886432 23344467889999999999999999999887643 5699
Q ss_pred EEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+|||+++ ++...+.. ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999997 55554432 3456899999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhccc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV--EQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.... .....+.. ...
T Consensus 160 ~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~----------- 225 (267)
T cd08229 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDY----------- 225 (267)
T ss_pred C-cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCC-----------
Confidence 2 22234578899999998865 45788999999999999999999999754321 11111110 000
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+ .....++..+.+||.+||..||.+|||+.++++
T Consensus 226 ---------~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 226 ---------PP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ---------CC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 00 011246788999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=308.83 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=192.5
Q ss_pred ceeeeeCCeEEEEEEECCCC---cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEec
Q 036673 116 AKVGQGTYSNVYKARDRDTG---KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDF 192 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 192 (469)
++||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++||||+++++++... ..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKGE---PLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC---ceEEEEEe
Confidence 35999999999999876554 78999998755433 4456788999999999999999999876532 36899999
Q ss_pred chh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc-
Q 036673 193 MQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT- 270 (469)
Q Consensus 193 ~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~- 270 (469)
+.+ +|.+.+... ..+++..+..++.|++.||+|||+.+|+|+||||+|||++.++.+||+|||++..+.........
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 77 APLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 986 566665543 37999999999999999999999999999999999999999999999999999876433221111
Q ss_pred -cccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 271 -SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 271 -~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~----------------- 216 (257)
T cd05060 156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ER----------------- 216 (257)
T ss_pred cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-Cc-----------------
Confidence 1123467999998865 458999999999999999998 99999876665444333211 00
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......++..+.+||.+||..||.+|||+.++++
T Consensus 217 -------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 -------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0122356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.78 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=209.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.+-...+.||+|+||.||+|+... ....||||.++.... .....+|.+|+++|..|+|||||+|+|+|...+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~-- 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCREGD-- 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC--
Confidence 456677889999999999998753 246899999976543 345688999999999999999999999998854
Q ss_pred EEEEEEecch-hhHHHHHhcC---------CC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcE
Q 036673 185 SLYLVFDFMQ-SDLTKIICRP---------GQ----KLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGML 250 (469)
Q Consensus 185 ~~~lv~e~~~-~~l~~~~~~~---------~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~ 250 (469)
-+|+|+|||. |||.+++... +. +|+..+.+.|+.||+.||.||-++.+|||||-..|+||.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 4699999999 5776666321 12 38999999999999999999999999999999999999999999
Q ss_pred EEeeecCcccccCCCCCCcc-cccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 036673 251 KIADFGLSNFFIPKQKGPLT-SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKL 328 (469)
Q Consensus 251 kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~ 328 (469)
||+|||+++.....+-.... ...-..+||+||.++- ..|++++|||||||+|||+++ |..||.+.++.+.+..|...
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999876544433322 3445789999999876 459999999999999999997 99999999999999887542
Q ss_pred hCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHh
Q 036673 329 CGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASAL 388 (469)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL 388 (469)
. +.......|.++.+||..|++.+|.+||+..||=
T Consensus 722 ~-------------------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 Q-------------------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred C-------------------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 1 1244567899999999999999999999998863
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=312.87 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=194.4
Q ss_pred ceeceeeeeCCeEEEEEEEC----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 113 DKLAKVGQGTYSNVYKARDR----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 113 ~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.+.+.||.|.||.||+|.+. ..+..|+||+++. ....+..+.+.+|++++.+++||||++++|++.... .+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccc--cccc
Confidence 35678999999999999998 4467899999954 344455688999999999999999999999998433 3799
Q ss_pred EEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||||+.+ +|.+.+... ...+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999985 677776665 56799999999999999999999999999999999999999999999999999986522111
Q ss_pred -CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 267 -GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 267 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
...........|+|||.+... .++.++||||||+++|||++ |+.||...+..+....+.+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------------
T ss_pred cccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc--------------
Confidence 112334567889999988654 48999999999999999999 7899988877766665532110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......++..+.+||..||..||.+|||+.++++
T Consensus 224 -----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 -----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0122346788999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=305.56 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=194.1
Q ss_pred eeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-
Q 036673 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS- 195 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~- 195 (469)
.||.|+||.||+|... ++..||+|++.... .......+.+|+.++..++||||+++++++.... ..++||||+++
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~ 77 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVMELVPGG 77 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEECCCCC
Confidence 5999999999999865 58899999986543 3344456889999999999999999999887654 46999999986
Q ss_pred hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccccc
Q 036673 196 DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVT 275 (469)
Q Consensus 196 ~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 275 (469)
++...+......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...............++
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 66666655555689999999999999999999999999999999999999999999999999975432222112223446
Q ss_pred CccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCc
Q 036673 276 LWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPS 354 (469)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (469)
+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.... .
T Consensus 158 ~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------------~-- 212 (250)
T cd05085 158 IKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----------------------R-- 212 (250)
T ss_pred ccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----------------------C--
Confidence 77999998865 457899999999999999998 999998776655444332110 0
Q ss_pred chhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 355 FREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 355 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......++..+.+|+.+||..||++|||+.++++
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 213 -MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0112346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=308.12 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=201.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||.|+||+||+|.+.. +..||||.+...... ...+.+|+.+++.++||||+++++++... ...+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecC--CceE
Confidence 34789999999999999999999864 578999998754332 35688999999999999999999887653 3469
Q ss_pred EEEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+||||+++ ++.+.+.... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999986 6666665432 468999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.........+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM------------- 223 (261)
T ss_pred hhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 111122234568999998875 457899999999999999998 99999887776666655332111
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......+.++.++|.+||+.||.+||++.++++
T Consensus 224 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 ------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 111234778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=309.34 Aligned_cols=252 Identities=21% Similarity=0.359 Sum_probs=201.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+..... ....+.+..|+.++..++||||+++.+++.... .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK--P 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC--C
Confidence 3578899999999999999999876554 799998865432 334567889999999999999999999887644 4
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.++||||+++ +|...+......+++..+..++.|++.||+|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 6999999997 555555555567999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCcc--cccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 265 QKGPLT--SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 265 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
...... ....++.|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....+......+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--------- 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--------- 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---------
Confidence 221111 1223457999998865 457899999999999999997 999998777665555443211110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+.++.+|+.+||..||.+||++.++++
T Consensus 231 ----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 ----------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=309.96 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=201.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.++|.+.+.||.|+||.||+|.+... ...||||...... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---P 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---C
Confidence 35689999999999999999987654 3578999886443 244556788999999999999999999987653 2
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.++||||+.+ ++.+.+......+++..+..++.||+.||+|||+.+++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 5899999985 666666555556899999999999999999999999999999999999999999999999999765333
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.........+++.|+|||.+.. ..++.++|||||||++|+|++ |.+||......+....+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------------ 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------------ 227 (270)
T ss_pred cceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------------
Confidence 2212222334568999998765 458899999999999999986 99999887766555443221000
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....++..+.+||.+||..+|.+|||+.+++..
T Consensus 228 -------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 -------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1224567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=325.12 Aligned_cols=278 Identities=32% Similarity=0.522 Sum_probs=225.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC------CCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD------HPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~~ 182 (469)
.++|.+....|+|-|++|.+|.+...|..||||+|+.+. -..+.=+.|++||++|+ --|+++|+-.|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--
Confidence 478999999999999999999999989999999998542 33355668999999994 3478888776666
Q ss_pred ccEEEEEEecchhhHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC-CcEEEeeecCcc
Q 036673 183 QYSLYLVFDFMQSDLTKIICRPG--QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS-GMLKIADFGLSN 259 (469)
Q Consensus 183 ~~~~~lv~e~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~ 259 (469)
..++|||||.+.-+|...+.+.+ ..|....++.|+.|++.||..|...||+|.||||.|||+++. ..+||||||.|.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 55789999999999888886654 347888999999999999999999999999999999999876 468999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
... .+..+.+..+..|+|||+++| ..|++..|+||+||.||||.||+..|++.+....+...+.+-|..+..+...
T Consensus 586 ~~~---eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FAS---ENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccc---cccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 753 344677888999999999998 5699999999999999999999999999999999999998888888776655
Q ss_pred cccCccCCC----------------------CCCCC--cchhcccC----------CChhHHHHHHHccccCCCCCCCHH
Q 036673 340 MKLTTTFRP----------------------QHYKP--SFREVFGE----------FPPSSYGILTTLLALDPAYRGTAA 385 (469)
Q Consensus 340 ~~~~~~~~~----------------------~~~~~--~~~~~~~~----------~~~~l~~li~~~L~~dP~~Rpta~ 385 (469)
-.....-.. ....| ++...... +-.++.+||.+||..||++|.|+.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 322111000 00011 11111111 224588999999999999999999
Q ss_pred HHhcCccCCC
Q 036673 386 SALQNEFFNA 395 (469)
Q Consensus 386 elL~hp~f~~ 395 (469)
|+|+||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999974
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=318.61 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=213.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
..+|..+.+||+|+||.|.+|..+.+.+.||||+++++- .+.+.++--..|-.+|... +-|.++.++..|..- ..+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm--DRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh--hhe
Confidence 467999999999999999999999999999999998762 2333344455677887766 567778887666553 358
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|+||||+.| +|...+.+ -+++.++.+..++..|+-||-+||++||+.||||.+|||||.+|++||+|||+++.-.- .
T Consensus 426 yFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~ 503 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-D 503 (683)
T ss_pred eeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-C
Confidence 999999997 55555544 45799999999999999999999999999999999999999999999999999975322 2
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.....+.||||.|+|||++.- .+|+.++|+||+||+|||||.|++||.++++.+..+.|......
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-------------- 568 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-------------- 568 (683)
T ss_pred CcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--------------
Confidence 334568899999999998764 67999999999999999999999999999999999988764321
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH-----HHHhcCccCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA-----ASALQNEFFNA 395 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta-----~elL~hp~f~~ 395 (469)
+...+|.++.++++.+|.+.|.+|..+ .++-.||||+.
T Consensus 569 ------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 569 ------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred ------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 233568899999999999999999764 58999999985
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=315.82 Aligned_cols=258 Identities=21% Similarity=0.316 Sum_probs=198.2
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCC--------------cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEe
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTG--------------KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLE 175 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~--------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 175 (469)
++|++.+.||+|+||.||+|++..++ ..||||++.... .......+.+|++++.+++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 58999999999999999999876432 358999987542 334456788999999999999999999
Q ss_pred eeEeeccccEEEEEEecchh-hHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 036673 176 GLATSRMQYSLYLVFDFMQS-DLTKIICRPG-----------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLL 243 (469)
Q Consensus 176 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIL 243 (469)
+++.... ..++||||+.+ ++...+.... ..+++..+..++.||+.||+|||+++++|+||||+|||
T Consensus 84 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9887643 46999999996 5555543321 13788999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh--CCCCCCCCChHH
Q 036673 244 IDKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI--GRPLMPGRTEVE 320 (469)
Q Consensus 244 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt--g~~pf~~~~~~~ 320 (469)
++.++.+||+|||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ +..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999765322211 1123344678999998765 458999999999999999998 677888766655
Q ss_pred HHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 321 QLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 321 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+..+........ ........+.+++.+.+||.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQG------------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhcc------------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5544432111000 00001122346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=307.80 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=191.7
Q ss_pred eeeeCCeEEEEEEEC--CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh
Q 036673 118 VGQGTYSNVYKARDR--DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS 195 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 195 (469)
||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~~ 78 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMASG 78 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCCC
Confidence 899999999999775 445679999986543 34445678899999999999999999998753 246899999986
Q ss_pred -hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC--cccc
Q 036673 196 -DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP--LTSR 272 (469)
Q Consensus 196 -~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~~~~ 272 (469)
+|.+.+......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+....... ....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 5555555445679999999999999999999999999999999999999999999999999997653322211 1122
Q ss_pred cccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCC
Q 036673 273 VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY 351 (469)
Q Consensus 273 ~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (469)
.+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+.... .
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~-------------------- 216 (257)
T cd05115 159 KWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R-------------------- 216 (257)
T ss_pred CCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C--------------------
Confidence 33578999998765 457899999999999999996 999998776665544332210 0
Q ss_pred CCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 352 KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 352 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+ ......++++.+||.+||..||++||++.++++
T Consensus 217 -~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 -L---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 122346789999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=315.86 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=199.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
..++|.+.+.||+|+||.||++.+. .++..||||+++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 4468999999999999999999753 345689999886543 234456788999999999 899999999988764
Q ss_pred cccEEEEEEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
. .+++||||+.+ +|...+.... ..+++.++..++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++.
T Consensus 112 ~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 112 G--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred C--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 3 47999999985 6666665433 338999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 036673 260 FFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 260 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 337 (469)
.+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+..........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~------- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY------- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC-------
Confidence 65332211 1122345778999998865 447899999999999999998 9999987665544433322100
Q ss_pred hhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.. ......++.+.+||.+||..||++|||+.++++
T Consensus 262 --------------~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 --------------RM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------------cC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 011245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=310.41 Aligned_cols=238 Identities=19% Similarity=0.284 Sum_probs=185.0
Q ss_pred eeeeeCCeEEEEEEECCC------------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 117 KVGQGTYSNVYKARDRDT------------GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.||+|+||.||+|..... ...||+|++... .......+.+|+.++..++||||+++++++.....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~- 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE- 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC-
Confidence 589999999999985422 236888987543 23344678889999999999999999999876543
Q ss_pred EEEEEEecchhhHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc-------EEEeeec
Q 036673 185 SLYLVFDFMQSDLTKII-CRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM-------LKIADFG 256 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-------~kl~DFG 256 (469)
.++||||++++.+..+ ......+++..+..++.||+.||+|||+++|+||||||+|||++.++. ++++|||
T Consensus 79 -~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 79 -NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred -CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 5899999997554444 344557999999999999999999999999999999999999987664 8999999
Q ss_pred CcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 036673 257 LSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTPSED 335 (469)
Q Consensus 257 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell-tg~~pf~~~~~~~~~~~i~~~~~~~~~~ 335 (469)
++..... .....++..|+|||++.....++.++|||||||++|+|+ +|..||......+.. .+....
T Consensus 158 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~------ 225 (262)
T cd05077 158 IPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ------ 225 (262)
T ss_pred CCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC------
Confidence 9875422 224567889999998865567899999999999999998 588888765433321 111100
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.......+.++.+||.+||+.||.+||++.++|++
T Consensus 226 --------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 --------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00112235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=307.06 Aligned_cols=244 Identities=24% Similarity=0.400 Sum_probs=196.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||.||++... +..||+|.++... ..+.+.+|+.+++.++|+||+++++++... ....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEE
Confidence 357999999999999999999775 7889999886432 235688999999999999999999876543 334799
Q ss_pred EEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+|||+++ ++...+.... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-- 155 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 155 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--
Confidence 9999986 6666665433 34899999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
......+..|+|||++.+ ..++.++|||||||++|+|++ |++||......+....+.+..
T Consensus 156 --~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05082 156 --QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 216 (256)
T ss_pred --CCCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 123344678999998765 458899999999999999997 999998765544444332110
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+ ...+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 217 ------~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 ------KM---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------CC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 122456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.43 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=198.0
Q ss_pred cCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.+|.+.+.||.|+||.||+|.+.. ++..+++|.+... .....+.+.+|+.++.+++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD-- 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC--
Confidence 468899999999999999998643 3567899987543 2334467889999999999999999999887643
Q ss_pred EEEEEEecchh-hHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC
Q 036673 185 SLYLVFDFMQS-DLTKIICRP---------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 248 (469)
..++||||+++ +|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 47999999986 555555432 23489999999999999999999999999999999999999999
Q ss_pred cEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036673 249 MLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIF 326 (469)
Q Consensus 249 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~ 326 (469)
.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999976533221 11234456788999998865 458899999999999999998 999998776655444332
Q ss_pred HHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 327 KLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
... .......++..+.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGR-------------------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCC-------------------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 110 00112245788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=307.08 Aligned_cols=252 Identities=32% Similarity=0.502 Sum_probs=200.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||.|+||.||+|.+..+++.||+|.++.. .........+.+|++++++++|+||+++++++... ...++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 5799999999999999999999989999999988643 23334457788999999999999999999988774 35699
Q ss_pred EEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
||||+++ +|...+.. ....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999996 55555432 3456899999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhccc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE--VEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+...
T Consensus 160 ~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 223 (267)
T cd08224 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-------------- 223 (267)
T ss_pred C-cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--------------
Confidence 2 22334568899999998865 4588999999999999999999999965431 1111111100
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+.+. ....++..+.++|.+||..+|.+|||+.++++
T Consensus 224 -------~~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 -------DYPPL---PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -------CCCCC---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00000 01246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=306.49 Aligned_cols=245 Identities=26% Similarity=0.362 Sum_probs=197.4
Q ss_pred ceeeeeCCeEEEEEEECC-CCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEec
Q 036673 116 AKVGQGTYSNVYKARDRD-TGK--IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDF 192 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 192 (469)
+.||.|+||+||+|.+.. +++ .||||.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 358999999999999865 333 6999998765443 556788999999999999999999998876 457999999
Q ss_pred chh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC--C
Q 036673 193 MQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG--P 268 (469)
Q Consensus 193 ~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~ 268 (469)
+++ +|...+.... ..+++..+..++.|++.||+|||+++++|+||||+|||++.++.+||+|||++..+...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 975 6666665543 46899999999999999999999999999999999999999999999999999876432211 1
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.......
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL--------------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---------------
Confidence 123456788999998765 458899999999999999998 999998777766555543210000
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.+|+.+||..+|++|||+.++++
T Consensus 221 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 011245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=308.96 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=199.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
.+|++.+.||.|+||.||+|.+..++. .||||++.... .......+..|+.+++.++||||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR--PV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC--ce
Confidence 568999999999999999999887664 69999986542 3445578899999999999999999998876543 46
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
++||||+++ ++...+......+++..++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999987 5555555555679999999999999999999999999999999999999999999999999987653322
Q ss_pred CCC-ccccc---ccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 266 KGP-LTSRV---VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 266 ~~~-~~~~~---gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
... ..... .+..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+....+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~--------- 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL--------- 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC---------
Confidence 211 11111 2457999998865 457899999999999999886 99999877665554444221100
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.+++.+||..+|.+||++.+++.
T Consensus 231 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 ----------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=306.77 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=198.2
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.+|++.+.||.|+||.||++.+.. +..+|+|.+...... ...+.+|++++++++||||+++++++.... ..++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERS--PICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCC--ceEEE
Confidence 578999999999999999998864 778999988644332 245788999999999999999998876643 46999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||+.+ .|...+......+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999997 4555554445568999999999999999999999999999999999999999999999999997653322211
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||......+....+......
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL---------------- 220 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC----------------
Confidence 223334678999998865 458899999999999999998 99999877665555443211000
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.. ....+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 221 ---~~------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 221 ---YK------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---CC------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00 11246889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=312.13 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=197.8
Q ss_pred cCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.+|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|++++..++|+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR-- 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC--
Confidence 57888999999999999999753 34678999987643 3344577899999999999999999998887643
Q ss_pred EEEEEEecchh-hHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc
Q 036673 185 SLYLVFDFMQS-DLTKIICRPG--------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM 249 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~ 249 (469)
..+++|||+.+ +|...+.... ..+++..+..++.||+.||+|||++||+|+||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 46999999986 5555543321 24889999999999999999999999999999999999999999
Q ss_pred EEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 036673 250 LKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFK 327 (469)
Q Consensus 250 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~ 327 (469)
+||+|||++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+....+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999975532221 11123345688999998866 458999999999999999998 9999987766655544432
Q ss_pred HhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 328 LCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.... .....+++.+.+||.+||+.||.+||++.++++
T Consensus 240 ~~~~-------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GREL-------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccC-------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1100 112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=309.95 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=200.0
Q ss_pred cCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
++|+++..||.|+||.||+|+.+. +.+.|++|.+.... .......+.+|+.++++++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--E 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--C
Confidence 579999999999999999999764 34689999875432 233457788999999999999999999987664 3
Q ss_pred EEEEEEecchh-hHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 185 SLYLVFDFMQS-DLTKIICRPG--------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
..++||||+++ +|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 46999999996 5555554322 15899999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 036673 256 GLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSE 334 (469)
Q Consensus 256 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 334 (469)
|++...............++..|+|||.+.+. .++.++|||||||++|+|++ |..||........+..+... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~-- 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KL-- 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--Cc--
Confidence 99875433222233445667889999987653 47889999999999999998 88899766555444433210 00
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
. ......++..+.++|.+||+.||.+|||+.++++.
T Consensus 237 -----------------~---~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 -----------------E---LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -----------------C---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 01123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=305.42 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=198.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||.||++.+.. +..+|+|.+... ......+.+|+.+++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 4689999999999999999998654 667999988643 2234678899999999999999999888765 34689
Q ss_pred EEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+|||+++ ++.+.+.. ....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999985 67766654 344688999999999999999999999999999999999999999999999999976533222
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......++..|+|||++.. ..++.++|+|||||++|+|++ |.+||...+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------------
Confidence 22223345678999998865 457889999999999999998 99999887665554433211000
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++.++.+++.+||+.||++||++.++++
T Consensus 223 -----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 223 -----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 112356789999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.23 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=201.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGK----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..+|++.+.||+|+||+||+|.+..++. .||+|.+..... ......+.+|+.++..++||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 4679999999999999999999876664 589998765433 4455678899999999999999999998876 3
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
..++||||+.+ ++.+.+......+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 46899999985 67777666566799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCc-ccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQKGPL-TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
...... ....++..|+|||.+.. ..++.++|+|||||++|||++ |.+||.+....+....+.... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~--------- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RL--------- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CC---------
Confidence 322111 12223568999998764 457899999999999999998 999998876655444332210 00
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......+..+.+++.+||..||.+|||+.++++
T Consensus 231 ---------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 ---------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111235678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=305.52 Aligned_cols=244 Identities=26% Similarity=0.422 Sum_probs=198.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||.|+||.||+|... ++.||||.+..... ..+.+.+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 467999999999999999999876 78999999865432 45678899999999999999999998876 345699
Q ss_pred EEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||||+++ ++...+.... ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-- 155 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-- 155 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence 9999996 6666654432 26899999999999999999999999999999999999999999999999999875221
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
......+..|+|||.+.. ..++.++|||||||++|+|++ |..||......+....+....
T Consensus 156 --~~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05039 156 --QDSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY---------------- 216 (256)
T ss_pred --cccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 113344668999998765 457889999999999999997 999998766554433332100
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.. .....+++.+.+||.+||..+|++|||+.++++
T Consensus 217 ------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 ------RM---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ------CC---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00 112346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=303.71 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=194.8
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS 195 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 195 (469)
++||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+.++++++||||+++++++.... ..++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEEcCCC
Confidence 359999999999999987 999999998754333 44567889999999999999999998887643 46999999986
Q ss_pred -hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc-cccc
Q 036673 196 -DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL-TSRV 273 (469)
Q Consensus 196 -~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 273 (469)
++.+.+......+++..+..++.+++.||+|||+++|+||||||+|||++.++.++|+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 66666655555789999999999999999999999999999999999999999999999999976532111111 1223
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (469)
.+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+......
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 214 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------------- 214 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC---------------------
Confidence 3567999998765 458999999999999999999 88999877655444333211000
Q ss_pred CcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 353 PSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++.++.+||.+||+.+|.+|||+.++|+
T Consensus 215 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 ----PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.81 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=205.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCc---E-EEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGK---I-VALKKVRFD-TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~-vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
++-.+.++||+|+||.||+|..+..+. . ||||..+.. ....+....|.+|+++|++++|||||+++|++.....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P- 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP- 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-
Confidence 344556899999999999999875422 3 899998752 3567788999999999999999999999999887544
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
++||||+|.| +|.+.+.+....++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++....
T Consensus 236 -l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 236 -LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred -cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 6999999997 66666666655799999999999999999999999999999999999999999999999999975421
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.........-...|+|||.+... .|+.++|||||||++||+++ |..||++....+...+|.......
T Consensus 315 -~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~---------- 382 (474)
T KOG0194|consen 315 -YVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM---------- 382 (474)
T ss_pred -eeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC----------
Confidence 11111122346789999988764 69999999999999999998 888999999998888774421110
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......|..+..++.+|+..||++|||+.++.+
T Consensus 383 --------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 383 --------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 112245678889999999999999999988765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=304.46 Aligned_cols=245 Identities=29% Similarity=0.529 Sum_probs=200.9
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS- 195 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~- 195 (469)
||.|+||.||++.+..+++.||+|++..... .......+..|+.+++.++||||+++++.+.. ...+++||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 6899999999999998899999999876532 22345678899999999999999999887765 4457999999965
Q ss_pred hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccccc
Q 036673 196 DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVT 275 (469)
Q Consensus 196 ~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 275 (469)
++.+.+... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 79 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 79 ELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 666555443 468999999999999999999999999999999999999999999999999998753322 223456778
Q ss_pred CccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcc
Q 036673 276 LWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSF 355 (469)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (469)
..|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......+.. ..
T Consensus 157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~------------------------ 209 (250)
T cd05123 157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DP------------------------ 209 (250)
T ss_pred ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CC------------------------
Confidence 89999998765 4478899999999999999999999987766444444322 00
Q ss_pred hhcccCCChhHHHHHHHccccCCCCCCCH---HHHhcCccC
Q 036673 356 REVFGEFPPSSYGILTTLLALDPAYRGTA---ASALQNEFF 393 (469)
Q Consensus 356 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta---~elL~hp~f 393 (469)
..+...++..+.+||.+||..||.+|||+ .++++||||
T Consensus 210 ~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 210 LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 01223347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=310.90 Aligned_cols=238 Identities=17% Similarity=0.296 Sum_probs=187.1
Q ss_pred eeeeeCCeEEEEEEECCCCc-------EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 117 KVGQGTYSNVYKARDRDTGK-------IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.||.|+||+||+|.+..++. .||+|.+... .....+.+..|+.+++.++||||+++++++.... ..++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ESIMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--CcEEE
Confidence 59999999999999865544 4888887532 2334467888999999999999999999887744 36899
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc--------EEEeeecCccc
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM--------LKIADFGLSNF 260 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~--------~kl~DFGla~~ 260 (469)
|||+.+ +|...+......+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999987 555555555556899999999999999999999999999999999999987765 69999999875
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
... .....+++.|+|||++.+...++.++|||||||++|+|++| .+||...+....... ... .
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~--~-------- 221 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YED--R-------- 221 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHc--c--------
Confidence 432 23456788999999987656688999999999999999998 566655444332221 110 0
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..+....+.++.+||.+||+.||.+|||+.++++.
T Consensus 222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 ----------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ----------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 01122345678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=315.27 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=197.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD-------TGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATS 180 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 180 (469)
.++|.+.+.||+|+||.||+|++.. +...+|+|.+..... ......+.+|+.++..+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3679999999999999999998743 235799999875432 33446688899999999 79999999998876
Q ss_pred ccccEEEEEEecchh-hHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 036673 181 RMQYSLYLVFDFMQS-DLTKIICRPG---------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI 244 (469)
Q Consensus 181 ~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl 244 (469)
.. ..|+||||+.+ +|..++.... ..+++.+++.++.||+.||+|||++|++||||||+|||+
T Consensus 96 ~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 96 DG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred CC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 44 57999999986 6666664421 248899999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCCC-cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHH
Q 036673 245 DKSGMLKIADFGLSNFFIPKQKGP-LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQL 322 (469)
Q Consensus 245 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~ 322 (469)
+.++.+||+|||++.......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 999999999999997653221111 112234578999998866 457899999999999999998 88999776544433
Q ss_pred HHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 323 HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..+.. .. .......++.++.+||.+||..+|.+|||+.+++++
T Consensus 253 ~~~~~-~~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKE-GH------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHc-CC------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 32211 00 001223567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=311.21 Aligned_cols=238 Identities=21% Similarity=0.288 Sum_probs=184.6
Q ss_pred eeeeeCCeEEEEEEECCC------------------------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee
Q 036673 117 KVGQGTYSNVYKARDRDT------------------------GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 172 (469)
.||+|+||.||+|....+ ...||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999975321 246889988543 223346688899999999999999
Q ss_pred eEeeeEeeccccEEEEEEecchhhHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC---
Q 036673 173 KLEGLATSRMQYSLYLVFDFMQSDLT-KIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG--- 248 (469)
Q Consensus 173 ~~~~~~~~~~~~~~~lv~e~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~--- 248 (469)
++++++.... ..++||||++++.+ ..+......+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 9999987754 46899999997544 44444456799999999999999999999999999999999999997654
Q ss_pred ----cEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHH-hCCCCCCCCChHHHHH
Q 036673 249 ----MLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLH 323 (469)
Q Consensus 249 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell-tg~~pf~~~~~~~~~~ 323 (469)
.+||+|||++..... .....++..|+|||.+.+...++.++|||||||++|||+ +|.+||......+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~-----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS-----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCcccccccc-----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999999864321 123457788999998876566899999999999999985 6999998765543322
Q ss_pred HHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 324 RIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 324 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
++.... ......++.+.+||.+||+.||.+|||+.++|++
T Consensus 233 -~~~~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKH--------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhcc--------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 111000 0111234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=316.41 Aligned_cols=269 Identities=23% Similarity=0.367 Sum_probs=215.0
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-----CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEee
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-----SEPESVKFMAREIRILQKLDHPNVIKLEGLATS 180 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 180 (469)
+...++|-++++||+|||+.||+|.+....+.||||+-..+. ......+...+|..|-+.|+||.||++++|+.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 444578999999999999999999999889999999875432 222334667899999999999999999999876
Q ss_pred ccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcEEEcC---CCcEEEeee
Q 036673 181 RMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER--GILHRDIKASNLLIDK---SGMLKIADF 255 (469)
Q Consensus 181 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NILl~~---~~~~kl~DF 255 (469)
... .+|-|+|||+|+.++++++....+++.+++.|+.||+.||.||.+. .|||-||||.||||.. .|.+||+||
T Consensus 539 Dtd-sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTD-SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccc-cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 543 4699999999988888888788899999999999999999999987 5999999999999954 478999999
Q ss_pred cCcccccCCCCC------CcccccccCccccchhccCC---CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 036673 256 GLSNFFIPKQKG------PLTSRVVTLWYRAPELLLGS---TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIF 326 (469)
Q Consensus 256 Gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~ 326 (469)
||++.+...... ......||.||++||.+.-. +..+.++||||+|||+|.++.|+.||..+.....+-..-
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999987544332 13456789999999988532 457889999999999999999999997654433222111
Q ss_pred HHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 327 KLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+.. + ...|+ .-+-++.++.+||++||+..-+.|....++..||||..
T Consensus 698 TIlkA-------------t--EVqFP-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 698 TILKA-------------T--EVQFP-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred chhcc-------------e--eccCC-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 10000 0 00111 12357889999999999999999999999999999975
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=309.81 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=200.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECC----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRD----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
..++|++.+.||+|+||.||+|.+.. ++..|++|++... ........+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~- 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG- 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 35789999999999999999999876 3588999988643 34455677889999999999999999999876542
Q ss_pred cEEEEEEecchh-hHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPG-------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
...+++++|+.+ ++...+.... ..+++..+..++.||+.||+|||+++++|+||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 346899999985 5555553321 45899999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCC-cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 036673 256 GLSNFFIPKQKGP-LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPS 333 (469)
Q Consensus 256 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 333 (469)
|+++.+.+..... .....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC----
Confidence 9998654332211 122345678999998865 458999999999999999999 999998766554333222110
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.. .....+++++.++|.+||..||++|||+.++++
T Consensus 237 ------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 ------------------RL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ------------------CC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 012245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=304.43 Aligned_cols=249 Identities=29% Similarity=0.459 Sum_probs=200.0
Q ss_pred cceeceeeeeCCeEEEEEEECCCC----cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTG----KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
+++.+.||.|+||.||++.+...+ ..||+|++..... ....+.+..|+.++..++|+||+++++++... ...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeE
Confidence 356788999999999999998766 8999999965433 22457888999999999999999999988775 4579
Q ss_pred EEEecchh-hHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQK-LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
++|||+.+ ++...+...... +++..+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999986 555555443333 9999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------- 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-------------- 222 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 211112336789999998754 558999999999999999998 8999987666555554422110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......++.++.+++.+||..||.+|||+.++++
T Consensus 223 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 -----------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -----------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0112236889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=311.41 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=199.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.++|++.+.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~- 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK- 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-
Confidence 4679999999999999999998753 57899999986442 2344567889999999999999999999887644
Q ss_pred cEEEEEEecchh-hHHHHHhcC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRP---------------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASN 241 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 241 (469)
..++||||+++ +|...+... ...+++..+..++.||+.||+|||+++++||||||+|
T Consensus 82 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 82 -PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred -ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 46999999996 565555421 1247889999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChH
Q 036673 242 LLIDKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEV 319 (469)
Q Consensus 242 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~ 319 (469)
||++.++.++|+|||++..+..... ........++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999876532221 11222344677999998765 458999999999999999997 88899776666
Q ss_pred HHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 320 EQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 320 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+....+..... ......++.++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNV-------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCC-------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 55444322100 0112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=311.31 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=195.0
Q ss_pred CcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.++..++||||+++++.+...+ .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG--P 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--C
Confidence 47888999999999999998753 23578999886443 2344567889999999999999999999887644 3
Q ss_pred EEEEEecchh-hHHHHHhc-----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 036673 186 LYLVFDFMQS-DLTKIICR-----------------------PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASN 241 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~-----------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 241 (469)
.+++|||+.+ ++...+.. ....+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 6899999996 55444432 11358899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChH
Q 036673 242 LLIDKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEV 319 (469)
Q Consensus 242 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~ 319 (469)
||+++++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999765332221 1223345678999998765 458899999999999999998 99999876655
Q ss_pred HHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 320 EQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 320 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+.... .. .....++.++.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~----------------------~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGY----------------------RM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCC----------------------CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4433221100 00 112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.06 Aligned_cols=254 Identities=23% Similarity=0.386 Sum_probs=211.3
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCc-----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR 181 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 181 (469)
.....-.+.+.||+|+||.||.|...+... .||||.++... .......|.+|..+|+.++|||||+++|++.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 445667888999999999999999875432 49999987654 345567899999999999999999999999885
Q ss_pred cccEEEEEEecchh-hHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEee
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRP------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIAD 254 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~D 254 (469)
.. .+|++|||+| +|+.++... ...++..+...++.||++|+.||+++++|||||...|+||+....+||+|
T Consensus 768 ~~--~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GP--PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CC--cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 44 4899999996 888888776 55699999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCCCcccc-cccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 036673 255 FGLSNFFIPKQKGPLTSR-VVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTP 332 (469)
Q Consensus 255 FGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 332 (469)
||+|+.+........... .-...|||||.+.. ..++.++|||||||+|||++| |..||++.+..+.+..+...-.-
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL- 923 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL- 923 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc-
Confidence 999995433332222222 33578999999986 569999999999999999998 89999999998887765543211
Q ss_pred CHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 333 SEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+|+.+.+||..||+.+|++||+...+++
T Consensus 924 ------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 ------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 123467889999999999999999999999988
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.79 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=198.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD-------TGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATS 180 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 180 (469)
.++|.+.+.||+|+||.||+|.+.. ....||+|.++... .......+.+|+.++..+ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4689999999999999999998642 34579999986543 234456788999999999 69999999998876
Q ss_pred ccccEEEEEEecchh-hHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 036673 181 RMQYSLYLVFDFMQS-DLTKIICRP---------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI 244 (469)
Q Consensus 181 ~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl 244 (469)
. ..++++|||+.+ +|...+... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 E--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred C--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 4 347999999986 565555432 2358899999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHH
Q 036673 245 DKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQL 322 (469)
Q Consensus 245 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~ 322 (469)
+.++.+||+|||++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999865322111 1112234567999998865 458999999999999999999 89999877665555
Q ss_pred HHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 323 HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..+.... . ......++.++.+||.+||..||.+|||+.++++
T Consensus 247 ~~~~~~~----------------------~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGH----------------------R---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCC----------------------C---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4432110 0 0112356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.66 Aligned_cols=258 Identities=19% Similarity=0.305 Sum_probs=196.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECC----------------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeee
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRD----------------TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 173 (469)
++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986543 34579999986542 3344567889999999999999999
Q ss_pred EeeeEeeccccEEEEEEecchh-hHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 036673 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPG----------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNL 242 (469)
Q Consensus 174 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 242 (469)
+++++.... ..++||||+.+ +|..++.... ..+++..+..++.||+.||+|||++||+|+||||+||
T Consensus 84 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999887644 46999999986 6666554321 2477889999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecCcccccCCCCCC-cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh--CCCCCCCCChH
Q 036673 243 LIDKSGMLKIADFGLSNFFIPKQKGP-LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI--GRPLMPGRTEV 319 (469)
Q Consensus 243 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt--g~~pf~~~~~~ 319 (469)
|++.++.++|+|||++..+....... .....+++.|+|||+..+ ..++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998653322111 122344678999998765 458999999999999999998 77888776655
Q ss_pred HHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 320 EQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 320 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+.+....... ..... .........++..+.+||..||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~--------~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFF--------RDQGR----------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHH--------hhccc----------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5443322110 00000 0000112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=307.91 Aligned_cols=253 Identities=29% Similarity=0.481 Sum_probs=200.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC---CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD---TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
+|.+.+.||.|+||+||++.+..++..+++|+++.. .........+..|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceE
Confidence 588999999999999999999887777777776532 122223345668999999999999999998877644 469
Q ss_pred EEEecchh-hHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 188 LVFDFMQS-DLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
+||||+.+ ++...+. .....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999997 4444443 23457999999999999999999999999999999999999975 5799999999976533
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.. .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+... .
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~------------ 221 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--P------------ 221 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--C------------
Confidence 22 22234567889999998765 45788999999999999999999999876655444433211 0
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.......++.++.++|.+||..||.+||++.++++||||
T Consensus 222 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 222 -----------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -----------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 001223567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=323.86 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=198.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 182 (469)
.++|.+.++||+|+||.||+|++. .++..||||+++.... ....+.+.+|+.+|.++. ||||+++++++....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 457888999999999999999864 3456899999975432 333456889999999997 999999999887744
Q ss_pred ccEEEEEEecchh-hHHHHHhcCC--------------------------------------------------------
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPG-------------------------------------------------------- 205 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~-------------------------------------------------------- 205 (469)
.+++||||+.+ +|.+.+.+..
T Consensus 115 --~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 115 --PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred --CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 57999999996 6666553321
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 036673 206 -----------------------------------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI 244 (469)
Q Consensus 206 -----------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl 244 (469)
..+++..+..++.||+.||+|||+.+|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 236778889999999999999999999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHH
Q 036673 245 DKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQL 322 (469)
Q Consensus 245 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~ 322 (469)
+.++.+||+|||++..+..... .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||......+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999986532221 11223456788999998865 457899999999999999998 89999776555444
Q ss_pred HHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 323 HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
...+..... + .....++.++.+||.+||..||.+||++.++++.
T Consensus 352 ~~~~~~~~~---------------------~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYR---------------------M---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCC---------------------C---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333221000 0 1123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.53 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=199.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEEC-------CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEe
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDR-------DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLAT 179 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 179 (469)
..++|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.++..+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3478999999999999999999753 234579999886432 234456788999999999 8999999999887
Q ss_pred eccccEEEEEEecchh-hHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 036673 180 SRMQYSLYLVFDFMQS-DLTKIICRP---------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLL 243 (469)
Q Consensus 180 ~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIL 243 (469)
.. ...++||||+.+ +|..++... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 92 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 92 QD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred cC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 64 356999999986 666555432 234788899999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHH
Q 036673 244 IDKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQ 321 (469)
Q Consensus 244 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~ 321 (469)
++.++.+||+|||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999865332211 1223345678999998866 458899999999999999998 8899987766555
Q ss_pred HHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 322 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
...+.... . . .....++..+.+||.+||..+|.+|||+.++++.
T Consensus 249 ~~~~~~~~-~---------------------~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGH-R---------------------M---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCC-c---------------------C---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 44332110 0 0 1123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=324.99 Aligned_cols=261 Identities=20% Similarity=0.316 Sum_probs=223.3
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.....+++++..||-|+||.|=++........+|+|++++. ..+....+.+..|-.||...+.|.||++|-.|.+ ..
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~k 493 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SK 493 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--ch
Confidence 34456788999999999999999988865556999998764 3344455778899999999999999999665554 66
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
++|++||-|-|+.+-.+++.++.|.+..++.++..+++|++|||++|||.|||||+|+||+.+|-+||.|||+|+.+...
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 78999999987554445555668999999999999999999999999999999999999999999999999999988543
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
..+.++||||.|.|||++++ +..+.++|.||||+++||||+|.|||.+.+....++.|++.+...
T Consensus 574 --~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------ 638 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------ 638 (732)
T ss_pred --CceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------------
Confidence 44678999999999999987 457999999999999999999999999999999999998764321
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~ 395 (469)
.+...++..+.+||+++-..+|.+|.- +.++-+|.||..
T Consensus 639 ------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 639 ------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred ------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 334567888999999999999999976 889999999985
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=304.47 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=189.9
Q ss_pred eeeeeCCeEEEEEEECC---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 117 KVGQGTYSNVYKARDRD---TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
.||+|+||+||+|.+.. ....||||.+... ........+.+|+.+++.++||||+++++++...+. ..+++|||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG-SPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC-CcEEEEecC
Confidence 58999999999998753 2457999987532 233445678899999999999999999997764433 368999999
Q ss_pred hh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC---CCc
Q 036673 194 QS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK---GPL 269 (469)
Q Consensus 194 ~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---~~~ 269 (469)
.+ ++...+......+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++..+..... ...
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 86 66666655445578888999999999999999999999999999999999999999999999975432211 111
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
....+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+.... .
T Consensus 160 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~----------------- 220 (262)
T cd05058 160 TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-R----------------- 220 (262)
T ss_pred ccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-C-----------------
Confidence 23345778999998765 458899999999999999999 577887665554433322100 0
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
+ .....++..+.+++.+||..||++||++.++++.
T Consensus 221 ----~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 ----L---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ----C---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0112357789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.25 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=198.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDT-------GKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
.+|++++.||+|+||.||+|++... ...||+|.+... ........+.+|+.++.++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 5799999999999999999986432 237899988643 2334457788999999999 899999999988764
Q ss_pred cccEEEEEEecchh-hHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRP---------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID 245 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~ 245 (469)
. .++++|||+++ +|...+... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 91 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 91 G--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred C--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 3 57999999986 666555432 23478889999999999999999999999999999999999
Q ss_pred CCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHH
Q 036673 246 KSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLH 323 (469)
Q Consensus 246 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~ 323 (469)
.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999765322111 1122334568999998865 458899999999999999998 899998776655544
Q ss_pred HHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCc
Q 036673 324 RIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391 (469)
Q Consensus 324 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 391 (469)
.+..... ......++..+.+||.+||+.+|.+|||+.+++++-
T Consensus 248 ~~~~~~~-------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 248 LLKEGHR-------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHcCCC-------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 4321100 011234577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=304.92 Aligned_cols=242 Identities=27% Similarity=0.371 Sum_probs=189.0
Q ss_pred eeeeeCCeEEEEEEECCCCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 117 KVGQGTYSNVYKARDRDTGK--IVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
.||+|+||.||+|.+..++. .+|+|.++.. ........+.+|+.++.++ .||||+++++++.... ..++||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--CceEEEEeC
Confidence 58999999999999987775 4688877632 2334456788999999999 8999999999887644 469999999
Q ss_pred hh-hHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecC
Q 036673 194 QS-DLTKIICRPG---------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL 257 (469)
Q Consensus 194 ~~-~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGl 257 (469)
.+ +|...+.... ..+++..+..++.|++.||+|||++|++|+||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 85 6666654321 2478999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 258 SNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 258 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
+...... ........+..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 159 ~~~~~~~--~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-------- 227 (270)
T cd05047 159 SRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-------- 227 (270)
T ss_pred ccccchh--hhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC--------
Confidence 8632111 11112233667999998765 558899999999999999997 99999776655444433110
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+.. .....++.++.+|+.+||..||.+|||+.++++
T Consensus 228 --------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 --------------YRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred --------------CCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000 112246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=301.52 Aligned_cols=264 Identities=25% Similarity=0.362 Sum_probs=209.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++.+-+..||.|+||+|++..++.+|+..|||.++..... ...++++.|.+...+- +.||||+++|.+..++. +|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cW 139 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CW 139 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--ee
Confidence 34566677899999999999999999999999999876553 3446677787765544 89999999998776443 69
Q ss_pred EEEecchhhHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 188 LVFDFMQSDLTKIICR----PGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
|.||.|.-++..++.. ....++|..+-.|....+.||.||.+. +||||||||+||||+..|.+||||||++..+.
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 9999999766554422 345699999999999999999999965 89999999999999999999999999998763
Q ss_pred CCCCCCcccccccCccccchhccCCCC-CCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhc
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTD-YGVGIDLWSAGCLLAEMFIGRPLMPGRTE-VEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.. -..+...|...|||||.+..... |+.++||||||++|||+.||..|+.+.+. .+++..+.. |.|+.-
T Consensus 220 ~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l----- 290 (361)
T KOG1006|consen 220 DS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPIL----- 290 (361)
T ss_pred HH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCee-----
Confidence 32 23456678899999999865544 89999999999999999999999976543 344444432 333210
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
..+ .---+++..+..+|..||.+|-..||...+++++||+....
T Consensus 291 -----------~~~--~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 291 -----------LFD--KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred -----------cCc--ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 000 11124788999999999999999999999999999998643
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=310.24 Aligned_cols=252 Identities=21% Similarity=0.306 Sum_probs=198.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGK----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|+..+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.++..++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-- 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT-- 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC--
Confidence 4678999999999999999999887775 47888876433 2333456889999999999999999999886532
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.++++||+++ ++.+.+......+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+..
T Consensus 83 -~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 83 -IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred -ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4789999985 67776666555789999999999999999999999999999999999999999999999999987543
Q ss_pred CCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+... +......+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~--------- 230 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERL--------- 230 (303)
T ss_pred cccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCC---------
Confidence 2221 1223345778999998865 458999999999999999997 899997765433322 22111000
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
......+..+.++|.+||..||++||++.++++.
T Consensus 231 ---------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ---------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112356788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=303.82 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=187.9
Q ss_pred eeeeeCCeEEEEEEECC--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 117 KVGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.... ..++||||+.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceEEEEEeCC
Confidence 59999999999997543 34578888875432 3344567889999999999999999999887643 4699999998
Q ss_pred h-hHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC-CC
Q 036673 195 S-DLTKIICRPG----QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK-GP 268 (469)
Q Consensus 195 ~-~l~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 268 (469)
+ +|.+.+.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 6 5655554432 2356788899999999999999999999999999999999999999999999865422211 11
Q ss_pred cccccccCccccchhccC------CCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 269 LTSRVVTLWYRAPELLLG------STDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.....+++.|+|||++.. ...++.++|||||||++|||++ |.+||....+.+.+..+.......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~--------- 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK--------- 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc---------
Confidence 123345678999998642 2346889999999999999999 788998777666555443321110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.........++..+.+++..|+ .||.+|||++++++
T Consensus 230 -----------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 -----------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -----------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0001123356788889999998 59999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=306.68 Aligned_cols=261 Identities=18% Similarity=0.199 Sum_probs=190.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHH---------HHHHHHHHHHHHhCCCCCeeeEee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPES---------VKFMAREIRILQKLDHPNVIKLEG 176 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~~~~ 176 (469)
.++|++.+.||+|+||+||+|.+..+ +..+|+|+.......... ......++..+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999999877 677888865433221100 011223445566779999999988
Q ss_pred eEeecc--ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEee
Q 036673 177 LATSRM--QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIAD 254 (469)
Q Consensus 177 ~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~D 254 (469)
.+.... ....+++++++..++...+.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 654432 234578888887666554433 23468889999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCC------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 036673 255 FGLSNFFIPKQK------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKL 328 (469)
Q Consensus 255 FGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~ 328 (469)
||+|+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+...........+.
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999987643221 11234568999999998875 45899999999999999999999999876432222211110
Q ss_pred hCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 329 CGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
++++.+.... ......+..+.++++.|+..+|.+||+..++++
T Consensus 249 ------~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 ------DFIKRLHEGK------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------HHHHHhhhhh------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111110000 012345788999999999999999999999875
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.33 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=197.3
Q ss_pred cceeceeeeeCCeEEEEEEECC---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc----c
Q 036673 112 YDKLAKVGQGTYSNVYKARDRD---TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ----Y 184 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----~ 184 (469)
|.+.+.||+|+||.||+|.+.. ++..||||++..........+.+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6678889999999999998653 57899999997665555566778899999999999999999998765432 2
Q ss_pred EEEEEEecchh-hHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCc
Q 036673 185 SLYLVFDFMQS-DLTKIICR-----PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla 258 (469)
..+++++|+.+ ++...+.. ....+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 34788899985 54444422 1124789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 259 NFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 259 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
......... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |++||...+..+....+.... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---- 234 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RL---- 234 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cC----
Confidence 865332211 1223345678999998765 457889999999999999999 899998776655444332210 00
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....++..+.+|+.+||..+|.+|||+.++++.
T Consensus 235 --------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 --------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1113467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=305.78 Aligned_cols=266 Identities=22% Similarity=0.347 Sum_probs=200.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECC----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRD----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
..|++.+.||+|+||.||+|.... ++..||||++...... .....+.+|+.+++.+.||||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 468888999999999999998653 4789999999755433 34578899999999999999999999887766667
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+++|||+++ ++...+......+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 8999999986 666666555546999999999999999999999999999999999999999999999999999876422
Q ss_pred CCCC--cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CC-CHHHHhhc
Q 036673 265 QKGP--LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG-TP-SEDYWKKM 340 (469)
Q Consensus 265 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~-~~-~~~~~~~~ 340 (469)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||......... +..... .. .......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIVTRLLELL 239 (284)
T ss_pred CcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccHHHHHHHH
Confidence 2111 112344567999998765 45789999999999999999999888653321100 000000 00 00000000
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..... ......++.++.+|+.+||..||.+|||+.++++
T Consensus 240 ~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGER----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCc----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 0112345688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=301.20 Aligned_cols=249 Identities=22% Similarity=0.274 Sum_probs=186.7
Q ss_pred eeeeeCCeEEEEEEECC--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 117 KVGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
.||+|+||.||+|.... ++..+|+|.++..... .....+.+|+.+++.++||||+++++++.... ..++||||++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~ 78 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLLVMEFCP 78 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEEEEECCC
Confidence 59999999999998653 4568999988755432 33356888999999999999999999887643 4689999999
Q ss_pred h-hHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC-CC
Q 036673 195 S-DLTKIICRP----GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK-GP 268 (469)
Q Consensus 195 ~-~l~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 268 (469)
+ +|..++... ...+++..+..++.|++.||+|||+.+|+|+||||+|||++.++++||+|||++........ ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 5 565555432 22467778889999999999999999999999999999999999999999999975422211 11
Q ss_pred cccccccCccccchhccCC------CCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 269 LTSRVVTLWYRAPELLLGS------TDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.....+++.|+|||++.+. ..++.++|||||||++|||++ |.+||......+...........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 228 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL---------- 228 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC----------
Confidence 2234567889999987532 135789999999999999996 99999876655443322211000
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+ ..+ ......+..+.++|..|+ .+|.+|||+++++.
T Consensus 229 ---~~----~~~---~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 ---KL----PKP---RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---CC----CCC---ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00 001 112235678899999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=323.17 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=207.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.-|..++.||-|+||.|.+++..+|...||+|.+++.. .....+..+..|-.||..-+.+-||+|+ |...+..++|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy--ySFQDkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY--YSFQDKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE--EEeccCCceEE
Confidence 34788999999999999999999999999999986542 2334446677899999999999999994 44455667999
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc------
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF------ 261 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~------ 261 (469)
||||++| ++..++.+- +.|+|..++.++..+..|+++.|..|+|||||||+|||||.+|+|||+|||||+-+
T Consensus 707 VMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999997 566666554 47999999999999999999999999999999999999999999999999998532
Q ss_pred ---cCCCCC--------------------------------CcccccccCccccchhccCCCCCCccccchhhHHHHHHH
Q 036673 262 ---IPKQKG--------------------------------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEM 306 (469)
Q Consensus 262 ---~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~el 306 (469)
...... .....+||+.|+|||++.. ..|+..+|+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHH
Confidence 100000 0124588999999999986 4589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC---
Q 036673 307 FIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT--- 383 (469)
Q Consensus 307 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt--- 383 (469)
+.|++||...+..+.-.++++ |... -.| ....+++.++.+||.++. .++..|..
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~n---------w~~~---l~~----------~~~~~ls~e~~~li~kLc-~sad~RLGkng 921 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVIN---------WRNF---LHI----------PYQGNLSKEALDLIQKLC-CSADSRLGKNG 921 (1034)
T ss_pred hhCCCCccCCCCCcceeeeee---------hhhc---ccc----------ccccccCHHHHHHHHHHh-cChhhhhcccc
Confidence 999999988877666555433 1110 000 112367899999998764 56788875
Q ss_pred HHHHhcCccCCCCC
Q 036673 384 AASALQNEFFNASP 397 (469)
Q Consensus 384 a~elL~hp~f~~~~ 397 (469)
++|+-.||||+.-.
T Consensus 922 ~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 922 ADQVKAHPFFKGID 935 (1034)
T ss_pred hhhhhcCccccccc
Confidence 77899999999644
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=301.07 Aligned_cols=251 Identities=25% Similarity=0.462 Sum_probs=199.7
Q ss_pred CcceeceeeeeCCeEEEEEEECC-CCcEEEEEEeecCC--------CCHHHHHHHHHHHHHHHh-CCCCCeeeEeeeEee
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRD-TGKIVALKKVRFDT--------SEPESVKFMAREIRILQK-LDHPNVIKLEGLATS 180 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~ 180 (469)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48888999999999999999987 68899999886431 223344567789998875 799999999998876
Q ss_pred ccccEEEEEEecchh-hHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeee
Q 036673 181 RMQYSLYLVFDFMQS-DLTKII---CRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 181 ~~~~~~~lv~e~~~~-~l~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
. ...+++|||+.+ ++.+.+ ......+++..++.++.|++.||.|||+ .+|+|+||+|+|||++.++.++|+||
T Consensus 81 ~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 N--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred C--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 4 457999999986 444443 2344569999999999999999999996 68999999999999999999999999
Q ss_pred cCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 036673 256 GLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335 (469)
Q Consensus 256 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 335 (469)
|++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...........+......+
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 232 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--- 232 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc---
Confidence 9998654332 3445678999999998875 457999999999999999999999997766554444433211110
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
. ....+++.+.+||.+||+.||.+||++.|+..+
T Consensus 233 ------------------~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 ------------------L---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ------------------C---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0 012457889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=302.12 Aligned_cols=235 Identities=20% Similarity=0.299 Sum_probs=184.2
Q ss_pred eeeeeCCeEEEEEEECCCC----------cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 117 KVGQGTYSNVYKARDRDTG----------KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
.||+|+||.||+|.+..++ ..+++|++...... ...+.+|+.+++.++||||+++++++.. .. .
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~--~ 75 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DE--N 75 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CC--c
Confidence 5999999999999998766 35888877543221 4678899999999999999999998876 32 4
Q ss_pred EEEEecchhh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-------cEEEeeecCc
Q 036673 187 YLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-------MLKIADFGLS 258 (469)
Q Consensus 187 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-------~~kl~DFGla 258 (469)
++||||+.++ |...+......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 8999999974 4444444444799999999999999999999999999999999999999888 7999999999
Q ss_pred ccccCCCCCCcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||......+....+.. .
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~---- 222 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q---- 222 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C----
Confidence 86532 2234567789999988764 368899999999999999999 5788866543222211110 0
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
. .........+.+||.+||..||.+|||+.++++
T Consensus 223 -------~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 -------H------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------C------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 000011268889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.19 Aligned_cols=228 Identities=24% Similarity=0.325 Sum_probs=181.9
Q ss_pred eCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-hHHH
Q 036673 121 GTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTK 199 (469)
Q Consensus 121 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 199 (469)
|.||.||++++..+++.||+|++.... .+.+|...+....||||+++++++... ...++||||+.+ +|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCHHH
Confidence 889999999999999999999986532 223455556667899999999988764 457999999996 5656
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCccc
Q 036673 200 IICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279 (469)
Q Consensus 200 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 279 (469)
.+... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++...... .....++..|+
T Consensus 75 ~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred HHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 55443 46999999999999999999999999999999999999999999999999988655322 23345577899
Q ss_pred cchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcc
Q 036673 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVF 359 (469)
Q Consensus 280 aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (469)
|||.+.+ ..++.++|||||||++|+|++|+.||...... + .. . .. ..+.
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~---~---------~~-~~~~ 198 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT---H---------TT-LNIP 198 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc---c---------cc-cCCc
Confidence 9997754 45788999999999999999999887432110 0 00 0 00 0122
Q ss_pred cCCChhHHHHHHHccccCCCCCCCH-----HHHhcCccC
Q 036673 360 GEFPPSSYGILTTLLALDPAYRGTA-----ASALQNEFF 393 (469)
Q Consensus 360 ~~~~~~l~~li~~~L~~dP~~Rpta-----~elL~hp~f 393 (469)
..++..+.+||.+||+.||.+|+|+ +++++||||
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 3467889999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=299.21 Aligned_cols=241 Identities=24% Similarity=0.403 Sum_probs=194.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++.+.||.|+||.||++.. +++.||+|++.... ....+.+|+.++..++||||+++++++.... .++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG---LYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC---cEEE
Confidence 5799999999999999999864 48899999986432 2356789999999999999999999876532 5899
Q ss_pred Eecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||+.+ ++...+... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999986 666666543 335899999999999999999999999999999999999999999999999999754221
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+..|+|||.+.+ ..++.++|||||||++|+|++ |++||...+..+....+....
T Consensus 154 -~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------- 214 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY----------------- 214 (254)
T ss_pred -CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-----------------
Confidence 122334678999998765 458899999999999999997 999998776655443332110
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.. .....++..+.+||.+||+.+|.+||++.++++
T Consensus 215 -----~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 -----RM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -----CC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 112356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=324.45 Aligned_cols=267 Identities=27% Similarity=0.452 Sum_probs=218.6
Q ss_pred hccCCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEee
Q 036673 102 AGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATS 180 (469)
Q Consensus 102 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 180 (469)
...++..++-|++...||.|.+|.||+++.+.+++.+|||++......+ +.+..|.+||+.+ .|||++.++++|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445677788999999999999999999999999999999997765444 3456788999888 79999999998865
Q ss_pred c---cccEEEEEEecchhhHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 181 R---MQYSLYLVFDFMQSDLTKIICR--PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 181 ~---~~~~~~lv~e~~~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
. ..+.+|||||||.|+....+.+ .+.++.|+.+..|++.++.||.+||.+.++|||||-.|||++.++.|||+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 3 3467999999999754443322 2567999999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCcccccccCccccchhccCC----CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 036673 256 GLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS----TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT 331 (469)
Q Consensus 256 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (469)
|++..+... .....+.+|||+|||||++... ..|+..+|+||||++..||.-|.||+-+......+..| ...
T Consensus 168 GvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRN 243 (953)
T KOG0587|consen 168 GVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRN 243 (953)
T ss_pred eeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCC
Confidence 999876432 3445688999999999998543 24778899999999999999999999876665544433 222
Q ss_pred CCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
|+.. + .-+...+.++.+||..||.+|-.+||+..++|+|||++.
T Consensus 244 PPPk-------------------L-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 244 PPPK-------------------L-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred CCcc-------------------c-cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 2211 1 113345778999999999999999999999999999984
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=327.62 Aligned_cols=203 Identities=32% Similarity=0.539 Sum_probs=171.3
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----ccEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----QYSL 186 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~~ 186 (469)
.|...+.||+|+||.||+++++.+|+.||||.++... .....+...+|+++|++|+|+|||+++++-.... ...-
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3555677999999999999999999999999987643 3344577889999999999999999988765544 3445
Q ss_pred EEEEecchh-hHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc--CCC--cEEEeeecCcc
Q 036673 187 YLVFDFMQS-DLTKIICRPG--QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID--KSG--MLKIADFGLSN 259 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~--~~kl~DFGla~ 259 (469)
.+|||||.| +|...+.++. ..|++.+++.++.++..||.|||++||+||||||.||++- .+| ..||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 899999997 5555554432 3599999999999999999999999999999999999983 334 47999999999
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR 316 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 316 (469)
-+. ++....+.+||+.|.+||++.....|+..+|.|||||++|+++||..||...
T Consensus 173 el~--d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 173 ELD--DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cCC--CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 874 4447889999999999998876678999999999999999999999999643
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=300.64 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=191.5
Q ss_pred eeeeeCCeEEEEEEECCCC------cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 117 KVGQGTYSNVYKARDRDTG------KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
.||.|+||.||+|.+.+.. ..+|||.+..... ......+.+|+.+++.++||||+++++++.... ..++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--CeEEEE
Confidence 5999999999999986544 7899998864422 234467889999999999999999999887643 479999
Q ss_pred ecchh-hHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-----cEEEeeecCc
Q 036673 191 DFMQS-DLTKIICR------PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-----MLKIADFGLS 258 (469)
Q Consensus 191 e~~~~-~l~~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-----~~kl~DFGla 258 (469)
||+++ ++...+.. ....+++..+..++.||+.||.|||+.+++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99986 66655543 223478999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 259 NFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 259 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~----- 231 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-R----- 231 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-c-----
Confidence 76532211 11223345788999998865 458999999999999999998 999998776655444331100 0
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......++..+.+||.+||+.+|.+||++.++++
T Consensus 232 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 -------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0112346788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=296.64 Aligned_cols=249 Identities=20% Similarity=0.317 Sum_probs=187.2
Q ss_pred eeeeeCCeEEEEEEECCC--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecch
Q 036673 117 KVGQGTYSNVYKARDRDT--GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
.||+|+||+||++..... ...+++|.+..... ....+.+.+|+.++..++||||+++++.+.... ..|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEEEEecCC
Confidence 599999999999976533 24566777654332 334567889999999999999999999887643 4699999999
Q ss_pred h-hHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC-CCCc
Q 036673 195 S-DLTKIICRP---GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ-KGPL 269 (469)
Q Consensus 195 ~-~l~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~~~ 269 (469)
+ +|..++... ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 6 666666442 2346777888999999999999999999999999999999999999999999986432111 1122
Q ss_pred ccccccCccccchhccCC------CCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 270 TSRVVTLWYRAPELLLGS------TDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
...++++.|+|||++... ..++.++|||||||++|||++ |.+||...+..+.+..+.......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---------- 228 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc----------
Confidence 345678999999987431 235788999999999999997 578888777766665544321100
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
...+ .....+++.+.++|..|+ .+|.+|||+.++++
T Consensus 229 -------~~~~---~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 -------LFKP---QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -------cCCC---ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0011 112346778899999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=292.36 Aligned_cols=259 Identities=24% Similarity=0.439 Sum_probs=210.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 185 (469)
..++|+++++||+|+|++|.+++++.|.+.||+|++++.. ...+.+.-+..|-.+..+- +||.+|-+...|.. +..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esr 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESR 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cce
Confidence 4578999999999999999999999999999999998763 3344556667788888766 89999999877766 445
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+++|.||++|+.+-+..+..+.++++.++.+...|+.||.|||++||+.||||.+|||||..|++||+|+|+++.- -..
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~-l~~ 404 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-LGP 404 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC-CCC
Confidence 8999999998655555555668999999999999999999999999999999999999999999999999999853 234
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCC-------CChHHHHHHHHHHhCCCCHHHHh
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPG-------RTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
.....++||||.|.|||++.+ ..|+..+|+|+|||+++||+.|+.||.- .+..+.+.+++-.
T Consensus 405 gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile---------- 473 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE---------- 473 (593)
T ss_pred CcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh----------
Confidence 445678999999999998876 5699999999999999999999999952 2233333333211
Q ss_pred hcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC------HHHHhcCccCCC
Q 036673 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT------AASALQNEFFNA 395 (469)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt------a~elL~hp~f~~ 395 (469)
..+ .+...++-.+..+++.-|.+||.+|.. ..++-.|+||+.
T Consensus 474 -----kqi----------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 474 -----KQI----------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred -----hcc----------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 000 122234556677899999999999964 579999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=312.91 Aligned_cols=275 Identities=24% Similarity=0.314 Sum_probs=188.5
Q ss_pred CccCcceeceeeeeCCeEEEEEEEC----------------CCCcEEEEEEeecCCCCHH------------HHHHHHHH
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDR----------------DTGKIVALKKVRFDTSEPE------------SVKFMARE 159 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~------------~~~~~~~E 159 (469)
..++|++.++||+|+||+||+|... ..++.||||.+........ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4679999999999999999999752 2356899999865322110 01223357
Q ss_pred HHHHHhCCCCCe-----eeEeeeEeec------cccEEEEEEecchh-hHHHHHhcCC----------------------
Q 036673 160 IRILQKLDHPNV-----IKLEGLATSR------MQYSLYLVFDFMQS-DLTKIICRPG---------------------- 205 (469)
Q Consensus 160 ~~~l~~l~hpnI-----v~~~~~~~~~------~~~~~~lv~e~~~~-~l~~~~~~~~---------------------- 205 (469)
+.++.+++|.++ ++++++|... .....||||||+.+ +|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 6677776532 12346999999996 4544443211
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCccccchhc
Q 036673 206 -QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284 (469)
Q Consensus 206 -~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 284 (469)
..+++..++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||++...............+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 1246778899999999999999999999999999999999999999999999976533222222233458999999987
Q ss_pred cCCCC-------------------C--CccccchhhHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 285 LGSTD-------------------Y--GVGIDLWSAGCLLAEMFIGRP-LMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 285 ~~~~~-------------------~--~~~~DvwslGv~l~elltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
..... | ....||||+|||+|+|++|.. ||........ ..+. .......|.....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~-~~~~~~~~r~~~~ 458 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQ-YDNDLNRWRMYKG 458 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhh-ccchHHHHHhhcc
Confidence 53211 1 134799999999999999874 6643221111 1111 0111122322111
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCC---CCCCCHHHHhcCccCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDP---AYRGTAASALQNEFFNA 395 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP---~~Rpta~elL~hp~f~~ 395 (469)
. . ..+ ..++.+++.+++||.+||..+| .+|+|+.|+|+||||..
T Consensus 459 ~------~--~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 Q------K--YDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred c------C--CCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 1 1 111 2356778999999999999876 68999999999999964
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=308.97 Aligned_cols=246 Identities=23% Similarity=0.401 Sum_probs=203.6
Q ss_pred cceeceeeeeCCeEEEEEEECCC----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDT----GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..+.++||+|-||.||+|...+- .-.||||..+.+.. ++..+.|..|..+|+.++|||||+++|+|.+.. +|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~P---~W 466 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP---MW 466 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeeccc---ee
Confidence 34467899999999999987543 34689999876543 344688999999999999999999999998644 69
Q ss_pred EEEecch-hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||||.++ |.|...+..+...|+......++.||+.||+|||+.++|||||-..|||+....-+||+|||+++++.....
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999 566666666677899999999999999999999999999999999999999999999999999998865554
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
...+...-..-|||||.+. .+.++.++|||-|||.+||++. |..||.+-.+.+.+-.+-+.-..
T Consensus 547 YkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl-------------- 611 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL-------------- 611 (974)
T ss_pred hhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC--------------
Confidence 4444444577899999774 5679999999999999999875 99999987776665544332111
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHH
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA 387 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~el 387 (469)
...+.+|+.+..|+.+||+.||.+||+..++
T Consensus 612 -----------P~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 612 -----------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred -----------CCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 2356789999999999999999999998764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.03 Aligned_cols=253 Identities=21% Similarity=0.356 Sum_probs=216.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCC---cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTG---KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.....|.++||.|-||.||+|+.+..| ..||||.++.... ......|+.|+.||.+++||||++|.|+..... -
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~--P 704 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK--P 704 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc--e
Confidence 455678899999999999999998665 5799999976533 345577999999999999999999999987644 4
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+.||.|||++ .|..++....+.|+..++..+++.|+.||.||-++++|||||...|||++.+-..||+||||++.+.++
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 6899999995 677777777788999999999999999999999999999999999999999999999999999987555
Q ss_pred CCCCcccccc--cCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 265 QKGPLTSRVV--TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 265 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.....++.-| ..+|.|||.+.- +.++.++||||+|++|||.++ |..||..-++++.++.|.+....|+
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-------- 855 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-------- 855 (996)
T ss_pred CCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC--------
Confidence 4333333333 678999998865 569999999999999999875 9999999999999999987665543
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..++|..+..|+..|+++|-..||...||+.+
T Consensus 856 -----------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 856 -----------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred -----------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 23678999999999999999999999998763
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=300.31 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=206.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+...+.++||+|-||.|.+|+... +..||||+++.... ......|.+|+++|.+|+|||||+++|+|...+. +++|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP--icmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP--LCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc--hHHH
Confidence 457788999999999999998764 79999999986643 3445889999999999999999999999988554 5999
Q ss_pred Eecch-hhHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 190 FDFMQ-SDLTKIICRPGQK-LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 190 ~e~~~-~~l~~~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+|||+ |+|.+++.....+ +.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++-+......
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999 5777777665333 355667789999999999999999999999999999999999999999999966544433
Q ss_pred C-cccccccCccccchhccCCCCCCccccchhhHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 268 P-LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF--IGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 268 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell--tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
. ....+-..+|||||.++.. .++.++|+|+|||++||++ +...||...++.+........+..+..
T Consensus 694 ~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~---------- 762 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR---------- 762 (807)
T ss_pred eeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc----------
Confidence 2 2244557899999998764 5899999999999999986 467899877777666554443322211
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....-..-++..+..||.+|+..|-++||+.+++-.
T Consensus 763 --------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 763 --------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred --------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1111223457889999999999999999999999853
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=293.74 Aligned_cols=283 Identities=29% Similarity=0.486 Sum_probs=213.1
Q ss_pred cCCCCccCcceeceeeeeCCeEEEEEEECC---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEe
Q 036673 104 LVPKSADSYDKLAKVGQGTYSNVYKARDRD---TGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLAT 179 (469)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 179 (469)
.++...+.|.++++||+|.|++||++.+.. ..+.||+|.+...... ..+.+|+++|..+ .+.||+++.+.+.
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 345556789999999999999999999887 7899999998654332 4578999999999 6999999977665
Q ss_pred eccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC-CcEEEeeecCc
Q 036673 180 SRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS-GMLKIADFGLS 258 (469)
Q Consensus 180 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~-~~~kl~DFGla 258 (469)
. +...++|+||++..-...+.. .++..+++.+++.++.||.++|.+|||||||||+|+|.+.. +.-.|+|||+|
T Consensus 106 n--nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 106 N--NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred c--CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 5 445799999999855554443 47899999999999999999999999999999999999764 67899999999
Q ss_pred ccccCCC-------------------------------------------CCCcccccccCccccchhccCCCCCCcccc
Q 036673 259 NFFIPKQ-------------------------------------------KGPLTSRVVTLWYRAPELLLGSTDYGVGID 295 (469)
Q Consensus 259 ~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 295 (469)
....... ........||++|+|||++......++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7211000 001124578999999999998888899999
Q ss_pred chhhHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHH----------HHhhcc-------------c-CccCCC-C
Q 036673 296 LWSAGCLLAEMFIGRPLMP-GRTEVEQLHRIFKLCGTPSED----------YWKKMK-------------L-TTTFRP-Q 349 (469)
Q Consensus 296 vwslGv~l~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~----------~~~~~~-------------~-~~~~~~-~ 349 (469)
|||.|||++-+++++.||. ..++.+.+..|....|.-... +|.... . ...+.. .
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999987764 455666666555444322111 222100 0 011111 0
Q ss_pred CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..........+.++..+.+|+.+||+.||.+|+||+++|+||||..
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0011223334456678999999999999999999999999999985
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.96 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=203.7
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEe
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 191 (469)
..+.++||.|.||.||.|.++.-...||||.++.+. -.+..|+.|+.+|+.|.|||+|+|+|+|..+.. +|||+|
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP--FYIiTE 343 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP--FYIITE 343 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC--eEEEEe
Confidence 455789999999999999999888999999987442 345789999999999999999999999988655 599999
Q ss_pred cch-hhHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 192 FMQ-SDLTKIICRPGQ-KLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 192 ~~~-~~l~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
||. |+|++++.+.++ .++.-..+.++.||..||.||..+++|||||-..|+|+.++..|||+||||++++..+.....
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 998 689988877554 367777888999999999999999999999999999999999999999999998755443333
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
....-..-|.|||-+.- ..++.++|||+|||+|||+.| |-.||++-+....+..+-+.+.
T Consensus 424 AGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR------------------ 484 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR------------------ 484 (1157)
T ss_pred cCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc------------------
Confidence 33334678999997754 558999999999999999987 8899998776655544332110
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+-...+++.+..||..||++.|..||+..++-+
T Consensus 485 -------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 485 -------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred -------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 0223467899999999999999999999987643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=276.47 Aligned_cols=243 Identities=38% Similarity=0.658 Sum_probs=195.8
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-hHHHH
Q 036673 122 TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKI 200 (469)
Q Consensus 122 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~ 200 (469)
+||.||+|.+..+++.+|+|++........ .+.+.+|+.++++++|+||+++++++... ...+++|||+++ ++...
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 589999999998899999999875533221 57888999999999999999999988764 456999999998 66655
Q ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCcccc
Q 036673 201 ICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280 (469)
Q Consensus 201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 280 (469)
+... ..+++..+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||.+....... ......++..|++
T Consensus 78 ~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred HHhc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 5443 338999999999999999999999999999999999999999999999999998764322 3445678899999
Q ss_pred chhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhccc
Q 036673 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFG 360 (469)
Q Consensus 281 PE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (469)
||.+.+ ..++.++||||||+++|+|++|..||......+............ ......
T Consensus 155 pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~ 211 (244)
T smart00220 155 PEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP----------------------FPPPEW 211 (244)
T ss_pred HHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC----------------------Cccccc
Confidence 998864 457889999999999999999999998744433333322211000 001111
Q ss_pred CCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 361 EFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 361 ~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.++..+.+++.+||..||.+||++.++++||||
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 167889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=312.02 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=194.0
Q ss_pred cceeceeeeeCCeE-EEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEE
Q 036673 112 YDKLAKVGQGTYSN-VYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 112 y~~~~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
|.-.+.+|.|+.|+ ||+|... |+.||||.+- .+......+|+..|+.- .|||||++ ||.+.+..++||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRy--yc~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRY--YCSEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEE--EeeccCCceEEEE
Confidence 33445699999986 7999987 8899999874 24446778999999988 79999999 6777778889999
Q ss_pred EecchhhHHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC---C--CcEEEeeecCcccc
Q 036673 190 FDFMQSDLTKIICRPGQK---LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---S--GMLKIADFGLSNFF 261 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~--~~~kl~DFGla~~~ 261 (469)
.|.|..+|.+.+...... ......+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+++.+
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999998888663111 122456888999999999999999999999999999976 3 46899999999988
Q ss_pred cCCCCC--CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 036673 262 IPKQKG--PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 262 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
...... ......||-+|+|||++.... .+.++||||||||+|+.++| ..||...... -..|+...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~--------- 729 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGN--------- 729 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCc---------
Confidence 655443 245678899999999987654 57799999999999999986 8899653222 12222210
Q ss_pred hcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+..+.+....++.+||.+||.+||..||+|.++|.||||=.
T Consensus 730 --------------~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 730 --------------YTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred --------------cceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 1111122222238899999999999999999999999999954
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=300.15 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=209.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCC-C--cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDT-G--KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
+...+.++||+|.||+|++|.+... | -.||||.++.+.... ....|.+|+.+|.+|+|||+++|||+..+.. +
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp---~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQP---A 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccch---h
Confidence 4566778899999999999998753 2 468999998765544 6688999999999999999999999987633 5
Q ss_pred EEEEecch-hhHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 187 YLVFDFMQ-SDLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 187 ~lv~e~~~-~~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.||||.+. |+|++.+.+ ....|.......|+.||+.||.||.++++|||||-..||||-....|||+||||.+.+..+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 79999999 578877766 4567899999999999999999999999999999999999999999999999999988655
Q ss_pred CCCC--cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 265 QKGP--LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 265 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.+.. .........|.|||.+.. ..++.++|||+|||+||||+| |+.||.+......++.|-+.-..
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL---------- 334 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL---------- 334 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC----------
Confidence 4432 122334678999998764 669999999999999999998 79999999988888776421111
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
.-...++..+.+++..||..+|++|||...|.+.-+
T Consensus 335 ---------------pRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 335 ---------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ---------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 113457889999999999999999999998864433
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=257.56 Aligned_cols=218 Identities=27% Similarity=0.448 Sum_probs=181.0
Q ss_pred CCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccc
Q 036673 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 183 (469)
+....++...+..||+|+||.|=+.++..+|...|+|.++.....+ ..+.+..|+.+..+. .+|.+|+++|.+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg- 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREG- 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhccc-
Confidence 4455667777888999999999999999999999999997664443 446677888887665 8999999999766543
Q ss_pred cEEEEEEecchhhHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 184 YSLYLVFDFMQSDLTKII---CRPGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
.+||.||.|..++..+. ...+..++|..+-+|+..++.||.|||++ .|+|||+||+||||+.+|++|+||||++.
T Consensus 119 -dvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 -DVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred -cEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 47999999998765443 55678899999999999999999999987 89999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCccccchhccC---CCCCCccccchhhHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLG---STDYGVGIDLWSAGCLLAEMFIGRPLMPG-RTEVEQLHRIFK 327 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGv~l~elltg~~pf~~-~~~~~~~~~i~~ 327 (469)
.+...- ..+...|...|||||.+.. ...|+.++||||||+.+.||.+++.||.. .++.+++.++++
T Consensus 198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 874322 2334678889999998743 34689999999999999999999999864 567788887765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.78 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=221.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|+++..+|.|+||.||+|+++.+++..|+|+++.... +...-+.+|+-+++..+|||||.+++-|.... .+|+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~d--klwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD--KLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhc--CcEE
Confidence 4789999999999999999999999999999999987644 33466788999999999999999999887644 4799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
.||||+|+.++.+....+++++.++..+.+..++||+|||++|-+|||||-.|||+++.|.+|++|||.+..+... -..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh-hhh
Confidence 9999999888888888889999999999999999999999999999999999999999999999999999876432 233
Q ss_pred cccccccCccccchhcc--CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 269 LTSRVVTLWYRAPELLL--GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
..+++||+.|||||+.. ....|+..+|||++|+...|+---++|.........+..+-+....|+
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp------------- 235 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP------------- 235 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC-------------
Confidence 56889999999999852 334689999999999999999888888877766666665544332221
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
-.+-....++.+.+|++.+|.++|++|||++.+|+|||....
T Consensus 236 --------~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 236 --------TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred --------cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 112223457788999999999999999999999999998753
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=317.12 Aligned_cols=252 Identities=20% Similarity=0.312 Sum_probs=183.2
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
..|...+.||+|+||.||+|++..++..||||++...... ...|++++++++|||||++++++.... ..|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEE
Confidence 3466778899999999999999888999999988643221 124688999999999999999997754 36999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH---ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|||+++ ++.+.+. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++..++. ||.+.....
T Consensus 762 ~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred EeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999996 5555553 3899999999999999999999 6699999999999999999888876 776644311
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCC-CCHHHHhhcccC
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE-VEQLHRIFKLCGT-PSEDYWKKMKLT 343 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~-~~~~~~~~~~~~ 343 (469)
.....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ...+......... .....|
T Consensus 835 ---~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 904 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW------ 904 (968)
T ss_pred ---CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe------
Confidence 123467899999998765 5589999999999999999999999853211 1111111111100 000000
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..+ ...... ........++.+++.+||+.||++|||+.|+++.
T Consensus 905 --~~~-~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 --IDP-SIRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred --eCc-cccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000 000000 0001122357789999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=274.86 Aligned_cols=265 Identities=23% Similarity=0.309 Sum_probs=190.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC--CCCCeeeEeeeEeecc--cc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL--DHPNVIKLEGLATSRM--QY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~~~--~~ 184 (469)
.....+.+.||+|.||.||+|... ++.||||++.. ...+.+.+|-+|.... .|+||++|++.-.... ..
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 345677888999999999999887 69999999864 3346778888887754 8999999987654333 22
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcEEEcCCCcEEEee
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER---------GILHRDIKASNLLIDKSGMLKIAD 254 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~ivHrDlkp~NILl~~~~~~kl~D 254 (469)
..+||++|.+. +|-+++.. ..++|....+++..+++||+|||+- .|+|||||+.||||..|++..|+|
T Consensus 282 eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred ceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 45999999985 55555544 3599999999999999999999973 499999999999999999999999
Q ss_pred ecCcccccCCCC-CCcccccccCccccchhccCCCCCC-----ccccchhhHHHHHHHHhCCCCCC-CCChHHHHHHHHH
Q 036673 255 FGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYG-----VGIDLWSAGCLLAEMFIGRPLMP-GRTEVEQLHRIFK 327 (469)
Q Consensus 255 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DvwslGv~l~elltg~~pf~-~~~~~~~~~~i~~ 327 (469)
||||..+.+... ......+||.+|||||++.+...+. .++||||+|.|||||++....+. +..+.-++.--..
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999988865432 3344689999999999998765554 45899999999999998764442 2111111100001
Q ss_pred HhCCCCHHHHhhcccCccCCCCCCCCcchhcccC--CChhHHHHHHHccccCCCCCCCHHHH
Q 036673 328 LCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGE--FPPSSYGILTTLLALDPAYRGTAASA 387 (469)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~L~~dP~~Rpta~el 387 (469)
+...|..+-+...-.. ...+|.+...|.. -..-+.+.|..|+..||+.|.||.-+
T Consensus 440 vG~hPt~e~mq~~VV~-----kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVR-----KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hcCCCCHHHHHHHHHh-----hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 1222322222111111 1122333333332 23457889999999999999998643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=294.21 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=198.8
Q ss_pred cCcceeceeeeeCCeEEEEEEECC-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRD-------TGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
++..+.+.||+|.||.|++|.... ....||||.++..... ...+.+..|+++|..+ .|+||+.++|.+..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 334566789999999999997541 1467999999876555 6668899999999999 69999999999988
Q ss_pred cccEEEEEEecch-hhHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc
Q 036673 182 MQYSLYLVFDFMQ-SDLTKIICRPG---------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID 245 (469)
Q Consensus 182 ~~~~~~lv~e~~~-~~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~ 245 (469)
...+++|+||+. |+|+..+...+ ..++..+...++.||+.|++||++.++|||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 445799999999 57777776555 3489999999999999999999999999999999999999
Q ss_pred CCCcEEEeeecCcccccCCCCCCccccc--ccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCC-hHHH
Q 036673 246 KSGMLKIADFGLSNFFIPKQKGPLTSRV--VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRT-EVEQ 321 (469)
Q Consensus 246 ~~~~~kl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~-~~~~ 321 (469)
.+..+||+|||+|+.............. -...|||||.+.. ..|+.++|||||||+||||+| |..||++-. ..+.
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 9999999999999865333322212222 2456999999877 679999999999999999998 889998744 3333
Q ss_pred HHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 322 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+..+.... .. +.....++++.++|+.|++.+|++||+..++.+
T Consensus 532 ~~~l~~G~-r~------------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 532 LEFLKEGN-RM------------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHhcCC-CC------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 33221110 00 122345889999999999999999999998775
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=279.74 Aligned_cols=203 Identities=30% Similarity=0.502 Sum_probs=175.1
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHH------HHHHHHHHHHHHhCC---CCCeeeEee
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPES------VKFMAREIRILQKLD---HPNVIKLEG 176 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~---hpnIv~~~~ 176 (469)
++...+|..++.||+|+||.|++|.++.+...|+||.+.+...-.+. .-.+--||.||..|+ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 44567799999999999999999999999999999999764321111 122456999999997 999999999
Q ss_pred eEeeccccEEEEEEecchh--hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEee
Q 036673 177 LATSRMQYSLYLVFDFMQS--DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIAD 254 (469)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~D 254 (469)
+|++.+. .||+||.-.. +|++.+... ..++|.++..|++|++.|+++||++||||||||-+||.++.+|-+||+|
T Consensus 637 fFEddd~--yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 637 FFEDDDY--YYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred eeecCCe--eEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 9988554 5999998774 666666443 4699999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCC
Q 036673 255 FGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMP 314 (469)
Q Consensus 255 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 314 (469)
||.|.+. ...+...++||..|.|||++.|..+.+..-|||+||++||.++....||.
T Consensus 714 fgsaa~~---ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYT---KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhh---cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999875 45667889999999999999988888999999999999999999888885
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=266.68 Aligned_cols=251 Identities=26% Similarity=0.331 Sum_probs=185.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC--CCCCeeeEeeeEeecc--cc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL--DHPNVIKLEGLATSRM--QY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~~~--~~ 184 (469)
..+..+.+.||+|.||.||+|.++ |+.||||++.... + ..+.+|.+|.+.. +|+||+.|++...... -.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---E--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccc---h--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 456788999999999999999998 8999999986322 2 5577888888865 9999999977543322 23
Q ss_pred EEEEEEecch-hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEcCCCcEEEeee
Q 036673 185 SLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER--------GILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 185 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
.+|||.+|-+ |+|.+++.+ ..++.....+++..++.||++||.. .|.|||||+.|||+.+++...|+|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 5899999999 477777765 4699999999999999999999963 4999999999999999999999999
Q ss_pred cCcccccCCCC---CCcccccccCccccchhccCCCCC-----CccccchhhHHHHHHHHhC----------CCCCCCCC
Q 036673 256 GLSNFFIPKQK---GPLTSRVVTLWYRAPELLLGSTDY-----GVGIDLWSAGCLLAEMFIG----------RPLMPGRT 317 (469)
Q Consensus 256 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwslGv~l~elltg----------~~pf~~~~ 317 (469)
|||.......+ ......+||-+|||||++...... -..+||||||.|+||+... ++||.+-.
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 99987644322 245678999999999998543221 1358999999999999742 36665422
Q ss_pred ----hHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCC--hhHHHHHHHccccCCCCCCCHHHHh
Q 036673 318 ----EVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFP--PSSYGILTTLLALDPAYRGTAASAL 388 (469)
Q Consensus 318 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~~L~~dP~~Rpta~elL 388 (469)
..+.+.+++ .. +.+.|.....|...+ ..+..||+.|+..+|..|.||-.+-
T Consensus 441 p~DPs~eeMrkVV---------------Cv-----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 441 PSDPSFEEMRKVV---------------CV-----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCCHHHHhcce---------------ee-----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 222222221 11 111222222222111 2356789999999999999987654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=283.68 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=203.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCC----cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTG----KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
...+..++||.|+||+||+|.+...| -+||||++..... ......+.+|+-+|.+|+|||++++++++....
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--- 771 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST--- 771 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch---
Confidence 34666789999999999999986544 4789999865533 344577889999999999999999999998755
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+-||++|+++ .|++.+...+..+-....+.|..||++||.|||++++|||||-..||||.....+||.|||+|+.+.++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 5799999994 788888888888999999999999999999999999999999999999999999999999999988665
Q ss_pred CCCCcc-cccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 265 QKGPLT-SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 265 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
...... .....+-|||=|.+.. ..|+.++|||||||.+||++| |..|+.+....+.-..+-+...
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR------------ 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER------------ 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc------------
Confidence 544322 2334677999998765 569999999999999999998 8899988766554433321110
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..-.+..+.++..+|.+||-.|+..||++.++..
T Consensus 919 -------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 -------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 0123346778889999999999999999988654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=237.73 Aligned_cols=213 Identities=38% Similarity=0.655 Sum_probs=179.2
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-h
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-D 196 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~-~ 196 (469)
||.|.+|.||++....+++.+++|++....... ....+.+|+.+++.+.|++|+++++++... ...+++|||+.+ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 689999999999998889999999987543321 346788999999999999999999888764 456999999995 6
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-CCcEEEeeecCcccccCCCCCCccccccc
Q 036673 197 LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-SGMLKIADFGLSNFFIPKQKGPLTSRVVT 275 (469)
Q Consensus 197 l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt 275 (469)
+...+......+++..+..++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 66665544346899999999999999999999999999999999999999 89999999999986533221 23345678
Q ss_pred CccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcc
Q 036673 276 LWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSF 355 (469)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (469)
..|++||.+.....++.++|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8999999876543678999999999999999
Q ss_pred hhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCc
Q 036673 356 REVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391 (469)
Q Consensus 356 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 391 (469)
..+.+++..||..||.+||++.++++|+
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1344689999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=238.37 Aligned_cols=211 Identities=37% Similarity=0.664 Sum_probs=173.7
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEe
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 191 (469)
|++.+.||.|++|+||++.+..+++.+|+|.+...... ...+.+.+|+..+..++|+||+++++++... ...++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEe
Confidence 66788899999999999999988999999998754332 2457888999999999999999999887664 34689999
Q ss_pred cchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 192 FMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 192 ~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
|+.+ ++...+......+++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9998 666666543322899999999999999999999999999999999999999999999999999876433211234
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCC-CChH-HHHHHH
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPG-RTEV-EQLHRI 325 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~-~~~~-~~~~~i 325 (469)
...++..|++||.+.+...++.++|+|+||+++++|++|++||.. .... ...+.+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 567788999999874445678899999999999999999999977 3444 333433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=295.70 Aligned_cols=203 Identities=19% Similarity=0.234 Sum_probs=146.1
Q ss_pred hCCC-CCeeeEeeeEeec-----cccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 036673 165 KLDH-PNVIKLEGLATSR-----MQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIK 238 (469)
Q Consensus 165 ~l~h-pnIv~~~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 238 (469)
.++| +||+.+++++... ....++++|||+.++|..++......+++.+++.++.||+.||+|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 5777777766211 123568889999999999887666679999999999999999999999999999999
Q ss_pred CCcEEEcCCC-------------------cEEEeeecCcccccCCCC---------------CCcccccccCccccchhc
Q 036673 239 ASNLLIDKSG-------------------MLKIADFGLSNFFIPKQK---------------GPLTSRVVTLWYRAPELL 284 (469)
Q Consensus 239 p~NILl~~~~-------------------~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~y~aPE~~ 284 (469)
|+||||+..+ .+||+|||+++....... ......+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 455666666543211000 001124679999999988
Q ss_pred cCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCCh
Q 036673 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPP 364 (469)
Q Consensus 285 ~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (469)
.+ ..|+.++|||||||+||||++|.+||.... ..+..+.... .++ . .....+
T Consensus 188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~--------------------~----~~~~~~ 239 (793)
T PLN00181 188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP--------------------Q----ILLNWP 239 (793)
T ss_pred cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh--------------------h----hhhcCH
Confidence 76 458999999999999999999998875321 1111111110 000 0 001134
Q ss_pred hHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 365 SSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 365 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
...+++.+||+.||.+|||+.|+|+||||..
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 5668999999999999999999999999976
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=240.25 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=194.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.+.|.+.+.||+|.||.+.+++++.+++.+++|.+... ....+.|.+|..---.| .|.||+.-+++.....+ ..+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d-~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD-AYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc-eEE
Confidence 47899999999999999999999999999999988643 23446788888765556 68999998776544444 458
Q ss_pred EEEecch-hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC--CCcEEEeeecCcccccCC
Q 036673 188 LVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK--SGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 188 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 264 (469)
+++||++ |+|...+... .+-|...+.++.|+++|+.|+|+.++||||||.+||||-. ...+||||||+....+..
T Consensus 99 F~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred EeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 8999999 5666655443 3889999999999999999999999999999999999832 347999999998754221
Q ss_pred CCCCcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
....-.+..|.+||++.. .-...+.+|||.||+++|.+|||.+||......+ ..||+-+
T Consensus 177 ----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-------------~~Y~~~~ 239 (378)
T KOG1345|consen 177 ----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-------------KPYWEWE 239 (378)
T ss_pred ----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-------------chHHHHH
Confidence 122233667999997642 1235678999999999999999999997433221 1222222
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCC---CCHHHHhcCccCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR---GTAASALQNEFFNA 395 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R---pta~elL~hp~f~~ 395 (469)
..... ..+.+...+..+++.+..+.++-|..+|++| -++.......|...
T Consensus 240 ~w~~r-----k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 240 QWLKR-----KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred HHhcc-----cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 11111 1122334456688999999999999999999 77888888788653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=237.19 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=202.3
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDT-----GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR 181 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 181 (469)
....+++....+-+|.||.||.|.+++. .+.|-+|.++.. ..+-....+..|...+..+.|||+..+.+++.+.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 3456788889999999999999977643 345667777543 3345567788999999999999999999988764
Q ss_pred cccEEEEEEecch-hhHHHHHh-----cC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEe
Q 036673 182 MQYSLYLVFDFMQ-SDLTKIIC-----RP--GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIA 253 (469)
Q Consensus 182 ~~~~~~lv~e~~~-~~l~~~~~-----~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~ 253 (469)
. ...++++.+++ |+|..++. +. .+.++..+...++.|++.|++|||.++|||.||-..|.+||+.-.+||+
T Consensus 360 ~-~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 360 Y-ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred c-CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 3 34578888888 57766665 22 2347888999999999999999999999999999999999999999999
Q ss_pred eecCcccccCCCCCCcc-cccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 036673 254 DFGLSNFFIPKQKGPLT-SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGT 331 (469)
Q Consensus 254 DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 331 (469)
|=.+++.+.+.+-+... .......||+||.+.+ ..|+.++|+|||||+||||+| |+.|+..-++.+...-+.+...
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR- 516 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR- 516 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce-
Confidence 99999987665543322 2334678999998876 569999999999999999998 8999988777766554433210
Q ss_pred CCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+ .-.-++|+++..++..||+.+|++||+.+|+..
T Consensus 517 ----------l--------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 ----------L--------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ----------e--------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 0 112357899999999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=265.72 Aligned_cols=268 Identities=26% Similarity=0.376 Sum_probs=204.3
Q ss_pred cCc-ceeceeeeeCCeEEEEEEECCCCcEEEEEEee----cCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSY-DKLAKVGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..| .....+|.|++|.|+.+......+.++.|... ...........+..|+.+-..|.|||++..+..+......
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 55678999999999988887766667766554 2222222233377788888999999998887766554433
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+-+||||+++|...+... ..++..++..+++|++.||+|||+.||.|||||++|+|++.+|.+||+|||.+..+.-.
T Consensus 397 --~~~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 397 --LQSMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred --hhhhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 344999999777766554 46999999999999999999999999999999999999999999999999999876433
Q ss_pred CC---CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 265 QK---GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 265 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.. ......+|+..|+|||++.+...-...+||||.|++++.|++|+.||......+....-....
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~------------ 541 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS------------ 541 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc------------
Confidence 32 345678899999999998876655667999999999999999999997654443321000000
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
...........++..++.+.+.+|.+||++||.+|.|+++||+.+||+...
T Consensus 542 -----~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 542 -----DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred -----cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 000111223345566788899999999999999999999999999998743
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=222.01 Aligned_cols=166 Identities=23% Similarity=0.274 Sum_probs=126.9
Q ss_pred hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccc
Q 036673 195 SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274 (469)
Q Consensus 195 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 274 (469)
|+|.+.+...+..+++.+++.++.||+.||+|||+++ ||+|||++.++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCC
Confidence 4566666655667999999999999999999999998 999999999999999 9999865322 2368
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ-LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
|+.|+|||++.+ ..++.++|||||||++|||++|++||........ +..+........ +
T Consensus 67 ~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------------~ 126 (176)
T smart00750 67 DPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------------------P 126 (176)
T ss_pred cccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------------------c
Confidence 999999998876 4589999999999999999999999976544322 222222111000 0
Q ss_pred cchhcccCCCh--hHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 354 SFREVFGEFPP--SSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 354 ~~~~~~~~~~~--~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
........++. ++.+||.+||..||.+|||+.++++|+|+.
T Consensus 127 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 127 RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00001112233 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=232.29 Aligned_cols=166 Identities=21% Similarity=0.244 Sum_probs=129.4
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECC-CCcEEEEEEeecCC---CCHHHHHHHHHHHHHHHhCCCCCeee-EeeeEeec
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRD-TGKIVALKKVRFDT---SEPESVKFMAREIRILQKLDHPNVIK-LEGLATSR 181 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~ 181 (469)
...++|++.+.||+|+||+||+|++.. +++.||||++.... ........+.+|+++|++++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 345789999999999999999999876 67888999875321 12334567899999999999999985 4331
Q ss_pred cccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcEEEcCCCcEEEeeecCccc
Q 036673 182 MQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDI-KASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 182 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~ 260 (469)
...||||||++|..+..+.. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|..
T Consensus 91 --~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 13599999999865553311 11 1467899999999999999999999 99999999999999999999987
Q ss_pred ccCCCCC-------CcccccccCccccchhcc
Q 036673 261 FIPKQKG-------PLTSRVVTLWYRAPELLL 285 (469)
Q Consensus 261 ~~~~~~~-------~~~~~~gt~~y~aPE~~~ 285 (469)
+...... ..+..++++.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 6443211 124567788999999774
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-25 Score=217.16 Aligned_cols=264 Identities=34% Similarity=0.531 Sum_probs=204.0
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHH-HHHHHHHHHHHHHhCCCC-CeeeEeeeEeeccccEEEEE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPE-SVKFMAREIRILQKLDHP-NVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~~~lv 189 (469)
|.+...||.|+|+.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++++... ...+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEEE
Confidence 778889999999999999987 7899999976644432 567889999999999988 799999988443 336999
Q ss_pred EecchhhHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-cEEEeeecCcccccCCC
Q 036673 190 FDFMQSDLTKIICRPGQ---KLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 265 (469)
++++.+..+..+..... .++......++.|++.++.|+|+.+++||||||+|||++..+ .++++|||++..+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999754444444332 699999999999999999999999999999999999999998 79999999998654333
Q ss_pred CC-----CcccccccCccccchhccCC--CCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHH
Q 036673 266 KG-----PLTSRVVTLWYRAPELLLGS--TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---VEQLHRIFKLCGTPSED 335 (469)
Q Consensus 266 ~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~ 335 (469)
.. .....++|..|+|||.+.+. ..+....|+||+|++++++++|..||..... .......+.....+.
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS-- 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc--
Confidence 21 34678899999999988763 4688999999999999999999999877664 333333333222210
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. ......... ......+.+++..++..+|..|.+..+...++|....
T Consensus 235 ----------~-~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 235 ----------L-ASPLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ----------c-ccccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0 000000000 1223578899999999999999999999999776653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-25 Score=215.75 Aligned_cols=255 Identities=23% Similarity=0.258 Sum_probs=190.1
Q ss_pred CcceeceeeeeCCeEEEEEEECCCC-cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC----CCeeeEeeeEeeccccE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTG-KIVALKKVRFDTSEPESVKFMAREIRILQKLDH----PNVIKLEGLATSRMQYS 185 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~~~~~~~~ 185 (469)
+|.+.++||+|+||.||++.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++... ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 8999999999999999999998764 6789998765432221 156778999988863 58888877664 23445
Q ss_pred EEEEEecchhhHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC-----CcEEEeeecCcc
Q 036673 186 LYLVFDFMQSDLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS-----GMLKIADFGLSN 259 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla~ 259 (469)
-||||+.+..+|.++.... ...|+...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 6999999999998877544 3789999999999999999999999999999999999999765 369999999998
Q ss_pred --cccCCCCC----C---cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 036673 260 --FFIPKQKG----P---LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 260 --~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 330 (469)
.+...... . .....||..|.++.+..+ ...+.+.|+||++.++.+|+.|..||.+.........+.....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 33222211 1 123459999999998776 4579999999999999999999999977664433333322110
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.... . ......+.++..++..+-..+...+|....+...
T Consensus 255 ~~~~------------------~---~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLT------------------D---RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhcc------------------c---cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 0000 0 0122345667777777777888889887776554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=202.20 Aligned_cols=208 Identities=21% Similarity=0.313 Sum_probs=171.9
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.|++.++||+|+||.++.|.+.-+++.||||.-...... -++..|....+.| ..++|..+ ||......+-.||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~v--YYFGqeG~~NiLV 102 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQV--YYFGQEGKYNILV 102 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCce--eeeccccchhhhh
Confidence 599999999999999999999999999999976543332 4577888888888 57899988 4555555566899
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-----cEEEeeecCcccccCC
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-----MLKIADFGLSNFFIPK 264 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-----~~kl~DFGla~~~~~~ 264 (469)
+|.+..+|.+++.-.+++|+...+..++.|++.-++|+|++.+|.|||||+|+||...+ .|.|+|||+|+.+.+.
T Consensus 103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 99999888777766677899999999999999999999999999999999999997554 5899999999987544
Q ss_pred CCC------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC---ChHHHHHHH
Q 036673 265 QKG------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR---TEVEQLHRI 325 (469)
Q Consensus 265 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~---~~~~~~~~i 325 (469)
... ...+..||.+||+-...++. .-+...|+-|||-|+++.|-|..||.+. +..+.+.+|
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 332 24567899999998877764 4688899999999999999999999874 334444444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=195.43 Aligned_cols=247 Identities=20% Similarity=0.252 Sum_probs=186.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC-CCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH-PNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~~ 187 (469)
.+.|+++++||.|+||.+|+|....+|..||||+-...... .++..|..+.+.|++ ..|..+..|..+.. +-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~--ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKD--YNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccc--cce
Confidence 47899999999999999999999999999999987544333 456789999999964 56666655555533 348
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC---CcEEEeeecCcccccCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS---GMLKIADFGLSNFFIPK 264 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~ 264 (469)
+|||.+..+|.+++.-..+.|+...++-++-|++.-++|+|.++++||||||+|+|..-+ ..+.|+|||+|+.+.+.
T Consensus 88 lVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 999999988887776666789999999999999999999999999999999999998543 46999999999887543
Q ss_pred CCCC------cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHH
Q 036673 265 QKGP------LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ---LHRIFKLCGTPSED 335 (469)
Q Consensus 265 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~~ 335 (469)
.... -....||.+|.+--...+ ...+...|+-|+|.+|.++.-|..||.+-..... ..+|...--
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~----- 241 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM----- 241 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc-----
Confidence 3321 245678999999776655 3357788999999999999999999998654433 333332111
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT 383 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 383 (469)
......+-..+|.++.-.|..|=..-=++-|.
T Consensus 242 ----------------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 242 ----------------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred ----------------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 11222333456677777777776555555555
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-26 Score=229.77 Aligned_cols=238 Identities=29% Similarity=0.422 Sum_probs=190.6
Q ss_pred eeeeCCeEEEEEEE---CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEEEEEecc
Q 036673 118 VGQGTYSNVYKARD---RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 118 lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+|+|+||.|++++. .+.+..+|+|++++.............|..++..++ ||.+|++.-.+..+ ..+++++++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--cchhHhhhhc
Confidence 79999999998754 345788999998765433322234556888888886 99999996555554 3468999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCccccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRV 273 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 273 (469)
.|+.+.........+.+.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++....... .|
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~c 154 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----AC 154 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----cc
Confidence 9855444444455688999999999999999999999999999999999999999999999999987643322 29
Q ss_pred ccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 274 gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
||..|||||++. ....++|.||||++++||+||..||.. +....|.+..-
T Consensus 155 gt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~----------------------- 204 (612)
T KOG0603|consen 155 GTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL----------------------- 204 (612)
T ss_pred cchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc-----------------------
Confidence 999999999886 367899999999999999999999987 56666654221
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCH-----HHHhcCccCCC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTA-----ASALQNEFFNA 395 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta-----~elL~hp~f~~ 395 (469)
.....++..+.+++..++..+|.+|.-+ .++++|+||+.
T Consensus 205 ---~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 205 ---EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred ---CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 1123456788899999999999999764 79999999984
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-25 Score=229.85 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=180.4
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC--CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT--SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.|...+.||.+.|=+|.+|++.+ |. |+||++-... ..-....+...|++ ...++|||++++.-+... ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 57778889999999999999885 54 9999985442 22233344445666 556699999998654333 334589
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|-+|+.++|.+.+.... -+...+.+.|+.||+.||.-+|..||+|+|||.+||||+.-..+.|+||..-+...-..+++
T Consensus 99 vRqyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99999999998876532 47888999999999999999999999999999999999999999999998765432222222
Q ss_pred ------cccccccCccccchhccCCC----------CCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 036673 269 ------LTSRVVTLWYRAPELLLGST----------DYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGT 331 (469)
Q Consensus 269 ------~~~~~gt~~y~aPE~~~~~~----------~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 331 (469)
..+...-.+|.|||.+.... ..+++.||||+||+++||++ |+|||.- .++...-.....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCcc
Confidence 12223346899999875311 15788999999999999987 7999942 222222111111
Q ss_pred CCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..+...+.+ -+..+++||..|++.||.+|.+|++.|+.
T Consensus 254 ~~e~~Le~I---------------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKI---------------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhC---------------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111111 13468899999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=194.97 Aligned_cols=141 Identities=21% Similarity=0.236 Sum_probs=108.1
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHH------------------------HHHHHHHHHHHHhCCCCC
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPES------------------------VKFMAREIRILQKLDHPN 170 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~hpn 170 (469)
...||+|+||.||+|.+. +|+.||||+++........ ......|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 356999999999999987 7999999999764221110 122345999999998877
Q ss_pred eeeEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCcEEEcCCCc
Q 036673 171 VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC-HERGILHRDIKASNLLIDKSGM 249 (469)
Q Consensus 171 Iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivHrDlkp~NILl~~~~~ 249 (469)
|.....+... . .+|||||++|+.+.........+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~--~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK--S--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec--C--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 6443322221 2 289999999854432222235799999999999999999999 799999999999999998 578
Q ss_pred EEEeeecCcccc
Q 036673 250 LKIADFGLSNFF 261 (469)
Q Consensus 250 ~kl~DFGla~~~ 261 (469)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-24 Score=224.54 Aligned_cols=224 Identities=27% Similarity=0.429 Sum_probs=168.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|+.++.|-.|+||.||+++++.+.+.+|+|+ +.+. .+.+ ||.++-+ . .+
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-------lilR-----------nilt~a~------n--pf 133 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-------LILR-----------NILTFAG------N--PF 133 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-------hhhh-----------ccccccC------C--cc
Confidence 34789999999999999999999999999999953 3211 1111 2333311 1 12
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
.| |+-...+ +.-++++.+. +.+++|||+.||+|||+||+|+||+.-|++|++|||+++........
T Consensus 134 vv-----gDc~tll-k~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 134 VV-----GDCATLL-KNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ee-----chhhhhc-ccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 22 3333322 2223455443 78999999999999999999999999999999999998653211100
Q ss_pred --------------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036673 268 --------------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS 333 (469)
Q Consensus 268 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 333 (469)
.....||||.|+|||++.. ..|+..+|+|++|+|+||.+-|..||.+++..+++..++.....-+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 1234589999999999876 4599999999999999999999999999999999888765432221
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC---CHHHHhcCccCCCC
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG---TAASALQNEFFNAS 396 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---ta~elL~hp~f~~~ 396 (469)
+-....++++.++|.++|+.+|..|. .+-++.+|+||+.-
T Consensus 279 -----------------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 279 -----------------------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred -----------------------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 11345788999999999999999994 57899999999853
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=197.36 Aligned_cols=237 Identities=20% Similarity=0.275 Sum_probs=152.6
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCC----------CCeeeEeeeE-
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-PESVKFMAREIRILQKLDH----------PNVIKLEGLA- 178 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h----------pnIv~~~~~~- 178 (469)
.+.....||.|+++.||.+.+..|++.+|||+....... ...++.+.+|.-.+..+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456778899999999999999999999999998665432 2346777777766655432 1122212211
Q ss_pred --------eecc---cc---EEEEEEecchhhHHHHHh---cCCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 036673 179 --------TSRM---QY---SLYLVFDFMQSDLTKIIC---RPGQK---LTEPQVKCYMQQLLSGLQHCHERGILHRDIK 238 (469)
Q Consensus 179 --------~~~~---~~---~~~lv~e~~~~~l~~~~~---~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 238 (469)
.... .+ ..+++|+-+.++|...+. ..... +.......+..|+++.+++||..||+|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1111 11 237788888887755542 22111 2223334556899999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCccccchhccC-------CCCCCccccchhhHHHHHHHHhCCC
Q 036673 239 ASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG-------STDYGVGIDLWSAGCLLAEMFIGRP 311 (469)
Q Consensus 239 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGv~l~elltg~~ 311 (469)
|+|+|++.+|.++|+||+.....+.. ......+..|.+||.... ...++.+.|.|+||+++|.|+++..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999887654221 111344678999996532 1347889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCC
Q 036673 312 LMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR 381 (469)
Q Consensus 312 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 381 (469)
||........ ....|..+. ++|+.++.||..+|+.||.+|
T Consensus 249 Pf~~~~~~~~-----------------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEAD-----------------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGST-----------------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccc-----------------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9975422110 001344555 789999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=193.74 Aligned_cols=174 Identities=13% Similarity=0.158 Sum_probs=130.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHH-HHHH------HHHHHHHHHhCCCCCeeeEeeeEeec
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPE-SVKF------MAREIRILQKLDHPNVIKLEGLATSR 181 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~hpnIv~~~~~~~~~ 181 (469)
.++|++++.||.|+||.||++.. ++..+|||++.......+ .... +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999755 367899999975433222 2222 57899999999999999998886643
Q ss_pred c------ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 182 M------QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 182 ~------~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
. ....+|+|||++|..+..+. .+++ ....+++.+|..||+.||+||||||+|||++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 12368999999985443332 2333 3466999999999999999999999999999998 999999
Q ss_pred cCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHH
Q 036673 256 GLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307 (469)
Q Consensus 256 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell 307 (469)
|........... ..+++ ...|+.++|+||||+.+..+.
T Consensus 179 g~~~~~~e~~a~-------------d~~vl-er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK-------------DRIDL-ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH-------------HHHHH-HhHhcccccccceeEeehHHH
Confidence 988754211110 00222 245778999999999887664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=188.14 Aligned_cols=140 Identities=22% Similarity=0.287 Sum_probs=110.8
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH------------------------HHHHHHHHHHHHHHhCCCCC
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP------------------------ESVKFMAREIRILQKLDHPN 170 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~~l~hpn 170 (469)
...||+|+||+||+|.+. +|+.||||+++...... .....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 79999999997652110 00123467999999999998
Q ss_pred eeeEeeeEeeccccEEEEEEecchhh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCC
Q 036673 171 VIKLEGLATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 171 Iv~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~ 248 (469)
|.....+... . .||||||++|. +...... ...++...+..++.|++.+|.+||+ .||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~--~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK--K--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec--C--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 8655444332 2 28999999985 3332222 3468899999999999999999999 9999999999999998 88
Q ss_pred cEEEeeecCcccc
Q 036673 249 MLKIADFGLSNFF 261 (469)
Q Consensus 249 ~~kl~DFGla~~~ 261 (469)
.++|+|||++...
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 9999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=197.11 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=180.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCC-----------------------------------cEEEEEEeecC---CCCH
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTG-----------------------------------KIVALKKVRFD---TSEP 150 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----------------------------------~~vavK~~~~~---~~~~ 150 (469)
.++|++...||+|....||.|+....| -+.|||.+..- ....
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 578999999999999999999865421 13466765321 2222
Q ss_pred HHHHHHHHHHH------HH--------Hh--------CCCCCeeeEeeeEeecc-------------------------c
Q 036673 151 ESVKFMAREIR------IL--------QK--------LDHPNVIKLEGLATSRM-------------------------Q 183 (469)
Q Consensus 151 ~~~~~~~~E~~------~l--------~~--------l~hpnIv~~~~~~~~~~-------------------------~ 183 (469)
...+.+.+|+- .+ +. -+|||||++.++|.+.- .
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 33344444431 11 11 15999999988765421 2
Q ss_pred cEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE--cCCC--cEEEeeecCcc
Q 036673 184 YSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI--DKSG--MLKIADFGLSN 259 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl--~~~~--~~kl~DFGla~ 259 (469)
..+|+||......|...+... ..+....+-++.|+++|+.|||.+||.|||+|++|||| |+++ .+.|+|||.+-
T Consensus 316 ~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 458999999999998887663 47788888999999999999999999999999999998 4444 57899999874
Q ss_pred cccC-----CCCCCcccccccCccccchhccCCCC-----CCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 036673 260 FFIP-----KQKGPLTSRVVTLWYRAPELLLGSTD-----YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLC 329 (469)
Q Consensus 260 ~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 329 (469)
-... .........-|.-.-||||+...... .-.++|.|+.|.+.||+++...||....+.-.-.+-
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---- 469 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---- 469 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----
Confidence 3211 00111223456788999998743221 125789999999999999999999874332111111
Q ss_pred CCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH---HHHhcCccCC
Q 036673 330 GTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA---ASALQNEFFN 394 (469)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta---~elL~hp~f~ 394 (469)
++ ...+......+++.+.+|+-.+|+.||++|+++ +.+|+-..|.
T Consensus 470 ----------------Yq----e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~ 517 (598)
T KOG4158|consen 470 ----------------YQ----ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWR 517 (598)
T ss_pred ----------------hh----hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhc
Confidence 11 111223455788999999999999999999995 4566654444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=182.15 Aligned_cols=190 Identities=16% Similarity=0.113 Sum_probs=137.7
Q ss_pred ceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEEEE
Q 036673 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS--EPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 113 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv 189 (469)
.+...|+.|+||+||++.. .+..++.+.+..... ..-....+.+|+++|++|. |++|++++++. ..+++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEE
Confidence 3556799999999998866 378888777754322 1112235789999999995 58899997751 24899
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcEEEcCCCcEEEeeecCcccccCCCCC-
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDI-KASNLLIDKSGMLKIADFGLSNFFIPKQKG- 267 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~~~- 267 (469)
|+|+.|..+.... +.. ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|........-
T Consensus 77 meyI~G~~L~~~~------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 77 RSYLAGAAMYQRP------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred EeeecCccHHhhh------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999986554321 111 2457889999999999999999999 799999999999999999999854332210
Q ss_pred ---C--------cccccccCccccchhccCCCCCC-ccccchhhHHHHHHHHhCCCCCCCCC
Q 036673 268 ---P--------LTSRVVTLWYRAPELLLGSTDYG-VGIDLWSAGCLLAEMFIGRPLMPGRT 317 (469)
Q Consensus 268 ---~--------~~~~~gt~~y~aPE~~~~~~~~~-~~~DvwslGv~l~elltg~~pf~~~~ 317 (469)
. ......++.|++|+.-.--...+ ...+.++.|+.+|.++|+..++.++.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 01123478889888542211223 45688899999999999998876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-23 Score=187.82 Aligned_cols=246 Identities=16% Similarity=0.200 Sum_probs=192.1
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
....+..++.+|.+...|..|+|++. |..+++|++..........+.|..|.-.|+-+.||||+.+++.|..+. .+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp--nl 262 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP--NL 262 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC--Cc
Confidence 34456677888999999999999998 667888998877666666788999999999999999999999998864 46
Q ss_pred EEEEecch-hhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEcCCCcEEEe--eecCccc
Q 036673 187 YLVFDFMQ-SDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERG--ILHRDIKASNLLIDKSGMLKIA--DFGLSNF 260 (469)
Q Consensus 187 ~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~kl~--DFGla~~ 260 (469)
.++..||+ |+|...+.... -.+...++..++.+|++|++|||+.. |.---|.+..++||++.+.+|. |--++-.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence 89999999 56666665543 23678899999999999999999873 4445689999999999887764 3222211
Q ss_pred ccCCCCCCcccccccCccccchhccCCCC--CCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTD--YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
.......|.||+||.++.... .-.++|+|||+++||||.|...||...+..+--.+|.-..
T Consensus 343 --------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg--------- 405 (448)
T KOG0195|consen 343 --------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG--------- 405 (448)
T ss_pred --------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc---------
Confidence 123455889999998876432 2357899999999999999999999888776655543210
Q ss_pred hcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHh
Q 036673 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASAL 388 (469)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL 388 (469)
--..+.+.++..+..||+-|+..||.+||..+.++
T Consensus 406 ---------------lrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 406 ---------------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ---------------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 01145567889999999999999999999987654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=172.60 Aligned_cols=136 Identities=19% Similarity=0.235 Sum_probs=104.2
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-----CCCCeeeEeeeEeeccc-cE-EE
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-----DHPNVIKLEGLATSRMQ-YS-LY 187 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~-~~-~~ 187 (469)
...||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ +||||++++|++..... .. +.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45699999999995 7766655 69998754322 336789999999999 67999999999987542 23 34
Q ss_pred EEEecch--h-hHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCcEEEcCC----CcEEEeeecCcc
Q 036673 188 LVFDFMQ--S-DLTKIICRPGQKLTEPQVKCYMQQLLSGL-QHCHERGILHRDIKASNLLIDKS----GMLKIADFGLSN 259 (469)
Q Consensus 188 lv~e~~~--~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~ 259 (469)
+|+||+. + +|.+.+.+ . .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-C-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEecCCCCcchhHHHHHHc-c-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 7899954 4 66666644 2 46666 46688888888 99999999999999999999743 479999965554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=177.32 Aligned_cols=144 Identities=24% Similarity=0.231 Sum_probs=111.5
Q ss_pred CcceeceeeeeCCeEEEEEE-ECCCCcEEEEEEeecCCCCH----------------------HHHHHHHHHHHHHHhCC
Q 036673 111 SYDKLAKVGQGTYSNVYKAR-DRDTGKIVALKKVRFDTSEP----------------------ESVKFMAREIRILQKLD 167 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 167 (469)
.|.+.+.||+|+||.||+|. +..+|+.||||+++...... .....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 66789999999987542110 01134568999999997
Q ss_pred CCC--eeeEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcEEE
Q 036673 168 HPN--VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG-ILHRDIKASNLLI 244 (469)
Q Consensus 168 hpn--Iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NILl 244 (469)
+.+ +.+++++ . . .+|||||++|..+.........+....+..++.||+.+|++||+.| |+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~---~-~--~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-R--NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-C--ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 533 3444332 1 2 3899999999554333323345677778899999999999999999 9999999999999
Q ss_pred cCCCcEEEeeecCcccc
Q 036673 245 DKSGMLKIADFGLSNFF 261 (469)
Q Consensus 245 ~~~~~~kl~DFGla~~~ 261 (469)
+ ++.++|+|||++...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=186.25 Aligned_cols=249 Identities=23% Similarity=0.386 Sum_probs=159.5
Q ss_pred cceeceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEee-----e--Ee-e
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG-----L--AT-S 180 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~-----~--~~-~ 180 (469)
+.+.+..+..+++.++......+ ...++-+....+ .........+++-.+....|-+..-+.+ + .. .
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d--~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~ 323 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD--SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRN 323 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhcc--chhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccc
Confidence 44455566666666665544432 223333332221 1122233445555555554444333322 1 11 1
Q ss_pred cc--ccEEEEEEecchh-hHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 181 RM--QYSLYLVFDFMQS-DLTKIICRP--GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 181 ~~--~~~~~lv~e~~~~-~l~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
.- ..++||.|++|.. .|.+|+.+. ....+......++.|++.|+.| ++.+|+|+||.||++..+..+||.||
T Consensus 324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhh
Confidence 11 2357899999996 666666432 3457788899999999999999 99999999999999999999999999
Q ss_pred cCcccccCCC-----CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 036673 256 GLSNFFIPKQ-----KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 256 Gla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 330 (469)
|+........ ....+..+||.+||+||.+.+ ..|+.++||||||+||+||+.- |...-+.......+.. +
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~---f~T~~er~~t~~d~r~-g 475 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQ---FSTQFERIATLTDIRD-G 475 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHH---hccHHHHHHhhhhhhc-C
Confidence 9997654333 224567789999999999987 5699999999999999999972 2111111111111111 1
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
..++.+| .+ .+.-.+|+..||...|.+||++.+.--|.|.
T Consensus 476 ~ip~~~~----------------------~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 476 IIPPEFL----------------------QD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CCChHHh----------------------hc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1111111 11 2344579999999999999988887777765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-21 Score=202.87 Aligned_cols=264 Identities=27% Similarity=0.402 Sum_probs=204.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC-CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR-DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~ 186 (469)
...|.+.+.||+|+|+.|-.+... ++...+|+|.+............+..|..+-..+. |+|++.+++....... .
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~--~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS--Y 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc--c
Confidence 356888888999999999998774 34566777777655434444566667888888886 9999999887766544 4
Q ss_pred EEEEecchhh-HHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEcCCC-cEEEeeecCccccc
Q 036673 187 YLVFDFMQSD-LTKIICRPGQ-KLTEPQVKCYMQQLLSGLQHCH-ERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFI 262 (469)
Q Consensus 187 ~lv~e~~~~~-l~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 262 (469)
+++++|..|+ +...+..... ..+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .++++|||+|..+.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 8999998874 4444424333 6788889999999999999999 99999999999999999999 99999999999875
Q ss_pred C--CCCCCcccccc-cCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 263 P--KQKGPLTSRVV-TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 263 ~--~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
. .........+| ++.|+|||.+.+........|+||+|+++.-+++|..|+........... .|..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-----------~~~~ 245 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-----------SWKS 245 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-----------eecc
Confidence 5 23334556788 99999999887755678899999999999999999999865443331100 0000
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
. . ...-...+..++....+++.++|..+|..|.+..++-.++|+..
T Consensus 246 ~--~--------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 N--K--------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c--c--------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 0 00012345677888999999999999999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-19 Score=192.70 Aligned_cols=196 Identities=23% Similarity=0.349 Sum_probs=148.3
Q ss_pred CCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeEeeeEeec
Q 036673 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD---HPNVIKLEGLATSR 181 (469)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~ 181 (469)
+......|.|.+.||+|+||+||+|...+ |+.||||+=+.... .+ |.-=.+++.+|+ -+.|..+...+...
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----WE-FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----ee-eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 44456789999999999999999999987 99999998653311 11 111223334444 23344443333333
Q ss_pred cccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-------CCcEEEe
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-------SGMLKIA 253 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-------~~~~kl~ 253 (469)
+. .+||+||.+. +|++++. ..+.+++..+..++.|++.-++.||..+|||+||||+|+||.. .--++|+
T Consensus 767 ~~--S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NA--SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred Cc--ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 33 4899999995 5666554 6667999999999999999999999999999999999999942 2359999
Q ss_pred eecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCC
Q 036673 254 DFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGR 310 (469)
Q Consensus 254 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~ 310 (469)
|||.+--+..-.. ......++|-.+-.+|+..| +.|++.+|.|.|+.+++-||.|+
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 9999865432222 34567788999999997766 67999999999999999999997
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=178.54 Aligned_cols=206 Identities=24% Similarity=0.370 Sum_probs=155.2
Q ss_pred HHhCCCCCeeeEeeeEeeccccEEEEEEecch-hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCC
Q 036673 163 LQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI-LHRDIKAS 240 (469)
Q Consensus 163 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i-vHrDlkp~ 240 (469)
|+.+.|.|+.+++|.+... ..+++|.+||. |++.+.+......+++-....++++|+.||+|||...| +|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4578999999999999886 45699999998 56777776666779999999999999999999998765 99999999
Q ss_pred cEEEcCCCcEEEeeecCcccccCC-CCCCcccccccCccccchhccCCCC------CCccccchhhHHHHHHHHhCCCCC
Q 036673 241 NLLIDKSGMLKIADFGLSNFFIPK-QKGPLTSRVVTLWYRAPELLLGSTD------YGVGIDLWSAGCLLAEMFIGRPLM 313 (469)
Q Consensus 241 NILl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DvwslGv~l~elltg~~pf 313 (469)
|.++|....+||+|||+....... .........-..-|.|||.+.+... .+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999999876321 1111222234667999998765311 366799999999999999999999
Q ss_pred CCCChH----HHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 314 PGRTEV----EQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 314 ~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
...... +.+..+.+ . ....+.|...... ++++++..++..|+..+|.+||+++++-.
T Consensus 159 ~~~~~~~~~~eii~~~~~-~-----------------~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-G-----------------GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccCChHHHHHHHHh-c-----------------CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 764322 22322222 0 0112233333222 56678999999999999999999988654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.2e-19 Score=161.18 Aligned_cols=138 Identities=22% Similarity=0.216 Sum_probs=106.8
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH--------------------HHHHHHHHHHHHHHhCCCCC
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP--------------------ESVKFMAREIRILQKLDHPN 170 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~hpn 170 (469)
.|.+.+.||.|+||.||++... +|+.||||+++...... .....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3788899999999999999876 69999999976532110 01123567999999998774
Q ss_pred --eeeEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC
Q 036673 171 --VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 171 --Iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 248 (469)
++.+++. ...++||||++|..+..+.. ......++.+|+.++.++|+.||+|+||||+|||++.++
T Consensus 95 i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPIDW------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceeec------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 4444332 12389999999865544322 144667889999999999999999999999999999999
Q ss_pred cEEEeeecCcccc
Q 036673 249 MLKIADFGLSNFF 261 (469)
Q Consensus 249 ~~kl~DFGla~~~ 261 (469)
.++|+|||++..+
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=160.10 Aligned_cols=136 Identities=18% Similarity=0.264 Sum_probs=106.3
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHH------HHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPE------SVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+.||+|++|.||+|++ ++..|+||+......... ....+.+|+.++..+.|++|.....++..... .+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~--~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN--FIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC--CEEE
Confidence 5699999999999987 477899998654322111 12457789999999999998766656554433 4899
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
|||++|..+..+.... .. ....++.+++.+|.+||+.+++|+|++|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~---~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSN---GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhc---cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999984443333322 22 7889999999999999999999999999999999 78999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-18 Score=154.78 Aligned_cols=132 Identities=17% Similarity=0.272 Sum_probs=99.7
Q ss_pred eeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC------HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE------PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
.||+|+||.||+|.. ++..|++|+....... ......+.+|+.++..+.|+++.....++..... .++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~--~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN--KTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC--CEEEE
Confidence 389999999999985 3788999986432211 1123567789999999988875544334444333 48999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
||++|..+..+...... .++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99998544433322111 8899999999999999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-18 Score=152.72 Aligned_cols=133 Identities=26% Similarity=0.317 Sum_probs=98.0
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHH----------------------HHHHHHHHHhCCCCC--
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKF----------------------MAREIRILQKLDHPN-- 170 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~hpn-- 170 (469)
.+.||+|+||+||+|.+. +++.||||+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 456999999999999887 6899999998754322111111 135666676664443
Q ss_pred eeeEeeeEeeccccEEEEEEecchh-----hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEE
Q 036673 171 VIKLEGLATSRMQYSLYLVFDFMQS-----DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLI 244 (469)
Q Consensus 171 Iv~~~~~~~~~~~~~~~lv~e~~~~-----~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl 244 (469)
+.+.+++ . ..++||||+++ ..+.... . ..++..++.+++.++.++|. .+|+|+||||+|||+
T Consensus 81 ~~~~~~~--~----~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 81 VPKPIDL--N----RHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred CCceEec--C----CCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 4444332 1 13899999998 2222211 1 16788999999999999999 999999999999999
Q ss_pred cCCCcEEEeeecCcccc
Q 036673 245 DKSGMLKIADFGLSNFF 261 (469)
Q Consensus 245 ~~~~~~kl~DFGla~~~ 261 (469)
+ ++.++|+|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=174.92 Aligned_cols=139 Identities=16% Similarity=0.201 Sum_probs=106.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCC-----HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSE-----PESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
...|...+.||+|+||+||++.+.. ..+++|+.... ... ......+.+|+.++..++|++|+....++....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3456778899999999999998764 34444443211 111 112356789999999999999988766665543
Q ss_pred ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 183 QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 183 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
. .++||||++|..+..... ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~--~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 E--KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred C--CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 3 489999999844433322 457789999999999999999999999999999 678999999999975
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=148.63 Aligned_cols=137 Identities=20% Similarity=0.288 Sum_probs=103.0
Q ss_pred ceee-eeCCeEEEEEEECCCCcEEEEEEeecCCC-----------CHHHHHHHHHHHHHHHhCCCCCe--eeEeeeEeec
Q 036673 116 AKVG-QGTYSNVYKARDRDTGKIVALKKVRFDTS-----------EPESVKFMAREIRILQKLDHPNV--IKLEGLATSR 181 (469)
Q Consensus 116 ~~lG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~ 181 (469)
..|| .|+.|+||.+... +..++||.+..... .......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4588 8999999999775 77899998753210 11223567889999999998875 6666654433
Q ss_pred cc--cEEEEEEecchh--hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecC
Q 036673 182 MQ--YSLYLVFDFMQS--DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL 257 (469)
Q Consensus 182 ~~--~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGl 257 (469)
.. +..+||||+++| ++...+.. ..+++.. +.+|+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 22 223699999997 44444432 3455543 57899999999999999999999999999999999999999
Q ss_pred ccc
Q 036673 258 SNF 260 (469)
Q Consensus 258 a~~ 260 (469)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-16 Score=137.04 Aligned_cols=132 Identities=22% Similarity=0.272 Sum_probs=108.1
Q ss_pred eeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC--CCeeeEeeeEeeccccEEEEEEe
Q 036673 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH--PNVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~~lv~e 191 (469)
+++.||.|.++.||++... +..++||....... ...+.+|+.++..+.| .++++++.+.... ...+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEE
Confidence 3567999999999999986 47899998864432 3567889999999976 5888887766553 34699999
Q ss_pred cchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 192 FMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER---GILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 192 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
|+.+..+..+ +......++.+++.+|++||.. +++|+||+|.|||++..+.++++|||++..
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9998544322 5677788899999999999985 699999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.9e-16 Score=158.40 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=194.3
Q ss_pred cCcceeceeee--eCCeEEEEEEE--CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecccc
Q 036673 110 DSYDKLAKVGQ--GTYSNVYKARD--RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 184 (469)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+.....+.....-.+|+.....+ .|+|.++.+..+.. ..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CC
Confidence 45677788999 99999999999 88899999998544333222223334677777777 69999997665555 44
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCcEEEcCC-CcEEEeeecCcc
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLS----GLQHCHERGILHRDIKASNLLIDKS-GMLKIADFGLSN 259 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~ 259 (469)
.+|+-+|+|...+..........++...++.++.+... ||.++|+.+|+|-|+||.||++..+ ...+++|||+..
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 57999999999888888777777999999999999999 9999999999999999999999999 889999999998
Q ss_pred cccCCCCCC----cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCC
Q 036673 260 FFIPKQKGP----LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR--TEVEQLHRIFKLCGTPS 333 (469)
Q Consensus 260 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~--~~~~~~~~i~~~~~~~~ 333 (469)
.+....-.. .....+...|++||+..+ -++...|+|+||.++.+..++..++... +...++..++ .+
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----ip 344 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----IP 344 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----Cc
Confidence 775443211 122256788999997754 4789999999999999998886555332 2222221111 01
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
. ++....+.++...+..||..||..|++++.+++|++...
T Consensus 345 ~----------------------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 345 L----------------------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred h----------------------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 1 222344566677899999999999999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.8e-16 Score=165.12 Aligned_cols=264 Identities=22% Similarity=0.262 Sum_probs=193.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..+.+.+.+-+-.|.++.++.+.-..+|...++|+..... ......+....+-.++-...+|-+++..- .......+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~--s~~~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFP--SFPCRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccC--CCCCCCCc
Confidence 5577888889999999999999888888777777654321 11111233334444444445677776532 22223346
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC--
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP-- 263 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~-- 263 (469)
+|+++|+++ ++...+.. ....+.+-++.++..+..+++|||...+.|+|++|.|+|+..++..+++|||+.....-
T Consensus 880 ~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred chhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 899999987 44444443 34688888999999999999999999999999999999999999999999984432110
Q ss_pred ----C----C--------------------CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCC
Q 036673 264 ----K----Q--------------------KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPG 315 (469)
Q Consensus 264 ----~----~--------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 315 (469)
. . ........+|+.|.+||.+++.. ....+|+|++|++++|.++|.+||..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0 00122456799999999888754 68889999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHH---HHhcCcc
Q 036673 316 RTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAA---SALQNEF 392 (469)
Q Consensus 316 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~---elL~hp~ 392 (469)
......+..|.+.. ..+.......+.++.+++..+|..+|.+|..+. ++-.|+|
T Consensus 1038 ~tpq~~f~ni~~~~-----------------------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRD-----------------------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred cchhhhhhccccCC-----------------------CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCc
Confidence 88877665554321 111233445788899999999999999999987 9999999
Q ss_pred CCCCCC
Q 036673 393 FNASPL 398 (469)
Q Consensus 393 f~~~~~ 398 (469)
|+..+.
T Consensus 1095 ~~~~~~ 1100 (1205)
T KOG0606|consen 1095 FQDVDW 1100 (1205)
T ss_pred cCCCCc
Confidence 997544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-13 Score=124.46 Aligned_cols=138 Identities=20% Similarity=0.242 Sum_probs=99.7
Q ss_pred ceeeeeCCeEEEEEEECC------CCcEEEEEEeecCCC-----------C---------HHHHHHHH----HHHHHHHh
Q 036673 116 AKVGQGTYSNVYKARDRD------TGKIVALKKVRFDTS-----------E---------PESVKFMA----REIRILQK 165 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~-----------~---------~~~~~~~~----~E~~~l~~ 165 (469)
..||.|--+.||.|.... .+..+|||+.+.... . ....+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 459999999999998654 257999998753210 0 11123333 89999999
Q ss_pred CCC--CCeeeEeeeEeeccccEEEEEEecchhhHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCc
Q 036673 166 LDH--PNVIKLEGLATSRMQYSLYLVFDFMQSDLT-KIICRPGQKLTEPQVKCYMQQLLSGLQHC-HERGILHRDIKASN 241 (469)
Q Consensus 166 l~h--pnIv~~~~~~~~~~~~~~~lv~e~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivHrDlkp~N 241 (469)
+.. -++..++++ . . -+|||||++++.+ ..... ...+++.++..+..+++.+|..| |..||||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~--~--~--~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL--K--K--HVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe--c--C--CEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 843 455666543 2 2 2899999987422 11111 22466677788899999999999 89999999999999
Q ss_pred EEEcCCCcEEEeeecCcccc
Q 036673 242 LLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 242 ILl~~~~~~kl~DFGla~~~ 261 (469)
||+. ++.+.|+|||.+...
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9997 478999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-13 Score=140.83 Aligned_cols=141 Identities=21% Similarity=0.256 Sum_probs=91.8
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH----------------------------HHH----------HHHH
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP----------------------------ESV----------KFMA 157 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------~~~----------~~~~ 157 (469)
+.||.|++|+||+|+.+ +|+.||||+.+...... ... -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999987 48999999986532100 000 0234
Q ss_pred HHHHHHHhC----CCCCeeeEeeeEeeccccEEEEEEecchhhHHHHHh-cCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 036673 158 REIRILQKL----DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIIC-RPGQKLTEPQVKCYMQQLLS-GLQHCHERG 231 (469)
Q Consensus 158 ~E~~~l~~l----~hpnIv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~-aL~~LH~~~ 231 (469)
+|+..+.++ .|.+-+.+-.++..... ..+|||||++|..+..+. .....+ ....++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~-~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTS-ERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcC-CceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 455555554 22222222222222111 238999999984433222 111112 23445566655 578899999
Q ss_pred ceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 232 ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
++|+|++|.||+++.++.++|+|||++..+
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.3e-13 Score=134.82 Aligned_cols=167 Identities=23% Similarity=0.373 Sum_probs=126.3
Q ss_pred EEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh--hHHHHHhcCC
Q 036673 128 KARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS--DLTKIICRPG 205 (469)
Q Consensus 128 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~ 205 (469)
.|..+.++.+|.|.+.+.... +......+-++-|+.|+||||+++++.+.... ++|||+|.+.- ..+..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV~Pl~~~lk~----- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERVRPLETVLKE----- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeeccccHHHHHHH-----
Confidence 466677788999998865443 44466778899999999999999988776644 68999999874 22322
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCccccchhc
Q 036673 206 QKLTEPQVKCYMQQLLSGLQHCH-ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284 (469)
Q Consensus 206 ~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 284 (469)
+....+...+.||+.||.||| ..+++|++|.-..|+|+..|..||++|.++........ +......--.|..|+.+
T Consensus 101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI 177 (690)
T ss_pred --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence 347778888999999999998 66899999999999999999999999998865322111 11222223456777754
Q ss_pred cCCCCCCccccchhhHHHHHHHHhC
Q 036673 285 LGSTDYGVGIDLWSAGCLLAEMFIG 309 (469)
Q Consensus 285 ~~~~~~~~~~DvwslGv~l~elltg 309 (469)
... ....|.|.|||++++++.|
T Consensus 178 ~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Ccc---ccchhhhhHHHHHHHHhCc
Confidence 321 2457999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.9e-13 Score=120.48 Aligned_cols=128 Identities=15% Similarity=0.161 Sum_probs=94.0
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee-eEeeeEeeccccEEEEEEecc
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI-KLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~~~lv~e~~ 193 (469)
++.|+.|.++.||+++.. +..|+||+...... ....+.+|+.++..+.+.+++ +++.+.. .. .++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CC--CeEEEEec
Confidence 356899999999999875 78899998754321 113456899999998655544 4543322 22 27999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI-----LHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i-----vHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
+|..+... ......++.+++.+|+.||..++ +|+|++|.|||++ ++.++|+|||.+..
T Consensus 74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98543321 11123457899999999999885 9999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.3e-14 Score=144.45 Aligned_cols=145 Identities=21% Similarity=0.285 Sum_probs=93.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC----------------------------H----HHHHH-
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE----------------------------P----ESVKF- 155 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------~----~~~~~- 155 (469)
...|+. +.||.|++|+||+|+.+++|+.||||+++..... . +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 7899999999999999988999999999754210 0 11122
Q ss_pred -----HHHHHHHHHhC----CCCCeeeEeeeEeeccccEEEEEEecchhhHHHHH---hcCCC---CCCHHHHHHHHHHH
Q 036673 156 -----MAREIRILQKL----DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKII---CRPGQ---KLTEPQVKCYMQQL 220 (469)
Q Consensus 156 -----~~~E~~~l~~l----~hpnIv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~---~l~~~~~~~i~~qi 220 (469)
+.+|+..+.++ .+.+.+.+=.++.+-. ...+|||||+.|.-+..+ ...+. .+.+..+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 33344444444 2333333222222211 123899999998433322 22221 24444455555555
Q ss_pred HHHHHHHHhCCceeccCCCCcEEEcCCC----cEEEeeecCccccc
Q 036673 221 LSGLQHCHERGILHRDIKASNLLIDKSG----MLKIADFGLSNFFI 262 (469)
Q Consensus 221 ~~aL~~LH~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~ 262 (469)
+ ..|++|+|+||.||+++.++ .++++|||++..+.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4 58999999999999999988 99999999997763
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.1e-14 Score=134.40 Aligned_cols=237 Identities=21% Similarity=0.254 Sum_probs=153.2
Q ss_pred EEEEEEECCCCcEEEEEEeecC-----CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc---ccEEEEEEecchh-
Q 036673 125 NVYKARDRDTGKIVALKKVRFD-----TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM---QYSLYLVFDFMQS- 195 (469)
Q Consensus 125 ~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~lv~e~~~~- 195 (469)
.||++.+...|..|+.-.+... ..+++..+ .-..-|-.+.|-|||+++.|+.+.. .....++.|||..
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~---~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssg 157 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRR---AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSG 157 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHH---HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccch
Confidence 5677777777766665443221 12222222 2234455567999999988876543 2356889999985
Q ss_pred hHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcEEEcCCCcEEEeeecCcccccC---CCCC
Q 036673 196 DLTKII---CRPGQKLTEPQVKCYMQQLLSGLQHCHER--GILHRDIKASNLLIDKSGMLKIADFGLSNFFIP---KQKG 267 (469)
Q Consensus 196 ~l~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~~~~ 267 (469)
.+.+.+ ......+....+.+|+-||+.||.|||+. -|+|+++....|++..+|-+||.--........ ....
T Consensus 158 s~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~ 237 (458)
T KOG1266|consen 158 SLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREA 237 (458)
T ss_pred hHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHh
Confidence 444433 33455689999999999999999999987 599999999999999999998863221111000 0000
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPL-MPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+-++|.|||.= .....+.++|||+||....+|..+..- -...+..+.-..+.+.....
T Consensus 238 Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l-------------- 302 (458)
T KOG1266|consen 238 EKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL-------------- 302 (458)
T ss_pred hhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec--------------
Confidence 11233457889999943 334567889999999999999876532 22222222211221111000
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
-..--+++|.+||+-.|..||++.++|.||.+-
T Consensus 303 ---------------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 303 ---------------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred ---------------cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 011123579999999999999999999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.7e-13 Score=138.48 Aligned_cols=252 Identities=21% Similarity=0.204 Sum_probs=176.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC-CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR-DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
..+|..+..||.|.|+.|+..... .++..|++|.+............-..|+-+...+ .|.+++.+...+..-.+ .
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--G 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--c
Confidence 356888999999999999998765 6788999998865543333223334566666666 68888886554443222 4
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC-CcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS-GMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~ 265 (469)
|+-.|||.+.....-..-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +.-++.|||.+..+.-.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 7889999874433332222358888999999999999999999999999999999999886 78899999998643111
Q ss_pred CCCcccccccCccc-cchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYR-APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......-++. .+|++.....+..++|++|||.-+.+.+++.+.-........ |.. ..
T Consensus 421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~~---------------~~ 479 (524)
T KOG0601|consen 421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IRS---------------GD 479 (524)
T ss_pred ---cccccccccccccchhhccccccccccccccccccccccccCcccCccccccee---eec---------------cc
Confidence 11223334455 366666666788999999999999999998754322111110 000 00
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
. ...+.....+..+.+.++..|+..|+.+.++..|.=|..
T Consensus 480 ~-----------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 480 T-----------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred c-----------cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0 011122356677899999999999999999999877654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.9e-11 Score=105.18 Aligned_cols=143 Identities=19% Similarity=0.259 Sum_probs=102.4
Q ss_pred eeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC------CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT------SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.+..|-+|+-+.|+++.+. |+.+.||.-.... ...-......+|+.+|.++.--.|.--.=++.+.... .
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~--~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG--Q 86 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC--e
Confidence 4567889999999999887 8888888532211 1122335677899999988543432222244443333 7
Q ss_pred EEEecchh--hHHHHHhcCCCCCCHHH-HHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC---cEEEeeecCccc
Q 036673 188 LVFDFMQS--DLTKIICRPGQKLTEPQ-VKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG---MLKIADFGLSNF 260 (469)
Q Consensus 188 lv~e~~~~--~l~~~~~~~~~~l~~~~-~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 260 (469)
|+|||++| .+.+.+......-.++. ...++++|-+.+.-||.++|+|+||..+||||..++ ++.++|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999998 56665554333333333 378999999999999999999999999999997765 468999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.6e-11 Score=106.01 Aligned_cols=132 Identities=21% Similarity=0.268 Sum_probs=93.4
Q ss_pred eeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCH-----HHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEP-----ESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
.|++|+-+.+|.+.+. |..+++|.=... -..+ -......+|+.+|.++.--.|..-.=++.++... .|+|
T Consensus 3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~--~I~m 78 (204)
T COG3642 3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG--LIVM 78 (204)
T ss_pred hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC--EEEE
Confidence 4789999999999775 555666643211 1111 1224566899999988544433222234444333 7999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
||++|.++....... ...+++.+-.-+.-||..||+|+||.++||++..++ +.++||||+.+
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999997777544322 256778888889999999999999999999998765 99999999974
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.8e-10 Score=112.25 Aligned_cols=215 Identities=19% Similarity=0.245 Sum_probs=152.9
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEee--ccccEEEEEEecchh--hH
Q 036673 122 TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATS--RMQYSLYLVFDFMQS--DL 197 (469)
Q Consensus 122 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~~~lv~e~~~~--~l 197 (469)
--.+.|++....+|..|++|.+.......- .....-+++++++.|+|||++.+++.. -....+++||+|.++ .|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 346789999999999999999943321111 122346888999999999999988753 335568999999996 55
Q ss_pred HHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 198 TKIICR--------------PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 198 ~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+.... .+...++..++.++.||..||.++|+.|+.-+-|.|.+||++.+..++|+.-|....+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 554422 223478999999999999999999999999999999999999998999987777766533
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPL-MPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
+. .+| +.. -.+-|.=.||.+++.|.||..- +.........
T Consensus 446 d~-------------~~~--le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~-------------------- 486 (655)
T KOG3741|consen 446 DP-------------TEP--LES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH-------------------- 486 (655)
T ss_pred CC-------------Ccc--hhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHH--------------------
Confidence 32 111 221 2345888999999999999632 1111111110
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
+..+...++.+++++|..+...++.+ -++.++|.+
T Consensus 487 ------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 ------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 11223356777888888888888876 677777665
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.7e-11 Score=109.07 Aligned_cols=142 Identities=18% Similarity=0.268 Sum_probs=102.8
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC--CeeeEeeeEeecc-ccEEEEEEec
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP--NVIKLEGLATSRM-QYSLYLVFDF 192 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~-~~~~~lv~e~ 192 (469)
+.|+.|.++.||++...+ |..+++|+....... .....+.+|++++..+.+. ++.+++.+..... ....++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 458999999999998754 688999987643321 1235678999999999653 4566765544321 1235899999
Q ss_pred chhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 036673 193 MQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE------------------------------------------- 229 (469)
Q Consensus 193 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~------------------------------------------- 229 (469)
++|..+...... ..+++.+...++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998544332211 346777777788888888888874
Q ss_pred -------------CCceeccCCCCcEEEcC--CCcEEEeeecCccc
Q 036673 230 -------------RGILHRDIKASNLLIDK--SGMLKIADFGLSNF 260 (469)
Q Consensus 230 -------------~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 260 (469)
..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-11 Score=126.38 Aligned_cols=158 Identities=23% Similarity=0.288 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC--------cccccccCccccchhccCCC
Q 036673 218 QQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP--------LTSRVVTLWYRAPELLLGST 288 (469)
Q Consensus 218 ~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~ 288 (469)
.+++.||.|+|.. ++||+.|.|++|.++..+.+||+.|+++....+....+ .........|.|||++.. .
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 3444999999965 89999999999999999999999999886543321111 111223677999998876 5
Q ss_pred CCCccccchhhHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHH
Q 036673 289 DYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSY 367 (469)
Q Consensus 289 ~~~~~~DvwslGv~l~ell-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (469)
..+.++|+|||||++|.+. .|++.|...........-.... .........++|.+++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~----------------------~~~~~~~s~~~p~el~ 242 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL----------------------NAGAFGYSNNLPSELR 242 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc----------------------ccccccccccCcHHHH
Confidence 6789999999999999999 6777666544332222111110 0111122257899999
Q ss_pred HHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 368 GILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 368 ~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
+=|.++|..|+..||++.+++..|||.....
T Consensus 243 ~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 243 ESLKKLLNGDSAVRPTLDLLLSIPFFSDPGL 273 (700)
T ss_pred HHHHHHhcCCcccCcchhhhhcccccCCchh
Confidence 9999999999999999999999999997543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.6e-10 Score=103.99 Aligned_cols=127 Identities=26% Similarity=0.345 Sum_probs=84.2
Q ss_pred EEEEEEECCCCcEEEEEEeecCC------------------------CCHHHHHHHHHHHHHHHhCCCC--CeeeEeeeE
Q 036673 125 NVYKARDRDTGKIVALKKVRFDT------------------------SEPESVKFMAREIRILQKLDHP--NVIKLEGLA 178 (469)
Q Consensus 125 ~Vy~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~ 178 (469)
.||.|...+ |..+|||+.+... ...-......+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 389998865 8899999875421 0011224567899999999765 45666543
Q ss_pred eeccccEEEEEEecch--hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 179 TSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH-CHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 179 ~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
.. . +|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+||
T Consensus 79 -~~--~--~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 79 -NR--N--VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp -ET--T--EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred -eC--C--EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 22 2 79999999 74444443321 2355677888888886555 579999999999999999887 9999999
Q ss_pred cCcccc
Q 036673 256 GLSNFF 261 (469)
Q Consensus 256 Gla~~~ 261 (469)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.1e-09 Score=100.48 Aligned_cols=134 Identities=16% Similarity=0.129 Sum_probs=91.8
Q ss_pred eEEEEEEECCCCcEEEEEEeecCCCCHHHH----------HHHHHHHHHHHhCCCCCee--eEeeeEeecc---ccEEEE
Q 036673 124 SNVYKARDRDTGKIVALKKVRFDTSEPESV----------KFMAREIRILQKLDHPNVI--KLEGLATSRM---QYSLYL 188 (469)
Q Consensus 124 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----------~~~~~E~~~l~~l~hpnIv--~~~~~~~~~~---~~~~~l 188 (469)
..|++.... |+.|.||........ +.. ..+.+|...+..|..-+|. .++.+..... ....+|
T Consensus 36 rrvvr~~~~--g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFELA--GKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEEEC--CEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 346666553 778999966322211 111 1367888888888433332 3333443221 234589
Q ss_pred EEecchh--hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-------CCcEEEeeecCc
Q 036673 189 VFDFMQS--DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-------SGMLKIADFGLS 258 (469)
Q Consensus 189 v~e~~~~--~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-------~~~~kl~DFGla 258 (469)
|+|++++ ++.+.+... ....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9999998 455554321 234667788899999999999999999999999999999975 468999999988
Q ss_pred cc
Q 036673 259 NF 260 (469)
Q Consensus 259 ~~ 260 (469)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-09 Score=101.54 Aligned_cols=137 Identities=24% Similarity=0.293 Sum_probs=101.7
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC--------------------CHHHHHHHHHHHHHHHhCCCC--
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS--------------------EPESVKFMAREIRILQKLDHP-- 169 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~~~~~E~~~l~~l~hp-- 169 (469)
+.+..+||.|--|.||.|.+.. |..+|||.-+.... ..-......+|.++|..|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 5667889999999999999885 89999997543210 011234567899999999544
Q ss_pred CeeeEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc
Q 036673 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM 249 (469)
Q Consensus 170 nIv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~ 249 (469)
.|.+.+++- .-++||||++|-.+..+ ++.......++..|+.-+.-+-..||||+|+.+-|||++++|.
T Consensus 172 ~VP~P~~~n------RHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAWN------RHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCccccc------cceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 677765532 23899999999554432 2245556666677777666666899999999999999999999
Q ss_pred EEEeeecCccc
Q 036673 250 LKIADFGLSNF 260 (469)
Q Consensus 250 ~kl~DFGla~~ 260 (469)
+.|+||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.6e-08 Score=98.46 Aligned_cols=250 Identities=14% Similarity=0.119 Sum_probs=149.9
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEee----eEee-ccccEEEE
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEG----LATS-RMQYSLYL 188 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~----~~~~-~~~~~~~l 188 (469)
...||+|+-+.+|..-.-. ..+.|++........ . +-+..|... .||-+-.=+. .... .....+-+
T Consensus 16 gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CccccCCccceeeecchhh---chhheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 4569999999999764432 245577654322111 1 123333333 5664432110 0111 12223567
Q ss_pred EEecchhh-HHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 189 VFDFMQSD-LTKIICRP------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 189 v~e~~~~~-l~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
+|..+.|. -...+... -....|+.+....+.|+.+.+.||+.|-+-+|+.++|+|+.+++.+.|.|=..-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 88888862 22222221 123778999999999999999999999999999999999999999999975543322
Q ss_pred cCCCCCCcccccccCccccchhcc-C---CCCCCccccchhhHHHHHHHHhC-CCCCCCCChH-----HHHHHHHHHhCC
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLL-G---STDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEV-----EQLHRIFKLCGT 331 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~-~---~~~~~~~~DvwslGv~l~elltg-~~pf~~~~~~-----~~~~~i~~~~~~ 331 (469)
.........+|.+.|.+||.-. + .-.-+...|.|.|||++++||.| +.||.+-... ..-..|......
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 2233345668899999999532 1 11235678999999999999987 8999763210 000011111000
Q ss_pred CCHHHHhhcccCccCCCCCCCCc-chhcccCCChhHHHHHHHcccc--CCCCCCCHH
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPS-FREVFGEFPPSSYGILTTLLAL--DPAYRGTAA 385 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~--dP~~Rpta~ 385 (469)
.. -+ ....+.+. ..--+.-+++++..|..+|++. ++.-|||++
T Consensus 246 ya------~~-----~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 246 YA------SD-----QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred ec------hh-----ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 00 00 01111111 1112345678889999999974 366899976
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.5e-08 Score=89.48 Aligned_cols=140 Identities=14% Similarity=0.198 Sum_probs=102.4
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecC---CCC-HHHHHHHHHHHHHHHhCCCCC--eeeEeeeE---eeccccEEEE
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFD---TSE-PESVKFMAREIRILQKLDHPN--VIKLEGLA---TSRMQYSLYL 188 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~-~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~---~~~~~~~~~l 188 (469)
-|.||-+.|+..... |+.+-+|.-... ... +-....|.+|+..|..|..-+ +.++. ++ .....+.-+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 467999999998765 457888865311 000 223467889999999984322 34443 22 2233455689
Q ss_pred EEecchh--hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc--EEEeeecCccc
Q 036673 189 VFDFMQS--DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM--LKIADFGLSNF 260 (469)
Q Consensus 189 v~e~~~~--~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~ 260 (469)
|+|-++| +|.+++... -.+.+......++.+++..+.-||+.|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9999985 666665442 235678888899999999999999999999999999999987777 99999987754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.4e-08 Score=90.88 Aligned_cols=106 Identities=25% Similarity=0.375 Sum_probs=79.4
Q ss_pred HHHHHHHHHHHhCCCCC--eeeEeeeEeecc--ccEEEEEEecchh--hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 036673 154 KFMAREIRILQKLDHPN--VIKLEGLATSRM--QYSLYLVFDFMQS--DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227 (469)
Q Consensus 154 ~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~--~~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (469)
....+|...+..|..-. +++.+.+..... ....+||+|++++ ++...+.... .++......++.+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHH
Confidence 45677888887774333 334444444322 2345899999997 4555444322 367788899999999999999
Q ss_pred HhCCceeccCCCCcEEEcCCC---cEEEeeecCccc
Q 036673 228 HERGILHRDIKASNLLIDKSG---MLKIADFGLSNF 260 (469)
Q Consensus 228 H~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 260 (469)
|++||+|+|+++.|||++.++ .+.|+||+.+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.2e-07 Score=87.30 Aligned_cols=137 Identities=22% Similarity=0.265 Sum_probs=94.9
Q ss_pred eeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH--------------------HHHH--HHHHHHHHHHhCC--CCCee
Q 036673 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP--------------------ESVK--FMAREIRILQKLD--HPNVI 172 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~--~~~~E~~~l~~l~--hpnIv 172 (469)
.|..|--+.||+|... ++..+|||+++...... .... -...|+.-|.++. +=.+.
T Consensus 55 ~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 5677888899999774 48999999986532211 1111 1235777777773 33444
Q ss_pred eEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEE
Q 036673 173 KLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLK 251 (469)
Q Consensus 173 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~k 251 (469)
+-+.+.. -.|||||++....-.-.-...++...++..+..++++.+.-|-. .++||+||+.-|||+. ++.+.
T Consensus 134 ~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 134 EPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 5544332 28999999865211111112234555788889999999998887 8999999999999999 88999
Q ss_pred EeeecCcccc
Q 036673 252 IADFGLSNFF 261 (469)
Q Consensus 252 l~DFGla~~~ 261 (469)
|+|||-|...
T Consensus 207 iID~~QaV~~ 216 (268)
T COG1718 207 IIDVSQAVTI 216 (268)
T ss_pred EEECcccccc
Confidence 9999988654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=8.4e-09 Score=105.21 Aligned_cols=248 Identities=17% Similarity=0.147 Sum_probs=167.6
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC-eeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN-VIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~~~l 188 (469)
.-|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++ ....+.+.++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~--d~~~E~~~~i 311 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE--DYDGEDYLWI 311 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc--cCCcccccch
Confidence 34666778999999999999887755544 7766432 23345899999999999 444433 3334556799
Q ss_pred EEecchhh--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQSD--LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~~--l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+++++.++ ...........+.+-+...+.+.-+++|++||+.-=+|+| |||..+ +..+..||+....+....
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence 99999865 2222222222355556677777888999999998778999 877655 689999999998774433
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
...+..+++.++|||+.... .+..+.|+|++|+-..+|.-|-+|-... ..... ..+..+.
T Consensus 386 -~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~----~~g~~p~------------ 445 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLP----MIGNGPN------------ 445 (829)
T ss_pred -ccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCC--ccccC----CCCCCCC------------
Confidence 35577889999999987664 4788999999999877887777665431 00000 0111110
Q ss_pred CCCCCCCcchhcccCCChhH-HHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSS-YGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l-~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
.+.+..- ...++.. .++...||...|..|+++..++.|.+|+.-++.
T Consensus 446 -----s~~L~~~-~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 446 -----SPMLTDK-SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred -----ccccchh-hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCccc
Confidence 0000000 0000111 146788999999999999999999999976543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.1e-06 Score=80.06 Aligned_cols=141 Identities=19% Similarity=0.266 Sum_probs=88.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHH-HH------HHHHHHHHHHhCC---CCCeeeEeeeE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPES-VK------FMAREIRILQKLD---HPNVIKLEGLA 178 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~------~~~~E~~~l~~l~---hpnIv~~~~~~ 178 (469)
.++|.+.+.+-......|.+.... |..+++|..+......+. .. ...+++..+..+. .-.++.++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 367888888988888888887664 789999987653222111 01 1223344344442 22333322222
Q ss_pred eecc---ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 179 TSRM---QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 179 ~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
.-.. ....+|+|||++|-.+..+. .+++ .+...|..++.-||+.|++|+|..|.|+++++++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 1111 12246899999994332221 1333 2446677889999999999999999999998655 999999
Q ss_pred cCccc
Q 036673 256 GLSNF 260 (469)
Q Consensus 256 Gla~~ 260 (469)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.2e-07 Score=94.81 Aligned_cols=140 Identities=21% Similarity=0.309 Sum_probs=86.1
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC----------------------------HHHH----H------HHH
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE----------------------------PESV----K------FMA 157 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------~~~~----~------~~~ 157 (469)
..|+.++-|+||+|+.++ |+.||||+.+..-.. .+.. + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 569999999999999986 999999997643110 0111 1 123
Q ss_pred HHHHHHHhC-----CCCCe--eeEeeeEeeccccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 036673 158 REIRILQKL-----DHPNV--IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229 (469)
Q Consensus 158 ~E~~~l~~l-----~hpnI--v~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (469)
+|..-+.++ +.++| .++ |...... -+|+|||++| .+.+........++...+...+.++ -+..+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V--~we~t~~--~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKV--YWEYTTR--RVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEecee--ehhccCC--cEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHh
Confidence 444444444 23443 223 2221222 2899999998 3322221111234533333222222 2333345
Q ss_pred CCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 230 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
.|++|.|..|.||+++.+|.+.+.|||+...+.
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 899999999999999999999999999987664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.4e-06 Score=81.28 Aligned_cols=140 Identities=20% Similarity=0.324 Sum_probs=80.6
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC--CeeeEeeeEeec-cccEEEEEEe
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP--NVIKLEGLATSR-MQYSLYLVFD 191 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~-~~~~~~lv~e 191 (469)
++.|+.|..+.||++...+ ..+++|+.... .....+.+|..+++.|... .+.+++.+.... .....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 4679999999999998874 58999987432 3456778899999888433 345665544332 2334689999
Q ss_pred cchhhHHHH--------------------HhcC---CCCCCHHH---------HHHH------------HHHHHH-HHHH
Q 036673 192 FMQSDLTKI--------------------ICRP---GQKLTEPQ---------VKCY------------MQQLLS-GLQH 226 (469)
Q Consensus 192 ~~~~~l~~~--------------------~~~~---~~~l~~~~---------~~~i------------~~qi~~-aL~~ 226 (469)
+++|..+.. +... ...+.... .... ...+.. .++.
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998732222 1111 01111100 0000 111222 3334
Q ss_pred HHh-------CCceeccCCCCcEEEc-CCCcEEEeeecCccc
Q 036673 227 CHE-------RGILHRDIKASNLLID-KSGMLKIADFGLSNF 260 (469)
Q Consensus 227 LH~-------~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 260 (469)
+++ ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 432 3599999999999999 666678999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.1e-06 Score=80.13 Aligned_cols=134 Identities=16% Similarity=0.147 Sum_probs=78.3
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN--VIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
..||.|..+.||+. .+..+++|....... ...+.+|.+++..+..-. +.+.+++....+ ...+|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD----KETIKREFDASRKVFSLGIPTPHPFDLVEDGG--RLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCC----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--eeeeeeeec
Confidence 45899999999984 144678898754321 234678999998885433 345555554433 357899999
Q ss_pred hhhH-HH---------------H-------HhcCC-CCCCHHH-HHHHHH----------HHHH-HHHHHHh----CCce
Q 036673 194 QSDL-TK---------------I-------ICRPG-QKLTEPQ-VKCYMQ----------QLLS-GLQHCHE----RGIL 233 (469)
Q Consensus 194 ~~~l-~~---------------~-------~~~~~-~~l~~~~-~~~i~~----------qi~~-aL~~LH~----~~iv 233 (469)
+|.. .. . ++.-. ....... ...+.. .+.. ...+|.. ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9841 10 0 11100 0111111 011100 0111 1222221 2478
Q ss_pred eccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 234 HRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 234 HrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.5e-06 Score=74.48 Aligned_cols=129 Identities=22% Similarity=0.266 Sum_probs=90.6
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee-eEeeeEeeccccEEEEEE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI-KLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~~~lv~ 190 (469)
-++.+.||+|++|.||++.+. |..+|+|+-+.+. ....+..|+++|..+.--++. +++.| ... ++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~y--g~~----~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFY--GED----FIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEe--chh----hhhh
Confidence 455678999999999999987 6799999875432 236688999999999776664 44332 222 5779
Q ss_pred ecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CCcEEEcCCCcEEEeeecCccc
Q 036673 191 DFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIK-ASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 191 e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk-p~NILl~~~~~~kl~DFGla~~ 260 (469)
||+.| .|..+... .+ +.-+..+++.---|-..||-|..|. |..++|..++.+.|+||.-|+.
T Consensus 92 e~i~G~~L~~~~~~----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 92 EYIDGRPLGKLEIG----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcCcchhhhhhc----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99999 44433321 11 2334556666566677899999986 5545555555999999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.7e-06 Score=94.18 Aligned_cols=204 Identities=20% Similarity=0.201 Sum_probs=136.4
Q ss_pred HHHHHHHHHHHhCCCCCeeeEeeeEeeccccE--EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 036673 154 KFMAREIRILQKLDHPNVIKLEGLATSRMQYS--LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231 (469)
Q Consensus 154 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~--~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (469)
.....|+..+..+.|+|++.++.|-....... +.+..++|....+..+...-..++....+.+..+++.||.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34456777888889999999977665433221 2234566665333333444457899999999999999999999996
Q ss_pred ceeccCCCC---cEEEcCCCcEEEe--eecCcccccCCCCCCcccccccCccccchhccCCCCCC--ccccchhhHHHHH
Q 036673 232 ILHRDIKAS---NLLIDKSGMLKIA--DFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG--VGIDLWSAGCLLA 304 (469)
Q Consensus 232 ivHrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DvwslGv~l~ 304 (469)
..|.-|..+ +-..+..+.+.++ ||+....+..... ......+..+.+||.... ..+. ...|+|.+|.++.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCcccccccccccc-ccchhhhhhHHHHHHHHHh
Confidence 666655555 4444566677777 9988876633322 234445667888886643 2233 3369999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCC-hhHHHHHHHccccCCCCCCC
Q 036673 305 EMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFP-PSSYGILTTLLALDPAYRGT 383 (469)
Q Consensus 305 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~~L~~dP~~Rpt 383 (469)
.+..|..+-.... ... .+.+..+ ....+++.+|+.-|+++|++
T Consensus 384 ~~~~~~~i~~~~~---~~~---------------------------------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 384 QLSQGEDISEKSA---VPV---------------------------------SLLDVLSTSELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred hhhhcCccccccc---chh---------------------------------hhhccccchhhhhhhhhhcchhhhhccc
Confidence 9998764321100 000 1111111 15667899999999999999
Q ss_pred HHHHhcCccCCCC
Q 036673 384 AASALQNEFFNAS 396 (469)
Q Consensus 384 a~elL~hp~f~~~ 396 (469)
+.++|.|+|.+..
T Consensus 428 ~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 428 ALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhhchhcccc
Confidence 9999999998753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.4e-06 Score=77.40 Aligned_cols=134 Identities=13% Similarity=0.102 Sum_probs=77.7
Q ss_pred eeeeCC-eEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEEEEEecchh
Q 036673 118 VGQGTY-SNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYLVFDFMQS 195 (469)
Q Consensus 118 lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 195 (469)
|-.|.+ ..||+.... +..+.||+..... ...+.+|+.+++.+. +--+.+++++.... ..-++||++++|
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCC
Confidence 444555 789999654 4678888875332 234667999988883 34455676655443 234899999988
Q ss_pred hHHHHH--------------------hcC---CCCCCHH--HHHHHHH--------------------HHHHHHHHHH--
Q 036673 196 DLTKII--------------------CRP---GQKLTEP--QVKCYMQ--------------------QLLSGLQHCH-- 228 (469)
Q Consensus 196 ~l~~~~--------------------~~~---~~~l~~~--~~~~i~~--------------------qi~~aL~~LH-- 228 (469)
..+... +.- ..++... ....... .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 432211 110 0011100 0000000 0111122221
Q ss_pred -----hCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 229 -----ERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 229 -----~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12489999999999999987789999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.5e-06 Score=84.96 Aligned_cols=137 Identities=16% Similarity=0.236 Sum_probs=86.7
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-----------------------------HHHHHH------HHHHH
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-----------------------------PESVKF------MAREI 160 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------------------------~~~~~~------~~~E~ 160 (469)
+.||.-+.|+||+|+.++ |+.||||+-+..... .+..+. |.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999987 999999986542111 011122 22333
Q ss_pred HHHHh----CCCCC------eeeEeeeEeeccccEEEEEEecchh---hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 036673 161 RILQK----LDHPN------VIKLEGLATSRMQYSLYLVFDFMQS---DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227 (469)
Q Consensus 161 ~~l~~----l~hpn------Iv~~~~~~~~~~~~~~~lv~e~~~~---~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (469)
+-..+ +.|-+ |.+++-.+.. .-+|+||||+| +.++.+.+. .++...+...+.++.. .-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~--~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYL--EQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHH--HHH
Confidence 32222 23445 4444322222 23899999998 334444443 3666654444433322 223
Q ss_pred HhCCceeccCCCCcEEEcC----CCcEEEeeecCcccc
Q 036673 228 HERGILHRDIKASNLLIDK----SGMLKIADFGLSNFF 261 (469)
Q Consensus 228 H~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~~~ 261 (469)
-..|++|+|-.|.|||++. ++.+.+-|||+...+
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 3568999999999999984 568999999999865
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.1e-05 Score=71.03 Aligned_cols=130 Identities=28% Similarity=0.350 Sum_probs=92.6
Q ss_pred ccCcceeceeeeeCC-eEEEEEEECCCCcEEEEEEeec---CC--------CCH--------HHHHHHHHHHHHHHhC--
Q 036673 109 ADSYDKLAKVGQGTY-SNVYKARDRDTGKIVALKKVRF---DT--------SEP--------ESVKFMAREIRILQKL-- 166 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~---~~--------~~~--------~~~~~~~~E~~~l~~l-- 166 (469)
..+++.++.||.|.- |.||+++.. |+.||||+++. .. ... ....-|..|..+..+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 999999887 78999999322 10 000 1224577888888877
Q ss_pred -CCCCe--eeEeeeEeecc----------------ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 036673 167 -DHPNV--IKLEGLATSRM----------------QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227 (469)
Q Consensus 167 -~hpnI--v~~~~~~~~~~----------------~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (469)
.+.++ |+++||..-.. .....||.||+.... .++ ..-+.+|.+-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHH
Confidence 34456 89988773321 112356777766543 122 23456778888999
Q ss_pred HhCCceeccCCCCcEEEcCCCcEEEeeecCc
Q 036673 228 HERGILHRDIKASNLLIDKSGMLKIADFGLS 258 (469)
Q Consensus 228 H~~~ivHrDlkp~NILl~~~~~~kl~DFGla 258 (469)
|..||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999996 4589999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.4e-05 Score=88.76 Aligned_cols=145 Identities=21% Similarity=0.375 Sum_probs=89.4
Q ss_pred eceeeeeCCeEEEEEEECCCC--cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCe--eeEeeeEeecc-ccEEEE
Q 036673 115 LAKVGQGTYSNVYKARDRDTG--KIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNV--IKLEGLATSRM-QYSLYL 188 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~~-~~~~~l 188 (469)
+..|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.|. |.+| .+++.++.+.. ....|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 567899999999998776432 46788876433211 12246779999999995 6665 67776665431 123589
Q ss_pred EEecchhhHHH------------------------HHhcCC----------CC--CCHHHHHHHHHH-------------
Q 036673 189 VFDFMQSDLTK------------------------IICRPG----------QK--LTEPQVKCYMQQ------------- 219 (469)
Q Consensus 189 v~e~~~~~l~~------------------------~~~~~~----------~~--l~~~~~~~i~~q------------- 219 (469)
||||++|..+. .++... .+ ....++..|..+
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 99999874210 011100 00 111223222221
Q ss_pred --HHHHHHHHHh-----------CCceeccCCCCcEEEcCC-C-cEEEeeecCccc
Q 036673 220 --LLSGLQHCHE-----------RGILHRDIKASNLLIDKS-G-MLKIADFGLSNF 260 (469)
Q Consensus 220 --i~~aL~~LH~-----------~~ivHrDlkp~NILl~~~-~-~~kl~DFGla~~ 260 (469)
+...+++|.. ..+||+|+++.|||++.+ + .+-|.||+++..
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2234566643 249999999999999853 3 357999999865
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.3e-05 Score=72.62 Aligned_cols=30 Identities=27% Similarity=0.481 Sum_probs=25.9
Q ss_pred CceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 231 GILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 231 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
.++|+|+.+.|||++.+...-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 489999999999998766667999998864
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=7.6e-06 Score=78.05 Aligned_cols=136 Identities=16% Similarity=0.229 Sum_probs=93.4
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-------H-------------HHHHHHHHHHHHHHhCC-CC
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-------P-------------ESVKFMAREIRILQKLD-HP 169 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~-------------~~~~~~~~E~~~l~~l~-hp 169 (469)
-|.+++.||-|--+-||.+-+.. |++.++|.-+..... . -..-...+|+..|+.|. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 47788999999999999998875 889999864322110 0 01123457888888883 32
Q ss_pred -CeeeEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC
Q 036673 170 -NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 170 -nIv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 248 (469)
-|.+.+++.. -++|||++.|-.+..+.. ...+..+...+..-+--|-.+|+||+|..--||++++++
T Consensus 172 fpVPkpiD~~R------H~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPIDHNR------HCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCcccccc------eeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 3444544332 389999999844333322 112334445555566677889999999999999999999
Q ss_pred cEEEeeecCcc
Q 036673 249 MLKIADFGLSN 259 (469)
Q Consensus 249 ~~kl~DFGla~ 259 (469)
.++++||--..
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999997543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00029 Score=70.98 Aligned_cols=77 Identities=18% Similarity=0.186 Sum_probs=52.5
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCC----CC-HHHHHHHHHHHHHHHhCC---CCCeeeEeeeEeeccccEE
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT----SE-PESVKFMAREIRILQKLD---HPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~~ 186 (469)
.+.||.|.+..||++...+.++.|+||.-.... .. +-....+..|.+.|..+. -.++++++.+.. .. .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~--~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--EL--A 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CC--C
Confidence 467999999999999987544689999853210 10 123456777888888862 346777865532 22 3
Q ss_pred EEEEecchh
Q 036673 187 YLVFDFMQS 195 (469)
Q Consensus 187 ~lv~e~~~~ 195 (469)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999875
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.84 E-value=6.2e-05 Score=71.70 Aligned_cols=132 Identities=19% Similarity=0.274 Sum_probs=75.5
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeEeeeEeeccccEEEEEEecchhh
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV-IKLEGLATSRMQYSLYLVFDFMQSD 196 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~lv~e~~~~~ 196 (469)
+..|-...+|+... ++..+++|.......... -...+|..+++.+..-.+ .+++.+ .. . ++||||++|.
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~i~~--~~-~---~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALG--VDRQREYQILQALSALGLAPKPILV--NE-H---WLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCccccccc--CcHHHHHHHHHHHHhcCCCCceEEE--eC-C---EEEEEeccCc
Confidence 56688889998873 367888987543211110 124678999998854333 344332 22 1 6899999873
Q ss_pred HHH------------------HHhcC---CCCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceeccC
Q 036673 197 LTK------------------IICRP---GQKLTE-PQVKCYMQQL---------LSGLQHCHE--------RGILHRDI 237 (469)
Q Consensus 197 l~~------------------~~~~~---~~~l~~-~~~~~i~~qi---------~~aL~~LH~--------~~ivHrDl 237 (469)
... .++.. ..+++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 221 01111 111221 1222222111 111222221 14899999
Q ss_pred CCCcEEEcCCCcEEEeeecCccc
Q 036673 238 KASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 238 kp~NILl~~~~~~kl~DFGla~~ 260 (469)
.|.|||+++++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.82 E-value=6.1e-05 Score=68.08 Aligned_cols=99 Identities=21% Similarity=0.155 Sum_probs=77.6
Q ss_pred HHHHHHHHhCCC-CCeeeEeeeEeeccccEEEEEEecchh-hHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHh---
Q 036673 157 AREIRILQKLDH-PNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKII--CRPGQKLTEPQVKCYMQQLLSGLQHCHE--- 229 (469)
Q Consensus 157 ~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~--- 229 (469)
..|.-+|+.+.+ +++++++|+|-. ++|.||... .+.... ...-...+|..+..++.+++..+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888888865 699999998843 789999995 332110 0011236899999999999999999997
Q ss_pred CCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 230 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
..+.-.|++++|+-+++++.+|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 35777999999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0004 Score=63.12 Aligned_cols=129 Identities=21% Similarity=0.323 Sum_probs=87.3
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCC--------------CCHHHHHHHHHHHHHHHhCC------CCCeeeEe
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDT--------------SEPESVKFMAREIRILQKLD------HPNVIKLE 175 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------hpnIv~~~ 175 (469)
..||.|+.=.||.--+ ....+||++.... ......++..+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4599999999997433 4568899987654 01122356667777776665 78899999
Q ss_pred eeEeeccccEEEEEEecch---h----hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC
Q 036673 176 GLATSRMQYSLYLVFDFMQ---S----DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 176 ~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 248 (469)
|+.....+ +-+|+|.+. | .|.+.+ .. ..+++ . +...+-.-.+||-+++|+.+||+|.||++....
T Consensus 84 G~veT~~G--~Glv~e~I~d~dG~~s~TL~~~l-~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVETNLG--LGLVVELIRDADGNISPTLEDYL-KE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEecCCc--eEEEEEEEECCCCCcCccHHHHH-Hc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 98877544 478888775 2 233443 32 23555 3 334444556788899999999999999995432
Q ss_pred ----cEEEeee
Q 036673 249 ----MLKIADF 255 (469)
Q Consensus 249 ----~~kl~DF 255 (469)
.+.|+|-
T Consensus 156 ~~~~~lvlIDG 166 (199)
T PF10707_consen 156 SGEFRLVLIDG 166 (199)
T ss_pred CCceEEEEEeC
Confidence 4777773
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00029 Score=66.04 Aligned_cols=72 Identities=18% Similarity=0.277 Sum_probs=45.3
Q ss_pred eceeeeeCCeEEEEEEECC-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeEeeeEeeccccEEEEEEec
Q 036673 115 LAKVGQGTYSNVYKARDRD-TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV-IKLEGLATSRMQYSLYLVFDF 192 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~lv~e~ 192 (469)
++.|..|-...+|++.... .+..|++|+...... ......+|+.++..+...++ ++++..+ . . .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~-~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF--Q-N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe--C-C---cEEEEe
Confidence 3557888889999997553 356888997653211 11123478889888854333 4453322 2 2 489999
Q ss_pred chh
Q 036673 193 MQS 195 (469)
Q Consensus 193 ~~~ 195 (469)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 887
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=8.6e-06 Score=90.82 Aligned_cols=215 Identities=12% Similarity=-0.014 Sum_probs=138.7
Q ss_pred HHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchh-hHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh
Q 036673 154 KFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPG---QKLTEPQVKCYMQQLLSGLQHCHE 229 (469)
Q Consensus 154 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~ 229 (469)
+....|...++...|+++.....-.........|.+++|+.+ .+...+.+.- ..+.+.-+.....+.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 445566667777789998876544333333345889999985 5666665432 234444444455555777777775
Q ss_pred C-----CceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHH
Q 036673 230 R-----GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLA 304 (469)
Q Consensus 230 ~-----~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ 304 (469)
. -.+|++||+-|.+|..+.++|++++|+.+... .........++++.|++|++.. ...++.++|+|..|+.+|
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHH
Confidence 4 27999999999999999999999999998432 2222344566788999999654 355788899999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH
Q 036673 305 EMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA 384 (469)
Q Consensus 305 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta 384 (469)
++..|.++|. ..++.+.+. ...+ ..+.++..-.|.++-.+...+|-+.-..||.-
T Consensus 1432 ~rs~~n~~fi-----~flq~~Lkg--iidn------------------~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q 1486 (2724)
T KOG1826|consen 1432 LRSDGNAYFI-----FFLQPALKG--IIDN------------------HTFFSIEKLKPGDANVEALHRLLWKYMERPGQ 1486 (2724)
T ss_pred HHhcccHHHH-----HHHHHHHcC--cccc------------------cccccccccCCCcccHHHHHHHHHHhhhcchh
Confidence 9998887763 222222221 1110 01111111123333344555555566788998
Q ss_pred HHHhcCccCCC
Q 036673 385 ASALQNEFFNA 395 (469)
Q Consensus 385 ~elL~hp~f~~ 395 (469)
...+.-+.|-.
T Consensus 1487 ~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1487 YISLSRDHFAV 1497 (2724)
T ss_pred hhhcccccccc
Confidence 88888888753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00069 Score=66.01 Aligned_cols=75 Identities=15% Similarity=0.135 Sum_probs=51.6
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC---CCeeeEeeeEeec-cccEEEEEE
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH---PNVIKLEGLATSR-MQYSLYLVF 190 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~~-~~~~~~lv~ 190 (469)
.+.||.|..+.||+....+ + .+.+|..+. ... ...+..|...|+.|.- -.|.++++++... .....+|||
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 4569999999999996543 3 467777432 111 1467889999998843 3577888776542 123359999
Q ss_pred ecchh
Q 036673 191 DFMQS 195 (469)
Q Consensus 191 e~~~~ 195 (469)
|+++|
T Consensus 93 E~i~G 97 (297)
T PRK10593 93 ERLRG 97 (297)
T ss_pred eccCC
Confidence 99886
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00043 Score=67.42 Aligned_cols=142 Identities=23% Similarity=0.273 Sum_probs=97.6
Q ss_pred ceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC----------------------CCCHHHHHH--HHHHHHHHHhCCC
Q 036673 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD----------------------TSEPESVKF--MAREIRILQKLDH 168 (469)
Q Consensus 113 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------------------~~~~~~~~~--~~~E~~~l~~l~h 168 (469)
.+...|..|--+.||.|...+ |..+|||+++-. ..++..+-. ...|+.-|.+|..
T Consensus 147 ~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 344568889999999997765 888999987421 122222222 2357777888754
Q ss_pred CCeeeEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEcCC
Q 036673 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH-ERGILHRDIKASNLLIDKS 247 (469)
Q Consensus 169 pnIv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NILl~~~ 247 (469)
-.|.----+..- . -+|||++++.+-+..-......++...+..+-.|++.-|.-|- .+++||.||.--|+|+- +
T Consensus 226 aGIP~PePIlLk-~---hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 226 AGIPCPEPILLK-N---HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D 300 (520)
T ss_pred cCCCCCCceeee-c---ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence 443322111111 1 2799999996544333334456888889999999998888776 56999999999999984 6
Q ss_pred CcEEEeeecCccc
Q 036673 248 GMLKIADFGLSNF 260 (469)
Q Consensus 248 ~~~kl~DFGla~~ 260 (469)
|.+.|+|.+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 7899999987753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00041 Score=67.74 Aligned_cols=71 Identities=24% Similarity=0.278 Sum_probs=44.6
Q ss_pred ceeeeeCCeEEEEEEECC------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeEeeeEeeccccEEEE
Q 036673 116 AKVGQGTYSNVYKARDRD------TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV-IKLEGLATSRMQYSLYL 188 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~l 188 (469)
+.|..|-...||++.... +++.+++|+...... ......+|..++..+....+ .++++++. + .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFP--N----GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeC--C----Cc
Confidence 446677778999987653 257899998654321 12345678888888843333 34544332 2 36
Q ss_pred EEecchh
Q 036673 189 VFDFMQS 195 (469)
Q Consensus 189 v~e~~~~ 195 (469)
|++|++|
T Consensus 75 v~e~i~G 81 (302)
T cd05156 75 IEEFIPS 81 (302)
T ss_pred hhheeCC
Confidence 8898876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0012 Score=64.93 Aligned_cols=30 Identities=23% Similarity=0.439 Sum_probs=26.4
Q ss_pred CceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 231 GILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 231 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
++||+|+.|.|||++.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 799999999999998765568999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00092 Score=65.47 Aligned_cols=142 Identities=15% Similarity=0.121 Sum_probs=80.1
Q ss_pred ceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeEeeeE----eeccccEE
Q 036673 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN--VIKLEGLA----TSRMQYSL 186 (469)
Q Consensus 113 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~----~~~~~~~~ 186 (469)
..++.|+.|....+|++... +..+++|+...... . ..+..|+.++..|.... +.+++... ........
T Consensus 25 ~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~-~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVK-A---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eeccccCCccccceEEEEeC--CCcEEEEEecCCCC-H---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 33566888888899998653 33577897654211 2 33456777777773222 33443211 11112346
Q ss_pred EEEEecchhhHH---------------HHHhcCCCCC--------CHHHHH---------------HHHHHHHHHHHHHH
Q 036673 187 YLVFDFMQSDLT---------------KIICRPGQKL--------TEPQVK---------------CYMQQLLSGLQHCH 228 (469)
Q Consensus 187 ~lv~e~~~~~l~---------------~~~~~~~~~l--------~~~~~~---------------~i~~qi~~aL~~LH 228 (469)
+++++|++|... ..++.....+ ...... .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 899999887210 1111100000 001100 00112334555554
Q ss_pred h-------CCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 229 E-------RGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 229 ~-------~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
. .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2 5799999999999999988778999998864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00074 Score=65.69 Aligned_cols=139 Identities=15% Similarity=0.141 Sum_probs=80.6
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeEeeeE----eeccccEEEE
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN--VIKLEGLA----TSRMQYSLYL 188 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~----~~~~~~~~~l 188 (469)
++.|..|....+|+.... +..+++|+... .. ...+..|+.++..|.+.+ +.+++... ........++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 456888888999998654 45788998753 11 244667888888874322 44443211 1111234589
Q ss_pred EEecchhhHHH---------------HHhcCCCC----------CCHHHH----------HHHHHHHHHHHHHHHh----
Q 036673 189 VFDFMQSDLTK---------------IICRPGQK----------LTEPQV----------KCYMQQLLSGLQHCHE---- 229 (469)
Q Consensus 189 v~e~~~~~l~~---------------~~~~~~~~----------l~~~~~----------~~i~~qi~~aL~~LH~---- 229 (469)
|++|++|.... .++..... ..+... ......+..++.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99999873210 11110000 011000 0011122334455443
Q ss_pred ---CCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 230 ---RGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 230 ---~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3699999999999999987789999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0027 Score=61.87 Aligned_cols=147 Identities=16% Similarity=0.219 Sum_probs=82.7
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC--CCeeeEeeeEeeccccEEEEE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH--PNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~~lv 189 (469)
..+++.+-.|..-.+|..... ++.+++. ...............+|..+|+.+.- --+...+++|....-...|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 344444534444455655554 7788888 33222333444666788888888743 223344555544332356899
Q ss_pred Eecchhh-HHH------------------HH---hcC--------CC--CCCHHHHHHHHHH--------------HHHH
Q 036673 190 FDFMQSD-LTK------------------II---CRP--------GQ--KLTEPQVKCYMQQ--------------LLSG 223 (469)
Q Consensus 190 ~e~~~~~-l~~------------------~~---~~~--------~~--~l~~~~~~~i~~q--------------i~~a 223 (469)
|+|++|. ... .+ +.- +. .....++..+..+ +..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 9999982 110 00 000 00 0011111111111 1223
Q ss_pred HHHHHhC--------CceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 224 LQHCHER--------GILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 224 L~~LH~~--------~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
..||+.+ .++|+|+.+.||+|+..+-+-|.||+++.+-
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4445443 3899999999999999988999999999763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0021 Score=61.86 Aligned_cols=30 Identities=20% Similarity=0.427 Sum_probs=25.7
Q ss_pred CceeccCCCCcEEEcCCCc-EEEeeecCccc
Q 036673 231 GILHRDIKASNLLIDKSGM-LKIADFGLSNF 260 (469)
Q Consensus 231 ~ivHrDlkp~NILl~~~~~-~kl~DFGla~~ 260 (469)
.++|+|+.|.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 56999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.001 Score=67.50 Aligned_cols=173 Identities=22% Similarity=0.322 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 036673 154 KFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233 (469)
Q Consensus 154 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 233 (469)
.++.--..+++.+.|+|...++++...... ...+|||+++-++.+...... +-..... .+++.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~-r~IVV~e~~~~Sled~~~~~~--l~~~s~~--------------~~~~~ 89 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHE-RVIVVMEHYTMSLEDILKTGN--LKDESLL--------------AHGVL 89 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccc-eEEEEehhhccchHHHHHhcc--cchhhhc--------------ccccc
Confidence 445567888999999999999877655433 478999999988887765432 2111111 12222
Q ss_pred eccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCC
Q 036673 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLM 313 (469)
Q Consensus 234 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf 313 (469)
|- || ++++| -++. . | |- ...+++||||+|.++.++.-|...+
T Consensus 90 ~~-----~~-------~~~td-~~~t------~-----------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 90 HL-----NI-------IYITD-HFLT------K-----------Y--PS------PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred ee-----hh-------hhccc-cccc------c-----------C--CC------CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 21 12 23333 0000 0 0 10 1124899999999999999999888
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 314 PGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 314 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
......+++..+.+....+.....-.+ ...+.-..+.-+..++.+|+-..|..||...++.+++-|
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~--------------e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~ 197 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAM--------------EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSF 197 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHH--------------HHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccH
Confidence 888888888777766544432221110 011222456677889999999999999999999999988
Q ss_pred CC
Q 036673 394 NA 395 (469)
Q Consensus 394 ~~ 395 (469)
..
T Consensus 198 ~e 199 (725)
T KOG1093|consen 198 TE 199 (725)
T ss_pred HH
Confidence 74
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0035 Score=61.94 Aligned_cols=75 Identities=17% Similarity=0.162 Sum_probs=47.9
Q ss_pred eeeeeCCeEEEEEEECCCCcEEEEEEeecC-----CCCHHHHHHHHHHHHHHHhCC--CC-CeeeEeeeEeeccccEEEE
Q 036673 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFD-----TSEPESVKFMAREIRILQKLD--HP-NVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~~~~l 188 (469)
.||.|....||++.....++.|+||.-..- ..-+-...+...|..+|+... -| .+.+++. .++.. ..+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~--~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEM--AVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ecccc--cee
Confidence 489999999999998654468999975211 111223345567888887762 34 4666643 33322 379
Q ss_pred EEecchh
Q 036673 189 VFDFMQS 195 (469)
Q Consensus 189 v~e~~~~ 195 (469)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0083 Score=60.42 Aligned_cols=76 Identities=14% Similarity=0.173 Sum_probs=50.2
Q ss_pred eeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC--C---HHHHHHHHHHHHHHHhCC---CCCeeeEeeeEeeccccE
Q 036673 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS--E---PESVKFMAREIRILQKLD---HPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~ 185 (469)
..+.||.|....||+..+. +..|+||.-..... . +........|...|+.+. ..++.+++.++.+.
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~---- 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM---- 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC----
Confidence 3567999999999999874 45689997642110 0 112344455677777663 34788887666532
Q ss_pred EEEEEecchh
Q 036673 186 LYLVFDFMQS 195 (469)
Q Consensus 186 ~~lv~e~~~~ 195 (469)
.+++|||+++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 2789999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.008 Score=59.85 Aligned_cols=137 Identities=15% Similarity=0.220 Sum_probs=78.3
Q ss_pred eceeeeeCCeEEEEEEECC----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee-eEeeeEeeccccEEEEE
Q 036673 115 LAKVGQGTYSNVYKARDRD----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI-KLEGLATSRMQYSLYLV 189 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~~~lv 189 (469)
+..|-.|-...+|++.... +++.|++|+...... ..+. -.+|..++..+..-++. ++++.+. + ..|
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~id-R~~E~~~~~~l~~~gl~P~~~~~~~--~----g~v 111 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFD-RDDEIRTFECMSRHGQGPRLLGRFP--N----GRV 111 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeec-hHHHHHHHHHHHHcCCCCceEEEEC--C----ceE
Confidence 3456568888999987532 246899998754321 1112 25799999888544443 4544432 2 257
Q ss_pred EecchhhHHH-----------H-------HhcCC---C--CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 036673 190 FDFMQSDLTK-----------I-------ICRPG---Q--KLTEPQVKCYMQQL-----------------LSGLQHC-- 227 (469)
Q Consensus 190 ~e~~~~~l~~-----------~-------~~~~~---~--~l~~~~~~~i~~qi-----------------~~aL~~L-- 227 (469)
++|+++..+. . ++... . ......+..++.++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 8888762211 0 11111 0 11123333333222 1112222
Q ss_pred --H----hCCceeccCCCCcEEEcC-CCcEEEeeecCccc
Q 036673 228 --H----ERGILHRDIKASNLLIDK-SGMLKIADFGLSNF 260 (469)
Q Consensus 228 --H----~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 260 (469)
. ...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 125899999999999986 46899999998865
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0073 Score=60.49 Aligned_cols=77 Identities=18% Similarity=0.163 Sum_probs=50.5
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeec----CCCCHHHHHHHHHHHHHHHhCC--CC-CeeeEeeeEeeccccEEE
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRF----DTSEPESVKFMAREIRILQKLD--HP-NVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~~~~ 187 (469)
++.||.|.-..||++.+...++.|+||.-.. ...-+-..++...|.++|+.+. .| .+.+++. .++.. ..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~--~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVM--NC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHH--hh
Confidence 5779999999999999854356799996421 1111233456667888888762 34 5666743 33332 37
Q ss_pred EEEecchh
Q 036673 188 LVFDFMQS 195 (469)
Q Consensus 188 lv~e~~~~ 195 (469)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 89999864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.016 Score=56.64 Aligned_cols=30 Identities=27% Similarity=0.531 Sum_probs=26.4
Q ss_pred CCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 230 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
.+++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999998754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.013 Score=58.04 Aligned_cols=136 Identities=15% Similarity=0.218 Sum_probs=76.6
Q ss_pred ceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeEeeeEeeccccEEEEEEe
Q 036673 116 AKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV-IKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~lv~e 191 (469)
+.|-.|-...+|+...... +..|++|+...... ..-.-.+|..+++.+..-++ .++++++ .+ .+|.+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~----G~i~~ 90 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVF--GN----GMIQS 90 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEe--CC----cEeeh
Confidence 4455588888999875432 24788998754322 11223478889888865555 3554443 22 25788
Q ss_pred cchhhHH------------------HHHhcCC---C--CCCHHHHHHHHHHH----------------------HHHHHH
Q 036673 192 FMQSDLT------------------KIICRPG---Q--KLTEPQVKCYMQQL----------------------LSGLQH 226 (469)
Q Consensus 192 ~~~~~l~------------------~~~~~~~---~--~l~~~~~~~i~~qi----------------------~~aL~~ 226 (469)
|++|..+ ..++... . +-.+..+..+..++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 8876321 1111111 0 11123333333222 111222
Q ss_pred HH----hC----CceeccCCCCcEEEcC-CCcEEEeeecCccc
Q 036673 227 CH----ER----GILHRDIKASNLLIDK-SGMLKIADFGLSNF 260 (469)
Q Consensus 227 LH----~~----~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 260 (469)
+. .. -++|.|+.+.|||+++ ++.++++||..|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 11 2799999999999975 47899999998864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.045 Score=53.59 Aligned_cols=30 Identities=20% Similarity=0.325 Sum_probs=28.1
Q ss_pred CceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 231 GILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 231 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.0065 Score=55.92 Aligned_cols=30 Identities=33% Similarity=0.679 Sum_probs=21.6
Q ss_pred CceeccCCCCcEEE-cCCCcEEEeeecCccc
Q 036673 231 GILHRDIKASNLLI-DKSGMLKIADFGLSNF 260 (469)
Q Consensus 231 ~ivHrDlkp~NILl-~~~~~~kl~DFGla~~ 260 (469)
-++|.||.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.05 Score=53.58 Aligned_cols=137 Identities=19% Similarity=0.275 Sum_probs=78.8
Q ss_pred eeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC------eeeEeeeEeeccc--cEEEE
Q 036673 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN------VIKLEGLATSRMQ--YSLYL 188 (469)
Q Consensus 117 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~~~--~~~~l 188 (469)
.|.+ .-..||+....+ |+. ++|+.... ... ..+..|+.+|..|.-.. |..+-|-....-. .+.+-
T Consensus 33 ~l~s-~eN~~f~~~~~~-g~~-iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 33 GLNS-EENSNFRVQTED-GRY-ILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred cccc-ccCceEEEEecC-CCe-EEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 3555 567889987764 444 99988754 222 45667888888873211 2222221111111 25678
Q ss_pred EEecchhhHHHH----------------HhcCCC-----------CCCHH----H---------HHHHHHHHHHHHHHHH
Q 036673 189 VFDFMQSDLTKI----------------ICRPGQ-----------KLTEP----Q---------VKCYMQQLLSGLQHCH 228 (469)
Q Consensus 189 v~e~~~~~l~~~----------------~~~~~~-----------~l~~~----~---------~~~i~~qi~~aL~~LH 228 (469)
+++|++|..... ++.... ...+. . -.....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 899998743331 111000 11121 0 0112234445555555
Q ss_pred hC--------C--ceeccCCCCcEEEcCCCc-EEEeeecCccc
Q 036673 229 ER--------G--ILHRDIKASNLLIDKSGM-LKIADFGLSNF 260 (469)
Q Consensus 229 ~~--------~--ivHrDlkp~NILl~~~~~-~kl~DFGla~~ 260 (469)
+. + +||+|+.|.|||++.+.. +.++||+-+..
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 42 3 999999999999999885 89999998863
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.065 Score=51.78 Aligned_cols=74 Identities=16% Similarity=0.215 Sum_probs=44.9
Q ss_pred ceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeEeeeEeeccccEEEEE
Q 036673 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD---HPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 113 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+-.+.|+.|....+|+.. .+++.+.||+-... ....|..|.+-|+.|. --.+.+++++....+.. |||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~--fLl 90 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA--FLL 90 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC--EEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc--eEE
Confidence 345668999999999987 45889999987522 2256778888888883 33466777766554333 899
Q ss_pred Eecchh
Q 036673 190 FDFMQS 195 (469)
Q Consensus 190 ~e~~~~ 195 (469)
|||++.
T Consensus 91 le~l~~ 96 (288)
T PF03881_consen 91 LEFLEM 96 (288)
T ss_dssp EE----
T ss_pred EEeecC
Confidence 999874
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.052 Score=54.75 Aligned_cols=74 Identities=20% Similarity=0.223 Sum_probs=43.1
Q ss_pred eeceeeeeCCeEEEEEEECCC-CcE-----EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee-eEeeeEeeccccEE
Q 036673 114 KLAKVGQGTYSNVYKARDRDT-GKI-----VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI-KLEGLATSRMQYSL 186 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~-~~~-----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~~ 186 (469)
.++.|..|-...+|++..... +.. |.+++... ..+..-.-.+|+.+++.|...++. ++++.+. .
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~---~--- 124 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG---D--- 124 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEeccHHHHHHHHHHHhCCCCCeEEEecC---C---
Confidence 344566688999999976532 122 44443211 111111224689999999666554 5544442 1
Q ss_pred EEEEecchhh
Q 036673 187 YLVFDFMQSD 196 (469)
Q Consensus 187 ~lv~e~~~~~ 196 (469)
++++||++|.
T Consensus 125 g~l~efIeGr 134 (383)
T PTZ00384 125 FTIQEWVEGN 134 (383)
T ss_pred EEEEEEeccc
Confidence 6999999873
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.14 Score=50.60 Aligned_cols=29 Identities=21% Similarity=0.181 Sum_probs=24.6
Q ss_pred CCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 230 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 4 578999998863
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.19 Score=57.29 Aligned_cols=31 Identities=26% Similarity=0.517 Sum_probs=26.6
Q ss_pred CCceeccCCCCcEEEcCCC--cEE-EeeecCccc
Q 036673 230 RGILHRDIKASNLLIDKSG--MLK-IADFGLSNF 260 (469)
Q Consensus 230 ~~ivHrDlkp~NILl~~~~--~~k-l~DFGla~~ 260 (469)
.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.036 Score=54.38 Aligned_cols=73 Identities=25% Similarity=0.347 Sum_probs=58.8
Q ss_pred cccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 182 MQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 182 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
+..+.|++|++-.+.+...- --...++..++.+.+.-++-+..+ ..-|||+.-.||||+ .|+|-|+||-+++.
T Consensus 297 e~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34557888888776654321 245788889999988888888765 799999999999999 99999999999985
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.077 Score=54.56 Aligned_cols=74 Identities=9% Similarity=0.174 Sum_probs=46.8
Q ss_pred eeceeeeeCCeEEEEEEECCC--------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee-eEeeeEeecccc
Q 036673 114 KLAKVGQGTYSNVYKARDRDT--------GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI-KLEGLATSRMQY 184 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~ 184 (469)
-++.|..|-.-.+|++..... ++.|.+++.-..... .-.-.+|..+++.+..-+|. ++++.+. +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~---lIdR~~E~~v~~~ls~~gi~P~l~~~f~---g- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE---LYNPISEFEVYKTMSKYRIAPQLLNTFS---G- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc---eeCHHHHHHHHHHHHHCCCCCceEEEeC---C-
Confidence 566777788889999976522 467889987443221 11234688888888655553 4544332 2
Q ss_pred EEEEEEecchhh
Q 036673 185 SLYLVFDFMQSD 196 (469)
Q Consensus 185 ~~~lv~e~~~~~ 196 (469)
+.|.+|++|.
T Consensus 182 --g~I~efi~g~ 191 (442)
T PTZ00296 182 --GRIEEWLYGD 191 (442)
T ss_pred --CEEEEeeCCc
Confidence 5678888863
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.12 Score=47.29 Aligned_cols=116 Identities=18% Similarity=0.258 Sum_probs=71.1
Q ss_pred eCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecchhhHHHH
Q 036673 121 GTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKI 200 (469)
Q Consensus 121 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~~l~~~ 200 (469)
++.++.-.+..+- | ...+|+++.-...- ....+..+..++.++. .|+++. -+ +.+..-++.|+|-.--
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~---ND-n~~~yGvIlE~Cy~~~--- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLK---ND-NNYKYGVILERCYKIK--- 140 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEee---cC-CCceeEEEEeeccCcc---
Confidence 4445544443332 2 34555554222210 1245677888888763 577774 22 4455578888886311
Q ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCCCcEEEcCCCcEEEeeecCc
Q 036673 201 ICRPGQKLTEPQVKCYMQQLLSGLQHCHE--RGILHRDIKASNLLIDKSGMLKIADFGLS 258 (469)
Q Consensus 201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~kl~DFGla 258 (469)
.....++..=+.+|.-.|+ .+.+|+|..|+|||-|..|.+||.|=+..
T Consensus 141 ----------i~~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 ----------INFSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ----------cchhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 0112233333567888894 37999999999999999999999987643
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.065 Score=53.39 Aligned_cols=57 Identities=19% Similarity=0.240 Sum_probs=38.8
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEc
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH-ERGILHRDIKASNLLID 245 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NILl~ 245 (469)
.|+-+|+.| +....+.... .++.....++.-.+.||--+- -.+++|.|+.|.||++.
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 567777777 5555554432 456566666666666654443 56899999999999994
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 469 | ||||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-60 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-60 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-60 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-60 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-60 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-60 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-60 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-60 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-60 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-60 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-60 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-60 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-60 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-60 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-59 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-59 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-59 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-59 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-59 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-59 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-59 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-59 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-59 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-59 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-59 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-59 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-59 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-59 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-59 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-59 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-59 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-59 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-59 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-59 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-59 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-59 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-59 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-59 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-59 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-58 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-58 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-57 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-56 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-56 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-56 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-56 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-56 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-54 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-53 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-48 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-47 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-47 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-46 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-46 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-46 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-45 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-45 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-45 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-45 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-45 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-45 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-45 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-45 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-45 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-44 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-44 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-44 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-44 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-44 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-44 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-44 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-44 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-44 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-44 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-44 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-44 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-44 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-44 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-44 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-44 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-44 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-44 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-43 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-43 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-43 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-43 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-43 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-43 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-43 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-43 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-43 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-43 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-43 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-43 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-43 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-43 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-43 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-43 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-43 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-43 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-43 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-43 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-43 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-43 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-43 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-43 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-43 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-43 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-43 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-43 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-43 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-43 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-43 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-43 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-43 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-43 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-43 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-43 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-43 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-43 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-43 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-43 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-43 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-43 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-43 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-43 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-43 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-43 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-43 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-43 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-43 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-43 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-43 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-43 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-43 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-43 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-43 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-43 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-42 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-42 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-42 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-42 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-42 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-42 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-41 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-41 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-40 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-40 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-40 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-39 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-39 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-39 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-39 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-39 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-39 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-39 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-39 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-39 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-39 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-39 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-39 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-39 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-39 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-39 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-39 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-39 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-39 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-39 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-39 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-39 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-39 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-39 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-39 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-39 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-39 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-39 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-39 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-37 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-35 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-35 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-35 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-35 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-35 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-35 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-35 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-35 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-35 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-35 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-35 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-35 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-35 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-35 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-35 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-35 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-35 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-35 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-35 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-35 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-35 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-35 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-34 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-34 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-34 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-34 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-34 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-34 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-34 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-34 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-33 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-33 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-32 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-32 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-32 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-31 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-31 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-31 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-30 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-30 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-28 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-28 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-27 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-27 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-27 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-27 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-27 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-26 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-26 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-26 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-26 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-26 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-26 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-26 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-26 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-26 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-26 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-26 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-26 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-26 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-26 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-26 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-26 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-26 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-26 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-26 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-26 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-26 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-26 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-26 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-26 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-25 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-25 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-25 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-25 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-25 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-25 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-25 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-25 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-25 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-25 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-25 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-25 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-24 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-23 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-23 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-23 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-23 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-23 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-23 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-23 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-23 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-23 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-23 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-23 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-23 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-23 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-23 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-23 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-23 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-23 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-23 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-23 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-23 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-23 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-23 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-23 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-23 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-23 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-23 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-23 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-22 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-22 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-22 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-22 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-22 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-22 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-22 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-22 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-22 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-22 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-22 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-22 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-22 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-22 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-22 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-22 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-22 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-21 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-21 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-21 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-21 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-21 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-21 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-20 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-20 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-20 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-20 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-20 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-20 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-20 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-20 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-20 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-20 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-20 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-20 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-20 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-20 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-20 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-20 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-20 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-20 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-20 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-20 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-20 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-20 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-20 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-20 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-20 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-20 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-20 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-20 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-20 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-20 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-20 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-20 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-20 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-19 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-19 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-19 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-19 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-19 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-19 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-19 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-19 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-19 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-19 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-19 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-19 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-19 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-19 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-19 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-19 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-19 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-19 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-19 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-19 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-19 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-19 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-19 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-19 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-19 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-19 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-18 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-18 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-18 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-18 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-18 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-17 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-17 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-17 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-17 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-17 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-16 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-16 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-16 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-15 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-09 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-07 |
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 478 bits (1233), Expect = e-169
Identities = 134/334 (40%), Positives = 185/334 (55%), Gaps = 17/334 (5%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKL 166
Y+KLAK+GQGT+ V+KAR R TG+ VALKKV + +E E A REI+ILQ L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLL 73
Query: 167 DHPNVIKLEGLATSRM------QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQL 220
H NV+ L + ++ + S+YLVFDF + DL ++ K T ++K MQ L
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF---IPKQKGPLTSRVVTLW 277
L+GL + H ILHRD+KA+N+LI + G+LK+ADFGL+ F Q T+RVVTLW
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337
YR PELLLG DYG IDLW AGC++AEM+ P+M G TE QL I +LCG+ + + W
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253
Query: 338 ---KKMKLTTTFR-PQHYKPSFREVFGEFPPSSYGI--LTTLLALDPAYRGTAASALQNE 391
+L + K ++ + Y + + LL LDPA R + AL ++
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 392 FFNASPLACDLSSLPVICREEDEPARTSRRKKRR 425
FF + P+ DL + R+K
Sbjct: 314 FFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHH 347
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 444 bits (1144), Expect = e-155
Identities = 128/340 (37%), Positives = 194/340 (57%), Gaps = 18/340 (5%)
Query: 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE--PESVKFMA-REIR 161
V A Y+KL +G+G ++ VYKARD++T +IVA+KK++ + + A REI+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 162 ILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLL 221
+LQ+L HPN+I L + ++ LVFDFM++DL II LT +K YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHKS--NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 222 SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRA 280
GL++ H+ ILHRD+K +NLL+D++G+LK+ADFGL+ F P + T +VVT WYRA
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRA 180
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
PELL G+ YGVG+D+W+ GC+LAE+ + P +PG ++++QL RIF+ GTP+E+ W M
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 341 K---LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397
TF+ P +F ++ L +P R TA AL+ ++F+ P
Sbjct: 241 CSLPDYVTFKSFPGIP-LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299
Query: 398 LACDLSSLPV------ICREEDEPARTSRRKKRRSSKGRK 431
LP +E+ PA +RK+ + +
Sbjct: 300 GPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGG 339
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 389 bits (1002), Expect = e-134
Identities = 119/338 (35%), Positives = 181/338 (53%), Gaps = 21/338 (6%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
++Y KL K+G+GTY+ VYK + + T +VALK++R + E + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N++ L + + SL LVF+++ DL + + G + VK ++ QLL GL +CH
Sbjct: 61 NIVTLHDIIHTEK--SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPELLLGST 288
+ +LHRD+K NLLI++ G LK+ADFGL+ IP + + VVTLWYR P++LLGST
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGST 176
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM-KL----T 343
DY ID+W GC+ EM GRPL PG T EQLH IF++ GTP+E+ W + T
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLS 403
+ P++ + +LT LL + R +A A+++ FF + +
Sbjct: 237 YNY-PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG--ERIH 293
Query: 404 SLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHH 441
LP + + +K S + H HH
Sbjct: 294 KLP--DTTSIFALKEIQLQKEASLRSAH-----HHHHH 324
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 381 bits (982), Expect = e-132
Identities = 121/295 (41%), Positives = 172/295 (58%), Gaps = 11/295 (3%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
Y+KL K+G+GTY V+KA++R+T +IVALK+VR D + E V A REI +L++L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKH 60
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N+++L + S L LVF+F DL K L VK ++ QLL GL CH
Sbjct: 61 KNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPELLLGS 287
R +LHRD+K NLLI+++G LK+A+FGL+ F IP + ++ VVTLWYR P++L G+
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGA 176
Query: 288 TDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTPSEDYW---KKMKLT 343
Y ID+WSAGC+ AE+ GRPL PG +QL RIF+L GTP+E+ W K+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398
+ S V + + +L LL +P R +A ALQ+ +F+
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-131
Identities = 122/317 (38%), Positives = 169/317 (53%), Gaps = 25/317 (7%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE--PESVKFMA-REIRILQ 164
S+ + +L K+G GTY+ VYK ++ TG VALK+V+ D+ E P + A REI +++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST----AIREISLMK 58
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKII-----CRPGQKLTEPQVKCYMQQ 219
+L H N+++L + + L LVF+FM +DL K + + L VK + Q
Sbjct: 59 ELKHENIVRLYDVIHTEN--KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWY 278
LL GL CHE ILHRD+K NLLI+K G LK+ DFGL+ F IP +S VVTLWY
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWY 174
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW- 337
RAP++L+GS Y ID+WS GC+LAEM G+PL PG + EQL IF + GTP+E W
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 338 --KKMKLTTTFRPQHYKPSFREVFGEFPP---SSYGI--LTTLLALDPAYRGTAASALQN 390
K+ Q R+V + L LL L+P R +A AL +
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294
Query: 391 EFFNASPLACDLSSLPV 407
+F +
Sbjct: 295 PWFAEYYHHASMGGSRS 311
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 380 bits (978), Expect = e-131
Identities = 125/299 (41%), Positives = 177/299 (59%), Gaps = 14/299 (4%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQ 164
+ Y KL KVG+GTY VYKA+D G+IVALK++R D +E E + A REI +L+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLD-AEDEGIPSTAIREISLLK 74
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
+L HPN++ L + S L LVF+FM+ DL K++ L + Q+K Y+ QLL G+
Sbjct: 75 ELHHPNIVSLIDVIHSER--CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPEL 283
HCH+ ILHRD+K NLLI+ G LK+ADFGL+ F IP + T VVTLWYRAP++
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDV 190
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM-KL 342
L+GS Y +D+WS GC+ AEM G+PL PG T+ +QL +IF + GTP+ W ++ +L
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 343 ----TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397
TF K + + F +L+ +L DP R +A A+ + +F
Sbjct: 251 PLWKQRTF-QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 379 bits (977), Expect = e-131
Identities = 108/303 (35%), Positives = 155/303 (51%), Gaps = 16/303 (5%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKF---MAREIRIL 163
+ Y+ +A++G G Y VYKARD +G VALK VR RE+ +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 164 QKL---DHPNVIKLEGLATSR---MQYSLYLVFDFMQSDLTKII-CRPGQKLTEPQVKCY 216
++L +HPNV++L + + + + LVF+ + DL + P L +K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 217 MQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVT 275
M+Q L GL H I+HRD+K N+L+ G +K+ADFGL+ + LT VVT
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVT 182
Query: 276 LWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335
LWYRAPE+LL ST Y +D+WS GC+ AEMF +PL G +E +QL +IF L G P ED
Sbjct: 183 LWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241
Query: 336 YWKKM-KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
W + L P + V E S +L +L +P R +A ALQ+ + +
Sbjct: 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
Query: 395 ASP 397
Sbjct: 302 KDE 304
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-130
Identities = 115/290 (39%), Positives = 168/290 (57%), Gaps = 11/290 (3%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
+ Y L K+G+GTY VYKA++ G+ ALKK+R + E E + REI IL++L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLE-KEDEGIPSTTIREISILKELKH 59
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++KL + ++ L LVF+ + DL K++ L K ++ QLL+G+ +CH
Sbjct: 60 SNIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPELLLGS 287
+R +LHRD+K NLLI++ G LKIADFGL+ F IP + T +VTLWYRAP++L+GS
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS 175
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW---KKMKLTT 344
Y ID+WS GC+ AEM G PL PG +E +QL RIF++ GTP+ W ++
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
+ + S +L+ +L LDP R TA AL++ +F
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-130
Identities = 99/304 (32%), Positives = 154/304 (50%), Gaps = 12/304 (3%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDH 168
+ Y+K+ K+G+G+Y V+K R+RDTG+IVA+KK + +K +A REIR+L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKH 61
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
PN++ L L R + L+LVF++ + + R + + E VK Q L + CH
Sbjct: 62 PNLVNL--LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYRAPELLLGS 287
+ +HRD+K N+LI K ++K+ DFG + P V T WYR+PELL+G
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGD 177
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL----- 342
T YG +D+W+ GC+ AE+ G PL PG+++V+QL+ I K G + +
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDL 402
F + G+L L +DP R T L + +F DL
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
Query: 403 SSLP 406
+
Sbjct: 298 AKEH 301
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-129
Identities = 98/304 (32%), Positives = 157/304 (51%), Gaps = 12/304 (3%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQK 165
+S + Y+ L VG+G+Y V K R++DTG+IVA+KK + + VK +A REI++L++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES-DDDKMVKKIAMREIKLLKQ 80
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
L H N++ L L + + YLVF+F+ + + L V+ Y+ Q+++G+
Sbjct: 81 LRHENLVNL--LEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLS-NFFIPKQKGPLTSRVVTLWYRAPELL 284
CH I+HRDIK N+L+ +SG++K+ DFG + P + V T WYRAPELL
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELL 196
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM-KL- 342
+G YG +D+W+ GCL+ EMF+G PL PG ++++QL+ I G + + K
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 343 ---TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399
+ + + + L +DP R A L ++FF A
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
Query: 400 CDLS 403
S
Sbjct: 317 ERFS 320
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-128
Identities = 117/395 (29%), Positives = 183/395 (46%), Gaps = 45/395 (11%)
Query: 94 DNIPKEVLAGLVPKSADSYDKL-AKVGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEP 150
D K L+ + D ++ KVG+GTY +VYKA+ +D K ALK++
Sbjct: 4 DYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM 63
Query: 151 ESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKII--------C 202
+ REI +L++L HPNVI L+ + S ++L+FD+ + DL II
Sbjct: 64 SAC----REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 203 RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI----DKSGMLKIADFGLS 258
+ +L VK + Q+L G+ + H +LHRD+K +N+L+ + G +KIAD G +
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 259 NFF-IP-KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR 316
F P K L VVT WYRAPELLLG+ Y ID+W+ GC+ AE+ P+ R
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239
Query: 317 TEV---------EQLHRIFKLCGTPSEDYW---KKMKLTTTFRPQHYKPSF--------- 355
E +QL RIF + G P++ W KKM +T + ++
Sbjct: 240 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM 299
Query: 356 REVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICREEDEP 415
+ + ++ +L LL +DP R T+ A+Q+ +F PL + P
Sbjct: 300 EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAG---CQIPYP 356
Query: 416 ARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSA 450
R ++ KG K Q +G++ +
Sbjct: 357 KREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPG 391
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 371 bits (956), Expect = e-127
Identities = 107/303 (35%), Positives = 172/303 (56%), Gaps = 17/303 (5%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQK 165
S D Y ++ K+G+GTY VYKA D T + VA+K++R + E E V A RE+ +L++
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE-HEEEGVPGTAIREVSLLKE 89
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
L H N+I+L+ + L+L+F++ ++DL K + + ++ +K ++ QL++G+
Sbjct: 90 LQHRNIIELKSVIHHNH--RLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVN 146
Query: 226 HCHERGILHRDIKASNLLIDKS-----GMLKIADFGLSNFF-IPKQKGPLTSRVVTLWYR 279
CH R LHRD+K NLL+ S +LKI DFGL+ F IP + T ++TLWYR
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYR 204
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339
PE+LLGS Y +D+WS C+ AEM + PL PG +E++QL +IF++ G P + W
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264
Query: 340 MK----LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395
+ +F K R + +LT +L +DP R +A +AL++ +F+
Sbjct: 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
Query: 396 SPL 398
+
Sbjct: 325 NDF 327
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 368 bits (947), Expect = e-126
Identities = 107/311 (34%), Positives = 162/311 (52%), Gaps = 16/311 (5%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARD-RDTGKIVALKKVRFDTSEPESVKFMA-REIRILQ 164
++ Y+ +A++G+G Y V+KARD ++ G+ VALK+VR + E + RE+ +L+
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ-TGEEGMPLSTIREVAVLR 66
Query: 165 KL---DHPNVIKLEGLATSRMQY---SLYLVFDFMQSDLTKII-CRPGQKLTEPQVKCYM 217
L +HPNV++L + T L LVF+ + DLT + P + +K M
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 218 QQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-IPKQKGPLTSRVVTL 276
QLL GL H ++HRD+K N+L+ SG +K+ADFGL+ + LTS VVTL
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTL 183
Query: 277 WYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY 336
WYRAPE+LL S+ Y +DLWS GC+ AEMF +PL G ++V+QL +I + G P E+
Sbjct: 184 WYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242
Query: 337 WKKM-KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395
W + L + + +L L +PA R +A SAL + +F
Sbjct: 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 396 SPLACDLSSLP 406
+
Sbjct: 303 LERCKENLDSH 313
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 329 bits (845), Expect = e-109
Identities = 108/300 (36%), Positives = 166/300 (55%), Gaps = 19/300 (6%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
SY +G G++ VY+A+ D+G++VA+KKV D +F RE++I++K
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRK 103
Query: 166 LDHPNVIKLEGLATS----RMQYSLYLVFDFMQSDLTKII---CRPGQKLTEPQVKCYMQ 218
LDH N+++L S + + L LV D++ + ++ R Q L VK YM
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDK-SGMLKIADFGLSNFFIPKQKGPLTSRVVTLW 277
QL L + H GI HRDIK NLL+D + +LK+ DFG + + + P S + + +
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 221
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337
YRAPEL+ G+TDY ID+WSAGC+LAE+ +G+P+ PG + V+QL I K+ GTP+ +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 338 KKMK-LTTTFR-PQHYKPSFREVF-GEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
++M T F+ PQ + +VF PP + + + LL P R T A + FF+
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-105
Identities = 104/297 (35%), Positives = 162/297 (54%), Gaps = 22/297 (7%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+Y +G G++ V++A+ ++ + VA+KKV D +F RE++I++ + HP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIVKHP 92
Query: 170 NVIKLEGLATSRMQYS----LYLVFDFMQSDLTKII---CRPGQKLTEPQVKCYMQQLLS 222
NV+ L+ S L LV +++ + + + Q + +K YM QLL
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 223 GLQHCHERGILHRDIKASNLLIDK-SGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
L + H GI HRDIK NLL+D SG+LK+ DFG + I + P S + + +YRAP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRYYRAP 210
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM- 340
EL+ G+T+Y ID+WS GC++AE+ G+PL PG + ++QL I K+ GTPS + K M
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270
Query: 341 --KLTTTFRPQHYKPSFREVF-GEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
+ F PQ F +VF PP + +++ LL P+ R TA AL + FF+
Sbjct: 271 PNYMEHKF-PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 6e-99
Identities = 90/318 (28%), Positives = 146/318 (45%), Gaps = 30/318 (9%)
Query: 98 KEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA 157
K D + GQGT+ V +++ TG VA+KKV D F
Sbjct: 11 AAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRN 64
Query: 158 REIRILQKL---DHPNVIKL------EGLATSRMQYSLYLVFDFMQSDLTKII---CRPG 205
RE++I+Q L HPN+++L G R Y L +V +++ L + R
Sbjct: 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY-LNVVMEYVPDTLHRCCRNYYRRQ 123
Query: 206 QKLTEPQVKCYMQQLLSGLQHCHER--GILHRDIKASNLLIDKS-GMLKIADFGLSNFFI 262
+K ++ QL+ + H + HRDIK N+L++++ G LK+ DFG +
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQL 322
P + P + + + +YRAPEL+ G+ Y +D+WS GC+ AEM +G P+ G QL
Sbjct: 184 PSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241
Query: 323 HRIFKLCGTPSEDYWKKMKLTTTFR--PQHYKPSFREVFGEF----PPSSYGILTTLLAL 376
H I ++ G PS + +K+ + T + VF + +Y +L+ LL
Sbjct: 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY 301
Query: 377 DPAYRGTAASALQNEFFN 394
P R AL + +F+
Sbjct: 302 LPEERMKPYEALCHPYFD 319
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 2e-98
Identities = 95/332 (28%), Positives = 155/332 (46%), Gaps = 51/332 (15%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
S+ Y +G G++ V + D ++GK ALKKV D ++ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 166 LDHPNVIKL--------EGLATSRMQYS----------------------------LYLV 189
LDH N+IKL + L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 190 FDFMQSDLTKII---CRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID- 245
+++ L K++ R G+ + + Y+ QL + H GI HRDIK NLL++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 246 KSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAE 305
K LK+ DFG + IP + P + + + +YRAPEL+LG+T+Y IDLWS GC+ E
Sbjct: 177 KDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 306 MFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR--PQHYKPSFREVFGEF- 362
+ +G+PL G T ++QL RI ++ GTP+++ +M T P +R++ E
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294
Query: 363 PPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
P + +L +L +P R A+ + FF+
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 1e-92
Identities = 91/303 (30%), Positives = 148/303 (48%), Gaps = 32/303 (10%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DH 168
D Y + K+G+G YS V++A + + V +K ++ P K + REI+IL+ L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 169 PNVIKLEGLATSRMQYSLYLVFDF-MQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
PN+I L + + + LVF+ +D ++ Q LT+ ++ YM ++L L +C
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYC 146
Query: 228 HERGILHRDIKASNLLID-KSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
H GI+HRD+K N++ID + L++ D+GL+ F+ P Q RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVD 204
Query: 287 STDYGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQLHRIFKLCGTPS-EDYWKKMKLTT 344
Y +D+WS GC+LA M + P G +QL RI K+ GT DY K +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 263
Query: 345 TFRPQHYKPSF----REVFGEFPPSSYGILTT---------LLALDPAYRGTAASALQNE 391
+ R+ + F S L + LL D R TA A+++
Sbjct: 264 --LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 392 FFN 394
+F
Sbjct: 322 YFY 324
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 3e-89
Identities = 99/323 (30%), Positives = 153/323 (47%), Gaps = 35/323 (10%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L +G G V+ A D D K VA+KK+ P+SVK REI+I+++LDH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNI 70
Query: 172 IKL-----------EGLATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQ 219
+K+ S + + +Y+V ++M++DL ++ L E + +M Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL--EQGPLLEEHARLFMYQ 128
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIP--KQKGPLTSRVVTL 276
LL GL++ H +LHRD+K +NL I+ +LKI DFGL+ P KG L+ +VT
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 277 WYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY 336
WYR+P LLL +Y ID+W+AGC+ AEM G+ L G E+EQ+ I + E+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 337 WKKMKLTTTF----RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
+++ ++ + L +L P R TA AL + +
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308
Query: 393 FNASPLACDLSSLPVICREEDEP 415
S + DEP
Sbjct: 309 M--SIYSF----------PMDEP 319
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 4e-89
Identities = 100/349 (28%), Positives = 153/349 (43%), Gaps = 66/349 (18%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D Y+ +G G+Y +V +A D+ ++VA+KK+ + K + REI IL +L+H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 170 NVIKLEGLATSRMQYS---LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
+V+K+ + + LY+V + SD K+ R LTE +K + LL G+++
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF-RTPVYLTELHIKTLLYNLLVGVKY 171
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLS--------------------------NF 260
H GILHRD+K +N L+++ +K+ DFGL+
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-----------IG 309
K LT VVT WYRAPEL+L +Y ID+WS GC+ AE+
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
Query: 310 RPLMPG--------------------RTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR-- 347
PL PG R +QL+ IF + GTPSE+ + ++ R
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI 351
Query: 348 ---PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P+ E F + +L +L +P R T L + FF
Sbjct: 352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 9e-89
Identities = 103/296 (34%), Positives = 158/296 (53%), Gaps = 20/296 (6%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR--FDTSEPESVKFMAREIRILQKLD 167
+Y VG G Y +V A D+ +G+ VA+KK+ F + K RE+ +L+ +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQ 81
Query: 168 HPNVIKLEGLATSRMQYS----LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
H NVI L + T YLV FMQ+DL KI+ G K +E +++ + Q+L G
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKG 138
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
L++ H G++HRD+K NL +++ LKI DFGL+ + +T VVT WYRAPE+
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEV 194
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343
+L Y +D+WS GC++AEM G+ L G+ ++QL +I K+ G P ++ +K+
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 344 TTFR-----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
PQ + F ++F P + +L +L LD R TAA AL + FF
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 8e-88
Identities = 96/294 (32%), Positives = 149/294 (50%), Gaps = 15/294 (5%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKLDHPN 170
Y L+ +G+G Y V A D VA+KK+ F+ + REI+IL + H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHEN 86
Query: 171 VIKLEGL--ATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
+I + + A + Q +Y+V D M++DL K++ Q L+ + ++ Q+L GL++
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYI 144
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGL--SNFFIPKQKGPLTSRVVTLWYRAPELLL 285
H +LHRD+K SNLL++ + LKI DFGL G LT V T WYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
S Y ID+WS GC+LAEM RP+ PG+ ++QL+ I + G+PS++ +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 346 FR-----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
P K + +F + +L +L +P R AL + +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-87
Identities = 98/302 (32%), Positives = 159/302 (52%), Gaps = 23/302 (7%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKLDHPN 170
+ + +G+G Y V A + TG+IVA+KK+ FD P REI+IL+ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHEN 70
Query: 171 VIKLEGL--ATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
+I + + S ++ +Y++ + MQ+DL ++I Q L++ ++ ++ Q L ++
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDHIQYFIYQTLRAVKVL 128
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLS---------NFFIPKQKGPLTSRVVTLWY 278
H ++HRD+K SNLLI+ + LK+ DFGL+ N Q+ + V T WY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTP-SEDYW 337
RAPE++L S Y +D+WS GC+LAE+F+ RP+ PGR QL IF + GTP S++
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 338 KKMKLTTTFR-----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
+ ++ P + ++F P +L +L DPA R TA AL++ +
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 393 FN 394
Sbjct: 309 LQ 310
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 9e-87
Identities = 107/294 (36%), Positives = 152/294 (51%), Gaps = 15/294 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y L+ VG G Y +V A D TG VA+KK+ K RE+R+L+ + H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 170 NVIKLEGLATSRMQYS----LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
NVI L + T +YLV M +DL I+ QKLT+ V+ + Q+L GL+
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLK 146
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
+ H I+HRD+K SNL +++ LKI DFGL+ +T V T WYRAPE++L
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPEIML 202
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
Y +D+WS GC++AE+ GR L PG ++QL I +L GTP + KK+ +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262
Query: 346 FR-----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
Q K +F VF P + +L +L LD R TAA AL + +F
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 1e-86
Identities = 102/294 (34%), Positives = 152/294 (51%), Gaps = 19/294 (6%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR--FDTSEPESVKFMAREIRILQKLDHP 169
Y L VG G Y V A D TG VA+KK+ F + K RE+R+L+ + H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHE 84
Query: 170 NVIKLEGLATSRMQYS----LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
NVI L + T YLV FM +DL K++ +KL E +++ + Q+L GL+
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLR 142
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
+ H GI+HRD+K NL +++ LKI DFGL+ + +T VVT WYRAPE++L
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVIL 198
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
Y +D+WS GC++AEM G+ L G ++QL I K+ GTP ++ ++++
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 346 FR-----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
P+ K F + P + +L +L LD R TA AL + +F
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 1e-85
Identities = 82/301 (27%), Positives = 137/301 (45%), Gaps = 21/301 (6%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESV---------KFMAREIRI 162
Y + G+Y V D G VA+K+V S+ +V K + REIR+
Sbjct: 24 YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 163 LQKLDHPNVIKLEGL--ATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQ 219
L HPN++ L + LYLV + M++DL ++I ++ ++ +M
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
+L GL HE G++HRD+ N+L+ + + I DF L+ T V WYR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYR 200
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339
APEL++ + +D+WSAGC++AEMF + L G T QL++I ++ GTP +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 340 MKLTTTFR------PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ ++ V P + ++ +L +P R + AL++ +F
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
Query: 394 N 394
Sbjct: 321 E 321
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 4e-82
Identities = 101/341 (29%), Positives = 153/341 (44%), Gaps = 62/341 (18%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR--FDTSEPESVKFMAREIRILQKLDHP 169
Y +G+G+Y VY A D++T K VA+KKV F+ K + REI IL +L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDCKRILREITILNRLKSD 85
Query: 170 NVIKLEGL--ATSRMQYS-LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
+I+L L +++ LY+V + SDL K+ + LTE +K + LL G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF-KTPIFLTEEHIKTILYNLLLGENF 144
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLS---------------------NFFIPKQ 265
HE GI+HRD+K +N L+++ +K+ DFGL+
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-----------RPLMP 314
K LTS VVT WYRAPEL+L +Y ID+WS GC+ AE+ PL P
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 315 G-----------------RTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR-----PQHYK 352
G ++ +QL+ IF + GTP+ED K + + P
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 353 PSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ ++ + +L ++L +P R T AL + +
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 1e-81
Identities = 99/327 (30%), Positives = 159/327 (48%), Gaps = 48/327 (14%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR--FDTSEPESVKFMAREIRILQKL-DH 168
Y+ + K+G+G Y V+K+ DR TG++VA+KK+ F + REI IL +L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELSGH 68
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++ L + + +YLVFD+M++DL +I L + + QL+ +++ H
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI--RANILEPVHKQYVVYQLIKVIKYLH 126
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLS--------------------NFFIPKQKGP 268
G+LHRD+K SN+L++ +K+ADFGLS +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKL 328
LT V T WYRAPE+LLGST Y GID+WS GC+L E+ G+P+ PG + + QL RI +
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246
Query: 329 CGTPSED------------------YWKKMKLTTTFRP-QHYKPSFREVFGEFPPSSYGI 369
PS + +++ + +K ++ + + +
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 370 --LTTLLALDPAYRGTAASALQNEFFN 394
L LL +P R +A AL++ F +
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-80
Identities = 91/303 (30%), Positives = 154/303 (50%), Gaps = 26/303 (8%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L +G G V A D + VA+KK+ K RE+ +++ ++H N+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 172 IKLEGLATSRMQYS----LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I L + T + +Y+V + M ++L ++I +L ++ + Q+L G++H
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHL 143
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H GI+HRD+K SN+++ LKI DFGL+ +T VVT +YRAPE++LG
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGM 201
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT--- 344
Y +D+WS GC++ EM G L PG ++Q +++ + GTP ++ KK++ T
Sbjct: 202 -GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260
Query: 345 -TFRPQHYKPSFREVFGE--FPPSSYGI----------LTTLLALDPAYRGTAASALQNE 391
RP++ SF ++F + FP S L+ +L +D + R + ALQ+
Sbjct: 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320
Query: 392 FFN 394
+ N
Sbjct: 321 YIN 323
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-79
Identities = 105/403 (26%), Positives = 178/403 (44%), Gaps = 52/403 (12%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L +G G V A D + VA+KK+ K RE+ +++ ++H N+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 172 IKLEGLATSRMQYS----LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I L + T + +YLV + M ++L ++I +L ++ + Q+L G++H
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHL 180
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H GI+HRD+K SN+++ LKI DFGL+ +T VVT +YRAPE++L
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL-G 237
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT--- 344
Y +D+WS GC++ EM + L PGR ++Q +++ + GTP ++ KK++ T
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297
Query: 345 -TFRPQHYKPSFREVF------------GEFPPSSYGILTTLLALDPAYRGTAASALQNE 391
RP++ +F ++F + +L+ +L +DPA R + ALQ+
Sbjct: 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 392 FFNA------SPLAC--------DLSSLPV------ICRE-----EDEPARTSRRKKRRS 426
+ N D + I +E E + + S
Sbjct: 358 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPS 417
Query: 427 SKGRKSTQSIHEGHHKRVSSVSSADETKGETESSKELEKNADP 469
S++S+ S S D+T S LE +A P
Sbjct: 418 GAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSS-LEASAGP 459
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 8e-66
Identities = 70/311 (22%), Positives = 129/311 (41%), Gaps = 52/311 (16%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
A ++++A +GQG + V KAR+ + A+KK+R + ++ E+ +L L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASLNH 61
Query: 169 PNVIKL-----------EGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCY 216
V++ + + + + +L++ ++ + L +I +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 217 MQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF-------------IP 263
+Q+L L + H +GI+HRD+K N+ ID+S +KI DFGL+ +P
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLH 323
LTS + T Y A E+L G+ Y ID++S G + EM P G V L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILK 239
Query: 324 RIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT 383
++ + D+ + ++ I+ L+ DP R
Sbjct: 240 KLRSVSIEFPPDFDD-----------NKMKVEKK-----------IIRLLIDHDPNKRPG 277
Query: 384 AASALQNEFFN 394
A + L + +
Sbjct: 278 ARTLLNSGWLP 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-63
Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 43/297 (14%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN- 170
Y L ++G G S V++ + + +I A+K V + ++ +++ EI L KL +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 171 -VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
+I+L + +Y+V + DL + + + + K Y + +L + H+
Sbjct: 89 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 145
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP-LTSRVVTLWYRAPELLLGS- 287
GI+H D+K +N LI GMLK+ DFG++N P S+V T+ Y PE +
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 288 ---------TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338
+ D+WS GC+L M G+ P + + Q+ ++
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLH-----------A 251
Query: 339 KMKLTTTFR-PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
+ P + ++V L L DP R + L + +
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDV-----------LKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-62
Identities = 75/364 (20%), Positives = 142/364 (39%), Gaps = 45/364 (12%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN- 170
Y L ++G G S V++ + +I A+K V + ++ +++ EI L KL +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 171 -VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
+I+L + +Y+V + DL + + + + K Y + +L + H+
Sbjct: 70 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 126
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP-LTSRVVTLWYRAPELLLGS- 287
GI+H D+K +N LI GMLK+ DFG++N P S+V T+ Y PE +
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 288 ---------TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338
+ D+WS GC+L M G+ P + + Q+ ++
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLH-----------A 232
Query: 339 KMKLTTTFR-PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397
+ P + ++V L L DP R + L + +
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDV-----------LKCCLKRDPKQRISIPELLAHPYVQIQT 281
Query: 398 LACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGET 457
++ + EE + + K+ ++++E + S SS+ +T +
Sbjct: 282 HP--VNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKK 339
Query: 458 ESSK 461
K
Sbjct: 340 RGKK 343
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-61
Identities = 75/364 (20%), Positives = 139/364 (38%), Gaps = 45/364 (12%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN- 170
Y L ++G G S V++ + + +I A+K V + ++ +++ EI L KL +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 171 -VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
+I+L + +Y+V + DL + + + + K Y + +L + H+
Sbjct: 117 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 173
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGST 288
GI+H D+K +N LI GMLK+ DFG++N P S+V + Y PE + +
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 289 D----------YGVGIDLWSAGCLLAEMFIGRPLMPGRTE-VEQLHRIFKLCGTPSEDYW 337
D+WS GC+L M G+ + +LH I
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF--- 289
Query: 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397
P + ++V L L DP R + L + +
Sbjct: 290 ----------PDIPEKDLQDV-----------LKCCLKRDPKQRISIPELLAHPYVQIQT 328
Query: 398 LACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGET 457
++ + EE + + K+ ++++E + S SS+ +T +
Sbjct: 329 --HPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKK 386
Query: 458 ESSK 461
K
Sbjct: 387 RGKK 390
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 4e-61
Identities = 71/289 (24%), Positives = 112/289 (38%), Gaps = 34/289 (11%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
S+ +L+++G G+Y V+K R ++ G++ A+K+ P+ E+ +K
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 166 L-DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
+ HP ++LE LYL + L + G L E QV Y++ L L
Sbjct: 113 VGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
H H +G++H D+K +N+ + G K+ DFGL G + Y APELL
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQEGDPRYMAPELL 228
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344
G YG D++S G + E+ L E ++ + L
Sbjct: 229 QG--SYGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQG------------YLPP 271
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
F R V L +L DP R TA + L
Sbjct: 272 EF-TAGLSSELRSV-----------LVMMLEPDPKLRATAEALLALPVL 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-59
Identities = 64/303 (21%), Positives = 114/303 (37%), Gaps = 27/303 (8%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ +GQG +NV++ R + TG + A+K + S V RE +L+KL+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHK 67
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPG--QKLTEPQVKCYMQQLLSGLQH 226
N++KL + L+ +F L ++ P L E + ++ ++ G+ H
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 227 CHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
E GI+HR+IK N++ D + K+ DFG + ++ S T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPD 185
Query: 283 LLLGSTD-------YGVGIDLWSAGCLLAEMFIGRP----LMPGRTEVEQLHRIFKLCGT 331
+ + YG +DLWS G G R E +++I +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391
+ +K + P + +L +L D ++
Sbjct: 246 GAISGVQKAENGPIDWSGDM-PVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----DQ 299
Query: 392 FFN 394
FF
Sbjct: 300 FFA 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-59
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 38/298 (12%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
P A+ Y+ L +G G+Y K R + GKI+ K++ + + + + E+ +L++
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKII---CRPGQKLTEPQVKCYMQQLL 221
L HPN+++ R +LY+V ++ + DL +I + Q L E V M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 222 SGLQHCHERG-----ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-T 275
L+ CH R +LHRD+K +N+ +D +K+ DFGL+ V T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGT 179
Query: 276 LWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335
+Y +PE + Y D+WS GCLL E+ P ++ E +I + G
Sbjct: 180 PYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFRRI 236
Query: 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P Y E I+T +L L +R + L+N
Sbjct: 237 ------------PYRYSDELNE-----------IITRMLNLKDYHRPSVEEILENPLI 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 64/305 (20%), Positives = 115/305 (37%), Gaps = 27/305 (8%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ +GQG +NV++ R + TG + A+K + S V RE +L+KL+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHK 67
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPG--QKLTEPQVKCYMQQLLSGLQH 226
N++KL + L+ +F L ++ P L E + ++ ++ G+ H
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 227 CHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
E GI+HR+IK N++ D + K+ DFG + ++ S T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPD 185
Query: 283 LLLGSTD-------YGVGIDLWSAGCLLAEMFIGRP----LMPGRTEVEQLHRIFKLCGT 331
+ + YG +DLWS G G R E +++I +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391
+ +K + P + +L +L D ++
Sbjct: 246 GAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----DQ 299
Query: 392 FFNAS 396
FF +
Sbjct: 300 FFAET 304
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-58
Identities = 67/304 (22%), Positives = 121/304 (39%), Gaps = 55/304 (18%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
+ + ++ +G G + V+KA+ R GK +K+V+++ + RE++ L K
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAK 60
Query: 166 LDHPNVIKL--------------EGLATSRMQYSLYLVFDFMQS-DLTKIIC-RPGQKLT 209
LDH N++ ++ L++ +F L + I R G+KL
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 210 EPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269
+ +Q+ G+ + H + +++RD+K SN+ + + +KI DFGL K G
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKR 178
Query: 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLC 329
T TL Y +PE + DYG +DL++ G +LAE+ L T E L
Sbjct: 179 TRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAEL-----LHVCDTAFETSKFFTDL- 231
Query: 330 GTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
+ + + + +L LL+ P R + L+
Sbjct: 232 --------RDGII-----SDIFDKKEKT-----------LLQKLLSKKPEDRPNTSEILR 267
Query: 390 NEFF 393
Sbjct: 268 TLTV 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 202 bits (514), Expect = 4e-58
Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 16/300 (5%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
++ ++ ++G G + V + +DTG+ VA+K+ R + S P++ + EI+I++K
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKK 68
Query: 166 LDHPNVIKL----EGLATSRMQYSLYLVFDFMQS-DLTKIICRPG--QKLTEPQVKCYMQ 218
L+HPNV+ +GL L ++ + DL K + + L E ++ +
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSG---MLKIADFGLSNFFIPKQKGPLTSRVVT 275
+ S L++ HE I+HRD+K N+++ + KI D G + + T V T
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFVGT 186
Query: 276 LWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335
L Y APELL Y V +D WS G L E G + Q H +
Sbjct: 187 LQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395
+ + F P+ L +L RGT F A
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLER--WLQCMLMWHQRQRGTDPQNPNVGCFQA 303
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-57
Identities = 76/351 (21%), Positives = 142/351 (40%), Gaps = 42/351 (11%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y +L K+G+G++ + + G+ +K++ + + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 170 NVIK-LEGLATSRMQYSLYLVFDFMQS-DLTKIIC-RPGQKLTEPQVKCYMQQLLSGLQH 226
N+++ E + SLY+V D+ + DL K I + G E Q+ + Q+ L+H
Sbjct: 84 NIVQYRESFEENG---SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLL 285
H+R ILHRDIK+ N+ + K G +++ DFG++ L + T +Y +PE+
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICE 198
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
Y D+W+ GC+L E+ + + + +I G+
Sbjct: 199 NK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFPPV---------- 245
Query: 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF-------FNASPL 398
HY R +++ L +P R + S L+ F F + L
Sbjct: 246 --SLHYSYDLRS-----------LVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 399 ACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSS 449
+ L + +P R ++S Q I + K ++
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAY 343
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 8e-57
Identities = 69/340 (20%), Positives = 135/340 (39%), Gaps = 69/340 (20%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
++ + +G+G + V++A+++ A+K++R E K M RE++ L KL+HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKLEHP 63
Query: 170 NVIK----------LEGLATSRMQYSLYLVFDFMQS-DLTKII--CRPGQKLTEPQVKCY 216
+++ E L S + LY+ + +L + ++
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 217 MQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS-----------NFFIPKQ 265
Q+ ++ H +G++HRD+K SN+ ++K+ DFGL
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
T +V T Y +PE + G+ Y +D++S G +L E+ L P T++E++ +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTL 237
Query: 326 FKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAA 385
+ F +F + P Y ++ +L+ P R A
Sbjct: 238 TDVR----------------------NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI 275
Query: 386 SALQNEFFNASPLACDLSSLPVICREEDEPARTSRRKKRR 425
+ ++N F + D P +T R++ R
Sbjct: 276 NIIENAVF----------------EDLDFPGKTVLRQRSR 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 8e-55
Identities = 63/295 (21%), Positives = 115/295 (38%), Gaps = 43/295 (14%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y + K+G+G +S V G ALK++ E + + RE + + +HPN+
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNI 88
Query: 172 IKLEG--LATSRMQYSLYLVFDFMQS-DLTKII---CRPGQKLTEPQVKCYMQQLLSGLQ 225
++L L ++ +L+ F + L I G LTE Q+ + + GL+
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV--------TLW 277
H +G HRD+K +N+L+ G + D G N +G + + T+
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 278 YRAPELLLGSTDYGVG--IDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335
YRAPEL + + D+WS GC+L M G P + + +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG--P-----------YDMVFQKGDS 255
Query: 336 YWKKMKLTTTF-RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
++ + + + + + +L +++ +DP R L
Sbjct: 256 VALAVQNQLSIPQSPRHSSALWQ-----------LLNSMMTVDPHQRPHIPLLLS 299
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-54
Identities = 77/310 (24%), Positives = 139/310 (44%), Gaps = 38/310 (12%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQ 164
P+S Y + +G+G ++ ++ D DT ++ A K V + +P + M+ EI I +
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 165 KLDHPNVIKLEG-LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLS 222
L H +V+ G + +++V + + L ++ R LTEP+ + Y++Q++
Sbjct: 71 SLAHQHVVGFHGFFEDND---FVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVL 126
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
G Q+ H ++HRD+K NL +++ +KI DFGL+ + T Y APE
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPE 185
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342
+L + +D+WS GC++ + +G+P E RI K +Y
Sbjct: 186 VLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY------ 232
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDL 402
+ P+H P + ++ +L DP R T L +EFF + +
Sbjct: 233 --SI-PKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP--- 275
Query: 403 SSLPVICREE 412
+ LP+ C
Sbjct: 276 ARLPITCLTI 285
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 7e-54
Identities = 97/367 (26%), Positives = 173/367 (47%), Gaps = 51/367 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y+ + +G+G++ V K +DR T + A+K + +++ + + RE+ +L+KLDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DL-TKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
N++KL + + Y+V + +L +II R ++ +E ++Q+ SG+ +
Sbjct: 82 NIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYM 137
Query: 228 HERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
H+ I+HRD+K N+L+ +K +KI DFGLS F K + R+ T +Y APE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVL 195
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS--EDYWKKMKL 342
G+ Y D+WSAG +L + G P G+ E + L R+ G + W+ +
Sbjct: 196 RGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQWRTI-- 249
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF-NASPLACD 401
+ ++ +L P+ R TA L++ + S
Sbjct: 250 --------------------SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289
Query: 402 LSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGETESSK 461
+S LP E A T+ R+ + K ++ S +++ DETK TE +
Sbjct: 290 ISDLPS-----LESAMTNIRQFQAEKKLAQAALLY------MASKLTTLDETKQLTEIFR 338
Query: 462 ELEKNAD 468
+L+ N D
Sbjct: 339 KLDTNND 345
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 8e-54
Identities = 98/368 (26%), Positives = 165/368 (44%), Gaps = 53/368 (14%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y ++ K+G G Y V RD+ T A+K +R + S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DL-TKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
N++KL + Y YLV + + +L +II R K E ++Q+LSG+ +
Sbjct: 97 NIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYL 152
Query: 228 HERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
H+ I+HRD+K NLL+ +K ++KI DFGLS F ++K + R+ T +Y APE+L
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTAYYIAPEVL 210
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS--EDYWKKMKL 342
Y D+WS G +L + G P G+T+ E L ++ K G + WK +
Sbjct: 211 RKK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK--GKYTFDSPEWKNV-- 264
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDL 402
+ ++ +L D R +A AL++ + ++
Sbjct: 265 --------------------SEGAKDLIKQMLQFDSQRRISAQQALEHPWI------KEM 298
Query: 403 SSLPVICREEDEPARTSRRKK--RRSSKGRKSTQSIHEGHHKRVSSVSSADETKGETESS 460
S E A + + S K ++ S ++S +ETK T+
Sbjct: 299 CSKKESGIELPSLANAIENMRKFQNSQKLAQAALLY------MASKLTSQEETKELTDIF 352
Query: 461 KELEKNAD 468
+ ++KN D
Sbjct: 353 RHIDKNGD 360
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 8e-54
Identities = 80/292 (27%), Positives = 127/292 (43%), Gaps = 37/292 (12%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQ 164
+ ++ K+G+G +S VY+A G VALKKV+ + +EI +L+
Sbjct: 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQK---LTEPQVKCYMQQL 220
+L+HPNVIK + L +V + + DL+++I ++ + E V Y QL
Sbjct: 88 QLNHPNVIKYYA--SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
S L+H H R ++HRDIK +N+ I +G++K+ D GL FF K S V T +Y +
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMS 204
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
PE + + Y D+WS GCLL EM + P + L+ + K
Sbjct: 205 PERIHEN-GYNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCKKI----------- 250
Query: 341 KLTTTFRP---QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
+ P HY R+ ++ + DP R
Sbjct: 251 -EQCDYPPLPSDHYSEELRQ-----------LVNMCINPDPEKRPDVTYVYD 290
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-53
Identities = 82/329 (24%), Positives = 144/329 (43%), Gaps = 40/329 (12%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQ 164
P+S Y + +G+G ++ ++ D DT ++ A K V + +P + M+ EI I +
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 165 KLDHPNVIKLEG-LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLS 222
L H +V+ G + +++V + + L ++ R LTEP+ + Y++Q++
Sbjct: 97 SLAHQHVVGFHGFFEDND---FVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVL 152
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
G Q+ H ++HRD+K NL +++ +KI DFGL+ + T Y APE
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPE 211
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342
+L + +D+WS GC++ + +G+P E RI K +Y
Sbjct: 212 VLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY------ 258
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDL 402
+ P+H P + ++ +L DP R T L +EFF + +
Sbjct: 259 --SI-PKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP--- 301
Query: 403 SSLPVICREEDEPARTSRRKKRRSSKGRK 431
+ LP+ C P R S RK
Sbjct: 302 ARLPITCLT--IPPRFSIAPSSLDPSNRK 328
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-53
Identities = 95/367 (25%), Positives = 170/367 (46%), Gaps = 51/367 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMAREIRILQKLDH 168
D Y +G+G++ V +D+ TG+ A+K + + + + + RE+++L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQS-DL-TKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
PN++KL + + YLV + +L +II R ++ +E ++Q+LSG+ +
Sbjct: 86 PNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITY 141
Query: 227 CHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
H+ I+HRD+K NLL+ K ++I DFGLS F +K + ++ T +Y APE+
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEV 199
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS--EDYWKKMK 341
L G+ Y D+WS G +L + G P G E + L ++ K G + WKK+
Sbjct: 200 LHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELPQWKKV- 254
Query: 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACD 401
S+ ++ +L P+ R +A AL +E+
Sbjct: 255 ---------------------SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
Query: 402 LSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGETESSK 461
+P + A + R+ + + K ++ S ++S DETK T
Sbjct: 294 SVDVPS-----LDNAILNIRQFQGTQKLAQAALLYM------GSKLTSQDETKELTAIFH 342
Query: 462 ELEKNAD 468
+++KN D
Sbjct: 343 KMDKNGD 349
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 73/300 (24%), Positives = 140/300 (46%), Gaps = 34/300 (11%)
Query: 101 LAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV-RFDTSEPESVKFMARE 159
LA + + + + +G+G+++ VY+A TG VA+K + + + V+ + E
Sbjct: 2 LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 160 IRILQKLDHPNVIKLEG-LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYM 217
++I +L HP++++L S +YLV + + ++ + + + +E + + +M
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSNY---VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 218 QQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW 277
Q+++G+ + H GILHRD+ SNLL+ ++ +KIADFGL+ + + T
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLAT-QLKMPHEKHYTLCGTPN 177
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337
Y +PE+ S +G+ D+WS GC+ + IGRP T L+++ DY
Sbjct: 178 YISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY- 229
Query: 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397
P + ++ LL +PA R + +S L + F + +
Sbjct: 230 -------EM-PSF-----------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 55/308 (17%), Positives = 105/308 (34%), Gaps = 59/308 (19%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-D 167
+ +L K+G G + +V+K R G I A+K+ + + + RE+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
H +V++ + + ++ +D R E ++K + Q+ G
Sbjct: 70 HSHVVRYFS--AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 224 LQHCHERGILHRDIKASNLLIDKSG-------------------MLKIADFGLSNFFIPK 264
L++ H ++H DIK SN+ I ++ M KI D G
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV-----T 182
Query: 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHR 324
+ + A E+L + + D+++ + PL +Q H
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL---PRNGDQWHE 239
Query: 325 IFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA 384
I + G PQ F E+ L ++ DP R +A
Sbjct: 240 IRQ--GRLPR------------IPQVLSQEFTEL-----------LKVMIHPDPERRPSA 274
Query: 385 ASALQNEF 392
+ +++
Sbjct: 275 MALVKHSV 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-52
Identities = 97/377 (25%), Positives = 166/377 (44%), Gaps = 61/377 (16%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-----------FDTSEPESVKFMAR 158
+SY K+ K+G G Y V ++++ A+K ++ + + + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 159 EIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DL-TKIICRPGQKLTEPQVKCY 216
EI +L+ LDHPN+IKL + + + YLV +F + +L +II R K E
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINR--HKFDECDAANI 151
Query: 217 MQQLLSGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRV 273
M+Q+LSG+ + H+ I+HRDIK N+L+ + +KI DFGLS+FF K L R+
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRDRL 209
Query: 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS 333
T +Y APE+L Y D+WS G ++ + G P G+ + + + ++ K G
Sbjct: 210 GTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK--GKYY 265
Query: 334 --EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391
+ WK + + ++ +L D R TA AL +
Sbjct: 266 FDFNDWKNI----------------------SDEAKELIKLMLTYDYNKRCTAEEALNSR 303
Query: 392 FFNASPLACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSAD 451
+ + S A ++ RK S K ++ S +++ +
Sbjct: 304 WIKKYANNINKSDQKT-----LCGALSNMRKFEGSQKLAQAAILF------IGSKLTTLE 352
Query: 452 ETKGETESSKELEKNAD 468
E K T+ K+L+KN D
Sbjct: 353 ERKELTDIFKKLDKNGD 369
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-52
Identities = 70/316 (22%), Positives = 119/316 (37%), Gaps = 44/316 (13%)
Query: 89 PKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS 148
P D+ +E +V K S+ +G G + R + VA+K++
Sbjct: 5 PSLEQDDGDEETSVVIVGK--ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRI----- 56
Query: 149 EPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQK 207
PE F RE+++L++ D HPNVI+ R Y+ + + L + + +
Sbjct: 57 LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ--FQYIAIELCAATLQEYVEQKDFA 114
Query: 208 LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM-----LKIADFGLSNFFI 262
+ +QQ SGL H H I+HRD+K N+LI I+DFGL
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 263 PKQK--GPLTSRVVTLWYRAPELLLGSTD--YGVGIDLWSAGCLLAEMF-IGRPLMPGRT 317
+ + T + APE+L +D++SAGC+ + G
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 318 EVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALD 377
+ + + L +H RE ++ ++A+D
Sbjct: 235 QRQANILL------------GACSLDCLHPEKHEDVIARE-----------LIEKMIAMD 271
Query: 378 PAYRGTAASALQNEFF 393
P R +A L++ FF
Sbjct: 272 PQKRPSAKHVLKHPFF 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-51
Identities = 72/239 (30%), Positives = 126/239 (52%), Gaps = 21/239 (8%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y+ + +G+G++ V K +DR T + A+K + +++ + + RE+ +L+KLDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS----DLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
N++KL + + Y+V + D +II R ++ +E ++Q+ SG+
Sbjct: 82 NIMKLFEILEDSSSF--YIVGELYTGGELFD--EIIKR--KRFSEHDAARIIKQVFSGIT 135
Query: 226 HCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
+ H+ I+HRD+K N+L+ +K +KI DFGLS F K + R+ T +Y APE
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPE 193
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS--EDYWKK 339
+L G+ Y D+WSAG +L + G P G+ E + L R+ G + W+
Sbjct: 194 VLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRT 248
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 80/311 (25%), Positives = 142/311 (45%), Gaps = 43/311 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDH 168
+ ++ +G+G + NVY AR++ + I+ALK + + + RE+ I L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 169 PNVIKLEG-LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
PN+++L G + +YL+ ++ + + + + K E + Y+ +L + L +
Sbjct: 69 PNILRLYGYFHDAT---RVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 124
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
CH + ++HRDIK NLL+ +G LKIADFG S + T TL Y PE++ G
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
+ +DLWS G L E +G+P T E RI ++ ++ TF
Sbjct: 182 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF--------TF 226
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406
P F + +++ LL +P+ R L++ + A+ SS P
Sbjct: 227 ------PDF------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN------SSKP 268
Query: 407 VICREEDEPAR 417
C+ ++ ++
Sbjct: 269 SNCQNKESASK 279
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-49
Identities = 93/328 (28%), Positives = 143/328 (43%), Gaps = 60/328 (18%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAR----EIRILQKL- 166
Y+ L +G+G++ V KA D + VALK VR + K R EIRIL+ L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLR 151
Query: 167 -----DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICR-PGQKLTEPQVKCYMQQL 220
+ NVI + T R + + F+ + +L ++I + Q + P V+ + +
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 221 LSGLQHCHERGILHRDIKASNLLI--DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWY 278
L L H+ I+H D+K N+L+ +K+ DFG S + + + + + + +Y
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQSRFY 265
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338
RAPE++LG YG+ ID+WS GC+LAE+ G PL+PG E +QL + +L G PS+
Sbjct: 266 RAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 339 KMKLTTTFRPQHYKP-------------------SFREVFGEFPPSSYGI---------- 369
K F P S R P S
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 370 ----LTTLLALDPAYRGTAASALQNEFF 393
L L DPA R T AL++ +
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV------RFDTSEPESVKFMAREIRIL 163
D Y +G G V A +R T K VA++ + E + + EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 164 QKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DL-TKIICRPGQKLTEPQVKCYMQQLL 221
+KL+HP +IK++ + Y+V + M+ +L K++ ++L E K Y Q+L
Sbjct: 195 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQML 249
Query: 222 SGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWY 278
+Q+ HE GI+HRD+K N+L+ ++ ++KI DFG S + + T Y
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLCGTPTY 307
Query: 279 RAPELLLGSTD--YGVGIDLWSAGCLLAEMFIGRP 311
APE+L+ Y +D WS G +L G P
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-49
Identities = 85/311 (27%), Positives = 144/311 (46%), Gaps = 40/311 (12%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAREIRILQKLDH 168
Y L +G+G ++ V AR TG+ VA+K K + + + + + RE+RI++ L+H
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNH 73
Query: 169 PNVIKL-EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
PN++KL E + T + LYL+ ++ ++ + G ++ E + + +Q++S +Q+
Sbjct: 74 PNIVKLFEVIETEKT---LYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQY 129
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
CH++ I+HRD+KA NLL+D +KIADFG SN F K L + Y APEL G
Sbjct: 130 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAPELFQG 187
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
G +D+WS G +L + G G+ E R+
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL-------------------- 227
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406
R ++ P + +L L L+P RGT +++ + NA +L
Sbjct: 228 RGKYRIPFY------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV 281
Query: 407 VICREEDEPAR 417
+ + R
Sbjct: 282 EPELDISDQKR 292
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 80/287 (27%), Positives = 125/287 (43%), Gaps = 37/287 (12%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDH 168
D +D +G+G + NVY AR++ I+ALK + + + REI I L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 169 PNVIKLEG-LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
PN++++ + +YL+ +F +L K + + G + E + +M++L L +
Sbjct: 74 PNILRMYNYFHDRKR---IYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHY 129
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
CHER ++HRDIK NLL+ G LKIADFG S + TL Y PE++ G
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMCGTLDYLPPEMIEG 186
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
T + +DLW AG L E +G P + E RI + D F
Sbjct: 187 KT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL--------KF 231
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P F S +++ LL P R +++ +
Sbjct: 232 ------PPF------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 172 bits (436), Expect = 2e-49
Identities = 45/316 (14%), Positives = 81/316 (25%), Gaps = 53/316 (16%)
Query: 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPES-VKFMAREIRILQKLDHP 169
+ + G S V+ RD + + ALK S ++ + +L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 170 N------------------------VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICR-- 203
+ +L + L+ DL +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 204 ----PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN 259
+ QL+ + +G++H NL I G L + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 260 FFIPKQKGPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE 318
K + V + Y E L S + ++ W G + ++ P
Sbjct: 243 ----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--P---- 292
Query: 319 VEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDP 378
F L + WK+ L S + P ++ L D
Sbjct: 293 -------FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL----PDFVKTLIGRFLNFDR 341
Query: 379 AYRGTAASALQNEFFN 394
R A++ F
Sbjct: 342 RRRLLPLEAMETPEFL 357
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-49
Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 23/239 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
Y +G+G++ V A + T A KK+ E V +EI I++ LDHP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS----DLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
N+I+L YLV + + +++ + + E M+ +LS +
Sbjct: 67 NIIRLYETFEDNTDI--YLVMELCTGGELFE--RVVHK--RVFRESDAARIMKDVLSAVA 120
Query: 226 HCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
+CH+ + HRD+K N L LK+ DFGL+ F P + + ++V T +Y +P+
Sbjct: 121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKVGTPYYVSPQ 178
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS--EDYWKK 339
+L G YG D WSAG ++ + G P T+ E + +I GT + E W
Sbjct: 179 VLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLN 233
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-49
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV------RFDTSEPESVKFMAREIRIL 163
D Y +G G V A +R T K VA+K + E + + EI IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 164 QKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DL-TKIICRPGQKLTEPQVKCYMQQLL 221
+KL+HP +IK++ + Y+V + M+ +L K++ ++L E K Y Q+L
Sbjct: 70 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQML 124
Query: 222 SGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWY 278
+Q+ HE GI+HRD+K N+L+ ++ ++KI DFG S + + T Y
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLCGTPTY 182
Query: 279 RAPELLLGSTD--YGVGIDLWSAGCLL 303
APE+L+ Y +D WS G +L
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-49
Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 26/242 (10%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAREIRILQKL 166
D+YD ++G+G +S V + + TG A K + + + ++ RE RI +KL
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKL 62
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQS-DL-TKIICRPGQKLTEPQVKCYMQQLLSGL 224
HPN+++L + YLVFD + +L I+ R + +E +QQ+L +
Sbjct: 63 QHPNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESI 118
Query: 225 QHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
+CH GI+HR++K NLL+ K +K+ADFGL+ + T Y +P
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSP 176
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMP--GRTEVEQLHRIFKLCGTPS--EDYW 337
E+L Y +D+W+ G +L + +G P P + +I G W
Sbjct: 177 EVLKKDP-YSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAYDYPSPEW 231
Query: 338 KK 339
Sbjct: 232 DT 233
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-49
Identities = 66/314 (21%), Positives = 115/314 (36%), Gaps = 50/314 (15%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+VG+G++ V++ +D+ TG A+KKVR + E E+ L P +
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 172 IKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
+ L G R + + + ++ L + L E + Y+ Q L GL++
Sbjct: 113 VPLYG--AVREGPWVNIFMELLEGGSLGQL----IKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 228 HERGILHRDIKASNLLIDKSG-MLKIADFG----LSNFFIPKQKGPLTSRVVTLWYRAPE 282
H R ILH D+KA N+L+ G + DFG L + K T + APE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKL--CGTPSEDYWKKM 340
+++G +D+WS+ C++ M G P T+ + K+ P +
Sbjct: 227 VVMGKP-CDAKVDIWSSCCMMLHMLNGCH--P-WTQYFRGPLCLKIASEPPPIREI---- 278
Query: 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400
P P + + L +P +R +A + +
Sbjct: 279 -------PPSCAPLTAQ-A----------IQEGLRKEPVHRASAMELRRKVGKALQEVGG 320
Query: 401 DLSSLPVICREEDE 414
S +E
Sbjct: 321 LKSPWKGEYKEPRG 334
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-49
Identities = 75/364 (20%), Positives = 137/364 (37%), Gaps = 56/364 (15%)
Query: 95 NIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALK-----KVRFDT-S 148
+ E LA + + Y ++ +G G + V+ A D++ K V +K KV D
Sbjct: 9 AVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWI 68
Query: 149 EPESVKFMAREIRILQKLDHPNVIKL-EGLATSRMQYSLYLVFDFMQS--DLTKIICRPG 205
E + + EI IL +++H N+IK+ + LV + S DL I R
Sbjct: 69 EDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF---FQLVMEKHGSGLDLFAFIDRHP 125
Query: 206 QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265
+L EP +QL+S + + + I+HRDIK N++I + +K+ DFG + + ++
Sbjct: 126 -RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ER 182
Query: 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
+ T+ Y APE+L+G+ G +++WS G L +
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL------------------- 223
Query: 326 FKLCGT-PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA 384
+ P + + ++ P P +++ LL P R T
Sbjct: 224 --VFEENPFCELEETVE--AAIHP----PYL------VSKELMSLVSGLLQPVPERRTTL 269
Query: 385 ASALQNEFFNASPLACDLSSLPVICREEDEPA-------RTSRRKKRRSSKGRKSTQSIH 437
+ + + D + V + E R ++ ++
Sbjct: 270 EKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEG 329
Query: 438 EGHH 441
HH
Sbjct: 330 HHHH 333
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-49
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 14/204 (6%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAREIRILQKL 166
D Y+ +G+G +S V + +R+TG+ A+K +F +S S + + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDL-TKIICR--PGQKLTEPQVKCYMQQLLS 222
HP++++L +S LY+VF+FM +DL +I+ R G +E YM+Q+L
Sbjct: 84 KHPHIVELLETYSSDG--MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 223 GLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
L++CH+ I+HRD+K +L+ + S +K+ FG++ RV T +
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFM 200
Query: 280 APELLLGSTDYGVGIDLWSAGCLL 303
APE++ YG +D+W G +L
Sbjct: 201 APEVVKREP-YGKPVDVWGCGVIL 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-48
Identities = 84/374 (22%), Positives = 149/374 (39%), Gaps = 64/374 (17%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAREIRILQKL 166
+ Y ++G+G +S V + G+ A + + + ++ RE RI + L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLL 67
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDL-TKIICRPGQKLTEPQVKCYMQQLLSGL 224
HPN+++L + + YL+FD + +L I+ R + +E +QQ+L +
Sbjct: 68 KHPNIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAV 123
Query: 225 QHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
HCH+ G++HR++K NLL+ K +K+ADFGL+ +Q+ T Y +P
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSP 182
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFI---GRPLMP--GRTEVEQLHRIFKLCGTPS--E 334
E+L YG +DLW+ G +L +I G P P + +I G
Sbjct: 183 EVLRKDP-YGKPVDLWACGVIL---YILLVGYP--PFWDEDQHRLYQQI--KAGAYDFPS 234
Query: 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
W + + P + ++ +L ++P+ R TAA AL++ + +
Sbjct: 235 PEWDTV-------------T---------PEAKDLINKMLTINPSKRITAAEALKHPWIS 272
Query: 395 ASPLACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETK 454
T K+ +++ RK +I + E
Sbjct: 273 HRSTVASCMHRQE----------TVDCLKKFNAR-RKLKGAILTVMLATRNFSVRKQEII 321
Query: 455 GETESSKELEKNAD 468
TE E N D
Sbjct: 322 KVTEQLIEAISNGD 335
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-48
Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 18/227 (7%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D + K+G G + +V+ +R +G +K + D S+ ++ + EI +L+ LDHP
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHP 80
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS----DLTKIICRPGQK--LTEPQVKCYMQQLLSG 223
N+IK+ + Y+V + + + +I+ + L+E V M+Q+++
Sbjct: 81 NIIKIFEVFEDYHNM--YIVMETCEGGELLE--RIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 224 LQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
L + H + ++H+D+K N+L +KI DFGL+ F + T+ T Y A
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMA 194
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
PE+ D+WSAG ++ + G G + E +
Sbjct: 195 PEVFKRD--VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-48
Identities = 67/249 (26%), Positives = 113/249 (45%), Gaps = 29/249 (11%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVK----FMAREIRI 162
++Y+ +G+G S V + + T K A+K + E V+ +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 163 LQKLD-HPNVIKLEGLATSRMQYSLYLVFDFMQS----DLTKIICRPGQKLTEPQVKCYM 217
L+K+ HPN+I+L+ + +LVFD M+ D + + L+E + + M
Sbjct: 77 LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFD--YLTEK--VTLSEKETRKIM 130
Query: 218 QQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW 277
+ LL + H+ I+HRD+K N+L+D +K+ DFG S P +K L T
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPS 188
Query: 278 YRAPELLLGSTD-----YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTP 332
Y APE++ S + YG +D+WS G ++ + G P R ++ L I + G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGNY 246
Query: 333 S--EDYWKK 339
W
Sbjct: 247 QFGSPEWDD 255
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 60/313 (19%), Positives = 112/313 (35%), Gaps = 44/313 (14%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKV---------------RFDTSEPESVK 154
+ Y + + QG ++ + K ALKK S
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 155 FMAREIRILQKLDHPNVIKL-EGLATSRMQYSLYLVFDFMQ--------SDLTKIICRPG 205
E++I+ + + + + +Y+++++M+ +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYD---EVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 206 QKLTEPQVKCYMQQLLSGLQHCH-ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264
+ +KC ++ +L+ + H E+ I HRD+K SN+L+DK+G +K++DFG S +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--- 202
Query: 265 QKGPLTSRVVTLWYRAPELLLGSTDY-GVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQL 322
+ T + PE + Y G +D+WS G L MF P + VE
Sbjct: 203 VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 323 HRIFKLCGTPSEDYWKKM-KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR 381
+ I ++ + F L L +PA R
Sbjct: 263 NNIRT------KNI--EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314
Query: 382 GTAASALQNEFFN 394
T+ AL++E+
Sbjct: 315 ITSEDALKHEWLA 327
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-48
Identities = 68/256 (26%), Positives = 112/256 (43%), Gaps = 28/256 (10%)
Query: 97 PKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESV 153
E + K +D+YD ++G+G +S V + + TG A K + + + +
Sbjct: 16 GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75
Query: 154 KFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDL-TKIICRPGQKLTEP 211
+ RE RI +KL HPN+++L YLVFD + +L I+ R + +E
Sbjct: 76 E---REARICRKLQHPNIVRLHDSIQEES--FHYLVFDLVTGGELFEDIVAR--EFYSEA 128
Query: 212 QVKCYMQQLLSGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGP 268
+QQ+L + +CH GI+HR++K NLL+ K +K+ADFGL+ +
Sbjct: 129 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 186
Query: 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI---GRPLMPGRTEVEQLHRI 325
T Y +PE+L Y +D+W+ G +L +I G P + +I
Sbjct: 187 WHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVIL---YILLVGYPPFWDEDQHRLYAQI 242
Query: 326 FKLCGTPS--EDYWKK 339
G W
Sbjct: 243 --KAGAYDYPSPEWDT 256
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 4e-48
Identities = 76/336 (22%), Positives = 126/336 (37%), Gaps = 77/336 (22%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAREIRILQKL 166
Y +GQG+Y V A + T I A+K K + P+ V+ + E+R+++KL
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQ-------------------------------- 194
HPN+ +L + + LV +
Sbjct: 86 HHPNIARLYEVYEDEQ--YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 195 --------SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI-- 244
+ E + M+Q+ S L + H +GI HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 245 DKSGMLKIADFGLSNFFIPKQKG---PLTSRVVTLWYRAPELLLGSTD-YGVGIDLWSAG 300
+KS +K+ DFGLS F G +T++ T ++ APE+L + + YG D WSAG
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 301 CLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS--EDYWKKMKLTTTFRPQHYKPSFREV 358
LL + +G PG + + + ++ + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNYNVL------------------ 303
Query: 359 FGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
P + +L+ LL + R A ALQ+ + +
Sbjct: 304 ----SPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-48
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D +G+GTY VY RD +A+K++ S + + EI + + L H
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR--YSQPLHEEIALHKHLKHK 79
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
N+++ G + + + + + S L + P K E + Y +Q+L GL+
Sbjct: 80 NIVQYLG--SFSENGFIKIFMEQVPGGSLSALLRSKWGPL-KDNEQTIGFYTKQILEGLK 136
Query: 226 HCHERGILHRDIKASNLLID-KSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
+ H+ I+HRDIK N+LI+ SG+LKI+DFG S + + TL Y APE++
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGTLQYMAPEII 195
Query: 285 LGSTD-YGVGIDLWSAGCLLAEMFIGRP 311
YG D+WS GC + EM G+P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 62/283 (21%), Positives = 120/283 (42%), Gaps = 35/283 (12%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
++G+G++ VYK D +T VA +++ + E +L+ L HPN+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 177 --LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG-- 231
+T + + + LV + M S L + R + ++ + +Q+L GLQ H R
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 232 ILHRDIKASNLLID-KSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
I+HRD+K N+ I +G +KI D GL+ K+ + + T + APE + Y
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPE--MYEEKY 206
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350
+D+++ G + EM P +E + +I++ ++T+ +P
Sbjct: 207 DESVDVYAFGMCMLEMATSEY--PY-SECQNAAQIYR-------------RVTSGVKPAS 250
Query: 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ E + + + R + L + FF
Sbjct: 251 FDKVAIPEVKEI-------IEGCIRQNKDERYSIKDLLNHAFF 286
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-47
Identities = 83/359 (23%), Positives = 143/359 (39%), Gaps = 53/359 (14%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL----- 166
Y + K+G G +S V+ A+D VA+K VR D E+ + EI++LQ++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADN 77
Query: 167 ------DHPNVIKLEG--LATSRMQYSLYLVFDFMQSDLTKIICR-PGQKLTEPQVKCYM 217
+++KL + +VF+ + +L +I + + + VK
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 218 QQLLSGLQHCH-ERGILHRDIKASNLLID------KSGMLKIADFGLSNFFIPKQKGPLT 270
+QLL GL + H GI+H DIK N+L++ +KIAD G + + T
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYT 193
Query: 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT------EVEQLHR 324
+ + T YR+PE+LLG+ +G G D+WS CL+ E+ G L + + + +
Sbjct: 194 NSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 325 IFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFP-----PSSYGI---------- 369
I +L G + K T TF +P Y
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 370 -LTTLLALDPAYRGTAASALQNEFFNASPLACDLS--SLPVICREEDEPARTSRRKKRR 425
L+ +L LDP R A + + + + ++ + D P + +
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVRDHK 371
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-47
Identities = 71/352 (20%), Positives = 126/352 (35%), Gaps = 46/352 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y +G+G + V++ + + K K V+ ++ VK +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++ L S L ++F+F+ D+ + I +L E ++ Y+ Q+ LQ H
Sbjct: 62 NILHLHESFESME--ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 229 ERGILHRDIKASNLLI--DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
I H DI+ N++ +S +KI +FG + P Y APE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH 177
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMP--GRTEVEQLHRIFKLCGTPS--EDYWKKMKL 342
D+WS G L+ + G P T + + I + + E+ +K++
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENI--MNAEYTFDEEAFKEI-- 230
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDL 402
S + + LL + R TA+ ALQ+ +
Sbjct: 231 -----------S---------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVST 270
Query: 403 SSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETK 454
+ + R ++ S I G R S + K
Sbjct: 271 KVIRTLKHR-----RYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVK 317
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-47
Identities = 84/346 (24%), Positives = 135/346 (39%), Gaps = 61/346 (17%)
Query: 119 GQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAREIRILQKLDHPNVIKL- 174
G+G Y V A +R T + VA+K R PE++K +EI I + L+H NV+K
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKFY 71
Query: 175 EGLATSRMQYSLYLV---------FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
+ YL FD I + EP + + QL++G+
Sbjct: 72 GHRREGNI---QYLFLEYCSGGELFDR--------IEPDI-GMPEPDAQRFFHQLMAGVV 119
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELL 284
+ H GI HRDIK NLL+D+ LKI+DFGL+ F + L TL Y APELL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344
+ +D+WS G +L M G +P + ++Y +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE--- 223
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSS 404
+ Y ++ + + +L +L +P+ R T ++ ++N
Sbjct: 224 ---KKTYLNPWK----KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276
Query: 405 LPVICREEDEPARTSRRKKR--------RSSKGRKSTQSIHEGHHK 442
+ P+ S+ + +S+ S S HH
Sbjct: 277 RVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHH 322
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-47
Identities = 65/314 (20%), Positives = 114/314 (36%), Gaps = 59/314 (18%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-H 168
+ +G G+ V G+ VA+K++ + EI++L + D H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRM-----LIDFCDIALMEIKLLTESDDH 68
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPG------QKLTEPQVKCYMQQLLS 222
PNVI+ T+ LY+ + +L ++ + E ++Q+ S
Sbjct: 69 PNVIRYYCSETTDR--FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGM-------------LKIADFGLSNFFIPKQ---K 266
G+ H H I+HRD+K N+L+ S + I+DFGL Q +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 267 GPLTSRVVTLWYRAPELLLGSTD------YGVGIDLWSAGCLLAEMF-IGRPLMPGRTEV 319
L + T +RAPELL S + ID++S GC+ + G+ P +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--PFGDKY 244
Query: 320 EQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPA 379
+ I + L + +++ ++ DP
Sbjct: 245 SRESNIIR----------GIFSLDEMKCLHDRSLI---------AEATDLISQMIDHDPL 285
Query: 380 YRGTAASALQNEFF 393
R TA L++ F
Sbjct: 286 KRPTAMKVLRHPLF 299
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-47
Identities = 77/290 (26%), Positives = 122/290 (42%), Gaps = 53/290 (18%)
Query: 119 GQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAREIRILQKLDHPNVIKL- 174
G+G Y V A +R T + VA+K R PE++K +EI I + L+H NV+K
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKFY 71
Query: 175 EGLATSRMQYSLYLV---------FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
+ YL FD I + EP + + QL++G+
Sbjct: 72 GHRREGNI---QYLFLEYCSGGELFDR--------IEPDI-GMPEPDAQRFFHQLMAGVV 119
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELL 284
+ H GI HRDIK NLL+D+ LKI+DFGL+ F + L TL Y APELL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344
+ +D+WS G +L M G +P + ++Y +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE--- 223
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
+ Y ++ + + +L +L +P+ R T ++ ++N
Sbjct: 224 ---KKTYLNPWK----KIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 71/236 (30%), Positives = 111/236 (47%), Gaps = 17/236 (7%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
++ + +G G +S V+ + R TGK+ ALK + S + EI +L+K+ H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKHE 66
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++ LE + S Y YLV + +L I G TE +QQ+LS +++ H
Sbjct: 67 NIVTLEDIYESTTHY--YLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH 123
Query: 229 ERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
E GI+HRD+K NLL +++ + I DFGLS Q G +++ T Y APE+L
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYVAPEVLA 180
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS--EDYWKK 339
Y +D WS G + + G P TE + +I + G +W
Sbjct: 181 Q-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEFESPFWDD 233
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 32/220 (14%)
Query: 119 GQGTYSNVYKARDRDTGKIVALK------------------------KVRFDTSEPESVK 154
G+G+Y V A + + A+K ++
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 155 FMAREIRILQKLDHPNVIKL-EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQ 212
+ +EI IL+KLDHPNV+KL E L + LY+VF+ + + ++ + L+E Q
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDP-NEDHLYMVFELVNQGPVMEVPTL--KPLSEDQ 138
Query: 213 VKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272
+ Y Q L+ G+++ H + I+HRDIK SNLL+ + G +KIADFG+SN F L++
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG-SDALLSNT 197
Query: 273 VVTLWYRAPELLLGST-DY-GVGIDLWSAGCLLAEMFIGR 310
V T + APE L + + G +D+W+ G L G+
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 10/233 (4%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D YD L ++G G + V++ ++ TG++ K + T P + EI I+ +L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHP 108
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
+I L + + L+ +F+ +L I K++E +V YM+Q GL+H H
Sbjct: 109 KLINLHDAFEDKYEM--VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 229 ERGILHRDIKASNLLI--DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
E I+H DIK N++ K+ +KI DFGL+ P + + T + APE++
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDR 224
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339
G D+W+ G L + G G ++E L + + ED +
Sbjct: 225 EP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 72/297 (24%), Positives = 110/297 (37%), Gaps = 53/297 (17%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRILQKLD 167
Y +G+G + V+ VA+K + S E+ +L K+
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 168 ----HPNVIKL-EGLATSRMQYSLYLVFDFMQS--DLTKIICRPGQKLTEPQVKCYMQQL 220
HP VI+L + T LV + DL I G L E +C+ Q+
Sbjct: 93 AGGGHPGVIRLLDWFETQEG---FMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQV 148
Query: 221 LSGLQHCHERGILHRDIKASNLLID-KSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
++ +QHCH RG++HRDIK N+LID + G K+ DFG P T T Y
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYS 205
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT-PSEDYWK 338
PE + + + +WS G LL +M +CG P E +
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDM---------------------VCGDIPFERDQE 244
Query: 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395
++ F P H P ++ LA P+ R + L + +
Sbjct: 245 ILEAELHF-PAH-----------VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 72/250 (28%), Positives = 110/250 (44%), Gaps = 32/250 (12%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSE---PESVKFMAREIRIL 163
YD +G+G S V + R TG A+K S E + RE IL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 164 QKL-DHPNVIKLEGLATSRMQYSLYLVFDFMQS----DLTKIICRPGQKLTEPQVKCYMQ 218
+++ HP++I L S ++LVFD M+ D + + L+E + + M+
Sbjct: 154 RQVAGHPHIITLIDSYESSS--FMFLVFDLMRKGELFD--YLTEK--VALSEKETRSIMR 207
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWY 278
LL + H I+HRD+K N+L+D + ++++DFG S P +K L T Y
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGY 265
Query: 279 RAPELLLGSTD-----YGVGIDLWSAGCLLAEMFIGRPLMP--GRTEVEQLHRIFKLCGT 331
APE+L S D YG +DLW+ G +L + G P P R ++ L I + G
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP--PFWHRRQILMLRMI--MEGQ 321
Query: 332 PS--EDYWKK 339
W
Sbjct: 322 YQFSSPEWDD 331
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-46
Identities = 74/329 (22%), Positives = 142/329 (43%), Gaps = 48/329 (14%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP-ESVKFMAREIRILQKLD 167
+ L ++G G++ VY ARD ++VA+KK+ + + E + + +E+R LQKL
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
HPN I+ G +++ +LV ++ + ++ + L E ++ L GL +
Sbjct: 113 HPNTIQYRG--CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR---VVTLWYRAPELL 284
H ++HRD+KA N+L+ + G++K+ DFG + + V T ++ APE++
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVI 222
Query: 285 LGSTD--YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLC--GTPSEDYWKKM 340
L + Y +D+WS G E+ +P P + + ++ + +P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKP--P-LFNMNAMSALYHIAQNESP-------- 271
Query: 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400
+ H+ FR F + + L P R T+ L++ F
Sbjct: 272 ----ALQSGHWSEYFRN----F-------VDSCLQKIPQDRPTSEVLLKHRFVLR---ER 313
Query: 401 DLSSL-PVICREEDEPARTSRRKKRRSSK 428
+ + +I R +D + R+ K
Sbjct: 314 PPTVIMDLIQRTKDAVRELDNLQYRKMKK 342
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-46
Identities = 81/385 (21%), Positives = 142/385 (36%), Gaps = 86/385 (22%)
Query: 69 SRSRKSVKKKISEDELVDGWPKWLVDN-------IPKEVLAGLVPKSADSYDKLAKVGQG 121
+ K DG+ D+ E Y+ + +G+G
Sbjct: 18 LYFQSMSSHKKERKVYNDGY-----DDDNYDYIVKNGEKWMD-------RYEIDSLIGKG 65
Query: 122 TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAR----EIRILQKL------DHPNV 171
++ V KA DR + VA+K ++ + K E+R+L+ + +
Sbjct: 66 SFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 172 IKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQK-LTEPQVKCYMQQLLSGLQHCHER 230
+ L+ R L LVF+ + +L ++ + ++ + + QQ+ + L
Sbjct: 119 VHLKRHFMFRNH--LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 231 --GILHRDIKASNLLI--DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
I+H D+K N+L+ K +KI DFG S + + + +YR+PE+LLG
Sbjct: 177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQSRFYRSPEVLLG 232
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
Y + ID+WS GC+L EM G PL G EV+Q+++I ++ G P + F
Sbjct: 233 -MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKF 291
Query: 347 RPQHYKPSFREVFGE-----------------------FPPSSYGI-------------- 369
+ ++ + P
Sbjct: 292 FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351
Query: 370 -LTTLLALDPAYRGTAASALQNEFF 393
+ +L DP R ALQ+ FF
Sbjct: 352 LILRMLDYDPKTRIQPYYALQHSFF 376
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-46
Identities = 73/316 (23%), Positives = 130/316 (41%), Gaps = 42/316 (13%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
+ D Y+ +G G + V A + VA+K++ + + + + +EI+ + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQ----KLTEPQVKCYM 217
HPN++ + L+LV + D+ K I G+ L E + +
Sbjct: 70 CHHPNIVSYYTSFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 218 QQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR----V 273
+++L GL++ H+ G +HRD+KA N+L+ + G ++IADFG+S F V
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 274 VTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRP----LMPGRTEVEQLHRIFKLC 329
T + APE++ Y D+WS G E+ G P + L +
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----LMLTLQ-N 242
Query: 330 GTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
P L T + + + + F + ++ L DP R TAA L+
Sbjct: 243 DPP--------SLETGVQDKEMLKKYGKSFRKM-------ISLCLQKDPEKRPTAAELLR 287
Query: 390 NEFFNASPLACDLSSL 405
++FF A + L
Sbjct: 288 HKFFQK---AKNKEFL 300
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-46
Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSE-PESVKFMAREIRILQK 165
D Y+ ++G G ++ V K R + TGK A K K R +S S + + RE+ IL++
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDL-TKIICRPGQKLTEPQVKCYMQQLLSG 223
+ HPN+I L + ++ + L+ + + +L + + + LTE + +++Q+L G
Sbjct: 65 IRHPNIITLHDIFENKT--DVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDG 120
Query: 224 LQHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
+ + H + I H D+K N+++ + +K+ DFG+++ + + T +
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFV 178
Query: 280 APELLLGSTDYGVGIDLWSAGCLL 303
APE++ G+ D+WS G +
Sbjct: 179 APEIVNY-EPLGLEADMWSIGVIT 201
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-45
Identities = 82/405 (20%), Positives = 146/405 (36%), Gaps = 41/405 (10%)
Query: 69 SRSRKSVKKKISEDELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYK 128
K V+ K + D + + + + D YD ++G G + V++
Sbjct: 116 DEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR 175
Query: 129 ARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188
+R TG A K V T + + +EI+ + L HP ++ L + +
Sbjct: 176 VTERATGNNFAAKFVM--TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM--VM 231
Query: 189 VFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI--D 245
+++FM +L + + K++E + YM+Q+ GL H HE +H D+K N++
Sbjct: 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK 291
Query: 246 KSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAE 305
+S LK+ DFGL+ PKQ + T + APE+ G G D+WS G L
Sbjct: 292 RSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYI 348
Query: 306 MFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPS 365
+ G G + E L + + + +
Sbjct: 349 LLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS----------------------ED 386
Query: 366 SYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICREEDEPARTSRRKKRR 425
+ LL DP R T AL++ + S +P +R ++ +
Sbjct: 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS--------SRYTKIRDSI 438
Query: 426 SSKGRKSTQSIH-EGHHKRVSSVSSADETKGETESSKELEKNADP 469
+K + + G SS+ + + A P
Sbjct: 439 KTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQP 483
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 70/307 (22%), Positives = 112/307 (36%), Gaps = 51/307 (16%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRILQKLD 167
Y +G G + +VY VA+K V D E + + E+ +L+K+
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 168 H--PNVIKL-EGLATSRMQYSLYLVFDFMQS--DLTKIICRPGQKLTEPQVKCYMQQLLS 222
VI+L + L+ + + DL I G L E + + Q+L
Sbjct: 105 SGFSGVIRLLDWFERPDS---FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLE 160
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGM-LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
++HCH G+LHRDIK N+LID + LK+ DFG + T T Y P
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 217
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT-PSEDYWKKM 340
E + +G +WS G LL +M +CG P E + +
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDM---------------------VCGDIPFEHDEEII 256
Query: 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400
+ F Q ++ LAL P+ R T + + L
Sbjct: 257 RGQVFF-RQR-----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304
Query: 401 DLSSLPV 407
+ + + +
Sbjct: 305 ETAEIHL 311
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 61/242 (25%), Positives = 114/242 (47%), Gaps = 21/242 (8%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSE-PESVKFMAREIRILQK 165
D YD ++G G ++ V K R++ TG A K K R +S S + + RE+ IL++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQS----DLTKIICRPGQKLTEPQVKCYMQQLL 221
+ HPNVI L + ++ + L+ + + D + + + LTE + +++Q+L
Sbjct: 71 IQHPNVITLHEVYENKT--DVILILELVAGGELFD--FLAEK--ESLTEEEATEFLKQIL 124
Query: 222 SGLQHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW 277
+G+ + H I H D+K N+++ +KI DFGL++ + + T
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPE 182
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337
+ APE++ G+ D+WS G + + G G T+ E L + + ++Y+
Sbjct: 183 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 338 KK 339
Sbjct: 242 SN 243
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-45
Identities = 46/320 (14%), Positives = 90/320 (28%), Gaps = 81/320 (25%)
Query: 119 GQGTYSNVYKARDRDTGKIVALKKVRFDTSEP-ESVKFMAREIRILQKL----------- 166
GQ +A D++TG+ + F P ++K M E+ L+ L
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 167 --------------DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKII------CRPGQ 206
+I++ S + ++ MQS+L +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 207 KLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266
L Q++ L H G++H ++ ++++D+ G + + F +
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL-----VRD 256
Query: 267 GPLTSRVVTLWYRAPELL----------LGSTDYGVGIDLWSAGCLLAEMFIGRPLMP-- 314
G V+ + PEL T D W+ G ++ ++ P
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL--PIT 314
Query: 315 GRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLL 374
+ IF+ C P +L L
Sbjct: 315 KDAALGGSEWIFRSC------------------------------KNIPQPVRALLEGFL 344
Query: 375 ALDPAYRGTAASALQNEFFN 394
R A++ +
Sbjct: 345 RYPKEDRLLPLQAMETPEYE 364
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-45
Identities = 65/362 (17%), Positives = 124/362 (34%), Gaps = 37/362 (10%)
Query: 106 PKSADSYDKLAKVGQG--TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRIL 163
Y+ L +G+G V AR + TG+ V ++++ + E V F+ E+ +
Sbjct: 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVS 80
Query: 164 QKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQ 219
+ +HPN++ + L++V FM DL G + E + +Q
Sbjct: 81 KLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLICTHFMDG--MNELAIAYILQG 136
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK------GPLTSRV 273
+L L + H G +HR +KAS++LI G + ++ + I + V
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 274 VTLWYRAPELLLGSTD-YGVGIDLWSAGCLLAEMFIGRP------------LMP------ 314
L + +PE+L + Y D++S G E+ G
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256
Query: 315 --GRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTT 372
+ + + + T+T RP + F P + +
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316
Query: 373 LLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICREEDEPARTSRRKKRRSSKGRKS 432
L +P R +A++ L + FF + ++ + + S
Sbjct: 317 CLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLV 376
Query: 433 TQ 434
T
Sbjct: 377 TN 378
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-45
Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 26/224 (11%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPN 170
+ +G ++ VY+A+D +G+ ALK++ ++E E + + +E+ ++KL HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 171 VIKLEGLATSRM------QYSLYLVFDFMQSDLTKII--CRPGQKLTEPQVKCYMQQLLS 222
+++ A+ Q L+ + + L + + L+ V Q
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 223 GLQHCHERG--ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS--------- 271
+QH H + I+HRD+K NLL+ G +K+ DFG + ++
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 272 --RVVTLWYRAPEL--LLGSTDYGVGIDLWSAGCLLAEMFIGRP 311
R T YR PE+ L + G D+W+ GC+L + +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-45
Identities = 75/352 (21%), Positives = 128/352 (36%), Gaps = 99/352 (28%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAR----EIRILQKL- 166
+ + K+G GT+ V + D K A+K VR ++K R E IL+K+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89
Query: 167 ----DHPNVIKLEG---------LATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQV 213
++ N++K G L + SLY + + + +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY---EIIT----RNNYNG---FHIEDI 139
Query: 214 KCYMQQLLSGLQHCHERGILHRDIKASNLLI-------------------------DKSG 248
K Y ++L L + + + H D+K N+L+ KS
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 249 MLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI 308
+K+ DFG + F + S + T YRAPE++L + V D+WS GC+LAE++
Sbjct: 200 GIKLIDFGCATF----KSDYHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYT 254
Query: 309 GRPLMPGRTEVEQLHRIFKLCGTP-----------------SEDYWKKMKLTTTFRPQHY 351
G L +E L + + ++D K
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314
Query: 352 KPSF----------REVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
K E+F +F L ++L +DP R + A L+++F
Sbjct: 315 KHVKKCLPLYKIIKHELFCDF-------LYSILQIDPTLRPSPAELLKHKFL 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 9e-45
Identities = 75/346 (21%), Positives = 122/346 (35%), Gaps = 79/346 (22%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGK-IVALKKVRFDTSEPESVKFMAR----EIRIL 163
+ Y+ + +G+GT+ V + D GK VALK +R +V EI +L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVL 70
Query: 164 QKL------DHPNVIKLEG---------LATSRMQYSLYLVFDFMQSDLTKIICRPGQKL 208
+K+ + + + +A + + + + K
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF--------EFLKENNFQP--Y 120
Query: 209 TEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI-------------------DKSGM 249
P V+ QL L+ HE + H D+K N+L K+
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 250 LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG 309
+++ADFG S F + T+ V T YR PE++L + D+WS GC+L E + G
Sbjct: 181 IRVADFG-SATFDHEH---HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRG 235
Query: 310 RPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF------RPQHYKPSFREVFGEFP 363
L E L + K+ G + + F ++ P
Sbjct: 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP 295
Query: 364 PSSY------------GILTTLLALDPAYRGTAASALQNEFFNASP 397
SY ++ +L DPA R T A AL + FF
Sbjct: 296 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSE-PESVKFMAREIRILQK 165
D YD ++G G ++ V K R++ TG A K K + S S + + RE+ IL++
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDL-TKIICRPGQKLTEPQVKCYMQQLLSG 223
+ H NVI L + +R + L+ + + +L + + + L+E + +++Q+L G
Sbjct: 72 VLHHNVITLHDVYENRT--DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDG 127
Query: 224 LQHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
+ + H + I H D+K N+++ +K+ DFGL++ + + T +
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFV 185
Query: 280 APELLLGSTDYGVGIDLWSAGCLL 303
APE++ G+ D+WS G +
Sbjct: 186 APEIVNY-EPLGLEADMWSIGVIT 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 73/318 (22%), Positives = 129/318 (40%), Gaps = 64/318 (20%)
Query: 119 GQGTYSNVYKARDRDTGKIVALK-----KVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
G+G+Y V + D +T A+K K+R + +VK +EI++L++L H NVI+
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNVIQ 70
Query: 174 LE---GLATSRMQYSLYLVFDFM---QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
L + +Y+V ++ ++ + ++ Q Y QL+ GL++
Sbjct: 71 LVDVLYNEEKQK---MYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYL 125
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL--TSRVVTLWYRAPELLL 285
H +GI+H+DIK NLL+ G LKI+ G++ P TS+ + ++ PE+
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPPEIAN 184
Query: 286 GSTDY-GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT-PSEDY-----WK 338
G + G +D+WSAG L + G P E ++
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNI---------------------TTGLYPFEGDNIYKLFE 223
Query: 339 KMKLTTTFR-PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS- 396
+ ++ P P +L +L +PA R + Q+ +F
Sbjct: 224 NIG-KGSYAIPGD-----------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
Query: 397 PLACDLSSLPVICREEDE 414
P A +P +D
Sbjct: 272 PPAEAPVPIPPSPDTKDR 289
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 86/317 (27%), Positives = 134/317 (42%), Gaps = 52/317 (16%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
YD + +G G + RD+ T ++VA+K + + E+V+ REI + L HPN+
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNI 78
Query: 172 IKL-EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
++ E + T L ++ ++ +L + IC G + +E + + + QQLLSG+ +CH
Sbjct: 79 VRFKEVILTPTH---LAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHS 134
Query: 230 RGILHRDIKASNLLIDKSGM--LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
I HRD+K N L+D S LKI DFG S S V T Y APE+LL
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT-PSEDYWKKMKLTTTF 346
G D+WS G L M L G P ED + +
Sbjct: 193 EYDGKIADVWSCGVTLYVM---------------------LVGAYPFEDP----EEPRDY 227
Query: 347 RPQHYKPSFREVFGEF--PPSSY------GILTTLLALDPAYRGTAASALQNEFFNASPL 398
R K R + ++ P +++ + DPA R + + +F + L
Sbjct: 228 R----KTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN-L 282
Query: 399 ACDLSSLPVICREEDEP 415
DL + + EP
Sbjct: 283 PADLMNESNTGSQFQEP 299
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 24/243 (9%)
Query: 110 DSYDKLAKV-GQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-D 167
D Y +V G G V + R TG+ ALK + +E+ +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASG 80
Query: 168 HPNVIKLEGL--ATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
P+++ + + + L ++ + M+ ++I R Q TE + M+ + +
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 224 LQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
+Q H I HRD+K NLL +K +LK+ DFG + L + T +Y A
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPCYTPYYVA 197
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK--LCGTPS--EDY 336
PE+L Y D+WS G ++ + G P T + + G
Sbjct: 198 PEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 337 WKK 339
W +
Sbjct: 257 WSE 259
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-44
Identities = 76/374 (20%), Positives = 152/374 (40%), Gaps = 51/374 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSE-PESVKFMAREIRILQK 165
D YD ++G G ++ V K R++ TG A K K + S + + RE+ IL++
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDL-TKIICRPGQKLTEPQVKCYMQQLLSG 223
+ HPN+I L + +R L+ + + +L + + + L+E + +++Q+L G
Sbjct: 72 VLHPNIITLHDVYENRTDV--VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDG 127
Query: 224 LQHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
+ + H + I H D+K N+++ +K+ DFGL++ + + T +
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFV 185
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMP--GRTEVEQLHRIFKLCGTPSEDYW 337
APE++ G+ D+WS G + + G P G T+ E L I + E+++
Sbjct: 186 APEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITAVSYDFDEEFF 242
Query: 338 KKM----KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ K +F + LL + R T AL++ +
Sbjct: 243 SQTSELAK-------------------DF-------IRKLLVKETRKRLTIQEALRHPWI 276
Query: 394 NASPLACDLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADET 453
+ + E+ + RR+ + S + K+V +S D
Sbjct: 277 TPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLR 336
Query: 454 KGETESSKELEKNA 467
E+++ + + +
Sbjct: 337 NCESDTEENIARRK 350
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-44
Identities = 46/198 (23%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 110 DSYDKLAKV-GQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
+ Y +K G+G ++ V + + TG+ A K ++ + + EI +L+
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 169 -PNVIKLEGLATSRMQYSLYLVFDFMQ-SDL-TKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
P VI L + + + L+ ++ ++ + + + ++E V ++Q+L G+
Sbjct: 88 CPRVINLHEVYENTSEI--ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 226 HCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
+ H+ I+H D+K N+L+ G +KI DFG+S + L + T Y APE
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPE 203
Query: 283 LLLGSTDYGVGIDLWSAG 300
+L D+W+ G
Sbjct: 204 ILNYDP-ITTATDMWNIG 220
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-44
Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 14/236 (5%)
Query: 110 DSYD--KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD 167
Y K +G G + V+K + TG +A K ++ T + + + EI ++ +LD
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK--TRGMKDKEEVKNEISVMNQLD 144
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQ-SDL-TKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
H N+I+L S+ LV +++ +L +II LTE +M+Q+ G++
Sbjct: 145 HANLIQLYDAFESKNDI--VLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIR 201
Query: 226 HCHERGILHRDIKASNLLI--DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
H H+ ILH D+K N+L + +KI DFGL+ + P++K L T + APE+
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEV 259
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339
+ D+WS G + + G G + E L+ I ++ ++
Sbjct: 260 VNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD 314
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-44
Identities = 64/343 (18%), Positives = 118/343 (34%), Gaps = 79/343 (23%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTG-KIVALKKVRFDTSEPESVKFMAR----EIRILQKL 166
Y+ + +G+G + V + D G + VA+K V+ +V EI++L+ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68
Query: 167 ------DHPNVIKLEG---------LATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEP 211
+++ + + S Y D K
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY--------DFIKENGFLP--FRLD 118
Query: 212 QVKCYMQQLLSGLQHCHERGILHRDIKASNLLID-------------------KSGMLKI 252
++ Q+ + H + H D+K N+L + +K+
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 253 ADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPL 312
DFG S + + ++ V T YRAPE++L + D+WS GC+L E ++G +
Sbjct: 179 VDFG-SATYDDEH---HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTV 233
Query: 313 MPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY---------------KPSFRE 357
P E L + ++ G + +K + F +E
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293
Query: 358 VFG---EFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397
+ ++ +L DPA R T AL++ FF+
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-44
Identities = 74/282 (26%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 119 GQGTYSNVYKARDRDTGKIVALK---KVRFDTSE-PESVKFMAREIRILQKLDHPNVIKL 174
G+G++ V A T + VALK + S+ V+ REI L+ L HP++IKL
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRHPHIIKL 74
Query: 175 -EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
+ + T + +V ++ +L I ++TE + + + QQ++ +++CH I+
Sbjct: 75 YDVITTPTD---IVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIV 130
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVG 293
HRD+K NLL+D + +KIADFGLSN L + + Y APE++ G G
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188
Query: 294 IDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK- 352
+D+WS G +L M +GR ++ Y
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS---------------------CVYVM 227
Query: 353 PSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
P F P + ++ ++ DP R T ++ +FN
Sbjct: 228 PDF------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-43
Identities = 79/290 (27%), Positives = 132/290 (45%), Gaps = 57/290 (19%)
Query: 119 GQGTYSNVYKARDRDTGKIVALK---KVRFDTSE-PESVKFMAREIRILQKLDHPNVIKL 174
G GT+ V + TG VA+K + + + + +K REI+ L+ HP++IKL
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK---REIQNLKLFRHPHIIKL 76
Query: 175 -EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
+ ++T ++V +++ +L IC+ G ++ E + + QQ+LS + +CH +
Sbjct: 77 YQVISTPTD---FFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
+HRD+K N+L+D KIADFGLSN L + + Y APE++ G G
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT-PSEDYWKKMKLTTTFRPQHY 351
+D+WS G +L + LCGT P +D +H
Sbjct: 191 EVDIWSCGVILYAL---------------------LCGTLPFDD-------------EHV 216
Query: 352 KPSFREVF-GEF------PPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
F+++ G F S +L +L +DP R T ++E+F
Sbjct: 217 PTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 72/331 (21%), Positives = 123/331 (37%), Gaps = 68/331 (20%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLE 175
+G+G++S K + + + A+K + + + +EI L+ + HPN++KL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQ---KEITALKLCEGHPNIVKLH 72
Query: 176 GLATSRMQYSLYLVFDFMQSD--LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
+ ++ +LV + + +I + + +E + M++L+S + H H+ G++
Sbjct: 73 EVFHDQL--HTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVV 128
Query: 234 HRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
HRD+K NLL + + +KI DFG + P PL + TL Y APELL + Y
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQNG-Y 186
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTP---SEDYWKKMKLTTTFR 347
DLWS G +L M L G S D
Sbjct: 187 DESCDLWSLGVILYTM---------------------LSGQVPFQSHD------------ 213
Query: 348 PQHYKPSFREVF-----GEFP-PSSY--GI-------LTTLLALDPAYRGTAASALQNEF 392
S E+ G+F + + LL +DP R + NE+
Sbjct: 214 RSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273
Query: 393 FNASPLACDLSSLPVICREEDEPARTSRRKK 423
+ A + K
Sbjct: 274 LQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-43
Identities = 81/321 (25%), Positives = 147/321 (45%), Gaps = 46/321 (14%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
+ + KL K+G+G++ V+K D T K+VA+K + + +E E ++ + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
P V K G + L+++ +++ DL + L E Q+ ++++L GL
Sbjct: 80 PYVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGL 132
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
+ H +HRDIKA+N+L+ + G +K+ADFG++ + + + V T ++ APE++
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY--WKKMKL 342
S Y D+WS G E+ G P P + K + L
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP--------------------PHSELHPMKVLFL 230
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDL 402
P + ++ + EF + L +P++R TA L+++F + A
Sbjct: 231 IPKNNPPTLEGNYSKPLKEF-------VEACLNKEPSFRPTAKELLKHKFILRN--AKKT 281
Query: 403 SSL-PVICREEDEPARTSRRK 422
S L +I R + A S
Sbjct: 282 SYLTELIDRYKRWKAEQSHDD 302
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 1e-42
Identities = 48/337 (14%), Positives = 97/337 (28%), Gaps = 68/337 (20%)
Query: 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPES-VKFMAREIRILQKL---------- 166
+GQ +A D++TG+ + F P + +K M E+ L+ L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 167 ---------------DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKII------CRPG 205
+I++ S + ++ MQS+L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 206 QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265
+ L Q++ L H G++H ++ ++++D+ G + + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 266 KGPLTSRVVTLWYRAPELLLGS----TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ 321
P+ A +L T D W+ G + ++ +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325
Query: 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR 381
IF+ C + +L L R
Sbjct: 326 SEWIFRSCKNIPQPVRA------------------------------LLEGFLRYPKEDR 355
Query: 382 GTAASALQNEFFNASPLACDLSSLPVICREEDEPART 418
A++ + L +LS+ + + + EP R
Sbjct: 356 LLPLQAMETPEYEQ--LRTELSAALPLYQTDGEPTRE 390
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 84/374 (22%), Positives = 159/374 (42%), Gaps = 69/374 (18%)
Query: 62 NGGGDGGSRSRKSVKKKISEDELVDGWPKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQG 121
+ G D G+ + ++ ++ + P+ + D K+G+G
Sbjct: 8 SSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLL-----------LDSYVKIGEG 56
Query: 122 TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR 181
+ V AR++ +G+ VA+K + D + + + + E+ I++ H NV+++ +
Sbjct: 57 STGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK--SYL 112
Query: 182 MQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDI 237
+ L+++ +F+Q +D+ + L E Q+ + +L L + H +G++HRDI
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 238 KASNLLIDKSGMLKIADFGLS---NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGI 294
K+ ++L+ G +K++DFG + +PK+K S V T ++ APE++ S Y +
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRK----SLVGTPYWMAPEVISRS-LYATEV 222
Query: 295 DLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPS 354
D+WS G ++ EM G P + V+ + R+ P KL P
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPP--------KLK---NSHKVSPV 270
Query: 355 FREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSL-PVICREED 413
R+ F L +L DP R TA L + F L P+I
Sbjct: 271 LRD-F----------LERMLVRDPQERATAQELLDHPFLL---QTGLPECLVPLI----- 311
Query: 414 EPARTSRRKKRRSS 427
+K+ S+
Sbjct: 312 -----QLYRKQTST 320
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 54/243 (22%), Positives = 97/243 (39%), Gaps = 23/243 (9%)
Query: 110 DSYDKLAKV-GQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-D 167
D Y ++V G G V + ++ T + ALK + + RE+ + +
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQ 113
Query: 168 HPNVIKLEGL--ATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
P+++++ + + L +V + + ++I R Q TE + M+ +
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 224 LQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
+Q+ H I HRD+K NLL + +LK+ DFG + LT+ T +Y A
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVA 231
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK--LCGTPS--EDY 336
PE +LG Y D+WS G ++ + G P + + G
Sbjct: 232 PE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290
Query: 337 WKK 339
W +
Sbjct: 291 WSE 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 77/300 (25%), Positives = 137/300 (45%), Gaps = 41/300 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
Y + K+GQG VY A D TG+ VA++++ + + + + EI ++++ +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNP 77
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
N++ + + L++V +++ +D+ + E Q+ ++ L L+
Sbjct: 78 NIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALE 130
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
H ++HRDIK+ N+L+ G +K+ DFG I ++ ++ V T ++ APE++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
YG +D+WS G + EM G P + L+ I GTP +L
Sbjct: 190 RK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP--------ELQ-- 237
Query: 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSL 405
P+ FR+ F L L +D RG+A LQ++F +A LSSL
Sbjct: 238 -NPEKLSAIFRD-F----------LNRCLEMDVEKRGSAKELLQHQFLK---IAKPLSSL 282
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 48/305 (15%)
Query: 49 HGGDGNGVGERVRNGGGDGGSRSRKSVKKKISEDELVDGWPKWLVDNIPKEVLAGLVPKS 108
H + E + + S + D +DG + D +
Sbjct: 7 HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNR---DAL------------ 51
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
+D ++ +++G+G S VY+ + + T K ALK ++ T + + V+ EI +L +L H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR---TEIGVLLRLSH 107
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQS----DLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
PN+IKL+ + + + LV + + D +I+ + +E ++Q+L +
Sbjct: 108 PNIIKLKEIFETPTEI--SLVLELVTGGELFD--RIVEK--GYYSERDAADAVKQILEAV 161
Query: 225 QHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
+ HE GI+HRD+K NLL LKIADFGLS + + + T Y AP
Sbjct: 162 AYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVCGTPGYCAP 219
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFI---GRPLMPGRTEVEQLHRIFK--LCGTPS--E 334
E+L G YG +D+WS G + +I G P E +F+ L
Sbjct: 220 EILRG-CAYGPEVDMWSVGIIT---YILLCGFE--PFYDERGD-QFMFRRILNCEYYFIS 272
Query: 335 DYWKK 339
+W +
Sbjct: 273 PWWDE 277
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAREIRILQKL 166
D Y+ +G G+YS + + T A+K K + D + EI IL +
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---------EEIEILLRY 72
Query: 167 -DHPNVIKLEGLATSRMQYSLYLVFDFMQSD--LTKIICRPGQKLTEPQVKCYMQQLLSG 223
HPN+I L+ + +Y+V + M+ L KI+ + + +E + + +
Sbjct: 73 GQHPNIITLKDVYDDGK--YVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKT 128
Query: 224 LQHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
+++ H +G++HRD+K SN+L ++I DFG + + G L + T +
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFV 187
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRP---LMPGRTEVEQLHRI 325
APE+L Y D+WS G LL M G P T E L RI
Sbjct: 188 APEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-42
Identities = 83/317 (26%), Positives = 143/317 (45%), Gaps = 47/317 (14%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
+ ++ + ++G G + VYKA++++TG + A K + +T E ++ EI IL DH
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
P ++KL G L+++ +F + + R LTEPQ++ +Q+L L
Sbjct: 76 PYIVKLLG--AYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEAL 130
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
H + I+HRD+KA N+L+ G +++ADFG+S K S + T ++ APE++
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 285 LGST----DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLC--GTPSEDYWK 338
+ T Y D+WS G L EM P P E+ + + K+ P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEP--P-HHELNPMRVLLKIAKSDPP------ 240
Query: 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398
L P + FR+ F L L +P R +AA L++ F ++
Sbjct: 241 --TLL---TPSKWSVEFRD-F----------LKIALDKNPETRPSAAQLLEHPFVSS--- 281
Query: 399 ACDLSSL-PVICREEDE 414
+L ++ + E
Sbjct: 282 ITSNKALRELVAEAKAE 298
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-42
Identities = 76/332 (22%), Positives = 123/332 (37%), Gaps = 58/332 (17%)
Query: 110 DSYDKLAKV-GQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-D 167
D Y V G+G ++ V + T + A+K + + + RE+ +L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQG 69
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
H NV++L + YLVF+ M+ S L+ I R + E + +Q + S L
Sbjct: 70 HRNVLELIEFFEE--EDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALD 125
Query: 226 HCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQ------KGPLTSRVVTL 276
H +GI HRD+K N+L ++ +KI DF L + L + +
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 277 WYRAPELLLGSTD----YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTP 332
Y APE++ ++ Y DLWS G +L +I L L G P
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVIL---YI---L---------------LSGYP 224
Query: 333 ---SEDYWKKMKLTTTFRPQHYKPSFREVF-GEFP-PSSY--GI-------LTTLLALDP 378
P F + G++ P I ++ LL D
Sbjct: 225 PFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDA 284
Query: 379 AYRGTAASALQNEFFNASPLACDLSSLPVICR 410
R +AA LQ+ + L + V+ R
Sbjct: 285 KQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR 316
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 33/278 (11%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQK 165
K + + +G+G++S V AR+ T + A+K + + V ++ RE ++ +
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
LDHP +KL T + LY + ++ +L K I + G E + Y +++S L
Sbjct: 87 LDHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSAL 143
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPEL 283
++ H +GI+HRD+K N+L+++ ++I DFG + P+ K + V T Y +PEL
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343
L DLW+ GC++ ++ G P P F+ G + K +KL
Sbjct: 204 LTEK-SACKSSDLWALGCIIYQLVAGLP--P-----------FR-AGNEYLIFQKIIKLE 248
Query: 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR 381
F P+ F P + ++ LL LD R
Sbjct: 249 YDF-PEK-----------FFPKARDLVEKLLVLDATKR 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 85/320 (26%), Positives = 150/320 (46%), Gaps = 42/320 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ +D L K+G+G+Y +VYKA ++TG+IVA+K+V + S+ + + +EI I+Q+ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEII---KEISIMQQCDSP 84
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
+V+K G + L++V ++ SD+ ++ + LTE ++ +Q L GL+
Sbjct: 85 HVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLE 139
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
+ H +HRDIKA N+L++ G K+ADFG++ + + + T ++ APE++
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTVIGTPFWMAPEVIQ 198
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
Y D+WS G EM G+P + + I P
Sbjct: 199 EI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPP--------TFR-- 246
Query: 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSL 405
+P+ + +F + F + L P R TA LQ+ F + A +S L
Sbjct: 247 -KPELWSDNFTD-F----------VKQCLVKSPEQRATATQLLQHPFVRS---AKGVSIL 291
Query: 406 -PVICREEDEPARTSRRKKR 424
+I D + ++R
Sbjct: 292 RDLINEAMDVKLKRQESQQR 311
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 81/290 (27%), Positives = 135/290 (46%), Gaps = 57/290 (19%)
Query: 119 GQGTYSNVYKARDRDTGKIVALK---KVRFDTSE-PESVKFMAREIRILQKLDHPNVIKL 174
G GT+ V + TG VA+K + + + + ++ REI+ L+ HP++IKL
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR---REIQNLKLFRHPHIIKL 81
Query: 175 -EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
+ ++T +++V +++ +L IC+ G +L E + + QQ+LSG+ +CH +
Sbjct: 82 YQVISTPSD---IFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
+HRD+K N+L+D KIADFGLSN L + + Y APE++ G G
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSCGSPNYAAPEVISGRLYAGP 195
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT-PSEDYWKKMKLTTTFRPQHY 351
+D+WS+G +L + LCGT P +D H
Sbjct: 196 EVDIWSSGVILYAL---------------------LCGTLPFDD-------------DHV 221
Query: 352 KPSFREVF-GEF------PPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
F+++ G F PS +L +L +DP R T ++E+F
Sbjct: 222 PTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-41
Identities = 77/331 (23%), Positives = 138/331 (41%), Gaps = 46/331 (13%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-D 167
A ++ + VG GTY VYK R TG++ A+K + E E +K +EI +L+K
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 79
Query: 168 HPNVIKLEG----LATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQ 219
H N+ G M L+LV +F +DL K G L E + ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICRE 137
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
+L GL H H+ ++HRDIK N+L+ ++ +K+ DFG+S + + G + + T ++
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWM 196
Query: 280 APELLLGSTD----YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335
APE++ + Y DLWS G EM G P + + L I + P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PAP--- 252
Query: 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395
+ + + F+ F + + L + + R +++ F
Sbjct: 253 ---------RLKSKKWSKKFQS-F----------IESCLVKNHSQRPATEQLMKHPFIRD 292
Query: 396 SPLACDLSSLPVICREEDEPARTSRRKKRRS 426
+ + + ++ + + R +K +
Sbjct: 293 ---QPNERQVRIQLKDHIDRTKKKRGEKDET 320
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 46/258 (17%), Positives = 86/258 (33%), Gaps = 30/258 (11%)
Query: 105 VPKSADSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMARE 159
+ +G+G ++ VY+A D + LK + P +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ--KPANPWEFYIGTQL 117
Query: 160 IRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM-QSDLTKIICR----PGQKLTEPQVK 214
+ L+ +K Q LV + L I P + + + V
Sbjct: 118 MERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 215 CYMQQLLSGLQHCHERGILHRDIKASNLLI-----------DKSGMLKIADFGLSNFFIP 263
+ ++L ++ H+ I+H DIK N ++ D S L + D G S
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 264 KQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPL-MPGRTEVEQ 321
KG T++ T ++ E+L + ID + + M G + + +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294
Query: 322 LHRIFKLCGTPSEDYWKK 339
+F+ P D W +
Sbjct: 295 PEGLFR--RLPHLDMWNE 310
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-40
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 22/232 (9%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKL 166
D ++ L +G+G +S V + + TG++ A+K + +D + V E +L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 167 DHPNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQ 219
D + +L ++ LYLV ++ DL ++ + G+++ + Y+ +
Sbjct: 119 DRRWITQL--------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
++ + H G +HRDIK N+L+D+ G +++ADFG V T Y
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 280 APELLLG------STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
+PE+L + YG D W+ G EMF G+ + E +I
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 8e-40
Identities = 70/339 (20%), Positives = 133/339 (39%), Gaps = 39/339 (11%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD 167
D ++K++++G G V+K + +G ++A K + + +P + RE+++L + +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECN 89
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
P ++ G S + + + M L +++ + G ++ E + ++ GL +
Sbjct: 90 SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTY 146
Query: 227 CH-ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT-----SRVVTLWYRA 280
+ I+HRD+K SN+L++ G +K+ DFG+S G L S V T Y +
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANSFVGTRSYMS 198
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRP--LMPGRTEVEQLHRIFKLCGTPSEDYWK 338
PE L G+ Y V D+WS G L EM +GR P E+E +
Sbjct: 199 PERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 339 KMKLTTTFRPQHYKPSFREVF----------------GEFPPSSYGILTTLLALDPAYRG 382
+ + +F G F + L +PA R
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317
Query: 383 TAASALQNEFF-NASPLACDLSSLPVICREEDEPARTSR 420
+ + F + D + ++P+ +
Sbjct: 318 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTH 356
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 56/227 (24%), Positives = 108/227 (47%), Gaps = 12/227 (5%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
+ + L ++G GT V+K R R TG ++A+K++R ++ E K + ++ ++ K
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE-NKRILMDLDVVLK 79
Query: 166 L-DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
D P +++ G + +++ + M + K+ R + E + ++ L
Sbjct: 80 SHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 225 QHCH-ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE- 282
+ + G++HRD+K SN+L+D+ G +K+ DFG+S + + Y APE
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPER 195
Query: 283 ---LLLGSTDYGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQLHRI 325
DY + D+WS G L E+ G+ P +T+ E L ++
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-39
Identities = 47/213 (22%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+G + K R+TG+++ +K++ E + + +E+++++ L+HPNV+K G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE--TQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ + L + ++++ L II + Q + + + SG+ + H I+HR
Sbjct: 75 VLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 236 DIKASNLLIDKSGMLKIADFGLS-------------NFFIPKQKGPLTSRVVTLWYRAPE 282
D+ + N L+ ++ + +ADFGL+ + + V ++ APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPG 315
++ G Y +D++S G +L E+ P
Sbjct: 193 MINGR-SYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 27/234 (11%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL- 166
+A+ L ++G+G Y +V K + +G+I+A+K++R E E K + ++ ++ +
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSS 78
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFM----QSDLTKIICRPGQKLTEPQVKCYMQQLLS 222
D P +++ G A R + ++ + M + + E + +
Sbjct: 79 DCPYIVQFYG-ALFR-EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 223 GLQHCH-ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL------TSRVVT 275
L H I+HRDIK SN+L+D+SG +K+ DFG+S G L T
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS--------GQLVDSIAKTRDAGC 188
Query: 276 LWYRAPELLLGSTD---YGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQLHRI 325
Y APE + S Y V D+WS G L E+ GR P + +QL ++
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 51/216 (23%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKL 166
+ ++ L +G+G + V + ++ K+ A+K + ++ + E +L
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 167 DHPNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQ 219
D + L Y+ LYLV D+ DL ++ + +L E + Y+ +
Sbjct: 132 DSKWITTL--------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
++ + H+ +HRDIK N+L+D +G +++ADFG + + V T Y
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 280 APELLLGSTD----YGVGIDLWSAGCLLAEMFIGRP 311
+PE+L YG D WS G + EM G
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 48/243 (19%), Positives = 88/243 (36%), Gaps = 44/243 (18%)
Query: 110 DSYDKLAKV-GQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-D 167
D Y ++V G G V + ++ T + ALK + + RE+ + +
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQ 69
Query: 168 HPNVIKLEGL--ATSRMQYSLYLVFDFMQ-SDL-TKIICRPGQKLTEPQVKCYMQQLLSG 223
P+++++ + + L +V + + +L ++I R Q TE + M+ +
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 224 LQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
+Q+ H I HRD+K NLL + +LK+ DFG A
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------------A 167
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK--LCGTPS--EDY 336
E Y D+WS G ++ + G P + + G
Sbjct: 168 KETTGEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225
Query: 337 WKK 339
W +
Sbjct: 226 WSE 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-38
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 26/233 (11%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL- 166
AD + + ++G+G Y V K R +G+I+A+K++R + E K + ++ I +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTV 63
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQ---SDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
D P + G A R + +++ + M K + GQ + E + ++
Sbjct: 64 DCPFTVTFYG-ALFR-EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 224 LQHCH-ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV------TL 276
L+H H + ++HRD+K SN+LI+ G +K+ DFG+S G L V
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS--------GYLVDDVAKDIDAGCK 173
Query: 277 WYRAPELLLGSTD---YGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQLHRI 325
Y APE + + Y V D+WS G + E+ I R P T +QL ++
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 71/281 (25%), Positives = 114/281 (40%), Gaps = 31/281 (11%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQ 164
P D + +G+G + V+ + + TGK+ A KK+ + + + E +IL
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQK---LTEPQVKCYMQQL 220
K+ ++ L + L LV M D+ I + EP+ Y Q+
Sbjct: 241 KVHSRFIVSLA--YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
+SGL+H H+R I++RD+K N+L+D G ++I+D GL+ Q T + A
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMA 357
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
PELLLG +Y +D ++ G L EM R R E + + +
Sbjct: 358 PELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR------------ 404
Query: 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR 381
+ Y F P+S LL DP R
Sbjct: 405 ---VLEQAVTYPDK-------FSPASKDFCEALLQKDPEKR 435
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR-FDTSEPESVKFMAREIRILQKL 166
A+ Y+ + +G+G + V R + T K+ A+K + F+ + F E I+
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 167 DHPNVIKLEGLATSRMQYS------LYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQ 219
+ P V++L Y+ LY+V ++M DL ++ + E + Y +
Sbjct: 127 NSPWVVQL--------FYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAE 176
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
++ L H G +HRD+K N+L+DKSG LK+ADFG + + V T Y
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 280 APELLL---GSTDYGVGIDLWSAGCLLAEMFIGRP 311
+PE+L G YG D WS G L EM +G
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-37
Identities = 87/374 (23%), Positives = 137/374 (36%), Gaps = 99/374 (26%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-- 166
Y + K+G G +S V+ + D K VA+K V+ E+ EIR+L+ +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRN 92
Query: 167 ---DHPN---VIKL------EGLATSRMQYSLYLVFDFMQSDLTKIICR-PGQKLTEPQV 213
+ PN V++L G+ + + +VF+ + L K I + Q L P V
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHI----CMVFEVLGHHLLKWIIKSNYQGLPLPCV 148
Query: 214 KCYMQQLLSGLQHCH-ERGILHRDIKASNLLI---------------------------- 244
K +QQ+L GL + H + I+H DIK N+L+
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 245 ---------------------DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
+ +KIAD G + + T + T YR+ E+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDIQTRQYRSLEV 264
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT------EVEQLHRIFKLCGTPSEDYW 337
L+GS Y D+WS C+ E+ G L + + + + I +L G
Sbjct: 265 LIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 338 KKMKLTTTF--------RPQHYKP-SFREVFGEFPPSS-------YGILTTLLALDPAYR 381
K + F KP EV E S L +L L P R
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 382 GTAASALQNEFFNA 395
TAA L++ + N+
Sbjct: 384 ATAAECLRHPWLNS 397
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 58/354 (16%), Positives = 117/354 (33%), Gaps = 100/354 (28%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTG-----KIVAL-------KKVR------------- 144
++ + +G+G + V++A+++ K + L +KV
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 145 -------------------------------FDTSEPESVKFMAREIRILQKLDHPNVIK 173
+ S P + + +IR + N +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 174 LEGLATSRMQYSLYLVFDFMQ-SDLTKII--CRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
L S + LY+ + +L + + Q+ ++ H +
Sbjct: 126 --QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLS-----------NFFIPKQKGPLTSRVVTLWYR 279
G++HRD+K SN+ ++K+ DFGL T +V T Y
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339
+PE + G+ Y +D++S G +L E+ L T++E++ I +
Sbjct: 244 SPEQIHGNN-YSHKVDIFSLGLILFEL-----LYSFSTQMERVRIITDVR---------- 287
Query: 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
F +F + P + ++ +L+ P R A ++N F
Sbjct: 288 ------------NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDH 168
D ++ L +G+G++ V + DT K+ A+K + E V+ + +E++I+Q L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 169 PNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLL 221
P ++ L YS +++V D + DL + + E VK ++ +L+
Sbjct: 75 PFLVNLW--------YSFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELV 125
Query: 222 SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
L + + I+HRD+K N+L+D+ G + I DF ++ + + +T+ T Y AP
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMAP 183
Query: 282 ELLL--GSTDYGVGIDLWSAGCLLAEMFIGRP 311
E+ Y +D WS G E+ GR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-36
Identities = 73/279 (26%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQ 164
P + +++ + +G+G + V + R TGK+ A KK+ + + E +IL+
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQK-LTEPQVKCYMQQLLS 222
K++ V+ L + +L LV M DL I GQ E + Y ++
Sbjct: 240 KVNSRFVVSLA--YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
GL+ H I++RD+K N+L+D G ++I+D GL+ Q + RV T+ Y APE
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPE 355
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342
++ Y D W+ GCLL EM G+ R + + + +L
Sbjct: 356 VVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-------------- 400
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR 381
P+ Y F P + + + LL DPA R
Sbjct: 401 -VKEVPEEYSER-------FSPQARSLCSQLLCKDPAER 431
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 46/209 (22%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
++G G++ VYK + VA+K + P+ ++ E+ +L+K H N++ G
Sbjct: 31 RIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 177 LATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ L +V + + S L + K ++ +Q G+ + H + I+HR
Sbjct: 88 -YS--TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIP-KQKGPLTSRVVTLWYRAPELLLG--STDYGV 292
D+K++N+ + + +KI DFGL+ ++ + APE++ S Y
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQ 321
D+++ G +L E+ G+ +Q
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 43/207 (20%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+G + VY R VA++ + + + +K RE+ ++ H NV+ G
Sbjct: 40 LIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 177 LATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
S L ++ + L ++ L + + Q+++ G+ + H +GILH+
Sbjct: 97 ACMSPPH--LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHK 154
Query: 236 DIKASNLLIDKSGMLKIADFGLS----NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG 291
D+K+ N+ D G + I DFGL +++ L + L + APE++ +
Sbjct: 155 DLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 292 VGI--------DLWSAGCLLAEMFIGR 310
D+++ G + E+
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+G G++ V++A G VA+K + E V RE+ I+++L HPN++ G
Sbjct: 44 KIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 177 LATSRMQYSLYLVFDFM-QSDLTKII--CRPGQKLTEPQVKCYMQQLLSGLQ--HCHERG 231
T L +V +++ + L +++ ++L E + + G+ H
Sbjct: 102 AVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG 291
I+HR++K+ NLL+DK +K+ DFGLS S T + APE+L
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEP-SN 217
Query: 292 VGIDLWSAGCLLAEMFIGR 310
D++S G +L E+ +
Sbjct: 218 EKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
VG+G + V KA+ R K VA+K++ SE E F+ E+R L +++HPN++KL G
Sbjct: 15 VVGRGAFGVVCKAKWR--AKDVAIKQIE---SESERKAFI-VELRQLSRVNHPNIVKLYG 68
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKII--CRPGQKLTEPQVKCYMQQLLSGLQHCHER--- 230
+ + LV ++ + L ++ P T + Q G+ + H
Sbjct: 69 ACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 231 GILHRDIKASNLLIDKSGM-LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
++HRD+K NLL+ G LKI DFG + + +T+ + + APE+ GS
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSN- 179
Query: 290 YGVGIDLWSAGCLLAEMFIGR 310
Y D++S G +L E+ R
Sbjct: 180 YSEKCDVFSWGIILWEVITRR 200
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 47/208 (22%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRF-----DTSEPESVKFMAREIRILQKLDHPNV 171
++G+G + V+K R +VA+K + +T E + RE+ I+ L+HPN+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQ--HCH 228
+KL GL + +V +F+ DL + + M + G++
Sbjct: 86 VKLYGLMHN----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 229 ERGILHRDIKASNLLIDKSGM-----LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
I+HRD+++ N+ + K+ADFGLS ++ + + APE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPET 197
Query: 284 LLG-STDYGVGIDLWSAGCLLAEMFIGR 310
+ Y D +S +L + G
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-34
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 9/221 (4%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL 166
+ + +D L +G+GT+ V R++ TG+ A+K +R + + V E R+LQ
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
HP + L+ + L V ++ +L + R TE + + Y +++S L+
Sbjct: 63 RHPFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALE 119
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELL 284
+ H R +++RDIK NL++DK G +KI DFGL I G T Y APE+L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCGTPEYLAPEVL 177
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
DYG +D W G ++ EM GR + I
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 36/200 (18%), Positives = 71/200 (35%), Gaps = 14/200 (7%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+ + ++K R + G + +K ++ + E L+ HPNV+ + G
Sbjct: 17 KLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKII-CRPGQKLTEPQVKCYMQQLLSGLQ--HCHERGI 232
S L+ +M L ++ + + Q + + G+ H E I
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG--STDY 290
+ + +++ID+ +I+ + F R+ + APE L
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTN 188
Query: 291 GVGIDLWSAGCLLAEMFIGR 310
D+WS LL E+
Sbjct: 189 RRSADMWSFAVLLWELVTRE 208
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQ 164
+ + + +G+G + VY R DTGK+ A+K + + E +L
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 165 KL---DHPNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVK 214
+ D P ++ + Y+ L + D M DL + + G +E ++
Sbjct: 245 LVSTGDCPFIVCMS--------YAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMR 295
Query: 215 CYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274
Y +++ GL+H H R +++RD+K +N+L+D+ G ++I+D GL+ F K + V
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVG 352
Query: 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRP 311
T Y APE+L Y D +S GC+L ++ G
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 106 PK-SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREI 160
PK S + L +G G++ V+ R R G+ A+K ++ + E E
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN---DER 57
Query: 161 RILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQ 219
+L + HP +I++ G T + ++++ D+++ +L ++ + + P K Y +
Sbjct: 58 LMLSIVTHPFIIRMWG--TFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAE 114
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW-- 277
+ L++ H + I++RD+K N+L+DK+G +KI DFG + K +T TL
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-----KYVPDVTY---TLCGT 166
Query: 278 --YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRP 311
Y APE++ Y ID WS G L+ EM G
Sbjct: 167 PDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYT 201
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 56/210 (26%), Positives = 106/210 (50%), Gaps = 18/210 (8%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRIL 163
D +D++ +G G++ V + +++G A+K + + E E RIL
Sbjct: 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL---NEKRIL 95
Query: 164 QKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLS 222
Q ++ P ++KLE + + +LY+V +++ ++ + R G + +EP + Y Q++
Sbjct: 96 QAVNFPFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVL 152
Query: 223 GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAP 281
++ H +++RD+K NLLID+ G +++ DFG + K+ T + T AP
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALAP 207
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFIGRP 311
E++L Y +D W+ G L+ EM G P
Sbjct: 208 EIILSK-GYNKAVDWWALGVLIYEMAAGYP 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 25/233 (10%)
Query: 108 SADSYDKLAKVGQGTYSNVYKAR---DRDTGKIVALKKVRFDT--SEPESVKFMAREIRI 162
+ ++ L +G+G Y V++ R +TGKI A+K ++ + E I
Sbjct: 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 163 LQKLDHPNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKC 215
L+++ HP ++ L Y+ LYL+ +++ +L + R G E
Sbjct: 75 LEEVKHPFIVDL--------IYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACF 125
Query: 216 YMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV- 274
Y+ ++ L H H++GI++RD+K N++++ G +K+ DFGL I G +T
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI--HDGTVTHTFCG 183
Query: 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
T+ Y APE+L+ + + +D WS G L+ +M G P G + + +I K
Sbjct: 184 TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 22/214 (10%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQK- 165
+D L +G+G+Y+ V R + T +I A+K V+ + ++ E + ++ E + ++
Sbjct: 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 166 LDHPNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQ 218
+HP ++ L L+ V +++ DL + R KL E + Y
Sbjct: 67 SNHPFLVGL--------HSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSA 117
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLW 277
++ L + HERGI++RD+K N+L+D G +K+ D+G+ + + G TS T
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPN 175
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRP 311
Y APE+L G DYG +D W+ G L+ EM GR
Sbjct: 176 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS 208
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 10/224 (4%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL 166
+ + ++ L +G+GT+ V +++ TG+ A+K ++ + + V E R+LQ
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
HP + L+ + + L V ++ +L + R +E + + Y +++S L
Sbjct: 206 RHPFLTALK--YSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALD 262
Query: 226 HCH-ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPEL 283
+ H E+ +++RD+K NL++DK G +KI DFGL I + G T Y APE+
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI--KDGATMKTFCGTPEYLAPEV 320
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
L DYG +D W G ++ EM GR + + I
Sbjct: 321 LED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 25/232 (10%)
Query: 108 SADSYDKLAKVGQGTYSNVYKAR---DRDTGKIVALKKVRFDT-SEPESVKFMAREIRIL 163
++ L +GQG++ V+ + D ++ A+K ++ T + V+ E IL
Sbjct: 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDIL 80
Query: 164 QKLDHPNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCY 216
+++HP ++KL Y+ LYL+ DF++ DL + + TE VK Y
Sbjct: 81 VEVNHPFIVKLH--------YAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFY 131
Query: 217 MQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-T 275
+ +L L H H GI++RD+K N+L+D+ G +K+ DFGLS I T
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGT 189
Query: 276 LWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
+ Y APE++ + D WS G L+ EM G G+ E + I K
Sbjct: 190 VEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 22/230 (9%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQK- 165
D+++ + +G+G++ V AR ++TG + A+K ++ D + + V+ E RIL
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 166 LDHPNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQ 218
+HP + +L L+ V +F+ DL I + + E + + Y
Sbjct: 81 RNHPFLTQLF--------CCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAA 131
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLW 277
+++S L H++GI++RD+K N+L+D G K+ADFG+ I G T+ T
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI--CNGVTTATFCGTPD 189
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
Y APE+L YG +D W+ G LL EM G E + I
Sbjct: 190 YIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP--ESVKFMAREIRILQKLDHPNVIKL 174
+G G + VY+A G VA+K R D E ++++ + +E ++ L HPN+I L
Sbjct: 14 IIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 175 EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG-- 231
G+ L LV +F + L +++ G+++ + + Q+ G+ + H+
Sbjct: 72 RGVCLKEPN--LCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 232 -ILHRDIKASNLLIDKSG--------MLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPE 282
I+HRD+K+SN+LI + +LKI DFGL+ + S + APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAAGAYAWMAPE 184
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGR 310
++ S + G D+WS G LL E+ G
Sbjct: 185 VIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 22/214 (10%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQK- 165
+D L +G+G+Y+ V R + T +I A++ V+ + ++ E + ++ E + ++
Sbjct: 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 166 LDHPNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQ 218
+HP ++ L L+ V +++ DL + R KL E + Y
Sbjct: 110 SNHPFLVGL--------HSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSA 160
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLW 277
++ L + HERGI++RD+K N+L+D G +K+ D+G+ + + G TS T
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPN 218
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRP 311
Y APE+L G DYG +D W+ G L+ EM GR
Sbjct: 219 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS 251
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 16/225 (7%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRIL 163
+ + +G+G++ V+ A + T + A+K ++ + E E R+L
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM---VEKRVL 71
Query: 164 QK-LDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLL 221
+HP + + T + + +L+ V +++ DL I K + Y +++
Sbjct: 72 SLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEII 128
Query: 222 SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRA 280
GLQ H +GI++RD+K N+L+DK G +KIADFG+ + T+ T Y A
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM--LGDAKTNTFCGTPDYIA 186
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
PE+LLG Y +D WS G LL EM IG+ G+ E E H I
Sbjct: 187 PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 14/303 (4%)
Query: 31 GRVVVQKAVGKENGKVSRHGGDGNGVGERVRNGGGDGGSRSRKSVKKKISEDELVDGWPK 90
G + + ++ G GE GS + +++K ++ G
Sbjct: 258 GSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKA 317
Query: 91 WLVDNIPKEVLAGLVPK----SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD 146
++ L +G+G++ V + + T ++ A+K ++ D
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD 377
Query: 147 T-SEPESVKFMAREIRILQK-LDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICR 203
+ + V+ E R+L P + +L + + LY V +++ DL I +
Sbjct: 378 VVIQDDDVECTMVEKRVLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQ 435
Query: 204 PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263
G + EP Y ++ GL +GI++RD+K N+++D G +KIADFG+ I
Sbjct: 436 VG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 493
Query: 264 KQKGPLTSRVV-TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQL 322
G T T Y APE++ YG +D W+ G LL EM G+ G E E
Sbjct: 494 -WDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
Query: 323 HRI 325
I
Sbjct: 552 QSI 554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 10/224 (4%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL 166
++ L +G+G++ V + + T ++ A+K ++ D + + V+ E R+L
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 167 D-HPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
P + +L + + LY V +++ DL I + G + EP Y ++ GL
Sbjct: 78 GKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGL 134
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPEL 283
+GI++RD+K N+++D G +KIADFG+ I G T T Y APE+
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--WDGVTTKTFCGTPDYIAPEI 192
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
+ YG +D W+ G LL EM G+ G E E I +
Sbjct: 193 IAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 22/228 (9%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRIL-QK 165
+ L +G+G++ V AR + A+K ++ + + K + E +L +
Sbjct: 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 166 LDHPNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQ 218
+ HP ++ L +S LY V D++ +L + R EP+ + Y
Sbjct: 96 VKHPFLVGLH--------FSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAA 146
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLW 277
++ S L + H I++RD+K N+L+D G + + DFGL I + TS T
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNSTTSTFCGTPE 204
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325
Y APE+L Y +D W G +L EM G P R E I
Sbjct: 205 YLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPN 170
Y+ +G G S V+ ARD + VA+K +R D +P RE + L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 171 VIKL--EGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
++ + G A + Y+V +++ L I+ G +T + + L
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS 132
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT--SRVV-TLWYRAPELL 284
H+ GI+HRD+K +N++I + +K+ DFG++ I +T + V+ T Y +PE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 285 LGSTDYGVGI--DLWSAGCLLAEMFIGRP 311
G + V D++S GC+L E+ G P
Sbjct: 192 RGDS---VDARSDVYSLGCVLYEVLTGEP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 59/234 (25%), Positives = 114/234 (48%), Gaps = 23/234 (9%)
Query: 108 SADSYDKLAKVGQGTYSNVYKAR---DRDTGKIVALKKVRFDT--SEPESVKFMAREIRI 162
++++ L +G G Y V+ R DTGK+ A+K ++ T + ++ + E ++
Sbjct: 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 163 LQKLDH-PNVIKLEGLATSRMQYS------LYLVFDFMQS-DLTKIICRPGQKLTEPQVK 214
L+ + P ++ L Y+ L+L+ D++ +L + + + TE +V+
Sbjct: 112 LEHIRQSPFLVTLH--------YAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQ 162
Query: 215 CYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274
Y+ +++ L+H H+ GI++RDIK N+L+D +G + + DFGLS F+ +
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 275 TLWYRAPELLLGSTD-YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327
T+ Y AP+++ G + +D WS G L+ E+ G E I +
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPN 170
Y + K+G G S VY A D VA+K + + E++K RE+ +L H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 171 VIKL------EGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
++ + + YLV ++++ L++ I G L+ + Q+L G
Sbjct: 73 IVSMIDVDEEDDCY--------YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDG 123
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT--SRVV-TLWYRA 280
++H H+ I+HRDIK N+LID + LKI DFG++ + LT + V+ T+ Y +
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA---KALSETSLTQTNHVLGTVQYFS 180
Query: 281 PELLLGSTDYGVGI--DLWSAGCLLAEMFIGRP 311
PE G D++S G +L EM +G P
Sbjct: 181 PEQAKGEA---TDECTDIYSIGIVLYEMLVGEP 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPN 170
Y VG+G +VY+A D +IVALK + +S+P M RE R +L P+
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 171 VIKL------EGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
V+ + +G LY+ + DL ++ R G L P+ ++Q+ S
Sbjct: 96 VVPIHDFGEIDGQ--------LYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSA 146
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS--RVV-TLWYRA 280
L H G HRD+K N+L+ + DFG++ LT V TL+Y A
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA---SATTDEKLTQLGNTVGTLYYMA 203
Query: 281 PELLLGST-DYGVGIDLWSAGCLLAEMFIGRP 311
PE S Y D+++ C+L E G P
Sbjct: 204 PERFSESHATYRA--DIYALTCVLYECLTGSP 233
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 60/289 (20%), Positives = 115/289 (39%), Gaps = 51/289 (17%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRD-TGKIVALKKVRFDTSEPESVKFMAREIRILQKLD 167
A Y+ + G +Y A DR+ G+ V LK + + + E+ E + L ++
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLV-HSGDAEAQAMAMAERQFLAEVV 137
Query: 168 HPNVIKL--EGLATSRMQYSL-YLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
HP+++++ T R + Y+V +++ L + GQKL + Y+ ++L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPA 194
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPE 282
L + H G+++ D+K N+++ + LK+ D G + + T ++APE
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLG-----AVSRINS-FGYLYGTPGFQAPE 247
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342
++ V D+++ G LA + + P GR + G P +D
Sbjct: 248 IVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRY----------VDGLPEDD------- 288
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391
P + S +L + DP R T A + +
Sbjct: 289 ----------PVLKT-----YDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 60/254 (23%), Positives = 108/254 (42%), Gaps = 31/254 (12%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G + V+KA+ + VA+K F + +S + E+ L + H N+++ G
Sbjct: 31 VKARGRFGCVWKAQLL--NEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMKHENILQFIG 85
Query: 177 --LATSRMQYSLYLVFDFMQ----SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+ + L+L+ F + SD K ++ ++ + + GL + HE
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHED 140
Query: 231 ----------GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYR 279
I HRDIK+ N+L+ + IADFGL+ F + T V T Y
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 280 APELLLGS----TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335
APE+L G+ D + ID+++ G +L E+ G + L ++ PS +
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260
Query: 336 YWKKMKLTTTFRPQ 349
+++ + RP
Sbjct: 261 DMQEVVVHKKKRPV 274
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 117 KVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
+G+G + V R +TG+ VA+K ++ ++ +EI IL+ L H N++
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLYHENIV 86
Query: 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
K +G+ T + L+ +F+ S L + + + K+ Q Y Q+ G+ + R
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL----WYRAPELLLGS 287
+HRD+ A N+L++ +KI DFGL+ I K T + WY APE L+ S
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWY-APECLMQS 204
Query: 288 TDYGVGIDLWSAGCLLAEMF 307
+ + D+WS G L E+
Sbjct: 205 K-FYIASDVWSFGVTLHELL 223
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 26/210 (12%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
VG+G Y V++ + G+ VA+K F + + +S F E+ L H N++
Sbjct: 15 CVGKGRYGEVWRGSWQ--GENVAVKI--FSSRDEKSW-FRETELYNTVMLRHENILGFIA 69
Query: 177 --LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER--- 230
+ + L+L+ + + L + L + + SGL H H
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 231 -----GILHRDIKASNLLIDKSGMLKIADFGLSNFFIP---KQKGPLTSRVVTLWYRAPE 282
I HRD+K+ N+L+ K+G IAD GL+ + RV T Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 283 LLLGSTDYGVG-----IDLWSAGCLLAEMF 307
+L + +D+W+ G +L E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 68/252 (26%), Positives = 107/252 (42%), Gaps = 27/252 (10%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
++G+G Y V+ + R G+ VA+K F T+E S F EI + H N++
Sbjct: 44 QIGKGRYGEVWMGKWR--GEKVAVKV--FFTTEEAS-WFRETEIYQTVLMRHENILGFIA 98
Query: 177 LAT--SRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER--- 230
+ LYL+ D+ ++ L + L + +SGL H H
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 231 -----GILHRDIKASNLLIDKSGMLKIADFGLSNFFIP---KQKGPLTSRVVTLWYRAPE 282
I HRD+K+ N+L+ K+G IAD GL+ FI + P +RV T Y PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 283 LLLGST-----DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337
+L S + D++S G +L E+ R + G E QL + PS +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 338 KKMKLTTTFRPQ 349
+++ RP
Sbjct: 276 REIVCIKKLRPS 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+G + V++ + R G+ VA+K F + E S F EI L H N++
Sbjct: 49 SIGKGRFGEVWRGKWR--GEEVAVKI--FSSREERSW-FREAEIYQTVMLRHENILGFIA 103
Query: 177 LATSRMQYS---LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER-- 230
A ++ + L+LV D+ + L + R +T + SGL H H
Sbjct: 104 -ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 231 ------GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ---KGPLTSRVVTLWYRAP 281
I HRD+K+ N+L+ K+G IAD GL+ RV T Y AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 282 ELLLGSTDYGVG-----IDLWSAGCLLAEMF 307
E+L S + D+++ G + E+
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-28
Identities = 58/200 (29%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 117 KVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
++G+G + +V R +TG++VA+KK++ T E F REI IL+ L H N++
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFE-REIEILKSLQHDNIV 74
Query: 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
K +G+ S + +L L+ +++ L + + +++ ++ Y Q+ G+++ +
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL----WYRAPELLLGS 287
+HRD+ N+L++ +KI DFGL+ +P+ K + WY APE L S
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWY-APESLTES 192
Query: 288 TDYGVGIDLWSAGCLLAEMF 307
+ V D+WS G +L E+F
Sbjct: 193 K-FSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 58/200 (29%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 117 KVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
++G+G + +V R +TG++VA+KK++ T E F REI IL+ L H N++
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFE-REIEILKSLQHDNIV 105
Query: 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
K +G+ S + +L L+ +++ L + + +++ ++ Y Q+ G+++ +
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL----WYRAPELLLGS 287
+HRD+ N+L++ +KI DFGL+ +P+ K + WY APE L S
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWY-APESLTES 223
Query: 288 TDYGVGIDLWSAGCLLAEMF 307
+ V D+WS G +L E+F
Sbjct: 224 K-FSVASDVWSFGVVLYELF 242
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 39/220 (17%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA-REIRILQKLDHPNVIKL- 174
+G+G Y VYK + VA+K F + ++ F+ + I + ++H N+ +
Sbjct: 20 LIGRGRYGAVYKGSLD--ERPVAVKV--FSFANRQN--FINEKNIYRVPLMEHDNIARFI 73
Query: 175 ----EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
A RM+Y L V ++ + L K + + GL + H
Sbjct: 74 VGDERVTADGRMEYLL--VMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 230 ---------RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP-------KQKGPLTSRV 273
I HRD+ + N+L+ G I+DFGLS ++ S V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 274 VTLWYRAPELLLGSTD------YGVGIDLWSAGCLLAEMF 307
T+ Y APE+L G+ + +D+++ G + E+F
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 44/309 (14%), Positives = 84/309 (27%), Gaps = 60/309 (19%)
Query: 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKF-MAREIRILQKLDHPNVIK 173
L G ++A D + VAL V P+ V L ++D P V +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 174 LEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
+ L + +V ++++ L ++ + MQ L + H G+
Sbjct: 96 V--LDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGV 150
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGV 292
S + + G + +A +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATM--------PDANPQD------------------- 183
Query: 293 GIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYK 352
D+ G L + + R +P L +
Sbjct: 184 --DIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-------------------DTAGQP 222
Query: 353 PSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICREE 412
++ + P + + D R +AS L N A+ +A L I +
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIR--SASTLLNLMQQATAVADRTEVLGPI---D 277
Query: 413 DEPARTSRR 421
+ P + R
Sbjct: 278 EAPVSAAPR 286
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 69/262 (26%), Positives = 119/262 (45%), Gaps = 29/262 (11%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
++G+G + V+ R R +VA+K R KF+ +E RIL++ HPN+++L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIVRLIG 179
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ T + +Y+V + +Q D + G +L + + +G+++ + +HR
Sbjct: 180 VCT--QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237
Query: 236 DIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL-----WYRAPELLLGSTDY 290
D+ A N L+ + +LKI+DFG+S + G + W APE L Y
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSRE---EADGVYAASGGLRQVPVKWT-APEALN----Y 289
Query: 291 GV---GIDLWSAGCLLAEMF-IGRPLMPGRT------EVEQLHRIFKLCGTPSEDYWKKM 340
G D+WS G LL E F +G P + VE+ R+ P + + M
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF-RLM 348
Query: 341 KLTTTFRPQHYKPSFREVFGEF 362
+ + P +PSF ++ E
Sbjct: 349 EQCWAYEPGQ-RPSFSTIYQEL 369
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 66/266 (24%), Positives = 126/266 (47%), Gaps = 39/266 (14%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+G G Y VY+ + VA+K ++ DT E E +F+ E +++++ HPN+++L G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFLK-EAAVMKEIKHPNLVQLLG 283
Query: 177 LATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ T + Y++ +FM + L + Q+++ + Q+ S +++ ++ +H
Sbjct: 284 VCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 235 RDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
R++ A N L+ ++ ++K+ADFGLS + + + W APE L +
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WT-APESLAYNK- 395
Query: 290 YGVGIDLWSAGCLLAEMF-IGRPLMPGRT------EVEQLHRIFKLCGTPSEDY------ 336
+ + D+W+ G LL E+ G PG +E+ +R+ + G P + Y
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 455
Query: 337 WKKMKLTTTFRPQHYKPSFREVFGEF 362
W+ P +PSF E+ F
Sbjct: 456 WQW-------NPSD-RPSFAEIHQAF 473
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 117 KVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
+G+G + V + TG++VA+K ++ D + +EI IL+ L H ++I
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEIDILRTLYHEHII 96
Query: 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
K +G SL LV +++ L + P + Q+ + QQ+ G+ + H +
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLS-------NFFIPKQKGPLTSRVVTLWYRAPELL 284
+HRD+ A N+L+D ++KI DFGL+ ++ ++ G WY APE L
Sbjct: 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WY-APECL 209
Query: 285 LGSTDYGVGIDLWSAGCLLAEMF 307
+ D+WS G L E+
Sbjct: 210 KEYK-FYYASDVWSFGVTLYELL 231
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 5e-26
Identities = 40/287 (13%), Positives = 85/287 (29%), Gaps = 62/287 (21%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD------TSEPESVKFMAREIR 161
+ + K+G+G + V++ VA+K + + S ++ + + EI
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 162 ILQKL---------DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRP-------- 204
I ++L I L + + Y L+ + + TK
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 205 -------------------GQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLI 244
+ + K + QL + L HRD+ N+L+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 245 DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLA 304
K+ + K+ G L + DY + +
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCG---------------LQVSIIDYTLSRLERDGIVVFC 240
Query: 305 EMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY 351
++ + L G + + I++L + + W + + HY
Sbjct: 241 DVSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY 285
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 20/203 (9%)
Query: 117 KVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
++G+G + +V R +TG +VA+K+++ + + F REI+IL+ L ++
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQ-REIQILKALHSDFIV 87
Query: 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
K G++ + SL LV +++ S L + R +L ++ Y Q+ G+++ R
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLS-------NFFIPKQKGPLTSRVVTLWYRAPELL 284
+HRD+ A N+L++ +KIADFGL+ ++++ ++ G WY APE L
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WY-APESL 202
Query: 285 LGSTDYGVGIDLWSAGCLLAEMF 307
+ + D+WS G +L E+F
Sbjct: 203 SDNI-FSRQSDVWSFGVVLYELF 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 21/220 (9%)
Query: 117 KVGQGTYSNVYKARDRDTGKI--VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
++G G + +V + R K VA+K ++ T + ++ + M RE +I+ +LD+P +++L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 75
Query: 175 EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
G+ + +L LV + L K + +++ V + Q+ G+++ E+ +
Sbjct: 76 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL----WYRAPELLLGSTD 289
HRD+ A N+L+ KI+DFGLS + T+R WY APE +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWY-APECIN---- 186
Query: 290 YGV---GIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRI 325
+ D+WS G + E G+ E + I
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 69/266 (25%), Positives = 126/266 (47%), Gaps = 41/266 (15%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+GQG + V+ T + VA+K ++ T PE F+ +E ++++KL H +++L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHEKLVQLYA 246
Query: 177 LATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ + + +Y+V ++M S L + G+ L PQ+ Q+ SG+ + +H
Sbjct: 247 VVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 235 RDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
RD++A+N+L+ ++ + K+ADFGL+ N + +Q + W APE L
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WT-APEAALYGR- 357
Query: 290 YGVGIDLWSAGCLLAEMF-IGRPLMPGRT------EVEQLHRIFKLCGTPSEDY------ 336
+ + D+WS G LL E+ GR PG +VE+ +R+ P +
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 417
Query: 337 WKKMKLTTTFRPQHYKPSFREVFGEF 362
W+K P+ +P+F +
Sbjct: 418 WRK-------EPEE-RPTFEYLQAFL 435
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 117 KVGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G G V R R G+ VA+K ++ +E + F+ E I+ + DHPN+I+
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHPNIIR 114
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
LEG+ T +V ++M++ L + + T Q+ ++ + +G+++ + G
Sbjct: 115 LEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL---WYRAPELLLGSTD 289
+HRD+ A N+L+D + + K++DFGLS T+ + W APE +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APEAIA---- 227
Query: 290 YGV---GIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRI 325
+ D+WS G ++ E+ G T + + +
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 19/220 (8%)
Query: 117 KVGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
VG G + V R + K VA+K ++ +E + F+ E I+ + DHPN+I+
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIR 110
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
LEG+ T + +V ++M++ L + + + T Q+ ++ + SG+++ + G
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL---WYRAPELLLGSTD 289
+HRD+ A N+LI+ + + K++DFGL + T+R + W +PE +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-SPEAIA---- 223
Query: 290 YGV---GIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRI 325
Y D+WS G +L E+ G + + + +
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 64/297 (21%), Positives = 123/297 (41%), Gaps = 43/297 (14%)
Query: 97 PKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKAR---DRDTGKI-VALKKVRFDTSEPES 152
P + L ++ ++ K +G G + VYK + + KI VA+K++R TS +
Sbjct: 4 PNQALLRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 153 VKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEP 211
+ + E ++ +D+P+V +L G+ + ++ L+ M L + +
Sbjct: 62 KEIL-DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 212 QVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS 271
+ + Q+ G+ + +R ++HRD+ A N+L+ +KI DFGL+ + ++ +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHA 176
Query: 272 RVVTL---WYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGR---PLMPGR---TEVEQ 321
+ W A E +L Y D+WS G + E+ G +P + +E+
Sbjct: 177 EGGKVPIKWM-ALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
Query: 322 LHRIFKLCGTPSEDY------WKKMKLTTTFRPQHYKPSFREVFGEFP-----PSSY 367
R+ + + Y W +P FRE+ EF P Y
Sbjct: 235 GERLPQPPICTIDVYMIMRKCWMI-------DADS-RPKFRELIIEFSKMARDPQRY 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 25/203 (12%)
Query: 117 KVGQGTYSNVYKARDRDTGKI---VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G + +V++ VA+K + TS+ KF+ +E +++ DHP+++K
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHIVK 80
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
L G+ T + ++++ + +L + L + Y QL + L + +
Sbjct: 81 LIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
+HRDI A N+L+ + +K+ DFGLS + + KG L + W APE +
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WM-APESIN-- 190
Query: 288 TDYGV---GIDLWSAGCLLAEMF 307
+ D+W G + E+
Sbjct: 191 --FRRFTSASDVWMFGVCMWEIL 211
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 69/266 (25%), Positives = 126/266 (47%), Gaps = 41/266 (15%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+GQG + V+ T + VA+K ++ T PE F+ +E ++++KL H +++L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHEKLVQLYA 329
Query: 177 LATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ + + +Y+V ++M S L + G+ L PQ+ Q+ SG+ + +H
Sbjct: 330 VVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386
Query: 235 RDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
RD++A+N+L+ ++ + K+ADFGL+ N + +Q + W APE L
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WT-APEAALYGR- 440
Query: 290 YGVGIDLWSAGCLLAEMF-IGRPLMPGRT------EVEQLHRIFKLCGTPSEDY------ 336
+ + D+WS G LL E+ GR PG +VE+ +R+ P +
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 500
Query: 337 WKKMKLTTTFRPQHYKPSFREVFGEF 362
W+K P+ +P+F +
Sbjct: 501 WRK-------EPEE-RPTFEYLQAFL 518
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 61/269 (22%), Positives = 115/269 (42%), Gaps = 41/269 (15%)
Query: 117 KVGQGTYSNVYKARDRDTGKI--VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
++G G + V K + + VA+K ++ + ++P + E ++Q+LD+P ++++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 175 EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
G+ + S LV + + L K + + + + + + + Q+ G+++ E +
Sbjct: 84 IGICEAE---SWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL----WYRAPELLLGSTD 289
HRD+ A N+L+ KI+DFGLS + + ++ WY APE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWY-APECIN---- 193
Query: 290 YGV---GIDLWSAGCLLAEMF-IGR---PLMPGR---TEVEQLHRIFKLCGTPSEDY--- 336
Y D+WS G L+ E F G+ M G +E+ R+ G P E Y
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 253
Query: 337 ---WKKMKLTTTFRPQHYKPSFREVFGEF 362
W ++ +P F V
Sbjct: 254 NLCWTY-------DVEN-RPGFAAVELRL 274
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 47/222 (21%), Positives = 89/222 (40%), Gaps = 26/222 (11%)
Query: 117 KVGQGTYSNVYKA--RDRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G + VY+ + KI VA+K + D + KFM E I++ LDHP+++K
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAVIMKNLDHPHIVK 77
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
L G+ + +++ + +L + R L + Y Q+ + +
Sbjct: 78 LIGIIE---EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
+HRDI N+L+ +K+ DFGLS + L + W +PE +
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WM-SPESIN-- 187
Query: 288 TDYGV---GIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRI 325
+ D+W + E+ G+ + + +
Sbjct: 188 --FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 50/221 (22%), Positives = 103/221 (46%), Gaps = 20/221 (9%)
Query: 117 KVGQGTYSNVYKARDRDTGKI----VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI 172
+G G + VYK + + VA+K ++ +E + V F+ E I+ + H N+I
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSHHNII 109
Query: 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG 231
+LEG+ + + ++ ++M++ L K + + + Q+ ++ + +G+++
Sbjct: 110 RLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 232 ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL---WYRAPELLLGST 288
+HRD+ A N+L++ + + K++DFGLS + T+ + W APE +
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-APEAIS--- 223
Query: 289 DYGV---GIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRI 325
Y D+WS G ++ E+ G + E + I
Sbjct: 224 -YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 66/266 (24%), Positives = 127/266 (47%), Gaps = 39/266 (14%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+G G Y VY+ + VA+K ++ DT E E +F+ +E +++++ HPN+++L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFL-KEAAVMKEIKHPNLVQLLG 76
Query: 177 LATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ T + Y++ +FM + L + Q+++ + Q+ S +++ ++ +H
Sbjct: 77 VCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 235 RDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
RD+ A N L+ ++ ++K+ADFGLS + + + W APE L +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WT-APESLAYNK- 188
Query: 290 YGVGIDLWSAGCLLAEMF-IGR---PLMPGR---TEVEQLHRIFKLCGTPSEDY------ 336
+ + D+W+ G LL E+ G P + +E+ +R+ + G P + Y
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 248
Query: 337 WKKMKLTTTFRPQHYKPSFREVFGEF 362
W+ P +PSF E+ F
Sbjct: 249 WQW-------NPSD-RPSFAEIHQAF 266
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 55/268 (20%), Positives = 113/268 (42%), Gaps = 45/268 (16%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
++G G + V+ + K VA+K +R E F+ E ++ KL HP +++L G
Sbjct: 15 EIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE--DFI-EEAEVMMKLSHPKLVQLYG 70
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ Q + LV +FM+ L+ + + + G+ + E ++HR
Sbjct: 71 VCLE--QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 236 DIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
D+ A N L+ ++ ++K++DFG++ + + + W +PE+ +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WA-SPEVFS----F 179
Query: 291 GV---GIDLWSAGCLLAEMF-IGRPLMPGRT------EVEQLHRIFKLCGTPSEDY---- 336
D+WS G L+ E+F G+ R+ ++ R++K + Y
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 239
Query: 337 --WKKMKLTTTFRPQHYKPSFREVFGEF 362
W++ RP+ +P+F + +
Sbjct: 240 HCWRE-------RPED-RPAFSRLLRQL 259
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 59/265 (22%), Positives = 110/265 (41%), Gaps = 34/265 (12%)
Query: 117 KVGQGTYSNVYKARDRDTGKI---VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G + +V++ VA+K + TS+ KF+ +E +++ DHP+++K
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHIVK 455
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
L G+ T + ++++ + +L + L + Y QL + L + +
Sbjct: 456 LIGVIT---ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
+HRDI A N+L+ + +K+ DFGLS + + KG L + W APE S
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WM-APE----S 563
Query: 288 TDYGV---GIDLWSAGCLLAEMF-IGR---PLMPGR---TEVEQLHRIFKLCGTPSEDYW 337
++ D+W G + E+ G + +E R+ P Y
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY- 622
Query: 338 KKMKLTTTFRPQHYKPSFREVFGEF 362
M + P +P F E+ +
Sbjct: 623 SLMTKCWAYDPSR-RPRFTELKAQL 646
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 60/256 (23%), Positives = 115/256 (44%), Gaps = 25/256 (9%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+G + +V R G VA+K ++ D + F+ E ++ +L H N+++L G
Sbjct: 200 TIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA---FL-AEASVMTQLRHSNLVQLLG 253
Query: 177 LATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ + LY+V ++M S + + R L + + + +++ +H
Sbjct: 254 VIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 235 RDIKASNLLIDKSGMLKIADFGLS-NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVG 293
RD+ A N+L+ + + K++DFGL+ + G L + W APE L +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WT-APEALREKK-FSTK 366
Query: 294 IDLWSAGCLLAEMF-IGR---PLMPGRTEVEQL---HRIFKLCGTPSEDYWKKMKLTTTF 346
D+WS G LL E++ GR P +P + V ++ +++ G P Y MK
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY-DVMKNCWHL 425
Query: 347 RPQHYKPSFREVFGEF 362
+P+F ++ +
Sbjct: 426 DAAT-RPTFLQLREQL 440
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 69/266 (25%), Positives = 121/266 (45%), Gaps = 41/266 (15%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
K+G G + V+ A K VA+K ++ + E F+ E +++ L H ++KL
Sbjct: 195 KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE--AFL-AEANVMKTLQHDKLVKLHA 250
Query: 177 LATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ T + +Y++ +FM S L + G K P++ + Q+ G+ +R +H
Sbjct: 251 VVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307
Query: 235 RDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
RD++A+N+L+ S + KIADFGL+ N + ++ + W APE + +
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK----WT-APEAINFGS- 361
Query: 290 YGVGIDLWSAGCLLAEMF-IGR---PLMPGRTEVEQL---HRIFKLCGTPSEDY------ 336
+ + D+WS G LL E+ GR P M + L +R+ + P E Y
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 421
Query: 337 WKKMKLTTTFRPQHYKPSFREVFGEF 362
WK RP+ +P+F +
Sbjct: 422 WKN-------RPEE-RPTFEYIQSVL 439
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 6/146 (4%)
Query: 117 KVGQGTYSNVYKARDRDTGKI---VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G + VY D A+K + T E +F+ E I++ HPNV+
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVLS 90
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
L G+ R + S +V +M+ DL I T + + Q+ G+++ +
Sbjct: 91 LLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLS 258
+HRD+ A N ++D+ +K+ADFGL+
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 6e-24
Identities = 69/269 (25%), Positives = 124/269 (46%), Gaps = 47/269 (17%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
++G G + V+ K VA+K ++ + P+ F+A E ++++L H +++L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPD--AFLA-EANLMKQLQHQRLVRLYA 75
Query: 177 LATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ T Q +Y++ ++M+ S + + G KLT ++ Q+ G+ ER +H
Sbjct: 76 VVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 235 RDIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
RD++A+N+L+ + KIADFGL+ N + ++ + W APE +
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK----WT-APEAIN---- 183
Query: 290 YGV---GIDLWSAGCLLAEMF-IGR---PLMPGR---TEVEQLHRIFKLCGTPSEDY--- 336
YG D+WS G LL E+ GR P M +E+ +R+ + P E Y
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 337 ---WKKMKLTTTFRPQHYKPSFREVFGEF 362
WK+ RP+ +P+F +
Sbjct: 244 RLCWKE-------RPED-RPTFDYLRSVL 264
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 15/217 (6%)
Query: 117 KVGQGTYSNVYKARDRDTGKI--VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
++G G + +V + R K VA+K ++ T + ++ + M RE +I+ +LD+P +++L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 401
Query: 175 EGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
G+ + +L LV + L K + +++ V + Q+ G+++ E+ +
Sbjct: 402 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL----WYRAPELLLGSTD 289
HR++ A N+L+ KI+DFGLS + T+R WY APE +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWY-APECINFRK- 515
Query: 290 YGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRI 325
+ D+WS G + E G+ E + I
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 55/268 (20%), Positives = 116/268 (43%), Gaps = 45/268 (16%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
++G G + V + + VA+K ++ + + +F +E + + KL HP ++K G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSED--EFF-QEAQTMMKLSHPKLVKFYG 70
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ + +Y +Y+V +++ + L + G+ L Q+ + G+ +HR
Sbjct: 71 VCSK--EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 236 DIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
D+ A N L+D+ +K++DFG++ + ++ + W APE+ Y
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK----WS-APEVFH----Y 179
Query: 291 GV---GIDLWSAGCLLAEMF-IGR---PLMPGR---TEVEQLHRIFKLCGTPSEDY---- 336
D+W+ G L+ E+F +G+ L +V Q HR+++ Y
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMY 239
Query: 337 --WKKMKLTTTFRPQHYKPSFREVFGEF 362
W + P+ +P+F+++
Sbjct: 240 SCWHE-------LPEK-RPTFQQLLSSI 259
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 51/264 (19%), Positives = 114/264 (43%), Gaps = 45/264 (17%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
++G G + V + R VA+K ++ + + +F+ E +++ L H +++L G
Sbjct: 31 ELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSED--EFI-EEAKVMMNLSHEKLVQLYG 86
Query: 177 LATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ T Q ++++ ++M + L + + Q+ + + +++ + LHR
Sbjct: 87 VCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 236 DIKASNLLIDKSGMLKIADFGLS-----NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
D+ A N L++ G++K++DFGLS + + R W PE+L+ Y
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WS-PPEVLM----Y 195
Query: 291 GV---GIDLWSAGCLLAEMF-IGRPLMPGRT------EVEQLHRIFKLCGTPSEDY---- 336
D+W+ G L+ E++ +G+ T + Q R+++ + Y
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255
Query: 337 --WKKMKLTTTFRPQHYKPSFREV 358
W + + +P+F+ +
Sbjct: 256 SCWHE-------KADE-RPTFKIL 271
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 56/234 (23%), Positives = 101/234 (43%), Gaps = 19/234 (8%)
Query: 104 LVPKSADSYDKLAKVGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREI 160
L+P +G+G + VY D + A+K + T + F+ RE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REG 73
Query: 161 RILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQ 219
+++ L+HPNV+ L G+ + +++ +M DL + I P + T + + Q
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 220 LLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL--- 276
+ G+++ E+ +HRD+ A N ++D+S +K+ADFGL+ + ++ +
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 277 -WYRAPELLLGSTDYGV---GIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRI 325
W A E L D+WS G LL E+ G P + H +
Sbjct: 193 KWT-ALESLQ----TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 61/261 (23%), Positives = 112/261 (42%), Gaps = 43/261 (16%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+G + +V R G VA+K ++ D + F+ E ++ +L H N+++L G
Sbjct: 28 TIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA---FL-AEASVMTQLRHSNLVQLLG 81
Query: 177 LATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
+ + LY+V ++M S + + R L + + + +++ +H
Sbjct: 82 VIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 235 RDIKASNLLIDKSGMLKIADFGLS-NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGV- 292
RD+ A N+L+ + + K++DFGL+ + G L + W APE L
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WT-APEALR----EKKF 191
Query: 293 --GIDLWSAGCLLAEMF-IGR---PLMPGR---TEVEQLHRIFKLCGTPSEDY------W 337
D+WS G LL E++ GR P +P + VE+ +++ G P Y W
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 251
Query: 338 KKMKLTTTFRPQHYKPSFREV 358
+PSF ++
Sbjct: 252 HL-------DAAM-RPSFLQL 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 6/146 (4%)
Query: 117 KVGQGTYSNVYKARDRDTGKI---VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G + VY D A+K + T E +F+ E I++ HPNV+
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVLS 154
Query: 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
L G+ R + S +V +M+ DL I T + + Q+ G++ +
Sbjct: 155 LLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLS 258
+HRD+ A N ++D+ +K+ADFGL+
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 66/338 (19%), Positives = 129/338 (38%), Gaps = 51/338 (15%)
Query: 97 PKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKAR---DRDTGKI-VALKKVRFDTSEPES 152
P + L ++ ++ K +G G + VYK + + KI VA+K++R TS +
Sbjct: 4 PNQALLRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 153 VKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEP 211
+ + E ++ +D+P+V +L G+ + ++ L+ M L + +
Sbjct: 62 KEIL-DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 212 QVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS 271
+ + Q+ G+ + +R ++HRD+ A N+L+ +KI DFGL+ + ++ +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHA 176
Query: 272 RVVTL---WYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGR---PLMPGR---TEVEQ 321
+ W A E +L Y D+WS G + E+ G +P + +E+
Sbjct: 177 EGGKVPIKWM-ALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
Query: 322 LHRIFKLCGTPSEDY------WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLA 375
R+ + + Y W R F E + +
Sbjct: 235 GERLPQPPICTIDVYMIMVKCW------------MIDADSRPKFREL----IIEFSKMAR 278
Query: 376 LDPAYRGTAASALQNEFFNASPLACDLSSLPVICREED 413
Y +Q + P D + + EED
Sbjct: 279 DPQRYL-----VIQGDERMHLPSPTDSNFYRALMDEED 311
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 24/223 (10%)
Query: 117 KVGQGTYSNVYKA--RDRDTGKI-VALKKVRFDTSEPESV--KFMAREIRILQKLDHPNV 171
K+G G++ V + + VA+K ++ D F+ RE+ + LDH N+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHRNL 83
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
I+L G+ + + +V + L + + + Y Q+ G+ + +
Sbjct: 84 IRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTL----WYRAPELLLG 286
+HRD+ A NLL+ ++KI DFGL +P+ + W APE L
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMR-ALPQNDDHYVMQEHRKVPFAWC-APESLK- 197
Query: 287 STDYGV---GIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRI 325
D W G L EMF G+ G + LH+I
Sbjct: 198 ---TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 50/271 (18%), Positives = 97/271 (35%), Gaps = 40/271 (14%)
Query: 117 KVGQGTYSNVYKARDRDTGKI-------VALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+GQGT++ ++K R+ G V LK + F ++ KL H
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF-EAASMMSKLSHK 72
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
+++ G+ LV +F++ L + + + +QL + +
Sbjct: 73 HLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 229 ERGILHRDIKASNLLIDKSGML--------KIADFGLSNFFIPKQ--KGPLTSRVVTLWY 278
E ++H ++ A N+L+ + K++D G+S +PK + + W
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------WV 184
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRT------EVEQLHRIFKLCGT 331
PE + + + D WS G L E+ G + E H++
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAA 243
Query: 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEF 362
+ + P H +PSFR + +
Sbjct: 244 E---LANLINNCMDYEPDH-RPSFRAIIRDL 270
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 47/213 (22%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 117 KVGQGTYSNVYKA--RDRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G + +V +A + D + VA+K ++ D ++ RE +++ DHP+V K
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 174 LEGLAT----SRMQYSLYLVFDFMQS-DLTKII--CRP---GQKLTEPQVKCYMQQLLSG 223
L G++ ++ FM+ DL + R L + +M + G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLTSRVVTLW 277
+++ R +HRD+ A N ++ + + +ADFGLS +++ L + W
Sbjct: 150 MEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK----W 205
Query: 278 YRAPELLLGSTDYGV---GIDLWSAGCLLAEMF 307
A E L + D+W+ G + E+
Sbjct: 206 L-ALESLA----DNLYTVHSDVWAFGVTMWEIM 233
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 54/274 (19%), Positives = 107/274 (39%), Gaps = 43/274 (15%)
Query: 114 KLAKV-GQGTYSNVYKAR---DRDTGKI-VALKKVRFDTSEPESVKFMAREIRILQKLDH 168
+ KV G G + V+K + ++ KI V +K + + + + LDH
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLAIGSLDH 74
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
++++L GL SL LV ++ L + + L + + Q+ G+ +
Sbjct: 75 AHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLTSRVVTLWYRAP 281
E G++HR++ A N+L+ +++ADFG++ + + + + W A
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WM-AL 186
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMF-IGR---PLMPGR---TEVEQLHRIFKLCGTPSE 334
E + Y D+WS G + E+ G + +E+ R+ + +
Sbjct: 187 ESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245
Query: 335 DY------WKKMKLTTTFRPQHYKPSFREVFGEF 362
Y W +P+F+E+ EF
Sbjct: 246 VYMVMVKCWMI-------DENI-RPTFKELANEF 271
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 46/212 (21%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 117 KVGQGTYSNVYKARDRDTGKI---VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G + +V + + VA+K ++ D S ++ E ++ HPNVI+
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 174 LEGLAT---SRMQYSLYLVFDFMQS-DLTKII--CRP---GQKLTEPQVKCYMQQLLSGL 224
L G+ S+ ++ FM+ DL + R + + + +M + G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLTSRVVTLWY 278
++ R LHRD+ A N ++ + +ADFGLS +++ + + + W
Sbjct: 161 EYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK----WI 216
Query: 279 RAPELLLGSTDYGV---GIDLWSAGCLLAEMF 307
A E L V D+W+ G + E+
Sbjct: 217 -AIESLA----DRVYTSKSDVWAFGVTMWEIA 243
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 49/215 (22%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
++GQG++ VY+ + K VA+K V S E ++F+ E ++++ + +V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHV 90
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTKII--CRP-------GQKLTEPQVKCYMQQLL 221
++L G+ + ++ + M DL + RP + ++ ++
Sbjct: 91 VRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 222 SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLTSRVVT 275
G+ + + +HRD+ A N ++ + +KI DFG++ +++ KG L R
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 205
Query: 276 LWYRAPELLLGSTDYGV---GIDLWSAGCLLAEMF 307
W +PE L GV D+WS G +L E+
Sbjct: 206 -WM-SPESLK----DGVFTTYSDVWSFGVVLWEIA 234
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 8e-21
Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 42/221 (19%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
++G+ + VYK VA+K ++ P +F E + +L HPNV
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRARLQHPNV 74
Query: 172 IKLEGLATSRMQYSLYLVFDFM----------------QSDLTKIICRPGQKLTEPQVKC 215
+ L G+ T L ++F + T L P
Sbjct: 75 VCLLGVVTKDQP--LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 216 YMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPL 269
+ Q+ +G+++ ++H+D+ N+L+ +KI+D GL +++ L
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 270 TSRVVTLWYRAPELLLGSTDYGV---GIDLWSAGCLLAEMF 307
R W APE ++ YG D+WS G +L E+F
Sbjct: 193 PIR----WM-APEAIM----YGKFSIDSDIWSYGVVLWEVF 224
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 67/278 (24%), Positives = 112/278 (40%), Gaps = 46/278 (16%)
Query: 117 KVGQGTYSNVYKAR-----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPN 170
+G+G + V +A T + VA+K ++ + E M E++IL + H N
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SELKILIHIGHHLN 92
Query: 171 VIKLEGLATSRMQYSLYLVFDFM----------------QSDLTKIICRPGQKLTEPQVK 214
V+ L G A ++ L ++ +F LT +
Sbjct: 93 VVNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 215 CYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGP 268
CY Q+ G++ R +HRD+ A N+L+ + ++KI DFGL+ ++ K
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGR---PLMPGRTEVEQL-- 322
L + W APE + Y + D+WS G LL E+F +G P + E +
Sbjct: 212 LPLK----WM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 323 --HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREV 358
R+ T E Y + M P +P+F E+
Sbjct: 266 EGTRMRAPDYTTPEMY-QTMLDCWHGEPSQ-RPTFSEL 301
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 117 KVGQGTYSNVYKARDRDTGK--IVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIK 173
+G+G + V KAR + G A+K+++ S+ + F E+ +L KL HPN+I
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNIIN 90
Query: 174 LEGLATSRMQYSLYLVFDFM----------------QSDLTKIICRPGQKLTEPQVKCYM 217
L G R LYL ++ I L+ Q+ +
Sbjct: 91 LLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 218 QQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS---NFFIPKQKGPLTSRVV 274
+ G+ + ++ +HRD+ A N+L+ ++ + KIADFGLS ++ K G L R
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 206
Query: 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307
W A E L S Y D+WS G LL E+
Sbjct: 207 --WM-AIESLNYSV-YTTNSDVWSYGVLLWEIV 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 61/280 (21%), Positives = 108/280 (38%), Gaps = 49/280 (17%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKL-DHPN 170
+G G + V +A K VA+K ++ E M E+++L L +H N
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLSYLGNHMN 88
Query: 171 VIKLEGLATSRMQYSLYLVFDFM------------------QSDLTKIICRPGQKLTEPQ 212
++ L G T ++ ++ I+ L
Sbjct: 89 IVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 213 VKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQK 266
+ + Q+ G+ + +HRD+ A N+L+ + KI DFGL+ + ++ K
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGR---PLMPGRTEVEQL 322
L + W APE + Y D+WS G L E+F +G P MP ++ ++
Sbjct: 207 ARLPVK----WM-APESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 323 ----HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREV 358
R+ P+E Y MK P +P+F+++
Sbjct: 261 IKEGFRMLSPEHAPAEMY-DIMKTCWDADPLK-RPTFKQI 298
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 52/223 (23%), Positives = 87/223 (39%), Gaps = 52/223 (23%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+G G + VY+ + VA+K + SE + + F+ E I+ K +H N+
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNI 95
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTK--IICRP----GQKLTEPQVKCYMQQLLSGL 224
++ G++ + +++ + M DL RP L + + + G
Sbjct: 96 VRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 225 QHCHERGILHRDIKASNLLIDKSG---MLKIADFGLSNFFIPKQKGPLTSRVV--TLWYR 279
Q+ E +HRDI A N L+ G + KI DFG++ R + +YR
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------------RDIYRASYYR 200
Query: 280 ------------APELLLGSTDYGV---GIDLWSAGCLLAEMF 307
PE + G+ D WS G LL E+F
Sbjct: 201 KGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIF 239
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 50/229 (21%)
Query: 117 KVGQGTYSNVYKAR-----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+G+G + V KA R VA+K ++ + S E + E +L++++HP+V
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEFNVLKQVNHPHV 88
Query: 172 IKLEGLATSRMQYSLYLVFDFM------------------------QSDLTKIICRPGQK 207
IKL G + L L+ ++ + + + +
Sbjct: 89 IKLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 208 LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFF 261
LT + + Q+ G+Q+ E ++HRD+ A N+L+ + +KI+DFGLS + +
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGV---GIDLWSAGCLLAEMF 307
+ + +G + + W A E L + D+WS G LL E+
Sbjct: 207 VKRSQGRIPVK----WM-AIESLF----DHIYTTQSDVWSFGVLLWEIV 246
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 60/276 (21%), Positives = 110/276 (39%), Gaps = 45/276 (16%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLD-HPN 170
+G G + V +A GK VA+K ++ E M E++I+ L H N
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-SELKIMSHLGQHEN 111
Query: 171 VIKLEGLATSRMQYSLYLVFDFM--------------QSDLTKIICRPGQKLTEPQVKCY 216
++ L G T + ++ ++ + + + +
Sbjct: 112 IVNLLGACTHGG--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 217 MQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLT 270
Q+ G+ + +HRD+ A N+L+ + KI DFGL+ + +I K L
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGR---PLMPGRTEVEQL---- 322
+ W APE + Y V D+WS G LL E+F +G P + ++ +L
Sbjct: 230 VK----WM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283
Query: 323 HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREV 358
+++ + P Y M+ P H +P+F+++
Sbjct: 284 YQMAQPAFAPKNIY-SIMQACWALEPTH-RPTFQQI 317
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 52/223 (23%), Positives = 87/223 (39%), Gaps = 52/223 (23%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+G G + VY+ + VA+K + SE + + F+ E I+ K +H N+
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNI 136
Query: 172 IKLEGLATSRMQYSLYLVFDFMQS-DLTK--IICRP----GQKLTEPQVKCYMQQLLSGL 224
++ G++ + +++ + M DL RP L + + + G
Sbjct: 137 VRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 225 QHCHERGILHRDIKASNLLIDKSG---MLKIADFGLSNFFIPKQKGPLTSRVV--TLWYR 279
Q+ E +HRDI A N L+ G + KI DFG++ R + +YR
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------------RDIYRAGYYR 241
Query: 280 ------------APELLLGSTDYGV---GIDLWSAGCLLAEMF 307
PE + G+ D WS G LL E+F
Sbjct: 242 KGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIF 280
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 57/276 (20%), Positives = 109/276 (39%), Gaps = 45/276 (16%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH-PNVIKLE 175
K+G G++ ++Y D G+ VA+K T P+ + E +I + + + +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPTIR 71
Query: 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+V + + L + +K + V Q++S +++ H + +HR
Sbjct: 72 WCGAEGDYN--VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR 129
Query: 236 DIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG- 291
D+K N L+ K ++ I DFGL+ + + YR + L G+ Y
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP------YRENKNLTGTARYAS 183
Query: 292 ----VGI------DLWSAGCLLAEMFIGR---PLMPGRTEVEQLHRIFK---------LC 329
+GI DL S G +L +G + T+ ++ RI + LC
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243
Query: 330 -GTPSE-----DYWKKMKLTTTFRPQHYKPSFREVF 359
G PSE ++ + ++ + + FR +F
Sbjct: 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 52/229 (22%), Positives = 94/229 (41%), Gaps = 55/229 (24%)
Query: 117 KVGQGTYSNVYKARDRDTGK-------IVALKKVRFDTSEPESVKFMAREIRILQKL-DH 168
+G+G + V A K VA+K ++ D +E + + E+ +++ + H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGKH 100
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFM----------------QSDLTKIICRPGQKLTEPQ 212
N+I L G T LY++ ++ I P +++T
Sbjct: 101 KNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 213 VKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272
+ QL G+++ + +HRD+ A N+L+ ++ ++KIADFGL +R
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL-------------AR 205
Query: 273 VV--TLWYR------------APELLLGSTDYGVGIDLWSAGCLLAEMF 307
+ +Y+ APE L Y D+WS G L+ E+F
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIF 253
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 52/229 (22%), Positives = 98/229 (42%), Gaps = 50/229 (21%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
+G+G + V++AR +VA+K ++ + S F RE ++ + D+PN+
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDNPNI 112
Query: 172 IKLEGLATSRMQYSLYLVFDFMQ------------------------SDLTKIICRPGQK 207
+KL G+ + L+F++M S ++
Sbjct: 113 VKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 208 LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFF 261
L+ + C +Q+ +G+ + ER +HRD+ N L+ ++ ++KIADFGLS +++
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGV---GIDLWSAGCLLAEMF 307
+ R W PE + Y D+W+ G +L E+F
Sbjct: 231 KADGNDAIPIR----WM-PPESIF----YNRYTTESDVWAYGVVLWEIF 270
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 50/232 (21%), Positives = 92/232 (39%), Gaps = 61/232 (26%)
Query: 117 KVGQGTYSNVYKARDRDTGKI-------VALKKVRFDTSEPESVKFMAREIRILQKL-DH 168
+G+G + V A K VA+K ++ D +E + + E+ +++ + H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGKH 134
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFM----------------QSDLTKIICRPGQKLTEPQ 212
N+I L G T LY++ ++ P ++L+
Sbjct: 135 KNIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 213 VKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272
+ Q+ G+++ + +HRD+ A N+L+ + ++KIADFGL +R
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL-------------AR 239
Query: 273 VV--TLWYR------------APELLLGSTDYGV---GIDLWSAGCLLAEMF 307
+ +Y+ APE L + D+WS G LL E+F
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIF 287
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 65/290 (22%), Positives = 118/290 (40%), Gaps = 70/290 (24%)
Query: 117 KVGQGTYSNVYKARDRDTGK-------IVALKKVRFDTSEPESVKFMAREIRILQKL-DH 168
+G+G + V A K VA+K ++ D +E + + E+ +++ + H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGKH 146
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFM----------------QSDLTKIICRPGQKLTEPQ 212
N+I L G T LY++ ++ I P +++T
Sbjct: 147 KNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 213 VKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR 272
+ QL G+++ + +HRD+ A N+L+ ++ ++KIADFGL+ R
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA-------------R 251
Query: 273 VV--TLWYR------------APELLLGSTDYGV---GIDLWSAGCLLAEMF-IGR---P 311
+ +Y+ APE L V D+WS G L+ E+F +G P
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307
Query: 312 LMPGRTEVEQL---HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREV 358
+P + L HR+ K +E Y M+ P +P+F+++
Sbjct: 308 GIPVEELFKLLKEGHRMDKPANCTNELY-MMMRDCWHAVPSQ-RPTFKQL 355
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 63/285 (22%), Positives = 112/285 (39%), Gaps = 54/285 (18%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKL-DHPN 170
+G G + V A K VA+K ++ E M E++++ +L H N
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMTQLGSHEN 110
Query: 171 VIKLEGLATSRMQYSLYLVFDFM-----------------------QSDLTKIICRPGQK 207
++ L G T +YL+F++ ++
Sbjct: 111 IVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 208 LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFF 261
LT + C+ Q+ G++ + +HRD+ A N+L+ ++KI DFGL+ + +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGR---PLMPGRT 317
+ + L + W APE L Y + D+WS G LL E+F +G P +P
Sbjct: 229 VVRGNARLPVK----WM-APESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 318 EVEQL----HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREV 358
+L ++ + E Y M+ F + +PSF +
Sbjct: 283 NFYKLIQNGFKMDQPFYATEEIY-IIMQSCWAFDSRK-RPSFPNL 325
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 42/220 (19%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
++G+G + V+ A + +VA+K ++ + SE F RE +L L H ++
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REAELLTMLQHQHI 105
Query: 172 IKLEGLATSRMQYSLYLVFDFMQ---------------SDLTKIICRPGQKLTEPQVKCY 216
++ G+ T L +VF++M+ L L Q+
Sbjct: 106 VRFFGVCTEGRP--LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 217 MQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS------NFFIPKQKGPLT 270
Q+ +G+ + +HRD+ N L+ + ++KI DFG+S +++ + L
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 271 SRVVTLWYRAPELLLGSTDYGV---GIDLWSAGCLLAEMF 307
R W PE +L Y D+WS G +L E+F
Sbjct: 224 IR----WM-PPESIL----YRKFTTESDVWSFGVVLWEIF 254
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 50/229 (21%), Positives = 90/229 (39%), Gaps = 59/229 (25%)
Query: 117 KVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
++G+G + V+ A + +VA+K ++ D + F RE +L L H ++
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-REAELLTNLQHEHI 79
Query: 172 IKLEGLATSRMQYSLYLVFDFM----------------QSDLTKIICRPGQKLTEPQVKC 215
+K G+ L +VF++M + + +L Q+
Sbjct: 80 VKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 216 YMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVT 275
Q+ SG+ + + +HRD+ N L+ + ++KI DFG+S R V
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS-------------RDVY 184
Query: 276 L--WYR------------APELLLGSTDYGV---GIDLWSAGCLLAEMF 307
+YR PE ++ Y D+WS G +L E+F
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIM----YRKFTTESDVWSFGVILWEIF 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 36/230 (15%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS--EPESVKFMAREIRILQKLD 167
+++D +G G + VYK RD G VALK+ ++S E F EI L
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEE---FET-EIETLSFCR 93
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFM-----QSDLTKIICRPGQKLTEPQVKCYMQQLL- 221
HP+++ L G R + + L++ +M + L P ++ Q ++ +
Sbjct: 94 HPHLVSLIGFCDERNE--MILIYKYMENGNLKRHLYGSD-LPTMSMSWEQ---RLEICIG 147
Query: 222 --SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWY 278
GL + H R I+HRD+K+ N+L+D++ + KI DFG+S + L++ V TL Y
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 279 RAPE------LLLGSTDYGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQ 321
PE L S D++S G +L E+ R ++
Sbjct: 208 IDPEYFIKGRLTEKS-------DVYSFGVVLFEVLCARSAIVQSLPREMV 250
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 39/170 (22%), Positives = 71/170 (41%), Gaps = 23/170 (13%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLE- 175
K+G G + +Y A + + A V+ E + + E++ Q++ + IK
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKV---EYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 176 ----------------GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQ 219
GL + + ++V + + DL KI + G + V +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIR 159
Query: 220 LLSGLQHCHERGILHRDIKASNLLID--KSGMLKIADFGLSNFFIPKQKG 267
+L L++ HE +H DIKA+NLL+ + +AD+GLS + P
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 57/282 (20%), Positives = 105/282 (37%), Gaps = 55/282 (19%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH-PNVIKLE 175
++G+G++ +++ + + VA+K + P+ + E R + L + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVY 72
Query: 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+ LV D + L ++ G+K + V +Q+L+ +Q HE+ +++R
Sbjct: 73 YFGQEGLHN--VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR 130
Query: 236 DIKASNLLIDKSGMLK-----IADFGLSNFFIPKQKG---PLTSRVVTLWYRAPELLLGS 287
DIK N LI + + DFG+ F+ P YR + L G+
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP---------YREKKNLSGT 181
Query: 288 TDYG-----VGI------DLWSAGCLLAEMFIGRPL----MPGRTEVEQLHRIFK----- 327
Y +G DL + G + G L + T ++ RI +
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYERIGEKKQST 240
Query: 328 ----LC-GTPSE--DYWKKMK-LTTTFRP--QHYKPSFREVF 359
LC G P E Y + L P + + F +V
Sbjct: 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 57/230 (24%), Positives = 105/230 (45%), Gaps = 47/230 (20%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
+G+G + VYK R D G +VA+K+++ + ++ ++F E+ ++ H N+++L G
Sbjct: 37 ILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHRNLLRLRG 94
Query: 177 L---ATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLS--------- 222
T R+ LV+ +M S + + RP + L
Sbjct: 95 FCMTPTERL-----LVYPYMANGSVASCLRERPESQPP-----------LDWPKRQRIAL 138
Query: 223 ----GLQHCHERG---ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV- 274
GL + H+ I+HRD+KA+N+L+D+ + DFGL+ + +T+ V
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRG 197
Query: 275 TLWYRAPE-LLLG-STDYGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQ 321
T+ + APE L G S++ D++ G +L E+ G+ R +
Sbjct: 198 TIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 8e-17
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 52/221 (23%)
Query: 117 KVGQGTYSNVYKAR-DRDTGKIVALKKVRFDTSEPESVK----FMAREIRILQKLDHPNV 171
K+G+G + VYK + VA+KK+ + + + F EI+++ K H N+
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLA-AMVDITTEELKQQFDQ-EIKVMAKCQHENL 92
Query: 172 IKLEGLATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLS------- 222
++L G ++ L LV+ +M S L ++ C G LS
Sbjct: 93 VELLGFSSDGDD--LCLVYVYMPNGSLLDRLSCLDGTPP------------LSWHMRCKI 138
Query: 223 ------GLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-T 275
G+ HE +HRDIK++N+L+D++ KI+DFGL+ + +TSR+V T
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198
Query: 276 LWYRAPELLLG-----STDYGVGIDLWSAGCLLAEMFIGRP 311
Y APE L G S D++S G +L E+ G P
Sbjct: 199 TAYMAPEALRGEITPKS-------DIYSFGVVLLEIITGLP 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 30/152 (19%), Positives = 63/152 (41%), Gaps = 12/152 (7%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH-PNVIKLE 175
K+G G + + ++ T + VA+K + P+ + E R ++L + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ----LHLEYRFYKQLGSGDGIPQVY 71
Query: 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
+V + + L + + + V QL+S +++ H + +++R
Sbjct: 72 YFGPCGKYN--AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYR 129
Query: 236 DIKASNLLIDKSGMLK-----IADFGLSNFFI 262
D+K N LI + G I DF L+ +I
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 20/170 (11%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI---- 172
+GQG + +Y A D ++ + V EP + E++ Q+ P I
Sbjct: 42 PIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 173 ---KLEGLATSRMQYSL----------YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQ 219
KL+ L + S +++ D SDL KI ++ + V +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 220 LLSGLQHCHERGILHRDIKASNLLID--KSGMLKIADFGLSNFFIPKQKG 267
+L L++ HE +H DIKASNLL++ + + D+GL+ + P+
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 47/279 (16%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLE 175
K+G G++ +Y + T + VA+K T P+ + E +I + L + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRILQGGTGIPNVR 69
Query: 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHR 235
LV D + L + +KL+ V Q+++ ++ H + LHR
Sbjct: 70 WFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
Query: 236 DIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG- 291
DIK N L+ ++ + I DFGL+ + + YR + L G+ Y
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH------QHIPYRENKNLTGTARYAS 181
Query: 292 ----VGI------DLWSAGCLLAEMFIGRPL----MPGRTEVEQLHRIFK---------L 328
+GI DL S G +L G L + T+ ++ +I + L
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 329 C-GTPSE-----DYWKKMKLTTTFRPQHYKPSFREVFGE 361
C G P+E Y + ++ + K FR++F
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 30/169 (17%), Positives = 55/169 (32%), Gaps = 20/169 (11%)
Query: 117 KVGQGTYSNVYKARDRDTGKI--------VALKKVRFDTSEPESVKFMAREIRI------ 162
+ +Y+A T +LK D F R +
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 163 --LQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICR-PGQKLTEPQVKCYMQQ 219
L + G + +Y +LV + L + P L+E V +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 220 LLSGLQHCHERGILHRDIKASNLLI--DKSGMLKIADFGLSNFFIPKQK 266
LL L+ HE +H ++ A N+ + + + +A +G + + P K
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 13/133 (9%)
Query: 202 CRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS--- 258
LT + CY Q+ G++ R +HRD+ A N+L+ + ++KI DFGL+
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 259 ---NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMP 314
++ K L + W APE + Y + D+WS G LL E+F +G P
Sbjct: 244 YKDPDYVRKGDARLPLK----WM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYP 297
Query: 315 GRTEVEQLHRIFK 327
G E+ R K
Sbjct: 298 GVKIDEEFCRRLK 310
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 61/443 (13%), Positives = 117/443 (26%), Gaps = 123/443 (27%)
Query: 7 KLSPPQNVVERLK-MEGGYVKGVSAGRVVVQKAVGKEN---------GKVSRHGGDGNGV 56
+L P +NV+ + + G K A V + V + + +
Sbjct: 146 ELRPAKNVL--IDGV-LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 57 GERVRNGGGDGGSRSRKSVKKKISEDELVDGWPKWLVDNIPKEVLAGLV------PKSAD 110
+ + + SRS S K+ + + L + L LV K+ +
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWN 260
Query: 111 SYDKLAKVGQGT-YSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRI-LQKL-- 166
+++ K+ T + V T ++L + E + + + Q L
Sbjct: 261 AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320
Query: 167 ----DHPNVIKLEGLA----TSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQ 218
+P + + + + ++ D LT II L + +
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD----KLTTIIESSLNVLEPAEYRKMFD 376
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLW- 277
+L + IP T + +W
Sbjct: 377 RL----------SVFPPSAH-----------------------IP------TILLSLIWF 397
Query: 278 ---YRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIF------- 326
+++ Y + ++ ++ I L LHR
Sbjct: 398 DVIKSDVMVVVNKLHKYSL-VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIP 456
Query: 327 -KLC----GTPSED-YW--------KKMKLTTTFRPQHYKPSFREVFGEF---------- 362
P D Y+ K ++ FR VF +F
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP------ERMTLFRMVFLDFRFLEQKIRHD 510
Query: 363 ---PPSSYGILTTLLALDPAYRG 382
+S IL TL L Y+
Sbjct: 511 STAWNASGSILNTLQQLK-FYKP 532
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 3e-05
Identities = 56/367 (15%), Positives = 101/367 (27%), Gaps = 110/367 (29%)
Query: 91 WLVDNIPKEVLAGLVPKS-ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE 149
W + + +E++ V + +Y L + T + + ++ ++
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMS----PIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124
Query: 150 PESVKFMAR-----EIRI-LQKL-DHPNVIKLEGLA----TSRMQYSLYLVFDFMQSDLT 198
+ ++R ++R L +L NV+ ++G+ T + D S
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVL-IDGVLGSGKTW-------VALDVCLSY-- 174
Query: 199 KIICRPGQK---LTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIAD 254
K+ C+ K L L++C+ +L LL
Sbjct: 175 KVQCKMDFKIFWLN--------------LKNCNSPETVL---EMLQKLLYQIDPNWTSRS 217
Query: 255 FGLSNFFIPKQKGPLTSRVVTLWYRA--PELLLGSTDYGVGI--DLWSAGCLLAEMFIGR 310
SN I + + + + L LL + ++ +A A
Sbjct: 218 DHSSN--IKLRIHSIQAELRRLLKSKPYENCLL--------VLLNVQNAKAWNA------ 261
Query: 311 PLMPGRTEVEQLHRIFKL-CGTPSEDYWKKMKLTTTFR-------PQHYK-PSFREVFGE 361
F L C K+ LTT F+ S
Sbjct: 262 ---------------FNLSC---------KILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 362 FPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLPVICREEDEPARTSRR 421
P + +LL Y L E +P LS + R D A
Sbjct: 298 LTPDE---VKSLLLK---YLDCRPQDLPREVLTTNPRR--LSIIAESIR--DGLATWDNW 347
Query: 422 KKRRSSK 428
K K
Sbjct: 348 KHVNCDK 354
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 469 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.59 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.71 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.54 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.4 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.33 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.28 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.06 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.02 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.78 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.45 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-63 Score=500.27 Aligned_cols=289 Identities=35% Similarity=0.574 Sum_probs=247.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec----ccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR----MQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~ 184 (469)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++... ...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4689999999999999999999999999999999977666666667889999999999999999999987643 235
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+|||||||+|+|...+.. ...+++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 6899999999998887765 457999999999999999999999999999999999999999999999999999876432
Q ss_pred ---CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 265 ---QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 265 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
......+.+||+.|||||++.+...|+.++|||||||++|||++|++||.+.+..+++..|+...+.|+...|....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 22345678999999999998887778999999999999999999999999999999999999999999887765543
Q ss_pred cCcc-----CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 342 LTTT-----FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 342 ~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
.... ..+......+..+++.+++++.+||.+||++||.+||||.|+|+||||+....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 2211 11223344566778889999999999999999999999999999999997543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-63 Score=474.30 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=207.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++|||||++++++.+. ..+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEE
Confidence 4789999999999999999999999999999999976532 233456789999999999999999999998774 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||||+|+|++.+... .++++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.... ..
T Consensus 90 ivmEy~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~ 166 (275)
T 3hyh_A 90 MVIEYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GN 166 (275)
T ss_dssp EEEECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC--CC
Confidence 99999999998888664 4799999999999999999999999999999999999999999999999999987533 23
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
...+.+||+.|||||++.+...++.++|||||||+||+|+||++||.+.+..+.+..+.+...
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~----------------- 229 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY----------------- 229 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 345789999999999998766567899999999999999999999999887777766654211
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.+...+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 230 ---------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 ---------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 112357899999999999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-63 Score=487.87 Aligned_cols=258 Identities=29% Similarity=0.486 Sum_probs=221.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
...|+++++||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|+.|+|||||++++++.+. ..+||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~i 148 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWV 148 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 357999999999999999999999999999999997653322 25678999999999999999999999874 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||||+| +|.+.+.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... ..
T Consensus 149 vmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~ 225 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VP 225 (346)
T ss_dssp EECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SC
T ss_pred EEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-CC
Confidence 9999997 45555443 46999999999999999999999999999999999999999999999999999876432 23
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
...+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..|..... +
T Consensus 226 ~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~--------------- 288 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-P--------------- 288 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-C---------------
T ss_pred cccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-C---------------
Confidence 4567899999999998865 5689999999999999999999999999988888877654211 1
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. ...+..+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 289 ------~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 289 ------R-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ------C-CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ------C-CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 0 122346799999999999999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-63 Score=488.19 Aligned_cols=260 Identities=24% Similarity=0.446 Sum_probs=221.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|++|+|||||++++++.+. ..+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~y 99 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLY 99 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEE
Confidence 45789999999999999999999999999999999987766667778899999999999999999999998874 4579
Q ss_pred EEEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
||||||+| +|.+.+... +..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999996 777777543 446899999999999999999999999999999999999999999999999999875321
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.++......
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------------- 243 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-------------- 243 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------------
T ss_pred cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------------
Confidence 112346789999999999876 56899999999999999999999999999988888887653211
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.....+|+++.+||.+||+.||++|||++|+|+||||+..
T Consensus 244 -----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 244 -----------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred -----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 1234678999999999999999999999999999999763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-63 Score=479.77 Aligned_cols=258 Identities=27% Similarity=0.443 Sum_probs=222.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++++.||+|+||+||+|+++.+++.||||++.... ......+.+.+|+.+|++|+|||||++++++.+. ..+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 367999999999999999999999999999999997532 1122346788999999999999999999988774 4689
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC-
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ- 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 265 (469)
||||||+| +|.+.+.. .+.+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus 109 ivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999997 66666644 4579999999999999999999999999999999999999999999999999999775433
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.....+.+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|.+...
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--------------- 251 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY--------------- 251 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------------
T ss_pred cccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 234567899999999999876 5689999999999999999999999999998888888765311
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHH------HhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAAS------ALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~e------lL~hp~f~~~ 396 (469)
.+...+++++.+||.+||++||++|||++| +++||||+.-
T Consensus 252 -----------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 252 -----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp -----------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred -----------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 122357899999999999999999999998 5899999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-62 Score=470.00 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=215.9
Q ss_pred cCc-ceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec--cccEE
Q 036673 110 DSY-DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR--MQYSL 186 (469)
Q Consensus 110 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~~ 186 (469)
.+| ++.++||+|+||+||+|++..++..||||++..........+.|.+|+.+|++|+|||||++++++... ....+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 778889999999999999999999999999987666666678899999999999999999999998653 34568
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEcC-CCcEEEeeecCccccc
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG--ILHRDIKASNLLIDK-SGMLKIADFGLSNFFI 262 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 262 (469)
|||||||+| +|.+.+. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+..
T Consensus 105 ~lvmEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~- 182 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK- 182 (290)
T ss_dssp EEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC-
T ss_pred EEEEeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC-
Confidence 999999997 5555554 3457999999999999999999999998 999999999999985 799999999999864
Q ss_pred CCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
......+.+||+.|||||++.+ .|+.++|||||||+||||+||++||.+......+...+.....|
T Consensus 183 --~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~---------- 248 (290)
T 3fpq_A 183 --RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp --CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred --CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC----------
Confidence 2234567899999999998864 48999999999999999999999998776665554443211111
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
......+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 249 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1223456789999999999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-62 Score=489.42 Aligned_cols=258 Identities=29% Similarity=0.486 Sum_probs=221.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.+.|+++++||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|+.|+|||||++++++... ..+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~i 225 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWV 225 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEE
Confidence 367999999999999999999999999999999997654332 35688999999999999999999999874 45799
Q ss_pred EEecchhh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||||+|+ |.+.+.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... ..
T Consensus 226 VmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~ 302 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VP 302 (423)
T ss_dssp EEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CC
T ss_pred EEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-Cc
Confidence 99999974 5554433 36999999999999999999999999999999999999999999999999999876432 23
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
...+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..|..... +
T Consensus 303 ~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~--------------- 365 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-P--------------- 365 (423)
T ss_dssp CBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C---------------
T ss_pred cccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-C---------------
Confidence 4567899999999998875 5689999999999999999999999999988888877654211 1
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. ...+..+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 366 ------~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 366 ------R-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp ------C-CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ------C-CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 0 122356899999999999999999999999999999998743
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=469.46 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=211.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC---CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR---DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.++|++++.||+|+||+||+|++. .+++.||||+++...........+.+|+.+|++|+|||||++++++.+. ..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET--TE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CE
Confidence 368999999999999999999984 4688999999975432222234577899999999999999999998874 45
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+|||||||+| +|.+.+.+ ...+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 7999999997 56665544 457999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.....+.+||+.|||||++.+ ..|+.++|||||||+||||+||++||.+.+..+.+..|.+...
T Consensus 180 -~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-------------- 243 (304)
T 3ubd_A 180 -EKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-------------- 243 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------
T ss_pred -CccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC--------------
Confidence 233457899999999999876 5689999999999999999999999999998888887765211
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH-----HHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA-----ASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta-----~elL~hp~f~~ 395 (469)
.+...+|+++.+||.+||+.||++|||+ +|+|+||||+.
T Consensus 244 ------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 244 ------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred ------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 1123578999999999999999999994 79999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-60 Score=467.50 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=214.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||++++++.+. ..+|
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~--~~~~ 126 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREG--PWVN 126 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEET--TEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 34679999999999999999999999999999999976432 24699999999999999999998874 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-cEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 265 (469)
||||||+| +|.+.+.. .+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 127 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999997 66665544 45799999999999999999999999999999999999999998 69999999998764432
Q ss_pred CC----CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 266 KG----PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 266 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.. .....+||+.|||||++.+ ..|+.++|||||||+||||+||++||.+.+..+.+.+|...
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------- 271 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE------------- 271 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-------------
T ss_pred cccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-------------
Confidence 21 1234689999999999876 56899999999999999999999999987776666666431
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHH-------------hcCccCCCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA-------------LQNEFFNASP 397 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~el-------------L~hp~f~~~~ 397 (469)
.+.+..+++.+++.+.+||.+||++||.+|||+.|+ |+|||+....
T Consensus 272 ----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 272 ----------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp ----------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred ----------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 122334566789999999999999999999999997 6899997643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-59 Score=464.18 Aligned_cols=284 Identities=27% Similarity=0.425 Sum_probs=221.9
Q ss_pred ccCCCCccCcceeceeeeeCCeEEEEEEEC---CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeE
Q 036673 103 GLVPKSADSYDKLAKVGQGTYSNVYKARDR---DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLA 178 (469)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 178 (469)
..+|...++|++.++||+|+||+||+|+++ .+++.||||++..... ...+.+|+++|..+ +|||||++++++
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 344566789999999999999999999875 4578999999864322 24577899999998 699999999988
Q ss_pred eeccccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC-CcEEEeeec
Q 036673 179 TSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS-GMLKIADFG 256 (469)
Q Consensus 179 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~-~~~kl~DFG 256 (469)
... .++|||||||+| +|.+.+ ..+++.+++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||
T Consensus 90 ~~~--~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 90 RKN--DHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EET--TEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEC--CEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 774 468999999986 566555 259999999999999999999999999999999999999877 799999999
Q ss_pred CcccccCCC---------------------------CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC
Q 036673 257 LSNFFIPKQ---------------------------KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG 309 (469)
Q Consensus 257 la~~~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg 309 (469)
+|+...... .....+.+||++|+|||++.+...|+.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 997643221 11234568999999999998877799999999999999999999
Q ss_pred CCCC-CCCChHHHHHHHHHHhCCCCHHHHhhcccCc-----------------------cCCCC-----CCCCcchhccc
Q 036673 310 RPLM-PGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT-----------------------TFRPQ-----HYKPSFREVFG 360 (469)
Q Consensus 310 ~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-----------------------~~~~~-----~~~~~~~~~~~ 360 (469)
++|| .+.++.+++..|+..+|.+....+....... ...+. .........+.
T Consensus 244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 9888 5667888999999888865443322211000 00000 00011123456
Q ss_pred CCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 361 EFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 361 ~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+++++.|||.+||++||++|+||+|+|+||||+.-
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 789999999999999999999999999999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=448.81 Aligned_cols=258 Identities=21% Similarity=0.404 Sum_probs=196.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc------
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ------ 183 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~------ 183 (469)
++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++|+|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46999999999999999999999999999999997653 34455778999999999999999999998876442
Q ss_pred ----cEEEEEEecchh-hHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeec
Q 036673 184 ----YSLYLVFDFMQS-DLTKIICRPGQ--KLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFG 256 (469)
Q Consensus 184 ----~~~~lv~e~~~~-~l~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFG 256 (469)
.++|||||||.+ +|.+.+..... ..++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 357999999997 55555544321 24567789999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCC-----------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036673 257 LSNFFIPKQKG-----------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRI 325 (469)
Q Consensus 257 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i 325 (469)
+|+.+...... ..++.+||+.|||||++.+ ..|+.++|||||||+||||++ ||... .+....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 99876433211 2345689999999999876 568999999999999999996 67543 2333322
Q ss_pred HHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 326 FKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
........ + ..+...++.+.+||.+||+.||.+|||+.|+|+||||+.-
T Consensus 238 ~~~~~~~~------------------p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 238 TDVRNLKF------------------P----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHTTCC------------------C----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHhcCCC------------------C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 22211110 0 1222346778899999999999999999999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=443.05 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=210.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.++||+|+||+||+|++.. .||||+++......+..+.|.+|+.+|++++|||||++++++... .+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD---NLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC---eEEE
Confidence 3678999999999999999998653 599999987666677778899999999999999999999987542 3689
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC-C
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ-K 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 266 (469)
|||||++ +|.+.+.....++++.++..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+...... .
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999996 6777776666789999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CCcccccccCccccchhccCC--CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 267 GPLTSRVVTLWYRAPELLLGS--TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
......+||+.|||||++.+. ..|+.++|||||||+||||+||++||.+.+....+..++....
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~-------------- 254 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY-------------- 254 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC--------------
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC--------------
Confidence 234567899999999998642 3589999999999999999999999998777666655543211
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..|.+......+++++.+||.+||+.||++|||+.|++++
T Consensus 255 ------~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 255 ------ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp ------CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ------CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1122334556789999999999999999999999987543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=471.26 Aligned_cols=263 Identities=25% Similarity=0.420 Sum_probs=228.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|+.|+|||||++++++.+ ...+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 47899999999999999999999999999999999753 33445778899999999999999999999876 446899
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC--CcEEEeeecCcccccCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS--GMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 265 (469)
|||||.| +|.+.+......+++.+++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+.+.+
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-- 309 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence 9999986 7777777666789999999999999999999999999999999999999854 8999999999998743
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..|......++.
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 377 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------- 377 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS-----------
T ss_pred CCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc-----------
Confidence 233557799999999999876 56899999999999999999999999999998888887654322221
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 400 (469)
..+..+++++.+||.+||+.||.+|||+.|+|+||||+....+.
T Consensus 378 -----------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 378 -----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp -----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred -----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 23456899999999999999999999999999999999755443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=471.14 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=213.9
Q ss_pred CCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC----CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEee
Q 036673 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD----TSEPESVKFMAREIRILQKLDHPNVIKLEGLATS 180 (469)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 180 (469)
.+...++|+++++||+|+||+||+|+++.+|+.||||++... ............++.++..++|||||+++++|.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 466789999999999999999999999999999999999643 2222333334455777888899999999988877
Q ss_pred ccccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 181 RMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 181 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
. ..+|||||||.| +|...+.. .+.|++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 264 ~--~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 P--DKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp S--SEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred C--CEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence 4 468999999997 66665544 4579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHH
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV---EQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~ 336 (469)
.+... ...+.+||+.|||||++.+...|+.++|||||||+||||++|++||.+.+.. +....+... .
T Consensus 341 ~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~----- 410 (689)
T 3v5w_A 341 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--A----- 410 (689)
T ss_dssp ECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--C-----
T ss_pred ecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--C-----
Confidence 76332 3456799999999999876567999999999999999999999999764322 222222211 0
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNA 395 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~ 395 (469)
..++..+|+++.+||.+||+.||.+|++ ++|+++||||+.
T Consensus 411 -------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 411 -------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred -------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 0223467999999999999999999998 799999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-56 Score=435.07 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=203.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.++|.+.++||+|+||+||+|++. .+++.||||+++. ......+.|.+|+.+|.+|+|||||+++|+|.+..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~- 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR- 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 467889999999999999999875 3588999999964 34555678999999999999999999999998744
Q ss_pred cEEEEEEecchh-hHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC
Q 036673 184 YSLYLVFDFMQS-DLTKIICRP--------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 248 (469)
.+|||||||++ +|.+++... ..++++.++..|+.||+.||+|||+++||||||||+||||+.++
T Consensus 117 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 117 -PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp -SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 47999999996 666665432 24699999999999999999999999999999999999999999
Q ss_pred cEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036673 249 MLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIF 326 (469)
Q Consensus 249 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~ 326 (469)
++||+|||+|+.+..... ......+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999987643322 22345689999999998876 568999999999999999999 899999988888777665
Q ss_pred HHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 327 KLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..... .....+++++.+||.+||+.||++|||+.|++++
T Consensus 275 ~g~~~-------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGREL-------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCC-------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCC-------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 42110 1223578999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=430.42 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=209.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.++|.+.++||+|+||+||+|++. .++..||||+++.. .....+.|.+|+.+|++|+|||||+++|++.+.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~- 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD- 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-
Confidence 367999999999999999999875 35789999999643 4455678999999999999999999999998754
Q ss_pred cEEEEEEecchh-hHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcE
Q 036673 184 YSLYLVFDFMQS-DLTKIICRP------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGML 250 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~ 250 (469)
.+|||||||++ +|.+.+... ...+++.++..|+.||+.||+|||+++||||||||+||||+.++++
T Consensus 89 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 89 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 46999999996 666666432 2469999999999999999999999999999999999999999999
Q ss_pred EEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 036673 251 KIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKL 328 (469)
Q Consensus 251 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~ 328 (469)
||+|||+|+........ .....+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999865433221 1234578999999999876 458999999999999999998 89999998888877776542
Q ss_pred hCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 329 CGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
... .....+|+++.+||.+||+.||++|||+.+++ +|++
T Consensus 247 ~~~-------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 247 RVL-------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp CCC-------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred CCC-------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 111 12245789999999999999999999999994 5664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=427.05 Aligned_cols=253 Identities=20% Similarity=0.326 Sum_probs=209.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
..+++++++||+|+||+||+|++. .+++.||||+++.... ....+.|.+|+.+|.+|+|||||+++|++.....
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 457889999999999999999864 3578999999975433 3445779999999999999999999999987543
Q ss_pred cEEEEEEecchh-hHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC
Q 036673 184 YSLYLVFDFMQS-DLTKIICRP---------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS 247 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~ 247 (469)
++||||||++ +|.+.+... ...+++.++..|+.||+.||+|||+++||||||||+||||+++
T Consensus 104 --~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 104 --LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp --CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred --EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 6999999996 676666432 1358999999999999999999999999999999999999999
Q ss_pred CcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 036673 248 GMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRI 325 (469)
Q Consensus 248 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i 325 (469)
+++||+|||+|+.+..... ......+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999987643332 23456789999999999876 458999999999999999998 89999998888777666
Q ss_pred HHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 326 FKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
...... .....+|+++.+||.+||+.||.+|||+.|++++
T Consensus 261 ~~~~~~-------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVL-------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCC-------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCC-------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 432111 1234678999999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-54 Score=414.87 Aligned_cols=284 Identities=40% Similarity=0.706 Sum_probs=244.6
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++++.||+|+||+||+|++..+++.||||++............+.+|+.++++++||||+++++++... ..+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEEE
Confidence 679999999999999999999999999999999987665555667788999999999999999999998774 457999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||++++++..+...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cccc
Confidence 999999998888877778999999999999999999999999999999999999999999999999999865322 2334
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRP-LMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
...++|+.|+|||++.+...++.++|||||||++|+|++|.. +|.+.+..+.+..+....+.+....|........+.+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 566889999999998876668999999999999999997755 5788888899999999999998887776654433322
Q ss_pred CC---CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 349 QH---YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 349 ~~---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.. ....+....+.+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 11 1223445566789999999999999999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-54 Score=419.25 Aligned_cols=284 Identities=41% Similarity=0.766 Sum_probs=238.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|+++++||+|+||+||+|++.. ++.||||++............+.+|+.+++.++||||+++++++... ..++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 95 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--RCLT 95 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--SCEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--CEEE
Confidence 34789999999999999999999964 89999999976554444557788999999999999999999988764 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+||||+++++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~ 174 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VR 174 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-CC
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-cc
Confidence 99999999999988887777999999999999999999999999999999999999999999999999999875322 22
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+...++.+....|........+.
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 34456789999999998776678999999999999999999999999999999999999999888776665543221111
Q ss_pred ----CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 348 ----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 348 ----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.......+....+.+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 111123445566778999999999999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=427.69 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=208.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC-CCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDT-----GKIVALKKVRFDTSEPESVKFMAREIRILQKLDH-PNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~ 182 (469)
.++|++.+.||+|+||+||+|.+..+ ++.||||++.... .....+.|.+|+.+|.+++| ||||+++|+|....
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 36899999999999999999998754 3689999997543 34455779999999999966 89999999987643
Q ss_pred ccEEEEEEecchh-hHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRP---------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK 246 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~ 246 (469)
..+|||||||++ +|.+.+... ...+++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus 142 -~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 142 -GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp -SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred -CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 346999999996 666666432 235899999999999999999999999999999999999999
Q ss_pred CCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 036673 247 SGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHR 324 (469)
Q Consensus 247 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~ 324 (469)
++.+||+|||+|+.+...... .....+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+....+.+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876443322 2345678999999999876 468999999999999999998 9999998765554444
Q ss_pred HHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 325 IFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 325 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
++.....+ .....+++++.+||.+||+.||++|||+.|+++|
T Consensus 300 ~i~~g~~~------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRM------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCC------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 43321111 1223578899999999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=429.61 Aligned_cols=286 Identities=35% Similarity=0.607 Sum_probs=229.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|..+. ||||+++++++...+...+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999999999999999999766556666778889999999997 99999999999876666789
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC---
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK--- 264 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 264 (469)
+|||||+++|...+.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999988887765 36999999999999999999999999999999999999999999999999999865321
Q ss_pred -----------------CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036673 265 -----------------QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFK 327 (469)
Q Consensus 265 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 327 (469)
.....+..+||++|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 112244568999999999998767799999999999999999999999999999999999999
Q ss_pred HhCCCCHHHHhhcccCcc------------CCCCCCCCcch---------hcccCCChhHHHHHHHccccCCCCCCCHHH
Q 036673 328 LCGTPSEDYWKKMKLTTT------------FRPQHYKPSFR---------EVFGEFPPSSYGILTTLLALDPAYRGTAAS 386 (469)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~Rpta~e 386 (469)
.++.|....+..+..... .........+. .....+++++.+||.+||+.||.+|||+.|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 999998876654321100 00001111110 011267899999999999999999999999
Q ss_pred HhcCccCCCC
Q 036673 387 ALQNEFFNAS 396 (469)
Q Consensus 387 lL~hp~f~~~ 396 (469)
+|+||||+..
T Consensus 326 ~l~Hp~~~~~ 335 (388)
T 3oz6_A 326 ALKHPFVSIF 335 (388)
T ss_dssp HTTSTTTTTT
T ss_pred HhCCHHHHHh
Confidence 9999999753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=436.10 Aligned_cols=289 Identities=34% Similarity=0.575 Sum_probs=230.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc---ccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM---QYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~ 185 (469)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.++|||||++++++.... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999999999999999999766566666788999999999999999999999885432 246
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+|+||||++++|...+... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 8999999999888877654 469999999999999999999999999999999999999999999999999998764221
Q ss_pred C--------------------------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-----------
Q 036673 266 K--------------------------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI----------- 308 (469)
Q Consensus 266 ~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt----------- 308 (469)
. ...+..+||++|+|||++.....|+.++|||||||+||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1 124566889999999987666779999999999999999998
Q ss_pred CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhhcccCc-----cCCCCCCCCcchhcccCCC
Q 036673 309 GRPLMPGRT--------------------EVEQLHRIFKLCGTPSEDYWKKMKLTT-----TFRPQHYKPSFREVFGEFP 363 (469)
Q Consensus 309 g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 363 (469)
|+++|++.+ ..+++..|+..++.|....+..+.... ...+......+...++.++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 788887765 367888999999999988776643211 1112233445666778889
Q ss_pred hhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 364 PSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 364 ~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
+++.+||.+||++||.+|||++|+|+||||+....
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 99999999999999999999999999999997543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=410.53 Aligned_cols=282 Identities=40% Similarity=0.726 Sum_probs=234.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++++.||+|+||+||+|++ .+++.||||++............+.+|+.+++.++||||+++++++... ..+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEEE
Confidence 5799999999999999999998 5689999999976543333346678999999999999999999998764 357999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||+.+++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-cccc
Confidence 999999988888776678999999999999999999999999999999999999999999999999999865322 1223
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|........+.+.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 45678999999999877667899999999999999999999999999999999999998888877666554433222211
Q ss_pred ---CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 350 ---HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 350 ---~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.....+......+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 1122344556678999999999999999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=428.85 Aligned_cols=289 Identities=35% Similarity=0.568 Sum_probs=240.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc---cE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ---YS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~ 185 (469)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999999999999999997665666667889999999999999999999998876432 45
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+||||||++++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 105 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 899999999988887765 4569999999999999999999999999999999999999999999999999998764322
Q ss_pred C---------------------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-----------CCCCC
Q 036673 266 K---------------------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-----------GRPLM 313 (469)
Q Consensus 266 ~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-----------g~~pf 313 (469)
. ...+..+||++|+|||++.....++.++|||||||++|||++ |.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 124677899999999987666779999999999999999997 56777
Q ss_pred CCCC-----------------hHHHHHHHHHHhCCCCHHHHhhcccCcc-----CCCCCCCCcchhcccCCChhHHHHHH
Q 036673 314 PGRT-----------------EVEQLHRIFKLCGTPSEDYWKKMKLTTT-----FRPQHYKPSFREVFGEFPPSSYGILT 371 (469)
Q Consensus 314 ~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (469)
.+.+ ..+++..|+..+|.|..+.+..+..... ..+......+...++.+++++.+||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 6654 4788899999999999887766443211 11222334456667789999999999
Q ss_pred HccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 372 TLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 372 ~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
+||+.||.+|||++|+|+||||+....
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999997543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=412.91 Aligned_cols=259 Identities=31% Similarity=0.512 Sum_probs=223.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++... ..+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEE
Confidence 35789999999999999999999999999999999987666666778889999999999999999999988764 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+++ ++.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred EEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 99999986 666655443 46999999999999999999999999999999999999999999999999999876332
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------------- 231 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---------------- 231 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence 3356778999999999998766556899999999999999999999999888777776654211
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.....+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 232 ----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 232 ----------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp ----------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred ----------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 11224688999999999999999999999999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-53 Score=435.39 Aligned_cols=282 Identities=32% Similarity=0.554 Sum_probs=231.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----cc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----QY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~ 184 (469)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999999999999999999765555666788899999999999999999999986543 24
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+||||||+++++...+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 216 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 216 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC------
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC-
Confidence 6799999999998887754 499999999999999999999999999999999999999999999999999987633
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++..|++.++.|...++..+....
T Consensus 217 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 -SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred -CcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 233566789999999999877 468999999999999999999999999999999999999999999988876653110
Q ss_pred c----CCCCCCCCcchhcccC------------CChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 T----FRPQHYKPSFREVFGE------------FPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~----~~~~~~~~~~~~~~~~------------~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. -.+......+...++. .++++.+||.+||++||.+|||++|+|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0 0001011111121111 15679999999999999999999999999999853
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=417.46 Aligned_cols=293 Identities=43% Similarity=0.705 Sum_probs=242.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc-----
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----- 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 182 (469)
..++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 457899999999999999999999999999999998765444444456789999999999999999999887643
Q ss_pred -ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 183 -QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 183 -~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
...+|+||||+++++...+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 3467999999999999888887778999999999999999999999999999999999999999999999999999865
Q ss_pred cCC---CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 036673 262 IPK---QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 262 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
... ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 422 22234566889999999998776678999999999999999999999999999999999999999888877766
Q ss_pred hcccCccCCCCCCC----Ccchhcc--cCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCC
Q 036673 339 KMKLTTTFRPQHYK----PSFREVF--GEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400 (469)
Q Consensus 339 ~~~~~~~~~~~~~~----~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 400 (469)
.......+...... ..+.... ...++.+.+||.+||+.||.+|||+.|+|+||||+..+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 55433222111110 0111100 01377899999999999999999999999999999866554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=417.99 Aligned_cols=283 Identities=36% Similarity=0.590 Sum_probs=238.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc----c
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ----Y 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----~ 184 (469)
.++|++++.||+|+||+||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 478999999999999999999999999999999997655556666788999999999999999999999876432 3
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+|+||||++++|...+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-
Confidence 4699999997788777765 4699999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.....++|++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+++..+.|+..++..+....
T Consensus 181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 24567889999999998876679999999999999999999999999999999999999999999988877653211
Q ss_pred c-----CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 345 T-----FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 345 ~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. ..+......+..++..+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 0122234456677788899999999999999999999999999999998743
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=412.58 Aligned_cols=283 Identities=40% Similarity=0.720 Sum_probs=223.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++... ..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTE--NKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--CeEEE
Confidence 4689999999999999999999999999999999976532 22235678999999999999999999988764 45799
Q ss_pred EEecchhhHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 189 VFDFMQSDLTKIICRP-----GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
||||++++|...+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 9999999887776432 23599999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. .......++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|......
T Consensus 161 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 161 P-VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp C-CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred C-cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 2 223445688999999999877667899999999999999999999999999999999999999999988887765543
Q ss_pred ccCCCCC---CCCcchh-----cccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 344 TTFRPQH---YKPSFRE-----VFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 344 ~~~~~~~---~~~~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+.+.. ....+.. ....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 3332211 1111111 22367899999999999999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=407.26 Aligned_cols=285 Identities=36% Similarity=0.643 Sum_probs=233.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHhC---CCCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE---PESVKFMAREIRILQKL---DHPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~ 182 (469)
.++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 57899999999999999999999999999999999754211 11123456777777766 4999999999987643
Q ss_pred c---cEEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCc
Q 036673 183 Q---YSLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258 (469)
Q Consensus 183 ~---~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla 258 (469)
. ..+++||||+.++|...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 2 3579999999998888876644 34999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|.
T Consensus 168 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSY--QMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTT--CCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCC--CcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 86532 233456789999999999876 458999999999999999999999999999999999999999888877665
Q ss_pred hcccCc-cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 339 KMKLTT-TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 339 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...... ...+......+....+.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 432211 1112223344566778899999999999999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=412.07 Aligned_cols=283 Identities=39% Similarity=0.698 Sum_probs=232.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++++.||+|+||+||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++... ..+++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEEEE
Confidence 6799999999999999999999999999999999654321 1112345799999999999999999998764 347999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||+++++...+...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-cccc
Confidence 999999999988887778999999999999999999999999999999999999999999999999999765322 2234
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC--
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR-- 347 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-- 347 (469)
...++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....|........+.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 456789999999998876778999999999999999999999999999999999999999998877766543222111
Q ss_pred --CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 348 --PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 348 --~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+......+....+.+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 1111223345566789999999999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=399.59 Aligned_cols=285 Identities=33% Similarity=0.602 Sum_probs=234.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.++++++||||+++++++... ...++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeEEE
Confidence 3689999999999999999999999999999999977666666667888999999999999999999998764 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||++++++..+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-SDY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-ccc
Confidence 9999999777777666677999999999999999999999999999999999999999999999999999875322 222
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+.+..+...............+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 34568899999999988767789999999999999999999999999999999998888888776655444333222211
Q ss_pred -----CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 349 -----QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 349 -----~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
......+....+.++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 111223344456789999999999999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=410.77 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=221.9
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP----ESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
..++|++.+.||+|+||+||+|++..+|+.||||++....... ...+.+.+|+.+|..++||||+++++++...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-- 87 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-- 87 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC--
Confidence 3467999999999999999999999999999999997653221 1346788999999999999999999988764
Q ss_pred cEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC----cEEEeeecCc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG----MLKIADFGLS 258 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~----~~kl~DFGla 258 (469)
..+|+||||+.| +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CEEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 457999999976 5655554 455799999999999999999999999999999999999998877 7999999999
Q ss_pred ccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
..+... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+..
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 240 (361)
T 2yab_A 167 HEIEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE--- 240 (361)
T ss_dssp EECCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH---
T ss_pred eEcCCC--CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch---
Confidence 876432 23456789999999998865 458999999999999999999999999998888887776543333332
Q ss_pred hcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.+..+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 241 -------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 241 -------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp -------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred -------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 34567899999999999999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=409.66 Aligned_cols=291 Identities=40% Similarity=0.711 Sum_probs=237.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE---PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-- 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC--
Confidence 457899999999999999999999999999999999754221 112246779999999999999999999987644
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+++||||+++++...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 46999999999988888777677999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....|.......
T Consensus 166 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 166 -NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp -CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2234567889999999998776668999999999999999999999999999999999999998888777665543222
Q ss_pred cCCC-C-CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCC
Q 036673 345 TFRP-Q-HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACD 401 (469)
Q Consensus 345 ~~~~-~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~ 401 (469)
.+.. . .....+...+..+++++.+||.+||+.||.+|||+.|+|+||||+..+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 1111 0 1112234556778999999999999999999999999999999998665543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=408.23 Aligned_cols=286 Identities=34% Similarity=0.682 Sum_probs=227.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++... ..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--HRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET--TEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC--CEEE
Confidence 34789999999999999999999999999999999976655545556778999999999999999999998774 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc-----CCCcEEEeeecCccccc
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID-----KSGMLKIADFGLSNFFI 262 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~-----~~~~~kl~DFGla~~~~ 262 (469)
|||||++++|...+.... .+++..++.++.||+.||+|||++||+||||||+||||+ ..+.+||+|||++..+.
T Consensus 110 lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 999999998888776543 699999999999999999999999999999999999994 45569999999998653
Q ss_pred CCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.. .......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....|.....
T Consensus 189 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Cc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 22 22345567899999999988766789999999999999999999999999999999999999998888776655443
Q ss_pred CccCCC---CCCCCcchh-cccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 343 TTTFRP---QHYKPSFRE-VFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 343 ~~~~~~---~~~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
...+.. ......+.. ....+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 222111 001111111 2233789999999999999999999999999999998743
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=414.25 Aligned_cols=284 Identities=38% Similarity=0.587 Sum_probs=227.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec----ccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR----MQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~ 184 (469)
.++|++++.||+|+||+||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999999999999999976555556667888999999999999999999988653 124
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+|+||||+.++|...+.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 5699999998888776654 4699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.....++|++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+++.++.|....+..+....
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 24467899999999998876678999999999999999999999999999999999999999999988776653211
Q ss_pred c-----CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 345 T-----FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 345 ~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
. ..+......+...+...++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 0 01122234556667788999999999999999999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=407.75 Aligned_cols=288 Identities=33% Similarity=0.571 Sum_probs=243.8
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc---
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM--- 182 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 182 (469)
....++|++++.||+|+||+||+|++..+++.||||++... ........+.+|+.+|.+++||||+++++++....
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 34457899999999999999999999999999999999743 34455577889999999999999999999886543
Q ss_pred ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 183 QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 183 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
...+|+||||++++|...+.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 102 ~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 102 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 245799999999988887765 359999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 263 PKQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 263 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.... ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 3322 12345689999999998877677899999999999999999999999999999999999999999988776653
Q ss_pred ccCcc-----CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 341 KLTTT-----FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 341 ~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..... ..+......+....+.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 22110 011222334556667889999999999999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=415.52 Aligned_cols=280 Identities=38% Similarity=0.641 Sum_probs=231.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec----ccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR----MQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~ 184 (469)
..+|++.+.||+|+||+||+|++..+++.||||++..... .+.+|+.+|+.++|||||++++++... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 3579999999999999999999999999999999865422 234799999999999999999988653 234
Q ss_pred EEEEEEecchhhHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC-CcEEEeeecCccc
Q 036673 185 SLYLVFDFMQSDLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS-GMLKIADFGLSNF 260 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~ 260 (469)
++++||||+++++...+. .....+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 578999999987665543 345679999999999999999999999999999999999999965 5789999999987
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
+... ......++|+.|+|||++.+...++.++|||||||+||||++|++||.+.+..+++..+++.++.|..+.|..+
T Consensus 207 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6332 23456788999999999877667899999999999999999999999999999999999999999998887765
Q ss_pred ccCc-cCC-CCCCCCcchh-cccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 341 KLTT-TFR-PQHYKPSFRE-VFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 341 ~~~~-~~~-~~~~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.... .+. +......+.. +...+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 3211 111 0111111222 234678999999999999999999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=404.68 Aligned_cols=267 Identities=24% Similarity=0.250 Sum_probs=189.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc--cEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ--YSLY 187 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~~~ 187 (469)
.+|.+.++||+|+||+||+|++. |+.||||++.... .....+..|+.++.+++|||||++++++..... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 46889999999999999999884 8999999986431 211223356666678899999999999987543 3579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEcCCCcEEEeeecCc
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER--------GILHRDIKASNLLIDKSGMLKIADFGLS 258 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~NILl~~~~~~kl~DFGla 258 (469)
||||||++ +|.+.+.. .++++..+..++.|++.||+|||++ +||||||||+||||+.++++||+|||+|
T Consensus 78 lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999996 66666654 3599999999999999999999987 9999999999999999999999999999
Q ss_pred ccccCCCCC---CcccccccCccccchhccCCC-----CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 036673 259 NFFIPKQKG---PLTSRVVTLWYRAPELLLGST-----DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 259 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 330 (469)
+........ .....+||+.|||||++.+.. .++.++|||||||+||||+||.+||......+....- ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~-~~~~ 234 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPS 234 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh-cccc
Confidence 876443321 233568999999999986532 3677999999999999999998877543221100000 0000
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhcc--cCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVF--GEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+....+...... ....|.+.... .+.+..+.+||.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~-----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 235 DPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhc-----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0000000000000 11111111111 123356889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=410.11 Aligned_cols=280 Identities=34% Similarity=0.603 Sum_probs=232.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec------
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR------ 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 181 (469)
..++|++++.||+|+||+||+|++..+++.||||++...... ..+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 457899999999999999999999999999999998754322 23799999999999999999988553
Q ss_pred ------------------------------cccEEEEEEecchhhHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 036673 182 ------------------------------MQYSLYLVFDFMQSDLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCH 228 (469)
Q Consensus 182 ------------------------------~~~~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (469)
...++++||||+++++...+. ..+..+++..++.++.||+.||+|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 234579999999987655543 45667999999999999999999999
Q ss_pred hCCceeccCCCCcEEEc-CCCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHH
Q 036673 229 ERGILHRDIKASNLLID-KSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF 307 (469)
Q Consensus 229 ~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell 307 (469)
++||+||||||+|||++ .++.+||+|||+|..+... .......+|+.|+|||++.+...++.++|||||||++|+|+
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 99999999999999998 6889999999999876333 23456788999999999887667899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc-C-CCCCCCCcchhc-ccCCChhHHHHHHHccccCCCCCCCH
Q 036673 308 IGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT-F-RPQHYKPSFREV-FGEFPPSSYGILTTLLALDPAYRGTA 384 (469)
Q Consensus 308 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~dP~~Rpta 384 (469)
+|++||.+.+..+++..+++..+.|....+..+..... + .+......+... ...+++++.+||.+||+.||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999999999999999999999999887776543211 0 111112223332 34588999999999999999999999
Q ss_pred HHHhcCccCCC
Q 036673 385 ASALQNEFFNA 395 (469)
Q Consensus 385 ~elL~hp~f~~ 395 (469)
.|+|+||||+.
T Consensus 317 ~e~l~hp~f~~ 327 (383)
T 3eb0_A 317 YEAMAHPFFDH 327 (383)
T ss_dssp HHHHTSGGGHH
T ss_pred HHHhcCHHHHH
Confidence 99999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=400.49 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=223.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+|+.++||||+++++++... ..+++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM--EELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEEEE
Confidence 47899999999999999999999999999999998643 23446688999999999999999999998774 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC--CCcEEEeeecCcccccCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK--SGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 265 (469)
||||+++ +|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999986 777777666567999999999999999999999999999999999999987 789999999999876432
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 224 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----------- 224 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-----------
T ss_pred -CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh-----------
Confidence 23456788999999998876 45799999999999999999999999999888888777664433332
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
..+..++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 225 -----------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 225 -----------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp -----------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred -----------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 23456789999999999999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=400.83 Aligned_cols=287 Identities=32% Similarity=0.611 Sum_probs=237.6
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
....++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 98 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KR 98 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CE
Confidence 3456889999999999999999999999999999999977666666667788999999999999999999998764 45
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+++||||++++++..+......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 177 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP- 177 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC-
Confidence 7999999999877777666667999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
........+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+......+........
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 22334567899999999987766789999999999999999999999999999999999988888776655443322211
Q ss_pred CCC-----CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 346 FRP-----QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 346 ~~~-----~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
+.. ...........+.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 111 11122344455678999999999999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=405.13 Aligned_cols=281 Identities=36% Similarity=0.609 Sum_probs=238.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc----
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY---- 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~---- 184 (469)
.++|.+.+.||+|+||+||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4689999999999999999999999999999999987666666678889999999999999999999998765432
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
..|+||||+.+++...+. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 248999999998877663 3599999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+...++..+....
T Consensus 197 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 197 ---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 23456889999999998876678999999999999999999999999999999999999999999888776543211
Q ss_pred -----cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 -----TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...+......+...++.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0112223345566677889999999999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=404.90 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=221.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++... ...|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEE
Confidence 3679999999999999999999999999999999987766666678899999999999999999999988764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC---cEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG---MLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~ 264 (469)
||||+.+ +|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999997 56565544 45799999999999999999999999999999999999998654 5999999999876422
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......+.
T Consensus 185 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------- 251 (362)
T 2bdw_A 185 --EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---------- 251 (362)
T ss_dssp --CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------
T ss_pred --cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc----------
Confidence 23456789999999998875 45899999999999999999999999998887777766543222111
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+..+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus 252 ------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 252 ------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp ------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 223467899999999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=392.90 Aligned_cols=258 Identities=26% Similarity=0.460 Sum_probs=218.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|.+..+++.||||++....... .+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~ 93 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGD--ELW 93 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECC--EEE
Confidence 4578999999999999999999999999999999997654332 366889999999999999999999988744 579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+.+ +|.+.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 94 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (297)
T ss_dssp EEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence 99999976 55555544 359999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 235 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-------------- 235 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC--------------
T ss_pred cccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 23456789999999998876 458999999999999999999999999888777766654322111
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
......++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 236 ---------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ---------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 01123578899999999999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=412.04 Aligned_cols=278 Identities=33% Similarity=0.545 Sum_probs=231.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC------CCCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL------DHPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~ 182 (469)
..+|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.++..+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR- 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-
Confidence 4679999999999999999999999999999999964 334456677899988887 577999999988774
Q ss_pred ccEEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc--EEEeeecCcc
Q 036673 183 QYSLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM--LKIADFGLSN 259 (469)
Q Consensus 183 ~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~ 259 (469)
..+++||||+.+++...+.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++.
T Consensus 172 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 -NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp -TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred -CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 4579999999999888886644 45999999999999999999999999999999999999999987 9999999997
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
... ......+||+.|+|||++.+. .++.++|||||||+||||++|.+||.+.+..+++..++..++.|+..++..
T Consensus 251 ~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 251 YEH----QRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp ETT----CCCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ecC----CcccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 642 223467899999999998864 589999999999999999999999999999999999999999999888776
Q ss_pred cccCccCCCCCC--------------------------------CCcchh-cccCCChhHHHHHHHccccCCCCCCCHHH
Q 036673 340 MKLTTTFRPQHY--------------------------------KPSFRE-VFGEFPPSSYGILTTLLALDPAYRGTAAS 386 (469)
Q Consensus 340 ~~~~~~~~~~~~--------------------------------~~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rpta~e 386 (469)
......+..... ...+.. +....++.+.+||.+||++||.+|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 543222111000 011111 12234788999999999999999999999
Q ss_pred HhcCccCCCC
Q 036673 387 ALQNEFFNAS 396 (469)
Q Consensus 387 lL~hp~f~~~ 396 (469)
+|+||||+..
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=414.46 Aligned_cols=288 Identities=36% Similarity=0.637 Sum_probs=218.9
Q ss_pred ccCcce-eceeeeeCCeEEEEEEEC--CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDK-LAKVGQGTYSNVYKARDR--DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~-~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.+.|++ .++||+|+||+||+|+++ .+++.||||++...... ..+.+|+.+|+.|+||||+++++++.......
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 355776 457999999999999976 46889999999754332 45778999999999999999999998777778
Q ss_pred EEEEEecchhhHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----cCCCcEEEe
Q 036673 186 LYLVFDFMQSDLTKIICR--------PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI----DKSGMLKIA 253 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl----~~~~~~kl~ 253 (469)
+||||||+.++++..+.. ....+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999999999988777642 12249999999999999999999999999999999999999 677899999
Q ss_pred eecCcccccCCCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh---------HHHH
Q 036673 254 DFGLSNFFIPKQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---------VEQL 322 (469)
Q Consensus 254 DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---------~~~~ 322 (469)
|||++..+..... ......+||+.|+|||++.+...++.++|||||||+||+|++|++||.+... .+++
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987643221 2344678899999999998766789999999999999999999999987654 4888
Q ss_pred HHHHHHhCCCCHHHHhhcccCcc-------CCCCCCC-C----cchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 323 HRIFKLCGTPSEDYWKKMKLTTT-------FRPQHYK-P----SFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~----~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..++..++.|....|..+..... +....+. . .+.......++.+.+||.+||+.||.+|||+.|+|+|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 99999999998877766532211 0100000 0 0111122347889999999999999999999999999
Q ss_pred ccCCCCCCCC
Q 036673 391 EFFNASPLAC 400 (469)
Q Consensus 391 p~f~~~~~~~ 400 (469)
|||...+.+.
T Consensus 335 p~f~~~~~~~ 344 (405)
T 3rgf_A 335 PYFLEDPLPT 344 (405)
T ss_dssp GGGTSSSCCC
T ss_pred hhhccCCCCc
Confidence 9999876554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=408.50 Aligned_cols=279 Identities=36% Similarity=0.616 Sum_probs=230.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----cc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----QY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~ 184 (469)
..+|++++.||+|+||+||+|++..++. ||+|++..... ...+|+.+|+.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4579999999999999999999987655 88888754322 1236999999999999999999886543 33
Q ss_pred EEEEEEecchhhHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc-CCCcEEEeeecCccc
Q 036673 185 SLYLVFDFMQSDLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID-KSGMLKIADFGLSNF 260 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 260 (469)
.+++||||++++++..+. .....+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 478999999987765543 3356799999999999999999999999999999999999999 799999999999987
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
+... ......++|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+++.++.|....+..+
T Consensus 192 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6333 23456788999999999877667999999999999999999999999999999999999999999998877765
Q ss_pred ccCccC--CCCCCCCcchh-cccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 341 KLTTTF--RPQHYKPSFRE-VFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 341 ~~~~~~--~~~~~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...... .+......+.. +...+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 422110 11111222222 334589999999999999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=408.15 Aligned_cols=282 Identities=31% Similarity=0.539 Sum_probs=224.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----cc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----QY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~ 184 (469)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999999999999999999876556666778899999999999999999999887643 23
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+|+||||+++++...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~- 179 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 179 (371)
T ss_dssp EEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc-
Confidence 6799999999988887753 589999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..++..++.+...++..+....
T Consensus 180 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 180 -SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred -ccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 223446789999999998876 458999999999999999999999999999999999999999988887776543110
Q ss_pred c----CCCCCCCCcchhcc------------cCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 T----FRPQHYKPSFREVF------------GEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~----~~~~~~~~~~~~~~------------~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. ..+......+.... ...+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0 00000001111111 1125679999999999999999999999999999854
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=400.72 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=216.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++++.||+|+||+||+|+++.+++.||||+++.... .......+.+|+.+|..++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEEE
Confidence 4789999999999999999999999999999999975311 112346678999999999999999999988764 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||++| +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... ..
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-TT
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc-CC
Confidence 99999997 55555443 45799999999999999999999999999999999999999999999999999986432 22
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....+.....
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------------- 222 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------------- 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 33557789999999998875 4689999999999999999999999998887776666643110
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.+...+++++.+||.+||+.||.+|| ++.++++||||...
T Consensus 223 ----------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 223 ----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 11235789999999999999999999 99999999999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=396.30 Aligned_cols=260 Identities=26% Similarity=0.406 Sum_probs=220.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP----ESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++.+.||+|+||+||+|.+..+++.||||++....... ...+.+.+|+.+|+.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--T 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--C
Confidence 367999999999999999999999999999999997653221 1346788999999999999999999988764 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC----cEEEeeecCcc
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG----MLKIADFGLSN 259 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~ 259 (469)
.+++||||+.+ +|.+.+ .....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 88 DVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEEEECCCSCBHHHHH-TTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCCHHHHH-HhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 57999999986 555555 4455799999999999999999999999999999999999999887 89999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+.........
T Consensus 167 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 238 (326)
T 2y0a_A 167 KIDFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED----- 238 (326)
T ss_dssp ECCTT--SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH-----
T ss_pred ECCCC--CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc-----
Confidence 76332 23456789999999998865 45899999999999999999999999998888877776554332222
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..+..++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 239 -----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 239 -----------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp -----------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -----------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 2344678899999999999999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=412.68 Aligned_cols=260 Identities=26% Similarity=0.443 Sum_probs=220.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|.+..+++.||+|++..........+.+.+|+.+|+.++||||+++++++... ...|+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE--GHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--SEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--CEEEE
Confidence 4689999999999999999999999999999999987655555667889999999999999999999988764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc---CCCcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID---KSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~ 264 (469)
|||||.| +|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 88 v~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999987 666666554 5699999999999999999999999999999999999998 4678999999999865432
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......+.
T Consensus 167 ~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------- 234 (444)
T 3soa_A 167 Q-QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS---------- 234 (444)
T ss_dssp C-CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----------
T ss_pred C-ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc----------
Confidence 2 22346789999999998865 45899999999999999999999999998888887777653322211
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+..+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 235 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 235 ------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 223567899999999999999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=407.09 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=212.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
.++|++++.||+|+||+||+|+++.+++.||||+++... ........+.+|+.+|..+ +||||+++++++... ..+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CEE
Confidence 478999999999999999999999999999999997531 1223346678999999988 799999999988764 457
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
||||||+.| +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.... .
T Consensus 100 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-~ 177 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-N 177 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-C
Confidence 999999997 55555543 45799999999999999999999999999999999999999999999999999985422 2
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+.....
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------------- 241 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--------------- 241 (353)
T ss_dssp --------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------------
T ss_pred CccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 233456789999999998875 4589999999999999999999999999998888887765211
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH------HHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA------ASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta------~elL~hp~f~~~ 396 (469)
.+...+++.+.+||.+||+.||.+||++ .++++||||+..
T Consensus 242 -----------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 242 -----------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred -----------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 1123468899999999999999999999 899999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=395.66 Aligned_cols=263 Identities=28% Similarity=0.413 Sum_probs=213.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++... ...|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeEE
Confidence 45789999999999999999999999999999999975432 22335678999999999999999999988764 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC-C
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ-K 266 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 266 (469)
+||||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999874444444555679999999999999999999999999999999999999999999999999998653222 2
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||..................
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------- 226 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------------- 226 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---------------
Confidence 23446789999999999887655578999999999999999999999876554332222111100
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
....+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 227 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 227 --------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp --------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred --------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 001234578999999999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=393.07 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=210.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC------------------------HHHHHHHHHHHHHHH
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE------------------------PESVKFMAREIRILQ 164 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~ 164 (469)
.++|++.+.||+|+||+||+|++..+++.||||++...... ....+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999999999999999999754311 112356889999999
Q ss_pred hCCCCCeeeEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 036673 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI 244 (469)
Q Consensus 165 ~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl 244 (469)
.++||||+++++++.......+|+||||++++.+..+.. ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 999999999999998766677899999999754443333 3479999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCC--CCccccchhhHHHHHHHHhCCCCCCCCChHHHH
Q 036673 245 DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD--YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQL 322 (469)
Q Consensus 245 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~ 322 (469)
+.++.+||+|||++..+.... .......||+.|+|||++.+... ++.++|||||||++|+|++|+.||.........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999998754322 22345689999999998865432 477899999999999999999999887766555
Q ss_pred HHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 323 HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
..+....... .....+++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 250 ~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEF------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCC------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCC------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 4443211000 01245788999999999999999999999999999995
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=406.83 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=214.2
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
...++|++.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++.... .
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~ 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT--D 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS--E
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--E
Confidence 3457899999999999999999999999999999998643111 111256889999999999999999999987744 5
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+++||||++|++++.+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 7999999998888877654 46999999999999999999999999999999999999999999999999999875332
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--------------------- 219 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--------------------- 219 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------------
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------------
Confidence 3345678999999999988755557899999999999999999999976432211100
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...........+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 220 -----i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 220 -----VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -----CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -----HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 0011112234578999999999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=397.10 Aligned_cols=281 Identities=36% Similarity=0.620 Sum_probs=236.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc----c
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ----Y 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----~ 184 (469)
.++|.+.+.||+|+||+||+|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++..... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999999999999999997665556666788999999999999999999998876433 2
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
..|+||||+.+++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 178 (353)
T ss_dssp CCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence 358999999998776653 3599999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+...++..+....
T Consensus 179 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 179 ---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 23456789999999998775678999999999999999999999999999999999999999999887766543211
Q ss_pred -----cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 -----TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...+....+.+....+.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0011222334455667789999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=393.15 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=208.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|+++++||+|+||+||+|++..+++.||||++............+..|+..+..+ +||||+++++++... ..+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEE
Confidence 679999999999999999999999999999999876555555555566677666655 999999999998764 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+.+++...+...+..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++...... ..
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~~ 212 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GA 212 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--CC
Confidence 9999999998888776778999999999999999999999999999999999999999999999999999865332 23
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||....... .+.. +...
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~~~--------------- 270 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYLP--------------- 270 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCCC---------------
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCCC---------------
Confidence 445679999999998875 58999999999999999999977765533222 1111 0011
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
......+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 271 -------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 -------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1234567899999999999999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=396.78 Aligned_cols=276 Identities=25% Similarity=0.384 Sum_probs=227.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-----CCCeeeEeeeEeeccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-----HPNVIKLEGLATSRMQ 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~~~~~~~~~ 183 (469)
.++|+++++||+|+||+||+|++..+++.||||++.. .......+..|+.+++.+. ||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-- 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-- 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--
Confidence 4789999999999999999999999999999999863 3344566788999999996 99999999998874
Q ss_pred cEEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC----------------
Q 036673 184 YSLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---------------- 246 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---------------- 246 (469)
..++|||||+.++|...+.... ..+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 4579999999878888876543 35999999999999999999999999999999999999975
Q ss_pred ---------CCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 036673 247 ---------SGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT 317 (469)
Q Consensus 247 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 317 (469)
++.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 78999999999986422 2346688999999998876 458999999999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcccCccCC---CCCC----CC-------------cchhcccCCChhHHHHHHHccccC
Q 036673 318 EVEQLHRIFKLCGTPSEDYWKKMKLTTTFR---PQHY----KP-------------SFREVFGEFPPSSYGILTTLLALD 377 (469)
Q Consensus 318 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~----~~-------------~~~~~~~~~~~~l~~li~~~L~~d 377 (469)
..+.+..+....+.++...+.......... .... .. .+.......++.+.+||.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 999999998888888877655433211100 0000 00 000111223577889999999999
Q ss_pred CCCCCCHHHHhcCccCC
Q 036673 378 PAYRGTAASALQNEFFN 394 (469)
Q Consensus 378 P~~Rpta~elL~hp~f~ 394 (469)
|.+|||+.|+|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999996
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=398.78 Aligned_cols=286 Identities=28% Similarity=0.492 Sum_probs=232.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC---------CHHHHHHHHHHHHHHHhCCCCCeeeEeeeE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS---------EPESVKFMAREIRILQKLDHPNVIKLEGLA 178 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 178 (469)
..++|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45789999999999999999999876 99999999865322 223347789999999999999999999988
Q ss_pred eec---cccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 179 TSR---MQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 179 ~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
... ....+|+||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 653 33468999999999999999887778999999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 036673 256 GLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335 (469)
Q Consensus 256 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 335 (469)
|++..... ........+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+...
T Consensus 179 g~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 179 NLAREDTA--DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp TC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred Cccccccc--ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 99975432 2234456889999999998775678999999999999999999999999999999999999999988766
Q ss_pred HHhhcccC------ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 336 YWKKMKLT------TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 336 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+...... ...........+....+.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 54332211 01111122234455667789999999999999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=414.77 Aligned_cols=268 Identities=22% Similarity=0.357 Sum_probs=222.7
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
....++|+++++||+|+||+||+|+++.+++.||||++..... .......+.+|+.++..++||||+++++++.+. .
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~ 147 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD--N 147 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--S
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--C
Confidence 3456899999999999999999999999999999999964211 011113377899999999999999999988764 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+|||||||.| +|...+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+..
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 57999999976 67777766566899999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCCcccccccCccccchhcc----CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 264 KQKGPLTSRVVTLWYRAPELLL----GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
.........+||+.|+|||++. +...++.++|||||||++|||++|++||.+.+..+.+..|.......
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------- 300 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF------- 300 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-------
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-------
Confidence 3333344578999999999986 23468999999999999999999999999999888888776421100
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCC--CCCHHHHhcCccCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAY--RGTAASALQNEFFNAS 396 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rpta~elL~hp~f~~~ 396 (469)
.+......+++++.+||++||+.+|.+ |++++|+++||||+..
T Consensus 301 --------------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 301 --------------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp --------------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred --------------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 011123457899999999999999988 9999999999999853
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=403.24 Aligned_cols=288 Identities=23% Similarity=0.363 Sum_probs=218.2
Q ss_pred CCccCcceeceeeee--CCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 107 KSADSYDKLAKVGQG--TYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
...++|++++.||+| +||+||+|++..+++.||||++..........+.+.+|+.+++.++|||||++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 99 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-- 99 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC--
Confidence 456789999999999 9999999999999999999999877666677788999999999999999999999988744
Q ss_pred EEEEEEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 185 SLYLVFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
.+|+|||||.+ +|...+... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 57999999986 555555443 3569999999999999999999999999999999999999999999999999986542
Q ss_pred CCC------CCCcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC----
Q 036673 263 PKQ------KGPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT---- 331 (469)
Q Consensus 263 ~~~------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~---- 331 (469)
... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 1122345789999999998764 46899999999999999999999999887766655443321110
Q ss_pred ----CCHHHHhhcc-------cCc-----cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 332 ----PSEDYWKKMK-------LTT-----TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 332 ----~~~~~~~~~~-------~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
+...+..... ... ...+.............+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 0000000000 000 000000011112345568899999999999999999999999999999986
Q ss_pred C
Q 036673 396 S 396 (469)
Q Consensus 396 ~ 396 (469)
.
T Consensus 340 ~ 340 (389)
T 3gni_B 340 I 340 (389)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=394.61 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=217.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++++.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.++..++||||+++++++.+. ..+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEE
Confidence 35789999999999999999999999999999999975311 112345678899999999999999999988764 457
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|+||||+.| +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999987 56555544 45799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....+.....
T Consensus 159 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------- 220 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--------------- 220 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------------
T ss_pred --ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------
Confidence 2346789999999998875 5689999999999999999999999999888877777654211
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.+...+++++.+||.+||+.||.+|| +++++++||||+..
T Consensus 221 -----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 221 -----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 11235688999999999999999999 99999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=391.01 Aligned_cols=287 Identities=32% Similarity=0.576 Sum_probs=233.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc---cc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM---QY 184 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~ 184 (469)
..++|++.+.||+|+||+||+|.+..+++.||||++... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 457899999999999999999999999999999999643 34455567889999999999999999999876532 24
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
..|+||||+.++|...+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 88 ~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 5799999999988887765 46999999999999999999999999999999999999999999999999999875432
Q ss_pred CCC---------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 036673 265 QKG---------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335 (469)
Q Consensus 265 ~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 335 (469)
... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 111 12345789999999988765678999999999999999999999999999999998888888776522
Q ss_pred HH-hhcccC-----ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 336 YW-KKMKLT-----TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 336 ~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.. ...... ....+......+...++.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 11 000000 000011112334556678899999999999999999999999999999998744
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=403.03 Aligned_cols=258 Identities=26% Similarity=0.473 Sum_probs=209.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 185 (469)
..++|+++++||+|+||+||+|+++.+++.||||+++.... .......+.+|..+|.++ +||||+++++++... ..
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CE
Confidence 35789999999999999999999999999999999976532 223345678899999887 899999999988764 45
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+||||||+.| +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 7999999997 55555443 45799999999999999999999999999999999999999999999999999985322
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChH--------H-HHHHHHHHhCCCCHH
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV--------E-QLHRIFKLCGTPSED 335 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--------~-~~~~i~~~~~~~~~~ 335 (469)
........+||+.|+|||++.+ ..++.++|||||||++|||++|++||...... + ....+... .
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~---- 278 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--Q---- 278 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--C----
T ss_pred CCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--c----
Confidence 2334567899999999998876 56899999999999999999999999643211 1 12222110 0
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH------HHHhcCccCCCC
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA------ASALQNEFFNAS 396 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta------~elL~hp~f~~~ 396 (469)
..+...++.++.+||.+||+.||.+||++ +|+++||||+..
T Consensus 279 --------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 279 --------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred --------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 01233578999999999999999999995 799999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=402.00 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=213.4
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
...++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+|..++|||||++++++... ..
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~ 89 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--ED 89 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 34578999999999999999999999999999999996431 1112346788999999999999999999888764 45
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+|+||||+.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-- 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC--
Confidence 799999998755544545556799999999999999999999999999999999999999999999999999987632
Q ss_pred CCCcccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHhhc
Q 036673 266 KGPLTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---VEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.......+||+.|+|||++.+ ...++.++|||||||++|+|++|++||..... .+....+....
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------- 236 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV----------- 236 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-----------
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-----------
Confidence 334567889999999998864 23589999999999999999999999975432 22222221110
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-HHHHhcCccCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-AASALQNEFFNA 395 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-a~elL~hp~f~~ 395 (469)
......++..+.+||.+||+.||.+||+ ++++++||||+.
T Consensus 237 ---------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 237 ---------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp ---------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred ---------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 0123357889999999999999999999 899999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=395.99 Aligned_cols=285 Identities=28% Similarity=0.481 Sum_probs=224.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc-----c
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM-----Q 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~ 183 (469)
.++|++.+.||+|+||+||+|++..+++.||||++...... ...+.+|+..+..++||||+++++++.... .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 47899999999999999999999999999999998654322 234567888889999999999999986533 2
Q ss_pred cEEEEEEecchhhHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcEEEcC-CCcEEEeeecC
Q 036673 184 YSLYLVFDFMQSDLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCH--ERGILHRDIKASNLLIDK-SGMLKIADFGL 257 (469)
Q Consensus 184 ~~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~-~~~~kl~DFGl 257 (469)
..+++||||+.+++...+. .....+++..+..++.||+.||.||| ++||+||||||+||||+. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3478999999998765543 35567999999999999999999999 999999999999999997 89999999999
Q ss_pred cccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 036673 258 SNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 258 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 337 (469)
+..+... .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+
T Consensus 179 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 9876432 23446678999999999877666899999999999999999999999999999999999999999998888
Q ss_pred hhcccCccCCC--CCCCCcchh----cccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 338 KKMKLTTTFRP--QHYKPSFRE----VFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 338 ~~~~~~~~~~~--~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
..+........ ......+.. .....++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 77643221100 000111112 22235788999999999999999999999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=393.38 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=213.0
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecccc
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 184 (469)
...++|++++.||+|+||+||+|+++.+++.||||++.... ........+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~ 83 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--S 83 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--S
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--C
Confidence 34578999999999999999999999999999999997653 3445567788999999988 899999999988764 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+|+||||+.+ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 57999999987 55555543 34699999999999999999999999999999999999999999999999999985322
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHHhCCCCH
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT---------EVEQLHRIFKLCGTPSE 334 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~---------~~~~~~~i~~~~~~~~~ 334 (469)
........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.... .......+... .
T Consensus 163 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~--- 235 (345)
T 3a8x_A 163 -PGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--Q--- 235 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--C---
T ss_pred -CCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--C---
Confidence 2233556789999999998876 458999999999999999999999997532 11122222110 0
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH------HHHhcCccCCCC
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA------ASALQNEFFNAS 396 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta------~elL~hp~f~~~ 396 (469)
. .+...++.++.+||.+||+.||.+||++ .++++||||+..
T Consensus 236 ------------------~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 236 ------------------I---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp ------------------C---CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred ------------------C---CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 0 1223578899999999999999999996 899999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=398.47 Aligned_cols=260 Identities=27% Similarity=0.476 Sum_probs=220.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+|..++||||+++++++... ..++
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ 124 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMV 124 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CEEE
Confidence 3578999999999999999999999999999999997532 33446788999999999999999999988764 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC--CCcEEEeeecCcccccCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK--SGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 264 (469)
+||||+.+ +|.+.+......+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999986 666666655567999999999999999999999999999999999999974 478999999999876332
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+........
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----------- 270 (387)
T 1kob_A 205 --EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD----------- 270 (387)
T ss_dssp --SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-----------
T ss_pred --cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence 23445689999999998875 5589999999999999999999999999888777776654211110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 271 -----------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 271 -----------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp -----------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 12234678999999999999999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=408.25 Aligned_cols=267 Identities=25% Similarity=0.399 Sum_probs=219.8
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
....++|++++.||+|+||+||+|+++.+++.||||++..... .......+.+|+.++..++||||+++++++.+. .
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~ 134 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE--N 134 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--S
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--C
Confidence 3456899999999999999999999999999999999964211 112234578899999999999999999888764 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+||||||+.| +|...+...+..+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||++..+..
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 67999999975 77777765555799999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCCcccccccCccccchhccC------CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLG------STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 337 (469)
.........+||+.|+|||++.. ...|+.++|||||||++|||++|++||.+.+..+.+..|.......
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----- 289 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL----- 289 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-----
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc-----
Confidence 33222345689999999998862 3458999999999999999999999999998888887776421000
Q ss_pred hhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCC---CCHHHHhcCccCCCC
Q 036673 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR---GTAASALQNEFFNAS 396 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R---pta~elL~hp~f~~~ 396 (469)
.+......+++++.+||++||+ +|.+| ++++|+++||||+.-
T Consensus 290 ----------------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 290 ----------------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ----------------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ----------------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 0011224678999999999999 99998 599999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=397.56 Aligned_cols=259 Identities=28% Similarity=0.433 Sum_probs=216.0
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecccc
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 184 (469)
...++|++.+.||+|+||+||+|+++.+++.||||+++.... .......+..|..++..+ +||||+++++++... .
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--E 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--S
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--C
Confidence 346789999999999999999999999999999999975311 112235677899999877 999999999888764 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+|+||||+.| +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 57999999986 56555543 34699999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. .......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+.... +
T Consensus 171 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~----------- 235 (345)
T 1xjd_A 171 G-DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--P----------- 235 (345)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C-----------
T ss_pred C-CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--C-----------
Confidence 2 223456789999999998876 458999999999999999999999999988877777664321 0
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHH-HHhcCccCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAA-SALQNEFFNAS 396 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~-elL~hp~f~~~ 396 (469)
.+...++.++.+||.+||+.||.+||++. ++++||||+..
T Consensus 236 -------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 236 -------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 11234788999999999999999999998 99999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=387.19 Aligned_cols=287 Identities=37% Similarity=0.638 Sum_probs=233.8
Q ss_pred CCccCcceeceeeeeCCeEEEEEEEC-CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeEeeeEee--
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDR-DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL---DHPNVIKLEGLATS-- 180 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-- 180 (469)
...++|++++.||+|+||+||+|++. .+++.||||++............+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45588999999999999999999995 6789999999975433222223455777777666 89999999998863
Q ss_pred -ccccEEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCc
Q 036673 181 -RMQYSLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258 (469)
Q Consensus 181 -~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla 258 (469)
.....+++||||+.++|...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 2345689999999998888776543 35999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|.
T Consensus 168 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 168 RIYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred ccccCC--CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 865322 22345678999999998876 458999999999999999999999999999999999999888888766654
Q ss_pred hcccCc-cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 339 KMKLTT-TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 339 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...... ..........+......++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 322111 1111112233455667889999999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=409.47 Aligned_cols=265 Identities=25% Similarity=0.389 Sum_probs=219.2
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
....++|+++++||+|+||+||+|+++.+++.||||++..... .......+.+|+.++..++|||||++++++.+ ..
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~ 142 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DR 142 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CC
Confidence 4557899999999999999999999999999999999964210 00111347789999999999999999998876 44
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+|||||||+| +|...+.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|.....
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 57999999976 66665544 3599999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCccccchhccCCC---CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGST---DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.........+||+.|+|||++.+.. .++.++|||||||+||||++|++||.+.+..+.+..|........
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------- 293 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT------- 293 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-------
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc-------
Confidence 3322344678999999999987533 278899999999999999999999999998888887765311000
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCC--CCCHHHHhcCccCCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAY--RGTAASALQNEFFNAS 396 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rpta~elL~hp~f~~~ 396 (469)
+ .....++.++.+||.+||+.+|.+ |++++|+++||||+..
T Consensus 294 ----------~-----p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 294 ----------F-----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp ----------C-----CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred ----------C-----CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 0 012357899999999999999988 9999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=394.41 Aligned_cols=256 Identities=27% Similarity=0.466 Sum_probs=219.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
+.|++++.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++... ...+|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEEE
Confidence 569999999999999999999999999999999976533 334456788999999999999999999998774 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||+.|++.+.+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 999999988888766566899999999999999999999999999999999999999999999999999986532
Q ss_pred cccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 269 LTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
....+||+.|+|||++.+ ...++.++|||||||++|||++|++||...+..+.+..+..... +
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~-------------- 271 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P-------------- 271 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C--------------
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-C--------------
Confidence 235689999999998853 35689999999999999999999999998887776665543211 0
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. .....+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 272 -------~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 272 -------A--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -------C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -------C--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0 0123568899999999999999999999999999999763
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=395.81 Aligned_cols=256 Identities=23% Similarity=0.417 Sum_probs=218.0
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
...++|++++.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.+|..++||||+++++++... ..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 115 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SN 115 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CE
Confidence 346889999999999999999999999999999999964311 112346688999999999999999999888764 45
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+||||||+.| +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 7999999986 66665544 34699999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 194 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------- 255 (350)
T 1rdq_E 194 ---RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-------------- 255 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------
T ss_pred ---CcccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 2346789999999998876 4589999999999999999999999999888877777654210
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNAS 396 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 396 (469)
.+...++.++.+||.+||+.||.+||+ ++++++||||+..
T Consensus 256 ------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 256 ------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 112357889999999999999999998 9999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=380.06 Aligned_cols=261 Identities=26% Similarity=0.429 Sum_probs=221.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHY 81 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--CEEE
Confidence 35789999999999999999999999999999999987666666678889999999999999999999988764 4569
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc---EEEeeecCcccccC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM---LKIADFGLSNFFIP 263 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~~~ 263 (469)
+||||+.+ ++...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 82 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999987 55555544 346999999999999999999999999999999999999987655 99999999976533
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+.......+.
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 228 (284)
T 3kk8_A 161 S--EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS--------- 228 (284)
T ss_dssp S--CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---------
T ss_pred C--ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc---------
Confidence 2 22345678999999998876 45899999999999999999999999988887777666543221110
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 229 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 229 -------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp -------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred -------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 1234678899999999999999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=394.75 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=212.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC---CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD---TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
++|++.+.||+|+||+||+|.+..+++.||||++... .......+.+.+|+.+++.++||||+++++++... ..+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEE
Confidence 5799999999999999999999999999999998642 11111346788999999999999999999988774 457
Q ss_pred EEEEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc---EEEeeecCcc
Q 036673 187 YLVFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM---LKIADFGLSN 259 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~ 259 (469)
|||||||++ +|...+.. .+..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 999999996 56555533 3346899999999999999999999999999999999999987655 9999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+. ..+....+.........
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~----- 253 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNP----- 253 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCH-----
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCc-----
Confidence 764322 22345689999999998876 45899999999999999999999999874 33444444432222111
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+..++.++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 254 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 254 -----------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp -----------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred -----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 223467899999999999999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=395.14 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=216.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 185 (469)
..++|++++.||+|+||+||+|++..+++.||||++..... .......+..|..+|..+ .||||+++++++... ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CE
Confidence 45789999999999999999999999999999999975311 112345678899999988 899999999888764 46
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+||||||+.| +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 7999999987 66655544 34699999999999999999999999999999999999999999999999999986422
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....+.....
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------------- 238 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-------------- 238 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------
T ss_pred CCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--------------
Confidence 2233456789999999998875 4589999999999999999999999999888887777754211
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~ 395 (469)
.+...++.++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 239 ------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 239 ------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 112357899999999999999999994 699999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=399.41 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=199.9
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
...++|++++.||+|+||+||+|++..+++.||||++....... ..+.+|+.+++.++||||+++++++... ..+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 91 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTP--THL 91 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeC--CEE
Confidence 34578999999999999999999999999999999997543322 4577999999999999999999998764 457
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc--EEEeeecCcccccC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM--LKIADFGLSNFFIP 263 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~~ 263 (469)
|+||||+.+ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 92 AIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999976 66665544 346999999999999999999999999999999999999987765 99999999975322
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.........++.......
T Consensus 171 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~---------- 238 (361)
T 3uc3_A 171 --HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK---------- 238 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC----------
T ss_pred --cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC----------
Confidence 22334568999999999988755444559999999999999999999987554332222222110000
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
... .....+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 239 -----~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 239 -----YSI-----PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -----CCC-----CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -----CCC-----CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 000 0112468899999999999999999999999999999653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=397.90 Aligned_cols=278 Identities=28% Similarity=0.406 Sum_probs=226.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC--------CCCeeeEeeeEee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD--------HPNVIKLEGLATS 180 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~~~~~~~~ 180 (469)
.++|+++++||+|+||+||+|++..+++.||||++.. .....+.+.+|+.+|+.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4789999999999999999999999999999999963 3445577889999999985 7889999998864
Q ss_pred c--cccEEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCC--------
Q 036673 181 R--MQYSLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSG-------- 248 (469)
Q Consensus 181 ~--~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~-------- 248 (469)
. ....+||||||+.++++..+.... ..+++..++.++.||+.||+|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 3 355689999999998888886653 5699999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------cEEEeeecCcccccCCCCCCcccccccCccccchhccCC
Q 036673 249 -----------------------------------------MLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287 (469)
Q Consensus 249 -----------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 287 (469)
.+||+|||++..... .....+||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----~~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----CSCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----cCccCCCCCcccCChhhcCC
Confidence 799999999987532 23456889999999998864
Q ss_pred CCCCccccchhhHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCC-CCc------
Q 036673 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRT------EVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY-KPS------ 354 (469)
Q Consensus 288 ~~~~~~~DvwslGv~l~elltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~------ 354 (469)
.++.++|||||||+||+|++|++||...+ ..+.+..+....+.++...+........+..... ...
T Consensus 269 -~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 269 -GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp -CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred -CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 58999999999999999999999998655 5677888888889888777654433222111000 000
Q ss_pred --c-------hhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 355 --F-------REVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 355 --~-------~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
+ .......+..+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0 011123356788999999999999999999999999996
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=383.52 Aligned_cols=287 Identities=33% Similarity=0.594 Sum_probs=228.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec-------
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR------- 181 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------- 181 (469)
.++|++++.||+|+||+||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 47899999999999999999999999999999998743 455567889999999999999999999887432
Q ss_pred -----cccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc-CCCcEEEeee
Q 036673 182 -----MQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID-KSGMLKIADF 255 (469)
Q Consensus 182 -----~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~-~~~~~kl~DF 255 (469)
....+|+||||++++|.+.+.. .++++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 2356799999999988877754 4699999999999999999999999999999999999997 5679999999
Q ss_pred cCcccccCCC--CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036673 256 GLSNFFIPKQ--KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS 333 (469)
Q Consensus 256 Gla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 333 (469)
|++....... ........+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+......+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9998764321 12234556799999999887656789999999999999999999999999999998888887776665
Q ss_pred HHHHhhcccCcc-C---CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 334 EDYWKKMKLTTT-F---RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 334 ~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
...+........ + ........+....+.++.++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 554443211100 0 00111233445567789999999999999999999999999999999875544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=385.18 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=219.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP----ESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++.+.||+|+||.||+|++..+++.||||++....... ...+.+.+|+.++..++||||+++++++... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR--T 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 467999999999999999999999999999999997653221 1346788999999999999999999988764 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC----cEEEeeecCcc
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG----MLKIADFGLSN 259 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~ 259 (469)
.+++||||+.+ +|.+.+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 57999999986 5655554 455799999999999999999999999999999999999999888 79999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 239 (321)
T 2a2a_A 168 EIEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE----- 239 (321)
T ss_dssp ECCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-----
T ss_pred ecCcc--ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-----
Confidence 76432 23456679999999998865 45899999999999999999999999998888777766543322222
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 240 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 240 -----------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp -----------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred -----------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 233467889999999999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=387.11 Aligned_cols=279 Identities=31% Similarity=0.558 Sum_probs=219.5
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++++.||+|+||+||+|++..+++.||||++.... .+.+.+|+.+|+.++ ||||+++++++........
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 3578999999999999999999999999999999986321 256889999999997 9999999999988666778
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-cEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 265 (469)
++||||+.++.+..+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+...
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~- 184 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 184 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-
Confidence 99999999755444443 489999999999999999999999999999999999999777 8999999999876433
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHH-HHhhcccC
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMP-GRTEVEQLHRIFKLCGTPSED-YWKKMKLT 343 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~ 343 (469)
.......+|+.|+|||++.+...++.++|||||||++|+|++|+.||. +....+.+..+....+.+... ++......
T Consensus 185 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 185 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 234566889999999998776678999999999999999999998884 556666676666655543211 11111000
Q ss_pred cc--C---CCCCCCCcch-----hcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 TT--F---RPQHYKPSFR-----EVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~--~---~~~~~~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.. + ........+. .....+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 00 0 0000000011 1123378999999999999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=405.97 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=218.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|.+.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++... ..+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 35789999999999999999999999999999999964311 112346788999999999999999999988774 457
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|+||||+.+ +|.+.+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~-- 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-- 168 (476)
T ss_dssp EEEEECCSSEEHHHHT-TSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT--
T ss_pred EEEEeCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc--
Confidence 999999976 555555 4456799999999999999999999999999999999999999999999999999987633
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------- 233 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--------------- 233 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---------------
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---------------
Confidence 23345678999999999988765557899999999999999999999998887777666643211
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.....+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 234 -----------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 -----------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1123468899999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=376.19 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=217.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++... ...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CeEEE
Confidence 46799999999999999999999999999999999764332 246788999999999999999999988764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---cCCCcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~ 264 (469)
||||+.+ +|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 84 VMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999987 55555544 3569999999999999999999999999999999999999 78899999999999876432
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+......++..
T Consensus 163 --~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 229 (277)
T 3f3z_A 163 --KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK--------- 229 (277)
T ss_dssp --SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH---------
T ss_pred --cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch---------
Confidence 23456689999999998865 38999999999999999999999999988888777766543333222
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 230 -------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 230 -------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp -------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred -------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 23357889999999999999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=387.06 Aligned_cols=256 Identities=26% Similarity=0.456 Sum_probs=205.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEEC---CCCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDR---DTGKIVALKKVRFDTS--EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.++|++++.||+|+||+||+|++. .+++.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-- 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence 478999999999999999999985 6799999999975421 223345678899999999999999999988764
Q ss_pred cEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
..+|+||||+.+ +|...+.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 457999999986 55555543 3469999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 173 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------ 238 (327)
T 3a62_A 173 HD-GTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------------ 238 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------------
T ss_pred cC-CccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 22 222345689999999998876 4589999999999999999999999999888877777654211
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNA 395 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~ 395 (469)
.+...++.++.+||.+||+.||.+|| ++.++|+||||+.
T Consensus 239 --------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 239 --------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp --------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred --------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 11235688999999999999999999 8999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=395.66 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=213.0
Q ss_pred Ccce--eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 111 SYDK--LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 111 ~y~~--~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.|.+ .+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+|.+++||||+++++++... ..++|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 163 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIVL 163 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEE
Confidence 3444 678999999999999999999999999997542 34457789999999999999999999998774 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE--cCCCcEEEeeecCcccccCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI--DKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~ 265 (469)
||||+++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999986 6767776665679999999999999999999999999999999999999 567899999999998764332
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 244 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------------ 308 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE------------ 308 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC------------
T ss_pred --ccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC------------
Confidence 2345679999999998865 5689999999999999999999999999998888887765422211
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
...+..+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 309 ----------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 309 ----------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp ----------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred ----------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 1234567899999999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=392.12 Aligned_cols=279 Identities=29% Similarity=0.501 Sum_probs=224.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CC-----CeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HP-----NVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~~~~~~~~~ 181 (469)
..++|++.+.||+|+||+||+|++..+++.||||++.. .......+..|+.++..++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 35789999999999999999999999999999999963 3344567788999998885 55 499999988774
Q ss_pred cccEEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcEEEc--CCCcEEEeeec
Q 036673 182 MQYSLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCH--ERGILHRDIKASNLLID--KSGMLKIADFG 256 (469)
Q Consensus 182 ~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NILl~--~~~~~kl~DFG 256 (469)
..+||||||++++|.+.+.... ..+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||+|||
T Consensus 129 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 --NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp --TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred --CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 4579999999999888886653 46999999999999999999999 57999999999999995 47789999999
Q ss_pred CcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 257 LSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 257 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
++..... .....++|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+....+.++...
T Consensus 207 ~a~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 207 SSCQLGQ----RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp TCEETTC----CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred Cceeccc----ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9987532 23467899999999998764 589999999999999999999999999999999999999999888777
Q ss_pred HhhcccCccC----C------------CCCCC----Ccchhccc------------------CCChhHHHHHHHccccCC
Q 036673 337 WKKMKLTTTF----R------------PQHYK----PSFREVFG------------------EFPPSSYGILTTLLALDP 378 (469)
Q Consensus 337 ~~~~~~~~~~----~------------~~~~~----~~~~~~~~------------------~~~~~l~~li~~~L~~dP 378 (469)
+........+ . ...+. ..+..... ..++++.+||.+||++||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 6542211000 0 00000 00111000 001378999999999999
Q ss_pred CCCCCHHHHhcCccCCCC
Q 036673 379 AYRGTAASALQNEFFNAS 396 (469)
Q Consensus 379 ~~Rpta~elL~hp~f~~~ 396 (469)
++|||+.|+|+||||+..
T Consensus 362 ~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTSCCHHHHTTSGGGCC-
T ss_pred hhCCCHHHHhcCcccccC
Confidence 999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=406.57 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=207.4
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++.... .+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT--EE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--EE
Confidence 4578999999999999999999999999999999997531 22233456788999999999999999999887744 57
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
||||||+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|.....
T Consensus 224 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEeeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence 999999997 4544443 34579999999999999999999998 9999999999999999999999999999986432
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+||+.|+|||++.+ ..++.++|||||||+||||++|++||.+.+..+....+.....
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------- 366 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------------- 366 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------
T ss_pred CCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--------------
Confidence 2233456789999999998876 4589999999999999999999999998888777766653211
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~ 395 (469)
.+...+++++.+||.+||+.||.+|| |+.|+|+||||+.
T Consensus 367 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 367 ------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 11235788999999999999999999 9999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=389.44 Aligned_cols=258 Identities=29% Similarity=0.432 Sum_probs=198.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+|..++||||+++++++... ..++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 124 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEIS 124 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeEE
Confidence 3578999999999999999999999999999999997542 235677899999999999999999998764 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC---CCcEEEeeecCcccccC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---SGMLKIADFGLSNFFIP 263 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 263 (469)
+||||+.+ +|.+.+.. ...+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 125 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999986 55555544 456999999999999999999999999999999999999975 88999999999986532
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVE-QLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+ .+..+.......
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~---------- 270 (349)
T 2w4o_A 204 --QVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF---------- 270 (349)
T ss_dssp -----------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC----------
T ss_pred --ccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc----------
Confidence 222446789999999998876 458999999999999999999999998766554 333333211110
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
....+..++.++.+||.+||+.||.+|||+.|+|+||||....
T Consensus 271 ------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 271 ------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 1123456789999999999999999999999999999998743
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=380.99 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=214.3
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
.|+..+.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.... ..++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEEE
Confidence 477888999999999999999989999999999765432 3466889999999999999999999888744 579999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
||++++.+..+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 199 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 199 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccc
Confidence 99987544444443 469999999999999999999999999999999999999999999999999998754322 2345
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+..... +
T Consensus 200 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~------------------ 259 (321)
T 2c30_A 200 SLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-P------------------ 259 (321)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-C------------------
T ss_pred cccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-C------------------
Confidence 6689999999998865 4589999999999999999999999998887766655543210 0
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. ......+++.+.+||.+||+.||++|||+.++|+||||....
T Consensus 260 ---~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 260 ---K-LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp ---C-CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ---C-cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 0 011235688999999999999999999999999999998643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=410.87 Aligned_cols=260 Identities=29% Similarity=0.482 Sum_probs=220.5
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|++++||||+++++++... ..+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 101 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYF 101 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEE
Confidence 346899999999999999999999999999999999755322 23457788999999999999999999998764 457
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---cCCCcEEEeeecCccccc
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 262 (469)
|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 102 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999986 55555544 4579999999999999999999999999999999999999 567899999999998763
Q ss_pred CCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
. .......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......+..
T Consensus 181 ~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------- 248 (484)
T 3nyv_A 181 A--SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL-------- 248 (484)
T ss_dssp C--CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--------
T ss_pred c--ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence 3 233456789999999998875 4899999999999999999999999999988888777653222211
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 249 --------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 249 --------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp --------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred --------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 2234678999999999999999999999999999999853
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=378.71 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=201.5
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|++..+++.||||++............+.++..+++.++||||+++++++.... ..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~--~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG--DVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--SEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC--CEE
Confidence 457899999999999999999999999999999999765444444455566666688899999999999988644 469
Q ss_pred EEEecchhhHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 188 LVFDFMQSDLTKIIC---RPGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 188 lv~e~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
+||||+++++...+. ..+..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 999999997755543 3566799999999999999999999998 999999999999999999999999999987633
Q ss_pred CCCCCcccccccCccccchhc---cCCCCCCccccchhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhh
Q 036673 264 KQKGPLTSRVVTLWYRAPELL---LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR-TEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DvwslGv~l~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
. .......||+.|+|||++ .....++.++|||||||++|+|++|+.||... .....+..+.......
T Consensus 163 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 233 (290)
T 3fme_A 163 D--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ------- 233 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-------
T ss_pred c--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-------
Confidence 2 223445789999999986 34456899999999999999999999999863 3444444333211000
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.....+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 234 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 234 -----------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -----------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -----------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 112357889999999999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=410.01 Aligned_cols=258 Identities=30% Similarity=0.499 Sum_probs=213.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|++..++..||||++............+.+|+.+|+.++||||+++++++... ..+|+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEE
Confidence 4579999999999999999999999999999999976543333446788999999999999999999998764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC---CcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS---GMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~ 264 (469)
|||||.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+||||+.. +.+||+|||++..+...
T Consensus 114 v~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999987 565555443 469999999999999999999999999999999999999764 45999999999876432
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......+..
T Consensus 193 --~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------- 258 (494)
T 3lij_A 193 --KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS---------- 258 (494)
T ss_dssp --BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS----------
T ss_pred --ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----------
Confidence 33456789999999998753 5899999999999999999999999999988888777654322211
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+..+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 259 ------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 259 ------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp ------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred ------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 224567899999999999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=394.86 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=208.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHH-HHhCCCCCeeeEeeeEeeccccE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRI-LQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
..++|++++.||+|+||+||+|+++.+++.||||++..... .......+.+|..+ ++.++||||+++++++... ..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS--SE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--CE
Confidence 45789999999999999999999999999999999976532 22333556677777 5678999999999888764 46
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+|+||||+.| +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 7999999987 55555543 45799999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....|.....
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------------- 256 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-------------- 256 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC--------------
T ss_pred CCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------------
Confidence 2233557789999999998876 5589999999999999999999999999888887777754210
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH----HHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA----ASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta----~elL~hp~f~~ 395 (469)
.+...++..+.+||.+||+.||.+||++ .++++||||+.
T Consensus 257 ------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 257 ------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp ------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 1224578999999999999999999997 69999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=408.09 Aligned_cols=261 Identities=30% Similarity=0.474 Sum_probs=218.1
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH-----------HHHHHHHHHHHHHHhCCCCCeeeEe
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP-----------ESVKFMAREIRILQKLDHPNVIKLE 175 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpnIv~~~ 175 (469)
...++|+++++||+|+||+||+|.+..+++.||||++....... ...+.+.+|+.+|+.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34578999999999999999999999999999999997543221 2346788999999999999999999
Q ss_pred eeEeeccccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC---cEE
Q 036673 176 GLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG---MLK 251 (469)
Q Consensus 176 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~---~~k 251 (469)
+++... ..+|||||||.+ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 113 ~~~~~~--~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFEDK--KYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEECS--SEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEcC--CEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 998764 457999999987 56565544 34699999999999999999999999999999999999998876 699
Q ss_pred EeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 036673 252 IADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGT 331 (469)
Q Consensus 252 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (469)
|+|||++..+... ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 190 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 190 IVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp ECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EEECCCCEEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999999876332 33456789999999998764 4899999999999999999999999999988888777654332
Q ss_pred CCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.... .+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 266 ~~~~----------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 266 FDFN----------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CCHH----------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCcc----------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 2222 234678999999999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=375.64 Aligned_cols=259 Identities=23% Similarity=0.319 Sum_probs=215.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec--cccE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR--MQYS 185 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 185 (469)
....|++.+.||+|+||+||+|.+..++..||+|++..........+.+.+|+.+++.++||||+++++++... ....
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 34568999999999999999999999999999999987666667778899999999999999999999988653 3456
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEc-CCCcEEEeeecCcccc
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG--ILHRDIKASNLLID-KSGMLKIADFGLSNFF 261 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NILl~-~~~~~kl~DFGla~~~ 261 (469)
+++||||+++ +|...+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 104 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 8999999987 55555543 356999999999999999999999999 99999999999998 7899999999999754
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
. ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||..................+
T Consensus 183 ~---~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 248 (290)
T 1t4h_A 183 R---ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------- 248 (290)
T ss_dssp C---TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------
T ss_pred c---ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc---------
Confidence 2 223456679999999998764 48999999999999999999999998866655544332211110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.......++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 249 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 249 --------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 1223456788999999999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=410.31 Aligned_cols=259 Identities=29% Similarity=0.513 Sum_probs=216.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|++++||||+++++++... ..+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS--SSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC--CEEEE
Confidence 3679999999999999999999999999999999964322222346788999999999999999999998764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc---CCCcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID---KSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~ 264 (469)
|||||.+ +|...+... ..+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+...
T Consensus 99 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999986 565655443 4699999999999999999999999999999999999995 4567999999999876332
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------- 243 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---------- 243 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS----------
T ss_pred --CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----------
Confidence 33456789999999998875 4899999999999999999999999999888888777553222211
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 244 ------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 244 ------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp ------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 2234678999999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=394.83 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=209.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC--CCCeeeEeeeEeeccccEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD--HPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~~ 186 (469)
..+|++++.||+|+||+||+|.+.. ++.||||++............+.+|+.+|..+. ||||+++++++.... .+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~--~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC--EE
Confidence 4569999999999999999999876 899999999877666677788999999999996 599999999887643 47
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|||||+..++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+.....
T Consensus 132 ~lv~E~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEECCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 999998777888877664 4799999999999999999999999999999999999995 58999999999987643322
Q ss_pred C-CcccccccCccccchhccCC----------CCCCccccchhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCH
Q 036673 267 G-PLTSRVVTLWYRAPELLLGS----------TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV-EQLHRIFKLCGTPSE 334 (469)
Q Consensus 267 ~-~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~ 334 (469)
. .....+||+.|+|||++.+. ..++.++|||||||+||||++|++||...... ..+..++....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~---- 285 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH---- 285 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS----
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc----
Confidence 2 23466899999999998641 35889999999999999999999999875432 33333321100
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.. ......+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 286 -----------------~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 286 -----------------EI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp -----------------CC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -----------------cC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 00 11223467899999999999999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=375.78 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=208.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|.+.+.||+|+||+||+|.+..++..||+|++...... ...+.+.+|+.+|+.++||||+++++++... ..+++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY--HNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecC--CeEEE
Confidence 46799999999999999999999999999999999765322 2346788999999999999999999998764 45799
Q ss_pred EEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---cCCCcEEEeeecCcccc
Q 036673 189 VFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFF 261 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~ 261 (469)
||||+.+ +|...+.. .+..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999986 66665533 23579999999999999999999999999999999999999 45678999999999865
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
... .......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----------- 242 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP----------- 242 (285)
T ss_dssp -----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred CCc--ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-----------
Confidence 332 23456678999999998753 578999999999999999999999998876665554432110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.+......+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 243 ------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 ------------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ------------CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ------------ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011112346889999999999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=387.53 Aligned_cols=260 Identities=30% Similarity=0.473 Sum_probs=217.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC------HHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE------PESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
.++|++.+.||.|+||+||+|++..+|+.||||++...... ....+.+.+|+.++..+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 36799999999999999999999989999999999765321 12245678999999999 899999999988764
Q ss_pred cccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
...|+||||+.+ +|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..
T Consensus 173 --~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 173 --SFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp --SEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 457999999997 55555543 34699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCcccccccCccccchhccC-----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLG-----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 335 (469)
+... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||........+..+......+..
T Consensus 250 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~- 326 (365)
T 2y7j_A 250 LEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS- 326 (365)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH-
T ss_pred cCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC-
Confidence 6432 23456789999999998753 235789999999999999999999999988877777666543322221
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+..++..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 327 ---------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 ---------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp ---------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 123467889999999999999999999999999999973
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=400.62 Aligned_cols=260 Identities=29% Similarity=0.462 Sum_probs=201.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC------CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS------EPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
.++|.+.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+|++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 4789999999999999999999999999999999975321 112223578999999999999999999987542
Q ss_pred ccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC---cEEEeeecCc
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG---MLKIADFGLS 258 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~---~~kl~DFGla 258 (469)
..|+||||+.+ +|.+.+ .....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||++
T Consensus 213 --~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 --DYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp --EEEEEEECCTTCBGGGGT-SSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred --ceEEEEEcCCCCcHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 36899999987 554544 4456799999999999999999999999999999999999997544 5999999999
Q ss_pred ccccCCCCCCcccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
..... .......+||+.|+|||++.+ ...++.++|||||||++|+|++|++||........+...+.....
T Consensus 290 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~----- 362 (419)
T 3i6u_A 290 KILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY----- 362 (419)
T ss_dssp TSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC-----
T ss_pred eecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC-----
Confidence 87632 233456789999999998753 345788999999999999999999999865443333222221100
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
......+..+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 363 ----------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 363 ----------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ----------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 1112344568899999999999999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=382.26 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=216.1
Q ss_pred ccCccee-ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 109 ADSYDKL-AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 109 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
.++|.+. +.||+|+||+||+|++..+++.||||++............+.+|+.++..+ .||||+++++++... ..+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--SEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--CeE
Confidence 3568887 899999999999999999999999999976544444557788999999999 569999999988764 457
Q ss_pred EEEEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC---CCcEEEeeecCcccc
Q 036673 187 YLVFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---SGMLKIADFGLSNFF 261 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~ 261 (469)
++||||+.+ +|...+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 999999997 55555433 2357999999999999999999999999999999999999988 789999999999876
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.........
T Consensus 185 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 254 (327)
T 3lm5_A 185 GHA--CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE------- 254 (327)
T ss_dssp -----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------
T ss_pred CCc--cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-------
Confidence 332 22345689999999998865 45899999999999999999999999998888777766553322211
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
..+..+++.+.+||.+||+.||.+|||++++|+||||+....
T Consensus 255 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 255 ---------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp ---------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred ---------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 223467889999999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=385.97 Aligned_cols=262 Identities=25% Similarity=0.404 Sum_probs=209.2
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC--CCeeeEeeeEeecccc
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH--PNVIKLEGLATSRMQY 184 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~ 184 (469)
...++|++++.||+|+||+||+|.+. +++.||||++..........+.+.+|+.+|..++| |||+++++++... .
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~ 82 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--Q 82 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--S
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--C
Confidence 34578999999999999999999885 58999999998776667777889999999999976 9999999988764 4
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+|||||+..++|.+.+... ..+++.++..++.||+.||+|||++||+||||||+||||+ ++.+||+|||++..+...
T Consensus 83 ~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 67999998888888887664 4699999999999999999999999999999999999997 678999999999876443
Q ss_pred CCC-CcccccccCccccchhccC----------CCCCCccccchhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Q 036673 265 QKG-PLTSRVVTLWYRAPELLLG----------STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV-EQLHRIFKLCGTP 332 (469)
Q Consensus 265 ~~~-~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~ 332 (469)
... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|++||...... ..+..+.....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-- 238 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-- 238 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS--
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc--
Confidence 322 2346689999999998853 245889999999999999999999999765432 22222221000
Q ss_pred CHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 333 SEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
........+..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 239 ----------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 239 ----------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp ----------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ----------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 0012234567899999999999999999999999999998643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=384.17 Aligned_cols=255 Identities=28% Similarity=0.472 Sum_probs=188.7
Q ss_pred cCccee---ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccE
Q 036673 110 DSYDKL---AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~---~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 185 (469)
++|++. +.||+|+||+||+|.+..+++.||||++... ....+.+|+.++..+. ||||+++++++... ..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CE
Confidence 346554 7799999999999999999999999999642 2356778999999996 99999999998764 45
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC---cEEEeeecCcccc
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG---MLKIADFGLSNFF 261 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~ 261 (469)
.||||||+++ +|.+.+.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 7999999987 66665554 45799999999999999999999999999999999999998766 8999999999865
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHHhCCCCH
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE-------VEQLHRIFKLCGTPSE 334 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-------~~~~~~i~~~~~~~~~ 334 (469)
... .......++|+.|+|||++.+ ..++.++|||||||++|+|++|++||...+. .+.+..+........
T Consensus 160 ~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~- 236 (325)
T 3kn6_A 160 PPD-NQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE- 236 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC-
T ss_pred CCC-CCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC-
Confidence 332 233456678999999998865 4589999999999999999999999986543 222333221111111
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 237 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 237 ---------------------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ---------------------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ---------------------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 12334678999999999999999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=382.83 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=213.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc--c
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ--Y 184 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~ 184 (469)
..++|++.+.||+|+||+||+|++..+++.||||++.... ........+.+|+.++..++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3578999999999999999999999999999999997653 344556778999999999999999999998876543 3
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
..|+||||+++ +|.+.+.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred ccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 46999999986 55555543 45799999999999999999999999999999999999999999999999999986643
Q ss_pred CCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+......+.
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 239 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-------- 239 (311)
T ss_dssp -------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH--------
T ss_pred cccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc--------
Confidence 322 12334678999999999876 4589999999999999999999999999888777666554322211
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
......++.++.+||.+||+.||.+||++.++|.|+|++.
T Consensus 240 --------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 --------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 1224467899999999999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=379.58 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=203.6
Q ss_pred CccCccee-ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccE
Q 036673 108 SADSYDKL-AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 108 ~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 185 (469)
..+.|++. +.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|.++ +||||+++++++... ..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~ 85 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DR 85 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CE
Confidence 45789985 789999999999999999999999999975532 2346788999999985 799999999998774 45
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc---EEEeeecCcccc
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM---LKIADFGLSNFF 261 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~ 261 (469)
+|+||||+.+ +|...+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 7999999985 66666544 346999999999999999999999999999999999999998776 999999999765
Q ss_pred cCCC------CCCcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChH------------
Q 036673 262 IPKQ------KGPLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV------------ 319 (469)
Q Consensus 262 ~~~~------~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~------------ 319 (469)
.... .......+||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 3221 112234568999999998864 134789999999999999999999999875421
Q ss_pred ---HHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 320 ---EQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 320 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.....+.......+ ...+..++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~i~~~~~~~~----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFP----------------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHCCCCCC----------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHHhccCcccC----------------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 12222221111111 12234578999999999999999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=385.78 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=208.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++.+.||+|+||+||+|.++.+++.||||++...... ..+|+++|.++ +||||+++++++.+ ...+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~ 91 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYV 91 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEE
Confidence 357899999999999999999999999999999999765332 34688888888 79999999998876 4467
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC----CcEEEeeecCcccc
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS----GMLKIADFGLSNFF 261 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~ 261 (469)
|+|||||.| +|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||+.+. +.+||+|||++...
T Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999986 66666654 4579999999999999999999999999999999999998543 35999999999875
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHHh
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR---TEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+. ...+.+..+.......
T Consensus 171 ~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~------ 242 (342)
T 2qr7_A 171 RAE-NGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL------ 242 (342)
T ss_dssp BCT-TCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC------
T ss_pred cCC-CCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc------
Confidence 432 233456789999999998865 44789999999999999999999999863 3334444443211110
Q ss_pred hcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
....+..+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus 243 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 243 ----------------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp ----------------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ----------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 012345688999999999999999999999999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=386.22 Aligned_cols=264 Identities=28% Similarity=0.437 Sum_probs=212.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC---CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD---TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.++|++.+.||+|+||+||+|.+..+++.||||++... .......+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE--QY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC--Ce
Confidence 46799999999999999999999999999999998643 12234457789999999999999999999998764 45
Q ss_pred EEEEEecchh-hHHHHHhc---------------------------------------CCCCCCHHHHHHHHHHHHHHHH
Q 036673 186 LYLVFDFMQS-DLTKIICR---------------------------------------PGQKLTEPQVKCYMQQLLSGLQ 225 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~---------------------------------------~~~~l~~~~~~~i~~qi~~aL~ 225 (469)
.++||||+++ +|.+.+.. ....+++..++.++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 7999999986 55554421 0112467889999999999999
Q ss_pred HHHhCCceeccCCCCcEEEcCCC--cEEEeeecCcccccCCCC---CCcccccccCccccchhccCC-CCCCccccchhh
Q 036673 226 HCHERGILHRDIKASNLLIDKSG--MLKIADFGLSNFFIPKQK---GPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSA 299 (469)
Q Consensus 226 ~LH~~~ivHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dvwsl 299 (469)
|||++||+||||||+||||+.++ .+||+|||++..+..... .......||+.|+|||++.+. ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 899999999986533222 124567899999999988642 568899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCC
Q 036673 300 GCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPA 379 (469)
Q Consensus 300 Gv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 379 (469)
||++|+|++|+.||.+....+....+......... .....+++.+.+||.+||+.||.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN----------------------PNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS----------------------GGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC----------------------cccccCCHHHHHHHHHHcCCChh
Confidence 99999999999999999888887776653221111 12234788999999999999999
Q ss_pred CCCCHHHHhcCccCCCC
Q 036673 380 YRGTAASALQNEFFNAS 396 (469)
Q Consensus 380 ~Rpta~elL~hp~f~~~ 396 (469)
+|||+.++|+||||+..
T Consensus 321 ~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 321 ERFDAMRALQHPWISQF 337 (345)
T ss_dssp TSCCHHHHHHSHHHHTT
T ss_pred HCCCHHHHhcChhhccC
Confidence 99999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=374.48 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=210.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++++.||+|+||+||+|++..+++.||||++.... ......+.+.+|+.++..++||||+++++++.. ...+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence 468999999999999999999999999999999986543 345566789999999999999999999998876 44579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+++ +|.+.+.. ..++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 88 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999987 55555543 35799999999999999999999999999999999999999999999999999987644433
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+..........
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------- 229 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV---------------- 229 (294)
T ss_dssp --------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC----------------
T ss_pred cccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC----------------
Confidence 33455679999999998876 4579999999999999999999999998887666544432110
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
..........+++.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus 230 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 230 -----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp -----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred -----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 1111234557889999999999999999999877777777764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=410.36 Aligned_cols=260 Identities=28% Similarity=0.473 Sum_probs=213.4
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
+...++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|..++|||||++++++... .
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~ 257 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--D 257 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--C
Confidence 4566889999999999999999999999999999999965311 112235678999999999999999999888764 4
Q ss_pred EEEEEEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 185 SLYLVFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
.+||||||+.| +|...+...+ ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 67999999986 6666555433 349999999999999999999999999999999999999999999999999998763
Q ss_pred CCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHhh
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---VEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~ 339 (469)
.. ......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+... ...+...+... .
T Consensus 338 ~~--~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~-------- 405 (576)
T 2acx_A 338 EG--QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-P-------- 405 (576)
T ss_dssp TT--CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-C--------
T ss_pred cC--ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-c--------
Confidence 32 23456789999999998876 4589999999999999999999999987642 22222221110 0
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNA 395 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~ 395 (469)
. .+...+++++.+||.+||+.||.+|| ++.|+++||||+.
T Consensus 406 -------------~---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 406 -------------E---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp -------------C---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred -------------c---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 0 12245789999999999999999999 8999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=387.27 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=208.5
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHH------HHHHHHHHHHHHHhCCCCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPE------SVKFMAREIRILQKLDHPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 181 (469)
..++|++++.||+|+||+||+|++..+++.||||++........ ....+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 34789999999999999999999999999999999976532211 234567899999999999999999998764
Q ss_pred cccEEEEEEecchh--hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 182 MQYSLYLVFDFMQS--DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 182 ~~~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
..+++||||+.+ ++...+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 102 --~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 --GFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp --SEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred --CEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 457999999865 5555554 44579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
..... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 179 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~------------ 238 (335)
T 3dls_A 179 YLERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE------------ 238 (335)
T ss_dssp ECCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT------------
T ss_pred ECCCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh------------
Confidence 76332 33456789999999999887655588999999999999999999999642110 00
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. .......+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 239 --------~------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 239 --------A------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp --------T------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred --------h------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 0 001122478899999999999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=372.66 Aligned_cols=254 Identities=19% Similarity=0.257 Sum_probs=207.9
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++... ..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence 35789999999999999999999999999999999987655555567788999999999 999999999998774 457
Q ss_pred EEEEecchh-hHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC---------------
Q 036673 187 YLVFDFMQS-DLTKIICRP---GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS--------------- 247 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~--------------- 247 (469)
++||||+++ +|.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999987 676666442 2569999999999999999999999999999999999999844
Q ss_pred ----CcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHH
Q 036673 248 ----GMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLH 323 (469)
Q Consensus 248 ----~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~ 323 (469)
..+||+|||++...... ....+|+.|+|||++.+...++.++|||||||++|+|++|.+++...... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~ 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---H 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---H
T ss_pred cCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---H
Confidence 47999999999875322 23468999999999877656778999999999999999999887554322 2
Q ss_pred HHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 324 RIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 324 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+... .+......+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus 239 ~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 239 EIRQG-------------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHTT-------------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHcC-------------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 22110 0012234678999999999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=368.94 Aligned_cols=262 Identities=28% Similarity=0.417 Sum_probs=212.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++... ...|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEEEE
Confidence 36799999999999999999999999999999999754332 3446788999999999999999999988764 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC-CC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ-KG 267 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 267 (469)
||||+++..+..+......+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..+.... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999874444444445579999999999999999999999999999999999999999999999999998653222 12
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......+|+.|+|||++.+...++.++|||||||++|+|++|..||.................
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 225 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------------- 225 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-----------------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-----------------
Confidence 234567899999999887655457889999999999999999999987654322211111000
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.....+..+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 226 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 226 ------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0001134578899999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=374.14 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=212.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++.+.||+|+||+||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence 45789999999999999999999999999999999864321 112235688999999999999999999998764 457
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
++||||+++ ++...+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 999999996 55555443 34699999999999999999999999999999999999999999999999999865422
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 224 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--------------- 224 (279)
T ss_dssp -------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------------
T ss_pred -ccccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC---------------
Confidence 22345678999999998865 5578999999999999999999999998887777666543211
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.....+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 225 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 225 -----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp -----------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred -----------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 11234678999999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=390.53 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=200.9
Q ss_pred CccCccee-ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHH-hCCCCCeeeEeeeEee--ccc
Q 036673 108 SADSYDKL-AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQ-KLDHPNVIKLEGLATS--RMQ 183 (469)
Q Consensus 108 ~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~--~~~ 183 (469)
..++|.+. +.||.|+||+||+|.+..+++.||||++... ..+.+|+.++. .++||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 34678887 7899999999999999999999999999632 34668888874 4589999999998864 335
Q ss_pred cEEEEEEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC---CCcEEEeeecCc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---SGMLKIADFGLS 258 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~kl~DFGla 258 (469)
.++|||||||.| +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 568999999986 7777776543 46999999999999999999999999999999999999998 789999999999
Q ss_pred ccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCH
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVE----QLHRIFKLCGTPSE 334 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~----~~~~i~~~~~~~~~ 334 (469)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+..... ....+.......
T Consensus 212 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~-- 286 (400)
T 1nxk_A 212 KETTS--HNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF-- 286 (400)
T ss_dssp EECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC--
T ss_pred cccCC--CCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC--
Confidence 86532 223456789999999998865 568999999999999999999999998754322 112221110000
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. ...+..++.++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 287 -----------------~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 287 -----------------P---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -----------------C---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----------------C---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 0 01235678999999999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=371.59 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=219.6
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
...++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 89 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DF 89 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--CE
Confidence 34578999999999999999999999999999999997653 3445567788999999999999999999998764 45
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+++||||+++ ++...+ .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 90 VFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEEECCTTCBHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEecCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 7999999996 454444 33457999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.....
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 232 (294)
T 2rku_A 169 -GERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------------- 232 (294)
T ss_dssp -TCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--------------
T ss_pred -ccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC--------------
Confidence 223445678999999998865 4579999999999999999999999998877666554432100
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLA 399 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 399 (469)
.....+++.+.+||.+||+.||.+|||+.++|+||||.....+
T Consensus 233 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 233 ------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 1123567899999999999999999999999999999876554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=383.91 Aligned_cols=258 Identities=21% Similarity=0.394 Sum_probs=202.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc-----
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ----- 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----- 183 (469)
.++|++++.||+|+||+||+|++..+++.||||++.... .....+.+.+|+.+|++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 367999999999999999999999999999999997654 23345778999999999999999999998865432
Q ss_pred --------------------------------------------------cEEEEEEecchh-hHHHHHhcCC--CCCCH
Q 036673 184 --------------------------------------------------YSLYLVFDFMQS-DLTKIICRPG--QKLTE 210 (469)
Q Consensus 184 --------------------------------------------------~~~~lv~e~~~~-~l~~~~~~~~--~~l~~ 210 (469)
.++++|||||.+ +|.+++.... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 247999999997 5555554432 23566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC-----------CCcccccccCccc
Q 036673 211 PQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK-----------GPLTSRVVTLWYR 279 (469)
Q Consensus 211 ~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~y~ 279 (469)
..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++........ ......+||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 77999999999999999999999999999999999999999999999987644321 1234567999999
Q ss_pred cchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcc
Q 036673 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVF 359 (469)
Q Consensus 280 aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (469)
|||++.+ ..++.++|||||||++|+|++|..|+.. ....+....... +....
T Consensus 244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~----------------------~~~~~ 295 (332)
T 3qd2_B 244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLK----------------------FPLLF 295 (332)
T ss_dssp CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTC----------------------CCHHH
T ss_pred ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccC----------------------CCccc
Confidence 9998876 4589999999999999999998766421 111111111100 01122
Q ss_pred cCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 360 GEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 360 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
...++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 334678899999999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=372.37 Aligned_cols=264 Identities=28% Similarity=0.483 Sum_probs=221.4
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
|...++|++++.||+|+||+||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.......
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 44568999999999999999999999999999999999877666667788999999999999999999999887776777
Q ss_pred EEEEEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcEEEcCCCcEEEeeec
Q 036673 186 LYLVFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERG-----ILHRDIKASNLLIDKSGMLKIADFG 256 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NILl~~~~~~kl~DFG 256 (469)
+++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 8999999986 66666543 2345999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 257 LSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 257 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+.....
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------ 233 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF------ 233 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------
T ss_pred hheeecccc-ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc------
Confidence 998653221 11234578999999998876 4589999999999999999999999998877666555543211
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
......++.++.+||.+||+.||.+|||+.|+|+|+|+...
T Consensus 234 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 -------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01223578899999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=378.63 Aligned_cols=261 Identities=26% Similarity=0.438 Sum_probs=219.6
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 115 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DF 115 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--Ce
Confidence 34578999999999999999999999999999999997552 3445567788999999999999999999998764 45
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+|+||||+.+ +|...+ .....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 116 ~~lv~e~~~~~~L~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 116 VFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEEECCCTTCBHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEecCCCCCHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 7999999996 555544 33457999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.....
T Consensus 195 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------- 258 (335)
T 2owb_A 195 -GERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------------- 258 (335)
T ss_dssp -TCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------------
T ss_pred -cccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC--------------
Confidence 223445678999999998876 4579999999999999999999999998877666555433110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
.....+++.+.+||.+||+.||.+|||+.|+|+||||.....
T Consensus 259 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 259 ------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 112356788999999999999999999999999999987544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=378.06 Aligned_cols=277 Identities=22% Similarity=0.404 Sum_probs=226.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEE-CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC------CeeeEeeeEeec
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARD-RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP------NVIKLEGLATSR 181 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~ 181 (469)
.++|++++.||+|+||+||+|.+ ..+++.||||++.. .......+.+|+.++..++|+ +|+++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46899999999999999999998 56789999999863 234457788999999998665 499999988774
Q ss_pred cccEEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC--------------
Q 036673 182 MQYSLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-------------- 246 (469)
Q Consensus 182 ~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-------------- 246 (469)
..+++||||+.+++.+.+.... .++++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 90 --~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 90 --GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp --TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred --CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 4579999999888888886644 36899999999999999999999999999999999999987
Q ss_pred -----CCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH
Q 036673 247 -----SGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ 321 (469)
Q Consensus 247 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~ 321 (469)
++.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||...+..+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 66899999999986422 2345688999999998876 4589999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCHHHHhhcccCccCCCCC--CC----------------CcchhcccCCChhHHHHHHHccccCCCCCCC
Q 036673 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQH--YK----------------PSFREVFGEFPPSSYGILTTLLALDPAYRGT 383 (469)
Q Consensus 322 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~----------------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 383 (469)
...+....+.++..++........+.... +. ..+.......++++.+||.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 88888888888887776544322211100 00 0000111223567899999999999999999
Q ss_pred HHHHhcCccCCC
Q 036673 384 AASALQNEFFNA 395 (469)
Q Consensus 384 a~elL~hp~f~~ 395 (469)
+.|+|+||||+.
T Consensus 323 ~~ell~hp~f~~ 334 (339)
T 1z57_A 323 LREALKHPFFDL 334 (339)
T ss_dssp HHHHTTSGGGGG
T ss_pred HHHHhcCHHHHH
Confidence 999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=371.45 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=213.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP----ESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
++|++.+.||+|+||+||+|++..+++.||||++....... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--TD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--Ce
Confidence 57999999999999999999999999999999997653221 1346788999999999999999999988764 45
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC----cEEEeeecCccc
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG----MLKIADFGLSNF 260 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~ 260 (469)
.++||||+.+ +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 7999999975 66655543 34699999999999999999999999999999999999998877 899999999986
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.+..+.........
T Consensus 162 ~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 232 (283)
T 3bhy_A 162 IEAG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE------ 232 (283)
T ss_dssp CC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH------
T ss_pred ccCC--CcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc------
Confidence 5332 22345678999999998865 45899999999999999999999999998877776665433222211
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.....++..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 233 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 233 ----------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ----------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ----------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 234567889999999999999999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=371.88 Aligned_cols=261 Identities=26% Similarity=0.457 Sum_probs=192.2
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
....++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.++..++||||+++++++... .
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 84 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--N 84 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--S
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--C
Confidence 3445789999999999999999999998999999999964311 112236788999999999999999999998764 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
..++||||+++ +|...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 57999999986 66666665556799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||......+.+..+..
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 226 (278)
T 3cok_A 165 PH-EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------------- 226 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----------------
T ss_pred CC-CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----------------
Confidence 22 22335678999999998865 4578999999999999999999999987554333221100
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.. ......++.++.+||.+||+.||.+|||+.++|+||||...
T Consensus 227 -----~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 -----AD-----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -----SC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -----cc-----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00 01223578899999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=369.59 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=218.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC---C----HHHHHHHHHHHHHHHhCC-CCCeeeEeeeEe
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS---E----PESVKFMAREIRILQKLD-HPNVIKLEGLAT 179 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 179 (469)
..++|++.+.||+|+||.||+|.+..+++.||||++..... . ....+.+.+|+.++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35789999999999999999999999999999999976431 1 223466789999999995 999999999887
Q ss_pred eccccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCc
Q 036673 180 SRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLS 258 (469)
Q Consensus 180 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla 258 (469)
. ....++||||+++ +|.+.+.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 95 ~--~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 T--NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred c--CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 6 4457999999986 66665544 357999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCccccchhcc-----CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLL-----GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS 333 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 333 (469)
...... .......+|+.|+|||++. ....++.++|||||||++|+|++|..||...+..+....+........
T Consensus 172 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 172 CQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp EECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred hhcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 876432 2345667899999999875 234578999999999999999999999998887776666554321111
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 250 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 250 ----------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp ----------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ----------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 01234578899999999999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=374.87 Aligned_cols=257 Identities=29% Similarity=0.446 Sum_probs=214.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.++..++||||+++++++... ..+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYEST--THYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccC--CEEEE
Confidence 3679999999999999999999999999999999975432 2235688999999999999999999988764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---cCCCcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~ 264 (469)
||||+.+ +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp EECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 9999986 66666544 3469999999999999999999999999999999999999 7788999999999976422
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+........
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----------- 227 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE----------- 227 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC-----------
T ss_pred --CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 23345678999999998865 4589999999999999999999999998888777666654321111
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 228 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 -----------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -----------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -----------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 12234678999999999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=392.38 Aligned_cols=263 Identities=25% Similarity=0.445 Sum_probs=207.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEEC---CCCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDR---DTGKIVALKKVRFDTS--EPESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
..++|++++.||+|+||+||+|++. .+++.||||+++.... .......+.+|+.+|..+ .||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3578999999999999999999984 4799999999864311 111224566899999999 799999999888764
Q ss_pred cccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
..++|||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 132 --~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 --TKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp --TEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --ceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 457999999987 66665544 34699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
+...........+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||...........+.......
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------- 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------- 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-------
Confidence 543333334456899999999998753 347899999999999999999999997543222111111110000
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNA 395 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~ 395 (469)
. ......++..+.+||.+||+.||.+|| |+.++++||||+.
T Consensus 282 ------------~---~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 282 ------------E---PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp ------------C---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ------------C---CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 0 012345788999999999999999999 9999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=379.39 Aligned_cols=260 Identities=30% Similarity=0.462 Sum_probs=206.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC------CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS------EPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 3679999999999999999999999999999999865321 1122345789999999999999999999886543
Q ss_pred ccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc---EEEeeecCc
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM---LKIADFGLS 258 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~---~kl~DFGla 258 (469)
.|+||||+.+ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 89 ---~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 ---YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp ---EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred ---eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 6999999987 5555554 4557999999999999999999999999999999999999987664 999999999
Q ss_pred ccccCCCCCCcccccccCccccchhcc--CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLL--GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
..... ........||+.|+|||++. +...++.++|||||||++|+|++|.+||........+...+.....
T Consensus 165 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 237 (322)
T 2ycf_A 165 KILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY----- 237 (322)
T ss_dssp EECCC--CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC-----
T ss_pred eeccc--ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc-----
Confidence 86532 11233567899999999874 3456889999999999999999999999765443222222211100
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
......+..++..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 238 ----------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 238 ----------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp ----------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ----------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 0112334567899999999999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=373.81 Aligned_cols=263 Identities=25% Similarity=0.402 Sum_probs=216.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS--EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.......+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4789999999999999999999999999999999964311 11234678899999999999999999999876656678
Q ss_pred EEEEecchhhHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQSDLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
++||||+.+++...+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999887666644 34569999999999999999999999999999999999999999999999999998764322
Q ss_pred C-CCcccccccCccccchhccCCC-CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 266 K-GPLTSRVVTLWYRAPELLLGST-DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 266 ~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. .......+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-------------
Confidence 2 2234567899999999886532 347799999999999999999999998877666655533110
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.....+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 231 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 231 -------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp -------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred -------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 12235788999999999999999999999999999998753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=379.75 Aligned_cols=277 Identities=25% Similarity=0.401 Sum_probs=226.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCC-cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC------eeeEeeeEeec
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTG-KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN------VIKLEGLATSR 181 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~ 181 (469)
.++|++++.||+|+||+||+|.+..++ +.||||+++. .......+.+|+.+++.++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 478999999999999999999998776 7999999863 2344567889999999997665 88888887764
Q ss_pred cccEEEEEEecchhhHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----------------
Q 036673 182 MQYSLYLVFDFMQSDLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI---------------- 244 (469)
Q Consensus 182 ~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl---------------- 244 (469)
..++|||||++++++..+.... ..+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 95 --~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 95 --GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp --TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred --CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 3579999999998888876654 469999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH
Q 036673 245 ---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ 321 (469)
Q Consensus 245 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~ 321 (469)
+.++.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||...+..+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5678999999999986422 2345689999999998876 4589999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCHHHHhhcccCccCCCCC--CC-------------Ccch---hcccCCChhHHHHHHHccccCCCCCCC
Q 036673 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQH--YK-------------PSFR---EVFGEFPPSSYGILTTLLALDPAYRGT 383 (469)
Q Consensus 322 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~-------------~~~~---~~~~~~~~~l~~li~~~L~~dP~~Rpt 383 (469)
+..+.+..+.++..++........+.... +. +.+. ......+.++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 99998988988887776654322211100 00 0000 001112457889999999999999999
Q ss_pred HHHHhcCccCCC
Q 036673 384 AASALQNEFFNA 395 (469)
Q Consensus 384 a~elL~hp~f~~ 395 (469)
+.|+|+||||+.
T Consensus 328 ~~e~l~hp~f~~ 339 (355)
T 2eu9_A 328 LAEALLHPFFAG 339 (355)
T ss_dssp HHHHTTSGGGGG
T ss_pred HHHHhcChhhcC
Confidence 999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=370.62 Aligned_cols=256 Identities=30% Similarity=0.476 Sum_probs=215.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..++||||+++++++... ..+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KRI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CEE
Confidence 35789999999999999999999999999999999864311 111235688999999999999999999998764 457
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
++||||+.+ +|...+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 999999986 666665443 4699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+.....
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------- 229 (284)
T 2vgo_A 167 -LRRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL--------------- 229 (284)
T ss_dssp -SCBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------------
T ss_pred -cccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---------------
Confidence 22345678999999998876 4589999999999999999999999998887776665543110
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.....++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 230 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 -----------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -----------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1123568899999999999999999999999999999853
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=382.53 Aligned_cols=281 Identities=28% Similarity=0.437 Sum_probs=223.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-----------CCCeeeEeee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-----------HPNVIKLEGL 177 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~ 177 (469)
.++|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.++.+++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 4689999999999999999999999999999999863 3344567889999999886 8999999998
Q ss_pred Eeecc--ccEEEEEEecchhhHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEc------CC
Q 036673 178 ATSRM--QYSLYLVFDFMQSDLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLID------KS 247 (469)
Q Consensus 178 ~~~~~--~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~------~~ 247 (469)
+.... ...+++||||+.++|...+... ...+++..+..++.||+.||+|||++ ||+||||||+||||+ ..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 87643 3468999999988888887653 34599999999999999999999998 999999999999994 34
Q ss_pred CcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC------hHHH
Q 036673 248 GMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT------EVEQ 321 (469)
Q Consensus 248 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~------~~~~ 321 (469)
+.+||+|||++..... .....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||...+ ..+.
T Consensus 175 ~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCC----CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 4899999999987532 2345688999999999876 458999999999999999999999998654 5677
Q ss_pred HHHHHHHhCCCCHHHHhhcccCccCCC----------CCCCCc------chhcccCCChhHHHHHHHccccCCCCCCCHH
Q 036673 322 LHRIFKLCGTPSEDYWKKMKLTTTFRP----------QHYKPS------FREVFGEFPPSSYGILTTLLALDPAYRGTAA 385 (469)
Q Consensus 322 ~~~i~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~------~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~ 385 (469)
+..+...++.++...+........+.. ....+. ...+...++.++.+||.+||+.||.+|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 788888888888776655432211100 000000 0011223457889999999999999999999
Q ss_pred HHhcCccCCCCC
Q 036673 386 SALQNEFFNASP 397 (469)
Q Consensus 386 elL~hp~f~~~~ 397 (469)
|+|+||||+...
T Consensus 330 ell~hp~f~~~~ 341 (373)
T 1q8y_A 330 GLVNHPWLKDTL 341 (373)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhhChhhhccc
Confidence 999999999743
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=414.09 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=217.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 185 (469)
..++|++++.||+|+||+||+|++..+++.||||+++... ........+..|..+|..+ .||||+.+++++.. ...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 4578999999999999999999999999999999997531 1112235677899999988 79999999887765 445
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+||||||+.| +|...+.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC-
T ss_pred EEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc-
Confidence 7999999987 55555544 35799999999999999999999999999999999999999999999999999985422
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..|.....
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------------- 559 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-------------- 559 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC--------------
T ss_pred CCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--------------
Confidence 2233557789999999998865 5689999999999999999999999999988888877754211
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCH-----HHHhcCccCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA-----ASALQNEFFNAS 396 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta-----~elL~hp~f~~~ 396 (469)
.+...+++++.+||.+||+.||.+||++ .|+++||||+..
T Consensus 560 ------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 560 ------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp ------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred ------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 1223578999999999999999999998 999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=380.12 Aligned_cols=277 Identities=22% Similarity=0.334 Sum_probs=211.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+|+.++||||+++++++.......+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4789999999999999999999999999999999975322 223466789999999999999999999988877667899
Q ss_pred EEecchh-hHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----cCCCcEEEeeecCcccc
Q 036673 189 VFDFMQS-DLTKIICRPG--QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFF 261 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~~ 261 (469)
||||+.+ +|...+.... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++..+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999986 6666664432 239999999999999999999999999999999999999 78888999999999876
Q ss_pred cCCCCCCcccccccCccccchhccC-------CCCCCccccchhhHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhC
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLG-------STDYGVGIDLWSAGCLLAEMFIGRPLMPGRT----EVEQLHRIFKLCG 330 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGv~l~elltg~~pf~~~~----~~~~~~~i~~~~~ 330 (469)
... ......+||+.|+|||++.. ...++.++|||||||++|||++|+.||.... ..+.+..+...
T Consensus 167 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 242 (319)
T 4euu_A 167 EDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG-- 242 (319)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH--
T ss_pred CCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC--
Confidence 432 23456679999999998752 3568999999999999999999999997433 23344444332
Q ss_pred CCCHHHHhhcccCccCCCCCC---CCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 331 TPSEDYWKKMKLTTTFRPQHY---KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
.|. ..+......... ...+ .+....+...++..+.+||.+||+.||++|||++|+|+||=
T Consensus 243 ~p~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPS-GAISGVQKAENG-PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCT-TCCEEEECSTTC-CEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCc-ccchhhhcccCC-ccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 111 111111100000 0000 01111222345667899999999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=398.73 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=214.1
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
+...++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|..++||||+++++++... .
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~ 258 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--T 258 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--C
Confidence 4556899999999999999999999999999999999965321 112235678999999999999999999888764 4
Q ss_pred EEEEEEecchh-hHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 185 SLYLVFDFMQS-DLTKIICRP---GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
.+||||||++| +|...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 57999999996 555555442 34699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHH
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE----VEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 336 (469)
+.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+... .+....+.....
T Consensus 339 ~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~------ 410 (543)
T 3c4z_A 339 LKAGQ-TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV------ 410 (543)
T ss_dssp CCTTC-CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC------
T ss_pred ccCCC-cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc------
Confidence 64322 22345689999999999876 5689999999999999999999999987532 333333322100
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCCC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNAS 396 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 396 (469)
.....+++++.+||.+||+.||.+||+ ++++++||||+..
T Consensus 411 --------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 411 --------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred --------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 122457899999999999999999996 5899999999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=371.09 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=206.2
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
...++|++.+.||+|+||+||+|++. ++.||||++..........+.+.+|+.+|++++||||+++++++.... .+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~ 109 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP--NL 109 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--CC
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--ce
Confidence 44578999999999999999999874 889999999877666677788999999999999999999999987654 36
Q ss_pred EEEEecchh-hHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 187 YLVFDFMQS-DLTKIICRPGQ--KLTEPQVKCYMQQLLSGLQHCHERG--ILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
++||||+.+ +|.+.+..... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999987 66666654321 3999999999999999999999999 999999999999999999999999999754
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......+
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------- 258 (309)
T 3p86_A 190 AST-FLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--------- 258 (309)
T ss_dssp -------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred ccc-ccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Confidence 322 222345689999999998876 457999999999999999999999999887776665543211111
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc--CccCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ--NEFFNA 395 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~--hp~f~~ 395 (469)
.....+++.+.+||.+||+.||.+|||+.++++ .++++.
T Consensus 259 ---------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 ---------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 223467889999999999999999999999998 566654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=368.61 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=205.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeEE
Confidence 4789999999999999999999998999999999864311 112345788999999999999999999988764 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+.+ +|.+.+... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 164 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 164 (276)
T ss_dssp EEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--
Confidence 99999986 666665443 46999999999999999999999999999999999999999999999999999875332
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
.......+|+.|+|||++.+....+.++|||||||++|+|++|..||...........+.....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 228 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF---------------- 228 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc----------------
Confidence 2234567899999999887655456899999999999999999999988776665555433110
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.....++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 229 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 229 ----------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ----------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 1123467889999999999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=385.79 Aligned_cols=266 Identities=16% Similarity=0.153 Sum_probs=195.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC--CCCCeeeEe-------eeE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKL--DHPNVIKLE-------GLA 178 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~hpnIv~~~-------~~~ 178 (469)
...|++.+.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.++..| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4569999999999999999999999999999999987644 334456777885555444 699988754 444
Q ss_pred eeccc---------------cEEEEEEecchhhHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCceeccC
Q 036673 179 TSRMQ---------------YSLYLVFDFMQSDLTKIICRPGQKLTEPQV------KCYMQQLLSGLQHCHERGILHRDI 237 (469)
Q Consensus 179 ~~~~~---------------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~ivHrDl 237 (469)
..... ..+||||||++++|.+.+...+..+++..+ ..++.||+.||+|||++||+||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33222 457999999999988888664444555555 677799999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 036673 238 KASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGR 316 (469)
Q Consensus 238 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~ 316 (469)
||+||||+.++.+||+|||++..... ......+|+.|+|||++.+. ..++.++|||||||+||+|++|++||.+.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999986521 12255677999999988642 45899999999999999999999999765
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 317 TEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 317 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..... ..+...... ........ ......+++.+.+||.+||+.||++|||+.++|+||||+.
T Consensus 297 ~~~~~-------------~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 297 TPGIK-------------GSWKRPSLR---VPGTDSLA-FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CTTCT-------------TCCCBCCTT---SCCCCSCC-CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred Ccccc-------------cchhhhhhh---hccccccc-hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 42200 000000000 00000111 1123478999999999999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=370.65 Aligned_cols=264 Identities=26% Similarity=0.436 Sum_probs=211.3
Q ss_pred CCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecc-
Q 036673 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRM- 182 (469)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~- 182 (469)
+....++|++++.||+|+||.||+|++..+++.||||++...... ...+.+|+.++.++ +||||+++++++....
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 345678999999999999999999999999999999999754332 25678999999999 8999999999987643
Q ss_pred ---ccEEEEEEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecC
Q 036673 183 ---QYSLYLVFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGL 257 (469)
Q Consensus 183 ---~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGl 257 (469)
...+++||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 4568999999987 666666543 24699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036673 258 SNFFIPKQKGPLTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS 333 (469)
Q Consensus 258 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 333 (469)
+....... .......+|+.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+.....
T Consensus 176 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 251 (326)
T 2x7f_A 176 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--- 251 (326)
T ss_dssp TC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---
T ss_pred ceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---
Confidence 98653221 22345678999999998862 34588999999999999999999999988777666554432110
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
+. .....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 252 -------------------~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 252 -------------------PR--LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp -------------------CC--CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred -------------------cc--CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 00 1123568899999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=382.66 Aligned_cols=282 Identities=25% Similarity=0.396 Sum_probs=212.9
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
...++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 106 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 106 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEE
Confidence 34578999999999999999999999999999999997653 455567889999999999999999999988874 457
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
++||||+++ +|...+.. ...+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++......
T Consensus 107 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999987 66555544 34699999999999999999999996 9999999999999999999999999999765322
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHHHHhhccc-
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLC-GTPSEDYWKKMKL- 342 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~- 342 (469)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.... +......+.....
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2345688999999998876 458999999999999999999999998876655433221110 0000000000000
Q ss_pred --CccCCCCCC--------------CCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 343 --TTTFRPQHY--------------KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 343 --~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...+..... ..........++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000000000 000001123468899999999999999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=394.77 Aligned_cols=255 Identities=16% Similarity=0.203 Sum_probs=200.7
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHH---HHHhCCCCCeeeEe------
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIR---ILQKLDHPNVIKLE------ 175 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~---~l~~l~hpnIv~~~------ 175 (469)
....++|++.+.||+|+||+||+|++..+++.||||++.... ......+.+.+|+. +|+.++|||||+++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 344678999999999999999999999899999999997542 23345577889994 55555899999988
Q ss_pred -eeEeeccc----------c-----EEEEEEecchhhHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 036673 176 -GLATSRMQ----------Y-----SLYLVFDFMQSDLTKIICRPG------QKLTEPQVKCYMQQLLSGLQHCHERGIL 233 (469)
Q Consensus 176 -~~~~~~~~----------~-----~~~lv~e~~~~~l~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~iv 233 (469)
+++...+. . ..||||||++|+|.+.+.... ..+++..+..++.||+.||+|||++||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 55544321 0 268999999988888775432 1233588889999999999999999999
Q ss_pred eccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCccccchhccCC----------CCCCccccchhhHHHH
Q 036673 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS----------TDYGVGIDLWSAGCLL 303 (469)
Q Consensus 234 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslGv~l 303 (469)
||||||+||||+.++.+||+|||++.... ......+| +.|+|||++.+. ..++.++|||||||+|
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999998532 23445677 999999998764 2589999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC
Q 036673 304 AEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT 383 (469)
Q Consensus 304 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 383 (469)
|||++|++||.+.........+ ......+++++.+||.+||+.||.+|||
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHHHHSSCCC------CCSGGG------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHHHHCCCCCcccccccchhhh------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 9999999999754432211111 1112467899999999999999999999
Q ss_pred HHHHhcCccCCC
Q 036673 384 AASALQNEFFNA 395 (469)
Q Consensus 384 a~elL~hp~f~~ 395 (469)
+.|+|+||||+.
T Consensus 354 ~~e~l~hp~f~~ 365 (377)
T 3byv_A 354 PLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHTSHHHHH
T ss_pred HHHHhhChHHHH
Confidence 999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=370.11 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=210.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++..++||||+++++++.... .++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 92 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG--KLW 92 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC--eEE
Confidence 3478999999999999999999999999999999986542 233467889999999999999999999887643 579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999987 4555555445679999999999999999999999999999999999999999999999999975431111
Q ss_pred CCcccccccCccccchhcc----CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 267 GPLTSRVVTLWYRAPELLL----GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.......+|+.|+|||++. ....++.++|||||||++|+|++|.+||...+....+..+.......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 241 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT---------- 241 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc----------
Confidence 1123457899999999874 34568899999999999999999999999888776665554321100
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
......++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 242 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 242 -------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp -------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred -------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 01123568899999999999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=366.79 Aligned_cols=258 Identities=29% Similarity=0.514 Sum_probs=215.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|++..+++.||||++............+.+|+.++++++||||+++++++... ..+++
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS--SSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--CeEEE
Confidence 3689999999999999999999998999999999976544344457788999999999999999999988764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC---CcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS---GMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~ 264 (469)
||||+.+ ++...+... ..+++..+..++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999986 665655443 469999999999999999999999999999999999999764 47999999999865332
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+........
T Consensus 178 --~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 242 (287)
T 2wei_A 178 --TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD----------- 242 (287)
T ss_dssp --SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------
T ss_pred --CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 22345578999999998865 388999999999999999999999998887776666544211111
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
...+..+++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 243 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 243 -----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp -----------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred -----------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 0123467899999999999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=366.64 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=203.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec-------
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR------- 181 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------- 181 (469)
.++|++++.||+|+||+||+|++..+++.||||++.. .....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3679999999999999999999999999999999964 234557788999999999999999999987653
Q ss_pred ----cccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeec
Q 036673 182 ----MQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFG 256 (469)
Q Consensus 182 ----~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFG 256 (469)
....+|+||||+++ +|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 24568999999986 7777776666678999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCC-------------CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC-hHHHH
Q 036673 257 LSNFFIPKQ-------------KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT-EVEQL 322 (469)
Q Consensus 257 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~-~~~~~ 322 (469)
++....... ........||+.|+|||++.+...++.++|||||||++|+|++ ||.... ..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 998653221 1223456789999999998765568999999999999999998 454322 22222
Q ss_pred HHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 323 HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..+..... .+.+ .+....+..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 239 ~~~~~~~~-------------------~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKLRSVSI-------------------EFPP---DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHSTTC-------------------CCCT---TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred Hhcccccc-------------------ccCc---cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 22211100 0011 123456778999999999999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=365.20 Aligned_cols=259 Identities=29% Similarity=0.473 Sum_probs=210.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..++||||+++++++... ..+|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 100 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKN--TDLW 100 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEE
Confidence 45789999999999999999999999999999999976432 25678999999999999999999988774 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+++ +|.+.+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999987 6666665445679999999999999999999999999999999999999999999999999997653321
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... .+
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-------------- 243 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PP-------------- 243 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC--------------
T ss_pred cccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-Cc--------------
Confidence 22345678999999998876 458999999999999999999999998877665554332211 00
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. ......++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 244 -------~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 -------T-FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -------C-CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -------c-cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 0 011234688999999999999999999999999999998743
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=362.21 Aligned_cols=256 Identities=28% Similarity=0.495 Sum_probs=215.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.+.|++++.||+|+||+||+|.+..+++.||||++...... ...+.+.+|+.++..++||||+++++++... ..+++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEE
Confidence 46799999999999999999999999999999999765432 3457788999999999999999999988774 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+++ ++...+ .. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 98 v~e~~~~~~L~~~~-~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 98 IMEYLGGGSALDLL-EP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp EEECCTTEEHHHHH-TT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred EEEeCCCCcHHHHH-hc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 9999997 555544 33 469999999999999999999999999999999999999999999999999998754322 2
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.... +
T Consensus 175 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~--------------- 236 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P--------------- 236 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C---------------
T ss_pred ccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C---------------
Confidence 2345678999999998865 458899999999999999999999998877666555443210 0
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
......++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 237 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 --------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp --------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred --------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01234678899999999999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=372.36 Aligned_cols=270 Identities=25% Similarity=0.394 Sum_probs=193.5
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|++..+++.||||++..... ......+.+|+.++..++||||+++++++.... ..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--ELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS--CEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--CcE
Confidence 35789999999999999999999988899999999865432 233467889999999999999999999887754 469
Q ss_pred EEEecchh-hHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 188 LVFDFMQS-DLTKIICR-------PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
+||||+.+ +|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999976 55555532 34569999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCC----CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 036673 260 FFIPKQK----GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335 (469)
Q Consensus 260 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 335 (469)
....... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.....................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 248 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE- 248 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT-
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc-
Confidence 6533211 12235578999999998865455899999999999999999999999887665554433221110000
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...........++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 249 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 249 ---------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp ---------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ---------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 0001112345678999999999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=366.81 Aligned_cols=261 Identities=24% Similarity=0.387 Sum_probs=197.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|++..+++.||||++..........+.+..+..+++.++||||+++++++... ..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEE
Confidence 35789999999999999999999999999999999986654444445555666678888999999999998774 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+++.+..........+++..+..++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++..+...
T Consensus 101 lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-- 178 (318)
T ss_dssp EEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--
Confidence 9999996655555544456799999999999999999999995 9999999999999999999999999999765332
Q ss_pred CCcccccccCccccchhcc----CCCCCCccccchhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 267 GPLTSRVVTLWYRAPELLL----GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR-TEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslGv~l~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.......+|+.|+|||++. ....++.++|||||||++|+|++|+.||... ...+.+..+..... +
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~--------- 248 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-P--------- 248 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-C---------
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-C---------
Confidence 2234567899999999885 2345789999999999999999999999874 44444444433110 0
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.......+++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 249 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 249 -------------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp -------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred -------------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 00112357889999999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=359.41 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=205.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|.+..+++.||+|++.. ......+.+.+|+.++..++||||+++++++... ...++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--CeeEE
Confidence 4789999999999999999999999999999998853 3456668899999999999999999999998874 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+.+ +|.+.+......+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999987 677777665678999999999999999999999999999999999999999999999999999875332221
Q ss_pred C-------------cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 036673 268 P-------------LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSE 334 (469)
Q Consensus 268 ~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 334 (469)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------~~~~~ 237 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------GLNVR 237 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------SBCHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------hhhhh
Confidence 1 125679999999998876 568999999999999999999999986532110000 00000
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 238 GFLD-----------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHH-----------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccc-----------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000 0123457889999999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=364.82 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=208.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..++|++.+.||+|+||+||+|++..++. .||||++.... .....+.+.+|+.+|..++||||+++++++....
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-- 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG--
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--
Confidence 34789999999999999999999986554 59999997543 4455677899999999999999999999987643
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+||||||+++ +|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 46999999986 67676666666899999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCC--cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 264 KQKGP--LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 264 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--------- 273 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL--------- 273 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred CccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC---------
Confidence 32221 223345778999998865 458999999999999999999 99999988887777665432111
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 274 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 ----------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112357889999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=366.06 Aligned_cols=252 Identities=18% Similarity=0.218 Sum_probs=205.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.| +||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccE
Confidence 36899999999999999999999999999999998755332 3477899999999 999999999988774 4579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc-----EEEeeecCccccc
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM-----LKIADFGLSNFFI 262 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~~ 262 (469)
+||||+.++|.+.+......+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++..+.
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999977888887766668999999999999999999999999999999999999999887 9999999998764
Q ss_pred CCCCC------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCC
Q 036673 263 PKQKG------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT---EVEQLHRIFKLCGTPS 333 (469)
Q Consensus 263 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~---~~~~~~~i~~~~~~~~ 333 (469)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.. ..+.+..+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 33221 1346789999999998876 558999999999999999999999998743 3333333332211111
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
. ......++ ++.+||..||+.||.+||++.++++
T Consensus 241 ~---------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 I---------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp H---------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred H---------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 11122344 8999999999999999999988776
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=372.87 Aligned_cols=275 Identities=23% Similarity=0.380 Sum_probs=212.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH---------------HHHHHHHHHHHHHHhCCCCCee
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP---------------ESVKFMAREIRILQKLDHPNVI 172 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hpnIv 172 (469)
..++|++.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.++..++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 357899999999999999999999 69999999986432111 1126788999999999999999
Q ss_pred eEeeeEeeccccEEEEEEecchh-hHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEE
Q 036673 173 KLEGLATSRMQYSLYLVFDFMQS-DLTKI------ICRP-GQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLL 243 (469)
Q Consensus 173 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~------~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIL 243 (469)
++++++... ..+++||||+++ +|.+. +... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 107 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred eEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 999998774 457999999997 55554 3321 5679999999999999999999999 99999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCc-cccchhhHHHHHHHHhCCCCCCCCCh-HHH
Q 036673 244 IDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGV-GIDLWSAGCLLAEMFIGRPLMPGRTE-VEQ 321 (469)
Q Consensus 244 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DvwslGv~l~elltg~~pf~~~~~-~~~ 321 (469)
++.++.+||+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|+|++|.+||..... .+.
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999999999875332 3456678999999999876545665 99999999999999999999988776 555
Q ss_pred HHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 322 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
...+.......+.. ...+...............++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 262 ~~~i~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 262 FNNIRTKNIEYPLD-------RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHTSCCCCCCCS-------SSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHhccCcCCccc-------hhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 44443221111100 000000000111122235688999999999999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=356.16 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=204.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+.|.....||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++... ..+++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEE
Confidence 345556689999999999999999999999999975432 3346788999999999999999999998764 457999
Q ss_pred Eecchh-hHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-CCcEEEeeecCcccccCCC
Q 036673 190 FDFMQS-DLTKIICRPG--QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-SGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 265 (469)
|||+++ +|...+.... ..+++..+..++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999975 6666655432 34679999999999999999999999999999999999987 8999999999998653321
Q ss_pred CCCcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..................
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 243 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence 223456789999999988643 23789999999999999999999999764433222111111100
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+ .....+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 244 -------~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 244 -------HP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -------CC---CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -------cc---cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 00 1234578899999999999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=358.56 Aligned_cols=255 Identities=20% Similarity=0.344 Sum_probs=200.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.++||+|+||+||+|.+.. .||||+++.........+.+.+|+.+|+.++||||+++++++... .+++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~l 96 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---QLAI 96 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC---ccEE
Confidence 4689999999999999999998653 599999987766777778899999999999999999999865432 3589
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC-C
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ-K 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 266 (469)
||||+.+ +|...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999986 6666666666779999999999999999999999999999999999999999999999999997653322 2
Q ss_pred CCcccccccCccccchhcc--CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 267 GPLTSRVVTLWYRAPELLL--GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......||+.|+|||++. ....++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------------- 242 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-------------- 242 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS--------------
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc--------------
Confidence 2334567899999999885 234578899999999999999999999988777666655543221
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..+.+..+...+++.+.+||.+||+.||.+|||+.++++
T Consensus 243 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 243 ------LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ------CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112233445577899999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=368.01 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=193.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..++|++.+.||+|+||+||+|++..++. .||||++..........+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45789999999999999999999887665 899999976654555668899999999999999999999988764332
Q ss_pred ----EEEEEEecchh-hHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEee
Q 036673 185 ----SLYLVFDFMQS-DLTKIICRP-----GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIAD 254 (469)
Q Consensus 185 ----~~~lv~e~~~~-~l~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~D 254 (469)
..++||||+.+ +|...+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 24899999997 565555321 22599999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 036673 255 FGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTP 332 (469)
Q Consensus 255 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 332 (469)
||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~- 258 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL- 258 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-
T ss_pred ccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC-
Confidence 999986533322 12234456789999998876 458999999999999999999 99999988777666655432110
Q ss_pred CHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-------HHHHhcCccCCCC
Q 036673 333 SEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-------AASALQNEFFNAS 396 (469)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-------a~elL~hp~f~~~ 396 (469)
.....+++++.+||.+||+.||.+||| ++++++|+|+...
T Consensus 259 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 259 ------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 123457889999999999999999999 7889999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=355.57 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=209.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|.+.. ++.||||++....... +.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS--SEE
T ss_pred ChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC--ceE
Confidence 34789999999999999999999875 7889999997554332 56889999999999999999999887644 469
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+++ ++...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999987 66666666666799999999999999999999999999999999999999999999999999986543322
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+......
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 226 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------------- 226 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------------
T ss_pred ccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC--------------
Confidence 23344566888999998865 458999999999999999999 99999988887776665432111
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 227 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 -----------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1122457889999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=370.71 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=207.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEEC-------CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEe
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDR-------DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLAT 179 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 179 (469)
..++|++.+.||+|+||+||+|++. .++..||||+++.. ......+.+.+|+.+|+.+ +||||+++++++.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 3478999999999999999999975 24568999999754 3445567889999999999 8999999999887
Q ss_pred eccccEEEEEEecchh-hHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 036673 180 SRMQYSLYLVFDFMQS-DLTKIICRPG---------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLL 243 (469)
Q Consensus 180 ~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIL 243 (469)
... .+|+||||+.+ +|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||
T Consensus 158 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp SSS--SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred cCC--CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 644 46999999987 6766665432 35899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHH
Q 036673 244 IDKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQ 321 (469)
Q Consensus 244 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~ 321 (469)
|+.++.+||+|||++..+..... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999986543322 22334567889999998876 458999999999999999999 9999988776655
Q ss_pred HHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 322 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
...+..... ......++.++.+||.+||+.||.+|||+.|++++
T Consensus 315 ~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGHR-------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTCC-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCC-------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 544322110 01223578899999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=367.34 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=189.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHH-HHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIR-ILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++++.||+|+||.||+|.+..+++.||||++..... ......+..|+. +++.++||||+++++++... ...
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~ 96 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDC 96 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--Cce
Confidence 35789999999999999999999999999999999976543 333445556665 77778999999999998774 357
Q ss_pred EEEEecchhhHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 187 YLVFDFMQSDLTKIICR----PGQKLTEPQVKCYMQQLLSGLQHCHER-GILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
++||||+.+++...+.. ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99999999977666542 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCCcccccccCccccchhcc---CCCCCCccccchhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHH
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLL---GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV-EQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 337 (469)
... .......||+.|+|||++. ....++.++|||||||++|+|++|+.||...... +.+..+.
T Consensus 177 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----------- 243 (327)
T 3aln_A 177 VDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV----------- 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-----------
T ss_pred ccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-----------
Confidence 332 2233457899999999873 2345889999999999999999999999764321 1111000
Q ss_pred hhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
......+. ......+++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 244 -------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 244 -------KGDPPQLS---NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp -------CSCCCCCC---CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------cCCCCCCC---CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 00000000 1123457899999999999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=355.69 Aligned_cols=253 Identities=19% Similarity=0.256 Sum_probs=209.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++.+.||+|+||+||+|.+..+++.||||++...... ..+.+|+.++..+ .|+||+++++++.. ....+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeE
Confidence 46899999999999999999999999999999998654322 3467899999999 89999999988765 44579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc-----EEEeeecCccccc
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM-----LKIADFGLSNFFI 262 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~~ 262 (469)
+||||+.++|.+.+...+..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999977888888776667999999999999999999999999999999999999987776 9999999998764
Q ss_pred CCCC------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCC
Q 036673 263 PKQK------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT---EVEQLHRIFKLCGTPS 333 (469)
Q Consensus 263 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~---~~~~~~~i~~~~~~~~ 333 (469)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ..+.+..+......
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 239 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-- 239 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH--
T ss_pred cccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC--
Confidence 4322 12346679999999998876 458999999999999999999999998743 33444433322111
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.........+++++.+||.+||+.||.+|||+.++++
T Consensus 240 -------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 -------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp -------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -------------------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1122334568899999999999999999999999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=370.55 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=207.6
Q ss_pred CccCcceeceeeeeCCeEEEEEE-----ECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKAR-----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
..++|++.+.||+|+||+||+|+ ...+++.||||++... ......+.+.+|+.++.++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 45789999999999999999999 4556789999999754 3344557789999999999 899999999988765
Q ss_pred cccEEEEEEecchh-hHHHHHhcCCC------------------------------------------------------
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPGQ------------------------------------------------------ 206 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------ 206 (469)
.. .+++||||+.+ +|.+.+.....
T Consensus 99 ~~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 99 GG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TS-CCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CC-ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 43 36999999997 66666644321
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC-Ccccccc
Q 036673 207 -----------KLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG-PLTSRVV 274 (469)
Q Consensus 207 -----------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~g 274 (469)
.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...... ......+
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 2899999999999999999999999999999999999999999999999999865333221 2345677
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCC
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKP 353 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (469)
|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+...+.....+
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 315 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------------------- 315 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC---------------------
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC---------------------
Confidence 999999998875 458999999999999999998 999998876555544443321111
Q ss_pred cchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 354 SFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 316 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1123468899999999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.11 Aligned_cols=251 Identities=21% Similarity=0.325 Sum_probs=207.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|.+.. +..||||++....... +.+.+|+.++.+++||||+++++++... ...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKE--YPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEE
T ss_pred chhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccC--CceE
Confidence 45789999999999999999998874 7789999997654332 5688999999999999999999988664 3479
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+++ ++.+.+...+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999986 56666655555699999999999999999999999999999999999999999999999999987644332
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+......
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 224 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-------------- 224 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------------
T ss_pred hcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC--------------
Confidence 22334456778999998865 458899999999999999999 99999988877766655332110
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 225 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 -----------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -----------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112357889999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=360.00 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=207.4
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC--CCCeeeEeeeEeecccc
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD--HPNVIKLEGLATSRMQY 184 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~ 184 (469)
...++|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.++..++ ||||+++++++... .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~ 101 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--Q 101 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--S
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC--C
Confidence 345789999999999999999999864 899999999877666677788999999999997 59999999988764 4
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+++|||+..++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||++..+...
T Consensus 102 ~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 57999998878888877654 47999999999999999999999999999999999999964 89999999999876433
Q ss_pred CCC-CcccccccCccccchhccCC----------CCCCccccchhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Q 036673 265 QKG-PLTSRVVTLWYRAPELLLGS----------TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV-EQLHRIFKLCGTP 332 (469)
Q Consensus 265 ~~~-~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~ 332 (469)
... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+.....
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-- 257 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-- 257 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS--
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc--
Confidence 221 23356789999999988641 35788999999999999999999999765433 22222221000
Q ss_pred CHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 333 SEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
. .......+..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 258 -------------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 258 -------------------E---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp -------------------C---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred -------------------c---cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 0 011234578899999999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=356.42 Aligned_cols=253 Identities=21% Similarity=0.329 Sum_probs=198.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..++|++.+.||+|+||+||+|.+..+ +..||||++... ......+.+.+|+.+++.++||||+++++++.. .
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---S
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---C
Confidence 457899999999999999999998653 457999998653 344556778999999999999999999998743 2
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
..|+||||+.+ +|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 36899999996 67777766556799999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
..........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+.....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------------ 235 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------ 235 (281)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------------
T ss_pred ccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC------------
Confidence 33333344566889999998865 458999999999999999996 9999998777666655532110
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 236 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 -------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01234678999999999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=350.60 Aligned_cols=250 Identities=17% Similarity=0.224 Sum_probs=211.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|++. ++.||||++..........+.+.+|+.++++++||||+++++++.......++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 4578999999999999999999986 88999999987766667778899999999999999999999998876556679
Q ss_pred EEEecchh-hHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 188 LVFDFMQS-DLTKIICRPGQ-KLTEPQVKCYMQQLLSGLQHCHERG--ILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
+||||+++ +|.+.+..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 99999986 77777765433 5999999999999999999999999 9999999999999999999999999876431
Q ss_pred CCCCCcccccccCccccchhccCCCC--CCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTD--YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.....+|+.|+|||++.+... ++.++|||||||++|+|++|+.||...+..+....+......+
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 230 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--------- 230 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC---------
Confidence 234578999999999876432 2337999999999999999999999888777666554321111
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 231 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 ---------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 123457889999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=371.86 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=210.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEE-----CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARD-----RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
..++|++++.||+|+||+||+|++ ..+++.||||++... ........+.+|+.++..++||||+++++++....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 357899999999999999999994 456789999998643 33444567889999999999999999999987644
Q ss_pred ccEEEEEEecchh-hHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC---cEEE
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPG------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG---MLKI 252 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~---~~kl 252 (469)
. .++||||+.+ +|...+.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||
T Consensus 148 ~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 148 P--RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp S--CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred C--CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 3 5999999976 7766665422 3599999999999999999999999999999999999999555 5999
Q ss_pred eeecCcccccCCC-CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 036673 253 ADFGLSNFFIPKQ-KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 253 ~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~ 330 (469)
+|||++..+.... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||......+....+.....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999997543221 222345677999999998875 458999999999999999998 9999999888777666543211
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
. .....++..+.+||.+||+.||.+|||+.+++++.++.
T Consensus 305 ~-------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 M-------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp C-------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 11235688999999999999999999999999998865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=353.75 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=205.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHH-----HHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESV-----KFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
..++|++.+.||+|+||+||+|++..+++.||||++.......... +.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 4578999999999999999999999999999999986543322111 67889999999999999999999886543
Q ss_pred ccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEcCCCc-----EEEee
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG--ILHRDIKASNLLIDKSGM-----LKIAD 254 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~-----~kl~D 254 (469)
++||||+.+ ++...+......+++..+..++.||+.||+|||++| |+||||||+|||++.++. +||+|
T Consensus 97 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 ----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp ----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred ----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 699999984 777888777778999999999999999999999999 999999999999988876 99999
Q ss_pred ecCcccccCCCCCCcccccccCccccchhccC-CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCC
Q 036673 255 FGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG-STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ--LHRIFKLCGT 331 (469)
Q Consensus 255 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~i~~~~~~ 331 (469)
||++.... .......||+.|+|||++.. ...++.++|||||||++|+|++|+.||........ ...+... +.
T Consensus 173 fg~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~ 247 (287)
T 4f0f_A 173 FGLSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GL 247 (287)
T ss_dssp CTTCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CC
T ss_pred CCcccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CC
Confidence 99997542 23456789999999998743 34578899999999999999999999986553332 2222111 10
Q ss_pred CCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+ .....+++++.+||.+||+.||.+|||+.++++
T Consensus 248 --------------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 --------------------RP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --------------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 123467889999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=359.09 Aligned_cols=263 Identities=23% Similarity=0.396 Sum_probs=203.6
Q ss_pred ccCcceeceeeeeCCeEEEEEE----ECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++++.||+|+||+||+|+ +..+++.||||++.. ......+.+.+|+.+|..++||||+++++++......
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4789999999999999999998 556799999999864 3455567889999999999999999999998776666
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+++||||+++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 67999999976 77777766666699999999999999999999999999999999999999999999999999987643
Q ss_pred CCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH------
Q 036673 264 KQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED------ 335 (469)
Q Consensus 264 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------ 335 (469)
... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..... .... ..+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~---~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMR---MIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHHH---HHCTTCCTHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChH--HHHh---hhcCccccchhHHH
Confidence 322 12234456888999998875 4589999999999999999999999864321 1111 11111100
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......... .......+++++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000000000 00123467899999999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=357.73 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=197.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++.+.||+|+||+||+|++..+++.||||++.... ......+.+.+|+.++..++||||+++++++... ..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--GQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--CeE
Confidence 3578999999999999999999999999999999987542 2344457788999999999999999999998774 457
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|+||||+++ +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999999997 66655543 3469999999999999999999999999999999999999999999999999998764433
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... +...+...
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~---------------- 250 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQA---------------- 250 (309)
T ss_dssp --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSC----------------
T ss_pred cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccC----------------
Confidence 333446678999999998865 458999999999999999999999998765442 22222111
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-CHHHHhc
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-TAASALQ 389 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-ta~elL~ 389 (469)
.+........++..+.+||.+||+.||.+|| |++++++
T Consensus 251 ------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 251 ------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0111233457889999999999999999999 7777765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=353.75 Aligned_cols=251 Identities=20% Similarity=0.323 Sum_probs=205.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|.+. ++..||||++....... +.+.+|+.++..++||||+++++++... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecC--CCeE
Confidence 3578999999999999999999887 47889999997554332 5688999999999999999999988764 3469
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+.+ +|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999976 66666665456799999999999999999999999999999999999999999999999999986543322
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+.......
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 241 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------------- 241 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC-------------
T ss_pred ccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC-------------
Confidence 22334556788999998875 458999999999999999998 999999888777766654321111
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
....+++.+.+||.+||+.||.+|||+.++|+|
T Consensus 242 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 ------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 122457889999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=366.75 Aligned_cols=269 Identities=22% Similarity=0.272 Sum_probs=203.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc--ccEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM--QYSL 186 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~~ 186 (469)
.++|++.++||+|+||+||+|++. ++.||||++... ......+.+|+.+|.+++||||+++++++.... ...+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 478999999999999999999886 799999999643 233345567999999999999999999987754 3457
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCcEEEcCCCcEEEeee
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER----------GILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
++||||+.+ +|.+.+.. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999987 66666654 3599999999999999999999999 9999999999999999999999999
Q ss_pred cCcccccCCCC-CCcccccccCccccchhccCC----CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 036673 256 GLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGS----TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 256 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 330 (469)
|++..+..... ......+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+..+............
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99987643322 223456899999999988763 3456788999999999999999999987544322211112222
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhccc--CCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFG--EFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+....+........ ..+.+...+. ..+.++.+||.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 256 HPSLEDMQEVVVHKK-----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SCCHHHHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhhhhhccc-----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 233222222111111 1111112111 12456899999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=363.69 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=181.5
Q ss_pred CccCcceec-eeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec--ccc
Q 036673 108 SADSYDKLA-KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR--MQY 184 (469)
Q Consensus 108 ~~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 184 (469)
..++|.+.+ .||+|+||+||+|++..+++.||||++... .. ........+..+.||||+++++++... ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 347899965 699999999999999999999999998642 22 222233345677999999999988652 345
Q ss_pred EEEEEEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC---CCcEEEeeecCcc
Q 036673 185 SLYLVFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---SGMLKIADFGLSN 259 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~ 259 (469)
.+++||||+.+ +|...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 57999999987 7777766543 46999999999999999999999999999999999999976 4559999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
.... ......++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.......
T Consensus 180 ~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 248 (336)
T 3fhr_A 180 ETTQ---NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG------- 248 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eccc---cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc-------
Confidence 6532 22345678999999998755 458899999999999999999999997665443322111100000
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+. .....+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 249 ----------~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 249 ----------QYG-FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------------C-CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ----------ccc-cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000 0012234678999999999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=367.83 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=206.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHhCC--CCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP----ESVKFMAREIRILQKLD--HPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~ 181 (469)
..++|++.+.||+|+||+||+|.+..+++.||||++....... .....+.+|+.+++.++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4578999999999999999999999999999999997643221 11234667999999996 59999999998764
Q ss_pred cccEEEEEEecch--hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc-CCCcEEEeeecCc
Q 036673 182 MQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID-KSGMLKIADFGLS 258 (469)
Q Consensus 182 ~~~~~~lv~e~~~--~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~-~~~~~kl~DFGla 258 (469)
...++|||++. ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||++
T Consensus 121 --~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 --DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp --SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred --CcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 35799999997 467666654 34699999999999999999999999999999999999999 7899999999999
Q ss_pred ccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 036673 259 NFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||..... +... .
T Consensus 198 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~------- 259 (320)
T 3a99_A 198 ALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q------- 259 (320)
T ss_dssp EECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C-------
T ss_pred ccccc---ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c-------
Confidence 87632 2234567899999999887655557889999999999999999999965321 1110 0
Q ss_pred hcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
......+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 260 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 260 -----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp -----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 01123578899999999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=370.62 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=208.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||.||+|.+..+++.||||+++.. ........+.+|+.+|+.++||||+++++++.... .+|
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS--SCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC--CcE
Confidence 457899999999999999999999988999999998744 33455567889999999999999999999987644 469
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|||||+++ +|.+.+...+..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++........
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999985 77777765555699999999999999999999999999999999999999999999999999976432211
Q ss_pred C-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 267 G-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
. ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+......
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------- 334 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL------------- 334 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC-------------
T ss_pred eecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 1 1122345778999998865 458999999999999999998 99999988776655444321100
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+++++.+||.+||+.||.+|||+.++++
T Consensus 335 ------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 ------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112346889999999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=360.97 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=209.2
Q ss_pred CCccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR 181 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 181 (469)
...++|++++.||+|+||.||+|++. .+++.||||+++... .......+.+|+.++..++||||+++++++...
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 44688999999999999999999997 345899999997543 445567889999999999999999999998764
Q ss_pred cccEEEEEEecchh-hHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPG-----------------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDI 237 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 237 (469)
. .+|+||||+.+ +|.+.+.... ..+++.+++.++.||+.||.|||++||+||||
T Consensus 123 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 123 K--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp S--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred C--ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 4 46999999987 6766665421 56999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCC
Q 036673 238 KASNLLIDKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPG 315 (469)
Q Consensus 238 kp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~ 315 (469)
||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999976533221 22335567899999998875 458999999999999999999 9999998
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 316 RTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 316 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
....+....+..... ......++..+.+||.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNI-------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCC-------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCc-------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 877766655533110 01224578899999999999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=363.96 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=209.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDT-------GKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATS 180 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 180 (469)
.++|.+.+.||+|+||+||+|++..+ +..||||++... ........+.+|+.++..+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 47899999999999999999997533 368999999755 3445567889999999999 99999999999876
Q ss_pred ccccEEEEEEecchh-hHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 036673 181 RMQYSLYLVFDFMQS-DLTKIICRPG---------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI 244 (469)
Q Consensus 181 ~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl 244 (469)
.. .+++||||+.+ +|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 147 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 DG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 44 36999999987 7776665432 359999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHH
Q 036673 245 DKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQL 322 (469)
Q Consensus 245 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~ 322 (469)
+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987643322 22345567899999998876 558999999999999999999 99999988776665
Q ss_pred HHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 323 HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..+...... .....+++++.+||.+||+.||.+|||+.|++++
T Consensus 304 ~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRM-------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCC-------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCC-------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 554321100 1124578899999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=347.57 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=194.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC--HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE--PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
..++|++.+.||+|+||+||+|.+. ++.||||++...... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP--N 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC--c
Confidence 4578999999999999999999985 889999998754322 233467889999999999999999999987644 4
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCcEEEcC--------CCcEEEee
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG---ILHRDIKASNLLIDK--------SGMLKIAD 254 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~--------~~~~kl~D 254 (469)
.++||||++++.+..+.. ...+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 699999998754444443 347999999999999999999999999 999999999999986 67899999
Q ss_pred ecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 036673 255 FGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSE 334 (469)
Q Consensus 255 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 334 (469)
||++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 160 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 232 (271)
T 3dtc_A 160 FGLAREWHRT---TKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--- 232 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC---
T ss_pred CCcccccccc---cccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC---
Confidence 9999865332 2235678999999998875 45899999999999999999999999988776665544321100
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
......+++.+.+||.+||+.||.+|||+.|++++
T Consensus 233 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 ---------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 01234578899999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=363.78 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=198.9
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHhC----CCCCeeeEeeeEe
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP----ESVKFMAREIRILQKL----DHPNVIKLEGLAT 179 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~hpnIv~~~~~~~ 179 (469)
..++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3578999999999999999999999999999999996543221 1223456799999998 8999999999887
Q ss_pred eccccEEEEEEec-chh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc-CCCcEEEeeec
Q 036673 180 SRMQYSLYLVFDF-MQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID-KSGMLKIADFG 256 (469)
Q Consensus 180 ~~~~~~~~lv~e~-~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~-~~~~~kl~DFG 256 (469)
... ..++|||| +.+ +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 109 ~~~--~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 109 TQE--GFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred cCC--eEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 654 45899998 554 66666654 34699999999999999999999999999999999999999 88999999999
Q ss_pred CcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 257 LSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 257 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
++...... ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||..... +....
T Consensus 186 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~------- 249 (312)
T 2iwi_A 186 SGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE------- 249 (312)
T ss_dssp SCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC-------
T ss_pred hhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc-------
Confidence 99876432 344667899999999887655445689999999999999999999965311 11100
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
..+...++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 250 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 250 -------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 012245788999999999999999999999999999998743
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=361.54 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=199.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEE----EEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIV----ALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++++.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.++.+++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 478999999999999999999998777654 777765332 2344577889999999999999999999987643
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.++|++|+.+ ++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 5788898885 77777777667899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |++||.+....+....+......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---------- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------
T ss_pred CcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC----------
Confidence 3322 2234456889999998876 458999999999999999999 99999887665544433221100
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 239 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 ---------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1123467889999999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=351.11 Aligned_cols=255 Identities=20% Similarity=0.236 Sum_probs=206.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.++..++|++++..+.++... ....+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceE
Confidence 357899999999999999999999999999999998765433 3477899999999999887776665443 44579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---cCCCcEEEeeecCcccccCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~ 264 (469)
+||||+.++|.+.+......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999999778888887666689999999999999999999999999999999999999 48889999999999876443
Q ss_pred CCC------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHH
Q 036673 265 QKG------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---VEQLHRIFKLCGTPSED 335 (469)
Q Consensus 265 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~ 335 (469)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... .+.+..+......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 236 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---- 236 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH----
T ss_pred ccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC----
Confidence 321 2345688999999998876 4589999999999999999999999986432 2233333221111
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.........+++++.+||.+||+.||.+|||+.++++
T Consensus 237 -----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 237 -----------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1111233567899999999999999999999998876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=364.76 Aligned_cols=265 Identities=19% Similarity=0.170 Sum_probs=201.4
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCC-----CcEEEEEEeecCCCCHHH---------HHHHHHHHHHHHhCCCCCeee
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDT-----GKIVALKKVRFDTSEPES---------VKFMAREIRILQKLDHPNVIK 173 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~ 173 (469)
..++|++.+.||+|+||+||+|.+..+ ++.||||++......... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999999764 588999998754211000 012334666777788999999
Q ss_pred EeeeEeecc--ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc--CCCc
Q 036673 174 LEGLATSRM--QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID--KSGM 249 (469)
Q Consensus 174 ~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~ 249 (469)
+++++.... ..++||||||+.++|...+......+++..++.++.||+.||+|||++||+||||||+||||+ .++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 999887643 356799999997788888777667899999999999999999999999999999999999999 8899
Q ss_pred EEEeeecCcccccCCCCC------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHH
Q 036673 250 LKIADFGLSNFFIPKQKG------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLH 323 (469)
Q Consensus 250 ~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~ 323 (469)
+||+|||++..+...... .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+........
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999999765432211 1234569999999998876 458999999999999999999999998643322222
Q ss_pred HHHHH-hCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 324 RIFKL-CGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 324 ~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..... .......+.... -....++.++.+||..||..||.+||++.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKC----------------FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCHHHHHHHH----------------SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHh----------------cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 22111 111111111000 001457889999999999999999999998876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=353.47 Aligned_cols=247 Identities=17% Similarity=0.258 Sum_probs=202.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCC-------cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEee
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTG-------KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATS 180 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 180 (469)
..++|++.+.||+|+||+||+|++..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3478999999999999999999998776 479999986432 3445778999999999999999999999887
Q ss_pred ccccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc--------EE
Q 036673 181 RMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM--------LK 251 (469)
Q Consensus 181 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~--------~k 251 (469)
... .++||||+.+ +|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 84 ~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 84 GDE--NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TTC--CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCC--CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 544 5899999985 777777665556999999999999999999999999999999999999998887 99
Q ss_pred EeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhC
Q 036673 252 IADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 252 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg-~~pf~~~~~~~~~~~i~~~~~ 330 (469)
|+|||++.... ......+|+.|+|||++.+...++.++|||||||++|+|++| .+||.......... +.....
T Consensus 162 l~Dfg~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~ 235 (289)
T 4fvq_A 162 LSDPGISITVL-----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRH 235 (289)
T ss_dssp ECCCCSCTTTS-----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTC
T ss_pred eccCccccccc-----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccC
Confidence 99999997542 223456899999999988756689999999999999999995 55555544443332 222100
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
......+.++.+||.+||+.||.+|||+.+++++
T Consensus 236 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 236 --------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp --------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1122346788999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=351.43 Aligned_cols=255 Identities=20% Similarity=0.237 Sum_probs=203.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.++..++|++++..+.++... ....+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceE
Confidence 457899999999999999999999999999999987654332 3477899999999999888777666543 44579
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---cCCCcEEEeeecCcccccCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~ 264 (469)
+||||+.++|.+.+......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999999778888887666679999999999999999999999999999999999999 78899999999999876443
Q ss_pred CC------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHH
Q 036673 265 QK------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV---EQLHRIFKLCGTPSED 335 (469)
Q Consensus 265 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~ 335 (469)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... ..+..+.....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 235 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM----- 235 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-----
T ss_pred ccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-----
Confidence 32 12345688999999998876 45899999999999999999999999864332 22222221110
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..........+++++.+||.+||+.||.+|||+.++++
T Consensus 236 ----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 ----------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ----------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ----------------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 01112334567899999999999999999999999886
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=350.07 Aligned_cols=254 Identities=19% Similarity=0.281 Sum_probs=204.9
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECC---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRD---TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
...++|++.+.||+|+||+||+|.+.. ++..||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 86 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP- 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS-
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-
Confidence 345789999999999999999998754 24569999987543 3455678899999999999999999999876532
Q ss_pred cEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
.|+||||+.+ +|...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 --~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 87 --TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp --CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred --CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 4899999996 6766666655679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
...........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||......+....+......
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---------- 233 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---------- 233 (281)
T ss_dssp --------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC----------
T ss_pred cccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC----------
Confidence 433333345567889999998865 458999999999999999998 99999877666555444332111
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 ---------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1123468899999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=354.28 Aligned_cols=258 Identities=21% Similarity=0.281 Sum_probs=201.5
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECC---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRD---TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
...++|.+.+.||+|+||+||+|.+.. ++..||||++..........+.+.+|+.++.+++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345789999999999999999998865 45689999998776666777889999999999999999999999876543
Q ss_pred c---EEEEEEecchh-hHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEee
Q 036673 184 Y---SLYLVFDFMQS-DLTKIIC-----RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIAD 254 (469)
Q Consensus 184 ~---~~~lv~e~~~~-~l~~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~D 254 (469)
. ..++||||+.+ +|...+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 3 45999999997 6655553 2335699999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 036673 255 FGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTP 332 (469)
Q Consensus 255 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 332 (469)
||++..+..... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+.....
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-- 267 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR-- 267 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--
T ss_pred cCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC--
Confidence 999986543221 12234456889999998876 558999999999999999999 9999988777665555433110
Q ss_pred CHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 333 SEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
......+++.+.+||.+||..||.+|||+.+++++
T Consensus 268 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 -----------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -----------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01234578899999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=353.72 Aligned_cols=263 Identities=22% Similarity=0.392 Sum_probs=202.6
Q ss_pred cCcceeceeeeeCCeEEEEEE----ECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.+|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.++..++||||+++++++.......
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 569999999999999999999 46679999999997543 2234467889999999999999999999998876667
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+++||||+++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 8999999987 777777565567999999999999999999999999999999999999999999999999999876433
Q ss_pred CC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-----HH
Q 036673 265 QK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED-----YW 337 (469)
Q Consensus 265 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-----~~ 337 (469)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|+... ... +....+..... ..
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~---~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSP--MAL---FLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH--HHH---HHHHHCSCCGGGHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcch--hhH---HhhccCCcccccCHHHHH
Confidence 22 12345567889999998876 45789999999999999999999886432 111 11111111111 00
Q ss_pred hhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
....... .......+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0000000 01123467899999999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=358.76 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=189.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEee------c
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATS------R 181 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~------~ 181 (469)
..+|++.+.||+|+||+||+|++..+++.||||++... .......+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 35799999999999999999999999999999998654 3455577889999999995 9999999998853 3
Q ss_pred cccEEEEEEecchhhHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEcCCCcEEEeeecC
Q 036673 182 MQYSLYLVFDFMQSDLTKIICR--PGQKLTEPQVKCYMQQLLSGLQHCHERG--ILHRDIKASNLLIDKSGMLKIADFGL 257 (469)
Q Consensus 182 ~~~~~~lv~e~~~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~kl~DFGl 257 (469)
....+++||||+.|+|.+.+.. ....+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 3456799999999988887754 4457999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-----------CcccccccCccccchhcc--CCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHH
Q 036673 258 SNFFIPKQKG-----------PLTSRVVTLWYRAPELLL--GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHR 324 (469)
Q Consensus 258 a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~ 324 (469)
+......... ......+|+.|+|||++. ....++.++|||||||++|+|++|+.||...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9876432221 112456899999999873 334578999999999999999999999976443322111
Q ss_pred HHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 325 IFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 325 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
.. . .......+..+.+||.+||+.||.+|||+.|++++-+
T Consensus 265 ~~-------------------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 KY-------------------------S---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -C-------------------------C---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cc-------------------------c---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 00 0 0112345677899999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=364.74 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=197.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEEC---CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDR---DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..++|++.+.||+|+||+||+|++. .++..||||+++... .....+.+.+|+.+|.+++||||+++++++....
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK-- 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--
Confidence 3468999999999999999999887 457789999997543 4455678999999999999999999999987644
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.++|||||+++ +|.+.+......+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 46999999975 77777766666799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCC--cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 264 KQKGP--LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 264 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
..... .....+++.|+|||++.+ ..++.++|||||||++|||++ |+.||...+..+....+......
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~--------- 269 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL--------- 269 (373)
T ss_dssp --------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC---------
T ss_pred CCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 32211 122345778999998875 458999999999999999998 99999988777666554332111
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 270 ----------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 ----------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ----------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 012246788999999999999999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=374.62 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=194.0
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.+|.+.+.||+|+||+||.. ...+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.. ...+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEE
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEE
Confidence 56999999999999997644 344689999999864322 2356899999999 89999999988776 445799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-----CCcEEEeeecCcccccC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-----SGMLKIADFGLSNFFIP 263 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~~ 263 (469)
|||||.++|.+.+......+++..+..++.||+.||+|||++||+||||||+||||+. ...+||+|||+|..+..
T Consensus 96 v~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 9999999999988877666777788899999999999999999999999999999953 23588999999987643
Q ss_pred CCC--CCcccccccCccccchhccC--CCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 036673 264 KQK--GPLTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 264 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
... ......+||+.|+|||++.+ ...++.++|||||||++|||++ |.+||........ ..+. +....
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~---~~~~~---- 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILL---GACSL---- 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHT---TCCCC----
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHh---ccCCc----
Confidence 321 22345789999999998864 3456789999999999999999 8999965443322 1111 11000
Q ss_pred hcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
... ......+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 248 ----------~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 248 ----------DCL-----HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ----------TTS-----CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ----------ccc-----CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 000 001123456889999999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=355.42 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=207.5
Q ss_pred CccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
..++|.+.+.||+|+||.||+|.+. .++..||||++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3578999999999999999999983 44689999999754 34555678899999999999999999999887644
Q ss_pred ccEEEEEEecchh-hHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPG-----------------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIK 238 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 238 (469)
.+++||||+.+ +|.+.+.... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 100 --PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp --SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred --ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 46999999985 6666665432 238999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 036673 239 ASNLLIDKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGR 316 (469)
Q Consensus 239 p~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~ 316 (469)
|+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986533221 12234466889999998875 458999999999999999999 99999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 317 TEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 317 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
........+..... ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 257 PPERLFNLLKTGHR-------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CGGGHHHHHHTTCC-------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHhhcCCc-------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 76555444322110 01234578999999999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=375.90 Aligned_cols=276 Identities=22% Similarity=0.336 Sum_probs=207.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+|+.++||||+++++++........++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4689999999999999999999999999999999965322 223466789999999999999999999998876667899
Q ss_pred EEecchh-hHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----cCCCcEEEeeecCcccc
Q 036673 189 VFDFMQS-DLTKIICRPG--QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI----DKSGMLKIADFGLSNFF 261 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~~ 261 (469)
||||+.+ +|...+.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999986 5555554322 239999999999999999999999999999999999999 77788999999999876
Q ss_pred cCCCCCCcccccccCccccchhccCC-------CCCCccccchhhHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhC
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGS-------TDYGVGIDLWSAGCLLAEMFIGRPLMPGR----TEVEQLHRIFKLCG 330 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwslGv~l~elltg~~pf~~~----~~~~~~~~i~~~~~ 330 (469)
... ......+||+.|+|||++.+. ..++.++|||||||++|||++|+.||... ...+.+..+.. +
T Consensus 167 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~ 242 (396)
T 4eut_A 167 EDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--G 242 (396)
T ss_dssp CCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--S
T ss_pred cCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--C
Confidence 332 223456799999999987541 34788999999999999999999999643 23344444433 2
Q ss_pred CCCHHHHhhcccCcc--CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 331 TPSEDYWKKMKLTTT--FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.|. ..+........ +.-....+....+...++..+.+||.+||+.||++|||+.+++++
T Consensus 243 ~p~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 KPS-GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCT-TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCc-ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 222 11111110000 000000011112223456678999999999999999999998543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=344.97 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=208.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|.+. +++.||||++....... +.+.+|+.++..++||||+++++++.... ..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 79 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PIC 79 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS--SCE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCC--CeE
Confidence 3478999999999999999999987 47899999997654332 56889999999999999999999887654 469
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+++ +|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99999986 67777766666799999999999999999999999999999999999999999999999999986533222
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+......
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~-------------- 224 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------------- 224 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------------
T ss_pred cccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC--------------
Confidence 22334566889999998865 458999999999999999999 89999988777766655432110
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 225 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 -----------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1122457889999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=347.45 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=209.2
Q ss_pred CccCcceec-eeeeeCCeEEEEEEEC--CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 108 SADSYDKLA-KVGQGTYSNVYKARDR--DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 108 ~~~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..++|.+.. .||+|+||+||+|.+. .++..||||++... ......+.+.+|+.++..++||||+++++++.. .
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 82 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---E 82 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---S
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---C
Confidence 346788877 9999999999999864 45788999999754 344566789999999999999999999998843 2
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
..++||||+.+ +|...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 36999999997 66666665666799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 264 KQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 264 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||......+....+.....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---------- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---------- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----------
T ss_pred CcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc----------
Confidence 322 11234456899999998865 458999999999999999998 9999988877666554432110
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
......+++.+.+||.+||..||.+|||+.+++++.+
T Consensus 232 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 ---------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ---------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0123467899999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=358.99 Aligned_cols=271 Identities=24% Similarity=0.310 Sum_probs=205.8
Q ss_pred CCCCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
+....++|++.+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 108 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERN-- 108 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT--
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--
Confidence 4556789999999999999999999965 589999998865433 34577889999999999999999999887644
Q ss_pred EEEEEEecchh-hHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 185 SLYLVFDFMQS-DLTKIICRPG---QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
.+++||||+++ +|.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 46999999986 5655554332 3599999999999999999999999999999999999999999999999999986
Q ss_pred ccCCC-CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 261 FIPKQ-KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 261 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+... ......
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~~~ 262 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESHNN 262 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHHTT
T ss_pred cccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhcccc
Confidence 53322 222345578999999998865 45899999999999999999999999765432211100000 000000
Q ss_pred cccCccCCCCCCCCcc-hhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCc
Q 036673 340 MKLTTTFRPQHYKPSF-REVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 391 (469)
..... ...+.+ .......+..+.+||.+||+.||++|||+.|++++-
T Consensus 263 ~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 263 GQLEQ-----IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp TCCCS-----SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccHHH-----hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00000 001111 112234567789999999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=351.66 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=209.4
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|.+..++..||||++.... ...+.+.+|+.+++.++||||+++++++.... .++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CEE
Confidence 4578999999999999999999999999999999996432 33467889999999999999999999887643 469
Q ss_pred EEEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+||||+.+ +|.+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999995 77776654 33469999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------------- 231 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------- 231 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-------------
T ss_pred cccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC-------------
Confidence 333445566889999998865 458999999999999999999 99999887765554444321100
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 232 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 232 ------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 122457889999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.30 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=202.0
Q ss_pred CccCcceec-eeeeeCCeEEEEEEE--CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 108 SADSYDKLA-KVGQGTYSNVYKARD--RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 108 ~~~~y~~~~-~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..++|++.+ .||+|+||+||+|.+ ..+++.||||++..........+.+.+|+.++..++||||+++++++.. .
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---E 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---S
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---C
Confidence 457899998 999999999999954 5567899999997665555556789999999999999999999998832 3
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
..++||||+.+ +|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 46899999986 55555544 45699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC--CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 264 KQKG--PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 264 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+....+....+.... .
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~--------- 238 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-R--------- 238 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C---------
T ss_pred CCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C---------
Confidence 3221 1223445788999998865 447899999999999999999 999999887766555443210 0
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 239 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 ---------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0123457889999999999999999999999885
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=352.40 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=208.4
Q ss_pred CccCcceeceeeeeCCeEEEEEEE-----CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARD-----RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
..++|++.+.||+|+||+||+|.+ ..+++.||||++.... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 347899999999999999999985 4567899999997543 344557789999999999 999999999998775
Q ss_pred cccEEEEEEecchh-hHHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPGQ-----------------KLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLL 243 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIL 243 (469)
. ..++||||+++ +|.+.+..... .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 100 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 100 G--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp S--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred C--CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 4 35999999986 77776655432 4899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHH
Q 036673 244 IDKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQ 321 (469)
Q Consensus 244 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~ 321 (469)
++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999876443221 1234557889999998865 458999999999999999999 9999988765555
Q ss_pred HHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 322 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
...+......+ .....++..+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 257 FYKMIKEGFRM------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHTCCC------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCCCC------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 54444321111 1123568899999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=359.10 Aligned_cols=257 Identities=22% Similarity=0.330 Sum_probs=205.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
..++|++.+.||+|+||+||+|.+. .++..||||++.... .......+.+|+.+|.++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3478999999999999999999973 356789999997542 223346788999999999 999999999998774
Q ss_pred cccEEEEEEecchh-hHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPGQ----------------------KLTEPQVKCYMQQLLSGLQHCHERGILHRDIK 238 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 238 (469)
. .+++||||+++ +|.+.+..... .+++..+..++.||+.||+|||++||+|||||
T Consensus 122 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 122 G--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp S--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred C--ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 4 46999999986 77777655432 37999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 036673 239 ASNLLIDKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGR 316 (469)
Q Consensus 239 p~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~ 316 (469)
|+||||+.++.+||+|||++..+...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999876433222 1234566889999998865 458999999999999999998 99999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 317 TEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 317 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
.....+..++.....+ .....+++++.+||.+||+.||.+|||+.++++|-.
T Consensus 279 ~~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKM------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCSHHHHHHHHTTCCC------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCC------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 6555554443321110 112346889999999999999999999999998654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=359.67 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=202.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcE----EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKI----VALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++++.||+|+||+||+|.+..+++. ||+|++..... ......+.+|+.++..++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---C
Confidence 47899999999999999999999888775 77777643321 2223456789999999999999999998853 2
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
..++||||+.+ +|.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 36899999985 77777766556799999999999999999999999999999999999999999999999999987644
Q ss_pred CCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 236 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL---------- 236 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC----------
T ss_pred ccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC----------
Confidence 3322 2345567889999998875 458999999999999999999 99999887665555444321100
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....++.++.+||.+||+.||.+|||+.+++++
T Consensus 237 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 237 ---------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122356778899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=360.05 Aligned_cols=267 Identities=22% Similarity=0.321 Sum_probs=207.4
Q ss_pred ccCcceeceeeeeCCeEEEEEE----ECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKAR----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4789999999999999999999 4667899999998653 445557789999999999999999999998877777
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+++||||+++ +|.+.+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 78999999975 66666655455699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC--CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC--HHHHhh
Q 036673 264 KQKG--PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS--EDYWKK 339 (469)
Q Consensus 264 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~ 339 (469)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ........ ......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM--MGCERDVPALSRLLEL 256 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--CC----CCHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--cccccccccHHHHHHH
Confidence 2221 2334567888999998875 457899999999999999999999987543221110 00000000 001111
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..... .......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LEEGQ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccc----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10000 001234678999999999999999999999999653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=357.33 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=199.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEE----EEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIV----ALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++++.||+|+||+||+|++..+++.| |+|.+.... .....+.+.+|+.++..++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence 478999999999999999999998887755 666664332 2334477889999999999999999999987643
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.++|++|+.+ ++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 5788888885 77777777667899999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 264 KQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---------- 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---------- 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------
T ss_pred ccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 322 12334456889999998875 458999999999999999999 99999887766555444321110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++.++.+||.+||..||.+|||+.|+++
T Consensus 239 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 ---------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ---------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112346788999999999999999999999997
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=357.11 Aligned_cols=260 Identities=17% Similarity=0.139 Sum_probs=197.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC---CCcEEEEEEeecCCCCHH---------HHHHHHHHHHHHHhCCCCCeeeEee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD---TGKIVALKKVRFDTSEPE---------SVKFMAREIRILQKLDHPNVIKLEG 176 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~~~~ 176 (469)
.++|++.+.||+|+||+||+|++.. ++..||||++........ ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4789999999999999999999987 788999999875432110 1133667889999999999999999
Q ss_pred eEeec--cccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC--cEEE
Q 036673 177 LATSR--MQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG--MLKI 252 (469)
Q Consensus 177 ~~~~~--~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~--~~kl 252 (469)
++... ....+|+||||+.++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 88763 24568999999965666665443 3799999999999999999999999999999999999999887 9999
Q ss_pred eeecCcccccCCCC------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC--ChHHHHHH
Q 036673 253 ADFGLSNFFIPKQK------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR--TEVEQLHR 324 (469)
Q Consensus 253 ~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~--~~~~~~~~ 324 (469)
+|||++..+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999987643221 11245688999999998876 45899999999999999999999999652 22222222
Q ss_pred HHHHhCCCCHHHHhhcccCccCCCCCCCCcchhccc--CCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 325 IFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFG--EFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 325 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
........+... ....+ .++.++.+||.+||+.||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 274 KTNLLDELPQSV-------------------LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHTTTHHH-------------------HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhcccccHHH-------------------HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 222211111111 11112 67889999999999999999999999886
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=353.58 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=206.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEE-----CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARD-----RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
..++|++.+.||+|+||+||+|++ ..+++.||||++.... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 357899999999999999999985 3467899999997543 344557788999999999 799999999988764
Q ss_pred cccEEEEEEecchh-hHHHHHhcCCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPGQ---------------KLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID 245 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~ 245 (469)
.. .+++||||+.+ +|...+..... .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 104 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 104 GG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TS-CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CC-ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 33 46999999996 66666654332 289999999999999999999999999999999999999
Q ss_pred CCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHH
Q 036673 246 KSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLH 323 (469)
Q Consensus 246 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~ 323 (469)
.++.+||+|||++..+...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+.
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 9999999999999876433221 1234567899999998875 458999999999999999998 999998766444443
Q ss_pred HHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 324 RIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 324 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..+.....+ .....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 262 ~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTRM------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCCC------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCccC------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333221110 1123468899999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=346.45 Aligned_cols=257 Identities=22% Similarity=0.280 Sum_probs=205.9
Q ss_pred CCCCccCcceeceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec
Q 036673 105 VPKSADSYDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR 181 (469)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 181 (469)
+.....+|++.+.||+|+||+||+|.+..+ ...||+|.+... ......+.+.+|+.++++++||||+++++++...
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 444567899999999999999999997643 346899988643 3445567889999999999999999999987554
Q ss_pred cccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
. ...++||||+.+ +|.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 99 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 99 E-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp S-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred C-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 3 346899999997 77777766667799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCC---CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 036673 261 FIPKQK---GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDY 336 (469)
Q Consensus 261 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 336 (469)
...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----- 251 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----- 251 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-----
T ss_pred ccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-----
Confidence 533221 12344567889999998865 458999999999999999999 67888777666555544332110
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 252 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 --------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112346788999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=358.79 Aligned_cols=270 Identities=20% Similarity=0.263 Sum_probs=202.9
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
...++|++.+.||+|+||+||+|++. +++.||||++...... .....+.+|+.++..++||||+++++++..... .
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~ 102 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE--R 102 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC--C
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc--e
Confidence 45688999999999999999999865 5899999998754322 112357899999999999999999999877544 5
Q ss_pred EEEEecchh-hHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 187 YLVFDFMQS-DLTKIICRP---GQKLTEPQVKCYMQQLLSGLQHCHER---GILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
++||||+.+ +|...+... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 899999987 666666543 23499999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCCHH
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR----TEVEQLHRIFKLCGTPSED 335 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~----~~~~~~~~i~~~~~~~~~~ 335 (469)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|++||... ...........
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 253 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-------- 253 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT--------
T ss_pred ccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH--------
Confidence 765444444555679999999998865 44899999999999999999999999521 00000111110
Q ss_pred HHhhcccCccCCCCCCCCc-chhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 336 YWKKMKLTTTFRPQHYKPS-FREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.......... ..... ........+..+.+||.+||+.||.+|||+.++++|-.-
T Consensus 254 ---~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 ---GLLKEKKLEA-LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp ---TTTSSCCSTT-SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ---HHhhchhhhh-hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000000000 00000 011122345679999999999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=342.65 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=204.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|.+. ++..||||++...... .+.+.+|+.+++.++||||+++++++... ..+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcCC---CcE
Confidence 3478999999999999999999986 4778999999754332 35688999999999999999999987643 358
Q ss_pred EEEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+||||+.+ +|.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 99999986 5655554321 269999999999999999999999999999999999999999999999999998764433
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+++.|+|||++.+ ..++.++|||||||++|+|++ |++||.+....+....+......
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 229 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------------- 229 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred cccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC-------------
Confidence 223344566889999998865 457899999999999999999 99999988777666554321100
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++.++.+||.+||..||.+|||+.++++
T Consensus 230 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 230 ------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 112357889999999999999999999999886
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=368.19 Aligned_cols=258 Identities=25% Similarity=0.342 Sum_probs=191.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.+.|.+.+.||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.+|..+ +||||+++++++.. ...+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 85 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLY 85 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred hheeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEE
Confidence 35567788999999999987644 46999999998643 235577899999876 89999999888765 45679
Q ss_pred EEEecchhhHHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC-------------C
Q 036673 188 LVFDFMQSDLTKIICRPGQK------LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS-------------G 248 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~------l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~-------------~ 248 (469)
||||||+++|.+.+...... .++..++.++.||+.||+|||++||+||||||+||||+.+ +
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999999888877654321 1333467899999999999999999999999999999754 4
Q ss_pred cEEEeeecCcccccCCCCC---CcccccccCccccchhccC------CCCCCccccchhhHHHHHHHHh-CCCCCCCCCh
Q 036673 249 MLKIADFGLSNFFIPKQKG---PLTSRVVTLWYRAPELLLG------STDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTE 318 (469)
Q Consensus 249 ~~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~ 318 (469)
.+||+|||++..+...... .....+||+.|+|||++.+ ...++.++|||||||++|||++ |.+||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999876443221 2335689999999998865 2458999999999999999999 9999976554
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 319 VEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 319 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.+ ..+........ .. +. .....+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus 246 ~~--~~i~~~~~~~~----------------~~-~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 246 RE--SNIIRGIFSLD----------------EM-KC--LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH--HHHHHTCCCCC----------------CC-TT--CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hH--HHHhcCCCCcc----------------cc-cc--cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 33 22222111000 00 00 001234578999999999999999999999999999974
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=343.39 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=205.9
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
+...-.|++.++||+|+||+||+|.+..++. .||+|++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 3444568888999999999999999765544 7999998643 34455678899999999999999999999987654
Q ss_pred ccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
. ..++||||+.+ +|...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 96 ~-~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 96 G-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp S-CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred C-CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 3 34899999975 777777766678999999999999999999999999999999999999999999999999999865
Q ss_pred cCCC---CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 036673 262 IPKQ---KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 262 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 337 (469)
.... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ +.+||...+..+....+......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------ 247 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL------ 247 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC------
T ss_pred cCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC------
Confidence 3321 122345567899999998865 458999999999999999999 56666666655544443321111
Q ss_pred hhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 248 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 -------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112346789999999999999999999999886
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=375.23 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=208.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||.||+|.+..++..||||++...... .+.+.+|+.+|++++||||+++++++.... .+|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC--cEE
Confidence 346799999999999999999999988999999999754332 467889999999999999999999987654 469
Q ss_pred EEEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|||||+.+ +|.+.+... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999985 777777543 3469999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+++.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+....+.....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------- 437 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------------- 437 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------
T ss_pred eeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 222334456789999998865 458999999999999999999 9999988776555444322110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
. .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 438 --------~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 --------M---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp --------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------C---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0 123457889999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=352.64 Aligned_cols=258 Identities=21% Similarity=0.312 Sum_probs=205.1
Q ss_pred CccCcceeceeeeeCCeEEEEEE-----ECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKAR-----DRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
..++|++++.||+|+||+||+|+ +..++..||||++... ........+.+|+.+++.++||||+++++++....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 45789999999999999999999 5567889999999643 33455567889999999999999999999987754
Q ss_pred ccEEEEEEecchh-hHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC---CCcEEE
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPG------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---SGMLKI 252 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~kl 252 (469)
. .|+||||+++ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++. +..+||
T Consensus 107 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 107 P--RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp S--CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred C--cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 3 5999999975 7776665433 34899999999999999999999999999999999999984 446999
Q ss_pred eeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 036673 253 ADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 253 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~ 330 (469)
+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+.....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 99999975533221 22334567899999998865 458999999999999999998 9999998877666555433110
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
. .....++..+.+||.+||+.||.+|||+.+++++.|+-
T Consensus 264 ~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 M-------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp C-------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0 11235788999999999999999999999999998864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=370.39 Aligned_cols=250 Identities=25% Similarity=0.401 Sum_probs=205.9
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
...++|++.+.||+|+||+||+|.+.. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.. ..+
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred echHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC---Ccc
Confidence 345789999999999999999999875 78899999975432 34678899999999999999999998763 236
Q ss_pred EEEEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 187 YLVFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
||||||+.+ +|.+.+... ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999986 676666542 236899999999999999999999999999999999999999999999999999875332
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.........+++.|+|||++.. ..++.++|||||||+||||++ |++||.+.+..+....+......+
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------- 405 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP----------- 405 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-----------
T ss_pred ceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2112233456788999998865 458999999999999999999 999999988877776654321111
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
....+++++.+||.+||..||.+|||+.++++
T Consensus 406 --------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 --------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12356889999999999999999999998875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=354.21 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=203.1
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEE--EEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccc
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIV--ALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 183 (469)
...++|++.+.||+|+||.||+|++..++..+ |||.+.... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 98 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-- 98 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--
Confidence 34578999999999999999999999888765 999887432 233446788999999999 999999999998774
Q ss_pred cEEEEEEecchh-hHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPG---------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS 247 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~ 247 (469)
..+|+||||+++ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 457999999986 7776665432 469999999999999999999999999999999999999999
Q ss_pred CcEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036673 248 GMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIF 326 (469)
Q Consensus 248 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~ 326 (469)
+.+||+|||++...... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.
T Consensus 179 ~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CeEEEcccCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 99999999999753221 12234566889999998865 457999999999999999998 999998887766554432
Q ss_pred HHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 327 KLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.... . .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~----------------------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYR----------------------L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCC----------------------C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCC----------------------C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2100 0 1123568899999999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=351.76 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=206.5
Q ss_pred CccCcceeceeeeeCCeEEEEEEEC-------CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEe
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDR-------DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLAT 179 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 179 (469)
..++|++.+.||+|+||+||+|++. .++..||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3478999999999999999999986 356789999997543 445567789999999999 9999999999887
Q ss_pred eccccEEEEEEecchh-hHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 036673 180 SRMQYSLYLVFDFMQS-DLTKIICRPG---------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLL 243 (469)
Q Consensus 180 ~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIL 243 (469)
... .+|+||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 112 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 112 QDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp SSS--CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cCC--ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 644 46999999987 6666665432 24899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHH
Q 036673 244 IDKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQ 321 (469)
Q Consensus 244 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~ 321 (469)
++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 99999999999999986543221 12234456889999998865 458999999999999999999 9999998877666
Q ss_pred HHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 322 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
...+...... .....++..+.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 269 FKLLKEGHRM-------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHTCCC-------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCC-------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5554332100 1123578899999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=349.91 Aligned_cols=254 Identities=19% Similarity=0.324 Sum_probs=201.8
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCC----cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTG----KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
..++|++.+.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.++..++||||+++++++...
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-- 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--
Confidence 3468999999999999999999987543 469999997543 344556788999999999999999999988764
Q ss_pred cEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
..++|||||+.+ +|...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 347999999987 7777776666679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC--CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 263 PKQKG--PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 263 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+......
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-------- 269 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-------- 269 (333)
T ss_dssp ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred cccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC--------
Confidence 33221 1223345789999998875 458999999999999999999 99999888777666555332111
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 270 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 -----------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -----------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123567899999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=351.08 Aligned_cols=255 Identities=16% Similarity=0.260 Sum_probs=208.2
Q ss_pred CCccCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR 181 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 181 (469)
...++|++.+.||+|+||+||+|.+. .+++.||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 34578999999999999999999876 35789999998754 3344456788999999999999999999988764
Q ss_pred cccEEEEEEecchh-hHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEE
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRP---------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLK 251 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~k 251 (469)
. ..++||||+.+ +|.+.+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 101 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 101 Q--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp S--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred C--ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 4 46999999986 666655431 14579999999999999999999999999999999999999999999
Q ss_pred EeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 036673 252 IADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLC 329 (469)
Q Consensus 252 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~ 329 (469)
|+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 999999986533221 11234466889999998865 458999999999999999999 899998887766665543211
Q ss_pred CCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 330 GTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
. ......++..+.+||.+||+.||.+|||+.+++++
T Consensus 258 ~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 L-------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp C-------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 01234578899999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=346.43 Aligned_cols=247 Identities=26% Similarity=0.437 Sum_probs=203.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEee---------
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATS--------- 180 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------- 180 (469)
++|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+.++..++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 57999999999999999999999899999999997542 245689999999999999999998754
Q ss_pred -----ccccEEEEEEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEe
Q 036673 181 -----RMQYSLYLVFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIA 253 (469)
Q Consensus 181 -----~~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~ 253 (469)
.....+++||||+++ +|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 224557999999997 777666432 3569999999999999999999999999999999999999999999999
Q ss_pred eecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036673 254 DFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS 333 (469)
Q Consensus 254 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 333 (469)
|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||... ......+.. +
T Consensus 165 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~--~--- 234 (284)
T 2a19_B 165 DFGLVTSLKND--GKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD--G--- 234 (284)
T ss_dssp CCTTCEESSCC--SCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT--T---
T ss_pred cchhheecccc--ccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc--c---
Confidence 99999876432 22345678999999998876 45899999999999999999999887421 111111100 0
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.....++..+.+||.+||..||.+|||+.++++|.+.-.
T Consensus 235 -----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 -----------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -----------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 112346788999999999999999999999999988643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=352.26 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=206.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCc-----EEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeec
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSR 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 181 (469)
..++|++.+.||+|+||+||+|.+..++. .||+|++.... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 45789999999999999999999976654 89999996543 345567789999999999 899999999998765
Q ss_pred cccEEEEEEecchh-hHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRP-------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS 247 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~ 247 (469)
. .+++||||+++ +|.+.+... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 123 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 123 G--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp S--SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred C--ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 4 46999999986 666665432 3468999999999999999999999999999999999999999
Q ss_pred CcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 036673 248 GMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRI 325 (469)
Q Consensus 248 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i 325 (469)
+.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.........+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 99999999999865433221 1234556889999998875 458999999999999999998 99999887665555444
Q ss_pred HHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 326 FKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......+ ......+..+.+||.+||+.||.+|||+.++++
T Consensus 280 ~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 280 VKDGYQM------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHTCCC------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCC------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 4321111 112245788999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=344.78 Aligned_cols=255 Identities=25% Similarity=0.309 Sum_probs=195.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHh--CCCCCeeeEeeeEeec--cc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK--LDHPNVIKLEGLATSR--MQ 183 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~--~~ 183 (469)
..++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 457899999999999999999988 4899999998642 23455667777776 7999999999987653 34
Q ss_pred cEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcEEEcCCCcEEEee
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH--------ERGILHRDIKASNLLIDKSGMLKIAD 254 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~ivHrDlkp~NILl~~~~~~kl~D 254 (469)
..+++||||+.+ +|.+.+.. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred ceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 567999999997 66666533 46999999999999999999999 99999999999999999999999999
Q ss_pred ecCcccccCCCCC---CcccccccCccccchhccCCC-----CCCccccchhhHHHHHHHHhC----------CCCCCCC
Q 036673 255 FGLSNFFIPKQKG---PLTSRVVTLWYRAPELLLGST-----DYGVGIDLWSAGCLLAEMFIG----------RPLMPGR 316 (469)
Q Consensus 255 FGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslGv~l~elltg----------~~pf~~~ 316 (469)
||++......... .....+||+.|+|||++.+.. .++.++|||||||++|||++| .+||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9999765433221 123458999999999887643 244789999999999999999 8888653
Q ss_pred C----hHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 317 T----EVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 317 ~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
. ....+..+....... + ..........++.++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~---------------~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQR---------------P---NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCC---------------C---CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCC---------------C---CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2 222222222111000 0 00001112235678999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=343.26 Aligned_cols=255 Identities=31% Similarity=0.487 Sum_probs=193.9
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
...++|++.+.||+|+||.||+|.+..+++.||||++... .........+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 106 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NE 106 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--Cc
Confidence 3457899999999999999999999999999999999753 23455667889999999999999999999998874 35
Q ss_pred EEEEEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 186 LYLVFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
.++||||+.+ +|...+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 7999999997 56555532 4557999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhh
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE--VEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 339 (469)
.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+ .....+
T Consensus 187 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~------- 256 (310)
T 2wqm_A 187 SSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYP------- 256 (310)
T ss_dssp -------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH-HTTCSC-------
T ss_pred cCCC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh-hcccCC-------
Confidence 3322 22345678999999998875 4589999999999999999999999976432 1222222 111100
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+ .....++.++.+||.+||..||.+|||+.++++
T Consensus 257 -------------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 257 -------------P---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -------------C---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------C---CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 012357889999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=359.60 Aligned_cols=255 Identities=17% Similarity=0.188 Sum_probs=200.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCC--------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeee-------
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDT--------GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK------- 173 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~------- 173 (469)
.++|++.+.||+|+||+||+|++..+ ++.||||++... ..+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 47899999999999999999999874 889999998743 34678999999999999987
Q ss_pred --------EeeeEeeccccEEEEEEecchhhHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 036673 174 --------LEGLATSRMQYSLYLVFDFMQSDLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI 244 (469)
Q Consensus 174 --------~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl 244 (469)
+++++... ...+||||||+.++|.+.+... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 55565542 4567999999976888777654 3579999999999999999999999999999999999999
Q ss_pred cCCC--cEEEeeecCcccccCCCC------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 036673 245 DKSG--MLKIADFGLSNFFIPKQK------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR 316 (469)
Q Consensus 245 ~~~~--~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 316 (469)
+.++ .+||+|||++..+..... .......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 999999999987643221 12244588999999998876 45899999999999999999999999875
Q ss_pred C-hHHHHHHHHHH-hCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 317 T-EVEQLHRIFKL-CGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 317 ~-~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
. ..+.+...... ...+. .+ ......+..++.++.+||.+||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~----------------~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPG----------------PF-VGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCC----------------CE-ECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChh----------------hh-hhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 33333322221 11110 00 0000113457899999999999999999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=370.21 Aligned_cols=254 Identities=16% Similarity=0.172 Sum_probs=196.0
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCC-CCeee-----------
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDH-PNVIK----------- 173 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-pnIv~----------- 173 (469)
.....|.+.+.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.++..+.| +|+..
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34556899999999999999999999999999999987432 222335778899999999987 32111
Q ss_pred ----------EeeeEeecc---ccEEEEEEecchhhHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 036673 174 ----------LEGLATSRM---QYSLYLVFDFMQSDLTKIIC------RPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234 (469)
Q Consensus 174 ----------~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 234 (469)
+..++.... ....+++|+++.++|.+.+. ..+..+++..+..++.||+.||+|||++||+|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 111111111 23368899999888877662 23445888899999999999999999999999
Q ss_pred ccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccccCccccchhcc---------CCCCCCccccchhhHHHHHH
Q 036673 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL---------GSTDYGVGIDLWSAGCLLAE 305 (469)
Q Consensus 235 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DvwslGv~l~e 305 (469)
|||||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++||
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999999999999999999865322 445677 9999999883 34558889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHH
Q 036673 306 MFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAA 385 (469)
Q Consensus 306 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~ 385 (469)
|++|+.||...+..+....+ ......+|+.+.+||.+||+.||.+|||+.
T Consensus 310 lltg~~Pf~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWI------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGG------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHCCCCCCCcchhhhHHHH------------------------------HhhcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999765432211110 011235789999999999999999999999
Q ss_pred HHhcCccCCC
Q 036673 386 SALQNEFFNA 395 (469)
Q Consensus 386 elL~hp~f~~ 395 (469)
++|+||||+.
T Consensus 360 ~~l~~~~~~~ 369 (413)
T 3dzo_A 360 QAMETPEYEQ 369 (413)
T ss_dssp HHTTSHHHHH
T ss_pred HHHhCHHHHH
Confidence 9999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=343.31 Aligned_cols=242 Identities=25% Similarity=0.400 Sum_probs=190.4
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|.+. ++.||||++... ...+.+.+|+.+|++++||||+++++++... .+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~~ 75 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLNP----VC 75 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT----TE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----cE
Confidence 4578999999999999999999886 789999998532 3346788999999999999999999887632 48
Q ss_pred EEEecchh-hHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCcEEEcCCCc-EEEeeecCccc
Q 036673 188 LVFDFMQS-DLTKIICRPGQ--KLTEPQVKCYMQQLLSGLQHCHE---RGILHRDIKASNLLIDKSGM-LKIADFGLSNF 260 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~ 260 (469)
+||||+++ +|.+.+..... .+++..+..++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999986 66666654332 47899999999999999999999 89999999999999998886 79999999976
Q ss_pred ccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHh
Q 036673 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVE--QLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~ 338 (469)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+.. +.
T Consensus 156 ~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~------- 221 (307)
T 2eva_A 156 IQT----HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT------- 221 (307)
T ss_dssp -------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC-------
T ss_pred ccc----ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC-------
Confidence 532 2334578999999998876 458999999999999999999999997543221 1111111 00
Q ss_pred hcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.......++..+.+||.+||+.||.+|||+.++++
T Consensus 222 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 222 ----------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ----------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00123467889999999999999999999999988
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=363.86 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=202.8
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-Cce
Confidence 45678999999999999999999886 7899999997543 2367889999999999999999999887643 247
Q ss_pred EEEEecchh-hHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQ-KLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
||||||+.+ +|.+.+...+. .+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999986 77777655433 4799999999999999999999999999999999999999999999999999854221
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
.....+++.|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+....+......
T Consensus 343 ----~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------ 405 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM------------ 405 (450)
T ss_dssp --------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC------------
T ss_pred ----ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 223467889999998876 458999999999999999998 99999887666555544321100
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 406 -------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 -------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 122457899999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=351.20 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=200.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec--cccEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR--MQYSL 186 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~~ 186 (469)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++... .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 46899999999999999999999999999999998653 345567889999999999999999999988643 34467
Q ss_pred EEEEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 187 YLVFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
++||||+.+ +|...+.. .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999997 66665543 45679999999999999999999999999999999999999999999999999987642
Q ss_pred CCCCC--------CcccccccCccccchhccCCC--CCCccccchhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Q 036673 263 PKQKG--------PLTSRVVTLWYRAPELLLGST--DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEV-EQLHRIFKLCGT 331 (469)
Q Consensus 263 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~ 331 (469)
..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... +........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--- 262 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--- 262 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence 21111 012345699999999886533 3688999999999999999999999431000 000000000
Q ss_pred CCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCc
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 391 (469)
.. . ......++.++.+||.+||+.||.+|||+.+++++-
T Consensus 263 -------------~~-----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 263 -------------QL-----S---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp -------------C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -------------cC-----C---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 00 0 011235688999999999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=348.87 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=201.4
Q ss_pred cCc-ceeceeeeeCCeEEEEEEE----CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 110 DSY-DKLAKVGQGTYSNVYKARD----RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 110 ~~y-~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
++| ++++.||+|+||+||++.. ..+++.||||++... ........+.+|+.+|+.++||||+++++++......
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 455 9999999999999988864 346899999999755 3445567789999999999999999999999887667
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+++||||+++ +|...+... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred eEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 78999999987 666655443 499999999999999999999999999999999999999999999999999987643
Q ss_pred CCC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-----H
Q 036673 264 KQK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED-----Y 336 (469)
Q Consensus 264 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-----~ 336 (469)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ......... .
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQGQMTVLRL 260 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCCHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhcccccchhHHHH
Confidence 321 12334567889999998875 4578999999999999999999999965322110 011111100 0
Q ss_pred HhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 337 WKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
........ .......++.++.+||.+||+.||.+|||+.++++
T Consensus 261 ~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TELLERGE----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccc----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00000000 01123457889999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=358.60 Aligned_cols=257 Identities=22% Similarity=0.281 Sum_probs=197.3
Q ss_pred CCCccCcceeceeeeeCCeEEEEEEECCCC---cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc
Q 036673 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTG---KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM 182 (469)
Q Consensus 106 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 182 (469)
+.....|++.+.||+|+||+||+|.+..++ ..||||.+... ......+.+.+|+.++++++||||+++++++....
T Consensus 85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 334456899999999999999999876432 46899998653 33355678899999999999999999999876543
Q ss_pred ccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
...++||||+.+ +|.+.+......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 164 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 164 -GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp -SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred -CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 345899999986 777777666667999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCC---CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 036673 262 IPKQKG---PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 262 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 337 (469)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~------ 315 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------ 315 (373)
T ss_dssp ---------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC------
T ss_pred cccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC------
Confidence 332211 1234556889999998875 458999999999999999999 78899876655544443221100
Q ss_pred hhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 316 -------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 -------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123468899999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=365.87 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=202.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|.+.. +..||||+++..... .+.+.+|+.+|++++||||+++++++.. ..++
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceE
Confidence 45789999999999999999999976 567999999764433 3568899999999999999999998865 2368
Q ss_pred EEEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|||||+.+ +|.+.+.. .+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999986 67666643 23459999999999999999999999999999999999999999999999999998764333
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........+++.|+|||++.+ ..++.++|||||||+||||++ |++||.+....+.+..+......
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------- 400 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------- 400 (452)
T ss_dssp --------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred eecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 222334456789999998875 458999999999999999999 99999988877766655432111
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC--ccCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN--EFFN 394 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h--p~f~ 394 (469)
.....+++.+.+||.+||+.||.+|||+.++++. .+|.
T Consensus 401 ------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 401 ------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 1123578899999999999999999999998863 4444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=366.56 Aligned_cols=254 Identities=20% Similarity=0.245 Sum_probs=203.7
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee-eEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVI-KLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~~ 186 (469)
..++|+++++||+|+||.||+|++..+++.||||++...... ..+.+|+.++..|.|++++ .+..++.. ....
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~ 78 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVE--GDYN 78 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEE
Confidence 357899999999999999999999999999999998765433 3467899999999875544 44434333 4457
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---cCCCcEEEeeecCcccccC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 263 (469)
+|||||+.++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||++..+..
T Consensus 79 ~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999999888888887666789999999999999999999999999999999999999 6889999999999987644
Q ss_pred CCCC------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCH
Q 036673 264 KQKG------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---VEQLHRIFKLCGTPSE 334 (469)
Q Consensus 264 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~ 334 (469)
.... .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+... .+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---- 233 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---- 233 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----
T ss_pred CccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----
Confidence 3321 1236789999999998876 4589999999999999999999999987543 333333322110
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......+...++.++.+||..||+.||.+||++.++++
T Consensus 234 -----------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 -----------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -----------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -----------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11122334567899999999999999999999987665
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=385.43 Aligned_cols=282 Identities=26% Similarity=0.343 Sum_probs=207.9
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEee----ccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATS----RMQ 183 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~ 183 (469)
..++|++.+.||.|+||+||+|.+..+|+.||||++... ......+.+.+|+.++..++||||+++++++.. ...
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 347899999999999999999999999999999998654 345556778999999999999999999988654 124
Q ss_pred cEEEEEEecchh-hHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCc---EEEeeecC
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPG--QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGM---LKIADFGL 257 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~---~kl~DFGl 257 (469)
...|+||||+.+ +|...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 456999999976 6666665432 26999999999999999999999999999999999999997765 99999999
Q ss_pred cccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 036673 258 SNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337 (469)
Q Consensus 258 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 337 (469)
+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............+...........
T Consensus 171 a~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQG--ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSC--CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccc--cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 9876432 23456789999999998865 56899999999999999999999999876544322111000000000000
Q ss_pred hhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
. .....+......+....+...+++.+.+||.+||.+||.+|||+.++|+||||+.
T Consensus 248 ~--~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 248 D--DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp C--CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred h--hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 0000011111112222344456788999999999999999999999999999973
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=345.97 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=197.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC-CCc--EEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD-TGK--IVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++.+.||+|+||+||+|++.. +++ .||||++.... ......+.+.+|+.++..++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 4689999999999999999998643 333 68999987543 23355678899999999999999999999887643
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.++||||+.+ +|.+.+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 5899999985 77777765556799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC--CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 264 KQKG--PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 264 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+......+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred cccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC--------
Confidence 3221 1234566889999998865 457899999999999999999 999999888777666554321110
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++.++.+||.+||..||.+|||+.++++
T Consensus 245 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 245 ----------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112357889999999999999999999999997
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=378.01 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=198.1
Q ss_pred ceeeeeCCeEEEEEEE--CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARD--RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
+.||+|+||+||+|.+ ..+++.||||+++.........+.+.+|+.+|.+++|||||++++++... .++||||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEEcc
Confidence 4799999999999965 45578999999986655555567899999999999999999999988643 368999999
Q ss_pred hh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC--CCcc
Q 036673 194 QS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK--GPLT 270 (469)
Q Consensus 194 ~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--~~~~ 270 (469)
.+ +|...+ .....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..... ....
T Consensus 452 ~~g~L~~~l-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 452 ELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp TTEEHHHHH-HHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCCCHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 97 555555 4445799999999999999999999999999999999999999999999999999987643322 1233
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCC
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 349 (469)
...+|+.|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+....+......
T Consensus 531 ~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------------------ 591 (635)
T 4fl3_A 531 HGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------ 591 (635)
T ss_dssp ----CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------------
T ss_pred CCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 4456789999998865 458999999999999999998 99999998887766655432110
Q ss_pred CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+++++.+||..||+.||++|||+.++++
T Consensus 592 -------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 123357899999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=341.47 Aligned_cols=240 Identities=22% Similarity=0.339 Sum_probs=189.2
Q ss_pred ccCccee-ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHH-HhCCCCCeeeEeeeEee--cccc
Q 036673 109 ADSYDKL-AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRIL-QKLDHPNVIKLEGLATS--RMQY 184 (469)
Q Consensus 109 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~--~~~~ 184 (469)
.++|.+. +.||+|+||.||+|.+..+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4678887 7899999999999999999999999998632 3466899888 56699999999998865 3355
Q ss_pred EEEEEEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC---CCcEEEeeecCcc
Q 036673 185 SLYLVFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---SGMLKIADFGLSN 259 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~ 259 (469)
.+++||||+++ +|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 68999999986 7777776543 46999999999999999999999999999999999999998 7899999999986
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
... ...++.++|||||||++|+|++|++||...........+.
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~------------- 211 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK------------- 211 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC-------------
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH-------------
Confidence 531 1346789999999999999999999997654432211100
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
.......+ ......+..+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 212 ----~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 212 ----TRIRMGQY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ----CSSCTTCC-SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ----HHHhhccc-cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00000000 011122356899999999999999999999999999999998743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=373.19 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=203.4
Q ss_pred ccCcceec-eeeeeCCeEEEEEEECC--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLA-KVGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~-~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.++|.+.+ .||+|+||+||+|.+.. ++..||||+++... .....+.+.+|+.+|+.++|||||++++++... .
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~ 409 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---A 409 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---S
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---C
Confidence 34556665 89999999999998763 46789999997643 233457789999999999999999999998652 3
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
++||||||.+ +|...+......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 7999999987 666666666667999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCC--cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 265 QKGP--LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 265 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.... .....+++.|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+....+.....
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----------- 557 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----------- 557 (613)
T ss_dssp ------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----------
T ss_pred CceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 2211 223345689999998865 458999999999999999998 9999998887776665543210
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHH---hcCccCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA---LQNEFFN 394 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~el---L~hp~f~ 394 (469)
......+++++.+||.+||..||.+|||+.++ |++.|+.
T Consensus 558 --------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 558 --------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp --------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 01234578999999999999999999999987 4555544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=339.85 Aligned_cols=245 Identities=24% Similarity=0.400 Sum_probs=194.2
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.+.||+|+||+||+|.+. ++.||||++.... ..+.+.+|+.++..++||||+++++++.... ..++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-CceE
Confidence 4578999999999999999999885 8899999986432 3367889999999999999999999876543 3469
Q ss_pred EEEecchh-hHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICRPG-QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+||||+++ +|.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999987 6766664432 23899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.....+++.|+|||++.+ ..++.++|||||||++|+|++ |++||......+....+....
T Consensus 171 ---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--------------- 231 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------- 231 (278)
T ss_dssp --------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------
T ss_pred ---ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 234467889999998865 458999999999999999998 999998776655444332110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
. ......+++.+.+||.+||..||.+|||+.++++
T Consensus 232 -------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 -------K---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------C---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0 0123457889999999999999999999999885
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=346.89 Aligned_cols=263 Identities=22% Similarity=0.391 Sum_probs=203.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEE----CCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARD----RDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++++.||+|+||.||+|+. ..+++.||||++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 46799999999999999999984 567999999998753 335557889999999999999999999988776655
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+++||||+++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 67999999986 77777776666799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC--CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH-H-----
Q 036673 264 KQKG--PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSE-D----- 335 (469)
Q Consensus 264 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-~----- 335 (469)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ... ....+.... .
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~---~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPP--AEF---MRMIGNDKQGQMIVFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHH---HHHHCTTCCTHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHH---HHhhccccchhhhHHH
Confidence 3221 1234456788999998875 447899999999999999999999886421 111 111111111 0
Q ss_pred HHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.......... ......+++++.+||.+||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000000000 0123457899999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=344.78 Aligned_cols=263 Identities=24% Similarity=0.282 Sum_probs=200.1
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC--CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT--SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.|...+.||+|+||+||+|.+ +++.||||++.... ......+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~l 107 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DLCL 107 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--ceEE
Confidence 355568999999999999986 48899999986532 23344577899999999999999999999887644 4699
Q ss_pred EEecchh-hHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 189 VFDFMQS-DLTKIICR--PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
||||+++ +|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence 9999975 66666543 23469999999999999999999999999999999999999999999999999998654322
Q ss_pred CC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||........+..+..........+....
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 261 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI---- 261 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHS----
T ss_pred ccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhc----
Confidence 21 1234578999999998865 3789999999999999999999999875543333332222111110000000
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.+.+.......+..+.+||.+||+.||.+|||+.+++++
T Consensus 262 -------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 262 -------DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp -------CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011111222345678999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=346.88 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=201.7
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
...++|++.+.||+|+||+||+|.+.. .||+|++..........+.+.+|+.+++.++||||+++++++.... .+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 104 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP--HL 104 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--CE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--ce
Confidence 345789999999999999999999864 4999999765443344456778999999999999999999988754 47
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC-
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK- 264 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 264 (469)
++||||+.+ +|.+.+......+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999986 66666655555799999999999999999999999999999999999998 689999999998764321
Q ss_pred ---CCCCcccccccCccccchhccC--------CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036673 265 ---QKGPLTSRVVTLWYRAPELLLG--------STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPS 333 (469)
Q Consensus 265 ---~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 333 (469)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...........+......
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-- 261 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-- 261 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC--
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC--
Confidence 1122345568999999998864 234788999999999999999999999988777666554321110
Q ss_pred HHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 334 EDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
. .....++.++.+||.+||..||.+|||+.++++
T Consensus 262 --------------------~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 262 --------------------N--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp --------------------C--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred --------------------C--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 011246788999999999999999999999997
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=369.49 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=207.4
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++.++||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|+.|+||||+++++++.. ..+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccce
Confidence 35679999999999999999999976 577999999765432 3568899999999999999999998865 2369
Q ss_pred EEEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|||||+.+ +|.+.+.. .+..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999986 67666643 23459999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........++..|+|||++.+ ..++.++|||||||+||||++ |+.||.+....+.+..+......
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------- 483 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------- 483 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred eecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 112233456789999998875 458999999999999999999 99999988877766655432110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC--ccCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN--EFFN 394 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h--p~f~ 394 (469)
.....++..+.+||.+||+.||.+|||+.++++. .+|.
T Consensus 484 ------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 ------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1123578899999999999999999999998864 4444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=344.25 Aligned_cols=252 Identities=28% Similarity=0.348 Sum_probs=190.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC--CCCCeeeEeeeEeeccc--c
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL--DHPNVIKLEGLATSRMQ--Y 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~~~~--~ 184 (469)
.++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|.+++..+ +||||+++++++..... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 468999999999999999999886 899999998642 123445566666655 99999999998877533 5
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEcCCCcEEEeee
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER--------GILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
.+++||||+.+ +|.+.+.. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 68999999987 77776654 3599999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCC---CcccccccCccccchhccCCCCCCcc------ccchhhHHHHHHHHhC----------CCCCCCC
Q 036673 256 GLSNFFIPKQKG---PLTSRVVTLWYRAPELLLGSTDYGVG------IDLWSAGCLLAEMFIG----------RPLMPGR 316 (469)
Q Consensus 256 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~------~DvwslGv~l~elltg----------~~pf~~~ 316 (469)
|++..+...... .....+||+.|+|||++.+.. +... +|||||||++|||++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999765433222 123568999999999887643 3443 8999999999999999 6666542
Q ss_pred C----hHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcch--hcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 317 T----EVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFR--EVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 317 ~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
. ............ ...+.+. .....+++++.+||.+||+.||.+|||+.++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIK--------------------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTS--------------------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhhHHHHhhh--------------------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2 122222221110 0011111 1122456779999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=352.12 Aligned_cols=276 Identities=23% Similarity=0.292 Sum_probs=193.3
Q ss_pred CCccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHH--HHhCCCCCeeeEeeeEee---c
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRI--LQKLDHPNVIKLEGLATS---R 181 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~~~~~~~~---~ 181 (469)
...++|++++.||+|+||+||+|++ +++.||||++.... ...+..|.++ +..++||||+++++.+.. .
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 3468999999999999999999977 48999999996432 2334444444 445899999999875533 2
Q ss_pred cccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcEEEcCCCcEE
Q 036673 182 MQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER---------GILHRDIKASNLLIDKSGMLK 251 (469)
Q Consensus 182 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~ivHrDlkp~NILl~~~~~~k 251 (469)
....++|||||+++ +|.+.+... .+++..+..++.||+.||+|||+. ||+||||||+||||+.++.+|
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 34467899999976 676666543 468999999999999999999999 999999999999999999999
Q ss_pred EeeecCcccccCCC-------CCCcccccccCccccchhccCC------CCCCccccchhhHHHHHHHHhCCCCC-CCCC
Q 036673 252 IADFGLSNFFIPKQ-------KGPLTSRVVTLWYRAPELLLGS------TDYGVGIDLWSAGCLLAEMFIGRPLM-PGRT 317 (469)
Q Consensus 252 l~DFGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslGv~l~elltg~~pf-~~~~ 317 (469)
|+|||++..+.... .......+||+.|+|||++.+. ..++.++|||||||++|||++|..|| .+..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998764321 1223356799999999988752 34567899999999999999996554 4332
Q ss_pred hHHHHHHHHH-HhCCCCHHHHhhcccCccCCCCCCCCcchhcc---cCCChhHHHHHHHccccCCCCCCCHHHH------
Q 036673 318 EVEQLHRIFK-LCGTPSEDYWKKMKLTTTFRPQHYKPSFREVF---GEFPPSSYGILTTLLALDPAYRGTAASA------ 387 (469)
Q Consensus 318 ~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~L~~dP~~Rpta~el------ 387 (469)
..+....+.. ....+....+........ ..+.+...+ ..+++.+.+||.+||+.||++|||+.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 1111111111 111222211111111111 111111111 1245579999999999999999999999
Q ss_pred hcCccCCCC
Q 036673 388 LQNEFFNAS 396 (469)
Q Consensus 388 L~hp~f~~~ 396 (469)
|-++|-++.
T Consensus 316 ll~~~~~~~ 324 (336)
T 3g2f_A 316 LMMIWERNK 324 (336)
T ss_dssp HHHCCCC--
T ss_pred HHHHHHhcc
Confidence 446776653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=349.51 Aligned_cols=250 Identities=16% Similarity=0.199 Sum_probs=193.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC------CHHHHHHHHHHHHHHHhCC---------CCCeee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS------EPESVKFMAREIRILQKLD---------HPNVIK 173 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------hpnIv~ 173 (469)
.++|++++.||+|+||+||+|++ +++.||||++..... .....+.+.+|+.+|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 589999999986532 2233467889999999885 888888
Q ss_pred EeeeEeec----------------------------cccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 036673 174 LEGLATSR----------------------------MQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGL 224 (469)
Q Consensus 174 ~~~~~~~~----------------------------~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL 224 (469)
+.+++... ....+|||||||.+ +++..+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 87765421 14568999999976 46666644 4689999999999999999
Q ss_pred HHHH-hCCceeccCCCCcEEEcCCC--------------------cEEEeeecCcccccCCCCCCcccccccCccccchh
Q 036673 225 QHCH-ERGILHRDIKASNLLIDKSG--------------------MLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283 (469)
Q Consensus 225 ~~LH-~~~ivHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~ 283 (469)
+||| ++||+||||||+||||+.++ .+||+|||+|+.... ...+||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhh
Confidence 9999 99999999999999999887 899999999987632 24589999999999
Q ss_pred ccCCCCCCccccchhhHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccC
Q 036673 284 LLGSTDYGVGIDLWSAGCL-LAEMFIGRPLMPGRTE-VEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGE 361 (469)
Q Consensus 284 ~~~~~~~~~~~DvwslGv~-l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (469)
+.+.. +.++|||||+++ .+++++|..||..... ......+....... .......+..
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~ 307 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK-------------------TKCNTPAMKQ 307 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS-------------------SCCCSHHHHH
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC-------------------cccchhhhhh
Confidence 87643 889999998776 7788999999843211 11112222110000 0111123445
Q ss_pred CChhHHHHHHHccccCCCCCCCHHHHh-cCccCC
Q 036673 362 FPPSSYGILTTLLALDPAYRGTAASAL-QNEFFN 394 (469)
Q Consensus 362 ~~~~l~~li~~~L~~dP~~Rpta~elL-~hp~f~ 394 (469)
+++++.+||.+||+.| ||.|+| +||||+
T Consensus 308 ~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 308 IKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred cCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 7889999999999987 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=368.88 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=206.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
..++|++.+.||+|+||+||+|.+..+ +..||||++... ......+.+.+|+.+|+.++||||+++++++.. .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---C
Confidence 457899999999999999999998653 467999998653 344555778999999999999999999998853 2
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+|+||||+.+ +|...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 36899999995 67776665556799999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 264 KQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
..........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+......
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----------- 611 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------- 611 (656)
T ss_dssp ----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-----------
T ss_pred CcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 33333344566889999998865 468999999999999999997 99999998887777666442111
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 612 --------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 --------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123457889999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=350.08 Aligned_cols=248 Identities=17% Similarity=0.208 Sum_probs=193.2
Q ss_pred CCccCcceeceeeeeCCeEEEEE-----EECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeEeeeE
Q 036673 107 KSADSYDKLAKVGQGTYSNVYKA-----RDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD---HPNVIKLEGLA 178 (469)
Q Consensus 107 ~~~~~y~~~~~lG~G~~g~Vy~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~ 178 (469)
...++|.+.+.||+|+||+||+| .+..+++.||||++.... ...+..|+.++..+. |+||+++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34578999999999999999999 466779999999986431 245678888888886 99999999988
Q ss_pred eeccccEEEEEEecchh-hHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-------
Q 036673 179 TSRMQYSLYLVFDFMQS-DLTKIICR----PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK------- 246 (469)
Q Consensus 179 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~------- 246 (469)
.... ..|||||||++ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 137 ~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 137 LFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp ECSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred ecCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 7754 46999999985 66666643 3457999999999999999999999999999999999999998
Q ss_pred ----CCcEEEeeecCcccccCC-CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH
Q 036673 247 ----SGMLKIADFGLSNFFIPK-QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ 321 (469)
Q Consensus 247 ----~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~ 321 (469)
++.+||+|||+|..+... ........+||+.|+|||++.+. .++.++|||||||++|||++|++||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 899999999999764322 22234567899999999988764 58999999999999999999999986432200
Q ss_pred HHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCcc
Q 036673 322 LHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392 (469)
Q Consensus 322 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 392 (469)
..... .+... ..++.+.+++..||+.+|.+|++..+.|.+.+
T Consensus 293 ------------------~~~~~---------~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 293 ------------------CKPEG---------LFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp ------------------EEECS---------CCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred ------------------eeech---------hcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 00000 00011 23567788999999999999987666665443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=335.82 Aligned_cols=252 Identities=25% Similarity=0.277 Sum_probs=195.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHh--CCCCCeeeEeeeEeeccc--cE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQK--LDHPNVIKLEGLATSRMQ--YS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~~--~~ 185 (469)
++|++.+.||+|+||+||+|.+. ++.||||++... ....+.+|++++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 67999999999999999999984 899999998532 23567789999988 799999999999876542 25
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcEEEcCCCcEEEeeec
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH--------ERGILHRDIKASNLLIDKSGMLKIADFG 256 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~ivHrDlkp~NILl~~~~~~kl~DFG 256 (469)
+++||||+.+ +|.+.+.. ..+++..++.++.||+.||.||| +.+|+||||||+||||+.++.+||+|||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 7999999997 77776654 35999999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCCC---CcccccccCccccchhccCCCC-----CCccccchhhHHHHHHHHhC----------CCCCCCCC-
Q 036673 257 LSNFFIPKQKG---PLTSRVVTLWYRAPELLLGSTD-----YGVGIDLWSAGCLLAEMFIG----------RPLMPGRT- 317 (469)
Q Consensus 257 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslGv~l~elltg----------~~pf~~~~- 317 (469)
++......... ......||+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 99876433221 2345678999999998865422 23689999999999999999 77886542
Q ss_pred ---hHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchh--cccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 318 ---EVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFRE--VFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 318 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
..+.+...+... ...+.+.. .....+..+.+||.+||+.||.+|||+.++++|
T Consensus 273 ~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQ--------------------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTS--------------------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHH--------------------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 122222221100 00111111 112334678999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=326.57 Aligned_cols=227 Identities=16% Similarity=0.134 Sum_probs=183.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.++..++||||+++++++... ...|+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcEEE
Confidence 689999999999999999999999999999999976543 355567889999999999999999999998774 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||++| +|.+.+ ..+ ....++..++.||+.||+|||++||+||||||+||||+.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l-~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVA-DTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEECCCEEEHHHHH-TTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEecCCCCHHHHH-hcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9999987 555554 332 4667889999999999999999999999999999999999999998543
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
|++ .++.++|||||||++|+|++|+.||.+.+..+.+.... ..
T Consensus 175 ----------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-----------------~~-- 217 (286)
T 3uqc_A 175 ----------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-----------------RD-- 217 (286)
T ss_dssp ----------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-----------------BC--
T ss_pred ----------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-----------------HH--
Confidence 333 26889999999999999999999998754322110000 00
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....+........+++++.+||.+||+.||.+| |+.|+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 0011122334556789999999999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.88 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=197.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc---c
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD-TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ---Y 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~ 184 (469)
.++|++.+.||+|+||+||+|.+.. +++.||||++... ........+.+|+.+|.+++||||+++++++..... .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3789999999999999999999976 6899999998653 344556778899999999999999999999877543 2
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
..||||||++|..+..+... .+++.+++.++.||+.||.|||++||+||||||+||||+.+ .+||+|||++......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 26999999997544433332 69999999999999999999999999999999999999885 9999999999875322
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
...+||+.|+|||++.+. ++.++|||||||+||+|++|.+||.+.... ..+
T Consensus 235 -----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~------------ 285 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLP------------ 285 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCC------------
T ss_pred -----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------ccc------------
Confidence 456799999999988653 488999999999999999999988642110 000
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
.. ......++.+.+||.+||+.||.+||++.++|.|+|+.
T Consensus 286 --------~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 --------ED--DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --------TT--CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------cc--ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 00112357889999999999999999999999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.20 Aligned_cols=186 Identities=16% Similarity=0.109 Sum_probs=129.9
Q ss_pred eeeeCCeEEEEEEECCCCcEEEEEEeecCCC--------CHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccccEEEE
Q 036673 118 VGQGTYSNVYKARDRDTGKIVALKKVRFDTS--------EPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 118 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~l 188 (469)
++.|++|.+..++..-.|+.||+|++..... .....+.|.+|+++|+++ .|+||+++++++++. ..+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~yL 319 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSGWL 319 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEEEE
Confidence 5567777777777777799999999976421 123346799999999999 799999999998774 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||||+|..+..+...++++++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... ...
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-~~~ 395 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-CSW 395 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CC
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC-Ccc
Confidence 99999985555555556678765 47899999999999999999999999999999999999999999875432 234
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRP 311 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~ 311 (469)
..+.+||+.|||||++.+. +..++|+||+|+++++|.++..
T Consensus 396 ~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred ccCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence 5678999999999988763 5778999999999988876643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=255.64 Aligned_cols=186 Identities=16% Similarity=0.107 Sum_probs=138.0
Q ss_pred ceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-H-----HHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-P-----ESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 113 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
...+.||+|+||+||+|.. .+..+++|+....... . ...+.+.+|+.+|++++||||+++..++..... .
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--K 414 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT--T
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc--c
Confidence 3456899999999999944 3789999987543222 1 123557899999999999999955445555433 4
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
||||||+++ +|.+.+.. +..++.||+.||+|||++||+||||||+|||++. .+||+|||+++......
T Consensus 415 ~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999985 66555533 6689999999999999999999999999999998 99999999998763321
Q ss_pred CC------CcccccccCccccchhccCC-CCCCccccchhhHHHHHHHHhCCCCC
Q 036673 266 KG------PLTSRVVTLWYRAPELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLM 313 (469)
Q Consensus 266 ~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf 313 (469)
.. .....+||+.|+|||++... ..|+..+|+|+..+-..+.+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 12367899999999988541 24778899999998888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=214.39 Aligned_cols=146 Identities=18% Similarity=0.210 Sum_probs=114.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH----------------HHHHHHHHHHHHHHhCCCCCeee
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP----------------ESVKFMAREIRILQKLDHPNVIK 173 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~hpnIv~ 173 (469)
..|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|..++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4466779999999999999999 779999999996432111 13466889999999998 4 55
Q ss_pred EeeeEeeccccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEE
Q 036673 174 LEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKI 252 (469)
Q Consensus 174 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl 252 (469)
+.+++.. ...|+||||++| +|.+ + . . .....++.||+.||.|||++||+||||||+||||+ ++.+||
T Consensus 166 v~~~~~~---~~~~lvmE~~~g~~L~~-l-~----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 166 VPKVYAW---EGNAVLMELIDAKELYR-V-R----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp SCCEEEE---ETTEEEEECCCCEEGGG-C-C----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEE
T ss_pred cCeEEec---cceEEEEEecCCCcHHH-c-c----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEE
Confidence 5554433 224899999987 5544 3 1 1 23557999999999999999999999999999999 999999
Q ss_pred eeecCcccccCCCCCCcccccccCccccchhcc
Q 036673 253 ADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285 (469)
Q Consensus 253 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 285 (469)
+|||+|.. +..|+|||++.
T Consensus 234 ~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CCCTTCEE--------------TTSTTHHHHHH
T ss_pred EECCCCeE--------------CCCCCHHHHHH
Confidence 99999964 34578999764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.2e-22 Score=189.90 Aligned_cols=139 Identities=20% Similarity=0.263 Sum_probs=106.7
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcE--EEEEEeecCCCCH----------------------HHHHHHHHHHHHHHhC
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKI--VALKKVRFDTSEP----------------------ESVKFMAREIRILQKL 166 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 166 (469)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999999667889 9999975432110 1123578999999999
Q ss_pred CCCCe--eeEeeeEeeccccEEEEEEecchh------hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccC
Q 036673 167 DHPNV--IKLEGLATSRMQYSLYLVFDFMQS------DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH-ERGILHRDI 237 (469)
Q Consensus 167 ~hpnI--v~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDl 237 (469)
.|++| +.++++ . . .+|||||+++ .+.+.... .++..+..++.||+.||.||| ++||+||||
T Consensus 128 ~~~~i~~p~~~~~--~--~--~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY--M--K--NVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE--E--T--TEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc--C--C--CEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 88764 334332 1 2 3899999953 33333221 345678899999999999999 999999999
Q ss_pred CCCcEEEcCCCcEEEeeecCcccc
Q 036673 238 KASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 238 kp~NILl~~~~~~kl~DFGla~~~ 261 (469)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.8e-19 Score=175.38 Aligned_cols=139 Identities=19% Similarity=0.243 Sum_probs=99.7
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC---------------CHHH-----HHHHHHHHHHHHhCCCCC
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS---------------EPES-----VKFMAREIRILQKLDHPN 170 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------~~~~-----~~~~~~E~~~l~~l~hpn 170 (469)
-|++...||.|+||.||+|.+. +|+.||||+++.... .... .....+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999986 499999999753210 0000 011235777777775544
Q ss_pred eeeEeeeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC--
Q 036673 171 VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-- 248 (469)
Q Consensus 171 Iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-- 248 (469)
+.-..-+... .. +|||||++|..+..+.. ......++.||+.+|.|||++|||||||||.||||++++
T Consensus 175 v~vp~p~~~~--~~--~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQS--RH--TIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEEE--TT--EEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeecc--Cc--eEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 4322112222 22 79999999855443322 234567889999999999999999999999999998876
Q ss_pred --------cEEEeeecCccc
Q 036673 249 --------MLKIADFGLSNF 260 (469)
Q Consensus 249 --------~~kl~DFGla~~ 260 (469)
.+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 389999997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.4e-12 Score=123.16 Aligned_cols=140 Identities=16% Similarity=0.115 Sum_probs=106.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~l 188 (469)
+.|++...++.|+++.||++... +..+++|+....... ....+.+|+.+|+.|. +.++.++++++... ...|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEE
Confidence 46888889999999999999754 689999998642111 1134778999999884 67788888877653 45699
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE--------------------------------------- 229 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------------------------------------- 229 (469)
||||++|..+..... +......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999954443321 122345788999999999998
Q ss_pred --------------------CCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 230 --------------------RGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 230 --------------------~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
..++|+|++|.|||++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998765667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=8.2e-12 Score=117.36 Aligned_cols=136 Identities=12% Similarity=0.100 Sum_probs=96.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeEeeeEeeccccEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN--VIKLEGLATSRMQYSL 186 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~~ 186 (469)
...|.+....+.|..+.||++.. .+|..++||+..... ...+.+|+.+++.+.+.+ +.+++++.... ...
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCC
Confidence 34566654445666799999965 457789999875431 134678999999885444 45577665543 346
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG----------------------------------- 231 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------------------------------- 231 (469)
++||||++|..+. . . ... ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~-~-~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL-S-S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT-T-S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC-c-C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999985443 1 1 122 2356778888888888643
Q ss_pred -----------------------ceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 232 -----------------------ILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 232 -----------------------ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
++|+|++|.|||+++++.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.19 E-value=4e-11 Score=118.69 Aligned_cols=143 Identities=15% Similarity=0.232 Sum_probs=103.9
Q ss_pred ceeceeeeeCCeEEEEEEECCCCcEEEEEEee--cCCCCHHHHHHHHHHHHHHHhCC--CCCeeeEeeeEeeccc-cEEE
Q 036673 113 DKLAKVGQGTYSNVYKARDRDTGKIVALKKVR--FDTSEPESVKFMAREIRILQKLD--HPNVIKLEGLATSRMQ-YSLY 187 (469)
Q Consensus 113 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~-~~~~ 187 (469)
..++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.|. +..+++++.++.+... ...|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 34677999999999999765 4678898765 32211 12246778999999996 4557788777665421 2358
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-------------------------------------- 229 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-------------------------------------- 229 (469)
+||||++|..+... .-..+++.+...++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999998543211 11247888999999999999999997
Q ss_pred --------------------CCceeccCCCCcEEEcCCCc--EEEeeecCccc
Q 036673 230 --------------------RGILHRDIKASNLLIDKSGM--LKIADFGLSNF 260 (469)
Q Consensus 230 --------------------~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~ 260 (469)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=2.8e-11 Score=116.96 Aligned_cols=182 Identities=15% Similarity=0.193 Sum_probs=118.3
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCC--eeeEeeeEeeccc-cEEEEEE
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPN--VIKLEGLATSRMQ-YSLYLVF 190 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn--Iv~~~~~~~~~~~-~~~~lv~ 190 (469)
++.++.|.+..||++. ..+++|+... ......+.+|+.+|+.+ .+.. +.+++.+...... ...|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4559999999999873 4588998642 23456788999999888 3333 3344433322221 1237899
Q ss_pred ecchhhHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 036673 191 DFMQSDLTK-IICRPGQKLTEPQVKCYMQQLLSGLQHCHE---------------------------------------- 229 (469)
Q Consensus 191 e~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------- 229 (469)
++++|..+. ... ..++..+...++.+++..|..||+
T Consensus 96 ~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 96 TKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp ECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred cccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999984332 222 247888888889999999988886
Q ss_pred ------------------CCceeccCCCCcEEEcC--CCcEEEeeecCcccccCCCCCCcccccccCcc---ccchhc--
Q 036673 230 ------------------RGILHRDIKASNLLIDK--SGMLKIADFGLSNFFIPKQKGPLTSRVVTLWY---RAPELL-- 284 (469)
Q Consensus 230 ------------------~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~~-- 284 (469)
..++|+|++|.|||++. ...+.|+||+.+..-.+..+ ......+ ..|+.+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHH
Confidence 13799999999999998 45688999999875322110 0001111 222211
Q ss_pred -cC-CC---------CCCccccchhhHHHHHHHHhCCCCC
Q 036673 285 -LG-ST---------DYGVGIDLWSAGCLLAEMFIGRPLM 313 (469)
Q Consensus 285 -~~-~~---------~~~~~~DvwslGv~l~elltg~~pf 313 (469)
.. .. ....-.+.|+++.++|.+.+|.++|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 00 0112258999999999999998766
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.8e-07 Score=90.34 Aligned_cols=135 Identities=13% Similarity=0.134 Sum_probs=92.7
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC---CeeeEeeeEeeccccEEEEEEe
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP---NVIKLEGLATSRMQYSLYLVFD 191 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~~~~~~~lv~e 191 (469)
+..++.|....||+. +..++||+.. .......+.+|+.+|..|.+. .|.+++.+.... ....|+||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEEe
Confidence 456889999999998 4668888742 234456788999999999653 245665555422 334589999
Q ss_pred cchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 036673 192 FMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER----------------------------------------- 230 (469)
Q Consensus 192 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------------------------------------- 230 (469)
|++|..+....- ..++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999844332111 1245556666666666666666642
Q ss_pred -------------------CceeccCCCCcEEEcC---CCc-EEEeeecCcccc
Q 036673 231 -------------------GILHRDIKASNLLIDK---SGM-LKIADFGLSNFF 261 (469)
Q Consensus 231 -------------------~ivHrDlkp~NILl~~---~~~-~kl~DFGla~~~ 261 (469)
.++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 455 489999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=2.6e-07 Score=87.10 Aligned_cols=133 Identities=14% Similarity=0.144 Sum_probs=89.9
Q ss_pred eeeeeCCe-EEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEEEEEecch
Q 036673 117 KVGQGTYS-NVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 117 ~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
.+..|..+ .||+......+..++||+-.. .....+.+|..+|+.|. +--|.+++.++.+.+ ..|+|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--DAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--EEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--eEEEEEEeeC
Confidence 35556555 699988777778899998652 23456788999998883 323567777776643 4699999999
Q ss_pred hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 036673 195 SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE--------------------------------------------- 229 (469)
Q Consensus 195 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------------------------------------------- 229 (469)
|..+..... ........+..++...|.-||.
T Consensus 104 G~~~~~~~~----~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 104 GKTAFQVLE----EYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp SEEHHHHHH----HCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred Ccccccccc----CCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 843322211 0112233445555555555553
Q ss_pred ------C-------CceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 230 ------R-------GILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 230 ------~-------~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
. .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1 279999999999999877778999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.1e-06 Score=87.72 Aligned_cols=78 Identities=13% Similarity=0.160 Sum_probs=48.3
Q ss_pred eeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC--CH---HHHHHHHHHHHHHHhCCC--CC-eeeEeeeEeeccccE
Q 036673 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS--EP---ESVKFMAREIRILQKLDH--PN-VIKLEGLATSRMQYS 185 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h--pn-Iv~~~~~~~~~~~~~ 185 (469)
..+.||.|.++.||++....+++.|+||....... .. .....+..|.++|..+.. +. +.+++.+ +...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~-- 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-- 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc--
Confidence 35679999999999997665578899998643211 00 112345679999887732 33 4456433 3323
Q ss_pred EEEEEecchh
Q 036673 186 LYLVFDFMQS 195 (469)
Q Consensus 186 ~~lv~e~~~~ 195 (469)
.++||||+++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 3799999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.19 E-value=8.6e-06 Score=79.15 Aligned_cols=31 Identities=19% Similarity=0.387 Sum_probs=28.0
Q ss_pred CCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 230 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4799999999999998888999999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=3.2e-06 Score=83.03 Aligned_cols=82 Identities=10% Similarity=0.115 Sum_probs=50.6
Q ss_pred eecee-eeeCCeEEEEEEEC---C---CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCC-C--CCeeeEeeeEeecc
Q 036673 114 KLAKV-GQGTYSNVYKARDR---D---TGKIVALKKVRFDTS-EPESVKFMAREIRILQKLD-H--PNVIKLEGLATSRM 182 (469)
Q Consensus 114 ~~~~l-G~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~~ 182 (469)
..+.| +.|....+|+.... + ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.++....
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 88889999998653 1 156789997643220 0000134567888888873 2 34667766654431
Q ss_pred -ccEEEEEEecchh
Q 036673 183 -QYSLYLVFDFMQS 195 (469)
Q Consensus 183 -~~~~~lv~e~~~~ 195 (469)
....|+||||++|
T Consensus 104 ~~g~~~~v~e~l~G 117 (357)
T 3ats_A 104 VLGTPFFLMDYVEG 117 (357)
T ss_dssp TTSSCEEEEECCCC
T ss_pred ccCCceEEEEecCC
Confidence 0234799999987
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.76 E-value=7.5e-05 Score=75.06 Aligned_cols=79 Identities=9% Similarity=0.041 Sum_probs=46.8
Q ss_pred HhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccc--cCccccchhccCCC--CCCccccchhhHHHH
Q 036673 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV--TLWYRAPELLLGST--DYGVGIDLWSAGCLL 303 (469)
Q Consensus 228 H~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~--~~~~~~DvwslGv~l 303 (469)
+...++|+|++|.|||++.++ +.|+||+.+.+-.+..+ ...... ...|.+|+...... .-....++..+...+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 345799999999999998876 99999999875311111 001111 23466666442110 011223445777777
Q ss_pred HHHHhC
Q 036673 304 AEMFIG 309 (469)
Q Consensus 304 ~elltg 309 (469)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00015 Score=69.23 Aligned_cols=132 Identities=15% Similarity=0.130 Sum_probs=72.4
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeEeeeEeeccccEEEEEEecc
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV-IKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~lv~e~~ 193 (469)
++.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ .+++.++ .... ++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~--~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATG--VMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTC--CEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCC--EEEEeec
Confidence 677999999999999 45888987542111 1112468877777632222 4554432 2222 6899999
Q ss_pred -hhhHH-------------------HHHhcCCCCC----C-HHHHHHHHHH--------------HHHHHHHHH----h-
Q 036673 194 -QSDLT-------------------KIICRPGQKL----T-EPQVKCYMQQ--------------LLSGLQHCH----E- 229 (469)
Q Consensus 194 -~~~l~-------------------~~~~~~~~~l----~-~~~~~~i~~q--------------i~~aL~~LH----~- 229 (469)
+|..+ ..++.....+ . ...+..+... +...+..|. .
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 65211 0111111111 1 1111111111 111111111 1
Q ss_pred ---CCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 230 ---RGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 230 ---~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
..++|+|+.+.||| ..++.+.|+||..+..
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 13899999999999 5667789999998865
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00022 Score=68.60 Aligned_cols=73 Identities=18% Similarity=0.193 Sum_probs=54.4
Q ss_pred eeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeEeeeEeeccccEEEEEE
Q 036673 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD---HPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
-.+.|+.|.+..+|+... ++..++||+.... ....+..|...|+.|. ...+++++.+.... ...|+||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvm 110 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLL 110 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEE
Confidence 356799999999999975 3678889987532 2466788999998883 35677777665543 3469999
Q ss_pred ecchh
Q 036673 191 DFMQS 195 (469)
Q Consensus 191 e~~~~ 195 (469)
||++|
T Consensus 111 e~l~G 115 (312)
T 3jr1_A 111 EALNK 115 (312)
T ss_dssp ECCCC
T ss_pred EeccC
Confidence 99986
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00045 Score=65.45 Aligned_cols=75 Identities=17% Similarity=0.215 Sum_probs=51.2
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC---CeeeEeeeEeeccccEEEE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP---NVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~~~~~~~l 188 (469)
..-+..+|.|..+.||+.+..+ |+.|+||+....... ....+..|+..|+.|.-- -+.+++++ .. . ++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~--~l 87 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--R--TL 87 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--T--EE
T ss_pred eEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--c--eE
Confidence 3456779999999999998764 899999986543221 124577899999988421 24455433 22 2 78
Q ss_pred EEecchh
Q 036673 189 VFDFMQS 195 (469)
Q Consensus 189 v~e~~~~ 195 (469)
||||+.+
T Consensus 88 v~e~l~~ 94 (288)
T 3f7w_A 88 AMEWVDE 94 (288)
T ss_dssp EEECCCC
T ss_pred EEEeecc
Confidence 9999864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00058 Score=61.26 Aligned_cols=97 Identities=18% Similarity=0.080 Sum_probs=64.9
Q ss_pred hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcccccc
Q 036673 196 DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274 (469)
Q Consensus 196 ~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 274 (469)
+|...+...+.++++++++.++.|.+.+|.-+-. ..-..+=+.|..|+|..+|+|.+.+ ..+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 5667776777899999999999999999887622 1212334557899999999998764 1111 11
Q ss_pred cCccccchhccCCCCCCccccchhhHHHHHHHHh
Q 036673 275 TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI 308 (469)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt 308 (469)
...+.|||... ...+.+.=|||||++||.-+-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 23466888653 335678899999999999884
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00085 Score=66.29 Aligned_cols=136 Identities=16% Similarity=0.163 Sum_probs=80.7
Q ss_pred ceeeeeCCeEEEEEEECC-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEE
Q 036673 116 AKVGQGTYSNVYKARDRD-------TGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~ 187 (469)
+.|..|....+|++.... ++..|++|+..... .....+.+|..+++.|. +.-..++++++. + .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFP--E----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C----c
Confidence 457778889999998742 35789999853221 12344568999998883 322356655442 2 3
Q ss_pred EEEecchhhHH------------------HHHhcCC----CCC--CHHHHHHHHHHHHH-------------------HH
Q 036673 188 LVFDFMQSDLT------------------KIICRPG----QKL--TEPQVKCYMQQLLS-------------------GL 224 (469)
Q Consensus 188 lv~e~~~~~l~------------------~~~~~~~----~~l--~~~~~~~i~~qi~~-------------------aL 224 (469)
+||||++|..+ ..++... ... -+.++..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 89999987211 1111111 112 24566666655422 23
Q ss_pred HHHHh----C----CceeccCCCCcEEEcCC----CcEEEeeecCccc
Q 036673 225 QHCHE----R----GILHRDIKASNLLIDKS----GMLKIADFGLSNF 260 (469)
Q Consensus 225 ~~LH~----~----~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 260 (469)
..|.+ . .++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33332 2 49999999999999876 7899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.001 Score=63.94 Aligned_cols=141 Identities=11% Similarity=0.098 Sum_probs=76.1
Q ss_pred eeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeEeee----EeeccccEEE
Q 036673 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN--VIKLEGL----ATSRMQYSLY 187 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~----~~~~~~~~~~ 187 (469)
-++.|+.|....+|+....+ + .+++|+...... ...+..|+.++..|...+ +.+++.. .........+
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEECC---EEEEEEEESS-C-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred EeeccCCCcccceEEEEeCC-c-cEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 34667888889999997653 3 688998864211 133556777777663212 2333211 0000123458
Q ss_pred EEEecchhhH---------------HHHHhcC--C--CC----CCHHHHHHH---------------HHHHHHHHHHHHh
Q 036673 188 LVFDFMQSDL---------------TKIICRP--G--QK----LTEPQVKCY---------------MQQLLSGLQHCHE 229 (469)
Q Consensus 188 lv~e~~~~~l---------------~~~~~~~--~--~~----l~~~~~~~i---------------~~qi~~aL~~LH~ 229 (469)
++|+|++|.. +..++.. . .+ ......... ...+...+++|..
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999998731 1111110 0 00 111111110 0113445555553
Q ss_pred -------CCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 230 -------RGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 230 -------~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
.+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3699999999999998876668999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0003 Score=69.21 Aligned_cols=72 Identities=6% Similarity=0.084 Sum_probs=42.3
Q ss_pred eceeeeeCCeEEEEEEECC--------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC-eeeEeeeEeeccccE
Q 036673 115 LAKVGQGTYSNVYKARDRD--------TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPN-VIKLEGLATSRMQYS 185 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~ 185 (469)
+..|+.|....+|++.... .+..+++|+..... ........|..+++.|...+ +.++++.. . .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N-G-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T-T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C-C--
Confidence 4568889899999998753 12688999864321 11112357888888774333 34665433 2 2
Q ss_pred EEEEEecchh
Q 036673 186 LYLVFDFMQS 195 (469)
Q Consensus 186 ~~lv~e~~~~ 195 (469)
++||+|++|
T Consensus 110 -~~v~e~i~G 118 (369)
T 3c5i_A 110 -GRIEEWLYG 118 (369)
T ss_dssp -EEEEECCCS
T ss_pred -cEEEEEecC
Confidence 689999986
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0022 Score=64.51 Aligned_cols=72 Identities=15% Similarity=0.187 Sum_probs=48.2
Q ss_pred eeceeeeeCCeEEEEEEECC-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeEeeeEeeccccE
Q 036673 114 KLAKVGQGTYSNVYKARDRD-------TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV-IKLEGLATSRMQYS 185 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~ 185 (469)
.++.|+.|....||++.... ++..+++|+.... .. ...+.+|+.++..|...++ .++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T---
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---
Confidence 34678889999999998753 2578999987421 11 1334579999988843334 56655432 2
Q ss_pred EEEEEecchh
Q 036673 186 LYLVFDFMQS 195 (469)
Q Consensus 186 ~~lv~e~~~~ 195 (469)
.+|++|++|
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 389999986
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0031 Score=63.94 Aligned_cols=73 Identities=18% Similarity=0.129 Sum_probs=47.2
Q ss_pred eeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeEeeeEeeccccEEEEEEec
Q 036673 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV-IKLEGLATSRMQYSLYLVFDF 192 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~lv~e~ 192 (469)
-++.|+.|....+|++.....+..+++|+....... . -...+|..++..|...++ .++++++ . . .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~-idR~~E~~vl~~L~~~gl~P~ll~~~--~-~---G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--I-INREREKKISCILYNKNIAKKIYVFF--T-N---GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--C-SCHHHHHHHHHHHTTSSSBCCEEEEE--T-T---EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--h-cCHHHHHHHHHHHHhcCCCCCEEEEe--C-C---eEEEEe
Confidence 456788899999999988654578999987432211 0 112479999998865555 4666554 2 2 359999
Q ss_pred chh
Q 036673 193 MQS 195 (469)
Q Consensus 193 ~~~ 195 (469)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.001 Score=64.36 Aligned_cols=31 Identities=29% Similarity=0.382 Sum_probs=27.4
Q ss_pred CCceeccCCCCcEEEcCC----CcEEEeeecCccc
Q 036673 230 RGILHRDIKASNLLIDKS----GMLKIADFGLSNF 260 (469)
Q Consensus 230 ~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 260 (469)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6899999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0021 Score=61.83 Aligned_cols=138 Identities=14% Similarity=0.074 Sum_probs=76.3
Q ss_pred ceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC--CeeeEeee---EeeccccEEEEEE
Q 036673 116 AKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP--NVIKLEGL---ATSRMQYSLYLVF 190 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~---~~~~~~~~~~lv~ 190 (469)
..|+ |....||++... +|+.+++|+........ ..+..|+.++..|... .+++++.. .........+++|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4466 888899988654 36679999986432222 4556788888777321 23444332 0000123457899
Q ss_pred ecchhhHH---------------HHHhc--CC------CCCCHHHH----------------------HHHHHHHHHHHH
Q 036673 191 DFMQSDLT---------------KIICR--PG------QKLTEPQV----------------------KCYMQQLLSGLQ 225 (469)
Q Consensus 191 e~~~~~l~---------------~~~~~--~~------~~l~~~~~----------------------~~i~~qi~~aL~ 225 (469)
+|++|... ..++. .. ..++.... ...+..++..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 99987211 01111 00 01222111 111112222222
Q ss_pred HH----HhCCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 226 HC----HERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 226 ~L----H~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 123589999999999999 4 899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0021 Score=62.43 Aligned_cols=30 Identities=27% Similarity=0.415 Sum_probs=27.5
Q ss_pred CceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 231 GILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 231 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
.++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 599999999999999888899999988865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0097 Score=59.53 Aligned_cols=137 Identities=9% Similarity=0.114 Sum_probs=81.8
Q ss_pred eeceeeeeCCeEEEEEEECCC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccE
Q 036673 114 KLAKVGQGTYSNVYKARDRDT-------GKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 185 (469)
-++.|..|-...+|++..... +..|++|+...... ..-...+|..+++.|. +.-..++++. ..+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~idR~~E~~~l~~L~~~gi~P~l~~~--~~~--- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KFYDSKVELDVFRYLSNINIAPNIIAD--FPE--- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEE--ETT---
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hhcCHHHHHHHHHHHHhcCCCCCEEEE--cCC---
Confidence 346677788999999987631 57899998643221 1112347888888874 3223455542 222
Q ss_pred EEEEEecchhhHH-----------HH-------Hhc--------C---C-CCCCHHHHHHHHHHHH--------------
Q 036673 186 LYLVFDFMQSDLT-----------KI-------ICR--------P---G-QKLTEPQVKCYMQQLL-------------- 221 (469)
Q Consensus 186 ~~lv~e~~~~~l~-----------~~-------~~~--------~---~-~~l~~~~~~~i~~qi~-------------- 221 (469)
++||+|++|..+ .. ++. . . .+.-+.++..|..++-
T Consensus 146 -~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~ 224 (424)
T 3mes_A 146 -GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKEL 224 (424)
T ss_dssp -EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHH
T ss_pred -CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhcccc
Confidence 789999987321 00 000 1 1 1112444444443321
Q ss_pred -----HHHHHHH--------------------h----CCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 222 -----SGLQHCH--------------------E----RGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 222 -----~aL~~LH--------------------~----~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
..+.+|. . ..++|+|+.+.||| +.++.+.|+||..|..
T Consensus 225 ~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 225 YSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233332 1 24899999999999 7788999999999864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.78 E-value=0.027 Score=55.84 Aligned_cols=29 Identities=28% Similarity=0.550 Sum_probs=25.1
Q ss_pred ceeccCCCCcEEE------cCCCcEEEeeecCccc
Q 036673 232 ILHRDIKASNLLI------DKSGMLKIADFGLSNF 260 (469)
Q Consensus 232 ivHrDlkp~NILl------~~~~~~kl~DFGla~~ 260 (469)
++|+|+.+.|||+ +++..+.|+||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4456799999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.45 E-value=0.018 Score=58.36 Aligned_cols=64 Identities=13% Similarity=0.166 Sum_probs=18.7
Q ss_pred ceeceeeeeCCeEEEEEEECCCCcEEEE------EEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEe
Q 036673 113 DKLAKVGQGTYSNVYKARDRDTGKIVAL------KKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLAT 179 (469)
Q Consensus 113 ~~~~~lG~G~~g~Vy~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 179 (469)
.+.+.|| ||.||++........||| |.++......+....+.+|..+++.++|||+++.++|..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4556777 999999998765568888 766543334444566888999999999999999987654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 469 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-80 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-78 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-75 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-73 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-73 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-72 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-71 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-71 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-71 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-70 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-70 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-69 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-69 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-68 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-66 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-66 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-63 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-63 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-63 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-60 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-59 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-58 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-55 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-54 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-54 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-52 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-46 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-26 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (639), Expect = 1e-80
Identities = 128/311 (41%), Positives = 178/311 (57%), Gaps = 15/311 (4%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL 166
Y+KLAK+GQGT+ V+KAR R TG+ VALKKV + + REI+ILQ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 167 DHPNVIKLEGLATS------RMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQL 220
H NV+ L + + R + S+YLVFDF + DL ++ K T ++K MQ L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG---PLTSRVVTLW 277
L+GL + H ILHRD+KA+N+LI + G+LK+ADFGL+ F + T+RVVTLW
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 278 YRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW 337
YR PELLLG DYG IDLW AGC++AEM+ P+M G TE QL I +LCG+ + + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 338 KKMKLTTTFR----PQHYKPSFREVFGEFPPSSYGI--LTTLLALDPAYRGTAASALQNE 391
+ + + K ++ + Y + + LL LDPA R + AL ++
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 392 FFNASPLACDL 402
FF + P+ DL
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 2e-78
Identities = 116/298 (38%), Positives = 175/298 (58%), Gaps = 8/298 (2%)
Query: 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD---TSEPESVKFMAREIRILQKLDHPN 170
KL +G+G ++ VYKARD++T +IVA+KK++ ++ + REI++LQ+L HPN
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+I L + + LVFDFM++DL II LT +K YM L GL++ H+
Sbjct: 62 IIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 231 GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDY 290
ILHRD+K +NLL+D++G+LK+ADFGL+ F + T +VVT WYRAPELL G+ Y
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMY 178
Query: 291 GVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350
GVG+D+W+ GC+LAE+ + P +PG ++++QL RIF+ GTP+E+ W M +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 351 YKP--SFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406
P +F ++ L +P R TA AL+ ++F+ P LP
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (599), Expect = 7e-75
Identities = 118/289 (40%), Positives = 171/289 (59%), Gaps = 7/289 (2%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+++ K+ K+G+GTY VYKAR++ TG++VALKK+R DT REI +L++L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKII-CRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++KL + + + LYLVF+F+ DL K + + P +K Y+ QLL GL CH
Sbjct: 62 NIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
+LHRD+K NLLI+ G +K+ADFGL+ F + T VVTLWYRAPE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCK 178
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR- 347
Y +D+WS GC+ AEM R L PG +E++QL RIF+ GTP E W + ++
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 348 --PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
P+ + F +V +L+ +L DP R +A +AL + FF
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 2e-73
Identities = 103/296 (34%), Positives = 158/296 (53%), Gaps = 19/296 (6%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
SY +G G++ VY+A+ D+G++VA+KKV D +F RE++I++KLDH
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHC 73
Query: 170 NVIKLEGL----ATSRMQYSLYLVFDFMQSDLTKII---CRPGQKLTEPQVKCYMQQLLS 222
N+++L + + L LV D++ + ++ R Q L VK YM QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 223 GLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
L + H GI HRDIK NLL+D +LK+ DFG + + + P S + + +YRAP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAP 191
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341
EL+ G+TDY ID+WSAGC+LAE+ +G+P+ PG + V+QL I K+ GTP+ + ++M
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 342 ---LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
F P + PP + + + LL P R T A + FF+
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 4e-73
Identities = 98/327 (29%), Positives = 154/327 (47%), Gaps = 13/327 (3%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
Y L+ +G+G Y V A D VA+KK+ + + + REI+IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 169 PNVIKLEGL---ATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
N+I + + T +YLV M +DL K++ Q L+ + ++ Q+L GL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLK 123
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK--GPLTSRVVTLWYRAPEL 283
+ H +LHRD+K SNLL++ + LKI DFGL+ P G LT V T WYRAPE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343
+L S Y ID+WS GC+LAEM RP+ PG+ ++QL+ I + G+PS++ +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 344 TTFR-----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398
P K + +F + +L +L +P R AL + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 399 ACDLSSLPVICREEDEPARTSRRKKRR 425
D + + E + K +
Sbjct: 304 PSDEPIAEAPFKFDMELDDLPKEKLKE 330
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 227 bits (579), Expect = 6e-72
Identities = 112/287 (39%), Positives = 162/287 (56%), Gaps = 7/287 (2%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y L K+G+GTY VYKA++ G+ ALKK+R + + REI IL++L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N++KL + L LVF+ + DL K++ L K ++ QLL+G+ +CH+
Sbjct: 61 NIVKLYD--VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
R +LHRD+K NLLI++ G LKIADFGL+ F T +VTLWYRAP++L+GS
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 290 YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349
Y ID+WS GC+ AEM G PL PG +E +QL RIF++ GTP+ W + + P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 350 ---HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ + S +L+ +L LDP R TA AL++ +F
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 1e-71
Identities = 108/328 (32%), Positives = 160/328 (48%), Gaps = 15/328 (4%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
Y L VG G Y V A D TG VA+KK+ K RE+R+L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 170 NVIKLEGLATSR----MQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
NVI L + T YLV FM +DL K++ +KL E +++ + Q+L GL+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLR 135
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
+ H GI+HRD+K NL +++ LKI DFGL+ +T VVT WYRAPE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVIL 191
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
Y +D+WS GC++AEM G+ L G ++QL I K+ GTP ++ ++++
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 346 FR-----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400
P+ K F + P + +L +L LD R TA AL + +F +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 401 DLSSLPVICREEDEPARTSRRKKRRSSK 428
D + D+ RT KR + K
Sbjct: 312 DEPQVQKYDDSFDDVDRTLDEWKRVTYK 339
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-71
Identities = 75/286 (26%), Positives = 128/286 (44%), Gaps = 27/286 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ +D + +G+G Y V A +R T + VA+K V + + + +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHE 63
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
NV+K G R YL ++ P + EP + + QL++G+ + H
Sbjct: 64 NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGST 288
GI HRDIK NLL+D+ LKI+DFGL+ F + L +++ TL Y APELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348
+ +D+WS G +L M G ++ Q + +K
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--------------------- 220
Query: 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
K ++ + + + +L +L +P+ R T ++ ++N
Sbjct: 221 --EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 8e-71
Identities = 116/289 (40%), Positives = 168/289 (58%), Gaps = 7/289 (2%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
Y+KL K+G+GTY V+KA++R+T +IVALK+VR D + REI +L++L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N+++L + S + LVF+F DL K L VK ++ QLL GL CH
Sbjct: 62 NIVRLHDVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
R +LHRD+K NLLI+++G LK+A+FGL+ F + ++ VVTLWYR P++L G+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKL 178
Query: 290 YGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348
Y ID+WSAGC+ AE+ RPL PG +QL RIF+L GTP+E+ W M ++P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 349 QHYKP---SFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
P S V + + +L LL +P R +A ALQ+ +F+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 226 bits (576), Expect = 1e-70
Identities = 76/354 (21%), Positives = 131/354 (37%), Gaps = 33/354 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D YD ++G G + V++ +R TG A K V T + + +EI+ + L HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESDKETVRKEIQTMSVLRHP 83
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
++ L + + ++++FM +L + + K++E + YM+Q+ GL H H
Sbjct: 84 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 229 ERGILHRDIKASNLLI--DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
E +H D+K N++ +S LK+ DFGL+ PKQ + T + APE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEG 199
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
G D+WS G L + G G + E L + + + +
Sbjct: 200 KP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI------ 252
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406
+ LL DP R T AL++ + S +P
Sbjct: 253 ----------------SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296
Query: 407 V-ICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGETES 459
+ + +T + R S D +E+
Sbjct: 297 SSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEA 350
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 4e-70
Identities = 108/308 (35%), Positives = 153/308 (49%), Gaps = 15/308 (4%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y L+ VG G Y +V A D TG VA+KK+ K RE+R+L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 170 NVIKLEGLATSRMQY----SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
NVI L + T +YLV M +DL I+ QKLT+ V+ + Q+L GL+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLK 135
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
+ H I+HRD+K SNL +++ LKI DFGL+ + T V T WYRAPE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIML 191
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
Y +D+WS GC++AE+ GR L PG ++QL I +L GTP + KK+ +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 346 FR-----PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400
Q K +F VF P + +L +L LD R TAA AL + +F
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 401 DLSSLPVI 408
D
Sbjct: 312 DEPVADPY 319
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 2e-69
Identities = 70/303 (23%), Positives = 130/303 (42%), Gaps = 26/303 (8%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D ++K++++G G V+K + +G ++A K + + +P + RE+++L + + P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSP 64
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
++ G S + + + + M + + ++ E + ++ GL + E
Sbjct: 65 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 230 R-GILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
+ I+HRD+K SN+L++ G +K+ DFG+S I S V T Y +PE L G+
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGT- 178
Query: 289 DYGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQLHRIFKLCGTPSE------------- 334
Y V D+WS G L EM +GR P+ P + +L ++ G +E
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 335 ----DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390
D M + +P + G F + L +PA R + +
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 391 EFF 393
F
Sbjct: 299 AFI 301
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 222 bits (567), Expect = 2e-69
Identities = 81/352 (23%), Positives = 145/352 (41%), Gaps = 34/352 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D YD L ++G G + V++ ++ TG++ K + T P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHP 86
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
+I L + Y + L+ +F+ +L I K++E +V YM+Q GL+H H
Sbjct: 87 KLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 229 ERGILHRDIKASNLLID--KSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
E I+H DIK N++ + K+ +KI DFGL+ P + + T + APE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDR 202
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
G D+W+ G L + G G ++E L + + ED + +
Sbjct: 203 E-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV------ 255
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF--NASPLACDLSS 404
P + + LL +P R T AL++ + + S L + S
Sbjct: 256 ----------------SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299
Query: 405 LPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSSADETKGE 456
+ + + + + GR + S H + + + + E
Sbjct: 300 SRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 5e-69
Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 33/290 (11%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D ++ + ++G G + VYKA++++T + A K + DT E ++ EI IL DHP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYMVEIDILASCDHP 69
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++KL +L+++ +F + ++ + LTE Q++ +Q L L + H
Sbjct: 70 NIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
+ I+HRD+KA N+L G +K+ADFG+S + S + T ++ APE+++ T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN-TRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 289 D----YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344
Y D+WS G L EM P + L +I K P+ +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSR----- 240
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
+ + L L + R T + LQ+ F
Sbjct: 241 -----------------WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 4e-68
Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 36/293 (12%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
A+ Y+ L +G G+Y K R + GKI+ K++ + + + + E+ +L++L H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPG---QKLTEPQVKCYMQQLLSGL 224
PN+++ R +LY+V ++ + DL +I + Q L E V M QL L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 225 QHCHERG-----ILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYR 279
+ CH R +LHRD+K +N+ +D +K+ DFGL+ + V T +Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYM 181
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339
+PE + + Y D+WS GCLL E+ P ++ E +I
Sbjct: 182 SPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227
Query: 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
+ FR + + I+T +L L +R + L+N
Sbjct: 228 ------------EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 7e-68
Identities = 105/297 (35%), Positives = 162/297 (54%), Gaps = 12/297 (4%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARD-RDTGKIVALKKVRFDTSEPESVKFMAREIRILQK 165
++ Y+ +A++G+G Y V+KARD ++ G+ VALK+VR T E RE+ +L+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 166 L---DHPNVIKLEG---LATSRMQYSLYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQ 218
L +HPNV++L ++ + + L LVF+ + D T + P + +K M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 219 QLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWY 278
QLL GL H ++HRD+K N+L+ SG +K+ADFGL+ + + TS VVTLWY
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWY 181
Query: 279 RAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYW- 337
RAPE+LL S+ Y +DLWS GC+ AEMF +PL G ++V+QL +I + G P E+ W
Sbjct: 182 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 338 KKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394
+ + L + + +L L +PA R +A SAL + +F
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 215 bits (548), Expect = 5e-67
Identities = 76/322 (23%), Positives = 140/322 (43%), Gaps = 36/322 (11%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDH 168
+ L ++G G++ VY ARD ++VA+KK+ + E + + +E+R LQKL H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
PN I+ G +++ +LV ++ + ++ + L E ++ L GL + H
Sbjct: 75 PNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
++HRD+KA N+L+ + G++K+ DFG ++ P S V T ++ APE++L
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAMD 187
Query: 289 D--YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
+ Y +D+WS G E+ +P + + L+ I
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------------------- 227
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406
Q+ P+ + G + + + L P R T+ L++ F + L
Sbjct: 228 --QNESPALQS--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL- 282
Query: 407 VICREEDEPARTSRRKKRRSSK 428
I R +D + R+ K
Sbjct: 283 -IQRTKDAVRELDNLQYRKMKK 303
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-66
Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 33/290 (11%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQKL 166
+ + ++ +G+G + NVY AR++ + I+ALK + + + RE+ I L
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
HPN+++L G +YL+ ++ + K E + Y+ +L + L +
Sbjct: 64 RHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
CH + ++HRDIK NLL+ +G LKIADFG S T+ TL Y PE++ G
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIEG 178
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
+ +DLWS G L E +G+P T E RI ++ T
Sbjct: 179 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-------------- 223
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396
P R+ +++ LL +P+ R L++ + A+
Sbjct: 224 -PDFVTEGARD-----------LISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 3e-66
Identities = 77/306 (25%), Positives = 133/306 (43%), Gaps = 36/306 (11%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
Y + K+GQG VY A D TG+ VA++++ + + + EI ++++ +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++ L++V +++ LT ++ E Q+ ++ L L+ H
Sbjct: 78 NIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH 133
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
++HRDIK+ N+L+ G +K+ DFG P+Q ++ V T ++ APE++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA 192
Query: 289 DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348
YG +D+WS G + EM G P + L+ I GTP +K
Sbjct: 193 -YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEK--------- 241
Query: 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSL-PV 407
L L +D RG+A LQ++F +A LSSL P+
Sbjct: 242 -------------LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK---IAKPLSSLTPL 285
Query: 408 ICREED 413
I ++
Sbjct: 286 IAAAKE 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 207 bits (527), Expect = 1e-63
Identities = 89/301 (29%), Positives = 147/301 (48%), Gaps = 26/301 (8%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL- 166
+ D Y + K+G+G YS V++A + + V +K ++ P K + REI+IL+ L
Sbjct: 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLR 87
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
PN+I L + + + LVF+ + +D ++ Q LT+ ++ YM ++L L
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALD 143
Query: 226 HCHERGILHRDIKASNLLIDKSGM-LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
+CH GI+HRD+K N++ID L++ D+GL+ F+ P Q+ RV + +++ PELL
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELL 201
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGR-PLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK-- 341
+ Y +D+WS GC+LA M + P G +QL RI K+ GT +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 342 ---------LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
L R + + E P + L LL D R TA A+++ +
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
Query: 393 F 393
F
Sbjct: 322 F 322
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 204 bits (521), Expect = 2e-63
Identities = 75/298 (25%), Positives = 125/298 (41%), Gaps = 41/298 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPES-------VKFMAREIRI 162
++Y+ +G+G S V + + T K A+K + S + +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 163 LQKL-DHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQL 220
L+K+ HPN+I+L T +LVFD M+ +L + L+E + + M+ L
Sbjct: 63 LRKVSGHPNIIQL--KDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRAL 119
Query: 221 LSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
L + H+ I+HRD+K N+L+D +K+ DFG S P +K L T Y A
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 281 PELLLGSTD-----YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSED 335
PE++ S + YG +D+WS G ++ + G P R ++ L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 336 YWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
W + + +++ L + P R TA AL + FF
Sbjct: 238 EWDD----------------------YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-63
Identities = 71/345 (20%), Positives = 122/345 (35%), Gaps = 34/345 (9%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ Y +G+G + V++ + + K K V+ ++ VK +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++ L S L ++F+F+ D+ + I +L E ++ Y+ Q+ LQ H
Sbjct: 62 NILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 229 ERGILHRDIKASNLLID--KSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
I H DI+ N++ +S +KI +FG + K Y APE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQH 177
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
D+WS G L+ + G T + + I T E+ +K
Sbjct: 178 DV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK-------- 228
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406
E + + LL + R TA+ ALQ+ + +
Sbjct: 229 --------------EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274
Query: 407 VICREEDEPARTSRRKKRRSSKGRKS-TQSIHEGHHKRVSSVSSA 450
+ + S R S +I V+ V A
Sbjct: 275 TLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVA 319
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 5e-63
Identities = 68/293 (23%), Positives = 120/293 (40%), Gaps = 31/293 (10%)
Query: 107 KSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQK 165
K + + +G+G++S V AR+ T + A+K + + V ++ RE ++ +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
LDHP +KL + LY + ++ R E + Y +++S L+
Sbjct: 65 LDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELL 284
+ H +GI+HRD+K N+L+++ ++I DFG + P+ K + V T Y +PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344
+ DLW+ GC++ ++ G P E +I KL E ++ K +
Sbjct: 183 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR--- 238
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397
++ LL LD R A P
Sbjct: 239 -----------------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (518), Expect = 1e-62
Identities = 81/317 (25%), Positives = 129/317 (40%), Gaps = 33/317 (10%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
D YD +G G +S V A D+ T K+VA+K + E + EI +L K+ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++ L+ + S LYL+ + +L I G TE + Q+L +++ H
Sbjct: 68 NIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 229 ERGILHRDIKASNLLI---DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
+ GI+HRD+K NLL D+ + I+DFGLS P L++ T Y APE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLA 182
Query: 286 GSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
Y +D WS G + + G P + + +I K YW +
Sbjct: 183 QK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI----- 236
Query: 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSL 405
S+ + L+ DP R T ALQ+ +
Sbjct: 237 -----------------SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQ 279
Query: 406 PVICREEDEPARTSRRK 422
V + + A++ ++
Sbjct: 280 SVSEQIKKNFAKSKWKQ 296
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-61
Identities = 52/284 (18%), Positives = 109/284 (38%), Gaps = 30/284 (10%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
++G G++ VYK + VA+K + P+ ++ E+ +L+K H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
N++ G +T+ L +V + + S L + K ++ +Q G+ + H
Sbjct: 65 NILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELLLGS 287
+ I+HRD+K++N+ + + +KI DFGL+ ++ ++ + APE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 288 TD--YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345
Y D+++ G +L E+ G+ +Q+ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------------- 224
Query: 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
+ P +V P + ++ L R L
Sbjct: 225 ---GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-60
Identities = 61/282 (21%), Positives = 115/282 (40%), Gaps = 33/282 (11%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEG 176
++G+G++ VYK D +T VA +++ + E +L+ L HPN+++
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 177 --LATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG--I 232
+T + + + LV + M S K + + + ++ + +Q+L GLQ H R I
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 135
Query: 233 LHRDIKASNLLI-DKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYG 291
+HRD+K N+ I +G +KI D GL+ K+ + + T + APE+ Y
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYEEK--YD 190
Query: 292 VGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY 351
+D+++ G + EM Q++R P+ +
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF------------DKVA 238
Query: 352 KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
P +E I+ + + R + L + FF
Sbjct: 239 IPEVKE-----------IIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-59
Identities = 65/292 (22%), Positives = 124/292 (42%), Gaps = 35/292 (11%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRILQK 165
D YD ++G G ++ V K R++ TG A K ++ + S + + RE+ IL++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
+ HPNVI L + ++ + L+ + + + LTE + +++Q+L+G+
Sbjct: 70 IQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 226 HCHERGILHRDIKASNLLIDKSGM----LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
+ H I H D+K N+++ + +KI DFGL++ + + T + AP
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAP 185
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341
E++ G+ D+WS G + + G G T+ E L + + ++Y+
Sbjct: 186 EIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT- 243
Query: 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
+ + LL DP R T +LQ+ +
Sbjct: 244 ---------------------SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-59
Identities = 93/336 (27%), Positives = 158/336 (47%), Gaps = 28/336 (8%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y L +G G V A D + VA+KK+ K RE+ +++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 172 IKLEGLATSRMQYS----LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
I L + T + +YLV + M ++L ++I ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHL 135
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H GI+HRD+K SN+++ LKI DFGL+ +T VVT +YRAPE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 192
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF- 346
Y +D+WS GC++ EM + L PGR ++Q +++ + GTP ++ KK++ T
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 347 ---------------RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391
P P+ E + +L+ +L +DPA R + ALQ+
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 392 FFNASPLACDLSSLP--VICREEDEPARTSRRKKRR 425
+ N ++ + P + ++ DE T K
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 348
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 190 bits (484), Expect = 4e-58
Identities = 59/289 (20%), Positives = 113/289 (39%), Gaps = 28/289 (9%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLD 167
+D Y+ +G G S V+ ARD + VA+K +R D + +P RE + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 168 HPNVIKLEGLATSRMQYS--LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
HP ++ + + Y+V +++ + I +T + + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP--LTSRVVTLWYRAPEL 283
H+ GI+HRD+K +N++I + +K+ DFG++ + + T Y +PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343
G + D++S GC+L E+ G P G + V ++ + P +
Sbjct: 186 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG---- 240
Query: 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEF 392
++ LA +P R A+ ++ +
Sbjct: 241 ------------------LSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-55
Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 33/288 (11%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQK-LD 167
+ + +G+G++ V+ A + T + A+K ++ D + V+ E R+L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 168 HPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
HP + + ++ L+ V +++ + K + Y +++ GLQ
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
H +GI++RD+K N+L+DK G +KIADFG+ + + T Y APE+LLG
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQ 178
Query: 288 TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347
Y +D WS G LL EM IG+ G+ E E H I
Sbjct: 179 K-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---------------------- 215
Query: 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA-LQNEFFN 394
+ P + + +L L +P R Q+ F
Sbjct: 216 -RMDNPFYPR---WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 186 bits (472), Expect = 3e-55
Identities = 64/295 (21%), Positives = 120/295 (40%), Gaps = 37/295 (12%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMA----REIRIL 163
+ + + +G+G + VY R DTGK+ A+K + + + + +A + ++
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 164 QKLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSG 223
D P ++ + + L + D M +E ++ Y +++ G
Sbjct: 62 STGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 224 LQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPEL 283
L+H H R +++RD+K +N+L+D+ G ++I+D GL+ F K+ + V T Y APE+
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEV 176
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343
L Y D +S GC+L ++ G ++ H I ++ T + +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDS---- 231
Query: 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR-----GTAASALQNEFF 393
F P +L LL D R A ++ FF
Sbjct: 232 ------------------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-55
Identities = 69/292 (23%), Positives = 103/292 (35%), Gaps = 43/292 (14%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVR----FDTSEPESVKFMAREIRILQ 164
Y +G G + +VY VA+K V D E + + E+ +L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 165 KLD--HPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLS 222
K+ VI+L + L L DL I G L E + + Q+L
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLE 121
Query: 223 GLQHCHERGILHRDIKASNLLIDKS-GMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
++HCH G+LHRDIK N+LID + G LK+ DFG + T T Y P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 178
Query: 282 ELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341
E + +G +WS G LL +M G E+ + F
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------------- 223
Query: 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393
Q + ++ LAL P+ R T + +
Sbjct: 224 ------RQRVSSECQH-----------LIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 182 bits (462), Expect = 3e-54
Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 39/292 (13%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL 166
S + L +G G++ V+ R R G+ A+K ++ + + V+ E +L +
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
HP +I++ G Q ++++ D+++ + R Q+ P K Y ++ L++
Sbjct: 62 THPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
H + I++RD+K N+L+DK+G +KI DFG + + + T Y APE++
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVST 175
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
Y ID WS G L+ EM G ++ +I
Sbjct: 176 KP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN------------------- 215
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR-----GTAASALQNEFF 393
+ F F +L+ L+ D + R + +F
Sbjct: 216 ----AELRFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 7e-54
Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 36/292 (12%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKL 166
+ + +D L +G+GT+ V R++ TG+ A+K +R + + V E R+LQ
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
HP + L+ + L V ++ + TE + + Y +++S L++
Sbjct: 63 RHPFLTALKY--AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLG 286
H R +++RDIK NL++DK G +KI DFGL I + + T Y APE+L
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLED 179
Query: 287 STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
+ DYG +D W G ++ EM GR + I
Sbjct: 180 N-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------------------- 217
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR-----GTAASALQNEFF 393
+ F P + +L LL DP R A +++ FF
Sbjct: 218 --LMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-53
Identities = 67/349 (19%), Positives = 124/349 (35%), Gaps = 38/349 (10%)
Query: 110 DSYDKLAKV-GQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-D 167
D Y ++V G G V + ++ T + ALK ++ RE+ + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 168 HPNVIKLEGL--ATSRMQYSLYLVFDFMQS-DLTKIIC-RPGQKLTEPQVKCYMQQLLSG 223
P+++++ + + L +V + + +L I R Q TE + M+ +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 224 LQHCHERGILHRDIKASNLLIDK---SGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRA 280
+Q+ H I HRD+K NLL + +LK+ DFG + + T +Y A
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVA 181
Query: 281 PELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
PE+L Y D+WS G ++ + G P + +
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR------------ 228
Query: 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400
R Y+ E + E ++ LL +P R T + + + S
Sbjct: 229 -----IRMGQYEFPNPE-WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
Query: 401 DLSSLPVICREEDEPARTSRRKKRRSSKGRKSTQSIHEGHHKRVSSVSS 449
+ED+ R K+ +S + K++ S+
Sbjct: 283 QTPLHTSRVLKEDKE-RWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 330
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-52
Identities = 61/292 (20%), Positives = 119/292 (40%), Gaps = 38/292 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
++ + ++G G + V+ VA+K ++ + P++ E ++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFL---AEANLMKQLQHQ 68
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTK--IICRPGQKLTEPQVKCYMQQLLSGLQHC 227
+++L + T +Y++ ++M++ + G KLT ++ Q+ G+
Sbjct: 69 RLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
ER +HRD++A+N+L+ + KIADFGL+ + + + APE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 288 TDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
T + + D+WS G LL E+ GR PG T E + + +
Sbjct: 186 T-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------- 225
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ--NEFFNAS 396
Y+ + P Y ++ P R T +FF A+
Sbjct: 226 ---GYRMVRPD---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 2e-52
Identities = 49/290 (16%), Positives = 96/290 (33%), Gaps = 33/290 (11%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
+ Y K+G G++ ++Y D G+ VA+K T P+ + E +I + +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 61
Query: 169 PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
I + Y +V + + L + +K + V Q++S +++ H
Sbjct: 62 GVGIPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 229 ERGILHRDIKASNLLIDKSGM---LKIADFGLSNFFIPKQKG------PLTSRVVTLWYR 279
+ +HRD+K N L+ + I DFGL+ + + + T Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339
+ LG + DL S G +L +G G + + +
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER------------ 227
Query: 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
+ + +P L +L + + Q
Sbjct: 228 ------ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (449), Expect = 5e-52
Identities = 59/294 (20%), Positives = 114/294 (38%), Gaps = 39/294 (13%)
Query: 106 PKSADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-TSEPESVKFMAREIRILQ 164
D +D++ +G G++ V + +++G A+K + + + ++ E RILQ
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
++ P ++KLE ++ ++ + R G + +EP + Y Q++
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTF 154
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELL 284
++ H +++RD+K NLLID+ G +++ DFG + G + T APE++
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEII 210
Query: 285 LGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344
L Y +D W+ G L+ EM G P ++ +I
Sbjct: 211 LSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS---------- 259
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR-----GTAASALQNEFF 393
F +L LL +D R +++F
Sbjct: 260 ----------------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (439), Expect = 3e-51
Identities = 57/280 (20%), Positives = 116/280 (41%), Gaps = 28/280 (10%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
K+G G Y VY+ + VA+K ++ DT E E +E +++++ HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHP 73
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE 229
N+++L G+ T + + F + L + Q+++ + Q+ S +++ +
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTD 289
+ +HRD+ A N L+ ++ ++K+ADFGLS + + APE L +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-K 192
Query: 290 YGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQ 349
+ + D+W+ G LL E+ ++ Q++ + + +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------------K 231
Query: 350 HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
Y+ E P Y ++ +P+ R + A Q
Sbjct: 232 DYRMERPE---GCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 173 bits (438), Expect = 4e-51
Identities = 49/290 (16%), Positives = 96/290 (33%), Gaps = 37/290 (12%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH-PN 170
Y ++G+G++ +++ + + VA+K + P+ + E R + L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTG 62
Query: 171 VIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHER 230
+ + + LV D + L ++ G+K + V +Q+L+ +Q HE+
Sbjct: 63 IPNVYYFGQEGLHN--VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 231 GILHRDIKASNLLIDK-----SGMLKIADFGLSNFFIPKQKG------PLTSRVVTLWYR 279
+++RDIK N LI + + M+ + DFG+ F+ + T Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 280 APELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339
+ LG + DL + G + G G + ++
Sbjct: 181 SINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK------- 232
Query: 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
RE+ FP Y + L
Sbjct: 233 -----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-51
Identities = 58/262 (22%), Positives = 103/262 (39%), Gaps = 17/262 (6%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDT-SEPESVKFMAREIRILQK 165
L K+G G++ V + VA+K ++ D S+PE++ RE+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGL 224
LDH N+I+L G+ + + +V + L + + + Y Q+ G+
Sbjct: 68 LDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPEL 283
+ + +HRD+ A NLL+ ++KI DFGL + +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 284 LLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTP------SEDY 336
L + + D W G L EMF G+ G + LH+I K +D
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 337 WKKMKLTTTFRPQHYKPSFREV 358
+ M +P+ +P+F +
Sbjct: 245 YNVMVQCWAHKPED-RPTFVAL 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 9e-51
Identities = 67/293 (22%), Positives = 126/293 (43%), Gaps = 38/293 (12%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+S K+GQG + V+ T + VA+K ++ T PE+ +E ++++KL H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
+++L + + +Y+V ++M S L + G+ L PQ+ Q+ SG+ +
Sbjct: 73 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
+HRD++A+N+L+ ++ + K+ADFGL+ + + + APE L
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 288 TDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
+ + D+WS G LL E+ GR PG E L ++ +
Sbjct: 190 R-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------------- 229
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ--NEFFNASP 397
Y+ E P S + ++ +P R T ++F ++
Sbjct: 230 ---GYRMPCPP---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-50
Identities = 67/299 (22%), Positives = 128/299 (42%), Gaps = 36/299 (12%)
Query: 108 SADSYDKLAKVGQGTYSNVYKARD---RDTGKIVALKKVRFDT--SEPESVKFMAREIRI 162
++++ L +G G Y V+ R DTGK+ A+K ++ T + ++ + E ++
Sbjct: 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81
Query: 163 LQKLDH-PNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLL 221
L+ + P ++ L + + L+L+ D++ ++ TE +V+ Y+ +++
Sbjct: 82 LEHIRQSPFLVTLHY--AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 222 SGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAP 281
L+H H+ GI++RDIK N+L+D +G + + DFGLS F+ + T+ Y AP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 282 ELLLGS-TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340
+++ G + + +D WS G L+ E+ G E I + Y +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ-- 257
Query: 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYR-----GTAASALQNEFFN 394
E + ++ LL DP R A ++ FF
Sbjct: 258 --------------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-50
Identities = 59/283 (20%), Positives = 112/283 (39%), Gaps = 40/283 (14%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
L +G+G + +V R G VA+K ++ + + E ++ +L H
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHS 60
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ--SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHC 227
N+++L G+ LY+V ++M S + + R L + + + +++
Sbjct: 61 NLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 228 HERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGS 287
+HRD+ A N+L+ + + K++DFGL+ Q + + + + APE L
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREK 175
Query: 288 TDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346
+ D+WS G LL E++ GR P + + R+ K
Sbjct: 176 K-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------- 215
Query: 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
YK + PP+ Y ++ LD A R + +
Sbjct: 216 ---GYKMDAPD---GCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-49
Identities = 55/286 (19%), Positives = 110/286 (38%), Gaps = 37/286 (12%)
Query: 117 KVGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
++G G + V K + K VA+K ++ + ++P + E ++Q+LD+P ++++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 175 EGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILH 234
G+ + S LV + + + + + + + + Q+ G+++ E +H
Sbjct: 74 IGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 235 RDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV--TLWYRAPELLLGSTDYGV 292
RD+ A N+L+ KI+DFGLS + + + APE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSS 189
Query: 293 GIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHY 351
D+WS G L+ E F G+ G E + K
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----------------------GE 227
Query: 352 KPSFREVFGEFPPSSYGILTTLLALDPAYRGTAAS---ALQNEFFN 394
+ P Y ++ D R A+ L+N +++
Sbjct: 228 RMGCPA---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-49
Identities = 58/256 (22%), Positives = 110/256 (42%), Gaps = 15/256 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
+ ++G G + V+ + VA+K +R E E ++ KL HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 170 NVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
+++L G+ Q + LVF+FM+ L+ + + + G+ +
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
E ++HRD+ A N L+ ++ ++K++DFG++ F + Q T + + +PE+ S
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS- 177
Query: 289 DYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTP-----SEDYWKKMKL 342
Y D+WS G L+ E+F G+ R+ E + I S ++ M
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237
Query: 343 TTTFRPQHYKPSFREV 358
RP+ +P+F +
Sbjct: 238 CWKERPED-RPAFSRL 252
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 7e-49
Identities = 56/285 (19%), Positives = 111/285 (38%), Gaps = 35/285 (12%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKL 166
+ + +G+G + +V++ VA+K + TS+ KF+ +E +++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQF 65
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
DHP+++KL G+ T ++++ + +L + L + Y QL + L
Sbjct: 66 DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLL 285
+ + +HRDI A N+L+ + +K+ DFGLS + + + + + APE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 286 GSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344
+ D+W G + E+ + G G + + RI
Sbjct: 183 FR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----------------- 224
Query: 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
+ PP+ Y ++T A DP+ R
Sbjct: 225 -----GERLPMPP---NCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-48
Identities = 49/256 (19%), Positives = 110/256 (42%), Gaps = 15/256 (5%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP 169
L ++G G + V + R VA+K ++ + + E +++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHE 59
Query: 170 NVIKLEGLATSRMQYSLYLVFDFM-QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCH 228
+++L G+ T + ++++ ++M L + + Q+ + + +++
Sbjct: 60 KLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 229 ERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGST 288
+ LHRD+ A N L++ G++K++DFGLS + + + + + PE+L+ S
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS- 176
Query: 289 DYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTP-----SEDYWKKMKL 342
+ D+W+ G L+ E++ +G+ T E I + SE + M
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236
Query: 343 TTTFRPQHYKPSFREV 358
+ +P+F+ +
Sbjct: 237 CWHEKADE-RPTFKIL 251
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-48
Identities = 58/289 (20%), Positives = 114/289 (39%), Gaps = 39/289 (13%)
Query: 117 KVGQGTYSNVYKARDRDTGK--IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKL 174
++G G + +V + R K VA+K ++ T + ++ + M RE +I+ +LD+P +++L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 74
Query: 175 EGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGIL 233
G+ + +L LV + L K + +++ V + Q+ G+++ E+ +
Sbjct: 75 IGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 234 HRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV--TLWYRAPELLLGSTDYG 291
HRD+ A N+L+ KI+DFGLS L + APE + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFS 190
Query: 292 VGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350
D+WS G + E G+ E + I Q
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE----------------------QG 228
Query: 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAAS---ALQNEFFNAS 396
+ E PP Y +++ R + ++ +++ +
Sbjct: 229 KRMECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (417), Expect = 6e-48
Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 26/284 (9%)
Query: 89 PKWLVDNIPKEVLAGLVPKSADSYDKLAKVGQGTYSNVYKARDRDTGK---IVALKKVRF 145
P V KE+ +G G + V + GK VA+K ++
Sbjct: 12 PNEAVREFAKEI-------DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS 64
Query: 146 DTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRP 204
+E + F+ E I+ + DHPNVI LEG+ T + ++ +FM+ L + +
Sbjct: 65 GYTEKQRRDFL-SEASIMGQFDHPNVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQN 121
Query: 205 GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264
+ T Q+ ++ + +G+++ + +HRD+ A N+L++ + + K++DFGLS F
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 265 QKGPLTSRVV----TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEV 319
P + + + + APE + + D+WS G ++ E+ G T
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 320 EQLHRIFKLCGTP-----SEDYWKKMKLTTTFRPQHYKPSFREV 358
+ ++ I + P + M H +P F ++
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH-RPKFGQI 283
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-46
Identities = 70/300 (23%), Positives = 108/300 (36%), Gaps = 30/300 (10%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH 168
A + +G+G + V++ + G+ VA+K S E F EI L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFREAEIYQTVMLRH 56
Query: 169 PNVIKLEGLATSRMQY--SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
N++ L+LV D+ + L + R +T + SGL
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLA 114
Query: 226 HCHE--------RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK---GPLTSRVV 274
H H I HRD+K+ N+L+ K+G IAD GL+ RV
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 275 TLWYRAPELLLGS-----TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLC 329
T Y APE+L S + D+++ G + E+ + G E QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVP 233
Query: 330 GTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
PS + +K+ RP R E I+ + A R TA +
Sbjct: 234 SDPSVEEMRKVVCEQKLRP---NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (411), Expect = 2e-46
Identities = 78/339 (23%), Positives = 134/339 (39%), Gaps = 54/339 (15%)
Query: 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV 171
Y + K+G G +S V+ A+D VA+K VR D E+ + EI++LQ+++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 172 IKLEGLATSRMQYSLYLVFDFMQSD---------------LTKIICRPGQKLTEPQVKCY 216
K + + + + L F+ + L I + + VK
Sbjct: 72 TKEDSMGANHI-LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 217 MQQLLSGLQHC-HERGILHRDIKASNLLIDKSGM------LKIADFGLSNFFIPKQKGPL 269
+QLL GL + GI+H DIK N+L++ +KIAD G + ++ +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT------EVEQLH 323
+R YR+PE+LLG+ +G G D+WS CL+ E+ G L + + +
Sbjct: 191 QTR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 324 RIFKLCGTPSEDYWKKMKLTTTFRPQHYK----------------PSFREVFGEFPPSSY 367
+I +L G + K T TF + +
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 368 GILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406
L+ +L LDP R A + + + L + +P
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLK-DTLGMEEIRVP 343
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-46
Identities = 65/317 (20%), Positives = 118/317 (37%), Gaps = 27/317 (8%)
Query: 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALK---KVRFDTSEPESVKFMAREIRILQK 165
+ K+ +G G + VYK G+ V + K + + P++ K + E ++
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQ 225
+D+P+V +L G+ + + L + + + + Q+ G+
Sbjct: 68 VDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 226 HCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV-TLWYRAPELL 284
+ +R ++HRD+ A N+L+ +KI DFGL+ ++K + + A E +
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 285 LGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLCGTP-----SEDYWK 338
L Y D+WS G + E+ G G E + K P + D +
Sbjct: 186 LHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244
Query: 339 KMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398
M +P FRE+ EF +A DP +Q + P
Sbjct: 245 IMVKCWMIDADS-RPKFRELIIEFSK---------MARDPQRY----LVIQGDERMHLPS 290
Query: 399 ACDLSSLPVICREEDEP 415
D + + EED
Sbjct: 291 PTDSNFYRALMDEEDMD 307
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-46
Identities = 62/311 (19%), Positives = 115/311 (36%), Gaps = 59/311 (18%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKI-----VALKKVRFDTSEPESVKFMAREIRILQ 164
++ + +G G + V A K VA+K ++ E M E++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMT 95
Query: 165 KL-DHPNVIKLEGLATSRMQYSLYLVFDFM-QSDLTKIICRPGQK--------------- 207
+L H N++ L G T +YL+F++ DL + +K
Sbjct: 96 QLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 208 -------LTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260
LT + C+ Q+ G++ + +HRD+ A N+L+ ++KI DFGL+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 261 FIPKQKGPL-TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTE 318
+ + + + + + APE L Y + D+WS G LL E+F +G PG
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 319 VEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDP 378
+++ + +K Y I+ + A D
Sbjct: 273 DANFYKLIQ---------------------NGFKMDQPF---YATEEIYIIMQSCWAFDS 308
Query: 379 AYRGTAASALQ 389
R + +
Sbjct: 309 RKRPSFPNLTS 319
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 6e-45
Identities = 58/284 (20%), Positives = 114/284 (40%), Gaps = 39/284 (13%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQ 164
++ + + +G+G + V++AR + +VA+K ++ + S F RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMA 71
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPG------------------ 205
+ D+PN++K L + + L+F++M DL + +
Sbjct: 72 EFDNPNIVK--LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 206 -----QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNF 260
L+ + C +Q+ +G+ + ER +HRD+ N L+ ++ ++KIADFGLS
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 261 FIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEV 319
P + Y D+W+ G +L E+F G G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 320 EQLHRIFKLCGTP-----SEDYWKKMKLTTTFRPQHYKPSFREV 358
E ++ + + + M+L + P +PSF +
Sbjct: 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPAD-RPSFCSI 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 7e-44
Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 17/255 (6%)
Query: 117 KVGQGTYSNVYKARDRD---TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIK 173
+G+G + VY D A+K + T E +F+ E I++ HPNV+
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVLS 92
Query: 174 LEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGI 232
L G R + S +V +M+ DL I T + + Q+ G++ +
Sbjct: 93 LLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 233 LHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL---TSRVVTLWYRAPELLLGSTD 289
+HRD+ A N ++D+ +K+ADFGL+ K+ + T + + + A E L
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK- 210
Query: 290 YGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK-----MKLT 343
+ D+WS G LL E+ G P P + + + +Y M
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270
Query: 344 TTFRPQHYKPSFREV 358
+ + +PSF E+
Sbjct: 271 WHPKAEM-RPSFSEL 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-42
Identities = 49/287 (17%), Positives = 114/287 (39%), Gaps = 35/287 (12%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTG----KIVALKKVRFDTSEPESVKFMAREIRILQK 165
+ +G G + VYK + + VA+K ++ +E + V F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 166 LDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLT-KIICRPGQKLTEPQVKCYMQQLLSGL 224
H N+I+LEG+ + + ++ ++M++ K + + + Q+ ++ + +G+
Sbjct: 66 FSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 225 QHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTS--RVVTLWYRAPE 282
++ +HRD+ A N+L++ + + K++DFGLS + T+ + + + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 283 LLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342
+ D+WS G ++ E+ ++ +
Sbjct: 184 AISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--------------- 227
Query: 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
++ + P + Y ++ + A R A +
Sbjct: 228 ------DGFRLPTPM---DCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 7e-42
Identities = 61/306 (19%), Positives = 106/306 (34%), Gaps = 54/306 (17%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQ 164
+ +G G + V +A D VA+K ++ E M E+++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81
Query: 165 KL-DHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICR-----------------PG 205
L +H N++ L G T ++ ++ DL + R
Sbjct: 82 YLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 206 QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265
L + + Q+ G+ + +HRD+ A N+L+ + KI DFGL+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 266 KGPLTSRVV-TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLH 323
+ + + APE + Y D+WS G L E+F +G PG + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 324 RIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT 383
++ K + ++ E P Y I+ T DP R T
Sbjct: 259 KMIK---------------------EGFRMLSPE---HAPAEMYDIMKTCWDADPLKRPT 294
Query: 384 AASALQ 389
+Q
Sbjct: 295 FKQIVQ 300
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-41
Identities = 61/302 (20%), Positives = 107/302 (35%), Gaps = 47/302 (15%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQ 164
D +G+G + V +A T + VA+K ++ + E M+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQSDLTKIICRPGQK---------------LT 209
H NV+ L G T + +V +L+ + + LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 210 EPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269
+ CY Q+ G++ R +HRD+ A N+L+ + ++KI DFGL+
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 270 TSRVV-TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRIFK 327
L + APE + Y + D+WS G LL E+F PG E+ R K
Sbjct: 193 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 328 LCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA 387
+ + + P Y + +P+ R T +
Sbjct: 252 ---------------------EGTRMRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSEL 287
Query: 388 LQ 389
++
Sbjct: 288 VE 289
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 8e-41
Identities = 68/300 (22%), Positives = 115/300 (38%), Gaps = 51/300 (17%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGKI--VALKKVRFDTSEPESVKFMAREIRILQKL- 166
+ +G+G + V KAR + G A+K+++ S+ + F E+ +L KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 68
Query: 167 DHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICR---------------PGQKLTE 210
HPN+I L G + LYL ++ +L + + L+
Sbjct: 69 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 211 PQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270
Q+ + + G+ + ++ +HRD+ A N+L+ ++ + KIADFGLS K T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMF-IGRPLMPGRTEVEQLHRIFKLC 329
+ + + A E L S Y D+WS G LL E+ +G G T E ++
Sbjct: 185 MGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 239
Query: 330 GTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
PQ Y+ Y ++ P R + A L
Sbjct: 240 ------------------PQGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-39
Identities = 44/297 (14%), Positives = 104/297 (35%), Gaps = 46/297 (15%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQ 164
+ ++GQG++ VY+ + + VA+K V S E ++F+ E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMK 78
Query: 165 KLDHPNVIKLEGLATSRMQYSLYLVFDFMQ-SDLTKIICRPG---------QKLTEPQVK 214
+ + +V++L G ++ + M DL + + ++
Sbjct: 79 EFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 215 CYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSRVV 274
++ G+ + + +HRD+ A N ++ + +KI DFG++ + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 275 -TLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRIFKLCGTP 332
+ + +PE L + D+WS G +L E+ G + + L +
Sbjct: 197 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------ 249
Query: 333 SEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389
+ + P + ++ +P R + +
Sbjct: 250 -------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-38
Identities = 60/305 (19%), Positives = 117/305 (38%), Gaps = 53/305 (17%)
Query: 110 DSYDKLAKVGQGTYSNVYKARDRDTGK-------IVALKKVRFDTSEPESVKFMAREIRI 162
D +G+G + V A K VA+K ++ D +E + + E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEM 71
Query: 163 LQKL-DHPNVIKLEGLATSRMQYSLYLVFDFM-QSDLTKII---------------CRPG 205
++ + H N+I L G T LY++ ++ + +L + + P
Sbjct: 72 MKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 206 QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265
++L+ + Q+ G+++ + +HRD+ A N+L+ + ++KIADFGL+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 266 KGPLT-SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHR 324
T + + + + APE L Y D+WS G LL E+F VE+L +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 325 IFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTA 384
+ K + ++ Y ++ P+ R T
Sbjct: 249 LLK---------------------EGHRMDKPS---NCTNELYMMMRDCWHAVPSQRPTF 284
Query: 385 ASALQ 389
++
Sbjct: 285 KQLVE 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (256), Expect = 3e-26
Identities = 30/202 (14%), Positives = 68/202 (33%), Gaps = 30/202 (14%)
Query: 117 KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFM--------AREIRILQKLDH 168
+G+G S V+ +K + + + VK + + +
Sbjct: 7 LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 169 PNVIKLEGLATSRM--QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQH 226
+ KL+GLA ++ ++ + + + + + +L +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVR-------VENPDEVLDMILEEVAK 118
Query: 227 CHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLTSR---VVTLWYRAPEL 283
+ RGI+H D+ N+L+ + G + I DF S + + R + ++
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS---- 173
Query: 284 LLGSTDYGVGIDLWSAGCLLAE 305
Y D+ SA + +
Sbjct: 174 ----RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 469 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.51 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.22 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-61 Score=467.08 Aligned_cols=290 Identities=40% Similarity=0.706 Sum_probs=242.1
Q ss_pred eeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 114 KLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE---PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
.+++||+|+||+||+|+++.+|+.||||+++..... ....+.+.+|+.+|++++|||||++++++...+ .+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehh
Confidence 467899999999999999999999999999654322 122356889999999999999999999998754 469999
Q ss_pred ecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCcc
Q 036673 191 DFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPLT 270 (469)
Q Consensus 191 e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 270 (469)
||+.++++..+...+..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~ 158 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYT 158 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-cccc
Confidence 999998888887777789999999999999999999999999999999999999999999999999998754332 2344
Q ss_pred cccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC--
Q 036673 271 SRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP-- 348 (469)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-- 348 (469)
..+||+.|+|||++.....|+.++|||||||++|||++|.+||.+.++.+++.+|.+.++.|....|...........
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 678999999999987767789999999999999999999999999999999999999999988776655433222111
Q ss_pred CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCCCCCCC
Q 036673 349 QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDLSSLP 406 (469)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~ 406 (469)
......+......+++++.+||.+||+.||++||||.|+|+||||+..+.+.....+|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p 296 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCC
Confidence 1112334566678899999999999999999999999999999999887776555444
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-61 Score=460.33 Aligned_cols=260 Identities=29% Similarity=0.447 Sum_probs=214.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|+++.+|+.||||++..... .+..+.+.+|+.+|++++|||||++++++.+. ..+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeEE
Confidence 5789999999999999999999999999999999976532 23346688999999999999999999998874 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC-C
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ-K 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 266 (469)
|||||++ +|.+.+ .....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+.... .
T Consensus 81 vmEy~~gg~L~~~l-~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 81 FLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEeccCCCcHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999997 555554 455679999999999999999999999999999999999999999999999999998764332 2
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+||+.|+|||++.+...++.++|||||||+||||++|++||....+............
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~---------------- 223 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------------- 223 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC----------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------------
Confidence 3345678999999999998766567889999999999999999999987665443333222111
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.....+..+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 224 -------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 224 -------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 011223467899999999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-60 Score=452.61 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=217.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++++.||+|+||+||+|+++.+++.||||++..... .......+.+|+.+|+.++|||||++++++.+. ..+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEE
Confidence 3679999999999999999999999999999999864321 122346788999999999999999999998874 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||||||++ +|...+.. ...+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|.... .
T Consensus 83 ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~---~ 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 158 (263)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC---C
T ss_pred EEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC---C
Confidence 99999997 55555543 4579999999999999999999999999999999999999999999999999998653 2
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..+.+...
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------- 221 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---------------- 221 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------------
T ss_pred CcccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 33456789999999999876 5589999999999999999999999999888877776643210
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.+...+|+++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 222 ----------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 222 ----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 112357899999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-60 Score=455.38 Aligned_cols=256 Identities=26% Similarity=0.471 Sum_probs=219.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+.+ .+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~i 94 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWV 94 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--EEEE
Confidence 35799999999999999999999999999999999765332 2367889999999999999999999988754 5799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
|||||+| +|...+.. ..+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.+... ..
T Consensus 95 vmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~ 171 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QS 171 (293)
T ss_dssp EEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TC
T ss_pred EEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc-cc
Confidence 9999997 55544433 36999999999999999999999999999999999999999999999999999876433 23
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+..... +.
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~-------------- 235 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE-------------- 235 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC--------------
T ss_pred cccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC--------------
Confidence 3456789999999999876 5689999999999999999999999999888887776654321 10
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
......+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 236 --------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp --------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0123457899999999999999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-60 Score=451.82 Aligned_cols=258 Identities=29% Similarity=0.504 Sum_probs=210.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|++++|||||++++++.+.....+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 47899999999999999999999999999999999877666667788999999999999999999999988766667899
Q ss_pred EEecchh-hHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 189 VFDFMQS-DLTKIICR---PGQKLTEPQVKCYMQQLLSGLQHCHERG-----ILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
|||||++ +|.+.+.. .+..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999986 56555532 3457999999999999999999999876 9999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
.+... .......+||+.|+|||++.+ ..|+.++|||||||++|||+||++||.+.+..+....+....
T Consensus 163 ~~~~~-~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~---------- 230 (269)
T d2java1 163 ILNHD-TSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---------- 230 (269)
T ss_dssp HC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----------
T ss_pred ecccC-CCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----------
Confidence 76432 223456789999999998865 558999999999999999999999999988877776664421
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
+..+...+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 231 ---------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 231 ---------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 012234578999999999999999999999999999995
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-59 Score=452.55 Aligned_cols=286 Identities=41% Similarity=0.757 Sum_probs=241.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++++.||+|+||+||+|++..+|+.||||+++.........+.+.+|+.+|++++|||||++++++.+. ..+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--cceeEE
Confidence 689999999999999999999999999999999976544444457788999999999999999999999874 457999
Q ss_pred EecchhhHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQSDLTKIIC-RPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||+.++++..+. .....+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~~ 158 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT 158 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SBC
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC-ccc
Confidence 9999987766654 34567999999999999999999999999999999999999999999999999999875332 233
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
....+||+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+.+..+++..+.+.+..|...........
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 45668999999999988777778999999999999999999999999999999999999999988877766544332222
Q ss_pred ---CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 349 ---QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 349 ---~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
......+......++.++.+||.+||+.||++|||+.|+|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 22334455667788999999999999999999999999999999987443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-59 Score=446.53 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=213.0
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec--cccEEEEE
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR--MQYSLYLV 189 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~~~lv 189 (469)
|++.++||+|+||+||+|++..+++.||+|++..........+.+.+|+++|++++|||||++++++... ....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3777889999999999999999999999999987655666677899999999999999999999998653 34568999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEc-CCCcEEEeeecCcccccCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERG--ILHRDIKASNLLID-KSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~ 265 (469)
||||++ +|...+. ....+++..++.++.||+.||+|||+++ |+||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EeCCCCCcHHHHHh-ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc---
Confidence 999997 5545443 3457999999999999999999999998 99999999999997 47899999999998642
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+||+.|+|||++.+ .|+.++|||||||+||||++|++||.+......+.+.+... ..+
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-~~~------------ 231 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKP------------ 231 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCC------------
T ss_pred CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-CCC------------
Confidence 233457789999999998865 48999999999999999999999998766655544433211 111
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFN 394 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 394 (469)
..+...+++++.+||.+||+.||++|||++|+|+||||+
T Consensus 232 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 ----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 122345688999999999999999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-60 Score=453.85 Aligned_cols=258 Identities=27% Similarity=0.392 Sum_probs=218.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
+.|++++.||+|+||+||+|+++.+++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+ .+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--eEEEE
Confidence 57999999999999999999999999999999997543 234467889999999999999999999988744 57999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||++ +|...+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|....... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999997 5555555555679999999999999999999999999999999999999999999999999997642211 12
Q ss_pred cccccccCccccchhccC----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 269 LTSRVVTLWYRAPELLLG----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
....+||+.|+|||++.. ...|+.++|||||||+||||++|++||.+.+..+.+..+.+....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~------------- 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP------------- 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC-------------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 345789999999998842 345889999999999999999999999998888877776542110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.......+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 234 ----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 234 ----------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ----------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ----------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 01123457899999999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-59 Score=454.70 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=220.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
..|++++.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.+|++++|||||++++++.+. ..+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEEE
Confidence 359999999999999999999999999999999976543 344557789999999999999999999998874 45799
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
|||||.++++..+.....++++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|.....
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 999999877666655556899999999999999999999999999999999999999999999999999986532
Q ss_pred cccccccCccccchhccC--CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 269 LTSRVVTLWYRAPELLLG--STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
....+||+.|+|||++.+ ...|+.++|||||||++|||++|.+||.+.+..+.+..+......+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 233 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-------------- 233 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 345689999999999864 2358999999999999999999999999988888777665421110
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.....+|+++.+||.+||+.||.+|||++|+|+||||...
T Consensus 234 ----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 234 ----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ----------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ----------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 0123568899999999999999999999999999999763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8e-59 Score=458.54 Aligned_cols=263 Identities=26% Similarity=0.421 Sum_probs=226.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|++|+|||||++++++.+. ..+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 46899999999999999999999999999999999643 334457789999999999999999999998874 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC--CCcEEEeeecCcccccCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK--SGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 265 (469)
|||||+| +|.+.+......+++.+++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+.+..
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~-- 178 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 178 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc--
Confidence 9999986 777777666678999999999999999999999999999999999999964 57899999999987633
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+......+..
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 246 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------- 246 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-----------
T ss_pred ccccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 333557789999999999876 45899999999999999999999999999988888877654322211
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLAC 400 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 400 (469)
..+..+++++.+||.+||+.||.+|||++|+|+||||+....+.
T Consensus 247 -----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 247 -----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp -----------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred -----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 23356789999999999999999999999999999998765443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-59 Score=452.44 Aligned_cols=259 Identities=29% Similarity=0.441 Sum_probs=203.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.+.|++++.||+|+||+||+|+++.+++.||||++...... .....+.+|+.+|++++|||||++++++.+. ..+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESG--GHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS--SEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 36799999999999999999999999999999999765332 2235678999999999999999999998764 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc---CCCcEEEeeecCcccccCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID---KSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~ 264 (469)
|||||+| +|.+.+.. ...+++.++..++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 85 vmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~- 162 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP- 162 (307)
T ss_dssp EECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC-
Confidence 9999996 66666654 45799999999999999999999999999999999999994 578999999999987533
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+....+....+.+....++
T Consensus 163 -~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~----------- 229 (307)
T d1a06a_ 163 -GSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD----------- 229 (307)
T ss_dssp -----------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-----------
T ss_pred -CCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-----------
Confidence 233456789999999999876 4689999999999999999999999999888887777654322111
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
......+|+++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 230 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 230 -----------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -----------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -----------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 12345688999999999999999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-58 Score=445.87 Aligned_cols=282 Identities=40% Similarity=0.722 Sum_probs=239.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|+++++||+|+||+||+|+++ +++.||||+++.........+.+.+|+.+|++++|||||++++++...+ ..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--ceeEE
Confidence 68999999999999999999997 6899999999765444444577889999999999999999999888754 46999
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
|||+.++++..+......+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+|...... ....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKY 157 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC-cccc
Confidence 999999888888887788999999999999999999999999999999999999999999999999999875332 2234
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC-
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP- 348 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~- 348 (469)
....+++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++....+.+....|...........
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 4567899999999998777789999999999999999999999999999999999999999988777766544333211
Q ss_pred --CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 349 --QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 349 --~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.............+++.+.+||++||++||++|||+.|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 12223345566778999999999999999999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-58 Score=458.03 Aligned_cols=259 Identities=28% Similarity=0.485 Sum_probs=224.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|++..+|+.||||++.... ......+.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 467999999999999999999999999999999997542 3444678899999999999999999999876 445799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc--CCCcEEEeeecCcccccCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID--KSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~ 265 (469)
|||||+| +|.+.+.....++++.+++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+|..+..
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-- 181 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 181 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC--
Confidence 9999996 66666666666799999999999999999999999999999999999998 578999999999987743
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+||+.|+|||++.+ ..|+.++|||||||+||+|+||++||.+.+..+.+..+......++.
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 249 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----------- 249 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred CCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 334566789999999998876 56899999999999999999999999999998888887654322211
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..+..+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 250 -----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 -----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -----------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 2345689999999999999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=451.55 Aligned_cols=295 Identities=43% Similarity=0.713 Sum_probs=239.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc-----
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----- 182 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 182 (469)
..++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|++++||||+++++++....
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 358999999999999999999999999999999998766554445577889999999999999999999875532
Q ss_pred -ccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 183 -QYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 183 -~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
...+|+||||+.++++.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3458999999999888888777778999999999999999999999999999999999999999999999999999765
Q ss_pred cCCC---CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 036673 262 IPKQ---KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWK 338 (469)
Q Consensus 262 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 338 (469)
.... .......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..+....+.+....+.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 4322 2234456899999999999877779999999999999999999999999999999999999999888776655
Q ss_pred hcccCccCCC----CCCCCcchhcc--cCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCCCCCC
Q 036673 339 KMKLTTTFRP----QHYKPSFREVF--GEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPLACDL 402 (469)
Q Consensus 339 ~~~~~~~~~~----~~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~ 402 (469)
.......+.. ......+...+ ...++.+.+||.+||++||++||||.|+|+||||+..|.|.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~~ 317 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCCC
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCCC
Confidence 5433222111 11111111111 1246788999999999999999999999999999988776654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-59 Score=449.75 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=215.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++++.||+|+||+||+|+++.+++.||||++.... ......+.+.+|+.+|++++|||||++++++.+. ..+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEE
Confidence 367999999999999999999999999999999996432 1122346788999999999999999999988764 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC-
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ- 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 265 (469)
||||||+| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus 85 ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999997 55555443 4579999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.++.+...
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--------------- 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY--------------- 227 (288)
T ss_dssp ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---------------
T ss_pred ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC---------------
Confidence 223456789999999999876 4589999999999999999999999999888888777654210
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHH------HhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAAS------ALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~e------lL~hp~f~~~ 396 (469)
.+...+++++.+||.+||+.||.+|||++| +++||||+..
T Consensus 228 -----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 228 -----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp -----------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred -----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 122357899999999999999999999998 5889999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-59 Score=459.31 Aligned_cols=278 Identities=26% Similarity=0.421 Sum_probs=211.1
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
..++|++++.||+|+||+||+|++..+|+.||||+++.... ......+.+|+.+|++++|||||++++++.+.. .+|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--EEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEE
Confidence 45789999999999999999999999999999999976533 344567889999999999999999999998754 579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
||||||.| +|...+.+ ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 99999997 55555543 4579999999999999999999997 59999999999999999999999999999876432
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcc---
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQ-LHRIFKLCGTPSEDYWKKMK--- 341 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~--- 341 (469)
...+.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+. ...+....+.+.........
T Consensus 159 --~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2346799999999999987 4599999999999999999999999987654332 21111112211110000000
Q ss_pred -cCccC---CC------------CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 342 -LTTTF---RP------------QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 342 -~~~~~---~~------------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..... .+ ....+. .....++.++.+||.+||+.||.+||||+|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCC--CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCcc--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00000 00 000000 011236789999999999999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=445.07 Aligned_cols=261 Identities=26% Similarity=0.404 Sum_probs=221.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC----HHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE----PESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ....+.+.+|+.+|++++|||||++++++.+. .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--T 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 36799999999999999999999999999999999754221 22357788999999999999999999998774 4
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC----cEEEeeecCcc
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG----MLKIADFGLSN 259 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~ 259 (469)
.+|||||||++ +|.+.+.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|.
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 57999999996 55555544 35799999999999999999999999999999999999998876 49999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
..... .......||+.|+|||++.+ ..++.++|||||||+||||++|++||.+.+..+.+..+......+..
T Consensus 166 ~~~~~--~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----- 237 (293)
T d1jksa_ 166 KIDFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED----- 237 (293)
T ss_dssp ECTTS--CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH-----
T ss_pred hcCCC--ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc-----
Confidence 76332 33456789999999998876 56899999999999999999999999999988888777654322222
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
..+..+|+.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 238 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 238 -----------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp -----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred -----------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 23456789999999999999999999999999999998643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-58 Score=446.27 Aligned_cols=285 Identities=37% Similarity=0.648 Sum_probs=235.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeEeeeEeec--
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDT-GKIVALKKVRFDTSEPESVKFMAREIRILQKL---DHPNVIKLEGLATSR-- 181 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~-- 181 (469)
..++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 457899999999999999999999755 67899999976543333334456788777666 899999999988643
Q ss_pred -cccEEEEEEecchhhHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 182 -MQYSLYLVFDFMQSDLTKII-CRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 182 -~~~~~~lv~e~~~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
....++++|||+.++++... ......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 34568999999998665443 4455679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
.... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..+....+.+....|..
T Consensus 165 ~~~~--~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 165 IYSF--QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCG--GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhcc--cccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 6532 233457789999999998876 5689999999999999999999999999999999999999999888776654
Q ss_pred cccCc-cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 340 MKLTT-TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 340 ~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
..... .................+++.+.+||.+||++||++||||.|+|+||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 33221 111222233455566788999999999999999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-58 Score=450.77 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=220.3
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+.+|+.++|||||++++++.+. ..+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--ccc
Confidence 35789999999999999999999999999999999975311 122346788999999999999999999988774 467
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|+|||||+|+.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... ..
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-~~ 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-TT
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc-CC
Confidence 99999999754444444455799999999999999999999999999999999999999999999999999986533 23
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+.....
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~---------------- 222 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------------- 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC----------------
Confidence 34567899999999998876 5689999999999999999999999999988877776654211
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.++..+|+++.+||.+||++||.+|+ +++|+++||||+..
T Consensus 223 ----------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 223 ----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ----------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 12345789999999999999999999 49999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=449.41 Aligned_cols=282 Identities=36% Similarity=0.591 Sum_probs=239.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc----cc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM----QY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~ 184 (469)
.++|+++++||+|+||+||+|.++.+|+.||||+++.........+.+.+|+.+|+.++|||||++++++...+ ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47899999999999999999999999999999999876666666788999999999999999999999987643 23
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+|||||||+.++...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~-- 172 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-- 172 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC--
Confidence 5699999997777666544 469999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
...+..+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++..++.......
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 173 --SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp --SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred --CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 234567899999999999877778999999999999999999999999999999999999999999988877654321
Q ss_pred c-----CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 345 T-----FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 345 ~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
. ..+......+......+++.+.+||.+||+.||.+||||.|+|+||||+.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1 112223345556677889999999999999999999999999999999863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5e-58 Score=447.03 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=220.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+.+|+.+|+.++|||||++++++.+. ..+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--Ceee
Confidence 468999999999999999999999999999999996431 1122346788999999999999999999988764 4679
Q ss_pred EEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 188 LVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 188 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
+|||||.|+.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 9999999866666656666799999999999999999999999999999999999999999999999999987532
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.++.....
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------------- 218 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL----------------- 218 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----------------
T ss_pred ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----------------
Confidence 2446789999999998876 4589999999999999999999999999988888877764211
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.....+++++.+||.+||+.||.+|+ |++++|+||||+..
T Consensus 219 ---------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 219 ---------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ---------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 12235788999999999999999996 99999999999863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-57 Score=431.54 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=221.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC-------HHHHHHHHHHHHHHHhCC-CCCeeeEeeeEee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE-------PESVKFMAREIRILQKLD-HPNVIKLEGLATS 180 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 180 (469)
.++|++.+.||+|+||+||+|++..+++.||||++...... ....+.+.+|+.+|++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999999999999999999765322 122356889999999996 9999999999876
Q ss_pred ccccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcc
Q 036673 181 RMQYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSN 259 (469)
Q Consensus 181 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 259 (469)
...+|||||||++ +|.+.+.. ..++++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred --CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 4568999999986 66666654 4579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCccccchhccC-----CCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLG-----STDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSE 334 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 334 (469)
.+... ......+||+.|+|||++.+ ...++.++|||||||+||+|++|++||.+.+..+....+......+.
T Consensus 159 ~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~- 235 (277)
T d1phka_ 159 QLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG- 235 (277)
T ss_dssp ECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-
T ss_pred EccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC-
Confidence 76443 23456789999999998752 34578899999999999999999999999998888777765321111
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
......+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus 236 ---------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 ---------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ---------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ---------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 0123468899999999999999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-57 Score=445.13 Aligned_cols=277 Identities=38% Similarity=0.642 Sum_probs=233.2
Q ss_pred CcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec----cccEE
Q 036673 111 SYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR----MQYSL 186 (469)
Q Consensus 111 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~~~ 186 (469)
+|+.+++||+|+||+||+|++..+|+.||||++..... .+.+|+.+|++++||||+++++++... +..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999975432 234799999999999999999988543 34568
Q ss_pred EEEEecchhhHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-cEEEeeecCccccc
Q 036673 187 YLVFDFMQSDLTKII---CRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFI 262 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 262 (469)
|||||||++++...+ ......+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||++..+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999998765554 34556799999999999999999999999999999999999999775 89999999998764
Q ss_pred CCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.. ......+||+.|+|||++.+...|+.++|||||||++|||++|++||...+..+++..+++.++.+....|.....
T Consensus 175 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 32 3345678999999999988777799999999999999999999999999999999999999999999888877543
Q ss_pred Ccc---CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 343 TTT---FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 343 ~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
... +......+........+++++.+||.+||++||++||||.|+|+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 211 11111112222334568899999999999999999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-57 Score=440.64 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=223.5
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||+||+|+++.+++.||||+++... .....+.+|+.+|+.++|||||++++++.+. ..+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM--EELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEE
Confidence 478999999999999999999999999999999997542 2235678999999999999999999998874 45799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC--CcEEEeeecCcccccCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS--GMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 265 (469)
|||||+| +|.+.+...+..+++.+++.|+.||+.||+|||++||+||||||+|||++.+ ..+||+|||++.....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 9999996 7777776666679999999999999999999999999999999999999854 4899999999987632
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|.+....++..
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 225 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE---------- 225 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH----------
T ss_pred CCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh----------
Confidence 233456788999999998865 558999999999999999999999999999998888887654443332
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 226 ------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 226 ------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 334578999999999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-57 Score=448.07 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=218.0
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+.+|+.+|+.++|||||++++++... ..++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc--cccc
Confidence 578999999999999999999999999999999986431 1122346788999999999999999999988774 4579
Q ss_pred EEEecchhh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
+||||+.++ +...+.. ...+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 118 ~v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred cccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 999999974 4454443 45799999999999999999999999999999999999999999999999999987632
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
.....+||+.|||||++.+ ..|+.++|||||||+||||+||++||.+.+....+..+.....
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------------- 255 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------------- 255 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred -ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC----------------
Confidence 2446789999999999876 5689999999999999999999999999988888877754211
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNAS 396 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 396 (469)
.....+++++.+||++||+.||.+|+ |++++|+||||+..
T Consensus 256 ----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 256 ----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ----------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 11235789999999999999999995 99999999999863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.8e-57 Score=448.36 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=210.9
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCC----CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDT----SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
+.++|++++.||+|+||+||+|++..+|+.||||++.... ...........|+.+++.++|||||++++++...
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-- 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-- 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--
Confidence 3578999999999999999999999999999999986431 1122222334457788888999999999988774
Q ss_pred cEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCccccc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFI 262 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 262 (469)
..+|||||||.| +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+.
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred CEEEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 457999999996 55555544 4579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 263 PKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.. .....+||+.|+|||++.....|+.++|||||||+||||+||++||.+....+... +.......
T Consensus 159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~---------- 224 (364)
T d1omwa3 159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM---------- 224 (364)
T ss_dssp SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSC----------
T ss_pred CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccC----------
Confidence 32 34567899999999998766678999999999999999999999998755433222 11111110
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCC-----HHHHhcCccCCCC
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGT-----AASALQNEFFNAS 396 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 396 (469)
.......+++++.+||.+||+.||.+||| |+|+|+||||+.-
T Consensus 225 ------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 225 ------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp ------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred ------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 01223468899999999999999999999 7999999999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=425.59 Aligned_cols=283 Identities=40% Similarity=0.705 Sum_probs=241.0
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|+++++||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++||||+++++++.... ..++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--ceeEE
Confidence 6899999999999999999999999999999999877666666788999999999999999999999887754 46899
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCCc
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGPL 269 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 269 (469)
++++.++++..+......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-~~~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-CSCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC-Cccc
Confidence 999999777777777778999999999999999999999999999999999999999999999999999876432 2234
Q ss_pred ccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCC
Q 036673 270 TSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPL-MPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRP 348 (469)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 348 (469)
....+++.|+|||++.+...++.++|||||||++|||++|+.| |.+.+..+++..+....+.+....|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 4556789999999988767789999999999999999998866 667777888888888888887766655443332222
Q ss_pred ---CCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 349 ---QHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 349 ---~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.............+++.+.+||.+||+.||.+||||+|+|+||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 12223344556678999999999999999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=433.69 Aligned_cols=288 Identities=33% Similarity=0.557 Sum_probs=237.6
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecc---cc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRM---QY 184 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~ 184 (469)
..++|+++++||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|++|+||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 3468999999999999999999999999999999997543 4455677889999999999999999999886543 23
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+||+++++.++|.+.+.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|......
T Consensus 85 ~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 4678888777788887754 36999999999999999999999999999999999999999999999999999875433
Q ss_pred CC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 265 QK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 265 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
.. ......+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..++...+...+..+..........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 2345678999999999987767789999999999999999999999999999999999888888887665433221
Q ss_pred C-----ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCCC
Q 036673 343 T-----TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASPL 398 (469)
Q Consensus 343 ~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 398 (469)
. ....+......+...++.+++++.+||.+||+.||.+||||.|+|+||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 1 0112233345566777889999999999999999999999999999999986433
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-56 Score=424.27 Aligned_cols=256 Identities=20% Similarity=0.310 Sum_probs=211.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|+.. ..||||+++.........+.|.+|+.+|.+++|||||++++++... .++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~---~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---QLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc---EEEE
Confidence 468999999999999999999764 3599999987665566678899999999999999999999987543 3689
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC-
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK- 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 266 (469)
|||||++ +|.+.+......+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999995 77777766667899999999999999999999999999999999999999999999999999987643322
Q ss_pred CCcccccccCccccchhccCC--CCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 267 GPLTSRVVTLWYRAPELLLGS--TDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..++.....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~------------- 227 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL------------- 227 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC-------------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-------------
Confidence 234567899999999998643 34789999999999999999999999988777666555442211
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.+.+......+|+++.+||.+||+.||.+|||+.|++++
T Consensus 228 -------~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 228 -------SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -------CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 223345566789999999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-56 Score=432.62 Aligned_cols=255 Identities=28% Similarity=0.458 Sum_probs=214.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHH-hCCCCCeeeEeeeEeeccccEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQ-KLDHPNVIKLEGLATSRMQYSLY 187 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~~~ 187 (469)
++|++++.||+|+||+||+|+++.+++.||||+++.... .....+.+..|+.++. .++|||||++++++.+. ..+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 689999999999999999999999999999999974311 1122345667777665 68999999999998874 4579
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||||||++ +|...+ .....+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 80 ivmEy~~~g~L~~~i-~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~ 157 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-D 157 (320)
T ss_dssp EEEECCTTCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEEeecCCCcHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-c
Confidence 99999997 555544 44557999999999999999999999999999999999999999999999999999865432 2
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+... .+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------------- 220 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------------- 220 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC--------------
T ss_pred ccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC--------------
Confidence 33456789999999999876 45899999999999999999999999999888877776431 11
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHH-HHhcCccCCC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAA-SALQNEFFNA 395 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~-elL~hp~f~~ 395 (469)
.+...+|+++.+||.+||+.||.+|||+. ++++||||+.
T Consensus 221 ----------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 221 ----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred ----------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 11235789999999999999999999995 8999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-56 Score=436.66 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=208.7
Q ss_pred ccCcceec-eeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEee--cccc
Q 036673 109 ADSYDKLA-KVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATS--RMQY 184 (469)
Q Consensus 109 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~ 184 (469)
.++|+++. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 47899875 599999999999999999999999999632 4567899987654 89999999998865 3456
Q ss_pred EEEEEEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC---CCcEEEeeecCcc
Q 036673 185 SLYLVFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---SGMLKIADFGLSN 259 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~ 259 (469)
.+|||||||+| +|.+.+... ...+++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 78999999985 777777654 356999999999999999999999999999999999999986 4679999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
..... ......+||+.|+|||++.+ ..|+.++|||||||+||+|+||++||.+.+..+....+........
T Consensus 163 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------ 233 (335)
T d2ozaa1 163 ETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------ 233 (335)
T ss_dssp ECCCC--CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS------
T ss_pred eccCC--CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC------
Confidence 76433 33457789999999998865 5689999999999999999999999988766555444332111000
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
..+. ...+..+|+++.+||.+||+.||++|||+.|+|+||||...
T Consensus 234 ---------~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 ---------YEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ---------SSCC---TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ---------CCCC---CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0000 01234578999999999999999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=428.75 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=205.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHhCC--CCCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEP----ESVKFMAREIRILQKLD--HPNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~ 182 (469)
.++|++.+.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999999999999999997542111 11233568999999996 899999999987744
Q ss_pred ccEEEEEEecchh--hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-CCcEEEeeecCcc
Q 036673 183 QYSLYLVFDFMQS--DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-SGMLKIADFGLSN 259 (469)
Q Consensus 183 ~~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~ 259 (469)
.+|+||||+.+ ++...+. .+..+++.+++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||+|.
T Consensus 83 --~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 --SFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp --EEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --eEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 57999999975 4444443 3457999999999999999999999999999999999999985 4799999999998
Q ss_pred cccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 260 FFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
.... ...+..+||+.|+|||++.+...++.++|||||||+||||++|++||.+.+ .+... ..
T Consensus 160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~------- 221 (273)
T d1xwsa_ 160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QV------- 221 (273)
T ss_dssp ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CC-------
T ss_pred eccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--cc-------
Confidence 6532 334567899999999998776666788999999999999999999997532 12111 00
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.+...+|+++.+||.+||+.||++|||++|+|+||||+..
T Consensus 222 -----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 222 -----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1223578999999999999999999999999999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=434.99 Aligned_cols=281 Identities=31% Similarity=0.527 Sum_probs=226.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec----cccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR----MQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~~ 185 (469)
++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|++++|||||++++++... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 689999999999999999999999999999999987766667777899999999999999999999998654 2367
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+|+|||||.++++..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~-- 171 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 171 (355)
T ss_dssp EEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc--
Confidence 89999999998888774 3699999999999999999999999999999999999999999999999999886532
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+......+++...+.+..++|........
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred ccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 333456789999999999876 5689999999999999999999999999999999999999999988888766432110
Q ss_pred --------CCCC--------CCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCC
Q 036673 346 --------FRPQ--------HYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNAS 396 (469)
Q Consensus 346 --------~~~~--------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 396 (469)
.... ...+........+++++.+||++||+.||++||||+|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000 00000111122346788999999999999999999999999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-55 Score=430.82 Aligned_cols=283 Identities=38% Similarity=0.590 Sum_probs=234.6
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeec----ccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSR----MQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~ 184 (469)
.++|+++++||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|++++|||||++++++... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4689999999999999999999999999999999987666666677889999999999999999999988543 223
Q ss_pred EEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 185 SLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 185 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
..+++++++.++|.+.+.. .++++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence 3456666555677766643 469999999999999999999999999999999999999999999999999997642
Q ss_pred CCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 265 QKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
.......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+....+.......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 234567899999999998877778999999999999999999999999999999999999999888877655432211
Q ss_pred -----cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCCCC
Q 036673 345 -----TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNASP 397 (469)
Q Consensus 345 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 397 (469)
..........+...+..+++++.+||.+||+.||.+||||.|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 01112223445566678899999999999999999999999999999998743
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.1e-55 Score=427.14 Aligned_cols=278 Identities=30% Similarity=0.531 Sum_probs=222.0
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEE
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~ 186 (469)
..++|+++++||+|+||+||+|++..+++.||||+++... .+.+.+|+.+|..++ ||||+++++++.......+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 3478999999999999999999999999999999986432 356789999999995 9999999999987767778
Q ss_pred EEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC-cEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG-MLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 265 (469)
++|||||.++.+..+. ..+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|......
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 9999999986554432 4699999999999999999999999999999999999998765 6999999999876433
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhh-cccC
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGR-TEVEQLHRIFKLCGTPSEDYWKK-MKLT 343 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~-~~~~ 343 (469)
......++|+.|+|||++.+...++.++|||||||++|+|++|+.||... +..++...+...++.+....+.. ....
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 33456789999999999887777899999999999999999999998654 45566666776666543222211 1111
Q ss_pred cc-----CCCCCCCCcc-----hhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccCCC
Q 036673 344 TT-----FRPQHYKPSF-----REVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFFNA 395 (469)
Q Consensus 344 ~~-----~~~~~~~~~~-----~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~~ 395 (469)
.. .........+ ......+++++.+||++||++||++||||+|+|+||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 0000111111 1123457899999999999999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.8e-55 Score=418.26 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=210.8
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc--cE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTS-EPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ--YS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~ 185 (469)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|+.++|||||++++++..... ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4789999999999999999999999999999999976533 45556789999999999999999999998876543 45
Q ss_pred EEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 186 LYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 186 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
+|||||||+|+.+........++++.+++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 79999999975544444444579999999999999999999999999999999999999999999999999987653322
Q ss_pred C--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccC
Q 036673 266 K--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLT 343 (469)
Q Consensus 266 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 343 (469)
. ......+||+.|+|||++.+ ..++.++|||||||++|||+||++||.+.+..+.+.+++.....+
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~----------- 233 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----------- 233 (277)
T ss_dssp -------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----------
T ss_pred ccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC-----------
Confidence 2 23456789999999999876 468999999999999999999999999998888877765432211
Q ss_pred ccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCccC
Q 036673 344 TTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNEFF 393 (469)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f 393 (469)
.....+.+|+++.+||.+||+.||.+||+..+.|.|+|+
T Consensus 234 -----------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 -----------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp -----------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -----------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 113345789999999999999999999965555556665
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=408.61 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=198.7
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++++.||+|+||+||+|++.+ ++.||||+++...... +.+.+|+.++++++|||||+++|++...+. ++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~--~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSS--CEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCc--eEEE
Confidence 579999999999999999999874 7789999997654332 568899999999999999999999987544 5999
Q ss_pred Eecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCCC
Q 036673 190 FDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKGP 268 (469)
Q Consensus 190 ~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 268 (469)
||||++ +|.+.+......+++..+..++.||+.||+|||+++|+||||||+||||+.++++||+|||+++.........
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999986 5666666666779999999999999999999999999999999999999999999999999998765444444
Q ss_pred cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCC
Q 036673 269 LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFR 347 (469)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 347 (469)
.....||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||...+..+.+..+......
T Consensus 159 ~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---------------- 221 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------------- 221 (263)
T ss_dssp ------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC----------------
T ss_pred ecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC----------------
Confidence 455678999999998876 458999999999999999999 57888777777666665442111
Q ss_pred CCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 348 PQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....+++++.+||.+||+.||++|||++|+|+|
T Consensus 222 ---------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 ---------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0123467899999999999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-54 Score=415.86 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=206.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|++..+++.||||+++..... .+.+.+|+.+|++++|||||++++++.+.+ .++|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCC--eeEE
Confidence 36799999999999999999999999999999999755433 356889999999999999999999987654 4699
Q ss_pred EEecchh-hHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|||||++ ++...+.. ....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999996 66666644 345799999999999999999999999999999999999999999999999999987654443
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
.......||+.|+|||++.+ ..|+.++|||||||++|||++|..||....+...+..++.....
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~--------------- 234 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------------- 234 (287)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC---------------
T ss_pred eeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC---------------
Confidence 33445568999999998876 45899999999999999999966555444444444433321111
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+ .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 235 ------~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 235 ------M---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------C---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1 123457899999999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=411.10 Aligned_cols=253 Identities=23% Similarity=0.407 Sum_probs=208.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|+++ +++.||||+++..... .+.|.+|+.+|.+++|||||++++++... .++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeeccC---CeEE
Confidence 368999999999999999999986 4789999999754433 35688999999999999999999987543 3589
Q ss_pred EEecchhh-HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQSD-LTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~~-l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|||||+++ |.+.+... ..++++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999974 44444322 23599999999999999999999999999999999999999999999999999998755444
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......||+.|+|||++.+ ..++.++|||||||+||||+| |.+||...+..+.+..+......
T Consensus 165 ~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-------------- 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------- 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 44556788999999998875 458999999999999999999 56777777766666555332110
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc--CccCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ--NEFFN 394 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~--hp~f~ 394 (469)
.....+++++.+||.+||+.||++|||+.++++ |+||.
T Consensus 230 -----------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 -----------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 112357889999999999999999999999998 78885
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-53 Score=411.90 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=199.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGK---IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.++|++.+.||+|+||+||+|+++.+++ .||||++.... .....+.|.+|+.+|++++|||||+++|++.... .
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--P 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--S
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--E
Confidence 4689999999999999999999987654 68899886543 3455677999999999999999999999987654 4
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
++||||||++ +|...+......+++.++..++.||+.||.|||+++|+||||||+||||+.++++||+|||+|+.+...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 6999999997 455556665667999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCC----cccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 036673 265 QKGP----LTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKK 339 (469)
Q Consensus 265 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 339 (469)
.... .....+|+.|+|||++.+ ..++.++|||||||+||||+| |++||.+.+..+.+..+......
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-------- 252 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-------- 252 (299)
T ss_dssp --------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred CCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 2211 223457899999998876 468999999999999999998 89999998888777666432111
Q ss_pred cccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 340 MKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....++.++.+||.+||+.||.+|||+.|++++
T Consensus 253 -----------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 -----------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1123578899999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=409.52 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=211.5
Q ss_pred ccCcceece-eeeeCCeEEEEEEECC--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 109 ADSYDKLAK-VGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 109 ~~~y~~~~~-lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
.++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+.|.+|+.+|.+++|||||++++++... .
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---A 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---e
Confidence 356888874 9999999999998764 3558999999754 3455667899999999999999999999988643 3
Q ss_pred EEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+|||||||++ +|...+...+..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 6899999996 666666666678999999999999999999999999999999999999999999999999999876443
Q ss_pred CC--CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 265 QK--GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 265 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+....+.+...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~----------- 230 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----------- 230 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----------
T ss_pred ccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 22 22335578999999998875 458999999999999999998 9999998887776665533110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHH---hcCccCC
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA---LQNEFFN 394 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~el---L~hp~f~ 394 (469)
+ .....+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 231 -----------~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 -----------M---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----------C---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------C---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0 1234678999999999999999999999877 6788874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=401.97 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=214.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|+++++||+|+||+||+|+++ +++.||||+++...... +.+.+|+.++.+++|||||++++++.... .+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~--~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR--PIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSS--SEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCC--ceEE
Confidence 368999999999999999999986 58899999998654443 56889999999999999999999987644 4799
Q ss_pred EEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC
Q 036673 189 VFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG 267 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 267 (469)
||||+.+ ++...+......+++..+..++.||++||+|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999985 566666666677999999999999999999999999999999999999999999999999999876555444
Q ss_pred CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccC
Q 036673 268 PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTF 346 (469)
Q Consensus 268 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 346 (469)
......+|+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+......
T Consensus 157 ~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--------------- 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------------- 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---------------
T ss_pred eecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 5556788999999998875 458999999999999999998 89999999888777666542111
Q ss_pred CCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 347 RPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
......++++.+||.+||+.||++|||+.++|+|
T Consensus 221 ----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 ----------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123467899999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=412.01 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=200.4
Q ss_pred ceeeeeCCeEEEEEEECC--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEEecc
Q 036673 116 AKVGQGTYSNVYKARDRD--TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVFDFM 193 (469)
Q Consensus 116 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 193 (469)
++||+|+||+||+|.+.. +++.||||+++.........+.+.+|+.+|++++|||||++++++... ..+||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEEEEEcC
Confidence 469999999999998653 457899999976655556667899999999999999999999988543 258999999
Q ss_pred hhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC--Cccc
Q 036673 194 QSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG--PLTS 271 (469)
Q Consensus 194 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~~~~ 271 (469)
+++.+..+......+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...... ....
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 97444444444567999999999999999999999999999999999999999999999999999876433221 2234
Q ss_pred ccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCccCCCCC
Q 036673 272 RVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQH 350 (469)
Q Consensus 272 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (469)
..||+.|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+....+.+...
T Consensus 170 ~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~-------------------- 228 (277)
T d1xbba_ 170 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------------------- 228 (277)
T ss_dssp -CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------------------
T ss_pred cCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence 578999999998876 458999999999999999998 8999998887766655532110
Q ss_pred CCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHH---hcCccCC
Q 036673 351 YKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASA---LQNEFFN 394 (469)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~el---L~hp~f~ 394 (469)
+ .....+|+++.+||.+||+.||++|||++++ |+|+|++
T Consensus 229 --~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 --M---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp --C---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --C---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 0 1234578999999999999999999999988 5676653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=414.92 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=205.6
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCc-----EEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGK-----IVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 183 (469)
++|++.++||+|+||+||+|++..+++ .||||++..... ......+.+|+.+|.++ +|||||++++++....
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 689999999999999999999876543 699999865432 23346788999999998 8999999999988754
Q ss_pred cEEEEEEecchh-hHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 036673 184 YSLYLVFDFMQS-DLTKIICRPG----------------------QKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKAS 240 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 240 (469)
.+|||||||++ +|.+.+.... ..+++..++.++.||+.||+|||+++||||||||+
T Consensus 115 -~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 115 -PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp -SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred -eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 46999999996 6666664432 24899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCCh
Q 036673 241 NLLIDKSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTE 318 (469)
Q Consensus 241 NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~ 318 (469)
|||++.++.+||+|||+|+........ ......||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876443322 2335678999999998875 458999999999999999998 8999998777
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 319 VEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 319 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.+.+.+++.....+ .....+|+++.+||.+||+.||++|||++|+++|
T Consensus 273 ~~~~~~~~~~~~~~------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKM------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCC------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCC------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66666655422111 1223578899999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=402.93 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=199.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDT---GKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 186 (469)
++|++.+.||+|+||+||+|++..+ +..||||+++.. ......+.+.+|+.+|++++|||||++++++.. ..+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeE
Confidence 6899999999999999999998754 356889988543 344556779999999999999999999998854 246
Q ss_pred EEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCC
Q 036673 187 YLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQ 265 (469)
Q Consensus 187 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 265 (469)
|+||||+.+ ++...+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999996 5556666666679999999999999999999999999999999999999999999999999998765444
Q ss_pred CCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCc
Q 036673 266 KGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTT 344 (469)
Q Consensus 266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 344 (469)
........||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------------- 228 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------- 228 (273)
T ss_dssp --------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------------
T ss_pred ceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 444556678999999998875 458999999999999999998 89999998887777666432110
Q ss_pred cCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 345 TFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
...+.+|+++.+||.+||+.||.+|||+.|+++|
T Consensus 229 ------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 ------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1234678999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=400.16 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=202.9
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++.+.||+|+||+||+|++..+ +.||||+++...... +.|.+|+.+|++++|||||++++++.+. .+++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEecC---CeEE
Confidence 36899999999999999999999864 679999997654432 5688999999999999999999988542 2589
Q ss_pred EEecchhh-HHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQSD-LTKIICR-PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~~-l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
|||||.++ +...+.. ....+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.+.....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999974 4444433 234699999999999999999999999999999999999999999999999999987654444
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
.......||+.|+|||++.. ..++.++|||||||+||||++| .+||.+....+.+..+......
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------------- 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 233 (285)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred eeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 44556788999999998875 4589999999999999999995 6667777776666655432111
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc--CccCCC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ--NEFFNA 395 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~--hp~f~~ 395 (469)
.....+++++.+||.+||+.||++|||++++++ ++||..
T Consensus 234 -----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 234 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 123467899999999999999999999999988 888875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=396.07 Aligned_cols=251 Identities=19% Similarity=0.319 Sum_probs=196.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCC----cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTG----KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
+.|++.++||+|+||+||+|.++.++ ..||||++.... .......|.+|+.+|.+++|||||+++|++.... .
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~--~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--P 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--S
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC--c
Confidence 57999999999999999999987654 479999996543 3444567889999999999999999999987644 4
Q ss_pred EEEEEecchhh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQSD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
+++|||||.++ +...+......+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 69999999975 44555556667999999999999999999999999999999999999999999999999999876433
Q ss_pred CCC--CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc
Q 036673 265 QKG--PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMK 341 (469)
Q Consensus 265 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 341 (469)
... ......||+.|+|||++.+ ..++.++|||||||+||||+++ .+||...+..+.+..+......
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---------- 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---------- 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred CccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC----------
Confidence 222 2334568999999998876 4689999999999999999995 5556655555555444321110
Q ss_pred cCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 342 LTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....++.++.+||.+||+.||++|||+.|+++
T Consensus 233 ---------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 ---------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ---------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 122357789999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=415.73 Aligned_cols=262 Identities=26% Similarity=0.459 Sum_probs=212.2
Q ss_pred ccCcceeceeeeeCCeEEEEEEE---CCCCcEEEEEEeecCC--CCHHHHHHHHHHHHHHHhCCC-CCeeeEeeeEeecc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARD---RDTGKIVALKKVRFDT--SEPESVKFMAREIRILQKLDH-PNVIKLEGLATSRM 182 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~ 182 (469)
.++|++++.||+|+||+||+|++ +.+|+.||||+++... ......+.+.+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47899999999999999999997 4468999999986432 112223567789999999977 89999998887754
Q ss_pred ccEEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccc
Q 036673 183 QYSLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFF 261 (469)
Q Consensus 183 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 261 (469)
.++++|||+.+ +|...+ .....+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+
T Consensus 103 --~~~~v~e~~~~~~L~~~i-~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 --KLHLILDYINGGELFTHL-SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp --EEEEEECCCCSCBHHHHH-HHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred --ceeeeeecccccHHHHHH-HhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 57999999997 454444 44456899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCcccccccCccccchhccCCC-CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 262 IPKQKGPLTSRVVTLWYRAPELLLGST-DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
............|++.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+....+.
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~------- 252 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------- 252 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-------
Confidence 544444456778999999999987543 468899999999999999999999988765555544443211000
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCC-----CHHHHhcCccCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRG-----TAASALQNEFFNA 395 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~ 395 (469)
+ .....+++++.+||.+||++||.+|| |++|+|+||||+.
T Consensus 253 ------------~---~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 253 ------------P---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp ------------C---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ------------C---CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 0 12345789999999999999999999 5899999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=404.06 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=202.6
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGK----IVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYS 185 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 185 (469)
++|+++++||+|+||+||+|.+..+|+ .||+|+++... .....+.+.+|+.+|++++|||||++++++.+..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 579999999999999999999988776 58888875432 2334577899999999999999999999987643
Q ss_pred EEEEEecch-hhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCC
Q 036673 186 LYLVFDFMQ-SDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPK 264 (469)
Q Consensus 186 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 264 (469)
.+++++|+. ++++..+......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 366677776 5788888777778999999999999999999999999999999999999999999999999999876543
Q ss_pred CCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Q 036673 265 QKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKL 342 (469)
Q Consensus 265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 342 (469)
... ......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+....+......
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~----------- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----------- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-----------
T ss_pred cccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 332 2334568999999998876 458999999999999999998 89999887766655544332111
Q ss_pred CccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcCc
Q 036673 343 TTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQNE 391 (469)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 391 (469)
.....+++.+.+||.+||+.||.+|||+.|+++|-
T Consensus 233 --------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 233 --------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp --------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 11235688999999999999999999999999883
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=393.16 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=199.3
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC-CC--cEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeecccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD-TG--KIVALKKVRFDT-SEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 184 (469)
.++|++++.||+|+||+||+|++.. ++ ..||||++.... ...+..+.|.+|+.+|++++|||||+++|++.+.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--- 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---
Confidence 3679999999999999999998753 23 378999987553 2334557899999999999999999999998653
Q ss_pred EEEEEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccC
Q 036673 185 SLYLVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIP 263 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 263 (469)
.+++|||||++ ++.+.+......+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 35899999985 66666655556799999999999999999999999999999999999999999999999999987644
Q ss_pred CCCC--CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 264 KQKG--PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 264 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
.... ......+++.|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+.+..+.+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 234 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 234 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred CCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--------
Confidence 3322 2234467889999998876 568999999999999999998 899999999888887765421111
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+|+++.+||.+||..||++|||+.++++
T Consensus 235 ----------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 ----------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123467899999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=395.90 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=196.9
Q ss_pred cCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 183 (469)
++|+++++||+|+||+||+|++.. +++.||||+++... .....+.+.+|+.++.++ .|+||+.+++++....
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~- 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC-
Confidence 679999999999999999999764 34789999987543 334456677888888777 6899999988776543
Q ss_pred cEEEEEEecchh-hHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCC
Q 036673 184 YSLYLVFDFMQS-DLTKIICRP---------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKS 247 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~ 247 (469)
..+++|||||++ +|...+... ...+++.++..++.||+.||+|||+++|+||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 346999999996 566655432 2358999999999999999999999999999999999999999
Q ss_pred CcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 036673 248 GMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRI 325 (469)
Q Consensus 248 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg-~~pf~~~~~~~~~~~i 325 (469)
+++||+|||+|+........ .....+||+.|+|||++.+ ..++.++|||||||++|||+|| .+||.+....+.+..+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999876443322 3445689999999998876 4589999999999999999986 6788877665555554
Q ss_pred HHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 326 FKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
+.....+ .....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 250 ~~~~~~~------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRM------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCC------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCC------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4321111 1234578899999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-50 Score=391.94 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=207.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.++|++++.||+|+||+||+|+++. +++.||||+++.. ......+.+.+|+.+|++++||||+++++++....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~- 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK- 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC-
Confidence 4689999999999999999999763 4679999998754 34455678999999999999999999999987754
Q ss_pred cEEEEEEecchh-hHHHHHhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 036673 184 YSLYLVFDFMQS-DLTKIICRP-----------------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKA 239 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~-----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 239 (469)
.++++|||+.+ +|.+.+... ...+++..+..++.||+.||+|||+++||||||||
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 90 -PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp -SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred -ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 46999999986 555555321 12489999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC-CCCCCCCC
Q 036673 240 SNLLIDKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRT 317 (469)
Q Consensus 240 ~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg-~~pf~~~~ 317 (469)
+||||+.++++||+|||+|+.+..... .......+|+.|+|||++.+ ..|+.++|||||||+||||++| .+||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999986543322 23345678999999998876 5589999999999999999998 57899888
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 318 EVEQLHRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 318 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..+.+..+..... ......+++++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~e~~~~v~~~~~-------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNI-------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCC-------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCC-------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8887776543210 1223467889999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=384.94 Aligned_cols=245 Identities=23% Similarity=0.389 Sum_probs=196.1
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEE
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 188 (469)
.++|++++.||+|+||.||+|+++ |..||||+++... ..+.+.+|+++|++++|||||+++|++.+.. ..+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEE
Confidence 467999999999999999999985 7899999996432 2366889999999999999999999886543 23699
Q ss_pred EEecchh-hHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCC
Q 036673 189 VFDFMQS-DLTKIICRP-GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 189 v~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 266 (469)
||||+++ +|.+.+... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--- 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC---
Confidence 9999986 566665432 23589999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 267 GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
......+|+.|+|||++.+ ..++.++|||||||++|||+| |++||...+..+....+.+..
T Consensus 156 -~~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~---------------- 217 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 217 (262)
T ss_dssp -------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------
T ss_pred -CCccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 2334577999999998876 458999999999999999998 799998877766665543210
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.+ .....+++++.+||.+||..||.+|||+.+++++
T Consensus 218 ------~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 ------KM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CC---CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11 2234578999999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-50 Score=387.71 Aligned_cols=262 Identities=18% Similarity=0.242 Sum_probs=206.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLV 189 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 189 (469)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+..|+++++.++|+|++..+..+... ....++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence 6799999999999999999999999999999998765433 3467899999999888766655544433 3456899
Q ss_pred EecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC---CCcEEEeeecCcccccCCCC
Q 036673 190 FDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK---SGMLKIADFGLSNFFIPKQK 266 (469)
Q Consensus 190 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~~ 266 (469)
|||+++++...+......+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.+.....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999999988888777778999999999999999999999999999999999999864 45799999999987644332
Q ss_pred C------CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 036673 267 G------PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCGTPSEDYWKKM 340 (469)
Q Consensus 267 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 340 (469)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|++||...........+......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--------- 231 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--------- 231 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH---------
T ss_pred ccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc---------
Confidence 1 2345689999999998876 45899999999999999999999999876655444333221100
Q ss_pred ccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHH---HHhcCccCCC
Q 036673 341 KLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAA---SALQNEFFNA 395 (469)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~---elL~hp~f~~ 395 (469)
............+|+++.+||.+||+.||.+||++. ++|+|+|.+.
T Consensus 232 ---------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 232 ---------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ---------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 001112234557899999999999999999999986 5678887643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=387.54 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=202.4
Q ss_pred CccCcceeceeeeeCCeEEEEEEECCCCcE--EEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeecccc
Q 036673 108 SADSYDKLAKVGQGTYSNVYKARDRDTGKI--VALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQY 184 (469)
Q Consensus 108 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 184 (469)
..++|++.++||+|+||+||+|+++.++.. ||||++..... .+..+.+.+|+++|.++ +|||||++++++... .
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~ 84 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 84 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--T
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--C
Confidence 457899999999999999999999988764 67777754322 23456789999999999 799999999998874 4
Q ss_pred EEEEEEecchh-hHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCC
Q 036673 185 SLYLVFDFMQS-DLTKIICRP---------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSG 248 (469)
Q Consensus 185 ~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 248 (469)
.+++||||+++ +|.+.+... ...+++.++..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 57999999996 666655432 35699999999999999999999999999999999999999999
Q ss_pred cEEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 036673 249 MLKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRIFK 327 (469)
Q Consensus 249 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg-~~pf~~~~~~~~~~~i~~ 327 (469)
.+||+|||+|+...... ......||+.|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+.+..+.+
T Consensus 165 ~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred ceEEccccccccccccc--cccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 99999999998653322 2335578999999999876 4589999999999999999996 567888777766655432
Q ss_pred HhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 328 LCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.. . + .....+++++.+||.+||+.||++|||+.++|++
T Consensus 242 ~~-~---------------------~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GY-R---------------------L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TC-C---------------------C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC-C---------------------C---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 0 0 1234578899999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=382.25 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=201.7
Q ss_pred ccCcceeceeeeeCCeEEEEEEECCCC-------cEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEee
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRDTG-------KIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATS 180 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 180 (469)
.++|++++.||+|+||.||+|++..++ ..||||+++.+.. ......+.+|+.++.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 378999999999999999999986544 4799999976543 44457788899999888 89999999999987
Q ss_pred ccccEEEEEEecchh-hHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 036673 181 RMQYSLYLVFDFMQS-DLTKIICRP---------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLI 244 (469)
Q Consensus 181 ~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl 244 (469)
.. .+++|||||.+ ++...+... ...+++.+++.++.||+.||+|||+++||||||||+|||+
T Consensus 91 ~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 DG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp SS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CC--eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 44 46999999996 555555432 2358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCC-CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHH
Q 036673 245 DKSGMLKIADFGLSNFFIPKQK-GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQL 322 (469)
Q Consensus 245 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~ 322 (469)
+.++.+||+|||+++....... .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999999987644332 23455678999999998876 568999999999999999998 79999887776555
Q ss_pred HHHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 323 HRIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
..+... ..+ .....+++++.+||.+||+.||.+|||+.|+|+
T Consensus 248 ~~i~~~-~~~------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEG-HRM------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTT-CCC------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcC-CCC------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 443221 111 123457899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=383.98 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=207.9
Q ss_pred cCcceeceeeeeCCeEEEEEEEC-----CCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeEeeeEeeccc
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDR-----DTGKIVALKKVRFDTSEPESVKFMAREIRILQKL-DHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 183 (469)
++|++.++||+|+||.||+|++. .+++.||||+++... .......+.+|+.++..+ +|||||++++++.....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 68999999999999999999863 456899999997653 445557788999999999 79999999999977544
Q ss_pred cEEEEEEecchh-hHHHHHhcC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEc
Q 036673 184 YSLYLVFDFMQS-DLTKIICRP-----------------GQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLID 245 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~~-----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~ 245 (469)
++||||||++ ++...+... ...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 102 --~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 102 --TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp --CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred --EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 6999999996 555555432 22589999999999999999999999999999999999999
Q ss_pred CCCcEEEeeecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHH
Q 036673 246 KSGMLKIADFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFI-GRPLMPGRTEVEQLH 323 (469)
Q Consensus 246 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~ 323 (469)
.++.+||+|||+++........ .....+||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999876433322 2345688999999998875 458999999999999999998 788888877767766
Q ss_pred HHHHHhCCCCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 324 RIFKLCGTPSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 324 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
+++.....+ .....+++.+.+||.+||+.||.+|||++|+|+
T Consensus 259 ~~i~~~~~~------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRM------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCC------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCC------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 665432111 112356889999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-49 Score=380.41 Aligned_cols=249 Identities=21% Similarity=0.262 Sum_probs=197.3
Q ss_pred eeceeeeeCCeEEEEEEECCCC---cEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccccEEEEEE
Q 036673 114 KLAKVGQGTYSNVYKARDRDTG---KIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQYSLYLVF 190 (469)
Q Consensus 114 ~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 190 (469)
..++||+|+||+||+|++..++ ..||||+++.. ......+.|.+|+++|.+++|||||+++|++.... ..+++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-CceEEEE
Confidence 3578999999999999987643 36999998643 45566688999999999999999999999887643 3579999
Q ss_pred ecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeeecCcccccCCCCC--
Q 036673 191 DFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADFGLSNFFIPKQKG-- 267 (469)
Q Consensus 191 e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 267 (469)
|||++ ++.+.+......+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99997 555556656667889999999999999999999999999999999999999999999999999876433222
Q ss_pred -CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcccCcc
Q 036673 268 -PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE-VEQLHRIFKLCGTPSEDYWKKMKLTTT 345 (469)
Q Consensus 268 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 345 (469)
......||+.|+|||++.. ..++.++|||||||+||||+||..||..... .+....+... ..+
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~------------- 253 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRL------------- 253 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCC-------------
T ss_pred eecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC-------------
Confidence 2334578999999998875 4589999999999999999997766654433 2333332211 000
Q ss_pred CCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhcC
Q 036673 346 FRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQN 390 (469)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 390 (469)
.....+++++.+||.+||+.||++|||+.|+++|
T Consensus 254 -----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 254 -----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1123568899999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=381.88 Aligned_cols=252 Identities=16% Similarity=0.248 Sum_probs=207.4
Q ss_pred ccCcceeceeeeeCCeEEEEEEECC-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc
Q 036673 109 ADSYDKLAKVGQGTYSNVYKARDRD-----TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ 183 (469)
Q Consensus 109 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 183 (469)
.++|++.+.||+|+||+||+|.+.. ++..||||+++... .......+.+|+.++.+++|||||++++++.....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3789999999999999999998852 35789999997543 44555678999999999999999999999876543
Q ss_pred cEEEEEEecchh-hHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEe
Q 036673 184 YSLYLVFDFMQS-DLTKIICR---------PGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIA 253 (469)
Q Consensus 184 ~~~~lv~e~~~~-~l~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~ 253 (469)
+++|||||.+ ++...+.. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++++||+
T Consensus 98 --~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 98 --TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp --CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred --eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 5999999986 55554432 12347999999999999999999999999999999999999999999999
Q ss_pred eecCcccccCCCCC-CcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCC
Q 036673 254 DFGLSNFFIPKQKG-PLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIG-RPLMPGRTEVEQLHRIFKLCGT 331 (469)
Q Consensus 254 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg-~~pf~~~~~~~~~~~i~~~~~~ 331 (469)
|||+|+.+...... .....++|+.|+|||.+.+ ..++.++|||||||+||||+|| .+||.+.+..+.+..+.+...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~- 253 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 253 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC-
Confidence 99999866433222 2344578999999998876 4588999999999999999998 588988888877776643211
Q ss_pred CCHHHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 332 PSEDYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 ------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1123457889999999999999999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.4e-48 Score=383.17 Aligned_cols=279 Identities=28% Similarity=0.426 Sum_probs=214.3
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-----------CCCeeeEeeeE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-----------HPNVIKLEGLA 178 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~ 178 (469)
++|+++++||+|+||+||+|++..+|+.||||+++.. ....+.+.+|+.+|+.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999999999999999999743 333466788999998875 57899999988
Q ss_pred eeccccEEEEEEecch--hh-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEcCCCc-----
Q 036673 179 TSRMQYSLYLVFDFMQ--SD-LTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE-RGILHRDIKASNLLIDKSGM----- 249 (469)
Q Consensus 179 ~~~~~~~~~lv~e~~~--~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~----- 249 (469)
........+++|+++. ++ ...........+++..++.++.||+.||+|||+ .||+||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 7765555566666554 32 233334455679999999999999999999998 89999999999999987653
Q ss_pred -EEEeeecCcccccCCCCCCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCC------hHHHH
Q 036673 250 -LKIADFGLSNFFIPKQKGPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRT------EVEQL 322 (469)
Q Consensus 250 -~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~------~~~~~ 322 (469)
++|+|||.+..... .....+||+.|+|||++.+ ..++.++|||||||++++|++|++||.... ..+.+
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 99999999986532 2356789999999998886 458999999999999999999999997543 44567
Q ss_pred HHHHHHhCCCCHHHHhhcccCccC----------CCCCCCC------cchhcccCCChhHHHHHHHccccCCCCCCCHHH
Q 036673 323 HRIFKLCGTPSEDYWKKMKLTTTF----------RPQHYKP------SFREVFGEFPPSSYGILTTLLALDPAYRGTAAS 386 (469)
Q Consensus 323 ~~i~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~e 386 (469)
..++..++.++...+........+ ......+ .........++.+.+||.+||++||.+||||.|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 777888888877766553321111 0000000 001112234678999999999999999999999
Q ss_pred HhcCccCCCC
Q 036673 387 ALQNEFFNAS 396 (469)
Q Consensus 387 lL~hp~f~~~ 396 (469)
+|+||||+..
T Consensus 325 ~L~Hp~f~~~ 334 (362)
T d1q8ya_ 325 LVNHPWLKDT 334 (362)
T ss_dssp HHTCGGGTTC
T ss_pred HhcCcccCCC
Confidence 9999999964
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5e-48 Score=372.71 Aligned_cols=252 Identities=20% Similarity=0.261 Sum_probs=205.5
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC-CCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDH-PNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~~l 188 (469)
++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|++++..|.| +||+.+++++... ...++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecC--CccEE
Confidence 6899999999999999999999999999999998654332 346689999999965 8999998887664 45699
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcC-----CCcEEEeeecCcccccC
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDK-----SGMLKIADFGLSNFFIP 263 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~~ 263 (469)
||||+++++...+...+..+++..+..++.|++.||+|||++||+||||||+||||+. ++.+||+|||+|+.+..
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999999998888777778999999999999999999999999999999999999974 57899999999987643
Q ss_pred CCC------CCcccccccCccccchhccCCCCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCH
Q 036673 264 KQK------GPLTSRVVTLWYRAPELLLGSTDYGVGIDLWSAGCLLAEMFIGRPLMPGRTE---VEQLHRIFKLCGTPSE 334 (469)
Q Consensus 264 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~ 334 (469)
... ......+||+.|||||++.+ ..++.++|||||||++|||++|..||.+... .....++.....
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~---- 233 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ---- 233 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH----
T ss_pred CccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC----
Confidence 321 12345689999999998876 5689999999999999999999999986543 233333322110
Q ss_pred HHHhhcccCccCCCCCCCCcchhcccCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 335 DYWKKMKLTTTFRPQHYKPSFREVFGEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.....+....+|+++.+||..|+..+|.+||+.+.+.+
T Consensus 234 -----------------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 234 -----------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -----------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01123445568899999999999999999999776543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=372.23 Aligned_cols=267 Identities=24% Similarity=0.244 Sum_probs=189.1
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeEeeeEeeccc--cEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNVIKLEGLATSRMQ--YSLY 187 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~~~ 187 (469)
.+|.+.+.||+|+||+||+|++. |+.||||++.... ........|+..+..++|||||++++++..... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 56889999999999999999874 8999999986431 211222345555567899999999999976543 3689
Q ss_pred EEEecchh-hHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCcEEEcCCCcEEEeeecCc
Q 036673 188 LVFDFMQS-DLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE--------RGILHRDIKASNLLIDKSGMLKIADFGLS 258 (469)
Q Consensus 188 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~~ivHrDlkp~NILl~~~~~~kl~DFGla 258 (469)
||||||.+ +|...+.+ ..+++..+..++.|++.||+|||+ +||+||||||+||||+.++.+||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999986 66666654 359999999999999999999996 59999999999999999999999999999
Q ss_pred ccccCCCC---CCcccccccCccccchhccCCC-----CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 036673 259 NFFIPKQK---GPLTSRVVTLWYRAPELLLGST-----DYGVGIDLWSAGCLLAEMFIGRPLMPGRTEVEQLHRIFKLCG 330 (469)
Q Consensus 259 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 330 (469)
........ ......+||+.|+|||++.+.. .++.++|||||||+||||+||.+||............ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~ 234 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPS 234 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-cccc
Confidence 87644332 1234578999999999886532 2567899999999999999999887543221100000 0000
Q ss_pred CCCHHHHhhcccCccCCCCCCCCcchhcc--cCCChhHHHHHHHccccCCCCCCCHHHHhc
Q 036673 331 TPSEDYWKKMKLTTTFRPQHYKPSFREVF--GEFPPSSYGILTTLLALDPAYRGTAASALQ 389 (469)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 389 (469)
.+........... ....|.+.... ......+.+||.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~-----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 235 DPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTT-----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhc-----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0111111110000 11112221111 122345889999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.6e-26 Score=207.18 Aligned_cols=166 Identities=17% Similarity=0.140 Sum_probs=121.5
Q ss_pred cceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCC----------------HHHHHHHHHHHHHHHhCCCCCeeeEe
Q 036673 112 YDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSE----------------PESVKFMAREIRILQKLDHPNVIKLE 175 (469)
Q Consensus 112 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~hpnIv~~~ 175 (469)
|.+.++||+|+||+||+|++. +|+.||||+++..... .........|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457889999999999999986 5899999987542110 11123455789999999999999886
Q ss_pred eeEeeccccEEEEEEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEcCCCcEEEeee
Q 036673 176 GLATSRMQYSLYLVFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHERGILHRDIKASNLLIDKSGMLKIADF 255 (469)
Q Consensus 176 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~kl~DF 255 (469)
++. .. +++|||+++.... .++...+..++.||+.+|+|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~----~~--~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWE----GN--AVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEE----TT--EEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred Eec----CC--EEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 542 11 7999999985433 24556677899999999999999999999999999999865 4899999
Q ss_pred cCcccccCCCCCCcccccccCcccc------chhccCCCCCCccccchhhHHHH
Q 036673 256 GLSNFFIPKQKGPLTSRVVTLWYRA------PELLLGSTDYGVGIDLWSAGCLL 303 (469)
Q Consensus 256 Gla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~DvwslGv~l 303 (469)
|+|........ ..|.. .+.+. +.|+..+|+||+.--+
T Consensus 147 G~a~~~~~~~~---------~~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW---------REILERDVRNIITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH---------HHHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc---------HHHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence 99976421110 01111 12221 4578999999976433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.45 E-value=2.6e-07 Score=84.41 Aligned_cols=140 Identities=16% Similarity=0.115 Sum_probs=87.4
Q ss_pred cCcceeceeeeeCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeEeeeEeeccccEEEE
Q 036673 110 DSYDKLAKVGQGTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLD-HPNVIKLEGLATSRMQYSLYL 188 (469)
Q Consensus 110 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~l 188 (469)
..|+.++..+.++.+.||+... ++..++||+........ ...+.+|..++..|. +--+.+++.+.... ...++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEE
Confidence 4577777666666679998864 36678888875432211 124567888887773 32355666555543 44689
Q ss_pred EEecchhhHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 036673 189 VFDFMQSDLTKIICRPGQKLTEPQVKCYMQQLLSGLQHCHE--------------------------------------- 229 (469)
Q Consensus 189 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------------------------------------- 229 (469)
||++++|......... ......++.++...|+.||+
T Consensus 88 v~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 9999998544322111 11122233444444444442
Q ss_pred --------------C------CceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 230 --------------R------GILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 230 --------------~------~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
. .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 279999999999999876677999998863
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=2.2e-06 Score=83.15 Aligned_cols=77 Identities=16% Similarity=0.163 Sum_probs=47.4
Q ss_pred eceeeeeCCeEEEEEEECCCCcEEEEEEeecC-----CCCHHHHHHHHHHHHHHHhC-CC--CCeeeEeeeEeeccccEE
Q 036673 115 LAKVGQGTYSNVYKARDRDTGKIVALKKVRFD-----TSEPESVKFMAREIRILQKL-DH--PNVIKLEGLATSRMQYSL 186 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~E~~~l~~l-~h--pnIv~~~~~~~~~~~~~~ 186 (469)
.+.||.|....||++.+..+++.|+||.-... ..-+........|.++|..+ .+ ..+.+++.+ +....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~-- 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA-- 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT--
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCC--
Confidence 45689999999999998877889999975321 11111223455688888766 22 345666443 33333
Q ss_pred EEEEecchh
Q 036673 187 YLVFDFMQS 195 (469)
Q Consensus 187 ~lv~e~~~~ 195 (469)
++|||++.+
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 799999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=8.3e-06 Score=73.60 Aligned_cols=70 Identities=11% Similarity=0.065 Sum_probs=45.2
Q ss_pred eeeeCC-eEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC--CeeeEeeeEeeccccEEEEEEecch
Q 036673 118 VGQGTY-SNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHP--NVIKLEGLATSRMQYSLYLVFDFMQ 194 (469)
Q Consensus 118 lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~~~lv~e~~~ 194 (469)
+..|.. +.||+.... ++..+++|....... ..+..|+.+|+.|... .+.+++.+..+. ...++||++++
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeee
Confidence 444543 679998764 467788897654322 2356788888777332 345666555443 34689999998
Q ss_pred h
Q 036673 195 S 195 (469)
Q Consensus 195 ~ 195 (469)
|
T Consensus 90 G 90 (255)
T d1nd4a_ 90 G 90 (255)
T ss_dssp S
T ss_pred c
Confidence 7
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.51 E-value=0.0001 Score=69.10 Aligned_cols=71 Identities=18% Similarity=0.197 Sum_probs=42.6
Q ss_pred eCCeEEEEEEECCCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-----eeEeeeEeeccccEEEEEEecchh
Q 036673 121 GTYSNVYKARDRDTGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV-----IKLEGLATSRMQYSLYLVFDFMQS 195 (469)
Q Consensus 121 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~~~~~lv~e~~~~ 195 (469)
+.--.||++...+ |..|++|+.+..... ..++..|+..|..|....| +..-+-.........+.+++++.|
T Consensus 33 s~EN~vy~v~~~d-g~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQDED-RRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECCTT-CCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEcCC-CCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 3346899998754 888999998754333 2556778888887742222 111111111113345788998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.29 E-value=0.00026 Score=68.13 Aligned_cols=71 Identities=15% Similarity=0.212 Sum_probs=48.0
Q ss_pred eceeeeeCCeEEEEEEECC-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeEeeeEeeccccEE
Q 036673 115 LAKVGQGTYSNVYKARDRD-------TGKIVALKKVRFDTSEPESVKFMAREIRILQKLDHPNV-IKLEGLATSRMQYSL 186 (469)
Q Consensus 115 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~ 186 (469)
++.|+.|-.-.+|++.... ..+.|.+++.- ..... ....+|..+++.+.-.++ .++++++. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~--~---- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETE---SHLVAESVIFTLLSERHLGPKLYGIFS--G---- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCH---HHHHHHHHHHHHHHHTTSSSCEEEEET--T----
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccchh---hHHHHHHHHHHHHHhCCCCCeEEEEcC--C----
Confidence 3578889999999998754 24567788764 22222 235579999998843344 46765543 2
Q ss_pred EEEEecchh
Q 036673 187 YLVFDFMQS 195 (469)
Q Consensus 187 ~lv~e~~~~ 195 (469)
.+|+||++|
T Consensus 117 g~I~efi~g 125 (395)
T d1nw1a_ 117 GRLEEYIPS 125 (395)
T ss_dssp EEEECCCCE
T ss_pred ceEEEEecc
Confidence 689999986
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.22 E-value=0.0022 Score=59.13 Aligned_cols=31 Identities=19% Similarity=0.351 Sum_probs=27.6
Q ss_pred CCceeccCCCCcEEEcCCCcEEEeeecCccc
Q 036673 230 RGILHRDIKASNLLIDKSGMLKIADFGLSNF 260 (469)
Q Consensus 230 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 260 (469)
.|+||+|+.++|||++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999887778999998864
|